
(IN-PACKAGE :SP)
(DEFPARAMETER SPARSER::*NS-RD-PHASE3-9301-9600*
  '(".475+1G" ".476−2A" ".4986+1G" ".4986+5G" ".4987−1G" ".5278−2delA"
    ".5332+1G" ".547+2T" ".7008−2A" ".8754+3G" ".8755−1G"
    ".8954−1_8955delGTTinsAA" "3NT" "A+A" "A+B" "A-601G" "A-C" "A-C3435T"
    "A-Cdk2" "A-D" "A-Site" "A-T" "A-allele" "A-c" "A-expressing" "A1"
    "A11156C" "A1669V" "A166A" "A1A1" "A1A2" "A1GATG" "A1GTAG" "A1–A4" "A2"
    "A24622T" "A2A1" "A2A2" "A2G1" "A2G2" "A2GATA" "A2GTAA" "A312P" "A375M"
    "A375P" "A391" "A391E" "A4" "A431or" "A49-mediated" "A49-β-TrCP" "A49R"
    "A5780G" "A647-labeled" "AA-HUF" "AA-HUFs" "AA-II" "AA-UUT" "AA-UUTs"
    "AAAKE" "AAGE" "AAII" "AALEALAEALEALAEALEALAEAAAA" "AATNRPNS" "AAV-Pin1"
    "AAV-Pin1-treated" "AAV-cont" "AAV2-Ang" "AAV2-GFP" "AAV2-angiogenin"
    "AAV9" "ABCF" "ABCF2-SMARCD3" "ABK" "AC93253" "ACCTGGAGGGCTGGGG"
    "ACF7-CCKVL" "ACRN" "AD-like" "ADAM-12" "ADAM-TS4" "ADP-ribozyl" "AEB071"
    "AF-1a" "AF-1b" "AFB1" "AFC" "AG+GG" "AG1463" "AG17" "AGA=11"
    "AGE-BSA-stimulated" "AGEs-enhanced" "AGEs-induced" "AIQ" "AJCC" "AKAP2"
    "AKT-dependent" "AKT-pS473" "AKT-pT308" "AKT2-mediatd" "AKTp308" "AKTp473"
    "ALDH1-positive" "ALDH−cells" "ALMS1" "ALSPAC" "AMIRA" "AML-M5" "AMM"
    "AMP+ADP" "AMPK-specific" "AMPK-β" "AMPKα2" "AMPKγ1" "AMRFARRS" "AOR"
    "AORs" "AP-1sites" "AP-2a" "APOBEC3C" "APP695" "APP695wt"
    "APP751-wild-type" "APP751wt" "APPswe" "APu" "AQQ" "AR-1" "AR-2" "AR-441"
    "AR-A04418" "AR-V4" "AR-antagonist" "AR-cofactor" "AR-immunoprecipitate"
    "AR-interactor" "AR-occupancy" "ARE-mediated" "ARG1" "ARG426" "ARMSs"
    "ARN509" "ARQ197" "ARRDC1-5" "ARV6" "ARVC" "ARVs" "AS-qPCR" "ASCO" "ASDs"
    "ASSET" "AST-120" "ASZ001" "AT-hook" "AT180" "ATM-Chk2-BRCA1-dependent"
    "ATM-ITCH-dependent" "ATM-pathway" "ATM-proficient" "ATMi" "ATP-Mg"
    "ATR-107" "ATR-107-A647" "ATR-Chk1-BRCA1" "ATR-Seckel" "ATR-defective"
    "ATR-mediated" "ATR-proficient" "ATTG" "AUC=0.67" "AUC=0.75" "AUS" "AV-45"
    "AVM" "AVMs" "AZD" "Abbott" "Abbud" "Abd-Allah" "Abelson" "Ac-DEVD-AFC"
    "Ac-FOXO1" "Ac-IETD-AFC" "Ac-LEHD-AFC" "AcH4" "AcK40" "Acaca" "Acetyl-FOXO"
    "Achilles" "Acinar-ductal" "AcoA" "Actin" "Activaton" "Activin-like"
    "Ad-Cre" "AdGFP" "AdPKC" "Affymetrix" "Africa" "African" "African-American"
    "African-Americans" "Afro-Caribbean" "Agata" "Aggregatibacter" "Ahn"
    "Akirins" "Akt-Foxo1" "Akt-S473-P" "Akt-Ser473-P" "Akt-dependent"
    "Akt-resistant" "Akt-substrate" "Alcohol-fed" "Aldefluor-negative"
    "Aldefluor-positive" "Aldrich" "Alexa" "Alexa647-labeled" "Alezheimer"
    "Align-GVGD" "Allah" "Allele-G" "Almeida" "Alonso" "Alstrom" "Alzheimer"
    "Alzheimer's" "Alzheimers" "Alzheimer’s" "America" "American" "Americans"
    "Amersham" "Ametrine" "Amgen" "Amplex" "AmpliChip" "Amsterdam" "Amstutz"
    "Amutations" "Amyvid" "Androgen-deprivation" "Ank-SH3-binding"
    "AnnexinV-FITC–positive" "Anselmi" "Antikörper" "Aoyaji" "Ap160"
    "Apico-basal" "Aplinia" "Arellano" "Arellano-Rodrigo" "Arg-Arg-Thr"
    "Arg-Gln-Met" "Arg194Trp" "Arg280His" "Arg399Cln" "Arg399Gln" "Argentina"
    "Arginine-phosphate" "Aristolactam-DNA" "Aristolochia" "Arizona" "Arkansas"
    "Arm-motif" "Arnold" "Arnold–Chiari" "ArrayExpress" "Ashkenazi"
    "Asia-Pacific" "Asian" "Asians" "Asma" "Astle" "Astra" "Astra-Zeneca"
    "Australia" "Auto-binding" "Auwerx" "Avon" "Axiophot" "A–T" "B+A" "B+B"
    "B-Site" "B-a" "B-b" "B-c" "B-factors" "B-form" "B-lineage" "B-type" "B1"
    "B16a" "B2" "B30.2" "B6" "B7" "BAADT" "BALB" "BALF1" "BAPTA-AM" "BART16"
    "BART5" "BARTs" "BAVMs" "BCL-9L" "BCL2-family" "BCL2-like" "BCLb"
    "BCR-ABL1-STAT5" "BFDiv" "BGJ" "BGJ-398" "BH1–BH2" "BH3-only" "BHRF1" "BHT"
    "BIM-extra" "BJ" "BLOCK-iT" "BMES" "BMIs" "BMI≥30" "BML" "BML-266" "BMMb"
    "BMMbs" "BPM" "BR21" "BRCA1-null" "BRCA1Aassociated" "BRCA2-siRNA" "BRCAx"
    "BSXB" "BT25" "BU" "BU-32" "BV" "BVS" "Ba" "Background" "Bagnoli" "Baier"
    "BakKO" "Balagopalan" "Balkan" "Balkans" "Baltimore"
    "Bannayan-Riley-Ruvalcaba" "Bao" "Baorong" "Barnes" "Barr" "Barrett"
    "Barrett’s" "Barrier-protective" "Barta" "Bastos" "Baugher" "Bcl"
    "Bcl-2-modulatory" "Bcl-xl" "BeadChip" "BeadChips" "Begg" "Begg's" "Begg’s"
    "Belgium" "Belgrade" "Bellizzi" "Bem1p" "Benigni" "Bentink" "Bethesda"
    "BiP-KDELR1-mediated" "Bianchi" "Bid" "Bid-Alexa" "Bifidobacterium"
    "BigBlue" "Bindl" "Binp-3L" "Binp3L" "Bioneer" "Biosystems" "Bis" "Black"
    "Blackburn" "Bloom-Richardson" "BlueGnome" "Boc-D-fmk" "Boltzmann"
    "Bonferoni" "Bonferrini" "Bonferroni" "Bonome" "Boolean" "Boston" "Boyden"
    "Brazil" "Brca2-null" "BrdUrd" "Breakes" "Breslow" "Brian" "British"
    "Brocklin" "Brookes" "Bruggen" "Brunet" "Brustmann" "Budnicka" "Bulingame"
    "Bunz" "Burkiewicz" "Burkitt" "Burkitt’s" "Burnichon" "Bzm" "B–D" "C-152T"
    "C-3" "C-4" "C-5" "C-A" "C-BLM" "C-ERB" "C-G" "C-Site" "C-allele" "C-helix"
    "C-labeled" "C-lobe" "C-lobes" "C-terminally" "C-theta" "C-type" "C-θ" "C1"
    "C1236T-G2677T" "C129129SvJae" "C12orf75" "C1654X" "C17-sphingosine"
    "C19orf21" "C1B" "C2" "C22∶0" "C24∶0" "C26∶0" "C26∶1" "C3H" "C57" "C57BJ"
    "C57BL6" "C6" "C6-originated" "C6orf204" "CA1D" "CAP" "CARD1" "CARD2"
    "CB-17" "CBFα1" "CBS4" "CC+CT" "CC-homozygote" "CCA-IMT" "CCAAT" "CCALD"
    "CCDN1" "CCL21-overlaid" "CCND1expression" "CCRL5" "CCT036477" "CD21hi"
    "CD24-null" "CD28-stimulated" "CD3-complexes" "CD34-LSKs" "CD3γ"
    "CD40L-dependent" "CD40L-mediated" "CD41+CD42" "CD41+c-Kit" "CD44v6"
    "CD45R" "CDB3" "CDE" "CDK-phosphorylation-mediated" "CDKN2BAS" "CE1-3"
    "CE5" "CEACAM1-HK2A" "CEACAM1-L" "CEAS" "CEP17" "CEP7" "CEPH" "CG11660"
    "CG11859" "CGC" "CGG" "CGP049090" "CH11" "CHAM4b" "CHB+JPT" "CHC007100"
    "CHC1L" "CHEK1+AR-LYN" "CHIP-interacting" "CHO9" "CHRF" "CI=1.01-1.81"
    "CIPI" "CK-II" "CKDGen" "CKS-17" "CL-GUVs" "CL-protein" "CLEs" "CLMP1"
    "CLMP2" "CLOVES" "CM-H2-DCF-DA" "CMN-like" "CMY" "CNNM2" "CNS2" "CNS3"
    "CNSs" "CNTROB" "CNV" "CNVs" "COH" "CONH" "COOH-group" "CP-690550" "CP13"
    "CPHD3" "CPMG" "CR5" "CRHR-2" "CRM1-that" "CROATIA" "CROATIA-Korcula"
    "CROATIA-Vis" "CRR2" "CRs" "CS-RPMI1640" "CSOS" "CT+TT" "CTCs" "CTG" "CTPP"
    "CTTTG" "CTTTGCT" "CUL4B-RNAi" "CW" "CWR22Pc" "CWR22R3" "CXCL" "CXCL-9"
    "CXR" "CXR9" "CaMKKβ" "Caenhorhabditis" "Cajal-Retzius" "Cal" "Calbiochem"
    "Calcusyn" "Calmette" "Calmette-Guérin" "Cambridge" "Campbell" "Canada"
    "Cancino" "Cang" "Capitani" "Cardiac-specific" "Cardio-facio-cutaneous"
    "Cardno" "Caribbean" "Carpinteria" "Carreira" "Cascón" "Caseine"
    "Caspase-8" "Castration-resistant" "Cat" "Caucasians" "Cav-1-shRNA" "Cbfα1"
    "Cdc-6-dependent" "Cdc14-like" "Cdc42" "Cdc48" "Cdk4DN" "CellTiter"
    "CellTiter-Blue" "Cengiz" "Cer2" "Cer5" "CerS" "ChIP-clone" "ChIP-grade"
    "ChIP–PCR" "Chang" "Chang-xi" "Charafe" "Charafe-Jauffret"
    "Chemotherapeutic-induced" "Chemscore" "Cheng" "Chi-Square" "Chi-square"
    "Chiari" "Childrens" "Chisari" "Chk1-Chk2-mediated"
    "Cholesterol-interference" "Chou" "Chou-Talalay" "Chq" "Christoffers"
    "Chung" "Cip" "Cis-eQTL" "Cis-regulatory" "Cl" "CldU" "ClinicalTrials"
    "Clippinger" "Cluster-2-related" "Cl " "Coarse-grain"
    "Cochran-Mantel-Hanzel" "Cohen" "ColIAI" "Cold-inducible" "Cole"
    "Collagenase-1" "College" "Colombini" "Combes" "Comino" "Comino-Mendez"
    "ConcanavalinA" "ConceptGen" "Conclusions" "Convection-enhanced"
    "Coomassie" "Coombs" "Core" "Core-fucose" "Core-fucosylation" "Costello"
    "Cowden" "Cowdin" "Cox-proportional" "Crb3–HA–PKCι" "Cre" "Crohn" "Crohn's"
    "Crohn’s" "Cross-Disorder" "Cross-sectional" "Cross-validation" "Crouzon"
    "Cruz" "Cryptochrome" "CtIP-12A-CDK" "CtIP-3A-ATM" "CtIP-5A-CDK"
    "CtIP-750-897" "CtIP-7A-CDK" "CtIP-8A-ATM" "CtIP-8E-ATM" "CtIP-CDK-12A"
    "CtIP-S231A" "CtIP-S506A" "CtIP-S664A" "CtIP-T847A" "Ctr-Fop" "Ctr-Top"
    "Cul5–EloB" "Cullin-RING" "Cullin–RING" "Cusi" "Custodio" "Cy3-to-Cy5"
    "Cy5-labeled" "CyclinD1and" "Cypriot" "Cys-box" "CytoChip" "CytoSelect"
    "CytoTox" "CytoTox-One" "Cytopathology" "Cytoscape" "Czech" "Cα" "Cβ" "C–E"
    "C→T" "D-F" "D-L" "D-box" "D-like" "D-loop" "D-prime" "D-type" "D10S210"
    "D10S537" "D1a" "D1–D4" "D2" "D2R" "D2S" "D2S-activated" "D2autoR"
    "D2autoRs" "D3" "D3R-DAT" "D5Z1" "D5Z2" "D7-1" "DACH1-cell-cycle" "DACH1ΔC"
    "DAF-fluorescent" "DAF-reactive" "DAFs" "DAKO" "DAT-D2S-N2A" "DAVID"
    "DBTRG" "DCFH" "DDB-XPC" "DDB2-defective" "DDI2" "DEST" "DEVD-ase" "DEXA"
    "DExD" "DFCI" "DGR" "DH+IS" "DHPLC" "DINNN" "DIPGs" "DIRT" "DK" "DK-SFM"
    "DKK1expression" "DLCBCL" "DMAG" "DMBI" "DN+IS" "DNA-DSB" "DNA-PK-cs"
    "DNA-binding" "DNA-damage-induced" "DNA-histone" "DNA-protein" "DNaseI"
    "DNp53" "DO7" "DOPAC" "DOPC-CL" "DPO" "DPP3-competition" "DRAK" "DRFs"
    "DS-AMKL" "DS-TMD" "DSBs" "DSGX" "DW" "DXA" "Dabbs" "Daejeon" "Dahl"
    "Daiane" "Daitoku" "Dalken" "Damage-induced" "Dana" "Dandy–Walker" "Daniel"
    "Danish" "Danube" "Darby" "Daten" "Dauer" "Dauno" "Daunorubicin" "Davis"
    "Debrecen" "Dehari" "DeltaNp73" "DenV" "Deng" "Descemet" "Detroit"
    "DharmaFECT" "Dharmacon" "Dhh-Cre" "DiGeorge" "Dick" "Diego" "Differenz"
    "Dikshit" "Dimri" "Dittert" "Divaris" "Dohme" "Double-Strand"
    "Double-strand" "Down-expression" "Dox" "Drug-gene" "Druker" "Ds" "Ds-red"
    "Dscam" "Dsi-HOXB7" "Dsi-PBX2-transfected" "Dsi-PBX2-treated"
    "Dsi-RNA-mediated" "Dual-immunofluorescent" "Dual-transfection" "Dulbecco"
    "Dulbecco's" "Dulbecco’s" "Dunn" "Duolink" "Dustin" "Dutch" "Duval" "D–F"
    "E-box" "E-boxes" "E-cadherin" "E19" "E21" "E3-Ub" "E3-Ubiquitin"
    "E3-ubiquitin" "E355A" "E377Q-NOS2-Flag" "E377Q-NOS2-overexpressing" "E4"
    "E5.5-8.5" "E5–6" "E74-like" "E746_A750" "E746_A750del"
    "E746_A750del-specifiac" "E746_A750del-specific" "E9" "EBERs" "EBP's"
    "EC-33" "ECAMs" "ECOG-033" "ED" "ED75" "ED75-ED90" "ED75∶0.39202" "ED90"
    "ED90∶0.55992" "EF7KO" "EF7WT" "EFGR" "EGF-R" "EGF-like" "EGFR-CD533"
    "EGFR-TK" "EGFR-Y1068-P" "EHop" "EHop-016" "EIF" "EIF-4E" "EIKONA3D"
    "ELISAs" "ELKF" "ELTDLP" "EM-C12" "EM9-V" "EM9-XH" "EMCI" "EMCV-RNA" "EMCs"
    "EMRs" "EMT-like" "ENF" "EPDC" "EPDCs" "EQ" "ER-negative" "ER-positive"
    "ER-resident" "ERC2" "ERE" "ERMS" "ERalphaSer118" "ERalphaSer294"
    "ERalphaSer294Ala" "ER–Golgi" "ESCRT" "ESGE" "ESHG" "ESR1-negative"
    "ESR1-positive" "ESRα" "ESRβ" "ETGE" "ETGE-deletion" "ETS-fusion"
    "EUFA1341" "EURTAC" "EUS" "EUS-FNA" "EVG" "Early-onset" "Early-passage"
    "Early-stage" "East-Asia" "Ebina" "Ebox" "Efimenko" "Egger" "Egger's"
    "Egger’s" "Eigenstrat" "Eight-week-old" "Eighty-five" "Elav-like" "Elf-1"
    "Elheiga" "EndMT" "Endo-H" "EndoH" "EndoS" "Endolysosomes"
    "Endothelial-to-Mesenchymal" "England" "English" "Enterococcus" "Entrez"
    "Epithelial-mesenchymal" "Epithelial-to-Mesenchymal" "Epstein"
    "Epstein–Barr" "Eramo" "ErbA" "ErbB2-mediated" "Erg" "Erk5" "Escudero"
    "Est2p" "Est2p's" "Etats" "Etoposide→cPARP" "Ets-family" "Euplotes"
    "Europe" "European" "European-American" "European-descent" "Europeans"
    "Evans" "Everhard" "Ewan" "Exo1" "Eμ" "Eμ-myc" "E–H" "F-C-A-M" "F-labeled"
    "F-x-x-R" "F1" "F2" "F3-FLT3-ITD" "F3p185" "F3p210" "FA2" "FA2G2" "FA2G2S1"
    "FAK-CD" "FAKsiRNA" "FANCD2-null" "FASL" "FBH" "FBH1–bio" "FBX015"
    "FC=1.19" "FC=1.57" "FC=1.76" "FEN" "FERM" "FEV1" "FGFR2-IIIb-1"
    "FGFR2-IIIb-2" "FHA" "FIGO" "FISH-positivity" "FITC-BSA" "FJH" "FK2" "FLAG"
    "FLAG-AMPKαβγ" "FLAG-AMPKγ" "FLAG-M2" "FLAG–USP52" "FLEX" "FLICE-like"
    "FLIP-L" "FLT3-ITD" "FLT3-ITD-dependent" "FLT3-ITD-driven"
    "FLT3-ITD-expressing" "FLT3-ITD-induced" "FLT3-ITD-mediated"
    "FLT3-ITD-positive" "FLT3L" "FLT3L→pS6" "FNA" "FOLFIRINOX" "FOPFLASH"
    "FOSL" "FP7" "FRP5" "FRY" "FT4" "FUNCTION" "FVC" "FXBO15" "Fabp4-Cre"
    "Factor-kB" "FancE" "FancI" "Farber" "Faul" "Favier" "Fbw"
    "Fbw8-substrate-targeting" "FcgRIIβ" "FcγRIIb" "Fe" "Fe-NTA"
    "Fe-NTA-induced" "FeLV" "Feed-back" "Felini" "Feo" "Fertility"
    "Fibroblast-like" "Fifty-one" "Fig.S2c–f" "Figure1A" "Figure1B" "Finnish"
    "Fiore" "Firestein" "First-degree" "Fischer" "Fl-n-src" "Flachsbart" "Flag"
    "Flag-IP-western" "Flag-MBP-1-expressing" "Flag-MBP-1-transfected"
    "Flag-agarose" "Flag-mtFANCD2" "Flag-p110β-CAAX" "Flag-p38β"
    "Flag-wtFANCD2" "Fleiss" "Flow-cytometry" "FluoroBlok" "Fms-like" "Fn"
    "Follow-up" "Fop-Flash" "Forty-five" "Forty-three" "FosL" "Fourier"
    "Fourty" "Fourty-eight" "Foy" "Fra-1" "Framingham" "France" "Francisco"
    "Frankel" "Fraumeni" "French" "Frescas" "Fucci" "Fugger" "Fujita" "Fukutin"
    "Full-heritage" "Furrie" "Furukawa" "Furukawa-Hibi" "FxxLF" "FynTyr213"
    "Fälle" "Färbung" "G+C" "G-BLM" "G-Lisa" "G-Rh2" "G-Rh2-induced"
    "G-Rh2-promoted" "G-allele" "G-banding" "G-overhang" "G-rich" "G-tube" "G0"
    "G0FN" "G0N" "G0–G1" "G1" "G1-arrest" "G1FN" "G1GTAG" "G1N" "G2" "G2677T"
    "G272V" "G2F" "G2GTAA" "G2N" "GA+AA" "GACRS" "GADD45β" "GADD53" "GAS2L1"
    "GAS2L3" "GATA1s" "GATHER" "GBM-10" "GBM-6" "GBM-like" "GBM10" "GBM301"
    "GBM39" "GC-box" "GCGGG" "GCN" "GCS" "GCSm" "GEA" "GEF-dead"
    "GEF-dependent" "GEF-expressing" "GEF-mediated" "GEFOS" "GEF–GTPase"
    "GEF–GTPase–nucleotide" "GEM-metabolism-related" "GEMI2" "GEMI4" "GEMI5"
    "GENECARDS" "GERxW" "GFAP-RNA" "GFAP-immunoreactive"
    "GFAP-immunoreactivity" "GFP-CYLD-C" "GFP-Ets-1-transfected" "GFP-PF"
    "GFP-dim-Ds-red-pos" "GFP-mt-pol" "GFP-reporter" "GFP-α-tubulin"
    "GFP–Crb3-expressing" "GFP–DCP1A-positive" "GG" "GGGAA" "GGGAACT" "GGGGK"
    "GGO" "GGO-414" "GGO-441" "GLC1Q" "GLY505" "GNPs" "GOBO" "GOG-172"
    "GOG-252" "GOI" "GRO-α" "GSD13" "GSD5" "GSE13030" "GSE1349" "GSE21034"
    "GSE4142" "GSK-2256098" "GST-CtIP-His" "GST-PRMTs" "GST-R5BD" "GST-VRK2A"
    "GST-WW" "GST-agarose" "GST-fusion" "GST-fusion-cytoplasmic" "GST-pull"
    "GST-pull-down" "GST-pulldown" "GST-tag" "GSTLYN" "GST–Par6β" "GTGGGCG"
    "GTPGDP" "GTPase–nucleotide" "GUVs" "GV" "GVGD" "GWAS-meta-analysis"
    "GWASs" "GXZ" "Gadd45α" "Gain-of-function" "Gajate" "Gallen" "Gallyas"
    "Gandhirajan" "Gas2l" "Gas2l1" "Gas2l2" "Gas2l3-DM1" "Gas2l3-DM2"
    "Gas2l3-DM3" "Gas2l3-DM4" "Gata1s" "Gatekeper" "Geboes" "Gegensatz"
    "Gelman" "Genbank" "Gender-specific" "GeneChip" "Genes-16" "Genetics"
    "GenoMEL" "Genomatix" "Genome-Wide" "Genome-wide" "Genotypes" "Gentrain"
    "GeparQuattro" "GeparQuinto" "GeparSixto" "GeparTrio" "German" "Germans"
    "Germany" "Gerota" "Giallongo" "Giannakou" "Gibco" "Giemsa" "Gillum"
    "Giovanni" "Gleason" "Gli-1" "Gli1" "Gln399Gln" "Glut4-storage" "Glutanine"
    "Glu→Ala" "Gly-TLR2" "Gly-TLR4" "GlyTLR4" "GoldScore" "Google" "Goosecoid"
    "Gothenburg" "GraFix" "Graft-Versus-Host-Disease"
    "Graft-Versus-Host-Disease(GVHD)" "Gram-negative" "Grb" "Grb2i"
    "Green–conjugated" "Greider" "Group-M" "Gu" "Guarente" "Gudmundsson"
    "Guerrero" "Guérin" "Gy" "Gα" "Gα-GTP" "Gβγ" "G–C" "G→A" "G→T" "H&E"
    "H-2DG" "H-L" "H-SB2" "H-TdR" "H-bond" "H-thymidine"
    "H-thymidine-incorporation" "H1" "H1-hESC" "H1–H5" "H2" "H2A-X" "H3"
    "H37Rv" "H3K27" "H3R17" "H4" "H459E" "H45A" "H469A" "H4K" "H4K16" "H4K16ac"
    "H4K20" "H4R17" "H4ac" "H5" "H538A" "H8" "H9" "HA-DAT-FLAG-D2S-N2A"
    "HA-FAK-pcDNA3" "HA-UB" "HA-Ub" "HA-c-Myb-immunoprecipitates" "HA-α-SNAP"
    "HA5-hTERT-V791Y" "HA5-hTERT-W930F" "HAART-associated" "HAF" "HAP-1a"
    "HASMC" "HASMCs" "HA–PKCι" "HBV-DNA-positive" "HBVGN" "HCC-EV" "HCG" "HCGβ"
    "HCV1a" "HCV1a-persistently" "HCV1a-replication" "HCV2a" "HD11-C3"
    "HDAC1-mediated" "HDMEC" "HECT-E3-Ubiquitin" "HEK293-FLT3-ITD" "HEL-299"
    "HEL-299s" "HEL-TERT-T" "HELLP" "HER-positive" "HER2-negative"
    "HER2-positive" "HERpositive" "HG-U133" "HGGs" "HI0180" "HIF-α" "HIF-β"
    "HIF1&alpha" "HIS" "HJL" "HL-60_EVI1" "HL-60_vec" "HL7702" "HLA-A2" "HME-1"
    "HNE-p53" "HNE-p53-positive" "HNMPA" "HNRNPA" "HNRNPA3P1-LOC100130539"
    "HNSCCs" "HNT-34" "HO33342" "HOMO-LUMO" "HON4917G" "HPLC-MS" "HPS70" "HPSG"
    "HPT-axis" "HR=0.03" "HR=0.07" "HR=0.67" "HR=0.68" "HR=0.80" "HR=0.95"
    "HR=0.97" "HR=0.98" "HR=1.2" "HR=1.30" "HR=1.46" "HRpQCT" "HR = 0.68"
    "HR = 0.95" "HSP90-organizing" "HSP90α" "HSP90αlpha" "HSPC157" "HSQC"
    "HSV-1" "HT-12" "HTLV-I" "HUF" "HUFs" "HUV-EC-C" "HXR9" "HYK" "HZ" "Haigis"
    "Halder" "Hanahan" "Hanna" "Hans" "HapMap" "HapMap-Sanger" "HapMap-imputed"
    "HapMap550K" "HaploReg" "Haplotypes" "Hapmap3" "Harbin" "Hardy-Weinberg"
    "Hardy–Weinberg" "Hcav-1" "Hct" "HeJ" "HeKa" "Heavy" "Heidelberg" "Heinz"
    "Heinz-Nixdorf" "Helix_3x" "Hematology" "Hemocentro" "Henan" "Hepes" "Her2"
    "Herrington" "Hh" "HiPerFect" "Hibi" "High-confidence" "High-fat"
    "High-grade" "High-level" "High-resolution" "High-risk" "HindIII"
    "Hinrichsen" "His-Plk1" "His-Ub" "His-tag" "His1927Arg" "Hispanic" "Hlatky"
    "Ho-PLLA-MS" "Hodgkin" "Hodgkin’s" "Hoechst" "Holliday" "Holm" "Hong"
    "Hoshino" "Hosmer" "Hosmer-Lemeshow" "Houlle" "Houston" "Hph-fusion" "Hsu"
    "Hu" "Hu7.5.1" "HuRSTA" "Huang" "HumanHap550" "Huntington" "Huntington’s"
    "Hupki" "Husgafvel-Pursiainen" "Hwang" "Häufigkeit" "I-DIRT" "I-PCR"
    "I-Sce1" "I-infected" "I-labeled" "I-labeling" "I-qPCR" "I133A" "I597S"
    "IBD-cancer" "IBD-cancers" "IBD-carcinogenesis" "IBD-carcinomas"
    "IBD-dysplasias" "IBD-dysplastic" "IBDN" "ICP0-null" "ICQ " "ICUE3" "IDCs"
    "IDH-1" "IEJs" "IFN-exposure" "IFN-pretreatment" "IFN-response" "IGP"
    "IGP1" "IGP13" "IGP17" "IGP2" "IGP23" "IGP24" "IGP26" "IGP29" "IGP3"
    "IGP31" "IGP36–IGP40" "IGP39" "IGP40" "IGP41" "IGP42" "IGP43" "IGP48"
    "IGP49" "IGP5" "IGP53" "IGP55" "IGP57" "IGP58" "IGP59" "IGP61" "IGP63"
    "IGP64" "IGP66" "IGP68" "IGP69" "IGP7" "IGP70" "IGP71" "IGP72" "IGP8"
    "IGP9" "IGT" "IGV" "II-1" "IIA" "IIE" "III-1" "III-2" "III-4" "III-6"
    "III-7" "III-dsDNA-sensing" "IIIB" "IIIa" "IIIa-IV" "IIIb-1" "IIIc" "IIIα"
    "II–III" "II–VI" "IKK-ε" "IKKEE" "IKKEE-Tg" "IKKs" "IL-13-PE-mediated"
    "IL-17-knockout" "IL-1β-stimulated-ADSC-conditioned" "IL-2B" "IL-2Rα"
    "IL-β" "IL6ST-ANKRD55" "ILIB" "IM-16425" "IMEx" "IMPUTE2" "IMY" "IMY-4"
    "IMY-N9" "IN-CA" "IN-CA-defective" "IN-CA-independent" "IN-CA–defective"
    "IN-CA–independent" "INDELs" "ING-4" "INrf2Thre55" "IP-westerns" "IPASS"
    "IPEX-like" "IPQ" "IPR000900" "IPR002110" "IPR003598" "IPR003599"
    "IPR003961" "IPR007087" "IPR007110" "IPed" "IQ" "IR-promoter" "IR-β" "IRC"
    "IS" "ISAR" "ISE-2" "ISG" "ISGs" "ISH" "ITC" "ITCH-CA" "ITCHS161A" "ITIM"
    "ITIM-pathways" "ITIMs" "IUGR=11" "IUGR=9" "IUI" "IV-2" "IV-4" "IV-5"
    "IV-8" "IV-9" "IVIS" "IVS21+1G" "IWR" "Icelanders" "Ig-like" "IgG-Fc" "Il"
    "Illumina" "ImClone" "Immuno-fluorescence" "Immunoglobulin-like"
    "Immunohistochemisch" "Immunohistochemische" "In-depth" "In-solution"
    "In-vitro" "Inc" "Indians" "Infertility" "IngenuitySystems" "Inhibitor-κB"
    "Inoue" "Ins" "Inter-individual" "Inter-observer" "InterPro"
    "Interaktionen" "Internet" "Intra-cranial" "Intra-observer" "Intra-strand"
    "Invasion-related" "Invitrogen" "Invivo" "Ischemic" "Isl1" "Islande"
    "Israel" "Ito" "IκB-super" "IκBα-like" "IκBαM" "I∶C" "J-F" "J-PB" "J82"
    "JAK2V167F" "JAK3A572V" "JAZF" "JBB" "JD" "JF" "JFH-1" "JFH1" "JH352"
    "JH574" "JHOC" "JHOC-8" "JHOC-9" "JLH" "JNJ" "JNJ-38877605" "JPV" "JR-1"
    "JZ" "Jacobs" "Jager" "Japanese" "Jauffret" "Jeghers" "Jewish"
    "Jewish-Ashkenazi" "Jews" "Jimenez" "Jiricny" "Jolla" "Joyce" "Junjie"
    "K-Ac" "K-ras" "K-variant" "K-x" "K-x-R" "K14-CreER" "K14-HPV16"
    "K14-HVP16" "K160A" "K160M" "K160M-GST" "K2" "K2-M" "K2-MYC" "K2-RAS"
    "K2-Vec" "K30R" "K401R" "K42A" "K470A" "K540M" "K63-Ub" "K805R" "K9" "K9m3"
    "KD-1" "KD-2" "KD-22" "KD-S3" "KDEL" "KDLER" "KDLER1" "KEAP1-BTB"
    "KEAP1-DPP3" "KEGG" "KEH" "KELCH" "KELCHβ-propeller" "KEN-box" "KIF1Bβ"
    "KIN001" "KIN001-102" "KIN102" "KOs" "KP372-1" "KRAS-GTP" "KRR" "KSLVK"
    "KYN" "Kadouri" "Kaiser" "Kamiyama" "Kannouche" "Kaplan" "Kaplan-Meier"
    "Kaplan-Meir" "Kaplan–Meier" "Karnofsky" "Karzinoms" "Kayser" "Keefe"
    "Kelch-like" "Keller" "Kenyon" "Kerfoot" "Keshamouni" "Kg" "Khosla" "Ki-67"
    "Ki-67-IR" "Ki-67-LI" "Ki67-LI" "Kilpivaara" "Kim" "Kinsler" "Kintu" "Kip"
    "Kirsten" "Kitamura" "Kiuru" "Kleberg" "Klefström" "Klinefelter"
    "Klingbeil" "Knock-down" "Kolesnick" "Kong" "Kong’s" "Korcula" "Korea"
    "Korean" "Kovtun" "Kraepelin" "Kretzler" "Kruskal-Wallis" "Krüppel-like"
    "Ku" "Kutta" "Kuzembayeva" "Kyoto" "L-A" "L-Arg" "L-type" "L1MC4a" "L5"
    "L747_P753delinsS" "L747_T751del" "L747_T751delinsPT" "L7ow" "LABA"
    "LAM-PCR" "LCF6" "LCL" "LCLs" "LCS6" "LDR" "LEF-binding" "LG3BP" "LIC"
    "LIN-11" "LINC00339-WNT4" "LINCS" "LINE-1" "LITA" "LIV-1si" "LJ" "LKB1-ve"
    "LKDIL" "LMCI" "LMM" "LMWIs" "LN18-Vector" "LOC100506035" "LOC285735"
    "LOC440389" "LOCCS" "LODO" "LPCT2" "LPX" "LQYLA" "LR4-NFκB" "LREA" "LRVTRN"
    "LSCCs" "LSI" "LTQ-Orbitrap" "LTR-β-gal" "LTS" "LUMO" "LUV" "LUVs"
    "LUX-Lung" "LVDd" "LY294004" "LYID589AAAA" "LZT" "Lai" "Lain" "Lanza"
    "Late-onset" "Lauri" "Leave-one-out" "Leber" "Lef" "Legerski" "Legius"
    "Leica" "Leiden" "Lemeshow" "Lenti6-EGFP-D64V" "Let-7f-2" "Levene" "Leydig"
    "Li" "Li-Fraumeni" "Li-Fraumeni-like" "Li-Fraumeni-syndrome" "Liao"
    "Libdock" "Lichtenstein" "Life-long" "Ligand" "Light" "Lineng" "Lipinski"
    "Lipinski’s" "Lipofectamine" "Liptak" "Lisa" "Littman" "Liu" "Liu’s"
    "Long-shan" "Lopez" "Lopez-Jimenez" "Lorente" "Lorenzo" "Lorenzo’s"
    "Loss-of-function" "LoxP" "LpdH" "LprA" "LprG" "Ltd" "Lu" "LuCaP" "Lue"
    "Luedemann" "Lunetta" "Luong" "Lx" "LxxLL-like" "LxΦx" "Lys-Asp-Glu-Leu"
    "Lys–Asp–Glu–Leu" "M-DNA" "M-MITF" "M-S" "M-band" "M-line" "M-phases"
    "M-substituted" "M-tropic" "M-value" "M-values" "M0" "M1c" "M5" "MAGENTA"
    "MAGIC5" "MAVS-CARD-proline-rich-domain" "MB453" "MBq" "MCBP" "MCDB170"
    "MCF-7TN-R" "MCLRs" "MCM2–7" "MDA-MB-231cells" "MDA-MB-231compared"
    "MDA-MD-231" "MDRV" "MDSC" "MDSCs" "MEC3-domain" "MEDLINE" "MEGM" "MEIS"
    "MEK1CA" "MESP" "MEX-3C" "MGC80-3" "MHCI" "MHCs" "MIB-1-LI" "MIBCs"
    "MIGR1-IRES-mcherry" "MIMM" "MIMM#221750" "MIP1α" "MIR1179" "MIR137"
    "MK-2461" "MK8033-carboplatin" "MK8033-carboplatin-paclitaxel" "MKK3b"
    "MKK3bE" "ML-120B" "MLCRs" "MLF3D" "MLH1+PMS2" "MLN-120b" "MLN120"
    "MLN120b" "MMC-treatment" "MMP-19" "MMTV-NIC" "MMTV-PyMT" "MMTVD"
    "MMTVD1-K2" "MOI" "MP3" "MPBBP1A" "MPRM1" "MRAIL" "MRT67303" "MS-MLPAav"
    "MSCV-myrAKT1-IRES-GFP" "MSH2+MSH3" "MSH2+MSH6" "MTS" "MV411" "MVAS"
    "MW∼24" "MYBBBP1A" "MYC-antagonist" "MYCN2" "MZ" "Mach2QTL" "Madeo" "Madin"
    "Madin-Darby" "Maillard" "Malay" "Malim" "Malim’s" "Malley" "Mangnolia"
    "Marcova" "Maringá" "Maroc" "Mass-spec" "MassARRAY" "Matlab" "Mayo"
    "McKean" "McKean-Cowdin" "McPherson" "Mcm10-SIRTs" "Mcm2–7"
    "Mda5-deficient" "Mec1" "Medica" "Mediterranean" "Meier" "Meir" "Mek1p"
    "Mendez" "Merck" "Messner" "Met-235–containing" "MetaSystem" "MetaSystems"
    "Metafer" "Metcalf" "Methodology" "Mev" "Mi2α" "MiR-141" "MiR-17"
    "MiR-17-3p" "MiR-17-92" "MiR-21" "MiR-221&222" "MiR-224" "MiR-506"
    "Michael" "Michael-adducts" "Michaelis" "Michalowicz" "MicroRNA-21"
    "MicroRNA-9" "MicroRNA155" "Microsystem" "Microsystems" "Migr1"
    "Migr1-IRES-GFP" "Migr1-hERG1-IRES-mcherry" "Mir-224" "Mishra" "Mishra’s"
    "Missing-in-Metastasis" "Mitchelmore" "MitoCapture" "MitoTracker"
    "Mitomycin" "Mn" "Modell" "Moderate-to-high" "Mol-6" "Moloney" "Mondo"
    "Monocyte-derived" "Montgomery" "Moree" "Morg" "Morley" "Moroni" "Moslehi"
    "Mosser" "MrOS" "Msh2" "Msh2-ATP" "Msh6-ATP" "Mu" "Mucosal-associated"
    "Muenke" "Mumford" "Mungamuri" "Mus" "Muscle-specific" "MutHLS"
    "MutS-bound" "MutSα" "MutSα-dependent" "Mutation-Frequencies"
    "Mutationsanalyse" "Mutsα" "Myh" "Müller" "Müllerian" "N-IBD" "N-IBDs"
    "N-acetyl-6-sulfatase" "N-acetyl-cystein" "N-ethylmalemide" "N-glycosidase"
    "N-glycosylase" "N-glycosylation" "N-helical" "N-hyperglycosylated"
    "N-lobe" "N-methyl-N" "N-methyltransferase" "N-nitrosobutyl" "N14A" "N1IC"
    "N1ICD" "N474A" "N8A" "N=14–42" "N=15" "N=28" "N=38" "N=4" "N=8" "NB88"
    "NBT" "NC-siRNA" "NC-siRNA-transfected" "NCBI" "NCEs" "NCI" "NCT00446225"
    "NCT00874419" "NDGR2" "NDRP1" "NEDD8ylation" "NEJ002" "NELL-1"
    "NER-defective" "NF-675" "NF-ĸB" "NF-κB1" "NFS-1" "NFT" "NFTs" "NFκB1"
    "NFλB" "NGR1" "NGTLRP6" "NHANES" "NICD1" "NICD2" "NICD3" "NIOSH" "NK-like"
    "NK-κB1" "NKX2–3" "NL-Luc-E" "NLSs" "NMB-7" "NMIBCs" "NMR-relaxation"
    "NNSPLICE" "NOD-SCID" "NOS2-interactor" "NRCM" "NRCMs" "NRG1β" "NRHC"
    "NS5M" "NSABP-B31" "NSC-23766" "NSLC" "NSPHS" "NSTEMI" "NU1025"
    "NU1025-induced" "NZB" "Na" "Na-HEPES" "Na-K-ATPase" "NaH" "Naftilan"
    "Nagelkerke" "Nagyerdei" "Narita" "Nbs1-R28A" "Nbs1-RRHK" "Nedd"
    "Nedd8-deconjugated" "Neill" "NetPhos" "Netherland" "Netherlands"
    "Netrin-treatment" "Netrins" "Neu" "Neumann" "Newcastle"
    "Newcastle-Ottawa-Scale" "Ngeow" "Ni" "Ni-NTA" "Nigricans" "Nimwegen"
    "Ninety-eight" "Ninety-one" "Ninety-three" "Ninety-two" "Niphatenone"
    "Niphatenones" "Niphates" "Nishizawa" "Nishizuka" "Nissen" "Niveau"
    "Nixdorf" "Noch3" "Noeva" "Nonidet" "Noonan" "Northern" "Norvège" "Norway"
    "Nottingham" "Novocastra" "Novus" "Nrf2" "Nrf2-ARE" "Nrf2-null" "NuRD"
    "NucTrans" "Nummer" "Nyholt" "N = 15" "N∼2000" "O-GlcNAcylated"
    "O-GlcNAcylation" "O-Me-cAMP" "O-charoenrat" "O-linked" "O-linked-mannose"
    "O-mannosyl-transferase" "O4" "ODNs" "OH" "OHdG" "OMIM" "OMIM304930"
    "ON-TARGETplus" "ONE-Glo" "OPCs" "OR" "OR3" "OR=0.66" "OR=0.72" "OR=0.77"
    "OR=0.85" "OR=0.86" "OR=0.91" "OR=1.03" "OR=1.07" "OR=1.08" "OR=1.09"
    "OR=1.16" "OR=1.17" "OR=1.35" "OR=1.40" "OR=1.45" "OR=1.64" "OR=1.67"
    "OR=2.54" "OR=5.44" "ORCADES" "ORFeome" "ORs" "OR = 1.07" "OR = 1.16"
    "OR = 1.17" "OR = 1.45" "OSW-1" "OT-II" "OVCAs" "OXPHOS" "Oberthuer"
    "Oberthuer-251" "Objective" "Obwohl" "Offenbacher" "Okamoto" "Okazaki"
    "Oktay" "Oliveira" "Olson" "Olson's" "Olympus" "Omni" "Omni1-Quad"
    "OmniExpress" "Oncology" "Oncomine" "One-hundred" "One-way" "Onyango"
    "Orazio" "Orbitrap" "Oregon" "Ouyang" "OvCa" "Ovarialkarzinomen" "Over-all"
    "Over-regulation" "Over-representation" "Overhauser" "Oxidative" "P0" "P1"
    "P13K" "P1CDB1" "P1CDO2" "P1CDO3" "P250R" "P301S" "P53" "P53-null"
    "P53–290" "P72" "P=0" "P=0.0002" "P=1" "P=4" "PAAG" "PAIL" "PAM50" "PAN+EV"
    "PANT" "PARG110" "PARG60" "PARPi" "PAS" "PAX3-FOXO1–dependent"
    "PAX3-FOXO1–negative" "PAX3-FOXO1–positive" "PAb240" "PB-VS." "PBB" "PBS-A"
    "PBS-D" "PBS-E" "PBST" "PBX2-miR-221&222-c-FOS" "PBX2→miR-221"
    "PBX2→miR-221&222→c-FOS" "PBX→miR-221&222→c-FOS" "PC-3" "PCR-CTPP"
    "PCR-LDR" "PCR-RFLP" "PCR-RLFP" "PCR-based" "PCR–RFLP" "PCT" "PCas" "PD123"
    "PD165" "PD20" "PD54" "PD6" "PD980259" "PDCD" "PDGFRi" "PDGRA" "PDGRFA"
    "PDW" "PE=8" "PEAR" "PET-CT" "PF-04217903" "PF-562271" "PFK115-584"
    "PGC1α-alt" "PGL" "PHEO" "PHEOs" "PHGF" "PHTS-patient-derived" "PI-9"
    "PI-DLBL" "PI-DLBLs" "PI3KCA" "PI3Kγin" "PIMRider" "PIN6" "PITCH1" "PKAIP"
    "PKC412+AT7867" "PKCα" "PKCαβ" "PKCβI" "PKCβII" "PKCη" "PKCθ-CD28" "PKCι"
    "PKF118-310" "PKF118-744" "PKF118–310" "PKF222-815" "PKM1" "PLATO" "PLCβ"
    "PLCγ" "PLCε" "PLINK" "PLT+RBC" "PLT+WBC" "PLT+WBC+RBC" "PMC-A"
    "PMC-A-treated" "PMC-C" "PMC-D" "PMC-F" "PML-RAR-α-negative" "PMN" "PMNs"
    "PMVEC" "PMVECs" "PON-1" "PPC" "PPIs" "PPxY" "PR-negative" "PRMT1G80R"
    "PRMT4-immunoprecipitates" "PROMO" "PRX2M" "PS1A246E" "PSB10" "PSB9" "PSGH"
    "PTEN-M3M4" "PTEN-R233X" "PTEN-R335X" "PTEN-null" "PTENp1" "PTENpg1"
    "PTENΨ1" "PVS" "PX-12" "PX-478" "PYK-SPECT" "Pacak" "Pacak–Zhuang" "Paik"
    "Pakistani" "Palandra" "Palombo" "PanIN" "PanIN-like" "PanIN1-like"
    "PanIN3-like" "PanINs" "Panafricain" "Panasiuk" "Panax" "Panova"
    "Panova-Noeva" "Paolo" "Papaveraceae" "Par3" "Par6-PDZ–binding"
    "Par6-PDZ–mediated" "Par6-ΔCRIB" "Par6α" "Par6γ" "Paraoxonase-1"
    "Pardanani" "Parke" "Parke-Davis" "Parkinson" "Parkinson's" "Patel"
    "Pavard" "Pdcd44" "Pearson" "Pearson's" "Pearsons" "Pearsons-R" "Pearson’s"
    "Peasland" "Pemetrexed" "Peptostreptococcus" "Periodontology" "PerkinElmer"
    "Perkins" "Petermann" "Peutz" "Peutz-Jeghers" "Pfads" "Pfeufer" "Pfizer"
    "Pflueger" "Pharmingen" "Phe-X-Glu" "PheWAS" "Phenylmethylsulfonyl"
    "Philadelphia" "Phosphorylation" "Phospo-kinase" "Pi+AGE-BSA" "Pi+BSA"
    "Pi-induced" "Pi-treated" "Pilsczek" "Pim-1" "Pin1-AAV" "Pin1KO"
    "Piscataway" "Plaines" "Planel" "Platelet-large" "Pleasic-Williams" "Plon"
    "Pml" "Poisson" "Poisson-Boltzmann" "PolII" "Polyphen" "Portland"
    "Post-hybridization" "Post-selection" "Post-transcriptional"
    "Post-transplant" "Powolny" "Powolny-Budnicka" "PredictABEL" "Preiss"
    "Preiss-Halder" "Preusser" "Principal" "Prkdc" "Profiler" "Promega"
    "Proteintech" "ProteoStat" "Prothymosin-α" "Pseudo-DUBs" "Ptenf" "PuPuPuC"
    "Purdue" "Pursiainen" "Pvu" "Pwd" "PyAPu" "P = 0.001" "P = 0.0018"
    "P = 0.003" "P = 0.0038" "P = 0.010" "P = 0.021" "P = 1" "P = 4" "Q-Q"
    "Q3501-K4069" "Q640Stop" "Q756X" "QG" "QQ" "QQ-plots" "QRS" "QTL" "QTLs"
    "QUATSO" "QXX" "Qi" "Qiagen" "Qian" "Qiu" "QuantiChrome"
    "Quantile-quantile" "R-AC" "R-FOXO3a" "R130X" "R28A" "R2–1" "R2–3" "R357A"
    "R357D" "R4" "R42A" "R43A" "R4A" "R4K" "R5" "R7" "R72" "R789" "R7A" "R7K"
    "R9" "RAD51-interaction" "RAD51-ssDNA" "RAD51–DNA" "RAGA" "RANK-L"
    "RANK-ligand" "RASopathy-like" "RAd66" "RAdMEK1CA" "RAdMKK3bE" "RAdSmad2"
    "RAdSmad3" "RAdSmad3DN" "RAdSmad4" "RAdp38α" "RAdpCA3" "REMARK" "REMBRANDT"
    "REML" "RFARRSVS" "RFLP" "RFP-H2B" "RHHY" "RHS" "RIDDLE" "RIG-I-like" "RIO"
    "RIOK" "RIOK2-RIOK1-mTor-Rictor" "RIOKs" "RKLKK" "RKx" "RLF-B" "RLFP" "RMR"
    "RMSDs" "RNA-ODN" "RNA-RNA" "RNAPII" "RNA–DNA" "RNF" "RNS-mediated-ICAM1"
    "RORγ" "RP11-454N6" "RP11-60H2" "RP11-671I19" "RP11–500M22" "RP2D"
    "RPMI+10%" "RPMI1640" "RPMVEC" "RPMVECs" "RPTC" "RPTCs" "RT-qPCR" "RUL036"
    "RUL153" "RVxF" "RXRXX" "RXXL" "RXXLXXXXN" "Rab5-CA" "Rab5-GDP" "Rab5-GTP"
    "Rac1-GTP" "Rac3" "Rac3-depletion-induced" "RacGEFs" "Rad-51" "Rad3"
    "Rad3-related" "Radiation-induced" "Radio-sensitive" "Radio-sensitivity"
    "Rahat" "Rahmioglu" "Rajaraman" "RankProd" "Ranunculaceae" "Rap-GEF2"
    "Ras-Raf-MEK-MAPK-targeting" "Ras-family" "Rayleigh" "Rb" "Re-expression"
    "Re-feeding" "Re-review" "Re-transformation" "Rebbeck" "Rebiopsy"
    "RecQ-like" "RecQL" "Receiver-operating" "Reddy" "RefSeq" "Reichner" "Rel"
    "Renilla-luciferase" "Ret-1" "Retinoic-acid" "Retroviruses" "Retzius"
    "Rev1-like" "Reverter" "Rewcastle" "Rex-GD" "Rex1incapable" "Rhaman"
    "Rheumatology" "Rho-family" "Rho-protein-dependent" "Rho-subfamily"
    "RhoGTPase-driven" "Ri" "Richardson" "Rictor-containing" "Riminton" "Rio1p"
    "Rio2p" "Robert" "Robledo" "Roche" "Rockford" "Rodrigo"
    "Rodríguez-Escudero" "Roock" "Rorg" "Rosen" "Rosetta" "Rossman" "Rossmann"
    "Rotkrua" "Rotterdam" "Rottner" "Row1" "Row2" "Row3" "RpL11-dependent"
    "RpL11-p53" "RpL11-p53-dependent" "Rsf-1" "Rsf-1-nducible" "Rsf-D1"
    "Rsf-D4" "Rubin" "Rudensky" "Rudolf" "Run-On" "Runge" "Runge-Kutta" "Runx"
    "Rushlow" "Ruskinn" "RxRxxS" "S+G2" "S-transition" "S1" "S1-S4" "S10A"
    "S11F" "S134A" "S163A" "S176" "S177" "S180" "S1981" "S19F" "S1C" "S1D"
    "S1–S4" "S203" "S233A" "S245A" "S252–261" "S276A" "S28ARunx2" "S2A" "S2B"
    "S3" "S33" "S347A" "S352A" "S360" "S37" "S3C" "S549A" "S555A" "S564A"
    "S568A" "S5A" "S5C" "S5F" "S5M" "S6" "S664A" "S679A" "S6A" "S6K" "S6M" "S7"
    "S712A" "S745A" "S746A" "S748A" "S8" "S807" "S889A" "S9"
    "S9-phosphorylated" "S9A" "S9D" "S9E" "SA-β-gal-stained" "SABA"
    "SABiosciences" "SAR" "SARMs" "SB20358" "SB204" "SBPHA-DPP3" "SCCAI" "SCEs"
    "SCFβ-TrCP" "SCNAs" "SCORM" "SD&ge" "SDD" "SDF" "SDHx" "SDS-polyacrylamide"
    "SD≥6" "SF-767" "SF5" "SGHPL" "SGHPL-5" "SGLNES" "SGNLES" "SHEEC" "SHIP145"
    "SIFT" "SIN-1" "SINDI" "SINE" "SIRT1-7" "SIRT1-antagonist" "SIRT1-sh3"
    "SIRT2-67" "SIRT2-mol6" "SIRT2-nf675" "SIRT2-salermide" "SIRT2-suramin"
    "SIRT2binding" "SIRT3-5" "SITILO" "SIVagm" "SIVmac" "SIs" "SJC" "SLEDAI"
    "SMARTpool" "SMM" "SN50" "SNCP" "SNF-related" "SNF2-like" "SNP-array"
    "SNP309G" "SNP309G’s" "SNP309T" "SNPG" "SNPas" "SNPin" "SNPs" "SNPwere"
    "SOCS1expression" "SPINK-1" "SPOTLITE" "SPRY-NOS2" "SPSBs" "SPSFENAHD"
    "SPSS" "SQCC" "SREBP-1s" "SREF" "SRH" "SRSF" "SRSF1-NRS" "SRs" "SSC" "SSPS"
    "SSPSs" "ST-segment" "STA5" "STAT-3β" "STAT-5" "STAT-C" "STAT1α" "STAT3-C"
    "STAT3-C-induced" "STAT3C" "STEMI" "STF-31" "STROBE" "SVZ-B" "SVZ-C-like"
    "SY" "SY-SY5Y" "SYBR" "Sae2-like" "Sakaguchi" "Sakai" "Sakowicz"
    "Sakowicz-Burkiewicz" "Sakurai" "Salamon" "Salanti" "Saltzman" "Salvatore"
    "Samsung" "Sanders" "Sanger" "Sanhueza" "Sanjun" "Sant-1" "SardiNIA"
    "Sarrio" "Sartore-Bianchi" "Sathya" "Saunders" "Savic" "Scansite"
    "Scatchard" "Scb" "Sce" "Scheidereit" "Scher" "Schlafen5" "Schouten"
    "Schrehardt" "Schwann" "Schwer" "Self-association" "Self-ubiquitylation"
    "Semeraro" "Semi-quantitative" "Sendai" "Seoul" "Separin" "Seq" "Ser-Pro"
    "Ser104" "Ser424-to-Ala" "Ser473" "Ser564-to-Ala" "Ser636" "Ser9"
    "Serine-to-alanine" "Serrano" "Serum-free-conditioned" "Seventy-seven"
    "Seventy-two" "Sex-specific" "Shh-N" "Shield1" "Shih" "Shimazu" "Shp2i"
    "Shtutman" "SiMES" "Siedman" "Sigismund" "Signa" "Significance" "Silva"
    "Silybum" "Single-SNP" "Single-locus" "Single-strand" "Sipahi" "Sir2-like"
    "Sirtuins" "Sitcheran" "Sixty-four" "Sixty-nine" "Sixty-six" "Sixty-three"
    "Sjalander" "Sjogren" "Sjogren’s" "Skorupa" "Skp1–Cul1–F-box"
    "Smad-dependence" "Smad2" "Smad3-dependent" "Smad3DN" "Small-molecule"
    "Snape" "Soft-genetics" "Someya" "Sos" "Sp1" "Spain" "Spanish" "Spearman"
    "Spetzler" "Spetzler-Martin" "Spetzler-grade" "Spry1" "Sprys" "Src-family"
    "Starr" "Starska" "Stat5_1" "Stat5_3" "Stat5a-IRES-GFP" "States"
    "Stephania" "Stichproben" "Stielow" "Stouffer" "Strebel" "Stress"
    "Stress-Induced" "Stronach" "Studie" "Studies" "Sturge-Weber-Krabble"
    "Sub-groups" "Sugden" "Sundaresan" "Sweden" "Swedish" "Sytox" "S→A" "T-DM1"
    "T-LBL" "T-allele" "T-helper" "T-lineage" "T-to-C" "T-to-G" "T-tubule" "T1"
    "T1D" "T1N0-N1M0" "T1N2-N3M0" "T202" "T205" "T207" "T245A" "T265-2c"
    "T271A" "T2D" "T2DM" "T2DN" "T2N0M0" "T2N1-N2M0" "T3" "T315A" "T356"
    "T3N0-N1M0" "T4" "T41" "T4aN0M0" "T6A" "T6D" "T6E" "T7" "T7-Pep" "T7-SRSF1"
    "T7-SRSF1-overexpressing" "T7-SRSF1–RPL5" "T7-tagged" "T847A" "T859A"
    "T859E" "TAAAT" "TAAT" "TAE" "TAE-226" "TAF089" "TATA" "TATA-box"
    "TATA-less" "TAU-1" "TAU-5" "TAp73" "TB-PEs" "TBE" "TBE2" "TBEs"
    "TBK1-deficent" "TBK1-null" "TBP-Luc" "TBP-Lue" "TBS" "TBS-T" "TBq"
    "TCF-4-dependent" "TCF-4-mediated" "TCFs" "TCRα" "TCRδ-knock-out" "TE-12"
    "TECT" "TEP" "TEPs" "TERT2" "TEV" "TEVsite" "TF-search" "TFBSs" "TFIIIA"
    "TFLLR" "TFN" "TFN-alpha" "TG+GG" "TGAT" "TGCCC" "TGF-b1" "TGFβ3" "TGFβR1"
    "TGFβRI" "TGFβΡ1" "TGX-221inhibited" "TLR-ligands" "TMR-TUBE2" "TNIP"
    "TNXIP" "TOPFLASH" "TORC2-depdendent" "TP-53" "TPases" "TRANSFAC" "TRDB"
    "TREM" "TRF1-FokI" "TRPML" "TRPMLs" "TRVb-1" "TRα" "TT+GT" "TT+TG"
    "TT-homozygote" "TTAGGG" "TTAGGG3" "TTAGGGTTAGCGTTAGGGp"
    "TTATTATTAGGGTTAGGGTTAGGGTT" "TTBS" "TTC" "TTCN" "TTFA" "TTT"
    "TUBE2-agarose" "TUNEL" "TV" "TXNIP-one" "Taiwan" "Taiwanese" "Taiyuan"
    "Talalay" "Talseth-Palmer" "Tampere" "Tanaka" "TanyNanyM1" "TaqMan"
    "TargetScan" "Tat-Sirt1" "Tcf" "Tconv" "Tec-family" "Teff" "Telomerase–DNA"
    "Tenovin-6" "Tension" "TetON-Flag-ELF3" "TetOn" "TetOn-Flag-ELF3-LNCaP"
    "Tetsu" "Texas" "Texas-Red-X-labelled" "Tg30tau" "TgAPP" "TgCRND8" "TgTau"
    "Tgfbr1f" "Th17" "Th22" "TheLKB1" "Theodosiou" "Thermo" "Thirty-five"
    "Thirty-four" "Thirty-one" "Thirty-seven" "Thirty-two" "Thompson" "Thr-Gln"
    "Thr202" "Thr308" "Thr–Pro" "Tianjin" "Tile-sampling" "Time-lapse"
    "Tindall" "Tl" "To-date" "Tocopherol" "Tokyo" "Toll-like" "Tollefsbol"
    "Top-Flash" "Tor2p" "Tothill" "Trastuzumab-DM1" "Tribolium" "Trinidad"
    "Tris-HCl" "Trivers" "Try705" "Tryggvadottir" "Tsou" "Tube-like" "Tveit"
    "Tweedie" "Tween" "Twenty-four" "Twenty-six" "Twenty-three" "Twenty-two"
    "Two-Pore" "Two-step" "Two-way" "Ty1" "Typhimurium" "Tyr204" "Tyr705-STAT3"
    "T–Q" "U1242" "U133" "U2OS-DSB-reporter" "U2OS-tet-SUV39H1" "U343" "U373"
    "U6" "U87MG-ΔEGFR" "U937_EVI1" "U937_vec" "UACC" "UACC-257" "UACC257" "UAZ"
    "UC1" "UC12" "UC13" "UC14" "UC15" "UC16" "UC17" "UC3" "UC6" "UC9" "UCSC"
    "UDP-N-acetylglucosamine" "UE" "UICC" "UICC-AJCC-TNM" "UICC–AJCC-TNM" "ULD"
    "UM-SCC" "UM-SCC11B" "UM-SCC6" "UM-UC1" "UM-UC12" "UM-UC13" "UM-UC14"
    "UM-UC15" "UM-UC16" "UM-UC17" "UM-UC18" "UM-UC3" "UM-UC6" "UM-UC9"
    "UMSCC11B" "UNC40" "UNC5A-D" "UPN" "UPN-251" "URC" "USA" "UTRs" "UUTs"
    "UV-DDB" "UV-carrier" "UV-carriers" "UV-damage" "UV-irradiated"
    "UV-irradiation" "UV-lesions" "UVC-irradiated" "UVC-response" "UWB1.289"
    "UbcH" "Ubiquitin-E3-Ligase" "Uddin" "Ueda" "Ulrich" "Unicamp" "Uno"
    "Uracil-N-glycosylase" "Utah" "V-shaped" "V3" "V4" "V5" "V5-His" "V5-tag"
    "V5-tagged" "V600E" "V791Y-telomerase–expressing" "VAD" "VCLFA" "VCO"
    "VCP-Flag-transfected" "VDJ" "VEALRRTG" "VEGAS" "VIM12" "VKESLV" "VLCFA"
    "VLCFA-CoA" "VLCFAs" "VSVG" "VUS" "VVIE790AAAA" "VX" "VX-745" "VZ"
    "Vairaktaris" "Val2985_Thr3001del" "Valencia" "Vande" "Vanderbilt"
    "Vannucchi" "Vec" "Vectibix" "Vector" "Veh" "Venus" "Verdin" "Verglich"
    "Vif–Cul5–EloB" "Virally-mediated" "Virchow" "Visekruna" "Vlaardingen"
    "Vlagtwedde" "Vollenbröker" "Vrouwe" "Vβ2" "Vβ2TCR" "W-C-G-L" "W414F" "WB"
    "WCC" "WEHI" "WF" "WFSM" "WGPs" "WHK" "WHTLF" "WI" "WJTOG3405" "WM852cells"
    "WP" "WRNp" "WST-1" "WT-hTERT" "WT-p53" "WT309T" "WTCCC2" "WTH" "Waals"
    "Wallis" "Wanfang" "Wani" "Warburg" "Warburg’s" "Wargo" "Wasswa"
    "Wasswa-Kintu" "Watson" "Watson-Crick" "Wayne" "Wege" "Weickert" "Weihua"
    "Weinberg" "Weinhofer" "Welander" "Well-designed" "Wellcome" "Wen-ying"
    "Werner" "Westergaard" "Western-blot" "Western-blotting" "Westhoff"
    "Wetzel" "Whatman" "Whibley" "Whitney" "Whole-genome" "Whole-mount"
    "Wilcoxen" "Wilcoxon" "Willcox" "Williams" "Wir" "Wistar-Kyoto"
    "Wolf-Parkinson-White" "Wollinella" "Wolter" "Wong" "Woude" "Wright-Giemsa"
    "Wu" "WxxLF" "Wyeth" "X-Ser" "X-ray" "XF24" "XH" "XIE" "XP-G" "XP-V"
    "XPC-defective" "XW" "XXFF" "XXM" "XY" "XYLB1" "XYW" "Xba" "XbaI" "Xiong"
    "Xp22.31" "Xpress" "Xq" "Xq11-12" "Xq12-q13.1" "Xq13" "Xq26" "Xq27.3"
    "Xq28" "Xu" "Y-C" "Y-L" "Y-RE" "Y-box" "Y-radiolabelled" "Y1022" "Y1023"
    "Y1221" "Y204" "Y239" "Y2H" "Y653" "Y654" "YCC" "YCY" "YFP-PI3Kγ" "YFS"
    "YPEN" "YQH" "YQL" "YQM" "YS" "YST-1" "YWxL" "YZ" "Yamakawa" "Yamamoto"
    "Yamanouchi" "Yamaza" "Yang" "Yatabe" "Yeast-two" "Yokosuka" "Yoruba"
    "Yosunkaya" "Yu" "Z-JS" "Z-VAD" "ZBBX" "ZF9" "ZH" "ZHH" "ZINC00679655"
    "ZINC19815502" "ZJ" "ZJY" "ZK191784" "ZQ" "ZR" "ZR-75" "ZVAD" "ZZ" "ZZ-tag"
    "Zagreb" "Zanella" "Zealand" "Zeiss" "Zellen" "Zeneca" "Zeste" "Zhang"
    "Zhou" "Zhu" "Zhuang" "Zhuo" "Zhuo-jia" "Zinzindohoue" "Zn" "Zn-finger"
    "ZnCl" "ZsGreen" "ZsGreen1" "Zulu" "a-arrestin" "a-arrestins" "a-c"
    "a-tubulin" "aBMD" "aCGH" "aHIF" "aK" "aPKCs" "aPKCι" "aPten" "aTP53"
    "aa3–8" "ab59718" "aberrances" "aberrancies" "abl-interactor"
    "above-menitoned" "absorbance" "absorptiometry" "accharomyces" "accès"
    "accélérée" "acetyl-lysine" "acetylaminofluorene" "acetylated-level"
    "acetylation–deacetylation" "acid-exposed" "acinar-ductal"
    "acinar-enriched" "actinin" "actino" "actinomycetemcomitans" "actinomycin"
    "actino­mycin" "activateas" "activatedlevel" "activators" "active-site"
    "actives" "activities" "acyl" "add-back" "adeno" "adenoids"
    "adenoma-carcinoma" "adenosines" "adenylate" "adheren" "adiocytes"
    "adipose-derived" "adjacentes" "adjuvante" "adnexa" "adrenalectomy"
    "adrenomyeloneuropathy" "adult-onset" "advanced-stage" "adventitia"
    "adénocarcinome" "adénocarcinomes" "aetio" "aetio-pathogenesis" "afferents"
    "afin" "ag" "agar" "age-at-menarche" "aggrecanase-1" "aglucon" "agressif"
    "ailleurs" "ainsi" "aktiver" "alarmins" "albicans" "algorithm" "algorithms"
    "alkyl" "allI" "allLKB1" "allele-A" "allele-C" "allele-G" "allele=0.97"
    "alleles" "allergies" "alloimmune" "allylaminogeldanamycin" "alors"
    "alpha-catalytic" "alpha-helical" "alphap" "alvespimycin" "amilorid"
    "amines" "amino-acid" "amino-terminal" "aminoacid" "aminoacids"
    "aminonucleoside" "amplicon" "amplicons" "amplifié" "amygdala"
    "amygdala-hippocampal" "améliorait" "améliorer" "anaerobium" "analysess"
    "analysiert" "anatomie" "anbei" "and-independent" "andBCL" "andK" "andLKB1"
    "andP27" "andand" "andare" "andis" "andp53" "ands" "andwhere" "andwith"
    "andΔEGFR" "and−1718" "aneuploid" "aneuploidy" "angiopoietin-like"
    "anhydride" "anilino" "anilino-quinazoline" "anilinopyrimidine"
    "anisotropy" "annexine" "années" "anophthalmia" "anorexia" "ans"
    "antagomiR" "antagomiR-221" "antero" "antero-posterior" "anthracyline"
    "anthracyline-taxane" "antiacancer" "antibody-agarose" "antibody-drug"
    "anticorps" "anticytochrome" "antigen-1" "antimicrotubule" "antipain"
    "antro" "antro-fundique" "apico" "apico-basal" "apk" "apkc" "apkciota"
    "apkczeta" "apnea" "apoenzyme" "apoptosis-signal-regulating"
    "apoptoticeffects" "apparentK" "approx" "après" "arabinofuranosyl"
    "arachnoid" "areal" "areflexia" "aripirazole" "aripriazole" "arisen"
    "arrest-induced" "arrest-specific" "arrhythmia" "arsenite-endemic"
    "arterioles" "as-yet" "as-yet-unidentified" "as-yet-unknown" "asPtf1a"
    "asRNA" "asRNAs" "ase" "ashthma" "asincreases" "asis" "assessements"
    "assette" "associé" "astigmat" "astroctye" "astrocyte-like" "at-risk"
    "at72" "ataxia-telangiectasia-like" "atelocollagen" "ation" "atrium"
    "attention-deficit" "atypia" "au3" "auch" "aucune" "ausgewertet"
    "ausschließen" "aussi" "auto-PARylation" "autoantibody-2" "autoantigens"
    "autocrine-activated" "autoimmune-enteropathy" "autologus"
    "autoradiography" "autoregulates" "autorités" "autosomal-dominant" "autres"
    "avancé" "avancée" "avancés" "avec" "avoir" "axial" "axon" "azaC"
    "azoxymethane" "a–h" "b-actin" "bHLHZ" "bacterially-expressed"
    "bait-binding" "baptisée" "barrier-protective" "bas" "basal-level"
    "basal-like" "base-pair" "basepair" "basepairs" "basée" "bcl-family"
    "bedeutend" "bedeutende" "begun" "bemerkt" "benzo" "benzoxazolyl"
    "benzylisoquinoline" "berberne" "berbrine" "berghei" "bescheiden" "betas"
    "between-studies" "between-study" "betweenand" "betweenandforthat"
    "betweenin" "betweenis" "betweenness" "bewertet" "bi" "bi-allelic"
    "bi-antennary" "bicuspid" "bien" "bientôt" "bifidum" "bilayer" "bilayers"
    "bilineage" "biliverdin" "binding-defective" "bio-synthesis" "biobank"
    "biobanks" "biocurcumax" "biospecimen" "biotin" "biphosphate" "bird-like"
    "bis-benzylisoquinoline" "bisphosphate" "bisulfate" "bivariate" "blocker"
    "blockers" "blood-based" "blood-brain" "blood–brain" "blood–retinal"
    "bolus" "bona" "bona-fide" "bonafide" "bone-marrow" "bone-marrow-derived"
    "bone-parameters" "bothandlevels" "boundary-fracture" "bovis"
    "box-dependent" "bp" "brachytherapy" "brain-tissue" "brainstem"
    "branched-chain" "brand-new" "break-apart" "breakpoint" "breakpoints"
    "brightfield" "broad-ranging" "broad-spectrum" "broader" "bronchoscopy"
    "brown-yellow" "browser" "by-product" "byLRP6" "byis" "bylevels"
    "bénéficier" "bénéficié" "c-FLIP-S" "c-Myb-dependence" "cETS" "cHER2"
    "cHER2-positive" "cIAPs" "cMPN" "cMPNs" "cMYB" "cPARP" "cPKC" "cPKCs"
    "cSTAT5" "cSTAT5A" "café-au-lait" "calcium-channel" "calculatedandas"
    "callosum" "callrate" "callrates" "camelpox" "campothecin"
    "cancer-endothelial" "candidats" "cap-dependent" "cap-independent"
    "cap-n-collar" "capase-8" "capillary-like" "cappedcannot" "cappeddue"
    "cappedlevel" "cappedwhich" "cappedwhose" "capsase-8" "capécitabine"
    "caractérise" "carbodiimide" "carbonyl" "carboplatin-paclitaxel"
    "carboxy-terminally" "carboxyl" "carboxyl-terminal"
    "carboxyl-terminal-binding" "carcinomes" "cardia" "cardiac-specific"
    "cardio-facio-cutaneous" "cardiomyopathies" "cargos" "carotid"
    "carried-out" "carrier-based" "carrier-free" "carriers" "case-by"
    "case-only" "caselevel" "cases-controls" "caspase-8-Bid-CL" "castaneum"
    "castration-recurrent" "castration-resistant" "catalyse"
    "catalytically-competent" "categorisations" "catheter" "catheters"
    "cation-π" "cavus" "cc5" "ccRCC" "ccRCCs" "cccDNA" "ccpRCCs" "cctagGT"
    "celiac" "cell-cycle-dependent" "cell-cycle-related" "cell-environment"
    "cell-like" "cell-of-origin" "cell-permeable" "cell-to-matrix"
    "cell-type-dependent" "cell-type-specific" "cellAline" "cells" "cellules"
    "celui" "centriole" "centromere" "centromère" "cephalostatin-1" "ceramides"
    "cerebellum" "cerebrum" "cerevisae" "cerevisiae" "cerium" "ces" "cesarean"
    "cette" "cetuximab-cisplatin" "ceux" "ch11q13.5" "chRCC" "chRCCs" "changer"
    "charcoal-stripped" "charge-charge" "charoenrat" "chemically-induced"
    "chemico" "chemo" "chemo-drugs" "chemo-kine-mediated" "chemo-radiotherapy"
    "chemo-resistance" "chemo-sensitivity" "chemoattractant" "chemoimmuno"
    "chemoimmuno-therapy" "chemokiines" "chemokine-and" "chemokinein"
    "chemoresistance" "chemoresistant" "chemotherapeutic-resistant"
    "chemotherapeutic-specific" "chemotherpy" "chemotype" "chi-square"
    "chi-squared" "childhood-onset" "children-ever-born" "chip-on-ChIP"
    "chirurgicales" "chizosaccharomyces" "chloroethyl" "cholecystitis"
    "cholesterol-interfering" "choline" "choroid" "chosen" "chr19" "chr9"
    "chromatid" "chromatids" "chromatin-immunoprecipitation" "chromophobe"
    "chromosome-associated" "chromsome" "chronically-infected" "ciblées"
    "ciliate" "cinq" "circuitry" "cis-regulatory" "cisplatine" "cistrome"
    "ckos" "classifier" "clathrin-coated" "clathrin-dependency"
    "clathrin-dependent-endocytosis" "claudin-low" "clear-cell" "clearer"
    "clematitis" "clinical-grade" "clinical-only" "clinically-defined"
    "clinically-effective" "clinicians" "cloning-compatible" "clony"
    "coactivate" "coactivates" "cobble-stone" "cobblestone-like" "coders"
    "codominant" "codon" "codon13-mutated" "codons" "coeliac" "cofilactin"
    "cofilin-mediated" "cohort-scale" "cohésives" "cold-induced" "cold-stable"
    "cold-tolerance" "colectomy" "coli" "colitis-associated" "collagenase-1"
    "collegues" "colligées" "colocalizations" "colonocytes" "colonoscopies"
    "colonoscopy" "colony-formation" "colony-forming" "combination-treated"
    "comme" "common-mediator" "commonest" "community-based" "comorbidities"
    "comparant" "competitive-binding" "composites" "comprendre" "compris"
    "compte" "con-focal" "concentration-dependently" "concentrationis"
    "concernant" "concisus" "conditionshould" "conditionwhich" "conductance"
    "confirmé" "confounder" "confounders" "congeners" "congenita" "considéré"
    "considérée" "considérés" "consistant" "constantk" "constantlevel"
    "contact-independent" "continuum" "contr" "contraction-induced" "contre"
    "control-AAV" "control-like" "control-population" "controlPten" "copellet"
    "copy-number" "core-binding" "core-fucose" "corticosteroid"
    "corticosteroids" "cost-effectiveness" "counter-intuitive" "coutries"
    "covariance" "covariate" "covariates" "coworkers" "craniotomy"
    "cromogranine" "cross-activate" "cross-checked" "cross-complementing"
    "cross-contamination" "cross-disorder" "cross-disorder-selected"
    "cross-ethnic" "cross-linker" "cross-linkers" "cross-over"
    "cross-phosphorylation" "cross-recruited" "cross-regulated"
    "cross-regulation" "cross-resistance" "cross-resistant" "cross-section"
    "cross-sectional" "cross-sectionally" "cross-talking" "cross-validate"
    "cross-validation" "cross-validations" "crossedLKB1"
    "crosslinker-treatment" "crossover" "cruciform-like" "cryo" "cryostat"
    "ctivities" "cttagGT" "cullin-RING–based" "culturedLKB1" "custom-assembled"
    "cut-off" "cut-points" "cutis" "cyan" "cyclin-CKD" "cycloheximide-chase"
    "cylcohexamide" "cylcophosphamide" "cysteins" "cyto" "cytoarchitecture"
    "cytology" "cytometer" "cytomix" "cytopenia" "cytophotometry" "cytoskelton"
    "cytosolic-predominant" "cytospin" "cytotol" "cytotoxicitiy" "d-f" "d4T-TP"
    "dA-dT" "dA∶dT" "dEGFRλ" "dKO" "dRIOK1" "dRIOK2" "dRIOKs" "dSMAC" "dTomato"
    "dU" "damage-based" "damage-induced" "damage-mediated" "damage-specific"
    "damagers" "dammarane" "dans" "dasatinib-like" "dataset" "datasets"
    "daughter-cell" "dauno" "day-old" "day-to-day" "days–1" "dbSNP" "dbSNP137"
    "de-adhesion" "de-bulking" "de-conjugation" "de-differentiated"
    "de-immunized" "de-regulation" "de-repression" "de-stabilised" "de2-7EGFR"
    "deaceatylases" "deacetyases" "deactylases" "death-1" "decondense"
    "decouple" "decreasek" "deeper" "deficiency-3" "deficit-hyperactivity"
    "defineas" "del17" "deletions" "delocalizes" "delta-aminolevulinate"
    "demande" "demostrates" "dendrite" "denine" "denticeless" "deoxycitidine"
    "deoxynucleotidyl" "deoxyuracil" "deoxyuridine" "deprivation-induced"
    "depuis" "der" "dernière" "detachment-induced" "deux" "devenue" "devrait"
    "df" "df=3" "di-leucine" "di-methylated" "di-ubiquitination"
    "diabetes-associated" "diabeticLRP6" "diacyglycerol" "diaminobenzidine"
    "diaminofluorescein" "diaminofluorescein-dyes" "diaphanous-related"
    "diastereomer" "dibutyryl" "dicoumarol-treatment" "dicuomarol"
    "dideoxycytidine" "dideoxyinosine" "diene" "diepoxide" "diese"
    "diet-induced" "diethylene" "differences" "differentiation-regulatory"
    "differentiation-suppressive" "differentlevels" "differents" "difficile"
    "diffusion-controlled" "différenciés" "difluoride" "digitalis" "digitorum"
    "diglycidyl" "dihydrodiol" "dihydroxyvitamin" "dimethylamonopropyl"
    "dimorphism" "dimycolate" "dinitrophenyl-S-glutathione" "dintirophenol"
    "dinucleotides" "dipeptidyl" "diphenyldifluoroketone" "diphosphate"
    "diploid" "direct-to-consumer" "dirigé" "dis" "discrepant"
    "disease-relevant" "disomy" "disponibles" "distant-metastases-free"
    "dithiocarbamate" "dnAMPK" "dnEBNA1" "dnFYN" "dnSRC" "docetaxel-platinum"
    "doi" "domai" "domain-domain" "dominant-negative" "dont"
    "dopamine-1-receptor" "dosage-dependent" "dose-dependently"
    "dose-escalation" "dose-limiting" "dose-response" "dot-like"
    "double-Flag-tagged" "double-chain" "double-fluorescent–labeled"
    "double-mutation" "double-null" "double-residue" "double-strand"
    "double-substitution" "doublings" "down-expression" "down-expressions"
    "down-modulated" "down-modulation" "down-slanting" "down-staging"
    "down-stream" "downfield" "doxorubicin-temozolomide" "doxycylin" "dp110"
    "drawn" "drawn-out" "drinkers" "driven-pTIMP-luc" "droplets" "drug-gene"
    "drug-like" "drug-likeness" "drug-resistance" "drug-sensitivity" "dsDNA"
    "dsDNA–ssDNA" "dual-color" "dual-labeling" "dualistische" "duplexes"
    "durée" "dyslipidemia" "dyspareunia" "dysplasia-carcinoma" "dyspnea"
    "dystrophycan" "décrite" "décrites" "définie" "détectée" "détectées"
    "déterminé" "eGFP-Ets-1-expressing" "eIF4EBP" "eMERGE-I"
    "eNOS-RNS-mediated" "earliest-stage" "early-onset" "early-passage"
    "early-stage" "echinoderm" "echocardiography" "ectopically-expressed"
    "effector-like" "effectors" "effectuates" "effet" "effets" "egg-extract"
    "eight-week-old" "eightfold" "eighty-eight" "eine" "einige" "el" "electro"
    "electrocardiography" "electrocytes" "element-binding" "elle" "eluate"
    "eluates" "elvitegravir" "emboli" "emmetropes" "empfindlich" "empty-vector"
    "encephalomyelitis" "encephalomyocarditis" "end-product" "end-stage"
    "end-to-end" "endo-β-N-glucosaminidase" "endocrinologists"
    "endocrinopathies" "endolysosome's" "endometrial-like" "endometriod"
    "endometrioid" "endometrium" "endometroid" "endoscopy" "endosomes"
    "endothelia" "endothelial-like" "endpoint" "endpoints" "energy-deprivation"
    "energy-rich" "enfuvirtide" "enhancer" "enhancer-binding"
    "enhancer-suppressor" "enhancesome" "enolases" "enolate" "enregistrées"
    "enterica" "enteropathy" "enthalpy" "enthüllen" "entre" "entropy" "environ"
    "enzyme-nucleic" "eosin" "eosinophilia" "epicardium" "epicatechin"
    "epidermoid" "epiphenomena" "epiphenomenon" "epistasis-based" "epithelia"
    "epithelial-derived" "epithelial-like" "epithelial-mesenchymal"
    "epithelial-to-mesenchymal" "epithelial–mesenchymal"
    "epithelia–to-mesenchyme" "epithelioid" "epithelium"
    "epithelium-fibroblasts" "epitrochlearis" "equi" "erythrocytes" "esiRNA"
    "esiRNAs" "esophagi" "esophagus-cardia" "est" "estomac" "et" "etal"
    "ethanol-fed" "ethnic-specific" "ethnically-similar" "ethnicities" "ethoxy"
    "ethylmalemide" "euglycemia" "euglycemic-hyperinsulinemic" "européenne"
    "européennes" "euthyroid" "ever-drinkers" "ex" "ex-smokers" "examen"
    "examinees" "exocrine" "exome" "exon-capture" "exon1" "exon10" "exon16"
    "exon19" "exon8" "exon9" "exons" "exotoxin" "experiements"
    "experimental-induced" "exposure-linked" "expressers" "expressions"
    "extra-gastrointestinal" "extra-neuronal" "ey" "fNrf2" "fWT" "facies"
    "facteur" "factor
1β"
    "factor-1" "factor-2" "faecalis" "fait" "families" "family-like" "fangchi"
    "far-reaching" "fascaplysin" "fast-proliferation" "fast-twitch"
    "fate-decision" "fat–fed" "fecal" "feed-back" "feedback-regulated"
    "feedforward" "female-specific" "femmes" "fibrates" "fibroblast-like"
    "fibroblastoid" "fibroblastoid-characteristic" "fibrosis-associated"
    "ficolin" "fide" "field-view" "filamin-C" "filipodia" "filter-bound"
    "fine-mapping" "fine-needle" "fine-tune" "fine-tuned" "fine-tuning"
    "finely-tuned" "finite-lifespan" "first-degree" "first-generation"
    "first-neighbor" "five-alanine" "five-degree-of-freedom" "five-disorder"
    "five-domain" "five-year" "fixé" "flammeus" "flavanoid" "flavanol"
    "flowchart" "flowcytometry" "fluorescente" "fluorometery" "fluorophenyl"
    "fluorophore" "fluorophores" "fluorphores" "fois" "fold-enrichment"
    "fold-increase" "follicle" "follicles" "follow-on" "follow-up" "followup"
    "forCYP3A4" "foralso" "forceps" "forebrain" "forebrains" "foresaw"
    "forkhead-box" "formaline" "formol" "forshows" "forty-six" "forty-three"
    "four-member" "four-state" "fragilis" "frameshift" "freely-available"
    "freeze-thaws" "frequently-altered" "fresh-frozen" "fresh-made" "fromRIOK2"
    "fromand" "frombecause" "frond-like" "front-rear" "front-to-back" "frozen"
    "fréquente" "full-heritage" "full-mouth" "full-term" "full-text" "fumarate"
    "functionis" "fundique" "furthest" "fusion-negative" "fusion-positive"
    "für" "gAgP" "gain-of-function" "gallate" "gallbladder" "ganlioneuromas"
    "gap-repair" "gastrique" "gastriques" "gastrocnemius" "gastrula" "gegen"
    "gel-shift" "gelatinase-specific" "geldanomycins" "gelonin" "genau"
    "gender-dependent" "gender-specific" "gene*environment" "gene*gender"
    "gene-I" "gene-disease" "gene-drug" "gene-environment" "gene-gene"
    "gene-pool" "gene-therapy" "gene-to-environment" "gene-to-gene" "gene-wide"
    "genetically-defined" "gene–environment" "gene–environmental" "gene–gene"
    "genic" "genome" "genome-wide" "genomes" "genomewide" "genotype"
    "genotype-phenotype" "genotype-to-phenotype" "genotyped-only" "genotypes"
    "genotype–phenotype" "genotypic-specific" "genüg" "germAcell"
    "germinal-center" "germline" "ght" "gingiva" "gingivalis" "glia–like"
    "globulin" "glomeruloneph" "glomerulonephritis" "glucan" "glucans" "gluco"
    "glucose-tolerance" "glucosylceramide" "glutamate-cysteine"
    "glutathione-synthesis" "gluthatione" "glycan" "glycans" "glycoforms"
    "glycome" "glycosyl" "goes" "gonad" "gondii" "gone" "goodness-of-fit"
    "gp120-DC" "graft-versus-host" "gram-negative" "granulosa"
    "granulosa-luteal" "greater" "greatest" "grevé" "group-M" "group-W"
    "groups19" "growth-cone" "growth-suppressive" "gène" "hCGh" "hCGn" "hCGα"
    "hCGβcf" "hENT1" "hGas2l3" "hK" "hK01-hK03" "hK02" "hK03" "hKO2" "hMLH3"
    "hMutLα" "hMutSα" "hNDRG2" "hRelB" "hTER" "hTERT-V791Y-clone"
    "hTERT-V791Y–expressing" "hTERT-W930F-F1" "hTERT-W930F-F2"
    "hTERT-W930F–expressing" "hTERT-immortalized" "hUNG-DNA" "hUNG-nonspecific"
    "hUNG2" "hVSMC" "haben" "hairpin-RNA" "hairpin-forming" "half-century"
    "half-filled" "half-life" "half-lives" "half-maximal" "half-site"
    "half-sites" "hamartomatous-polyposis" "hamartomatous-polyposis-related"
    "hammerhead" "haplo" "haplo-insufficiency" "haplogroup" "haplotype"
    "haplotype-results" "haplotypes" "hard-to-treat" "haveandand"
    "head-and-neck" "head-to-tail" "healthyLRP6" "heat-shock" "heavier"
    "heavily-pretreated" "heavy-chain" "heavy-smoker" "helicase-like" "helices"
    "helix" "helix–loop–helix" "hematoxylin-and-eosin" "hematoxylin-eosin"
    "hemi" "hemi-methyladenine" "hepato" "hepato-GI" "hepato-gastrointestinal"
    "hepatocyte-specific" "herceptine" "heretofore-appreciated" "hetero"
    "hetero-dimers" "heterodimers" "heteroduplex" "heterotetramer"
    "heterotrimer" "heterozygote" "hexamers" "hexapeptide" "hg18" "hg19"
    "high-FRET" "high-affinity" "high-carbohydrate" "high-complexity"
    "high-confidence" "high-density" "high-dose" "high-efficiency"
    "high-energy" "high-expression" "high-fidelity" "high-grade"
    "high-incidence" "high-level" "high-mobility" "high-quality"
    "high-resolution" "high-risk" "high-salt" "high-volume" "high=15" "high=20"
    "high=23.6" "high=27.7" "higher-level" "higher-order" "hilar" "hindlimb"
    "hinge-and-latch" "histo" "histo-pathologic" "histo-pathological"
    "histologies" "histology" "histone-lysine" "histopathology" "histotypes"
    "holmium-166" "homeodomain" "hommes" "homo-hexamers" "homoduplex"
    "homogenates" "homolog" "homologies" "homologs" "homopolymeres"
    "hormonally-regulated" "hormone-naïve" "host-virus" "hotspot" "hotspots"
    "hr" "hsa-miR-372" "hsa-miR-373" "ht" "humanisé" "humans" "hunter-gatherer"
    "hydatidiform" "hydrolizes" "hydroxy" "hydroxybutyl"
    "hydroxydeoxyguanosine" "hydroxyl" "hydroxylases" "hydroxymethyl"
    "hydroxymethylglutaryl" "hydroxytryptamine" "hyper" "hyper-morphic"
    "hyper-pigmentation" "hyper-proliferation" "hyper-proliferative"
    "hyperconvex" "hyperdiploid" "hyperimmunoglobulin" "hyperinsulinaemia"
    "hyperinsulinemia" "hyperinsulinemic-euglycemic" "hypermotile" "hyperoxia"
    "hyperpermeablilty" "hypertophy" "hyphae" "hypo-morphic" "hypo-responsive"
    "hypodia" "hypoglycemia" "hypolipidemia" "hypomagnesemia" "hypomorphs"
    "hypomotile" "hypopharynx" "hypothalamic-pituitary-thyroid"
    "hypothalamo-pituitary-adrenal" "hypothalamus-pituitary-thyroid"
    "hypothermia" "hypotonia" "hypoxia-responsive-element" "hétérogénéité"
    "höher" "höhere" "i.e.and" "i22" "iE" "iM" "iRefWeb" "ice-cold"
    "identifier" "identity-by-state" "ie" "ii" "iii" "ike" "ill-defined"
    "imagestream" "immorto" "immuhistochemistry" "immune-activated"
    "immune-associated" "immune-complex" "immune-mediated" "immune-related"
    "immune-relevant" "immune-signaling" "immuno" "immuno-fluorescence"
    "immuno-slot" "immunoassay" "immunoassays" "immunochemo"
    "immunochemo-therapy" "immunocytochemistry" "immunoglobin" "immunoglobulin"
    "immunogold" "immunohistochemistry" "immunohistochimie"
    "immunohistochimique" "immunohystochemistry" "immunomarquage"
    "immunophenotype" "immunophilins" "immunopositiven" "immunoprecipitations"
    "immunoprofile" "immunoprofiles" "immunoproteasome" "immunopurifications"
    "immunosurveillance" "immunotherapies" "immédiat" "impedance" "importin-β"
    "importinα" "in-depth" "in-frame" "in-gel" "in-house" "in-situ"
    "in-solution" "in-turn" "in-vitro" "inDdx58" "inFig" "inIfih1" "inLKB1"
    "inLRP6" "inPten" "inand" "inase-1" "inase-2" "inbut" "incl"
    "includingL747_T751del" "inclus" "incomplet" "increasedK" "increasingvalue"
    "increasses" "indel" "indiqué" "indiscriminant" "individual-disorder"
    "individuals" "induced-apoptosis" "infection-induced" "inflamm"
    "inflammation-driven" "influenceprotein" "informativeness" "inhibitis"
    "inhibitor-PD98059" "inhibitor-resistance" "inis" "initial-rate" "inleads"
    "inlevel" "innate-immune" "inositide" "inp160" "inside-out" "insightful"
    "insulinlike" "insulitis" "integrants" "integrators" "intensité"
    "inter-connectivity" "inter-endothelial" "inter-individual"
    "inter-laboratory" "inter-leukin" "inter-observer" "inter-origin"
    "inter-tumor" "interactome" "interactomes" "intercalate" "intercalates"
    "interdomain" "interefere" "intergene" "intergenes" "intergrin"
    "intermediate-affinity" "intermediate-risk" "internal-tandem"
    "internationally-accepted" "internationally-recognised" "interobserver"
    "interquartile" "interstrand" "interwoven" "intra" "intra-kinetochore"
    "intra-luminal" "intra-strand" "intra-tumor" "intra-tumoral"
    "intracellular-specific" "intraclass" "intracytoplasm" "intragene"
    "intrastrand" "intron" "intron-6" "intron-8" "intron1" "introns"
    "invadopodes" "invaginations" "invariant" "invasion-associated"
    "invasion-promoting" "invasive-type" "inverse-variance" "invitro"
    "inward-facing" "iodine-replete" "iodophenol" "iodophenoxy" "ionic"
    "iron-transportation" "irradiation-induced" "ischemia-reperfusion"
    "ischemic-hypoxic" "ischemic-reperfusion" "islet-cell" "isoenzymes"
    "isoflurane" "isomerizes" "isomers" "isothiocynates" "isotype" "isotypes"
    "isozyme" "isozymes" "ist" "isu" "itsdownstream" "iv" "iver"
    "junction-associated" "kBq" "kNrf2" "kappa-light-chain-enhancer" "kappaBs"
    "karyotype" "katsumadai" "kazal-1" "kcal" "kd" "keV" "keepingthroughout"
    "kg" "kilobases" "kinapse" "kinase-β" "kinaspe" "kinome" "kinome-wide"
    "kit-8" "knappskog" "knock-down" "knock-in" "knocked-down" "knockin"
    "knockout-mouse" "laboratoire" "laevis" "lambda" "lamella" "lamptors"
    "lane4" "lane6" "large-scale" "laryngectomy" "laser-generated" "late-G1"
    "late-onset" "late-passage" "late-stage" "later-time" "lateralis" "lavage"
    "le" "lead-like" "leadsto" "lectin-like" "left-most" "leptomeninges"
    "lesion-binding" "lesion-specific" "let-7f-2" "letztmalig"
    "leucine-to-proline" "leukemia-like" "leukin" "leukophilia" "leuprolide"
    "leur" "levels" "levles" "library-derived" "life-extension" "lifecourse"
    "lifespan" "lifespans" "ligand-independency" "light-smoker" "like-Modifier"
    "like-modifier" "limb-girdle" "limit-cycle" "limitation-induced" "limites"
    "limitiert" "lineage-specific" "lineage-survival" "lineages" "linescans"
    "lipidemia" "lipoarabinomannan" "lipomannan" "lipopolysaccaride"
    "lipopolysaccharide" "lipopolysacharides" "lipoproteins" "liposome"
    "liquid-crystalline" "literature-based" "litterature" "littermate"
    "littermates" "little-to-no" "littérature" "live-cell" "liver-dominant"
    "liver-only" "liée" "lobectomy" "locally-advanced" "locis" "loco-regional"
    "lod" "log-lank" "long-acting" "long-axis" "long-chain" "long-lasting"
    "long-lived" "long-standing" "long-tract" "longer-term" "longtemps"
    "longum" "longus" "look-up" "look-ups" "looked-for" "loop2" "loop3"
    "loss-of-function" "low-abundance" "low-affinity" "low-degree"
    "low-density" "low-dose" "low-energy" "low-frequency" "low-grade"
    "low-incidence" "low-level" "low-magnification" "low-penetrance"
    "low-penetrant" "low-resolution" "low-risk" "low-volume" "low-μM"
    "low=1.00" "lowvalues" "loxP" "lpha" "lpr" "lumena" "lumens" "luprorelin"
    "lupus-like" "lymphadenopathy" "lymphnode" "lymphoblastoid" "lymphoma-10"
    "lymphopenia" "lymphotoxin" "lyosNa" "lypodystrophy" "m-cherry" "mAR-V2"
    "mAR-V4" "mCRCs" "mCherry-LacI-FokI" "mCherry-LacI-FokI-induced" "mIU"
    "mK3+5" "mM" "mN" "mPanIN" "mPanINs" "mRFP" "mRNA-miRNA" "mRelB" "mTERT"
    "mTor" "mTor-complex-1" "mTor-complex-2" "mach2qtl" "macrophage-like"
    "macrovessels" "made" "make-up" "malades" "maladie" "male-female"
    "male-specific" "maleLKB1" "malformation-arteriovenous" "mammoplasty"
    "mammosphere" "manipulation-based" "mannoside" "mannosyl" "marché"
    "marianum" "marquage" "marquées" "masse" "mastectomy" "materials"
    "maternal-fetal" "mating-type" "matrilysins" "mauvais" "maximum-likelihood"
    "mean-age-diagnosis" "mean-age-onset" "mean-fold" "mean ± SD" "mean ± SEM"
    "mean±SD" "mean±SEM" "mean±s" "mean ± SD" "mechanical-resistant"
    "mediastinoscopy" "mediatd" "mediated-PCR" "meditators" "medium-throughput"
    "medulla" "mega-analysis" "mega-complexes" "megacomplexes" "melanin"
    "melanocortin-1" "melanogaster" "melanomas" "melatonin" "mellitus"
    "members" "membrane-cytoskeleton-associated" "membrane-impermeable"
    "membrane-permeable" "membrane-proximal" "membres" "meninges"
    "mesenchymal-epithelial" "mesenchyme" "mesenchyme-like" "meshwork"
    "mesoderm" "mesothelium" "meta-regression" "meta-static" "metallodrugs"
    "metalloendopeptidases" "metaphase-to-anaphase" "metastasectomy"
    "methoxyestradiol" "methyl-7-guanosine" "methyl-directed" "methyladenine"
    "methylcytosine" "methylene" "methylene-tetrahydrofolate" "methyllysine"
    "methylmorpholino" "methylome" "methylphenyl" "miCUL4B" "miNeg" "miR-10"
    "miR-101" "miR-103" "miR-106" "miR-106b" "miR-124a" "miR-125" "miR-126"
    "miR-128" "miR-128-binding" "miR-128-induced" "miR-128-overexpressed"
    "miR-128-transfected" "miR-128±chemotherapeutic" "miR-130a" "miR-132"
    "miR-133a" "miR-141" "miR-143" "miR-15" "miR-150" "miR-16" "miR-16-1"
    "miR-17" "miR-17-3p" "miR-17-5p" "miR-17-92" "miR-17-expressing"
    "miR-17-overexpressed" "miR-17-overexpressing" "miR-17-transfected"
    "miR-17–92" "miR-182" "miR-183" "miR-184" "miR-188" "miR-188-3p" "miR-18a"
    "miR-18a-associated" "miR-19" "miR-195" "miR-195-binding"
    "miR-195-downregulation-induced" "miR-195-induced" "miR-195-inhibited"
    "miR-195-mediated" "miR-195-mut" "miR-195-overexpressing"
    "miR-195-transfected" "miR-199" "miR-199a" "miR-200" "miR-200-mediated"
    "miR-200b" "miR-203" "miR-20a" "miR-21" "miR-21-Pdcd4-JNK"
    "miR-21-Spry1-ERK" "miR-21-dependent" "miR-21-induced" "miR-21-mediated"
    "miR-21-mimic" "miR-21-regulated" "miR-21-treated" "miR-210" "miR-21and"
    "miR-21apparently" "miR-221" "miR-221&222" "miR-222" "miR-224"
    "miR-224-dysregulated" "miR-23" "miR-25" "miR-26" "miR-27" "miR-29c"
    "miR-302" "miR-302d" "miR-303" "miR-328" "miR-34" "miR-34a-c" "miR-371-3p"
    "miR-371-5p" "miR-371–373" "miR-372" "miR-373" "miR-378" "miR-410"
    "miR-421" "miR-424" "miR-503" "miR-506" "miR-506-DOPC"
    "miR-506-transfected" "miR-506’s" "miR-520b" "miR-885-5p" "miR-9" "miR-9-1"
    "miR-9-2" "miR-9-3" "miR-9-induced" "miR-9-mediated" "miR-9-meditaed"
    "miR-98" "miR-99" "miR-99a" "miR-Ctrl" "miR-Ctrl-transfected" "miR-array"
    "miR-nc" "miR128-induced" "miR506" "miRANDA" "miRMD" "miRNA-mRNA"
    "miRNA-regulatory" "miRNA15" "miRnome" "miRs-31" "micro-architecture"
    "micro-cinematography" "micro-environment" "micro-mechanical"
    "micro-metastases" "microRNA-195" "microRNA-221" "microRNA-9"
    "microalbuminuria" "microaneurysms" "microarchitecture" "microbiota"
    "microcluster" "microclusters" "microcopy" "microdomains" "micrograph"
    "micrographs" "microhomologies" "microhomology" "micrometases"
    "micrometastases" "micropipette" "micropore" "micropthalmia"
    "microsatellite" "microsecond" "microseconds" "microspheres"
    "microstructure" "microvessel" "mid-1800s" "mid-1960s" "mid-blastula"
    "mid-life" "middle-passage" "midface" "midpoint" "midzone" "mieux"
    "mild-moderate" "millisecond" "mimosine" "mini-chromosome" "mini-gene"
    "minichromosome" "minigene" "minus-end" "mir" "mir-188-3p"
    "mis-localization" "mis-segregation" "misclassifications" "miscode"
    "missense" "mitoK" "mitochondrial-membrane" "mitochondrially-toxic"
    "mitoses" "mitosome" "mitotic-spindle" "mittels" "mixed-polyposis" "ml "
    "mock-infected" "mock-treated" "model-selection" "moderate-affinity"
    "moderate-level" "moderate-load" "moderate-or-severe" "moderate-severe"
    "moderate-to-high" "moderately-differentiated" "modest-burden" "moduli"
    "modulus" "moins" "mois" "mol-6" "mol6" "molecular-cascade" "molecule-1"
    "mono-zygotic" "monocyte-derived" "monocytogenes" "monodisperse" "monokine"
    "monolayer" "monolineage" "monolysocardiolipin" "monophosphate" "monosomes"
    "monosomy" "monotherapy" "month-old" "months" "montré" "morbidities"
    "morpholino" "morpholinopropyl" "motif-containing" "motifs" "motile"
    "moyen" "moyenne" "msec" "msh" "mt" "muFLT" "muFLT3-ITD" "mucosa" "mucosae"
    "multi-component" "multi-drug" "multi-ethnic" "multi-focal"
    "multi-function" "multi-functional" "multi-hit" "multi-institutional"
    "multi-line" "multi-modal" "multi-organ" "multi-potency" "multi-subunit"
    "multi-systemic" "multi-variate" "multicenter" "multicentre" "multicolour"
    "multicomplex" "multidomain" "multienzyme" "multilineage" "multilocus"
    "multimer" "multinucleate" "multiparameter" "multipass" "multipath"
    "multiple-dimensional" "multiple-testing" "multiprotein" "multirisk"
    "multistage" "multisystem" "multivariate" "muscle-invasive"
    "muscle-specific" "muscularis" "musculus" "mutageneis" "mutant-GTP"
    "mutants" "mutation-carriers" "mutation7" "mutations" "mutli" "mutli-angle"
    "myAKT+ERG" "mycin" "myocardium" "myocytes" "myofiber" "myofibers"
    "myofibroblast-like" "myofilaments" "myotillin" "myotoxin" "myrAKT"
    "myrAKT+ERG" "myrAkt+ERG" "myristate" "mysosin" "médiane" "métastases"
    "métastatique" "métastatiques" "mögliche" "n=1" "n=12" "n=14" "n=15" "n=16"
    "n=2" "n=20" "n=218" "n=22" "n=27" "n=28" "n=3" "n=4" "n=5" "n=6" "n=7"
    "n=79" "n=9" "n=97" "nBAF" "nLDL" "nPKC" "nPKCs" "nRPTC" "nRPTCs" "nano"
    "nano-gold" "nanoelectrospray" "nanoliposomes" "nanoparticle-delivery"
    "nanopore" "nanosecond" "nasopharynx" "native-fold" "naturally-occurring"
    "nc" "near-4C" "near-background" "near-basal" "near-complete"
    "near-normoxic" "near-universally" "nearest" "nearest-neighbor"
    "nearsightedness" "nebulin-like" "necesitate" "necroses"
    "negative-regulators" "negatively-stained" "neo-adjuvant" "neoadjuvant"
    "neocortex" "neonatal-pediatric" "neoplasias" "nephropathy" "netrin-DSCAM"
    "nette" "neu-mediated" "neu-negative" "neu-positive" "neu-targeted"
    "neural-precursor-cell-expressed" "neurite" "neuro-degeneration"
    "neuro-glial" "neuro-oncological" "neuroectoderm" "neuroendocrine"
    "neuron-like" "neuropathologies" "neurosphere" "neurospheres"
    "neurosurgery" "neutropenia" "never-drinkers" "never-smokers" "newer"
    "newly-synthesized" "next-generation" "ngml" "nicht" "nidus" "nighttime"
    "nine-residue" "nitorosurea" "nitrilotriacetate" "nitro"
    "nitro-N-nitrosoguanidine" "nitro-group" "nitrophenanthrene"
    "nitrophenathrene" "nitrosobutyl" "nitrosoguanidine" "nitubacin"
    "node-metric" "node-metrics" "noise-driven" "nonAA" "nonAA-UUT"
    "nonAsignificant" "noncarriers" "nonfat" "nonhistone" "nonobese"
    "nonphosphoproteins" "nonrandom" "nonsense-mediated" "nonsense-mutant"
    "nonsignificant" "nontarget" "normal-inflammation-cancer" "normals"
    "nosology" "noteworthiness" "notre" "noté" "notée" "nouvelles"
    "now-familiar" "npBAF" "nt" "nuclear-soluble" "nucleases" "nucleo"
    "nutrient-replete" "nystagmus" "nécessaire" "négatifs" "n = 3" "n = 4"
    "n = 1" "n = 14" "n = 16" "n = 2" "n = 20" "n = 22" "n = 3" "n = 4" "n = 5"
    "n = 7" "n = 8" "n = 9" "ob" "obervations" "object-related" "objectives"
    "observée" "oculis" "odds-ratio" "oder" "oeso" "oeso-gastrique" "oesophage"
    "oestrogen" "ofCYP3A5" "ofLKB1" "ofLRP6" "ofPten" "ofSNP" "ofalong"
    "ofamplitude" "ofand" "ofandas" "ofandto" "ofaswhich" "ofat" "ofdue"
    "ofeven" "off-rate" "off-target" "officinalis" "offor" "ofin" "ofis"
    "ofnetwork" "ofonandin" "ofonin" "oforand" "ofoscillations" "ofto"
    "ofvaries" "ofwas" "ofwhich" "ofwill" "ofwith" "ofwithallowsto" "ofwithand"
    "ofwithwill" "oleoyl" "oleoyl-CL" "oligo" "oligoadenylate" "oligomycin"
    "oligos" "oluble" "omologues" "on-going" "on-rate" "on-target" "onco"
    "onco-kinase" "onco-miRNA" "oncogenic-stress-induced" "oncology"
    "oncomicroRNA" "oncomirs" "one-dimensional" "one-ended" "one-half"
    "one-quarter" "one-sided" "one-tenth" "one-third" "one-way" "ones" "onk"
    "onset-of-symptoms" "ontogeny" "oophorectomies" "open-angle" "open-label"
    "opératoires" "organelle" "organelles" "origin-recognition" "oropharynx"
    "ortholog" "orthologue" "orthologues" "orthomyxoviruses" "osteoblast-like"
    "osteoblasts" "ou" "ought" "out-compete" "out-growth" "out-of-frame"
    "out-of-pocket" "outs" "outside-in" "outward-facing" "over-activation"
    "over-duplication" "over-interpreted" "over-phosphorylated"
    "over-representation" "overdominant" "overdose" "overexpressd" "overridden"
    "overtimes" "overview" "oxaliplatinum" "oxgenase-1" "oxidases"
    "oxidative-phosphorylation" "oxidative-stress" "oxoG" "oxoGuanine"
    "oxoguanosine" "oxygenase-1" "oxygens" "p110s" "p110β-CAAX" "p110β-null"
    "p18INK4b" "p21INK4a" "p27-1" "p27-2" "p27Kip" "p300-mediated"
    "p38-NF-κB-signaling" "p38K" "p38MAPK" "p473-Akt" "p53-R175H-mutant"
    "p53-RpL11-dependent" "p53-activators" "p53-null" "p53-wt" "p53AKT" "p53Ab"
    "p53Abs" "p53CD" "p53Ctrl" "p53I2" "p53MA" "p53MYC" "p53Myc" "p53within"
    "p53wt" "p53β" "p53γ" "p53γ-tdTomato" "p53–290" "p85α" "p=0" "p=0.0002"
    "p=0.001" "p=0.0018" "p=0.002" "p=0.0022" "p=0.003" "p=0.0038" "p=0.004"
    "p=0.006" "p=0.008" "p=0.009" "p=0.01" "p=0.010" "p=0.012" "p=0.019"
    "p=0.02" "p=0.021" "p=0.028" "p=0.03" "p=0.038" "p=0.04" "p=0.047" "p=0.05"
    "p=0.06" "p=0.14" "p=0.52" "p=0.53" "p=0.87" "p=1" "p=1.24×10" "p=1.36×10"
    "p=2.8×10" "p=4.5×10" "p=5.3×10" "p=5.7" "p=7.21×10" "p=8.51×10"
    "p=8.92×10" "pA" "pBMN" "pBMN_EVI1-IRES-eGFP" "pCHK-2" "pCMV4" "pDS"
    "pEFIRES-B-eYFP-USP52" "pEGFP" "pEGFP-C1" "pEGFR" "pFGFR2" "pFOXO"
    "pFOXO3a" "pFOXO3a-S253" "pFlag" "pFlag-CMV" "pFlag-MBP-1-transfected"
    "pG-300" "pG-E300" "pG-E500" "pG-E700" "pGAL4" "pGL-3-Bax-Luc" "pGL3-A"
    "pGL3-G" "pGL3-basic" "pGL4-basic" "pGrb2" "pHSP27" "pHaMDR1" "pIERS-Pdcd4"
    "pIRES-Spry1" "pIRES2" "pIRES2-ZsGreen1" "pLHRE-firefly-luciferase"
    "pLKO2.0" "pLVX" "pLVX-TetOn" "pLenti" "pM" "pMAPK" "pMIA" "pMIA-II" "pMir"
    "pMir-report" "pPKCβI" "pPKCβII" "pQCT" "pRD" "pRD-DEST" "pRD-ORFeome"
    "pRL-CMV" "pRL-SV40" "pRL-SV40-Renilla-luciferase" "pRelA" "pS" "pS473"
    "pS564" "pS564-Daxx" "pS792" "pSIRT3" "pSLIKhygro" "pSMAC" "pSTAT" "pSTAT3"
    "pSer-104-MDA5" "pSer-88-MDA5" "pSer564-Daxx" "pShc" "pSmad3" "pT172"
    "pT308" "pT3N" "pTNM" "pTrk-PLCγ–immunoreactive" "pVP16" "pY542"
    "pack-year" "pack-years" "packs-year" "packyears" "paclitaxel-carboplatin"
    "pair-signal" "pair-wise" "paired-end" "paired-sample" "pairings"
    "pancreata" "pancreatitis" "pancytopenia" "pannus" "para-cancerous"
    "paracrine" "paraffine" "paraganglia" "paralogues" "parenchyma"
    "parent-infant" "particles" "particularités" "parvulins" "passen" "pasts"
    "patho" "pathobiology" "pathogen-associated" "pathogen-induced"
    "pathogen-specific" "pathologically-confirmed" "pathologique"
    "pathophysiology" "patient-level" "patient-population" "patient-years"
    "pattern-recognition" "paxilin" "pc" "pc-DNA3.1-HBx" "pcDNA-GFP-msh-UTR"
    "pcDNA3" "pcDNAHA" "pcDNAHA2-PRMT1" "penetrance" "penetrant" "pentanediol"
    "peptidome" "perhaps" "periamygdaloid" "perisplenitis" "peritoneum"
    "permis" "persistently-infected" "person-years" "personnes" "pes" "pg1as"
    "phTG1" "phTG5" "phTG7" "phTG7-4" "phamacophore" "pharmacophore"
    "phase-contrast" "phenome" "phenome-wide" "phenotype-correlation"
    "phenoxyquinazoline" "phenylpyridinium" "phenylthiocarbamide" "philtrum"
    "phonotype" "phophosites" "phorbolester" "phosphate-binding" "phosphatome"
    "phosphatydylinositide" "phospho-FGFR" "phosphoSTAT3" "phosphoSer118"
    "phosphodiester" "phosphoethanolamine" "phosphoinositide-3-kinase-like"
    "phosphoinositides" "phosphoproteome" "phosphor-STAT3" "phosphor-serine"
    "phosphor-specific" "phosphorothioate" "phosphorylation-ubiquitylation"
    "phosphorylationRIOK2" "phosphorylation–dephosphorylation" "phosphotau"
    "phosphtyrosine" "photo-induced" "photolesions" "photoproducts"
    "physical-chemical" "phytohemagglutinin" "phytyl" "pial" "picoseconds"
    "pif-treatment" "pilaris" "pinhole" "pituitary-thyroid" "pièces"
    "placebo-controlled" "plana" "plasmacytoid" "plasmosomes" "platelet-large"
    "platings" "platinum-doublet" "platinum–DNA" "pleiotropy" "plexes"
    "plexiform" "ploidy" "plotin" "plupart" "pluripotency-associated"
    "plus-end" "plus-ends" "plusieurs" "pmel*+BRAF" "pmid" "pmir-GLO-CDK1"
    "pneumonectomy" "polarity-dependent" "pole–localized" "poly-L-lysine"
    "poly-Q" "polyI" "polyaclylamidegel" "polyendocrinopahy"
    "polyendocrinopathy" "polyethylenimine" "polyinosine"
    "polyinosine-polycytidylic" "polymerase-1" "polymorphism" "polymorphisms"
    "polypectomy" "polyphenol" "polyphenols" "polypoid" "polyprotein"
    "polysomy" "polytene" "polyuridine" "polyvinylidene" "pombe" "pontine"
    "poor-impulse" "poorer" "poorest" "poorly-differentiated"
    "population-level" "portant" "porte" "porteurs" "porté" "positif"
    "positive-control" "positive-sense" "positiveone" "positron" "positrons"
    "post-1930" "post-MI" "post-UV" "post-capillary" "post-delivery"
    "post-dose" "post-embryonic" "post-exposure" "post-hoc" "post-infarct"
    "post-infection" "post-injury" "post-irradiation" "post-lysis"
    "post-menopausal" "post-mitotic" "post-mortem" "post-natal"
    "post-operative" "post-polypectomy" "post-prandial" "post-procedure"
    "post-progression" "post-remission" "post-repair" "post-replication"
    "post-replicative" "post-selection" "post-transcriptional"
    "post-transcriptionally" "post-transfection" "post-translational"
    "post-translationally" "post-treatment" "postmalignant" "postmortem" "posé"
    "potentiel" "pourcentage" "poursuite" "pp" "praecox" "premaxilla" "prend"
    "preplate" "pressure-overload" "preterm" "pri-miR-371–373" "primagraft"
    "primary-cultured" "primary-like" "primer-specific" "primitive-type"
    "primosome" "priori" "prioritise" "pro-angiogenic" "pro-apoptogenic"
    "pro-apoptosis" "pro-atherogenic" "pro-death" "pro-differentiative"
    "pro-fibrogenic" "pro-fibrotic" "pro-hypertrophic" "pro-inflammatory"
    "pro-invasive" "pro-life" "pro-megakaryocyte" "pro-megakaryocytic"
    "pro-metastasis" "pro-mitotic" "pro-neural" "pro-proliferative"
    "pro-recombinogenic" "pro-survival" "pro-tumorigenic" "proMMPs" "proband"
    "probands" "procaspase-3" "proche" "procédure" "progenitor-like"
    "progenitors-specific" "progeny" "progeroid" "progression-free-survival"
    "prohibitsto" "proliferator-activated" "proliferator–activated" "prolonge"
    "promoter-firefly" "promoter-less" "promoter-proximal"
    "promoter-regulatory" "promoter-reporter" "promoterless" "promotingrole"
    "pronostique" "proof-of-concept" "proof-of-principle" "propria"
    "proprotein" "prostaglandins" "prostatectomy" "proteasome-mediated"
    "protein-A" "protein-DNA" "protein-level" "protein-ligand" "protein-like"
    "protein-possibly" "protein-tyrosine" "protein–ligand"
    "proteolytically-sensitive" "proteome" "proteome-scale" "proteomes"
    "proteomic-scale" "proteomics-based" "proto" "protooncogene"
    "protooncoproteins" "protéine" "proven" "près" "précoce" "prédictif"
    "prédominance" "préliminaire" "présente" "présentés" "pseudo-abasic"
    "pseudo-monomer" "pseudocontrols" "pseudogene" "pseudogenes"
    "pseudohypoxia" "pseudoknot" "pseudosubstrate" "pseudosubstrates"
    "pseudotypes" "psychopathology" "publishedK" "pull-down" "pulls-down"
    "pulmonologists" "pulpa" "pulse-chase" "pulse-label" "pyknoses" "pylori"
    "pyridine" "pyrrolidinone" "péjoratif" "p = 0.05" "p = 0.06" "p " "p = 0"
    "p = 0.0002" "p = 0.002" "p = 0.0022" "p = 0.004" "p = 0.006" "p = 0.008"
    "p = 0.009" "p = 0.01" "p = 0.02" "p = 0.03" "p = 0.04" "p = 0.05" "q21of"
    "qMSP" "qMSP1" "qMSP2" "qRT" "qt-RT-PCR" "qtPCR" "quality-control"
    "quality-of-life" "quantile-quantile" "que" "qui" "quinoxaline" "r-square"
    "r-squared=0.136" "r=0.612" "r=0.824" "rFSH" "rGel" "rLH" "rRNA" "rRNAs"
    "rad3" "radiation-induced" "radio-sensitization" "radio-therapy"
    "radioiodine" "radioligands" "radiophamaceuticals" "radiosurgery"
    "raft-dependent" "raft-linking" "raison" "random-effect" "random-effects"
    "random-primed" "rank-sum" "rare-cutting" "rarer" "ratiois" "ratiowas"
    "re-ChIP" "re-Chip" "re-aggregation" "re-analyzed" "re-assembled"
    "re-association" "re-biopsies" "re-biopsy" "re-combination" "re-confirmed"
    "re-diagnosed" "re-distributed" "re-distribution" "re-docked" "re-engage"
    "re-entry" "re-establish" "re-establishes" "re-establishing"
    "re-establishment" "re-evaluated" "re-evaluation" "re-examination"
    "re-examined" "re-expressed" "re-expression" "re-fed" "re-feeding"
    "re-form" "re-introduced" "re-introduction" "re-localization"
    "re-normalization" "re-orientation" "re-oxygenation" "re-plotted"
    "re-positioning" "re-review" "re-scored" "re-sequencing" "re-sorted"
    "re-stimulated" "re-structuring" "re-synthesis" "re-tested"
    "re-vascularization" "re-wiring" "reChIP" "reaction-restriction"
    "reaction–restriction" "read-out" "read-outs" "readout" "readouts"
    "real-time-PCR" "real-world" "realtime" "reattach" "receiver-operator"
    "receptor-1" "receptor-bound" "receptor-cofactor" "receptor-ligand"
    "receptor-like" "recirculate" "recombinat" "recouple" "red-pinkish-colored"
    "redirects" "reduction-of-function" "reduction-oxidation" "reentrant"
    "reevaluate" "refractile" "region–which" "regrowth" "regs" "regulationg"
    "regulator-two" "regulators" "relatedness" "relocalizes" "remodeler"
    "remodelers" "remodeller" "remodellers" "repair-driven"
    "replication-associated" "replication-competent" "replicaton" "replicon"
    "replicons" "reponse" "reporter-based" "represse" "repressors"
    "reproductive-aged" "rescueddEGFRλ" "researchs" "resin-bound" "responders"
    "response-element-binding" "response-elements" "restoresp21" "retenu"
    "reticula" "retro" "retrotransposon" "retrouvée" "retrovirus" "reuptake"
    "reverse-transcribed" "reverse-transcription" "reversion-inducing"
    "reversion-inducing-cysteine-rich" "revertant" "revertants" "reçu"
    "rhabdoviruses" "ribose" "ribosomal-protein" "ribosomal-stress"
    "ribosylases" "ribozyl" "right-hand" "rightmost" "risk-modifier"
    "risk-score" "ritterazine" "rmTOR" "rnCM" "rotarod" "rotein" "rotein1"
    "rounded-up" "rowth" "rpm" "rrest" "rs10028213" "rs101917151" "rs1021188"
    "rs10225230" "rs10232819" "rs10234685" "rs1024582" "rs10282436"
    "rs10411210" "rs1042522" "rs1042713" "rs10486302" "rs1049110" "rs10508881"
    "rs1051730" "rs10519203" "rs10795668" "rs10917151" "rs10917469"
    "rs10965235" "rs10974944" "rs10975519" "rs11112872" "rs11129801"
    "rs11191454" "rs11191732" "rs11206890" "rs11226373" "rs1122979"
    "rs11252394" "rs1143634" "rs1144393" "rs11584787" "rs11601239" "rs11710456"
    "rs11925054" "rs11984041" "rs12155400" "rs12205363" "rs12260727"
    "rs12279250" "rs12374816" "rs12535837" "rs1254319" "rs12700667" "rs1277836"
    "rs12778366" "rs12828421" "rs12883458" "rs13271465" "rs1352075"
    "rs139292572" "rs1443434" "rs144567652" "rs144848" "rs1519761" "rs1522113"
    "rs1625895" "rs1652333" "rs1656404" "rs166330" "rs166332" "rs16826658"
    "rs16892766" "rs16969968" "rs17084051" "rs17348299" "rs17495520"
    "rs17560407" "rs17561" "rs17576" "rs17638544" "rs17648524" "rs17878362"
    "rs1799750" "rs1799782" "rs1799782∶Arg194Trp" "rs1799889" "rs1800587"
    "rs1801173" "rs1801174" "rs1805126" "rs1816769" "rs1933752" "rs2062377"
    "rs2072209" "rs2107595" "rs213273" "rs213274" "rs213276" "rs21661074"
    "rs2186369" "rs2230739" "rs2234693" "rs2235529" "rs226716" "rs2268388"
    "rs2273773" "rs227395" "rs2279744" "rs2293303" "rs2293445" "rs2334693"
    "rs235770" "rs2380165" "rs2412546" "rs2473277" "rs2521634" "rs25487"
    "rs25487∶Arg399Gln" "rs271170" "rs2736100" "rs2796498" "rs2909430"
    "rs2983521" "rs308738" "rs3087386" "rs3138144" "rs34535804" "rs34897046"
    "rs3765728" "rs3802842" "rs3826782" "rs401681" "rs404256" "rs429358"
    "rs4319515" "rs4417527" "rs4444235" "rs4654783" "rs4704397" "rs4722551"
    "rs4722750" "rs4723002" "rs4750316" "rs4778879" "rs4779584" "rs4869742"
    "rs4878639" "rs4912408" "rs4930561" "rs4939827" "rs495366" "rs509208"
    "rs514921" "rs522616" "rs522616A" "rs524952" "rs565453" "rs5800607"
    "rs6002674" "rs603965" "rs61764370" "rs6421315" "rs649392" "rs6499766"
    "rs6554163" "rs6757804" "rs6795970" "rs6800541" "rs6859974" "rs6907340"
    "rs6909279" "rs692243" "rs6983267" "rs6988229" "rs7045138" "rs7069102"
    "rs7124327" "rs719725" "rs7210902" "rs7224668" "rs723296" "rs7240777"
    "rs7553035" "rs7652995" "rs7744813" "rs7751941" "rs7762018" "rs7762544"
    "rs7798431" "rs7839059" "rs7850258" "rs8112048" "rs861539∶Thr241Met"
    "rs909674" "rs9287237" "rs9296009" "rs9340799" "rs9347083" "rs947474"
    "rs950286" "rs9533090" "rs961253" "rs965513" "rs992918" "rs9929218"
    "run-in" "rupture-tension" "réalisé" "réalisée" "réalisées" "régions"
    "réponse" "résultats" "s00401-013-1101-1" "sICAM-1" "sICAM1" "sTNFRII"
    "sTREM-1" "sVCAM1" "salerimide" "salerimide-complex" "saline-injected"
    "saline-treated" "saline–Tween" "salmeterol" "salt-bridge" "samplings"
    "sans" "santé" "sarcomatoid" "sc-9007" "scheint" "schweinfurthin" "sclera"
    "scr-ls-LNCaP" "scratch-wound" "scratch-wounds" "screenings"
    "second-generation" "second-messenger" "second-site" "secondaires"
    "secondarily-transplanted" "sein" "self-administration" "self-antigens"
    "self-avoidance" "self-cleavage" "self-contradictory" "self-degradation"
    "self-mutagenesis" "self-protection" "self-reactive" "self-regulation"
    "self-renew" "self-renewal" "self-reported" "self-sufficient"
    "self-sustaining" "selumetenib" "semi" "semi-CRIB" "semi-flexible"
    "semi-quantitative" "semi-quantitatively" "semi-solid" "senescence-like"
    "senescent-like" "sensors" "sensu" "separation-of-function" "sequelae"
    "sequence-level" "sequence-specific" "sequenom" "ser866" "serines"
    "serology" "serotype" "serum-deprivation-induced" "serum-replete"
    "set-point" "set-up" "seuil" "seven-day" "sex-specific" "sh#2" "shCON"
    "shCav-1" "shControl" "shGRP" "shGRP-R" "shMYBBP1A" "shRNA-constructs"
    "shRNA-resistance" "shRNA-treated" "shRelB-1" "shRelB-3" "shSCR" "shan"
    "shape-changing" "shear-stress-dependent" "short-acting" "short-hairpin"
    "short-range" "short-term" "short-time" "showedTP53" "shp16-shp53-MYC-D1"
    "shp53-MYC" "shp53-MYC-RAS" "shp53-RAS" "shβ" "shβ-5d+stau" "shβ-Fop"
    "shδ193" "shδ203" "shδ800" "si-Scb" "si-VRK2-06" "si-VRK2-M" "si-YB-1#1"
    "si-YB-1#2" "si-YB-1-induced" "si-YB-induced" "si-control-treated"
    "si-ls-LNCaP" "si3" "siAR" "siControl" "siELF3#1" "siELF3#2" "siFOS"
    "siGFP" "siMYBBP1A" "siPKR" "siPin1" "siRNA#1" "siRNA#2" "siRNA-library"
    "siSIRT1" "siTGF" "siTGF-β1" "siTSP-1" "siVRK2" "siVRK2-06" "siVRK2-M"
    "siYB-1" "siYB-1#1" "sib-pair" "side-affects" "side-by-side" "side-chain"
    "side-effects" "side-note" "sideroblasts" "sifurin" "sigmoid"
    "sigmoidoscopy" "signaling-incompetent" "silico" "sillico" "silver-stain"
    "similark" "simplest" "simulatingandlevels" "single-cell" "single-chain"
    "single-gene" "single-lipid" "single-locus" "single-molecule"
    "single-nucleotide" "single-particle" "single-payer" "single-photon"
    "single-round" "single-signal" "single-strand" "single-substitution"
    "singulo" "sinusoids" "sip53" "sirtuin" "sirutin2" "sister-chromatid"
    "situ" "six-nucleotide" "six-subunit" "six-well" "skeletal-muscle" "sl"
    "slight-to-moderate" "slow-reversible" "slow-type" "small-animal"
    "small-cell" "small-interfering" "small-molecule" "small-molecules"
    "small-scale" "small-study" "smaller-scale" "smaller-sized" "smokers"
    "smoother" "snakebites" "sodium-induced" "sof" "soft-agar" "soit" "soleus"
    "solute" "solutionofas" "sont" "soraphen" "sorbitol" "sotrastaurin"
    "spacer" "spd" "specifiac" "specific-gene" "spectraplakin-like"
    "spectraplakins" "spezifisch" "sphere-like" "sphinganine" "sphingohpids"
    "sphingosine" "spindle-like" "splenectomy" "splice-site" "squamus"
    "src-family" "ss" "ss-DNA" "stabilizedlevel" "stably-silenced" "stade"
    "stainings" "stainp185" "star-shape" "state-of-the-art" "statistisch"
    "statut" "steady-state" "steeper" "stem-cell" "stem-like" "stembody"
    "stemness" "step-wise" "stepwise" "stereo-chemical" "stereocentre"
    "stereochemistry" "stereology" "stimulators" "stool-based" "stopgain"
    "stopgains" "strand-directed" "strand-transfer" "stratum-specific" "strep"
    "stress-activated" "stress-associated" "stress-dependent" "stress-fiber"
    "stress-induced" "stress-inducible" "stress-mediated" "stress-responsive"
    "stress-specific" "stressful" "stressors" "stress–driven" "stress–induced"
    "striate" "striations" "stricto" "stromal-conditioned" "stromal-derived"
    "stromal-mediated" "stromal-protected" "stromal-secreted" "stromelysins"
    "structure-activity" "structure-based" "structure-function"
    "structure–activity" "study-level" "study-wide" "sub-G0" "sub-G1"
    "sub-cellular" "sub-compartments" "sub-complex" "sub-complexes"
    "sub-domains" "sub-dominant" "sub-endothelial" "sub-family" "sub-group"
    "sub-groups" "sub-images" "sub-lethal" "sub-lineages" "sub-micron"
    "sub-nanomolar" "sub-network" "sub-nuclear" "sub-optimal" "sub-pathway"
    "sub-picomolar" "sub-pockets" "sub-population" "sub-score" "sub-set"
    "sub-stoichiometric" "sub-surface" "sub-type" "sub-types" "subG" "subclass"
    "subclassifications" "subcutis" "subdomain" "subfamilies" "sublines"
    "subplate" "subscores" "subserosa" "subspecies" "substituents"
    "substrateless" "substrates" "subthreshold" "subtype" "succinate"
    "sugeriert" "sulfate-polyaclylamidegel" "sulfonate" "sulfonylurea"
    "sundromes" "super-family" "super-repressor" "super-resolution"
    "super-shift" "supernatant" "supernatants" "suppressant" "supérieur"
    "surexprimant" "surface-tether" "surgically-confirmed" "surnamin" "survie"
    "switch-like" "symptomatology" "synapse" "synapses" "synaptophysine"
    "synergises" "synergism" "synovia" "synthases" "synthesome" "syringomyelia"
    "system-wide" "sélectionner" "série" "séries" "t-reference" "t=0" "t=25"
    "t=4.480" "t=5.005" "t=5.476" "tFCI" "tPKCβI" "tRNA" "tRNAs" "tSNP" "tSNPs"
    "tTreg" "tachycardia" "tachyphylaxis" "tacrolimus" "tail-length"
    "tailor-made" "tandem-affinity" "tandemly-duplicated" "tandemly-repeated"
    "tangle-like" "target-gene" "taux" "taxane-based" "tdTomato" "teashirt"
    "telomerase-essential" "telomerase-immortalized" "telospot" "temozolimide"
    "temperature-sensitive" "tenovin" "tenovin-6" "tenovin-6-dependent"
    "tenovin-6-induced" "tenovin-6-treated" "tenovins" "termand"
    "tert-butyl-4-hydroxyanisole" "testes-specific" "testing––suggesting"
    "tet-H1299" "tet-off" "tetra-polar" "tetranda" "tetrandra" "tetrazolium"
    "tg" "thalamus" "thaliana" "thatLKB1" "thatLRP6" "thathas" "thatis"
    "thatmakes" "thatstabilizesas" "theBrg1" "theI" "theK" "theLKB1" "theLRP6"
    "thePten" "theSNP" "theca" "thedEGFRλ" "thefirst" "thegenotype" "their-3"
    "thelevel" "thelevels" "thenwill" "thep53" "thermally-driven"
    "thermolabile" "theta" "thinner" "thio-1,2" "thirty-nine" "thr202"
    "three-dimensional" "thrombo" "thrombo-embolic" "thrombocythemia"
    "thrombocytocrit" "thrombopenia" "thrombus" "thymectomy"
    "thymidine-only-containing" "thyroidectomy" "thyroxine" "thérapeutiques"
    "tightly-bound" "tightly-regulated" "tile-sampling" "tilland" "tilt-pair"
    "time-chase" "time-course" "time-dependently" "time-lapse" "time-points"
    "time-span" "time-toprogression" "timecourse" "timeframe" "timeline"
    "timepoint" "tissue-1" "tissue-specificity" "tissues" "titer" "titers"
    "titres" "to-GDP" "toPTEN" "tocopherols" "todEGFRλ" "todecay" "toimpact"
    "toin" "toll-like" "tolloid" "too-high" "too-low" "tooris" "top53"
    "topology" "touche" "toute" "tracheostomy" "tranducer" "tranfectants"
    "trans-autocatalytic" "trans-farnesylthiosalicyclic" "trans-membrane"
    "trans-peptidation" "transcription-PCR" "transcription-quantitative"
    "transcriptome" "transdifferentiate" "transducer" "transfectant"
    "transfections" "transformants" "transient-transfection"
    "transmembrane-spanning" "transporter-1" "transposon" "transposons"
    "transwell" "treatment-naive" "tri-polar" "triage" "triamine" "triazolo"
    "tributylstannyl" "trilineage" "trim-and-fill" "trimester" "trimethyl"
    "trimethylates" "trinucleotide" "triphosphate" "triple-helical"
    "triple-negative" "triple-transgenic" "trisomy" "trisphosphate"
    "tristetrapolin" "trois" "trum" "tryptophanyl" "tryptophanyl-tRNA" "tubal"
    "tube-like" "tubule" "tubules" "tubuli" "tug-of-war" "tumeur" "tumeurs"
    "tumor-endothelial" "tumor-protective" "tumor-stromal" "tumor-suppressive"
    "tumor-to-blood" "tumor-to-muscle" "tumor-to-organ" "tumor-to-tissue"
    "tumorales" "tumorigenen" "tumorigenicTP53" "tumorpshere" "tumorsphere"
    "tumorspheres" "tunor" "ture" "turn-around" "turn-over" "turned-off"
    "turned-on" "twelve-lead" "twenty-four" "twenty-nine" "twenty-one"
    "twenty-seven" "twin-studies" "twin-study" "two-cell" "two-hybrid"
    "two-point" "two-sample" "two-sided" "two-specific" "two-stage" "two-state"
    "two-tailed" "two-thirds" "two-way" "twoPten" "type-1" "type-2" "type-I"
    "tyr204" "tyrosyl" "uPR" "uRPTC" "uRPTCs" "ubiquitin-proteasomal"
    "ubiquitin-proteosome" "ubiquitination-proteasome" "ubiquitins"
    "ubiquitinylation-based" "ubiquitome" "ultra-performance" "ultralow"
    "ultrasonography" "ultrastructure" "un" "un-irradiated" "uncommoness"
    "uncontrolledgrowth" "uncoupler" "uncouplers" "und" "under-estimate"
    "under-evaluate" "under-powered" "undergoes" "undergone" "underpinnings"
    "undertaken" "une" "units" "univariate" "unknownsK"
    "unlabeledoligonucleotides" "unmet" "unresponsiveness" "unsere" "untangle"
    "untersucht" "untersuchten" "up-regulatory" "up-stream" "upper-stream"
    "upshift" "urea" "utilisé" "utilizingwhich" "v-ErbA" "v-ets" "v567es"
    "vA49rev" "vBMD" "vBMDs" "vHCS" "vMCF-7" "vacuoles" "vacuolin-1" "vacuolus"
    "vagal" "valosin" "valproid" "values" "var" "variables" "variants"
    "variate" "variola" "vascular-targeting" "vasculopathy" "vasospasm" "vaste"
    "vastus" "vaut" "vdw" "vector-transfection" "vectormtDNA" "vectors"
    "vehicle-treated" "venules" "verfügbaren" "verlässlich" "verschieden"
    "versus-proficient" "vesicle-like" "vesicles" "vesicular-like" "vi"
    "viceversa" "vif-like" "vinorelbine-platinum" "vinylcyclohexene"
    "vinylpyrrolidinone" "virally-mediated" "viremia" "virion-bound"
    "vis-à-vis" "visually-evoked" "vitro" "vivo" "viz" "voltage-sensitive"
    "vont" "voxel" "vs.195014.7" "vu" "vwd" "vΔA49" "waren" "wash-out"
    "washings" "web-based" "web-resource" "website" "wedelactone"
    "well-accepted" "well-behaved" "well-conserved" "well-defined"
    "well-demarcated" "well-designed" "well-developed" "well-documented"
    "well-measured" "well-orchestrated" "well-organized" "well-powered"
    "well-recognized" "well-specific" "well-standardized" "well-studied"
    "well-suited" "well-tolerated" "well-type" "wenn" "whenand" "whereasLKB1"
    "whereasRIOK2" "wherelevel" "whichis" "whilep53" "whole-body" "whole-cell"
    "whole-cellular" "whole-endolysosomal" "whole-genome" "whole-plasma"
    "whole–genome" "wide-field" "wide-range" "wide-ranging" "wide-set"
    "widely-accepted" "widely-used" "wider-role" "wild-type-like" "wildtype"
    "withI" "withPten" "withdEGFRλ" "withdrawn" "within-cohort" "within-study"
    "withp53" "work-up" "workers" "workflow" "workup" "world-wide" "would-be"
    "written" "wtEGFR" "wurde" "wurden" "x-axis" "x-ray" "x10" "xIPLx" "xL"
    "xi" "xxL" "y-axis" "yeast-2-hybrid" "yeast-two" "yet-to-be"
    "yet-to-be-defined" "yrosine" "yttrium" "yttrium-90" "ytttium" "ytttium-90"
    "z-axis" "z-score" "z-scores" "z-stack" "zeigte" "zeta-chain" "ziemlich"
    "zinc-chloride" "zinc-dependent" "zu" "zwischen" "zymography" "×10" "×Flag"
    "×His" "×His-tag" "×Myc" "×p53" "× 10" "× 10" "âge" "échantillon"
    "éditeurs" "égal" "épidémiologiques" "étude" "étudiée" "étudiées" "été"
    "évaluer" "ĸB" "Δ-EGFP" "Δ133p53" "Δ2,3" "Δ2-transfected" "Δ20" "Δ235–260"
    "Δ237–241" "Δ246–250" "Δ2CARD" "Δ355–362" "Δ40p53" "Δ41" "ΔA49"
    "ΔAP-1-hTBP" "ΔC" "ΔCRIB" "ΔDB" "ΔEGFP" "ΔEGFR-positive" "ΔETGE"
    "ΔElk-1-hTBP" "ΔG" "ΔMEK" "ΔN" "ΔN270" "ΔNS1" "ΔNp63" "ΔR" "ΔRRM1" "ΔRRM2"
    "ΔRS" "Δexon3" "Δexon5q" "Δexons" "Δt" "ΔΨ" "α-CTL" "α-CTL+anti-miR-21"
    "α-PDCD4" "α-PDCD4+α-miR-21" "α-SNAP" "α-SNAPs" "α-SPRY1" "α-arrestin"
    "α-difluoromethylornithine" "α-dystrophycan" "α-helices" "α-primase"
    "α-satellite" "α-subunit" "α-subunits" "α1-PDX" "α1-antitrypsin-Portland"
    "α1-blockers" "α2-agonists" "α2a" "α2b" "α2c" "α2β1" "α3" "α4" "α5" "α6"
    "αV" "αβ-blockers" "β-1,4-galactosidase" "β-4" "β-N-acetylglucosamine"
    "β-N-acetylglucosaminidase" "β-TrCP-A49" "β-catenin-mediated" "β-enolase"
    "β-glucan" "β-glucan-containing" "β-glucan-induced" "β-glycerol"
    "β-hairpin" "β-oxidation" "β-subunit" "β-transducing" "β1-intergrin"
    "β1-β5" "β3" "β4" "β7-β8" "βI" "βII" "βcatenin-dependent" "γ-GCS" "γ-SNAP"
    "γ-glutamate-cysteine" "γ-glutamyl-transferase" "γ-irradiation"
    "γ-phosphate" "γ-radiation-induced" "γ-sarcoglycan" "γ-subunits"
    "γ-tocopherol" "γ2" "γH2A-X" "γH2Ax" "γc" "δ-tocopherols" "δKO" "δWT"
    "ε-Proteobacteria" "ε-amino" "ε4" "κ1" "κ1-site" "κB" "κB1" "κB2" "κB3"
    "κB4" "λ-phosphatase" "λ-value" "λ=1" "μCT" "μL" "μg" "μmoL" "μmol" "χ2"
    "‘ETGE’" "”-system" "−0.7%" "−1" "−2" "−9" "−animals" "−double"
    "−phenotype" "−strains" "≅32,000" "ﬂow" "ﬂux"))

(DEFPARAMETER SPARSER::*BIO-ENTITY-HEADS-PHASE3-9301-9600*
  '("Dikshit" "Bruggen" "hyphal killing experiements" "autologus"
    "experiements" "glucans" "Pilsczek" "BFDiv" "albicans" "fluorometery"
    "confocal microcopy" "Sytox" "microcopy" "DNaseI" "Reichner" "VIM12" "WGPs"
    "PMN" "co-recognition" "0.5–1" "Mn"
    "the ubiquitous tissue matrix component Fn" "fungal hyphae" "hyphae"
    "anti-fungal" "PMNs" "glucan" "Fn" "g/ mL" "U/ ml" "U/ mL" "Units/ml"
    "30 mins" "the proximal tubule" "recouple" "nRPTC"
    "losartan-treated uRPTCs" "n=28" "ICUE3" "FEN" "uRPTC" "n=15" "Naftilan"
    "Kamiyama" "n=6" "Supernatants" "VEH" "Kyoto" "nRPTCs" "uRPTCs" "RPTC"
    "sulfonate" "RPTCs" "dopamine-1-receptor" "re-establishing" "co-incubation"
    "n=3" "D 2 R" "AKAP2" "∼11%" "copellet" "MAPF" "+TIP" "short-time"
    "just four centrioles" "centrioles" "6DP" "Cyto" "phosphoproteome" "7AP"
    "9AC" "upshift" "orthologues" "homologies" "C19orf21"
    "adenomatous polyposis coli (APC)" "+TIPs" "2-methyl-2,4-pentanediol"
    "Non-Muscle" "+ 50" "–7 µ" "4 C" "co-depletion" "-α-"
    "the previously associated SNPs" "Beadchip" "the prior associated SNPs"
    "the associated polymorphism" "rs34897046" "LODO" "LOCCS" "rs1522113"
    "Wyeth" "theta ( PRKCQ )" "leukin" "an intergenic SNP rs11252394"
    "intronic SNPs" "our associated polymorphisms" "Liptak" "rs6988229"
    "rs11252394" "ARG1" "FBAT" "ACRN" "GACRS" "CAMP" "tachyphylaxis" "PEFR"
    "salmeterol" "LABA" "SABA" "BDR" "p= 0" "Krüppel-like" "n = 20" "= 0.003"
    "exon 9" "= 0.014" "1.21×10" "FEV 1" "TCRα" "KDLER" "Capitani"
    "effectuates" "perisplenitis" "muFLT3" "pulpa" "sinusoids" "muFLT" "hK02"
    "mK3+5" "KDLER1" "hKO2" "lentiviral pseudotypes" "pseudotypes" "hK"
    "EsiRNA" "pRL-SV40-Renilla-luciferase" "esiRNAs" "pLHRE-firefly-luciferase"
    "C3H/HeJ" "leukemia-like" "Fms-like" "esiRNA" "2 μg" "30 min" "eq" "CPMG"
    "solute" "oxygens" "Michaelis" "90mer"
    "highly stereospecific 5–10 kcal/mol" "pairings" "Watson" "the duplex S6M"
    "M-substituted" "S6M" "S5M" "NS5M" "diastereomer" "1 → 2are" "1 → 2"
    "2 → 1" "phosphodiester" "≤ 10" "A + B" "non-target" "→5" "= 1/"
    "nontarget" "5→3" "SF5" "S19F" "S11F" "S5F" "only 4–5 bp" "sl" "U/G" "U/A"
    "/ K" "± 0.04" "JF" "YQL" "RHS" "XYW" "GXZ" "pylori"
    "the histologic subtype" "SNP309T/T" "SNP309G/G" "serology" "P  = 0.03"
    "non- cardiac" "P  = 0.01" "1.21-1.89" "P  = 0.02" "P  = 0.04"
    "non-cardiac" "SNP309T/G" "≤ 0.05" "T/T" "homeodomain" "Δ3–8/R42A"
    "ΔDB 1–433" "RXXLXXXXN" "S9E" "S9D" "T6E" "T6D" "S9A" "N8A" "R7K" "R7A"
    "R4K" "R4A" "4–7" "CERs" "T6A" "Δ3–8" "LRVTRN" "MRAIL" "6E" "6D" "=  2"
    "-245" "co-transfecting" "Dutch" "echocardiography" "electrocytes"
    "overweight/obese" "the last years polymorphisms" "FIRKO" "cerevisae"
    "HR = 0.95" "= 0.69" "HR = 0.68" "= 0.53" "= 0.82"
    "benign and indeterminate follow-up cytology" "DPO" "benign cytology"
    "thyroidectomy" "diagnostic lobectomy" "lobectomy" "Cytopathology"
    "Bethesda" "assessements" "initial benign cytology"
    "suspicious malignant US" "the serial follow-up US" "benign ones"
    "20 (54.1%) benign ones" "discordant cytology" "had ambiguous cytology"
    "the indeterminate cytology" "non-diagnostic" "ultrasonography" "n = 22"
    "= 15" "= 10" "n = 8" "Conclusions/Significance"
    "especially chromosome 10 polysomy" "Everhard" "Malley" "Preusser"
    "stereotactic biopsy" "Wallis" "KPS" "qMSP1" "qMSP2" "21.4%1" "MLPAav"
    "Karnofsky" "-methylguanine-DNA methyltransferase (MGMT)" "qMSP" "HGG"
    "−250" "p = 0.009" "/µL" "/ β" "6F" "specific haematopoietic lineages"
    "synergises" "VLD" "different haematopoitic lineages" "proto" "polytene"
    "remodellers" "NUMAC" "coactivates" "methylated H3R17" "knockin" "H3R17"
    "PRMTs" "Mi2α/β" "coactivate" "NuRD" "remodeller" "-250"
    "Penicillin/Streptomycin" "this precise subset" "protein A/G" "peptidome"
    "domai" "GSTLYN" "masse" "ORFeome" "DEST" "pRD" "PLATO" "10 min" "Anti-P53"
    "non-receptor protein" "XIE" "Zhuo" "LIU" "shan" "Qian" "xi" "Chang"
    "HUANG" "ZHANG" "3435 TT" "2677 TT" "Gu" "2677TT"
    "a significantly higher CsA C 0 /D" "ofCYP3A5" "non-expressers"
    "expressers" "1/" "del/del" "1236TT-2677TT-3435TT"
    "a significantly higher CsA C  0 /D" "A significantly higher CsA C  0 /D"
    "TTT" "G2677T/A" "ins/del" "and 3A5" "a considerably higher CsA C  0 /D"
    "/D" "ATTG" "exon1" "P =0.002" "T/A" "adenoids" "BART 1-5p"
    "sustaining Burkitt’s" "bonafide" "the EBV-positive Burkitt’s" "Sugden"
    "Kuzembayeva" "BARTs" "an EBV-negative Burkitt’s"
    "Three biological replicates" "D7-1" "the residual viral genomes"
    "approximately one-half" "two recently explanted canonical Burkitt’s"
    "dnEBNA1" "EBERs" "Canonical Burkitt’s" "canonical Burkitt’s" "Burkitt’s"
    "Burkitt" "hg18" "Cyclin D1b" "VDJ" "rs649392" "rs1352075" "11q13.3"
    "all possible subsets" "ASSET" "nonsignificant" "rs603965"
    "the associated P -value" "Eigenstrat" "ploidy" "414,804 autosomal SNPs"
    "non-Northern" "Omni" "Nixdorf" "Heinz" "Heidelberg" "UKBS" "Germany"
    "BeadChips" "constitutional genotype" "hyperdiploid" "CCDN1" "PI3Kγ in"
    "chemoattractants" "TFLLR" "mouse 4T1.2 mammary carcinoma allografts"
    "= 4.5" "Non-metastatic" "mean ± S" "Gβγ" "p53 within" "vectormtDNA"
    "-dideoxyinosine" "dideoxyinosine" "-dideoxycytidine" "dideoxycytidine"
    "≥ 3" "~85%" "85-60kDa" "co-reside" "5F4" "non-CEACAM1" "Caspase 3/8"
    "which lacks both the ITIMs" "CH11" "CEACAM1-4L co-localized"
    "re-distribution" "re-evaluated" "30 min" "Ig-like" "CARD1"
    "rhabdoviruses (VSV)" "orthomyxoviruses" "rhabdoviruses" "DenV" "ΔNS1"
    "inIfih1" "F-x-x-R/K-x-R/K" "RVxF" "MAVS-CARD-proline-rich-domain (PRD)"
    "polyinosine" "EMCV" "encephalomyocarditis" "Cal" "SPSFENAHD" "ELTDLP"
    "VEALRRTG" "aminoacid" "A/R" "2CARD" "CARD2" "phosphatome" "~90%" "S5A"
    "R/K" "Co-Immunoprecipitation" "I:C" "non-phosphorylation" "ytttium"
    "Panasiuk" "failed previous oxaliplatinum" "oxaliplatinum" "SITILO"
    "endovascular catheters" "microspheres" "catheters" "immuhistochemistry"
    "yttrium" "≥ 3" "p  = 0.05" "p  =  0.06" "p = 0.05" "p = 0.06" "GY" "JZ"
    "HZ" "XW" "alphap" "only two polymorphisms" "Herrington" "periamygdaloid"
    "amygdala" "aripriazole" "Alonso" "Ouyang" "Cardno" "southern Europeans"
    "CT+TT" "CC+CT" "C-allele" "subscores" "global haplotype" "T-allele"
    "separate genotypes" "Weickert" "whose polymorphisms" "ESRβ"
    "symptomatology" "aripirazole" "psychopathology" "PANSS" "ESRα" "= 31"
    "p = 0.02" "p = 0.05" "Rs2234693" "sVCAM1"
    "causative unidentified polymorphisms" "SNPs/levels" "Hlatky" "Allah"
    "the A  519  -T  −340 haplotype" "genotypes/haplotypes" "A1GTAG" "A2GTAA"
    "sTNFRII" "rs514921" "rs1144393" "Cheng" "11q21-22" "non-obese" "Haplotype"
    "A1GATG" "rs495366" "P  = 0.002" "P  = 0" "± SD" "sICAM1" "P  = 0.003"
    "P  = 4" "= 8" "= 5" "= 2" "P  = 1" "Nagyerdei" "Debrecen" "GV" "Tween"
    "DK" "withdrawn" "the stratified squamous epithelium" "LXSN"
    "the cutaneous and mucosal epithelia"
    "11 homologous non-receptor tyrosine kinases" "HFK"
    "non-receptor tyrosine kinases" "YZ" "ZHH" "YQM" "LPX" "the Begg’s"
    "overdominant" "Wanfang" "= 25" "OR3" "exon 10" "P = 0.008" "Palandra" "/s"
    "ImageStream" "γc" "Williams" "ATR-107-A647" "imagestream" "lpr"
    "non-competitive" "MOA" "n = 4" "n = 3" "= 6" "+ 2" "Sanjun" "Junjie"
    "Baorong" "Lineng" "non-LNM" "LNM" "= 0" "diabetic nephropathy"
    "proximal and distal tubules" "NAD(P)H:NAD" "biliverdin" "fNrf2" "kNrf2"
    "Nuclear factor (erythroid-derived 2)-like" "oxygenase-1" "OHdG"
    "hydroxydeoxyguanosine" "DH+IS" "DN+IS" "Dahl" "AST-120" "4/5" "mg/kg/day"
    "n=16" "n = 16" "NAD(P)H:quinone oxidoreductase" "Willcox" "Lunetta"
    "Flachsbart" "Anselmi" "Gillum" "Verdin" "Saunders" "Auwerx" "Tollefsbol"
    "Lanza" "Shimazu" "Qiu" "Someya" "Schwer"
    "an N-terminal amphipathic alpha helix" "Frankel" "Rahat" "pSIRT3" "Bao"
    "Lauri" "Dimri" "Sundaresan" "Daitoku" "Pml" "Kitamura" "Frescas" "Brunet"
    "Hibi" "Furukawa" "Giannakou" "Yamaza" "Zanella" "Tindall" "insulinlike"
    "Benigni" "Onyango" "Scher" "Ahn" "Bellizzi" "Guarente" "Haigis" "Oliveira"
    "Kenyon" "forkhead box protein O1" "–76 " "mean ± SD" "+4 " "μg/ml "
    "morpholinopropyl" "radioiodine" "positrons" "6f" "6e" "Tsou" "Davis"
    "Parke" "d  " "Scatchard" "A431 or" "non-treatment" "approximately 1/50"
    "tumor/muscle" "good tumor/blood" "ID/g" "6c" "approximately 74 TBq/mmol"
    "= 1/10" "6d" "I-labeling" "f" "Morley" "iodophenol" "4-chloro-compound"
    "Rewcastle" "using acetic anhydride" "anhydride" "ethoxy" "Brocklin"
    "AMIRA" "approximately 14.8 MBq" "isoflurane" "Medica" "keV" "pinhole"
    "SPECT/CT" "at least 30 min" "Whatman" "AG17" "HNMPA" "Tl" "TBq/mmol"
    "sigmoid" "kBq" "WI" "TECT" "Signa" "penicillin/streptomycin"
    "trypsin/EDTA" "serum-supplemented Dulbecco’s" "buffer/MeOH" "NaH" "μL"
    "tributylstannyl" "MBq" "radiophamaceuticals" "-IPQ" "IPQ" "Iodophenoxy"
    "-6,7-diethoxyquinazoline" "radioligands" "pM" "Zeneca" "Astra" "I-labeled"
    "SPECT" "phenoxyquinazoline" "-6,7-diethoxyquinazoline (PHY)" "iodophenoxy"
    "= 27" "non-EGFR" "1 h" "= 4.5 " "= 9 " "= 1 " "60 min" "n  = 4" "n  = 3"
    "= 11" "= 6" "4H" "= 5" "= 8" "= 1" "10 min" "30 min" "= 7" "1H" "1 H"
    "4 h" "5 ± 3" "GA/GG" "1.28-1.78" "1.51-3.12" "1.26-1.75" "1.63-3.40"
    "387Leu" "_006288.2" "_000019.9" "Glutanine" "genotypes/alleles" "= 20"
    "OR = 1.67" "= 12" "= 16" "= 23" "= 24" "Kovtun" "GrB/FRP5"
    "an amphipathic helix" "de-immunized" "pHaMDR1" "GrB/26"
    "approximately 4 h" "U/μmoL"
    "-butoxycarbonyl-L-alanyl-L-alanyl-L-aspartyl-thiobenzylester (BAADT)"
    "BAADT" "publishedK" "apparentK" "AALEALAEALEALAEALEALAEAAAA" "cytotol"
    "rGel" "gelonin" "Kd" "Dalken" "GrB/4D5/26" "GrB/4D5" "Annexin V/Propidium"
    "Achilles" "neoplasias" "pasts" "PCas" "non-nuclear" "pFOXO3a" "pFOXO"
    "chemico" "Caseine" "Co-IP" "4 h" "72 h" "non-histone" "Firestein"
    "nuclear/cytoplasmic"
    "miR-128-transfected HCT116 p53+/+ and p53 null cells HCT116 p53−/−"
    "HCT116 p53−/−" "Lain" "miR-128-transfected MDA-MB-231 cells"
    "HCT116 p53+/+" "Subset" "IngenuitySystems" "2  μ g" "2 h" "10 min"
    "P –value" "p53+/+" "FOLFIRINOX" "non-GEM" "low=1.00" "high=23.6" "63±79"
    "590±620" "576±3973" "757±2195" "242±629" "pre-treated tissue biopsy"
    "hENT1" "deoxycitidine" "EUS" "9 P" "oncomine" "Seq" "CIPI" "subG"
    "DACH1ΔC" "Proteintech" "oculis" "teashirt" "ey" "RDGN" "=38" "=97"
    "katsumadai" "Aplinia" "flavanoid" "CHC007100" "β-catenin/Tcf" "tetrandra"
    "benzylisoquinoline" "bis" "Rosen" "HQBA" "methylphenyl" "Coombs" "Brookes"
    "el" "IWP" "IWR" "CCT036477" "Ewan" "PKF118-310" "PFK115-584" "Gandhirajan"
    "CGP049090" "PKF118–310" "Kim" "Goosecoid" "ΔNp63" "homolog (LBH)"
    "Shtutman" "Tetsu"
    "This complex comprises adenomatous polyposis coli (APC)" "coli (APC)"
    "a transcriptional co-regulator" "TGFβ3" "EMT-like" "protein 1A" "Pin1KO"
    "further analyses involving NRCM" "HW/ BW" "siPin1-treated NRCMs" "siPin1"
    "NRCM" "cardiac hypertophy" "NRCMs" "hypertophy" "CSA" "Pin1 KO" "LVDd"
    "Pwd" "meditators" "Alzheimers" "interwoven" "Ser/Thr–Pro"
    "pcDNA-GFP-msh-UTR" "2 /2" "8 × 10" "the optimal 2-3  μ g" "2p23"
    "breakpoint" "3a/b" "echinoderm" "Non-small cell lung carcinoma" "2-3 "
    "5b" "≥15%" "= 45" "non-small cell lung carcinoma"
    "non-small cell lung carcinomas" "adventitia" "mutated 5 bases" "AVM"
    "sporadic BAVM" "nidus" "AVMs" "typical BAVMs" "Spetzler" "BAVMs"
    "the area around rs522616" "rs522616" "BAVM" "4 hrs" "P  = 0.02"
    "essential confounders" "exposed/non-exposed" "STROBE" "QUATSO"
    "Newcastle-Ottawa-Scale (NOS)" "df  " "28/28" "29/29" "Kadouri"
    "non-exposed" "≥29" "≥28" "Rebbeck" "RR/ORs" "≤26" "the actual RR/OR"
    "Israel" "= 0.14" "p  = 0" "df  = 3" "p =  0" "non-humans" "BRCA 1/2"
    "commitment/differentiation" "ELKF" "homogenates" "sorbitol" "KD-2" "KD-1"
    "R2–1" "PRMT1 G80R" "R2–3" "pcDNAHA" "p38β" "re-introduced" "Deng"
    "Clippinger" "cccDNA" "±2.63%" "pyknoses"
    "irregular and depressed plasmosomes" "rough endoplasmic reticula"
    "reticula" "plasmosomes" "pc-DNA3.1"
    "respectively reached peak values at 72 h" "pc" "~45–55%" "g/day"
    "proximal convoluted tubules" "aglucon" "P13K"
    "HBV-associated glomerulonephritis (HBVGN)" "membranous nephropathy (MN)"
    "Combes" "Tropical Africa" "HO33342"
    "hepatitis B virus-associated glomerulonephritis (HBVGN)" "HBVGN" "±0.04"
    "±0.02" "Annexin V/propidium" "72 h" "and 1 female"
    "17-dimethylaminoethylamino-17-demethoxygeldanamycin" "alvespimycin"
    "allylaminogeldanamycin" "benign PHEOs/PGLs" "Jimenez" "Lopez" "VHL / SDHx"
    "Succinate" "pseudohypoxia" "KIF1B β" "Hereditary and sporadic PHEOs/PGLs"
    "Pacak" "Favier" "Zhuang" "Robledo" "Cascón" "PGLs" "bilateral PHEOs"
    "bHLHZ" "Mendez" "Comino" "retroperitoneal PGL" "PGL"
    "hereditary PHEOs/PGLs" "NF1 -mutated PHEOs" "2q11"
    "clustering hereditary PHEOs/PGLs" "sporadic PHEOs" "Welander"
    "about 14% of sporadic PHEOs/PGLs" "Burnichon"
    "hypoxia-inducible factor 2α" "PHEO/PGL" "succinate" "Neumann"
    "the sympathetic and parasympathetic paraganglia" "the adrenal medulla"
    "paraganglia" "almost all inherited PHEOs/PGLs" "PHEOs/PGLs" "SDHx" "PHEOs"
    "PHEO" "Colombini" "Kolesnick" "-C17-ceramide" "BakKO" "-sphingosine"
    "acyl" "sphingosine" "sphinganine" "-ceramides" "MV411" "glucosylceramide"
    "deconvolute" "sphingohpids" "BCL2-like" "ceramides" "campothecin" "BCLb"
    "CerS" "Anti-apoptotic" "X 10" "Cdk1/2" "FOPFLASH" "TOPFLASH"
    "pmir-GLO-CDK1/2" "CDK1/2" "mimosine" "miCUL4B" "miNeg"
    "total active replicons 3 h" "replicons" "CldU" "-deoxyuridine" "SRs"
    "minichromosome" "5 B" "S3 C" "C57BJ/6" "del17" "phonotype" "dnAMPK"
    "Dscam" "21q22.2–22.3" "orthologue" "UNC40" "Netrins" "netrin" "Astle"
    "autoregulates" "exonic splicing enhancers" "ΔRS" "ΔRRM1" "overexpressd"
    "ΔRRM2" "NRS" "SRSF" "BJ" "monosomes" "interacted non-specifically" "DIRT"
    "Approximately 1/3" "anti-tumorigenic" "dintirophenol" "uncouplers"
    "Carreira" "Orazio" "Warburg’s" "TTFA" "UACC257" "A375P" "pmel*+BRAF"
    "+MITF" "*+BRAF" "Wargo" "serial biopsies" "UACC" "qtPCR"
    "the two E-boxes significantly inhibited this response" "E-boxes"
    "a proximal Ebox" "E-box" "Ebox" "sillico" "micropthalmia" "MitoTracker"
    "OXPHOS" "adiocytes" "p = 0.03" "p = 1" "non-melanomas" "antiacancer"
    "AR-1" "fluorescent oligo" "es" "μ g" "BU" "Escudero" "ASDs" "-R335X"
    "thePten" "twoPten" "inPten" "WT/M3M4" "aPten" "M3M4" "~60%" "R335X"
    "R233X" "~40%" "toPTEN" "-CC" "Cowden" "* P" "P =0.04" "~30%" "n =4" "~65%"
    "esophagi" "leukophilia" "lipopolysaccharide (LPS)" "gingiva"
    "non-transgenic mice" "andp53" "4-nitroquinoline-1-oxide" "squamus"
    "non-transcriptional" "4NQO" "R72/R72" "shδ800" "and 2D" "Y239/40" "pShc"
    "Y1221/1222" "shδ203" "shδ193" "shSCR" "δWT" "δKO"
    "the triple-negative tumor subtype" "GOBO" "Keshamouni" "-101" "For 3D"
    "to 2D" "and 2B" "P =0.03" "P= 0.01" "and 3D" "TRDB" "DN/WT" "primosome"
    "Euplotes" "congenita" "AAAKE" "Helix" "MLF3D" "nano"
    "a characteristic V-shaped" "Fourier" "for 3D" "V-shaped" "images/class"
    "cryo" "GraFix" "telospot" "-13×Myc" "_3×Flag" "-ZZ" "13×Myc" "_hTERT"
    "TEV" "×Flag" "×Myc" "TEVsite" "monodisperse" "micrograph" "pseudoknot"
    "G-overhang" "Blackburn" "Greider" "protein/DNA" "2 - 3" "2 -3" "Lane 4"
    "co-purify" "Lane 6" "co-purifies" "2- 3" "alarmins" "autoantigens"
    "insulitis" "corticosteroids" "6p21" "rs12778366" "dbSNP" "IV-2" "LOD"
    "endocrinologists" "U/L" "26-year-old" "nonobese" "polyendocrinopahy" "+ 1"
    "Anti-Inflammatory" "Kg/m 2" "the previously reported ITC" "ITC"
    "non-labeled" "d  " "loop3" "loop2" "anisotropy" "p53CD" "NFκB 1" "= 0.50"
    "rs10975519" "incl" "10q26" "Luong" "Nyholt" "rs4722551"
    "the moderate and severe subset" "rs2473277" "rs13271465" "CDKN2BAS"
    "rs10965235" "–e" "e" "the same ancestral haplotype" "rs4654783"
    "rs10917151" "rs16826658" "rs7210902" "HSPC157"
    "the Long Intergenic Non-protein" "Breslow" "Cochran-Mantel-Hanzel"
    "rs1519761" "rs10508881" "HNRNPA3P1-LOC100130539" "rs6907340" "rs6757804"
    "rs2235529" "4.51×10" "relatedness" "callrates" "filtering 580,699 SNPs"
    "hwe" "callrate" "Gentrain" "OmniExpress" "the intergenic SNP rs12700667"
    "rs12700667" "9p21" "Uno"
    "two large Genome-Wide Association Studies (GWAS)" "Studies (GWAS)"
    "Rahmioglu" "Montgomery" "dyspareunia" "LINC00339" "6p22.3" "10q11.21"
    "HNRNPA" "Bonferoni" "1p36.12" "2q23.3" "Cl " "= 27" "= 19" "8p" "= 1.25"
    "OR = 1.07" "P = 0.05" "OR = 1.17" "OR = 1.16" "P = 1" "Non-protein" "= 6"
    "7p15" "P = 4" "four representative ISGs" "Replicate"
    "four prototypic ISGs" "ISG" "the characteristic 6 bp" "TTAGGG3"
    "approximately 35 population doublings" "HEL-299s" "representative ISGs"
    "at least 100 population doublings" "type-1" "HSV-1" "bps"
    "non-immortalized" "μg" "flotillin1/2" "Sigismund" "Fiore" "Paolo"
    "amilorid" "0–3" "Hinrichsen" "+6" "hyperimmunoglobulin"
    "the thymic medulla" "medulla" "4/108" "8/38" "and 3/11" "dbSNP137"
    "Genomes" "primagraft" "2.25 × 10" "1-2" "Danish" "Finnish" "6q25.1"
    "rs2334693" "+ CC" "OR=1.67" "OR=1.40" "allele: I" "inFig"
    "The two most frequently studies polymorphisms" "Xba" "Pvu" "rs9340799"
    "rs2234693" "using Begg's" "= 0.99" "= 0.82" "= 0.79" "P = 0.01"
    "P = 0.003" "P = 0.05" ": I" "inclusion/exclusion" "P =0.003" "=1.67"
    "P =0.05" "sequenom" "re-biopsies" "adrenalectomy" "catheter"
    "162 underwent rebiopsy" "rebiopsy" "Rebiopsy" "3/24" "4/75" "re-biopsy"
    "n=2" "HER2/CEP17" "Met/PI3K/AKT2" "Met/PI3K/AKT" "5/21" "Rhaman" "JHOC"
    "Met/PI3K" "20q13.2" "Yamamoto" "domain 1A" "Fe" "nitrilotriacetate" "OCC"
    "19q" "14% of" "/8" "Sprys" "59.5±7.7%" "nc" "onco" "HELF" "± SD" "_is"
    "_are" "C1654X" "Cypriot" "British" "FRY" "SCNAs" "_patients" "Subtype"
    "≤35" "Brazil" "hormonal receptors and HER2 expression/amplification"
    "expression/amplification" "5/10" "p = 0.021" "BRCA1 / 2" "Amstutz"
    "NucTrans" "vHCS" "Fascaplysin" "DMBI" "_PRS9" "Keller" "―a"
    "the more aggressive ARMSs" "ERMS" "fascaplysin" "ARMSs" "Hct" "Vannucchi"
    "Noeva" "Panova" "Rodrigo" "Arellano" "multilineage" "increasses"
    "Argentina" "Campbell" "clony" "consistant" "thrombocytocrit (PCT)" "PCT"
    "thrombocytocrit" "PLT+RBC" "PLT+WBC" "monolineage" "10.0–50.0"
    "Granulopoiesis/erythropoiesis" "thrombopenia" "splenectomy" "/L"
    "non-reactive" "bilineage" "trilineage" "PDW" "p = 0.001" "Bastos"
    "epiphenomenon" "Separin" "reattach" "decondense" "Wolter" "linescans"
    "stembody" "midzone" "UbcH10–" "UbcH" "hGas2l3" "derivate" "derivates"
    "D-box" "RXXL" "GAS2L1" "GAS2L3" "Gas2l3" "Gas2l" "GAR" "rrest-" "rrest"
    "rowth" "spectraplakins" "ESCRT" "APC/C" "1 hr" "–2 µ" "non-degradable"
    "co-operatively" "MEK1CA" "obervations" "RAdMEK1CA" "RAdMKK3bE" "RAdSmad3"
    "MKK3bE" "constitutively active MKK3b" "MKK3b" "Smad3DN" "RAd66" "RAdSmad4"
    "EF7KO" "EF7WT" "proMMPs" "zinc-dependent metalloendopeptidases"
    "metalloendopeptidases" "extracellular signal-regulated kinase 1/2"
    "p38 MAPKs" "in 1∶1" "Qi" "−9" "immunoglobulins" "researchs" "j" "CD44v6"
    "AJCC" "P = 0.010" "P = 0.003" "± SDs" "n = 4" "n = 16"
    "d4T-associated acute pancreatitis" "less toxic NRTI" "monophosphate"
    "deoxyuridine" "1298 A → C" "thermolabile" "677 C → T" "MTND2/HON4917G"
    "haplogroup" "acute clinical pancreatitis" "SPINK-1"
    "both acute pancreatitis" "Acute pancreatitis" "kazal-1" "conductance"
    "B+B  " "B+A  " "A+B  " "A+A" "1.23–7.41" "1298A→C" "677C→T"
    "patient-years (PY)" "developed pancreatitis" "lypodystrophy" "NRTI"
    "HAART" "cells/mm" "d4T-associated pancreatitis" "HALS" "methylene"
    "acute pancreatitis" "non-mutated" "C → T" "copies/ml" "C→T" "2/2" "≥60"
    "P = 0.021" "P = 0.002" "UC1" "UC17" "UC16" "UC15" "IVIS" "center/right"
    "UC9" "UC6" "mol/L" "UC13" "UC12" "UC14" "UC3" "MIBCs" "NMIBCs" "BGJ-398"
    "BGJ" "non-invasively" "P = 0.0018" "P = 0.0038" "5 /50 µ"
    "invasion/metastasis" "poorest" "Jager" "Cusi" "M-values" "DEXA" "U/ml"
    "±SD" "mmol/l" "relatively few human biopsies" "NAFLD"
    "expression/phosphorylation" "M-value" "hyperinsulinaemia" "lateralis"
    "vastus" "= 0.52" "= 0.73" "= 0.27" "n = 7" "Ser9/21" "–250 µ" "immunogold"
    "Kerfoot" "Kong’s" "co-variables" "vascular emboli" "emboli" "subserosa"
    "propria" "muscularis" "gastric epithelia" "non-overexpression" "P  = 0"
    "micrometastases" "Eosin" "mTOR" "shGRP" "shCON" "pathobiology" "mediatd"
    "$200" "Tanaka" "only adenocarcinoma histology" "interquartile"
    "bronchoscopy" "Oncology (ASCO)" "pulmonologists" "Seoul" "Samsung"
    "N = 15" "N = 9" "N = 5" "P = 0" "N = 1" "non-squamous" "exon 19"
    "the chromatin around DSBs" "Sae2-like" "MMEJ" "mRFP" "CtIP-5A-CDK"
    "-T245A/T315A" "-K160M-GST" "K160M-GST" "S347A" "-R28A" "S276A"
    "-S549A/S568A" "5mCDK" "FHA/BRCT" "RRHK" "EQ" "5mCDKs" "S549A/S568A"
    "CtIP-7A-CDK" "T847A/S889A" "CtIP-3A-ATM" "ATMi" "/dsDNA"
    "FHA/BRCT domains" "Ku" "+S" "consequently no p65 co-precipitated"
    "viral protein D8" "SGLNES" "S7/12E" "S7/12A" "IκBα-like" "vA49rev"
    "SGNLES" "DSGX" "Sendai" "titres" "vΔA49" "ΔA49" "revertant" "TAAAT" "A49R"
    "camelpox" "protein A49" "VACV" "variola" "non-specifically" "2–3 S" "I∶C"
    "OSW-1" "schweinfurthin" "ritterazine" "metallodrugs" "vi" "AUS" "=218"
    "genechip" "HuRSTA" "strong anti-proliferative" "OVCAs" "Talalay" "Chou"
    "CellTiter" "n=8" "OVCA" "P=0.03" "P=0.02" "platinum/taxane" "=79"
    "GTGGGCG" "-GCGGG" "GCGGG" "TTCC" "cruciform-like" "gene/protein" "PARG60"
    "PARG110" "N-methyl-N" "+50" "-siRNA-transfected" "DharmaFECT" "SMARTpool"
    "PKAIP" "Akirins" "non-Rel" "κB1/2" "κB1/κB2" "supershifts" "κB2" "κB1"
    "κB4" "κB3" "Supershift" "nucleo" "M4/M5" "4C" "κ B" "-76"
    "the Kaiser Northern California biobank" "Biobank" "biobank" "Kaiser"
    "Algorithm" "myenteric plexes" "gastrointestinal mucosa" "spinal afferents"
    "cholecystitis" "plexes" "afferents" "vagal" "Holm" "Pfeufer"
    "supraventricular and ventricular tachycardia" "coders" "atrium"
    "atrial fibrillation/flutter" "rs6795970" "rs6800541" "rs11129801"
    "C6orf204" "rs1805126" "msec" "Vanderbilt" "biobanks" "EMRs" "PheWAS"
    "the most significant SNPs" "p=1"
    "electronic medical record (EMR) algorithms" "EMR" "reentrant"
    "arrhythmias" "QRS" "p=0.14" "=1.07" "=6" "VAD" "anti-parallel" "adenylate"
    "uncoupler" "AMP+ADP" "AMPKγ" "lpha" "ethylmalemide" "oluble" "oligomycin"
    "pT172" "hyh" "AMPK α2" "AMPKα2" "~2-fold" "pT308" "co-precipitation"
    "Atelocollagen" "at least four Y-box" "Y-box" "co-ordinately"
    "absence/reduction" "Bulingame" "siYB-1#1" "atelocollagen" "si-YB-1#2"
    "si-YB-1#1" "siYB-1" "alternative si-YB-1#2" "=10" "=12" "1.0 × 10" "1 h"
    "96 h" "siRNA#2" "siRNA#1" "36-month" "=−" "HR=1.30" "95% CI=0" "HR=0.67"
    "histologic subtype" "95% CI =0" "HR=0.68" "HR=0.98" "=0.69–1.37"
    "vs IV phase III trial GOG-172" "interstrand" "antimicrotubule" "⩽10%"
    "GOG-172" "GOG" "intraperitoneal platinum/taxane" "EOC" "P =0.028" "=1.46"
    "=0.98" "=0.69" "HR=0.97" "χ  2" "absent/low" "P =0.0002" "P =0"
    "plasma membrane/cytoplasm" "S37" "the fluorescent dye Hoechst" "3 mg/kg"
    "BALB/C" "± 0.18" "SIRT1-sh3" "Lentiviral vector pLKO2.0" "pLKO2.0"
    "BML-266" "tenovin-6-induced" "tenovin-6-treated" "NBT" "tenovin-6-"
    "Giemsa" "cytospin" "Tenovin" "AC93253" "haplo" "BML" "U/mL" "CD34 +"
    "co-repressors" "overtimes" "intercellular cell adhesion molecule-1"
    "molecule-1" "Amplex" "p473-Akt" "ECAMs" "ShCav-1" "DCFH" "Hcav-1"
    "shCav-1" "HUV-EC-C" "ultralow" "adhesion molecule-1" "non-treated" "4 H"
    "soraphen" "Olson's" "Elheiga" "Olson" "Yoruba" "Utah" "Arkansas" "*gender"
    "the first visit diabetic BMIs" "fibrates" "gene*environment"
    "*environment" "BeadChip" "BMIs" "recorded full-heritage Pima Indians"
    "subsequently developed T2DM" "WF" "stratified analyses revealed rs2268388"
    "WFSM" "Stouffer" "the DN-associated ACACB SNP rs2268388" "QTL"
    "Dyslipidemia" "BMI≥30" "kg/m 2" "non-T2DM" "Germans" "T2DM"
    "nephropathy (DN)"
    "Acetyl coenzyme A carboxylase B gene ( ACACB ) single nucleotide polymorphism (SNP) rs2268388"
    "rs2268388" "p = 0.0002" "p = 0.0022" "non-statistically" "p = 0"
    "non-alcoholic" "∼5%" "Non-diabetic" "= 0.03" "= 0.049" "= 0.02" "= 0.09"
    "possible shared genetic underpinnings" "phenome" "Offenbacher" "continuum"
    "gAgP" "available SNPs" "Michalowicz" "NHANES" "Asma"
    "an unlikely confounder" "confounder" "severe CP— P = 2"
    "never smokers ( n = 1825)—OR = 0.77" "—OR = 0.77"
    "the intronic rs11112872" "rs11112872" "rs7762544" "rs12883458"
    "gingivalis" "actinomycetemcomitans" "Aggregatibacter" "Divaris"
    "rs12260727" "rs3826782" "rs11925054" "member 5A" "Periodontology"
    "rs2521634" "Americans (EA)" "ever/never" "P = 2.8 × 10" "OR = 0.77"
    "= 0.56" "= 0.05" "P = 0.06" "OR = 1.64" "P = 0" "= 0.15" "P = 4" "= 0.07"
    "= 1.41" "= 0.18" "= 6" "= 0.14" "6 × 10" "P = 1" "95% CI = 1" "−7" "10p15"
    "RpL11-p53-dependent" "RpL11-p53" "ZVAD" "mutation/amplification"
    "p53-RpL11-dependent" "GBM39" "mTor-complex-1" "EIF" "Rio1p"
    "mTor-complex-2" "ofPten" "controlPten" "withPten" "ΔEGFR-positive" "RIOKs"
    "mutation/overexpression" "Neurosphere" "overexpression/mutation" "dRIOKs"
    "RIOK" "dRIOK1" "KEGG" "dRIOK2" "rescueddEGFRλ" "todEGFRλ" "withdEGFRλ"
    "dp110" "dEGFRλ" "post-embryonic larval glia" "Rio2p" "ght"
    "invasive neoplastic glia" "ΔEGFR" "RIO" "RpL11-dependent" "RpL" "mTor"
    "orthologs" "n = 20" "n = 14" "intraclass"
    "the previously identified QT SNPs" "tri/tetracyclic" "5.0 × 10"
    "approximately 2.5 million autosomal SNPs" "UAZ" "tri/tetracyclics"
    "phenylthiocarbamide" "Arizona" "sulfonylurea" "QT" "= 0.69" "~2.5 million"
    "re-wiring" "patho" "oxidases" "Druker" "Brian" "miRNA15/16" "andBCL" "XL"
    "ΔN" "Y/F" "EE/AA" "ESR/CMH" "amines (CMH)" "amines" "electro" "DTPA"
    "triamine" "diethylene" "Abelson" "Stat5_1" "TTCN" "Stat5a/b" "γH2A-X"
    "N-acetyl-cystein (NAC)" "Ba/F3p210" "Stat5a-IRES-GFP" "Amutations"
    "Philadelphia" "BCR-ABL1" "2 ×10" "p = 0" "1  +" "the presynaptic D3R"
    "D3R" "D2R" "isozyme" "unique isoenzymes" "isoenzymes" "i/o" "D 2 S" "N=8"
    "pPKCβII" "Veh" "PKCβI" "=6.46" "PKCβII" "isozymes" "df = 3" "=6–15"
    "0.001 ( xref ) F (5,45)=5" "D2S" "postmortem" "Reuptake" "D2autoR" "Cβ"
    "D2autoRs" "≤15" "PLCβ" "= 10" "N=4" "= 4" "= 38" "N=5" "N=14" "βII" "βI"
    "aetio" "broad ethnic group categorisations" "categorisations"
    "multicentre" "English" "thrombo" "Zulu" "Africa" "rs1799889"
    "epiphenomena" "prioritise" "HELLP" "C/EBP's" "−4200" "+96" "−1718"
    "astroctye" "p38K-" "dendrite" "reuptake" "p38K" "-1β" "exon 1" "∼5-fold"
    "_s" "C/EBP" "Gadd45α" "epidermoid" "berberne" "Immuno" "berbrine" "min/+"
    "arrhythmia" "immorto" "Papaveraceae" "Ranunculaceae" "= 0"
    "the mutational hotspots" "Yamakawa" "Ametrine" "pMIA" "HL-60_EVI1"
    "HL-60_vec" "6q22" "U937_vec" "U937_EVI1" "a comprehensive overview" "_vec"
    "_EVI1" "60 min" "monocyte/macrophage" "1 h" "anti-HCV" "2.13∶1" "non-HCC"
    "at least one NFKB1 -94 Ins polymorphism" "Del/Ins" "AORs" "A/G" "4q23–24"
    "SDF" "C/T" "1.32∼3.77" "AOR" "-κB" "∼30%" "Non-drinkers" "≥2" "MLN120"
    "heat shock protein 90kDa" "co-modulates" "co-modulate" "Scheidereit"
    "UMSCC11B" "a smaller subset" "17AAG" "MLN120b" "G2M phase" "MLN-120b"
    "DMAG" "Wedelactone" "FOSL" "Nottingham" "Lymphotoxin" "Perkins"
    "constitutively active IKKs" "HeKa" "IKKα/β" "co-activation" "FosL"
    "kappaBs" "geldanomycins" "wedelactone" "Co-expression" "non-catalytic"
    "Activator Protein-1" "other ethnic-specific SNPs" "CEPH" "Detroit"
    "a slightly larger dataset" "2q11.1-q11.2" "rs1051730" "NRI" "Lemeshow"
    "Hosmer" "rs3087386" "chromsome" "rs7124327" "OR=0.72" "OR=0.85" "OR=0.77"
    "1.17-1.68" "1.05-1.77" "1.14-1.87" "rs950286" "rs10519203" "rs16969968"
    "rs308738" "heavier" "packyears" "noteworthiness" "non-discovery" "BFDP"
    "PLINK" "Pearson's" "15q" "American (AA)" "Wayne" "Houston" "G/T" "α5"
    "= 0" "P= 1" "95% CI= 1" "=0.86" "CD44 +" "p=0" "P= 0" "P=0.004" "=1.03"
    "=0.72" "P=0.002" "≤ 0.001" "P=0.0002" "P=0" "Luedemann" "Lue" "1h"
    "ethanol-fed" "PMH" "60min" "TFIIIA" "tRNAs" "rRNAs" "ULD-" "SDD-"
    "K30R/K401R" "E355A/R357D" "mutli" "E355A/R357A" "the contralateral SDD"
    "2-methyl-2,4-pentanediol (MPD)" "pentanediol" "morpholino"
    "methylmorpholino" "roughly co-planar" "carbonyl" "anilinopyrimidine"
    "interdomain" "midpoint" "MRT67303" "scaffold/dimerization" "SDD" "ULD"
    "Anti-V5" "/NADH" "=27" "=23" "/K" "= 19" "β3" "α3" "non-phosphorylated"
    "~35%" "psychiatric dis" "dis" "Crohn’s" "coeliac" "multilocus"
    "the bipolar disorder dataset" "·0031" "L-type"
    "cross-disorder-selected SNPs" "summarises" "Nagelkerke"
    "the 14 risk SNPs suggested disorder-specific effects for either bipolar disorder (three SNPs)"
    "genome-wide significant SNPs"
    "any additional genome-wide significant SNPs" "MIR" "pp" "·88×10" "·60×10"
    "3p21" "·2" "multirisk" "10q24" "·005" "·167" "pseudocontrols"
    "psychiatric nosology" "genome-wide single-nucleotide polymorphism (SNP)"
    "trum" "Psychiatric nosology" "praecox" "Kraepelin" "nosology" "χ 2"
    "Barnes" "Abbud" "TRVb-1" "H-2DG" "convincing co-localization" "PPxY"
    "visual/betas" "SREF" "12-hour" "=0" "cryptochrome"
    "the Cul1-associated proteome" "GEF–GTPase–nucleotide"
    "competitive inhibitors decreasek" "increasedk" "onk" "decreasek" "aK"
    "cyan" "GGGGK" "containing at least four ubiquitins" "Nedd" "≥2-fold" "=25"
    "2.2 × 10" "−7 s" "ZJY" "YQH" "CW" "XXM" "185-kD" "-HER2-transfected"
    "XbaI" "HindIII" "COX-2/PGE 2" "2 h" "at 72 " "Non-targeting"
    "Non-transfected" "1 × 10" "20 h" "PcDNA3" "WP" "ZZ"
    "Lymphoid enhancer-binding factor-1" "DKK1expression" "subclassifications"
    "multisystem" "hydatidiform" "preterm" "the β-catenin" "The β-catenin"
    "trimester" "transcriptional initiation/elongation"
    "T cell-specific factors (TCFs)/lymphoid enhancer-binding factor-1"
    "spiral arterioles" "arterioles" "EVT" "cesarean" "±0.54" "P = 0.001" "=20"
    "Olig2+" "Olig2 +" "OPCs" "the mesenchymal glioma subtype" "REMBRANDT"
    "shRelB-3" "BT25" "shControl" "shRelB-1" "sphere-like" "pLenti" "hRelB"
    "re-expressed" "mRelB" "Sitcheran" "Saltzman" "protein IκBα" "HGGs"
    "a particularly aggressive mesenchymal subtype" "n = 9" "Non-essential"
    "NK-like" "DRAK" "4c" "IGV" "GEA" "Browser" "Cistrome"
    "two biological replicates" "TTC" "ISRE" "Liao" "re-analyzed" "Barta"
    "CEAS" "three biological replicates" "chip-on-ChIP" "STAT5A/B" "5B"
    "cistrome" "U133" "co-stimulation" "CD4+CD8+" "-on-ChIP" "non-spliceogenic"
    "the proband’s" "proband" "3 computational supervised learning algorithms"
    "GVGD" "ovarian epithelium" "LCL" "Plon" "NNSPLICE" "SSPS/Ri" "SSPSs"
    "Coomassie" "Val2985_Thr3001del" "_Thr3001del"
    "constitutionally heterozygous polymorphisms" "LCLs"
    "informative exonic polymorphisms" "8755−1G" "rs144848" ".8754+3G"
    ".4986+5G" "213−11T" "_134+6delAAGT" ".7008−2A" ".8954−1_8955delGTTinsAA"
    ".8755−1G" ".5278−2delA" ".476−2A" ".4986+1G" "441+2T" ".475+1G" ".5332+1G"
    ".4987−1G" ".547+2T" "_8955delGTTinsAA"
    "the nearly invariant dinucleotides" "minigene" "breast/ovarian" "VUS"
    "a premature termination codon (PTC)" "codon (PTC)" "informativeness"
    "premature termination codons" "benign polymorphisms" "= 95" "+2" "Liu’s"
    "α6" "Hwang" "MCAO" "pEGFP" "Mitchelmore" "GenBank" "toxic DSBs" "Peasland"
    "_1" "_3" "XH" "CHO9" "sub-optimal de-bulking" "BER/SSBR" "SSBR" "= 0.99"
    "p = 0.04" "p = 0.01" "p = 0.05" "p = 0.02" "p = 0.002" "= 0.007"
    "p = 0.004" "p = 0.008" "p = 0.006" "co-variants" "Begg's" "codominant"
    "= 1.18" "SNP309 T" "95%CI = 1" "AZD" "phosphoethanolamine" "choline"
    "fumarate" "M/mg" "anilino" "BIBW" "Meir" "LKB1-ve" "LKB1+" "LKB1++"
    "LKB1+++" "immunohistochemistry (IHC)" "40–50" "Klefström" "BLG" "fl/fl"
    "−/−/" "FOXO1/3a" "±0.2 µ" "±0.04 µ" "non-essential" "Yamanouchi"
    "CHOP/GADD53" "Stielow" "diacyglycerol" "KDEL-" "KDEL" "thio-1,2"
    "3-benzyl-7-" "triazolo" "benzoxazolyl" "nLDL" "AdPKC" "AdGFP"
    "obvious 48 h" "hVSMC" "lipoproteins (LDL)" "anti-phosphotyrosine"
    "siControl" "siVRK2" "pGL-3-Bax-Luc" "xl" "qt" "2D2" "Barr" "Epstein"
    "BHRF1" "VRK2A" "2 × 10" "2H" "PCDNA3" "p53 wt" "=0.936" "=0.568"
    "factor-2" "nonhistone" "WTCCC2" "IIa" "FC=1.76" "p=0.0038" "=0.0038"
    "=0.00000103" "LITA" "SMM" "p=0.0018" "p=0.0022" "=0.0018" "rs 2107595"
    "rs11984041" "Tampere" "carotid" "7p21.1" "=1.19" "p=0.038" "n=7" "=28"
    "=15" "Mcm2–7" "PAIL" "kb/min" "the next 8 h" "PAAG" "substrateless" "AcoA"
    "WB" "Zn" "ortholog" "SIRTs" "acetylation/deacetylation" "cerevisiae"
    "accharomyces" "∼2-fold" "7AAD" "anti-His" "–7" "late population doublings"
    "mTERT" "F-C-A-M" "Est2p's" "Oregon" "RRL-" "TTAGGGTTAGCGTTAGGGp" "26GTT"
    "+4nt" "+2nt" "26GTT (TTATTATTAGGGTTAGGGTTAGGGTT)"
    "TTATTATTAGGGTTAGGGTTAGGGTT" "hTERT-W930F-F2" "hTERT-W930F-F1" "PD6"
    "hTERT-" "hTERT" "hTERTs" "RRL" "TERTs" "ciliate" "Est2p" "Est" "castaneum"
    "Tribolium" "pairs/cell division" "G-rich" "n = 3" "n = 2" "∼90%" "Dohme"
    "Merck" "intercalate" "mycin" "actino" "overridden" "control-like" "Venus"
    "rightmost" "intercalates" "cytophotometry" "∼30-min"
    "nucleolar RNA synthesis 20 h" "the subsequent 20 h" "S/G2/M" "actinomycin"
    "Fucci" "yet-to-be-defined" "mid-1960s" "mid-1800s" "feedforward" "2 h"
    "20 h" "4 h"
    "the amplified centrosomes displayed robust Aurora-A co-localization"
    "centriole" "multipolar mitoses" "chromatids" "HU" "DNp53" "vMCF-7"
    "G 1 /S" "PSI-treated IVT human Gli1:V5/HIS" "Gli1:V5/HIS" "HIS:aPKC" "IVT"
    "subthreshold" "medulloblastomas/GNPs" "medulloblastomas/granular" "GNPs"
    "Sant-1" "apkczeta" "apk" "apkciota" "apkc" "iota/lambda" "anti-acetylated"
    "non-polarized" "sigmoidoscopy" "6.7mg/L" "1.2mg/L" "2.2mg/L" "1.6mg/L"
    "variate" "2.4mg/L" "4.8mg/L" "7.3mg/L" "re-scored" "interobserver"
    "67/149" "colectomy" "WCC" "WBC" "endoscopy" "Geboes" "Mayo" "SCCAI"
    "re-evaluation" "=0.0002" "mg/L" "chRCCs" "intron 1" "a unique RCC subtype"
    "ccpRCCs" "pathological re-examination" "-IIIc" "Gerota" "website"
    "FGFR2-IIIb-2" "FGFR2-IIIb-1" "metanephric mesenchyme (MM)"
    "mesenchymal FGFR2 IIIc ccRCCs" "20kbp" "exon9" "exon19" "chRCC"
    "the metanephric mesenchyme (MM)" "mesenchymal IIIc" "ISAR" "sideroblasts"
    "PKM1" "the eukaryotic genome" "re-examination" "chromophobe" "methylome"
    "IIIc" "ccRCCs" "ccRCC" "P = 0.047" "T3/T4" "= 0.034" "co-targeting"
    "co-mutational" "Patel" "co-mutation" "3/5" "dyspnea" "non-responding"
    "3 +" "2 +" "mg/dL" "≤ 2" "microvessel" "endpoint" "Lipinski’s" "Lipinski"
    "NCEs" "4h" "2h" "low-μM" "chemotype" "urea" "quinoxaline" "kinome" "~ 5%"
    "mg/Kg" "= 11" "± 0.2" "Eight-week-old" "non-malignant" "~ 50%" "Westhoff"
    "Eramo" "mammosphere" "synonymous SNPs" "Ds" "and 1K" "NICD1" "NICD2"
    "constitutively active NICD1" "flowcytometry" "Dick" "=0.038" "p= 0.001"
    "p= 0.003" "stem cell-like" "best/flexible" "flowchart" "ChemScore"
    "GoldScore" "TAF089" "2JKO" "Chemscore" "Libdock" "Pharmacophore"
    "phamacophore" "FERM" "Nimwegen" "TAE" "a comprehensive pharmacophore"
    "pharmacophore (MCBP)" "MCBP" "multicomplex" "drug-like" "anti-metastatic"
    "multipath" "Valencia" "Qiagen" "HiPerFect" "Daejeon" "Bioneer" "Tokyo"
    "Jolla" "Calbiochem" "anticytochrome" "2 μg/mL" "Ac-LEHD-AFC" "Piscataway"
    "Amersham" "nonfat" "Gelman" "difluoride" "polyvinylidene"
    "electrotransfer" "rpm" "antipain" "Rockford" "Ac-DEVD-AFC" "Ac-IETD-AFC"
    "Pharmingen" "BD" "AFC" "Ac" "MitoCapture" "-7" "anti-proliferation"
    "dammarane" "Panax" "micrometases" "non-expressing"
    "primary and secondary tumorpshere" "tumorpshere" "NOD/SCID"
    "significantly greater tumorsphere" "HER2+" "CD44+" "tumorsphere"
    "tumorspheres" "England" "/β" "p =0.004" "p =0.009" "p =0.05" "p =0.012"
    "ER +" "demostrates" "AP-2a" "-repression" "Activaton" "diene"
    "pyrrolidinone" "hydroxymethyl" "hydroxy" "stereochemistry" "substituents"
    "-fluorophenyl" "fluorophenyl" "Christoffers" "cerium"
    "commercial ( R )-5-hydroxymethylpyrrolidine-2-one" "stereocentre"
    "commercial N -vinylpyrrolidinone" "enolate" "-vinylpyrrolidinone"
    "vinylpyrrolidinone" "OMM" "Multidomain" "= 14" "=  8" "–76" "= 11" "20H"
    "= 16" "oropharynx/hypopharynx" "or 2G" "Vairaktaris"
    "the homozygous 2G/2G genotype" "1G/1G" "Zhou" "Nishizawa" "charoenrat"
    "excluding Zinzindohoue’s" "Zinzindohoue" "1.21–1.65" "1.06–1.82"
    "1.29–2.08" "1.05–1.53" "1.07–1.79" "polymorphism (SNP)" "matrilysins"
    "comorbidities" "hypopharynx" "oropharynx" "nasopharynx" "Google" "MEDLINE"
    "= 0.018" "= 0.001" "11q22" "Collagenase-1" "vasculogenic/angiogenic"
    "TGF-β-induced cardiac EndMT" "treated EMCs"
    "epicardial markers Wilms Tumor protein homolog" "epithelioid" "EPDC"
    "multipotent EPDCs" "myocardium" "the epicardial mesothelium" "EPDCs"
    "mesothelium" "epicardium" "EndMT" "PDCD4-" "PDCD" "fibroblastoid" "EMCs"
    "96h" "∼20%" "–150" "Bianchi" "ORR" "0.44–1.14" "ﬂow" "Moroni" "GCN"
    "= 0.13" "P  = 0.53" "= 9" "P  = 0.004" "P  = 0.008" "Rushlow"
    "constitutional deletions/duplications" "Schouten" "QMFPCR"
    "subcytogenetic deletions/duplications" "13q14" "deletions/duplications"
    "SYBR" "Ito" "Naturally occurring sexual dimorphism" "ofSNP" "betweenin"
    "2G/2G" "theSNP" "95% CI=1" "The homozygous 2G/2G genotype" "20q11.2-q13.1"
    "stromelysins" "PEXG" "Schrehardt" "1G/2G" "rs17576" "rs1799750" "PACG"
    "Pakistani" "=0.019" "=17" "p=0.02" "=0.96" "=1.63" "=0.14" "p=0.009"
    "ClinicalTrials" "Identifier" "retro" "Oberthuer" "p27-2" "p27-1"
    "glycogen synthase kinase-3β" "the last 24 h" "exogenous spd" "spd" "MYCN2"
    "NB88" "the most significant P-value" "Amsterdam" "anti-migratory"
    "∼1.5-fold" "P=0.04" "∼70%" "_at" "μ g/ml" "Cip/Kip" "VKESLV" "Par6-ΔCRIB"
    "ΔCRIB" "Morg1-" "Morg" "Apico" "PKCι/λ" "intergrin" "vesicles/vacuoles"
    "lumens" "I133A/S134A" "ΔC" "aPKCι/λ" "Par6β" "Par6α" "melanogaster"
    "Darby" "Madin" "apico" "1.6 × 10" "4 × 10" "/S" "exactly cPKCs"
    "the classical PKCα/β isotypes"
    "radioactively labelled IL-2 promoter oligos"
    "labelled IL-2 promoter oligos" "oligos" "Ex"
    "peripheral T and B cell subsets" "lifespans" "PKCα/β" "LMWIs" "Nishizuka"
    "CD4 + CD8 +" "2 μg" "1 × 10" "mean ± SD" "5 × 10" "mean ± SEM" "C57BL/6 "
    "the respiratory epithelial NOS2 interactome" "quantitative interactome"
    "B30.2/SPRY" "paralogues"
    "both the qualitative and quantitative interactomes" "interactomes"
    "pulldowns" "apoenzyme" "proteomes" "PSB9" "immunoproteasome"
    "tryptophanyl" "±6-fold" "±1.4-fold" "Rosetta" "cytomix"
    "the qualitative NOS2 proteome" "the cytokine-inducible interactome"
    "Greater" "subsequent replicate LC-MS/MS" "LC-MS/MS" "eluates"
    "yeast-2-hybrid" "cytosolic phospholipase A2α"
    "precisely orchestrated PPIs" "indiscriminant" "congeners" "eosinophilia"
    "SPSBs" "DINNN" "SPSB" "SILAC" "the respiratory epithelium"
    "human respiratory epithelia" "D/E" "Anti-Flag" "toll-like" "PDGRA" "M:F"
    "DIPG" "Lai" "=0.011" "pediatric and adult HGAs" "p=0.01" "only 12 HGAs"
    "brainstem/cerebellum" "brainstem" "DIPGs" "123 pediatric HGAs"
    "Pediatric HGAs" "simplest" "the proneural subtype"
    "both pediatric and adult HGAs" "pontine" "gain/amplification"
    "adult and pediatric HGAs" "pediatric HGAs" "HGAs" "co-amplified" "OR 3"
    "p=0.52" "n=9" "=22" "=16" "=0.028" "=0.53" "non-amplified" "_fs"
    "polyuridine" "Bacterial lipopolysacharides (LPS)" "lipopolysacharides"
    "UVC-" "intrastrand" "ILIB" "bacterial lipopolysaccaride (LPS)"
    "lipopolysaccaride" "UVB" "acetylaminofluorene" "laevis" "musculus" "Mus"
    "hypothermia" "Bacterial lipopolysaccharide (LPS)" "UVC" "siRNA #1"
    "diphenyldifluoroketone" "biocurcumax" "timepoint"
    "The sporadic STS-26T cells" "NFS-1" "ase" "I/II" "Re-expression" "chemo−"
    "13q31.1" "neuro" "multimer" "reponse" "spearman" "Whitney" "pre-miR-18a"
    "miRanda" "Silico" "IQR" "miR-18a" "=  0.005" "P1CDB1" "prostaglandins"
    "Wollinella" "intestinal biopsies" "fragilis" "bifidum" "longum"
    "Bifidobacterium" "anaerobium" "Peptostreptococcus" "faecalis"
    "Enterococcus" "Furrie" "MOIs" "typhimurium" "Typhimurium" "enterica"
    "Non-Gly-TLR4" "made" "non-glycosylated" "intestinal microbiota" "concisus"
    "even different polymorphic locis" "locis" "limites" "Huang" "ture"
    "Tweedie" "Duval" "the Egger’s" "5G/5G:I" "= 1.09–1.59" "= 1.03–1.18"
    "4G/5G+5G/5G" "MassARRAY" "insertion/deletion" "withI" "= 0.014" "= 0.075"
    "= 1.19" "OR = 1.45" "= 1.45" "= 1.07" "= 1.24" "+4" "= 25" "= 1.09" "= 20"
    "= 1.03" "transcriptionally inactive regions replicate" "SARMs" "Sathya"
    "CWR22R3" "4-hour" "synthesome" "megacomplexes" "co-sedimentation"
    "co-sediments" "Co-sediment" "ICQ " "FCS-" "FCS" "multienzyme" "Reddy"
    "hammerhead" "co-sedimented" "G 0 /G 1" "–50 µ" "2×10" "RPMI 1640"
    "Methodology/Principal" "mesoderm" "lymphnode" "LIV-1si" "gastrula" "ZR"
    "LZT" "4,5-dimethylthiazol-2-yl" "increasedK" "Y653/654" "Muenke" "±0.4"
    "unknownsK" "andK" "re-normalization" "re-plotted" "copies/cell" "fWT"
    "concentrationis" "/Φ" "±0.20" "ratiowas" "±0.2" "ratiois" "/S " "±0.16"
    "decouple" "anti-Y653/4" "ER/cis-Golgi" "Cruz" "HPSG" "kcal/mole" "A391E"
    "Nigricans" "deconvolutes" "Crouzon" "x 10" "p = 0.03" "AML#2" "Calcusyn"
    "+/−MK2206" "KIN102" "RPMI+10%" "WEHI" "ED" "LINCS" "KIN001"
    "stromal-mediated chemoresistance" "iver" "etal" "yrosine" "ike" "1 hr"
    "1 +" "Anti-phospho" "LSCCs" "Starska" "Starr" "SPSS" "SOCS1 Expression"
    "LR" "SOCS1 expression" "oncomicroRNA" "MicroRNA 155" "promotingrole"
    "itsdownstream" "poor/moderate" "SOCS1expression" "laryngectomy" "LSCC"
    "mean ±SD" "96 h" "ColIAI" "siFurin" "decreased activity compared phTG5"
    "Taqman" "CytoSelect" "sifurin" "siTSP-1" "siTGF" "siGFP" "PAI/L"
    "approximately 1250 pg/ml" "dithiocarbamate" "CytoTox" "ZF9/core" "phTG6"
    "phTG7-4" "phTG7" "phTG1" "phTG5" "+11" "co-infection" "polyprotein"
    "invasion/cell migration" "–3.5" "C26∶0" "C24∶0" "TTCAAAG" "CTTTG"
    "CTTTGCT" "TBE2" "VCLFA" "Lorenzo’s" "Lorenzo" "C26∶0/C22∶0" "TBE" "Luc"
    "TBEs" "Weinhofer" "VLCFA" "VLCFAs" "ACALD" "adrenomyeloneuropathy" "CCALD"
    "lane 6" "2-3" "RPMI1640" "codon 13-mutated" "Guerrero" "Roock" "Messner"
    "GTPGDP" "ΔG" "kcal/mol" "anti-correlation" "covariance" "R789/GAP" "mCRCs"
    "Gajate" "Tveit" "Anti-epidermal growth factor receptor" "Amgen" "ImClone"
    "influenceprotein" "of/as" "ofwill" "leadsto" "cappedwhich" "ofwithwill"
    "goes" "activateas" "cappedcannot" "stages/conditions" "cappeddue"
    "betweenand" "cappedwhose" "inlevel" "ofwithallowsto" "andand" "andis"
    "functionis" "andwhere" "the stochastic steady state solutions ofandas"
    "ofalong" "ofandas" "haveandand" "i.e.and" "CLEs" "ands" "differents"
    "ofonin" "plotin" "defineas" "ofeven" "toin" "forshows"
    "simulatingandlevels" "ofonandin" "whenand" "inis" "fromand" "thenwill"
    "inbut" "ofto" "conditionshould" "positiveone" "solutionofas"
    "conditionwhich" "termand" "inand" "inleads" "andare" "calculatedandas"
    "caselevel" "constantlevel" "ofwithand" "oforand" "ofamplitude"
    "ofoscillations" "foralso" "thathas" "toimpact" "lowvalues" "ofat" "offor"
    "cappedlevel" "ofin" "ofwhich" "byis" "uncontrolledgrowth" "utilizingwhich"
    "thelevel" "wherelevel" "tilland" "ofdue" "todecay" "prohibitsto" "andwith"
    "frombecause" "bylevels" "tooris" "ofvaries" "ofandto" "asis"
    "thatstabilizesas" "ofaswhich" "differentlevels" "thefirst"
    "betweenandforthat" "increasingvalue" "keepingthroughout" "bothandlevels"
    "ofwith" "thatmakes" "thatis" "stabilizedlevel" "activatedlevel"
    "larger values (cell death condition) ofand" "betweenis" "ofand" "whichis"
    "thelevels" "ofis" "asincreases" "Kutta" "Runge" "ofnetwork" "iv"
    "Gatekeper" "increased trabecular vBMD" "the trabecular vBMD SNP rs9287237"
    "all identified cortical vBMD" "several sex-specific QTLs"
    "sex-specific QTLs" "Framingham" "QTLs" "Khosla" "femoral cortical vBMD"
    "The cortical vBMD SNPs rs7839059" "both these cortical vBMD"
    "the trabecular and cortical vBMD" "genome-wide significant cortical vBMD"
    "cortical vBMD and bone microstructure" "the four cortical vBMD SNPS"
    "SNPS" "Malmö" "Gothenburg" "the four cortical vBMD SNPs"
    "The trabecular vBMD SNP rs9287237" "the five genome-wide significant SNPs"
    "both cortical and trabecular vBMDs"
    "the 64 genome-wide significant aBMD SNPs" "the cortical vBMD SNP rs271170"
    "lumbar spine aBMD" "All five genome-wide significant vBMD SNPs" "GEFOS"
    "previously described aBMD SNPs" "identified genome-wide significant SNPs"
    "REML" "the genome-wide significant SNPs" "trabecular bone microstructure"
    "BV/TV" "The genome-wide significant trabecular vBMD SNP rs9287237"
    "The four genome-wide significant cortical vBMD SNPs" "Cortical vBMD SNPs"
    "The pQCT-derived cortical vBMD"
    "the identified genome-wide significant cortical and trabecular vBMD"
    "about trabecular bone microstructure" "all five cortical vBMD SNPs"
    "Trabecular vBMD" "rs271170"
    "the four genome-wide significant cortical vBMD SNPs"
    "the previous reported aBMD" "rs4869742" "rs7751941" "rs2062377"
    "the two cortical vBMD" "rs9533090"
    "the previously reported aBMD related SNPs" "rs6909279" "rs7839059"
    "rs17638544" "cortical and trabecular vBMD" "YFS" "μCT" "voxel" "HRpQCT"
    "lumbar and hip aBMD" "femoral neck aBMD" "trabecular vBMD" "Cortical vBMD"
    "trabecular and cortical vBMDs" "trabecular microstructure"
    "dual x-ray absorptiometry (DXA)" "absorptiometry (DXA)" "DXA"
    "absorptiometry" "LOC285735" "cortical vBMD" "trabecular or cortical vBMD"
    "Sweden" "MrOS" "microstructure" "rs9287237" "rs1021188"
    "cortical and trabecular vBMDs" "vBMDs" "pQCT" "vBMD" "aBMD" "areal"
    "Mach2QTL" "n = 3" "HumanHap550" "8×10" "= 0.07" "= 0.028" "= 4" "4×10"
    "n = 2" "= 1" "n = 1" "n = 5" "ITCHS161A" "ScanSite" "NetPhos" "ΔMEK"
    "ConcanavalinA" "Breakes" "anti–phospho" "pCDNA3" "S/T" "reChip" "reChIP"
    "re-ChIP" "κ1" "κ1-site" "timecourse" "damagers" "BCL" "hetero"
    "deacetyases" "oligoadenylate" "Co-immunoprecipitations" "2μg"
    "co-regulated" "carboxyl" "co-occupancy" "TetOn-Flag-ELF3-LNCaP" "A312P"
    "TetON" "TetOn" "pLVX" "siELF3#2" "siELF3#1" "siAR" "SAR" "groups19"
    "the biological endpoints" "mean ± SD" "–250" "Sy" "Acaca" "RecQL"
    "Trp53+/-" "Trp53+/−" "Trp53 +/−strains" "NU1025" "EUFA1341" "Δ-EGFP/3"
    "Δ-EGFP" "FancE" "FancI" "57%+/−2" "Radiation-induced DSBs" "Trp53 +/−"
    "rescreen" "Fourty" "nucleases" "=0.0022" "radiation-induced DSBs" "Prkdc"
    "microhomologies" "C57BL/6-" "Interactome" "BALB" "BALB/c-" "24 h" "48 h"
    "RNA:protein" "sense:asRNA" "ODNs" "phosphorothioate" "protein:RNA"
    "DNA methyltransferase 3A" "repressive chromatin remodelers" "Zeste"
    "RNAPII" "browser" "UCSC" "Pseudogenes" "pseudogenes"
    "the respective PTENpg1" "asRNAs" "asRNA" "PTENpg1" "pseudogene" "pcDNA 3"
    "1–2 µ" "= 1" "1–2" "non-functional" "n=1" "=4" "PR/uPR" "months/PR/uPR"
    "SD≥6" "months/uPR" "≥6" "=11" "RP2D" "=1" "anorexia" "n=5" "=9" "Weihua"
    "months/PR" "SD&ge" "&ge" "hypomagnesemia" "—2" "n=14" "redirects"
    "isothiocynates" "N-nitrosobutyl" "hydroxybutyl" "nitrosobutyl" "diepoxide"
    "vinylcyclohexene" "polyphenols" "-epicatechin" "epicatechin" "flavanol"
    "Dietary tocopherols" "tocopherol" "INrf2Thre55" "KRR"
    "cytoprotective gene expression/induction" "expression/induction" "DGR"
    "Kelch" "oxidative/electrophilic" "melatonin" "GCS" "azoxymethane"
    "officinalis" "Mangnolia" "the medicinal plant Silybum marianum" "marianum"
    "Silybum" "gallate" "phytyl" "Tocopherol" "BHT" "Alezheimer" "ashthma"
    "hyperoxia" "glomeruloneph" "Oxidative/electrophilic" "tocopherols" "PC-3"
    "ERE" "Balagopalan" "TCR/CD3" "let-7f-2" "O-linked" "BSXB" "Let-7f-2" "mir"
    "mean ± SEM" "ConceptGen" "mean± SD" "mean±SD" "SLEDAI"
    "approximately 500 bp" "MFI" "female/male" "Xq" "methylcytosine" "188-3p"
    "XXY" "Klinefelter" "≤ 0.05" "p=0.04" "≥ 1" "non-stimulated" "p110s" "CAAX"
    "Salamon" "p110α/p85α" "p110β/p85α" "p85α" "R5BD" "trisphosphate"
    "phosphoinositides" "flox/+" "a further four SNPs" "polypectomy" "Houlle"
    "p=0.03" "testing––suggesting" "microsatellite" "=10.74" "p=0.003"
    "rs992918" "=0.07" "=0.88–1.07" "=0.52" "=0.97" "Canada" "person-years"
    "20p12.3" "18q21.1" "16q22.1" "15q13.3" "14q22.2" "10p14" "9p24" "8q24.21"
    "11q23.1" "8q23.3" "homozygous non-carriers" "rs16892766" "rs6983267"
    "rs719725" "rs10795668" "rs3802842" "rs4444235" "rs4779584" "rs9929218"
    "rs4939827" "rs10411210" "rs961253" "=1.09" "p=0.008" "=0.009" "=0.003"
    "=0.95" "p=0.002" "p=0.004" "non-risk" "19q13" "genotype (GG)" "US"
    "GG genotype" "p53/Rb" "mutated genotype (GG)" "GA+AA" "co-dominant"
    "non-drinkers" "rs2736100" "5p15.33" "rs401681" "Taiyuan" "= 0.64" "= 0.73"
    "= 0.72" "– 2" "Yokosuka" "AEB071" "sotrastaurin" "Baier" "rs947474" "T1D"
    "immunological unresponsiveness" "#300" "microcluster" "Aldrich"
    "the F-actin-dependent peripheral pSMAC" "kinaspe" "symmetrical synapse"
    "kinapse" "Teff" "TIRF" "dSMAC" "pSMAC" "tunor" "Moloney" "berghei"
    "gondii" "x10" "Burkiewicz" "Sakowicz" "monocytogenes" "14-3-3ζ" "xL" "Bcl"
    "Fasl" "mucosa-associated lymphoid tissue-1" "tissue-1" "Littman"
    "hydrolizes" "thalamus" "~291–378" "pseudosubstrate" "subfamilies" "#249"
    "C-theta" "theta" "gone" "Riminton" "tacrolimus" "us" "alloimmune" "& E"
    "A β" "Cre/LoxP" "non-redundant" "HJL" "FJH" "HYK" "KEH" "Antral follicle"
    "Follicle" "Anti-Müllerian" "late dominant follicles" "Westergaard"
    "IVF/ICSI" "IVF/" "co-treatment" "pre-ovulatory antral follicles" "theca"
    "gonad" "anti-Müllerian" "rFSH" "COH" "ICSI" "rLH" "IVF" "granulosa"
    "N-glycosylase" "P =0.021" "a 2:1" "pg/mL" "anti-HIV" "+12" "+3" "Ebina"
    "Ty1" "retrotransposon" "AAV" "D64A/R+" "R+" "#2413" "co-infected" "ENF"
    "enfuvirtide" "revertants" "MAGIC5" "EVG" "elvitegravir" "integrants"
    "progeny" "dinucleotides" "I-infected"
    "the integrated proviral DNA (Figure  xref A) selectively generated PCR amplicons"
    "amplicons" "Ad-I-" "NL-Luc-E" "VSVG" "Sce" "Sakurai" "non-homologous"
    "macrophage-like" "anti-HIV-1" "YCC" "YCY" "vacuolus" "intracytoplasm"
    "normal tissues/cells" "hTER" "TTAGGG" "tetrazolium" "developed coutries"
    "coutries" "Mitomycin" "chronic superficial gastritis mucosa" "P =0.006"
    "=0.013" "≥ 30" "A/B" "SNCP" "Childrens" "∼40%" "necesitate" "u" "≤0.05"
    "Ara-C/Dauno" "CRs" "ITD +" "ITD+" "the healthy BMMb and FLT3 ITD"
    "Both healthy BMMb" "healthy BMMbs" "BMMbs" "PCA" "Levene"
    "Ara-C/Daunorubicin" "cPARP" "healthy BMMb" "BMMb" "FLT3L" "ECOG"
    "Oncology" "ITDs" "outs" "SCNP" "ITD" "≥50%" "≥30" "Non-apoptotic"
    "non-apoptotic" "xxL" "YWxL" "xIPLx" "KSLVK" "GERxW" "RMR" "RHHY" "SIVmac"
    "SIVagm" "x" "LQYLA" "Malim’s" "Malim" "non-permissive" "collegues"
    "Strebel" "non-angiogenic/invasive" "Lu" "epithelial-like" "absent/less"
    "around necroses" "necroses" "CD533" "angiogenic biopsies"
    "this moderate-to-high pEGFR" "invasive/non-angiogenic" "pEGFR" "pMAPK"
    "10q" "aCGH" "macrovessels" "wtEGFR" "BBB" "40–50 " "non-angiogenic"
    "anti-invasive" "co-amplification" "× 10" "−2" "pStat3" "–2 " "–50 "
    "co-activated" "ischemia/reperfusion" "tFCI" "PRX2M" "overexpressors"
    "non-OGD" "PANT" "progenitor-like" "inhibitis" "stricto" "sensu"
    "de-differentiated" "IDH-1" "radial glia" "Immunohistochemical stainings"
    "stainings" "smoother" "6×10" "cryostat" "striate" "p53MA" "p53MYC"
    "multinucleate" "p53AKT" "p53Ctrl" "cell-like" "CD8+" "1/3" "blockers"
    "hCGα" "Laurence A Cole" "Cole" "zymography" "non-transfected" "HCG" "HCGβ"
    "the important anti-invasion" "ZK191784" "SGHPL" "Leydig"
    "Extracellular signal-regulated kinase1/2" "hCGn" "hCGh" "brachytherapy"
    "aspiration/biopsy" "Savic" "Shih" "forceps" "neuroendocrine"
    "synaptophysine" "cromogranine" "routine diagnostic biopsy" "histotypes"
    "CTCs" "FNA" "lavage" "paraffine" "formaline" "a traditional Sanger's"
    "a traditional Sanger" "EURTAC" "IPASS" "FLEX" "rarer" "45-50" "genic"
    "~45-50" "CGG" "CTG" "LREA" "SqCC" "_A750" "non-small-cell"
    "state-of-the-art" "relocalizes" "∼15%" "T2D" "HFD" "2DG" "VCO"
    "myofilaments" "epitrochlearis" "striations" "tubules" "transverse tubuli"
    "tubuli" "longus" "digitorum" "soleus" "= 22" "nmol/L" "ATR-Chk1-" "Bunz"
    "Chung" "asynchronous NHF" "S1981" "J/m 2" "NHF" "micropore" "Oh"
    "photolesions" "Vrouwe" "ss" "Rad3-" "6-4PP" "photoproducts" "co-recruited"
    "Rad3" "AmpliChip" "potential mutational hotspots" "20/21" "HUF" "HUFs"
    "Hupki" "miscode" "analyses/experimental" "cctagGT" "cttagGT" "Exome" "APu"
    "PyAPu" "ag" "all possible A:T" "LOF" "these unusual A:T" "nonAA"
    "Belgrade" "Zagreb" "Balkan" "Nephropathy" "Danube" "JD" "Aristolactam-DNA"
    "the intended herb diuretic Stephania tetranda" "tetranda" "Stephania"
    "fangchi" "Belgium" "snakebites" "endemic nephropathy" "AAII"
    "nitrophenanthrene" "myotoxin" "ICGC" "IARC" "non-transcribed" "Balkans"
    "UUTs" "nephropathy" "clematitis" "Aristolochia" "nitrophenathrene" "UUT"
    "G:C" "T:A" "A:T" "ABK" "YS" "SRH" "regs" "peritoneum" "immunosurveillance"
    "Tgfbr1f/f/Ptenf/f" "Ptenf/f" "Tgfbr1f/f" "Gr-1+" "CD11b+" "MDSCs"
    "littermate" "CreER" "cytotoxicitiy" "HNSCCs" "TGFβRI" "MDSC" "2cKO"
    "exotoxin" "the squamous epithelium" "=0.002" "Anti-tumor" "–50"
    "five-year" "Dulbecco's" "synovia" "vivo" "invasive pannus" "OA"
    "tranducer" "pannus" "fibroblast-like" "Fibroblast-like" "co-authorship"
    "Feo" "Salvatore" "Giallongo" "Agata" "normal mammary epithelium"
    "These IHC" "IDCs" "AcH4" "ERP5/7" "ERP3/4" "ERP1/2" "promoterless" "pFlag"
    "kelch" "IDC" "=14" "A/T" "–72" "D-type" "co-inheritance" "POAG" "Müller"
    "GGO-414" "GGO" "karyotype" "12q14" "NTG" "III-1" "SSC/0.3% NP-40"
    "6-Thio-GTP" "allograft" "planar bilayers" "microclusters" "recombinat"
    "EHop" "6-thio-GTP" "TCR/CD3 complex" "Vβ2TCR+" "Vβ2TCR−" "Vβ2TCR"
    "use TNF-treated CIITA-transduced HDMEC monolayers" "HDMEC" "cytoskelton"
    "platelet-endothelial cell adhesion molecule-1" "TEP" "TEPs"
    "sub-micron ventral adhesive and invasive filipodia" "filipodia"
    "a microvascular EC monolayer" "venules" "recirculate" "mysosin"
    "non-muscle" "anti-Phospho" "Sos" "mutations/deletions" "TCSPC" "∼2.64"
    "cyto" "pY542" "strep" "Grb2 is" "pGrb2" "Y653/Y654" "C-terminally"
    "tyrosyl" "Shp2 is" "heterotetramer" "pFGFR2" "Grb2i" "nonphosphoproteins"
    "∼2.5-fold" "∼80%" "immunoprofiles" "Dittert" "Jauffret" "Charafe"
    "de-regulation" "Sarrio" "CSOS" "UICC" "BVS" "DRFs" "endothelia"
    "immunoprofile" "oestrogen" "= 0.018" "= 0.042" "1+" "P  = 0.008" "= 0.015"
    "P  = 0.004" "P  = 0.047" "especially Daiane de Almeida"
    "the Hemocentro Regional de Maringá" "Almeida" "Daiane" "Unicamp" "Maringá"
    "Hemocentro" "diagnostic workup" "workup" "acquired uniparental disomy"
    "Kilpivaara" "uniparental disomy" "disomy" "Pardanani" "cMPN"
    "essential thrombocythemia (ET)" "thrombocythemia" "cMPNs" "rs10974944"
    "46/1" "p =  0.006" "= 2" "additional important transcription factor/s"
    "an essential transcriptional co-activator" "C-152T" "-1 Mu4"
    "transcription factor/s" "-135" "-165" "cMYB/cETS" "-150"
    "unlabeledoligonucleotides" "GGGAA" "GGGAACT" "-199" "TFBS" "TATA"
    "TRANSFAC" "PROMO" "TFBSs" "-152" "-167" "-1986" "-2486" "-512" "-2965"
    "-50" "18p11.22" "CDE" "a stress-inducible non-ABC transporter"
    "immunocytochemistry" "hypolipidemia" "6-Diamidino-2-phenylindole"
    "non-Hispanic" "ZBBX" "K-variant" "soluble Aβ" "hoc" "rs509208" "rs429358"
    "LMCI" "EMCI" "Amyvid" "fibrillar Aβ" "the Alzheimer’s" "positron"
    "cortical Aβ" "non-enzymatic" "ε4" "Xiong" "ZJ" "LTS" "immunoassays" "NSLC"
    "the exon 19 del IHC" "the EGFR mutation-specific IHC" "Zealand"
    "bronchial washings" "washings" "E746_A750del-specifiac IHC" "specifiac"
    "the E746_A750del-specific IHC" "L747_T751delinsPT" "L747_P753delinsS"
    "NPV" "the L858R-specific IHC" "The Cohen’s" "Cohen" "Fleiss" "the IHC"
    "E746_A750del" "_2253delinsCCAACG" "_T751delinsPT" "_2257del"
    "_P753delinsS" "_2254del" "_T751del" "EGFR mutation-specific IHC" "Yu"
    "mutation-specific IHC" "E746_A750del-specific IHC" "L858R-specific IHC"
    "E746_A750del-specific" "_A750del" "7/50" "AQQ" "ZH" "LJ" "ZQ"
    "re-expression" "the serous cystadenocarcinoma subtype" "endometroid"
    "endometriod" "Semi" "paxilin" "coverslips" "non-metastatic"
    "normal colorectal epithelium" "α2β1"
    "its heterologous binding partner integrin β1" "p = 0.001"
    "nucleus/cytoplasm" "5-HT+SB204" "SB204" "S+G2/M" "-3A" "pEGFP-c2-"
    "-siRNA" "Dauer" "hepato" "anti-apoptoticeffects" "hydroxytryptamine"
    "growth factor-1" "48H" "lipoarabinomannan (LAM)" "mannoside (PIM)"
    "dimycolate" "mannoside" "lipomannan" "lipoarabinomannan" "LprG" "LprA"
    "LpdH" "Graft-Versus-Host-Disease(GVHD)" "CCL8/MCP-2" "levles" "MOI"
    "mcp- 2 /ccl8" "mcp-2/ccl8" "chemokinein" "non-TB" "10-kD"
    "macrophage inflammatory protein-1 alpha"
    "IFN-inducible T-cell alpha chemoattractant" "chemokiines" "cysteins"
    "resistance/susceptibility" "H37Rv" "Guérin" "Calmette" "bovis"
    "MCP-2/CCL8" "C57/BL6" "CD3 +" "-1 alpha" "Faul" "Vollenbröker"
    "hypomotile" "hypermotile" "Marcova" "Kretzler" "ultrastructure" "PAN+EV"
    "a dense meshwork" "meshwork" "Daniel" "allografts" "cytoarchitecture"
    "aminonucleoside (PAN)" "aminonucleoside" "w/v" "mitosome" "DOPC/CL" "mN/m"
    "oleoyl" "mol/mol" "the elastic moduli" "moduli" "bilayers" "Evans"
    "caspase-8+" "Alexa" "fluorophore" "multicolour" "micropipette" "GUV"
    "insertion/adsorption" "lateral membrane compression/expansion"
    "compression/expansion" "bilayer" "GUVs" "Liposome" "-LUV" "LUV" "-LUVs"
    "LUVs" "liposomes" "liposome" "monolysocardiolipin" "CL" "microdomains"
    "∼ 70%" "non-mutant" "MASI" "M/W" "24/85" "28/85" "1,247/1,431"
    "1,154/1,431" "the most common histologic subtype" "Yatabe" "chemotherpy"
    "multistage" "aberrances" "Na" "DHPLC" "IIIa" "≥40" "genetic/epigenetic"
    "SABiosciences" "Profiler" "tranfectants" "transfectants" "transfectant"
    "absorbance" "WST-1" "ZsGreen" "ZsGreen1" "pIRES2" "pIRES" "−1717" "−2642"
    "furthest" "Genomatix" "actives" "*10" "≤10" "~1.5-fold" "Co-transfection"
    "CBFα1" "diabetic vasculopathy" "vasculopathy" "Genbank"
    "Pi-treated HASMCs" "μmol/L" "Cbfα1" "HASMC" "Pi+AGE-BSA" "mmol/L"
    "osteoblast-like" "Maillard" "QuantiChrome" "HASMCs" "synapses"
    "had reached layer V/IV" "V/IV" "TrkB-" "TrkB" "vesicle-like" "Na-K-ATPase"
    "glycosyl" "dnFYN" "dnSRC" "forebrain" "df" "pTrk" "forebrains" "VZ/SVZ"
    "phospholipase Cγ" "subplate" "Retzius" "preplate" "pial" "SVZ" "neocortex"
    "Thr202/Tyr204" "= 8" "= 2" "heterozygotes" "ovarian tumours 12/98" "12/98"
    "relatively uncommon 2/14" "TNBC" "platinum/taxol" "PEO4/6" "Stronach"
    "Sakai" "ER+" "4/33" "cellAline" "3/41" "14/20" "germAcell" "is 1/33"
    "1/41" "nonAsignificant" "The premature stop codon" "endometrioid" "Korean"
    "The immortalised ovarian epithelial cell line HI0180" "HI0180" "UPN-251"
    "frameshift" "1199del29" "nonpathogenic polymorphisms" "Pearsons" "UPN"
    "-1A" "a 2-week" "basal-like" "non-mutation" "DW" "PSGH" "BV" "deltaNp73"
    "rs3765728" "timeframe" "Planel" "cerebrum" "TAp73" "VEGAS" "one-half"
    "the smallest datasets (ADNI)" "ADNI" "28/540" "reliably imputed SNPs"
    "overdose" "C3H/C57BL6" "Cancino" "Gallyas" "phosphotau" "Tg30tau"
    "month-old" "CP13" "day-old" "AT180" "Wetzel"
    "a homozygous wild type (wt) Trp73 genotype" "TgAPP" "CNVs" "reevaluate"
    "neurites"
    "simultaneously introducing separate human APP and tau transgenes" "TgTau"
    "transgenes" "neuropathologies" "Aβ" "Alzheimer’s" "non-demented"
    "duplications/deletions" "10 AD genome-wide association datasets" "TgCRND8"
    "young mice modeling Alzheimer’s" "NFTs" "DeltaNp73" "mg/mL" "6E10"
    "=0.047" "= 0.02" "JBB" "ARVC" "areflexia" "cavus" "pes" "enolases"
    "myofiber" "M-band" "the de Moree’s" "Moree" "EGF-like" "P-loop"
    "Immunoglobulin-like" "multipass" "Fukutin" "The literature-based dataset"
    "the most meaningful PPIs" "actinin" "PYGM" "myotillin" "cardiomyopathies"
    "DAVID" "tubule" "Duolink" "Pearson’s" "Alstrom" "gastrocnemius" "iRefWeb"
    "the global human proteome" "Immunoglobulin" "InterPro" "Cytoscape"
    "secondary and tertiary screenings" "RefSeq" "PIMRider" "identifier" "pmid"
    "IMEx" "the literature-based dataset" "PPIs"
    "additional secondary and tertiary Y2H screenings" "screenings" "Y2H"
    "dystrophycan" "PPI" "Huntington’s" "Huntington" "myofibers" "Δ40p53"
    "Clearly further studies analysing TP53 haplotypes"
    "the rs17878362 A2/rs1042522 P72/rs1625895 A haplotype" "P72/rs1625895"
    "A1/rs1042522" "The most frequently found haplotype" "heterozygote"
    "Swedish" "Sjalander" "the TP53 intronic polymorphisms rs17878362"
    "Whibley" "rs1625895" "rs1042522" "=1.02" "the homozygous A1A1 genotype"
    "the homozygous A2A2 genotype" "Northern Europe" "the Northern Europe"
    "Egger's" "The Egger's" "=0.99–1.18" "=1.08" "PIN6" "ACCTGGAGGGCTGGGG"
    "rs17878362" "Mediterranean" "A2A2" "A1A2" "A1A1" "=1.22–1.74" "=1.45"
    "Homozygote" "insertion/duplication" "=1.16" "=0.87" "=2" "=1.26"
    "P- values" "P- value" "bilateral oophorectomies" "oophorectomies"
    "Metcalf" "Pavard" "Silva" "antagonistic pleiotropy" "Tryggvadottir"
    "important confounders" "predominantly Ashkenazi Jews" "Jews" "Moslehi"
    "Ashkenazi" "Jewish" "Oktay" "Hanna" "Keefe" "McPherson" "French" "oocytes"
    "noncarriers" "= 0.045" "safer" "Xq27.3"
    "cultured ovarian surface epithelium (OSE)" "epithelium (OSE)"
    "nanoliposomes" "p = 0.004" "sublines" "bisulfate" "azaC" "Datasets"
    "=0.02" "Bagnoli" "Dataset" "p=0.05" "cobblestone-like" "frond-like"
    "frozen" "TCH" "Tianjin" "-Mu" "Mu"
    "the poor prognostic mesenchymal subtype" "iM/iE"
    "the same immunoreactive subtype" "the immunoreactive subtype"
    "nearly all (103 of 105; p<10 -6 , two-sided Fisher’s exact test; xref ) transcriptional mesenchymal subtype"
    "fallopian tube epithelium" "the integrated mesenchymal subtype" "iE"
    "a clinically relevant mesenchymal subtype" "246, 129, and 185 serous OvCa"
    "Bonome" "Bentink" "Tothill" "serous OvCa" "mesenchymal subtype"
    "459 serous OvCa" "the transcriptome mesenchymal subtype"
    "500 serous histological subtype" "the mesenchymal subtype"
    "a mesenchymal subtype" "a robust integrated mesenchymal subtype" "OvCa"
    "=0.01" "= 0.01" "= 0.009" "=0.06" "=1.24" "=0.04" "Rubin"
    "a clinically relevant molecular subtype" "Niphatenone" "alkyl"
    "Niphatenones" "digitalis" "Niphates" "enhancers" "BADGE" "diglycidyl"
    "co-repressor" "de-repression" "Lx" "LKDIL" "AF-1a" "AF-1b" "-1a"
    "subdomains" "TAU-1" "WHTLF" "repopulate" "constitutively active ARVs"
    "CWR22Pc" "Gleason" "Pflueger" "RKLKK" "RKx"
    "the premature translation stop codon" "LuCaP" "v567es"
    "a premature translation termination codon" "prostatectomy" "ARV6"
    "luprorelin" "subspecies" "leuprolide" "WxxLF" "FxxLF" "helices" "Exons"
    "approximately 180 kilobases" "immunophilins" "ARV" "ARVs" "CRPC" "1–3"
    "dicuomarol" "13×p53" "strong p53β" "Chq" "Bzm"
    "Proteasomal inhibition increases p53γ" "doxorubicin-treated H1299 p53β"
    "p53β-" "arabinofuranosyl" "×p53" "68±4"
    "electric cell-substrate impedance" "ECIS" "impedance" "tdTomato"
    "retroviral constructs/vectors" "blocker" "p53γ" "p53β" "co-treated"
    "synergism" "samplings" "nonsynonymous polymorphisms" "Harbin" "1.17–2.38"
    "1.16–2.32" "1.14–2.33" "homozygotes" "399Gln/Gln" "pathophysiology" "LDR"
    "three well-characterized nonsynonymous polymorphisms" "underpinnings"
    "P = 0.001" "= 0.013" "at 72" "= 0.004" "Skorupa" "stereology" "DOPAC"
    "modest angiogenin expression co-localized" "AAV2" "SY" "rRNA"
    "and 1-methyl-4-phenylpyridine" "Wildtype" "1-methyl-4-phenyl-1,2"
    "serotype" "adeno" "1-methyl-4-phenylpyridinium" "phenylpyridinium" "= 17"
    "& D" "1/2" "-methyl-" "methoxyestradiol" "26/77" "Non- BRCA" "23/50"
    "44/50" "34/50" "2/50" "4/50" "10/50" "4/16" "2/16" "3/29" "16/29" "2/29"
    "9/16" "12/16" "7/16" "6/16" "10/16" "these IHC" "24/29" "non-BRCA"
    "non- BRCA" "immunophenotype" "mastectomy" "transporter-1" "= 0.015"
    "17/29" "P-values" "= 0.005" "d" "annexine" "−dox" "doxycylin" "shβ" "dox"
    "non-BRCA1/2" "statistically significant lod" "lod" "re-sequencing"
    "Thompson" "Snape" "Netherland" "a premature stop codon" "aminoacids"
    "snps" "Biosystems" "Polyphen" "SIFT" "BRCAx" "RUL036" "_2364delGAA"
    "Spain" "Netherlands" "TaqMan" "stopgain" "1100delC" "RUL153" "Spanish"
    "CNTROB" "stopgains" "indels" "INDELs" "y/o" "exome" "indel"
    "co-segregation" "Lipofectamine" "triphosphate" "invitro" "miR-99a"
    "J/cm 2" "around 24 h" "cytometer" "oncology" "nu/nu" "–2" "mg/ml"
    "protooncoproteins" "IQ" "GS" "8/15" "microarchitecture" "Rb" "At 72"
    "MIMM" "#221750" "the causative ones" "Icelanders" "ESHG" "MAGENTA" "KYN"
    "Gudmundsson" "the FT4-associated SNPs" "the TSH-associated SNPs"
    "FT4-associated SNPs" "GRS" "SardiNIA" "bivariate"
    "the top TSH-associated SNPs" "tolloid" "16q12.2" "18q22" "America"
    "rs1443434" "MIR1179" "MAF / LOC440389" "thyroxine" "tachycardia"
    "previously detected polymorphisms" "MAF/LOC440389"
    "the known sexual dimorphism" "dimorphism" "FT4" "euthyroid" "= 0.04"
    "= 0.008" "= 0.05" "1.9×10" "= 1.79×10" "= 5" "= 7" "= 8" "∼2.5 million"
    "multicenter" "an extra pleural pneumonectomy" "pneumonectomy"
    "non-significant" "non-CNS" "stereotactic radiosurgery" "radiosurgery"
    "Eight patients underwent craniotomy" "craniotomy" "Intra" "metastasectomy"
    "biospecimen" "triage" "Sanger" "any diagnostic algorithm"
    "a falsely negative IHC" "the positive ALK IHC" "2+" "DFCI" "Farber" "Dana"
    "Cervical mediastinoscopy" "mediastinoscopy" "mediastinal lymphadenopathy"
    "lymphadenopathy" "hilar" "false negative IHC"
    "discrepant ALK FISH and ALK IHC" "cytology" "droplets" "JLH"
    "diaminobenzidine" "Carpinteria" "DAKO" "Newcastle" "Novocastra" "H&E"
    "Microsystems" "Microsystem" "Leica" "Axiophot" "Zeiss" "SSC/0.3%NP-40"
    "SSC" "°C" "eosin" "LSI" "negative ALK IHC" "Korea" "France" "5A4"
    "Plaines" "Abbott" "followup" "discrepant" "ALK IHC" "~5%" "Efimenko"
    "stimulators" "readout" "dTomato" "rnCM" "Transducer" "ADSC"
    "anti-inflammatory" "co-workers" "2 μg" "Thr 202/Tyr 204" "48h" "1× 10"
    "24h" "newer" "TCR/CD28" "death-1" "follicles" "IL-17-producing γδT cells"
    "lymphotoxin" "Budnicka" "Powolny" "Visekruna" "the last 9 exons" "Rorg"
    "RORγ" "encephalomyelitis (EAE)" "encephalomyelitis" "Dustin" "γδT cells"
    "PKCθ" "CNS3" "CNS2" "Enhancer" "IKKEE" "Tg" "MHCs" "non-self-antigens"
    "tTreg" "Rudensky" "immunotherapies" "commensal microbiota" "microbiota"
    "endocrinopathies" "Sakaguchi" "CNSs" "Another unique T-cell subset" "Th17"
    "T-helper" "the adhesion molecule leukocyte function-associated antigen-1"
    "NF-κB1" "Tconv" "Th22" "CD8 +" "the ethnic factors/differences"
    "ethnicities/races" "IIA" "comprises" "DFS" "Multivariate" "Taiwanese"
    "= 0.003" "p  = 0.001" "the potential causative SNPs" "rs2293303"
    "possible confounders" "rs1816769" "rs565453" "Meier" "Kaplan" "tSNP"
    "adenomatous polyposis coli ( APC )" "coli ( APC )" "coli" "tSNPs"
    "= 0.002" "P  = 0.006" "P  = 0.001" "co-regulators" "AIQ" "co-precipitated"
    "TMPRSS2:Erg" "synthesise" "glomerulonephritis" "polymerase-1" "-2"
    "BRCA1/2" "co-localise" "immunopurifications" "regrowth" "C/S"
    "S564A/S712A" "autoradiography" "pS564-Daxx" "PVS" "QG" "lane 4" "drawn"
    "hypodia" "mediators/signaling pathways" "activation/phosphorylation"
    "phosphorylation/signaling" "formation/function" "proprotein" "pSmad3"
    "TGFβR1" "h" "valproid" "nitubacin" "supernatants" "Portland" "invadopodes"
    "action/signaling" "factor-1" "D-loop" "the intronic polymorphisms" "C/C"
    "A/C" "RecQ-like" "These introns separate exons" "introns" "multiprotein"
    "Holliday" "SCEs" "IIIα" "Richardson" "intergene" "intragene"
    "naturally occurring polymorphisms" "catalyses" "A/A" "intergenes" "intra-"
    "CTPP" "RLFP" "Genotypes" "Zhu" "Lef" "MCF-7TN-R" "chemoresistant"
    "chemoresistance" "p38 MAPK" "WHK" "ICH" "SJC" "Okamoto" "Wani" "ĸB"
    "successful co-development" "co-transfection" "motile" "pRelA" "IκBαM"
    "pSTAT3" "IKKs" "transducers" "κB" "μg/mL" "≥ 5" "Toll-like" "P  = 0.001"
    "emmetropes" "lifecourse" "presence/absence" "SNPwere" "PDGRFA" "Descemet"
    "lymphoblastoid" "eQTL" "non-myopic" "ofwas" "p=0.006" "a corneal astigmat"
    "astigmat" "=–0.012" "thegenotype" "=–0.128" "=–0.125" "=–0.167" "=–0.163"
    "SNPin" "SNPas" "the associated SNPs" "1p36.2" "SCORM" "SiMES" "Malay"
    "=4.5" "=2.8×10" "steeper" "GWASs" "plana" "Taiwan" "Kong" "Hong"
    "rs6554163" "CEU" "Polymorphism" "ALSPAC" "Avon" "axial" "4q12"
    "Non-invasive" "=0.006" "2–3" "VX-745" "VX" "doublings" "nonrandom" "S/S"
    "mild progeroid" "facies" "rad3" "inflamm" "WRNp" "Werner" "progeroid"
    "rad3 (ATR)" "Seckel" "senescence-like" "helicase-like"
    "activator protein-1" "TALE" "immunohystochemistry" "CXR9-" "CXR" "contr"
    "siFOS" "viceversa" "HXR9-treated A375M" "CXR9" "MTS"
    "the antagomiR-treated A375M" "antagomiR" "+1" "TAAT" "Dsi" "miR-221&222"
    "A375M" "→c-FOS" "the small cell permeable peptide HXR9" "hexapeptide"
    "MEIS" "HXR9" "&222" "C/" "mg/kg" "rs6859974" "mannosyl" "rs4722750" "JAZF"
    "rs17560407" "=0.73" "rs4319515" "rs12279250" "PEAR" "European-" "priori"
    "HCTZ" "=8" "6.6 × 10" "P -values" "non-adenomatous" "46/440"
    "submucosal ganglioneuromas/matosis" "polypoid" "Ngeow" "≥1"
    "The predominant polyp histological subtype" "Stepwise" "ganlioneuromas"
    "≥5" "the predominant polyp histology" "=0.014" "polyps/patient"
    "colonoscopies" "hyperplastic/serrated" "~20%" "Entrez" "NCBI" "ought"
    "uncommoness" "the adenomatous sundromes" "sundromes" "clinicians"
    "histologies" "Univariate" "univariate" "using Fischer’s" "Fischer"
    "P =0.012" "P =0.001" "=0.03" "=0.008" "P -value" "Non-synonymous"
    "non-polyposis" "glia" "STS-26T cells" "NRG1β" "T265-2c" "transformants"
    "the doxycycline-inducible lentiviral vector pSLIKhygro" "pSLIKhygro"
    "FluoroBlok" "YST-1" "adjacent non-neural tissues" "plexiform" "~70%" "&D"
    "analysess" "the colitis-associated dysplasia-carcinoma timeline"
    "timeline" "fecal" "mutageneis" "AUROC" "normals" "colonoscopy"
    "normal colonic mucosa" "Wu" "GI" "IBDN" "viz" "dysplasias"
    "intestinal dysplasia" "colonocytes" "miRnome"
    "the non-inflamed colonic mucosae" "non-inflamed" "Virchow" "Rudolf"
    "mucosae" "p=0.001" "G0/G1" "=0.012" "titers" "NS3/4A" "Foy" "IMY" "JFH-1"
    "replicon" "replicaton" "HCV 2a" "HCV2a" "antiviral ISGs" "Chisari" "siPKR"
    "2HDD4" "vitro" "IRES" "enhancesome" "HCV1a" "ISGs" "MEX-3C"
    "Caenhorhabditis" "miRMD" "-UTR-dependent" "co-localizing"
    "an obvious co-localization" "S5C" "CHX" "non-translating"
    "-tail-length-independent" "S2B" "HAF" "NEDD8ylation" "S1D" "RCGTG" "si3"
    "ubiquitome" "Thermo" "Roche" "Novus" "Nonidet" "Non-Targeting (NT)"
    "Dharmacon" "TARGETplus" "Promega" "PerkinElmer" "Ruskinn" "Invivo"
    "Invitrogen" "–USP52" "μg/ml" "Gibco" "DMEM" "USP52/PAN2" "aHIF" "bases"
    "tristetrapolin" "hydroxylases" "factor 1α" "USP52" "Non-specific"
    "co-localizes" "Non-ubiquitylated" "Non-Targeting" "24 h" "48 h"
    "caractérise" "candidats" "Vu" "leur" "reçu" "adénocarcinome" "cisplatine"
    "capécitabine" "avancée" "tumeur" "porteurs" "Ce" "régions" "autres"
    "bientôt" "devrait" "membres" "Etats" "Norvège" "Lichtenstein" "Islande"
    "UE" "européenne" "toute" "immédiat" "vaut" "prolonge" "accès" "avoir"
    "permis" "européennes" "santé" "autorités" "accélérée" "examen" "procédure"
    "bénéficié" "demande" "Herceptine" "sans" "trois" "près" "médiane"
    "améliorait"
    "fréquente dans les adénocarcinomes du cardia qui sont de type intestinal et bien différenciés"
    "différenciés" "bien" "fréquente" "centromère" "égal" "amplifié"
    "considéré"
    "basolatéral ou latéral avec un seuil de 10% de cellules marquées"
    "cohésives" "adjacentes" "cinq" "opératoires" "incomplet" "compte" "prend"
    "ou" "confirmé" "définie" "agressif" "potentiel" "liée" "elle" "péjoratif"
    "pronostique" "considérée" "bénéficier" "vont" "sélectionner" "devenue"
    "secondaires" "raison" "ces" "effets" "améliorer" "ciblées"
    "thérapeutiques" "nouvelles"
    "car la plupart des patients restent longtemps"
    "Un diagnostic précoce de cette maladie est difficile" "longtemps"
    "difficile" "précoce" "la durée moyenne de survie après le diagnostic est"
    "disponibles" "mois" "environ" "après" "moyenne" "grevé" "ni" "pTNM"
    "aucune" "ailleurs" "concernant" "enregistrées"
    "fréquent chez les hommes que chez les femmes et il touche" "personnes"
    "touche" "fois" "effet"
    "Les résultats épidémiologiques dans notre série concordent avec ceux de la littérature"
    "série" "épidémiologiques" "ainsi" "réalisé" "montré" "carcinomes" "porté"
    "moins" "métastases" "avancé" "stade" "présentés" "notée" "que" "alors"
    "retrouvée" "fundique" "antro"
    "Une nette prédominance masculine est observée avec 24 hommes et 7 femmes"
    "soit" "femmes" "hommes" "observée" "prédominance" "nette" "Une" "moyen"
    "ans" "entre" "compris" "âge" "marché" "malades" "survie" "Cette"
    "réalisée" "dernière" "négatifs" "comme" "considérés" "Les"
    "immunomarquage" "hétérogénéité" "vu" "chirurgicales" "retenu" "marquées"
    "seuil" "tumorales" "cellules" "pourcentage" "marquage" "intensité" "basée"
    "immunohistochimie" "fluorescente (FISH)" "inclus" "formol" "fixé"
    "réalisées" "fluorescente" "immunohistochimique" "déterminé" "pièces"
    "posé" "deux" "durée" "pathologique" "anatomie" "laboratoire" "colligées"
    "porte" "Notre" "et/ ou" "gène" "protéine" "fait" "/ ou" "AMM" "Maroc"
    "anticorps monoclonal humanisé dirigé contre" "métastatiques" "gastrique"
    "oeso" "oesophage" "bas" "estomac" "indiqué" "qui" "adjuvante"
    "métastatique" "années" "depuis" "utilisé" "contre" "dirigé" "humanisé"
    "anticorps" "aussi"
    "Un statut HER2 positif est un facteur de mauvais pronostic et est associé à une maladie"
    "maladie" "associé" "sont" "décrites" "sein" "étudiées" "détectées"
    "Panafricain" "éditeurs" "ce" "particularités" "comprendre" "mieux" "afin"
    "nécessaire" "échantillon" "cette" "poursuite" "baptisée" "vaste"
    "littérature" "séries" "plupart" "supérieur" "il" "Aoyaji" "noté" "celui"
    "proche" "notre" "surexprimant" "taux" "Le" "ceux" "avec" "comparant"
    "avancés" "évaluer" "dont" "gastriques" "tumeurs" "portant" "préliminaire"
    "étude" "une" "résultats" "présente" "les"
    "Un statut HER2 positif est un facteur de mauvais pronostic et un facteur prédictif de la réponse à"
    "herceptine" "réponse" "prédictif" "mauvais" "facteur" "positif" "statut"
    "Un" "adénocarcinomes" "à" "décrite" "est" "du" "le" "étudiée" "plusieurs"
    "dans" "détectée" "été" "immunochemo" "Warburg" "chemoimmuno" "rmTOR"
    "chronic lymphocytic leukemia/small lymphocytic lymphoma" "rs11584787"
    "haplotypes" "=0.021" "=0.001" "Wilcoxon" "follicle" "histo" "FOX"
    "rs4912408" "DLCBCL" "the follicular lymphoma subtype" "= 0.001"
    "Haplotypes" "non-Hodgkin’s" "95%CI" "non-Hodgkin" "FcγRIIb" "up/up"
    "titer" "unresponsiveness" "Lyn−/−phenotype" "CD45−/−" "ITIM" "MZ"
    "co-ligation" "L/L" "H/H" "fide" "bona" "receptor-like" "ITIMs" "Hyper"
    "lupus-like" "hyper-" "hyper" "= 7" "T202/Y204" "marked skeletal dysplasia"
    "thatLKB1" "KOs" "hypoglycemia" "internet" "Ser636/639" "p-S6K1"
    "eightfold" "hydroxymethylglutaryl" "andLKB1" "&E" "inLKB1" "Necropsy"
    "theLKB1" "ofLKB1" "LoxP" "Jeghers" "Peutz" "F-box/WD" "protein 1c" "Fbw"
    "24 h" "= 5" "48 h" "Anti-FLAG" "636/639" "rs1254319" "anophthalmia"
    "retinal pigment epithelium" "heterotrimer" "rs17648524" "sclera"
    "HaploReg" "1-3" "Rotterdam" "15q14" "the 18 best associated SNPs" "Yang"
    "~2.5 million autosomal single nucleotide polymorphisms" "HapMap"
    "Australia" "Europe" "nearsightedness" "associated SNPs" "CREAM" "=7"
    "4.44×10" "=5" "thaliana" "~18-fold" "modulus" "subdomain" "nanosecond"
    "microsecond" "picoseconds" "millisecond" "microseconds"
    "a modest interaction enthalpy" "entropy" "enthalpy" "non-vertebrate"
    "non-nearest" "bound cofilactin" "cofilactin" "~8–20" "nt" "nearest"
    "composites" "species compatible actin non-cooperatively"
    "non-cooperatively" "semi" "TCFs" "non-canonical" "cylcohexamide"
    "thatLRP6" "inLRP6" "ofLRP6" "GDR" "mg/m 2" "euglycemia" "ISI" "12mg/dl"
    "probands" "IGT" "mg/dl" "BMI" "non-carriers" "OGTT" "non-carrier"
    "undertaken" "hyperinsulinemia" "=3" "ob/ob" "non-diabetic" "integrators"
    "TPC1/2" "circuitry" "depolarizes" "delocalizes" "rotarod" "ΔΨ" "Cang" "Cl"
    "phophosites"
    "the transfected ATP-insensitive endolysosomal channel TRPMLs" "TRPMLs"
    "lamptors" "lyosNa" "dKO" "ATP-Mg" "TRPML" "cardiac myocytes" "myocytes"
    "organelle" "bisphosphate" "ionic" "endolysosomes" "Endolysosomes"
    "endolysosome's" "endolysosome" "LysoNa" "mitoK" "lysoNa" "organelles"
    "= 0.06" "C-labeled" "re-feeding" "= 3"
    "the most conserved mammalian sirtuins" "ubiquitins"
    "hypoxia-inducible factor (HIF)-1alpha" "-1alpha" "PPRE" "tenovin"
    "tenovins" "polyphenol" "o" "SENP" "AMP/Protein kinase A" "stressful"
    "Halder" "Preiss" "co-substrate" "-OH"
    "the most evolutionarily conserved sirtuin" "homologs"
    "the most evolutionarily conserved mammalian sirtuin" "co-activators"
    "the remaining highly suggestive SNPs" "misclassifications" "rs1933752"
    "this gene cause Leber’s" "Leber" "Hematology" "Wellcome"
    "microalbuminuria" "CKDGen" "rs213274" "rs213273"
    "gene-wide significance (p<1.7×10 −4 ) around SNP rs213276" "rs213276"
    "hotspots" "rs723296" "rs10486302" "Indians (SINDI)" "SINDI" "Indians"
    "Americans" "rs10234685" "rs10225230" "ARIC" "BMES" "6.6×10" "±0.23"
    "rs12155400"
    "systolic blood pressure and site specific population stratification covariates"
    "covariates" "Singapore Indian Asians" "dyslipidemia" "vasospasm" "∼0.7"
    "p " "covariate" "microaneurysms" "= 3" "4.8×10" "Petermann" "Fugger"
    "singulo" "pombe" "chizosaccharomyces"
    "the ubiquitylated FBH1 yielded similark" "similark" "TUBE2" "non-Ub"
    "co-transfections" "tighter" "constantK" "constantk" "B-form" "Ni"
    "Okazaki" "oligo" "fluorophores" "sof" "theK" "ssDNA" "dsDNA" "biotin"
    "polyethylenimine" "bio" "FBH" "TIRFM" "non-ubiquitylated"
    "anti-recombinogenic" "re-establishment" "ation" "ribozyl"
    "the eukaryotic proteome" "separate DNA duplexes" "duplexes" "Sox2+"
    "deactylases (HDAC)" "deactylases" "SN50" "remodeler" "supershift" "ckos"
    "Oct6+" "thinner" "hindlimb" "Dhh" "dibutyryl" "remodelers" "axons"
    "Schwann" "PNS" "non-targeting" "codons" "philtrum" "premaxilla" "Codon"
    "neuroectoderm" "CLOVES" "9p" "postmalignant" "pre-" "cerebellum"
    "leptomeninges" "meninges" "biopsy" "Kinsler" "Histology" "mortem" "Chiari"
    "Arnold" "choroid" "syringomyelia" "arachnoid" "parenchyma" "melanin"
    "commonest" "non-melanocytic" "individual CMN" "CMN" "p53wt" "axon" "tg"
    "APPswe/PS1A246E" "Serrano" "Xu" "SIN-1" "foresaw" "neurite" "3NT"
    "protein-bound 4-hydroxy-2-nonenal (HNE)" "nitro" "4-hydroxy-2-nonenal"
    "litterature" "Alzheimer's (AD)" "Giovanni" "ZnCl" "and 3-nitro-tyrosine"
    "Michael" "APP751wt" "Alzheimer's" "Alzheimer" "5 × 10" "-nitro-" "isotype"
    "trinucleotide" "cs" "microhomology" "re-synthesis" "N-glycosylase (UNG)"
    "U:G" "dU" "deoxyuracil" "isotypes" "immunoglobin" "Legerski" "adduct"
    "cylcophosphamide" "nitorosurea" "chloroethyl" "Bis" "MutS" "chromatid"
    "MRN" "-nitrosoguanidine (MNNG)" "-nitrosoguanidine" "nitrosoguanidine"
    "8-oxG:A" "Myh" "oxoG" "8-oxoG:A" "oxoGuanine" "particularly O 6 meG:T"
    "bulky adducts" "dihydrodiol" "benzo" "adducts" "proteosome" "NLSs" "Mutsα"
    "Msh" "non-aligned" "co-activator" "XXFF" "QXX" "Palombo" "Jiricny"
    "trimethyl" "homoduplex" "rotein" "ATP/ADP" "-heteroduplex" "heteroduplex"
    "an A denine nucleotide b" "assette" "denine" "adenosines" "Active MutSα"
    "A duplex at least 60 basepairs" "basepairs" "multiparameter" "hydroxyl"
    "the unbent URC" "URC" "IRC" "basepair" "G:T" "eukaryotic MutSα" "hMutLα"
    "methyladenine" "hemi" "omologues" "msh" "meG:T" "MutSα" "hMutSα" "MutHLS"
    "anti-angiogenesis" "neurosphere" "temozolimide" "miR-17-3p"
    "computational algorithms" "miR-17-" "SFM" "pMir" "YPEN" "tube-like"
    "Tube-like" "Transwell" "U343" "miR-17-5p" "hypoxia inducible factor-1α"
    "stem-like" "oncomirs" "neurospheres" "&alpha" "non-adherent" "German"
    "GeparSixto" "GeparQuinto" "situ" "Dabbs" "GeparTrio" "HRs"
    "trastuzumab/chemotherapy" "trastuzumab/" "anthracyline" "qRT" "Paik"
    "STEPP" "NSABP" "Gallen" "non-trastuzumab" "cHER2" "IHC/SISH" "FFPE" "SISH"
    "GeparQuattro" "neoadjuvant" "biopsies" "= 0.03" "Ser104/106" "proven"
    "phosphoSer118" "EralphaSer294" "FLV" "kd" "isomerizes" "parvulins"
    "Ser/Thr-Pro" "LBD" "non-proliferative" "ERalphaSer294"
    "Co-immunoprecipitation" "units/mL" "CCND1 expression" "necropsy" "MMTVD1"
    "aberrancies" "Vec" "48R-shp16-shp53-MYC-D1" "48R-shp16-Vec"
    "48R-shp16-D1/K2" "48R-shp16-D1" "48R-shp16" "retroviruses"
    "48R-shp16-shp53" "HME-1" "MMTVD" "p16-" "p" "MEGM" "mammoplasty"
    "lifespan" "Studies" "0.33–1.64" "AG/GG" "histopathology" "non-SCC" "Henan"
    "stressors" "Gα" "immuno" "TE-12" "SHEEC" "A:G" "cardia" "10q23" "CGC"
    "biphosphate" "esophageal epithelium" "PLCε" "PLC ε" "non-cancer" "Fujita"
    "intra" "and 3A" "S203/T205" "Runx" "lambda" "pS/T" "9ARunx2" "PyMT"
    "osteoblasts" "interefere" "6-diamidino-2-phenylindole"
    "the previously observed FANCD2 co-localization" "PD20" "PD 20" "co-peaks"
    "co-IPed" "co-IP" "mtFANCD2" "Kannouche" "wtFANCD2" "threat/damage" "mt"
    "protein D2" "co-localization" "Dulbecco’s" "Cryptochrome" "TBS"
    "polyaclylamidegel" "Phenylmethylsulfonyl" "Dulbecco" "MYBBBP1A" "gluco"
    "publicly available datasets" "Oncomine" "Sanhueza" "protein 1a" "× 10"
    "5 × 10" "co-transfected" "pcDNA3" "JPV" "kappa-light-chain-enhancer"
    "cIAPs" "MDA-MB-231 cells" "clearer" "Joyce" "VM" "capillary-like" "Boyden"
    "Lisa" "Baugher" "Sanders" "Rottner" "ubiquitin/proteasome" "BPM"
    "the histopathological re-evaluation" "Written" "Neill" "LI" "Brustmann"
    "Wong" "Hsu" "Mishra’s" "and 1+" "Mishra" "selumetenib" "11/54" "5/6"
    "and 1/8" "mitoses/10" "64/70" "Dehari" "10q25" "topology" "Siedman"
    "stepwise" "Robert" "Baltimore" "wenn" "ausschließen" "verlässlich"
    "ziemlich" "scheint" "genau" "genüg" "spezifisch" "empfindlich" "Wege"
    "tumorigenen" "verschieden" "Interaktionen" "mögliche" "einige" "enthüllen"
    "Modell" "dualistische" "passen" "Daten" "unsere" "limitiert" "Nummer"
    "bescheiden" "Studie" "diese" "Obwohl" "waren" "oder" "letztmalig" "nicht"
    "ist" "Pfads" "sugeriert" "bemerkt" "auch" "haben" "13/59" "Verglich"
    "höher" "Häufigkeit" "Karzinoms" "bedeutend" "zwischen" "aktiver"
    "Differenz"
    "Gruppe war eine statistisch bedeutende höhere Expression von p53 (P < 0.001) und topoII alpha (P = 0.001) mit Ki67 median von 56.5 im Gegensatz zu"
    "zu" "Gegensatz" "höhere" "bedeutende" "statistisch" "eine" "zeigte"
    "Stichproben" "verfügbaren" "wurde"
    "Ki67 Expression war bewertet mittels Olympus Image Analysis System als der Prozent von immunopositiven Zellen"
    "mittels" "bewertet" "Niveau" "Zellen" "immunopositiven" "ausgewertet"
    "Färbung" "gegen" "Antikörper" "untersucht" "Immunohistochemisch"
    "analysiert" "wurden" "Fälle" "für" "Mutationsanalyse" "anbei"
    "Ovarialkarzinomen" "Immunohistochemische" "untersuchten" "Wir" "Olympus"
    "= 0.003" "TXNIP-/-" "Mondo" "an intestinal epithelium" "Hoechst" "#2" "#1"
    "TNXIP" "TNIP" "FAKsiRNA" "Dox-" "Dox" "myristate" "OH" "1alpha" "DBTRG"
    "dihydroxyvitamin" "anti-sense" "Woude" "Vande" "bolus" "Wilcoxen" "U373"
    "clinically relevant animal survival endpoints" "endpoints" "gavage"
    "=0.05" "Phosphorylation/activation" "GBM-10" "U1242" "EFGR" "Spearman"
    "Pfizer" "JNJ" "anti-tumor" "= 0.004" "= 0.002" "= 0.005" "× 10"
    "non-responsive" "haplotype" "hotspot" "penetrant" "the largest dataset"
    "=0.010" "NRHC" "86insA" "non-synonymous" "non-melanoma" "Non-melanoma"
    "LMM" "GenoMEL" "immunoassay" "Kirsten rat sarcoma viral oncogene homolog"
    "Factor-kB" "the Kirsten rat sarcoma viral oncogene homolog (KRAS)"
    "homolog (KRAS)" "Kirsten" "Purdue" "FEV1" "Kintu" "Wasswa" "Trivers"
    "co-authors" "Pursiainen" "multivariate" "packs-year" "non-smokers"
    "the squamous histological subtype" "bronchial dysplasia" "Barrett’s"
    "Barrett" "units/ml" "p53Ab" "p53Abs" "written" "CHEK1+AR-LYN"
    "the less stringent log-rank P-value" "P-value" "betweenness" "GeneCards"
    "GENECARDS" "GATHER" "Pearson" "GSE1349" "non-receptor tyrosine kinase"
    "non-differential" "Reverter" "non-differentially" "RankProd"
    "ArrayExpress" "Hanahan" "workflow" "Boolean" "non-specific"
    "non-cancerous" "exonic inclusion/skipping" "inclusion/skipping"
    "there no algorithm" "regulating exonic inclusion/skipping" "hrs"
    "non-lymphoid" "a more stringent algorithm" "synapse (IS)" "FASL"
    "Schlafen5" "denticeless" "SIs" "SI" "stimulated/inhibited" "P/I"
    "phorbolester/ionomycin" "GeneChip" "transcriptome" "proteome" "SHIP145"
    "intron" "MHCI" "Madeo" "non-infected" "appreciable co-localization" "UB"
    "co-localize" "micrographs" "ProteoStat" "anti-PAS" "anti-Flag"
    "S352AS746AS748A" "S746A/S748A" "S352A/S748A" "S352A/S746A" "RFARRSVS"
    "AMRFARRS" "AATNRPNS" "RXRXX" "Scansite" "anti-phospho" "Orbitrap" "hr"
    "BALB/c" "hexamers" "ctivities" "TPases" "dysplasia" "interactome"
    "valosin" "anti-FLAG" "/G1" "represses" "gallbladder" "Rotkrua" "enhancer"
    "Inoue" "Scb" "si" "transwell" "Renilla" "26/86" "58/86" "deeper" "ets"
    "1 × 10" "3+" "5-year" "Cengiz" "Kiuru" "Jacobs" "penetrance" "Arg194Trp"
    "194Trp" "Hu" "Custodio" "Arg399Gln" "399Gln" "19q13.2–13.3" "the Egger's"
    "Both Begg's" "homozygote" "Yosunkaya" "1.15–1.52" "1.13–1.65" "1.05–1.56"
    "1.00–1.47" "1.01–1.73" "Felini" "Liu" "Rajaraman" "Francisco (UCSF)"
    "UCSF" "Francisco" "Texas" "NIOSH" "NCI" "Cowdin" "McKean"
    "Several nonsynonymous coding polymorphisms" "codon" "DSBR"
    "Arg194Trp/Arg280His" "Arg/Arg" "95% CI" "95% CIs" "IEJs" "PMVEC" "ﬂux"
    "2.7±0.4-fold" "2.5±0.2-fold" "RPMVEC" "iii" "ii" "PMVECs" "Monolayers"
    "Ω*cm 2" "shRNAs" "35±5%" "21±6%" "hyperpermeablilty" "*cm 2" "monolayers"
    "Monolayer" "adheren" "invaginations" "RPMVECs" "PLCβ/PKC" "re-orientation"
    "antero" "cargos" "PAK1/2" "p38MAPK" "cPKC" "PKCη" "pseudosubstrates"
    "lamella" "nPKC" "aPKCs" "nPKCs" "cPKCs" "CCKVL" "Memo/ACF7" "Rayleigh"
    "β1" "Dunn" "Retroviruses" "-CONH" "CONH" "homopolymeres" "retrovirus" "Il"
    "sTREM-1" "TFN-alpha" "TFN" "polymorphisms (SNP)" "Polymorphisms"
    "responders" "TREM" "und" "monokine" "CXCL" "ficolin" "summarise"
    "confirmative ELISAs" "ELISAs" "supernatant" "donor 7 only 350 pg/ml"
    "nearly 700 pg/ml" "pg/ml" "phytohemagglutinin (PHA)" "phytohemagglutinin"
    "carbodiimide" "dimethylamonopropyl" "Isu" "helix" "N-helical" "FeLV" "isu"
    "confounders" "at least one G-allele" "healthy Caucasians"
    "homozygous SNP309 variant genotype" "knappskog"
    "A commonly occurring T-to-G polymorphism" "T/G" "HNSCC" "SNP309 G" "G/G"
    "SNP309G’s" "SNP309G" "Begg’s" "Begg" "95% CI " "95%CI " "TT+TG" "TG+GG"
    "Ueda" "Weinberg" "Czech" "Norway" "RFLP" "SNP309T" "G-allele" "rs2279744"
    "OC" "GG" "Cyclin D1/Cyclin E1" "c" "b" "QQ" "Zhang" "represse"
    "LN18/Vector" "re-introduction" "Cyclin E1" "publicly available algorithms"
    "miRANDA" "TargetScan" "their-3" "anti-proliferative" "BrdUrd" "realtime"
    "-UTRs" "UTRs" "non-tumor" "neurosurgery" "CNS" "G1/G0" "non-coding"
    "Salanti" "allI" "Asians" "the heterozygous genotype" "5G/5G" "Semeraro"
    "Egger’s" "Egger" "theI" "Sipahi" "4G/4G" "HWE" "Genotype" "Lorente"
    "Asian" "coworkers" "Caucasians" "+5G/5G" "4G/5G" "ORs" "polymorphism"
    "2/5" "Hoshino" "FIGO" "CKD" "soft agar" "agar" "and 1.01±0.21"
    "and 1.01±0.19" "EV" "+++" "++" "insightful" "HL7702" "inositide" "a 2D"
    "brightfield" "refractile" "PDGFRi" "ngml" "RacGEFs" "chemoattractant"
    "GEF-dead" "monolayer" "catalyse" "multidomain" "changer" "ex" "ac"
    "anti-atherogenic" "electrocardiography" "NSTEMI" "STEMI" "overview"
    "lipoproteins" "thrombus" "Paraoxonase-1" "ACS" "g/mL" "MESP" "mol6"
    "surnamin" "RMSDs" "RMSF" "RMSD" "SIRT" "nf675" "Mol-6" "Salerimide"
    "salerimide" "vdw" "vwd" "Waals" "preform" "LUMO" "pharmacophore"
    "Parkinson's" "Parkinson" "regulationg" "co-substrates" "invariant"
    "Rossman" "pyridine" "Rossmann" "sirtuins" "Sirtuin" "-ribosylases"
    "ribosylases" "diphosphate" "Sirtuins" "deaceatylases" "sirtuin" "der"
    "Boltzmann" "Poisson" "Cα" "unexpected pleiotropy" "EndoS" "UC" "A2G2"
    "A2G1" "PHGF" "5×10" "examinees" "N∼2000" "N -glycosylation" "datasets"
    "PredictABEL" "IGP48" "Caribbean" "African" "corticosteroid" "Trinidad"
    "Bonferroni" "silico" "N-glycosylation" "replicate" "G2N" "G1N" "1.6×10"
    "G2F" "1×10" "IGP9" "subclass" "glycoforms" "Fab glycans" "nBAF" "npBAF"
    "IGP41" "IGP17" "IGP 2" "ABCF2" "IGP31" "IGP42" "IGP2" "IGP23" "rs9296009"
    "trimethylates" "rs4930561" "FA2" "Japanese" "rs2072209" "transducer"
    "total neutral IgG glycans" "rs17348299" "IGP57" "IGP53" "IGP13" "FA2G2"
    "rs6421315" "rs2186369" "Crohn's" "IGP39" "rs909674" "IGP" "rs7652995"
    "rs11710456" "polymorphisms" "2.27×10" "×10" "NSPHS" "ORCADES" "Korcula"
    "CROATIA" "its N -linked glycans" "-glycome" "GWA" "Leiden"
    "N -linked glycans" "CE" "isomers" "bi" "glycan" "glycome" "pleiotropy"
    "Hodgkin" "celiac" "Crohn" "ABCF" "GWAS" "Europeans" "European" "UPLC"
    "N -linked IgG glycans" "glycans" "= 0.0006" "the respective subsets"
    "plasmacytoid" "broader" "non-human" "MLCRs" "synapse" "Fc" "g/ml"
    "viremia" "ELISA" "C-type" "400,000/ml" "deoxynucleotidyl" "TUNEL" "EndoH"
    "MCLRs" "AV/PI" "Pre" "non-reducing" "AV+PI−" "ie" "AV+PI+" "vs"
    "anti-apoptotic" "phosphatydylinositide" "replicates" "non-integrin" "pre"
    "bacterial lipopolysaccharide (LPS)" "lipopolysaccharide" "subsets" "∼50%"
    "co-cultures" "co-cultured" "only just begun" "begun" "hypomorphs"
    "dataset" "co-occurrence" "SQCC" "oxgenase-1" "GCSm" "readouts"
    "KELCHβ-propeller" "AAGE" "co-localized" "lysis" "eluate" "SBPHA" "ΔETGE"
    "greatest" "KELCH" "a novel probabilistic scoring algorithm" "SPOTLITE"
    "APMS" "ESGE" "This architectural re-structuring" "DPP3" "dipeptidyl"
    "‘ETGE’" "ETGE" "its associated adnexa" "adnexa" "mitoses" "transposons"
    "subcutis" "C57BL/6" "shp53" "subtypes" "sarcomatoid" "transposon"
    "progenitors/CD34+LSKs/" "CD34+" "LSKs" "ubiquitination/proteosome"
    "targets/effectors" "CHRF" "CMY" "CD41+c-Kit" "un" "LIC" "MyrAKT"
    "MyrAKT+ERG" "platings" "≤8N" "Migr1" "Gata1s" "CD41+CD42" "myrAKT+ERG"
    "Migr1-IRES-GFP" "MSCV-myrAKT1-IRES-GFP" "MIGR1-IRES-mcherry" "myrAkt"
    "myrAKT" "non-DS" "GATA1s" "ontogeny" "AMKL" "CC" "Oncology/College"
    "centromere" "Internet" "Kayser" "virtual diagnostic algorithms"
    "Klingbeil" "Ulrich" "CEP17" "a diagnostic algorithm"
    "all diagnostic algorithms" "algorithms" "Matlab" "polysomy" "monosomy"
    "aneuploidy" "ASCO/CAP" "Theodosiou" "ASCO" "equi" "Metafer"
    "fluorescent ISH (FISH)" "ISH" "IHC" "classifier" "MetaSystems"
    "MetaSystem" "≤ 2" "non-overlapping" "WTH" "Uddin" "histological subtype"
    "subtype" "poorer" "normal/diploid" "non-GCB" "Hans" "algorithm" "chemo-"
    "chemo" "IIE" "diploid" "histology" "DLBLs" "DLBL"
    "death associated protein kinase-3" "undergoes" "nystagmus" "Missense"
    "Mumford" "~50%" "P-MEK1/2" "callosum" "congenital cutis" "cutis"
    "hyperconvex" "flammeus" "pilaris" "nighttime" "bicuspid" "CNV" "SNPs"
    "Affymetrix" "Boston" "co-twin" "trisomy"
    "the distal and proximal breakpoints" "breakpoints" "USA" "Diego" "Inc"
    "Illumina" "Cambridge" "Ltd" "BlueGnome" "CytoChip" "Nissen" "tracheostomy"
    "at least exons" "exons" "41,898–3" "hg19"
    "frequent obstructive sleep apnea" "Kleberg" "XY" "missense"
    "cardio-facio-cutaneous" "Costello" "Legius" "OMIM" "Noonan" "Germline"
    "on/off" "obstructive sleep apnea" "apnea" "hypotonia" "midface" "19p13.3"
    "non-invasive" "whole ovarian cancer genome" "TCGA" "Genome"
    "non-transformed" "/Xpress" "anti-V5" "ones" "co-overexpression" "G1/S"
    "RK3E-p53 R175H" "G1/S-phase" "RSF/cyclin E1" "Immunohistochemistry"
    "p53 R175H" "tubal" "genomewide" "≥3" "≤2" "amplification/overexpression"
    "ch11q13.5" "amplicon" "endometrium" "co-upregulated" "nanoelectrospray"
    "11q13.5" "germline" "immunoglobulin" "pulldown" "downfield" "HSQC" "H4K"
    "Overhauser" "methyllysine" "H4K16ac" "H4K16" "16p" "PolII" "H4ac"
    "at least several hundred kilobases" "kilobases" "FokI" "RIDDLE" "IRIF"
    "methylated histone H4K20" "H4K20" "methylated H4K20" "Ub" "RNF8-" "RNF"
    "BRCA1−/−" "PARPi" "ribose" "E5.5-8.5" "The pathogenic sequelae" "sequelae"
    "anti-cancer" "Narita" "homolog" "Mungamuri" "UV" "D5Z1" "DSBs" "re-entry"
    "-PuPuPuC" "PuPuPuC" "TGCCC" "spacer" "bp" "LTR" "SINE" "LINE-1" "Gy"
    "pericentric heterochromatin K9m3" "K9m3" "var" "SUV39H1/2" "genome"
    "Fraumeni" "Li" "aneuploid" "genomes" "DSB" "arisen" "transdifferentiate"
    "Mosser" "Pancreatitis" "subset" "ErbA" "v" "GSK3α/β" "/S phase" "/G 1"
    "genotypes" "CD45R" "CD3+" "genotype" "pancreata" "approx" "wildtype"
    "more advanced mPanINs" "atypia" "93.1+/−0.7%" "PanIN"
    "Both ductal and acinar lumena" "acinar and ductal lumena" "lumena"
    "mesenchyme" "littermates" "mPanIN" "epidermal growth factor-like"
    "mPanINs" "PanINs" "pancreatitis" "protooncogene" "Cdkn2a/2d" "exocrine"
    "oxygen/nitrogen" "fluorphores" "paracrine" "epithelium"
    "oral and ovarian epithelia" "#3" "siRNAs" "sICAM -1" "NOF/ht" "OKF6/TERT2"
    "co-culture" "sICAM-1" "Bonferrini" "gluthatione" "8-oxo-Gua"
    "oxoguanosine" "synthases" "DAFs" "diaminofluorescein"
    "the ovarian epithelia" "epithelia" "immunohistochemistry" "mucosa"
    "organotypic co-culture" "wt-" "wt" "non-tumorigenic" "spindle-like"
    "rounder" "shRNA" "mutagenizes" "siRNA" "unmet" "greater" "monotherapy"
    "lipidemia" "Perhaps" "et" "Bindl" "secretory enteropathy" "mellitus"
    "stemness" "perhaps" "multi" "lineages" "globulin (ATG)" "suppressant"
    "globulin" "neutropenia" "Lymphopenia" "naïve" "enteropathy"
    "polyendocrinopathy" "chosen" "undergone" "neonatal thymectomy"
    "thymectomy" "erythrocytes" "Sjogren’s" "Sjogren" "Rheumatology" "American"
    "untangle" "DiGeorge" "cytopenia" "pancytopenia" "lymphopenia"))

(DEFPARAMETER SPARSER::*BIO-CHEMICAL-HEADS-PHASE3-9301-9600*
  '(("a fungal PAMP" . SPARSER::PROTEIN) ("β 1 and β 2" . SPARSER::COLLECTION)
    ("ERK and MAPK" . SPARSER::COLLECTION)
    ("both the fungal ligand" . SPARSER::LIGAND)
    ("counter-receptor" . SPARSER::PROTEIN)
    ("DPI, SOD, and catalase" . SPARSER::COLLECTION) ("SOD" . SPARSER::PROTEIN)
    ("a nonphysiological stimulant" . SPARSER::DRUG)
    ("stimulant" . SPARSER::DRUG) ("fungal components" . SPARSER::COMPONENT)
    ("DCFDA" . SPARSER::DRUG) ("iodonium" . SPARSER::MOLECULE)
    ("DPI" . SPARSER::PROTEIN) ("vestigial" . SPARSER::PROTEIN-FAMILY)
    ("fungal filaments" . SPARSER::PROTEIN-FAMILY)
    ("intact hyphal filaments" . SPARSER::PROTEIN-FAMILY)
    ("an anti-CR3" . SPARSER::ANTIBODY)
    ("the phagocytic component" . SPARSER::COMPONENT)
    ("cytochalasin" . SPARSER::MOLECULE)
    ("homogenous condensed chromatin" . SPARSER::BIO-COMPLEX)
    ("bar" . SPARSER::PROTEIN) ("PicoGreen" . SPARSER::MOLECULE)
    ("UO126 or PD 98059" . SPARSER::COLLECTION)
    ("Neutrophils" . SPARSER::PROTEIN) ("CR3-" . SPARSER::PROTEIN)
    ("the anti-CD11b" . SPARSER::ANTIBODY)
    ("TNFα (30 ng/ml) or IL-8 (7 ng/ml)" . SPARSER::COLLECTION)
    ("both fMLF and Mn +2" . SPARSER::COLLECTION)
    ("dextran or mannan" . SPARSER::COLLECTION)
    ("BSA or fibrinogen" . SPARSER::COLLECTION)
    ("fMLF or IL-8" . SPARSER::COLLECTION) ("fMLF" . SPARSER::MOLECULE)
    ("PAMP" . SPARSER::PROTEIN) ("Pathogenic fungi" . SPARSER::PROTEIN)
    ("Polymorphonuclear leukocytes" . SPARSER::PROTEIN)
    ("Dectin-1, or ROS" . SPARSER::COLLECTION)
    ("CD11b/CD18" . SPARSER::COLLECTION)
    ("the ubiquitous matrix component fibronectin"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NET" . SPARSER::PROTEIN) ("microbicidal enzymes" . SPARSER::ENZYME)
    ("NETs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β 1" . SPARSER::PROTEIN)
    ("pERK 1/2" . SPARSER::PROTEIN) ("ND4" . SPARSER::PROTEIN)
    ("PD 98059" . SPARSER::MOLECULE)
    ("2’,7’- dichlorodihydrofluorescein diacetate" . SPARSER::DRUG)
    ("GE2" . SPARSER::PROTEIN) ("anti-microbial" . SPARSER::DRUG)
    ("Dectin-1" . SPARSER::PROTEIN) ("CR3" . SPARSER::PROTEIN)
    ("c-Myc-" . SPARSER::PROTEIN) ("ACE" . SPARSER::PROTEIN)
    ("Ang II or PMA" . SPARSER::COLLECTION)
    ("GRK4 and recouple" . SPARSER::COLLECTION)
    ("Either losartan (10 μmol/L, 3 hr) or 10074-G5 (30 μmol/L, 3 hr) pre-treatment"
     . SPARSER::COLLECTION)
    ("losartan or 10074-G5" . SPARSER::COLLECTION)
    ("losartan, and Ang II" . SPARSER::COLLECTION)
    ("S2 and S3 segments" . SPARSER::COLLECTION)
    ("autocrine Ang II" . SPARSER::PROTEIN)
    ("angiotensinogen" . SPARSER::PROTEIN) ("SFM" . SPARSER::PROTEIN)
    ("media (SFM)" . SPARSER::PROTEIN)
    ("the avian myelocytomatosis viral oncogene v-Myc" . SPARSER::PROTEIN)
    ("SHR" . SPARSER::PROTEIN)
    ("the 7 member GRK family, which are serine-threonine kinases that are involved in the desensitization of G protein-coupled receptors (GPCRs)"
     . SPARSER::PROTEIN-FAMILY)
    ("GRK" . SPARSER::PROTEIN) ("PMA or Ang II" . SPARSER::COLLECTION)
    ("losartan" . SPARSER::PROTEIN) ("APA" . SPARSER::PROTEIN)
    ("esters (PMA)" . SPARSER::MOLECULE)
    ("phospho-c-Myc and GRK4" . SPARSER::COLLECTION)
    ("angiotensin converting enzyme" . SPARSER::PROTEIN)
    ("i19" . SPARSER::PROTEIN) ("CD13" . SPARSER::PROTEIN)
    ("Angiotensin II" . SPARSER::PROTEIN) ("Ang III" . SPARSER::PROTEIN)
    ("v-Myc" . SPARSER::PROTEIN)
    ("G protein-coupled receptor kinase 4" . SPARSER::PROTEIN)
    ("NHE3" . SPARSER::PROTEIN)
    ("sodium/hydrogen exchanger 3" . SPARSER::PROTEIN)
    ("D 3 R" . SPARSER::PROTEIN) ("AT 1" . SPARSER::PROTEIN)
    ("aminopeptidase A" . SPARSER::PROTEIN) ("GRK4" . SPARSER::PROTEIN)
    ("the cortical localized dynein–dynactin complex" . SPARSER::BIO-COMPLEX)
    ("cortical localized p150 glued" . SPARSER::PROTEIN)
    ("MISP–p150 glued" . SPARSER::COLLECTION)
    ("LGN–NuMA" . SPARSER::COLLECTION) ("LGN-NuMA" . SPARSER::COLLECTION)
    ("Nedd1" . SPARSER::PROTEIN) ("ezrin/radixin/moesin" . SPARSER::COLLECTION)
    ("pericentrin or AKAP450" . SPARSER::COLLECTION)
    ("AKAP-KL" . SPARSER::COLLECTION) ("KL" . SPARSER::PROTEIN)
    ("MISP or control siRNA" . SPARSER::COLLECTION)
    ("p150 glued or MISP" . SPARSER::COLLECTION)
    ("p150 glued and actin" . SPARSER::COLLECTION)
    ("taxol or nocodazole" . SPARSER::COLLECTION)
    ("microtubules and p150 glued" . SPARSER::COLLECTION)
    ("a subunit of the dynactin complex and a +TIP binding protein (Fig. S5 D)"
     . SPARSER::COLLECTION)
    ("stabilizers" . SPARSER::MOLECULE) ("protein (MAPF)" . SPARSER::PROTEIN)
    ("EB3" . SPARSER::PROTEIN) ("EB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the nonphosphorylatable MISP 7AP and 9AC mutants" . SPARSER::MUTANT)
    ("the Plk1 phospho-mimetic MISP 6DP mutant" . SPARSER::MUTANT)
    ("Mad2" . SPARSER::PROTEIN)
    ("the centriolar marker Cep135" . SPARSER::PROTEIN)
    ("pericentrin" . SPARSER::PROTEIN)
    ("α-tubulin and the centrosomal marker γ-tubulin" . SPARSER::COLLECTION)
    ("the centrosomal marker γ-tubulin" . SPARSER::PROTEIN)
    ("both nonphosphorylatable mutants" . SPARSER::MUTANT)
    ("Plk1 and Cdk1" . SPARSER::COLLECTION) ("Mad" . SPARSER::PROTEIN)
    ("clear BubR1" . SPARSER::PROTEIN) ("SAC" . SPARSER::PROTEIN)
    ("24 h or 28 h" . SPARSER::COLLECTION) ("GFP-H2B" . SPARSER::COLLECTION)
    ("RFP-H2B" . SPARSER::PROTEIN-PAIR) ("GFP-MISP" . SPARSER::COLLECTION)
    ("Histone" . SPARSER::PROTEIN) ("polymerized actin" . SPARSER::PROTEIN)
    ("cortical actin" . SPARSER::PROTEIN)
    ("antibodies and phalloidin" . SPARSER::COLLECTION)
    ("nonphosphorylatable alanines" . SPARSER::AMINO-ACID)
    ("Cdk1 and 7AP" . SPARSER::COLLECTION) ("mitotic MISP" . SPARSER::PROTEIN)
    ("Cdk1–cyclin" . SPARSER::COLLECTION)
    ("MISP and Cdk1" . SPARSER::COLLECTION)
    ("an important mitotic kinase" . SPARSER::KINASE)
    ("a novel substrate and interaction partner" . SPARSER::COLLECTION)
    ("GST-MISP" . SPARSER::COLLECTION)
    ("the last 179 amino acids" . SPARSER::AMINO-ACID)
    ("Plk1 and Plk1" . SPARSER::COLLECTION) ("GST-Plk1" . SPARSER::COLLECTION)
    ("the highest phosphorylated form" . SPARSER::FORM)
    ("ectopically expressed Flag-MISP" . SPARSER::COLLECTION)
    ("expressed Flag-MISP" . SPARSER::COLLECTION)
    ("Flag-MISP" . SPARSER::COLLECTION) ("MISP and Plk1" . SPARSER::COLLECTION)
    ("AKAP" . SPARSER::PROTEIN)
    ("substrates and effectors" . SPARSER::COLLECTION)
    ("a novel mitotic phosphoprotein and Plk1 substrate" . SPARSER::SUBSTRATE)
    ("phosphoprotein and Plk1" . SPARSER::COLLECTION)
    ("a mitotic phosphoprotein and substrate" . SPARSER::COLLECTION)
    ("phosphoprotein and substrate" . SPARSER::COLLECTION)
    ("a previously uncharacterized actin-binding protein" . SPARSER::PROTEIN)
    ("its upstream cortical targeting factors NuMA and LGN"
     . SPARSER::COLLECTION)
    ("spindle pole–localized Plk1" . SPARSER::PROTEIN)
    ("NuMA and LGN" . SPARSER::COLLECTION)
    ("This binding mechanism dynamically targets Plk1" . SPARSER::PROTEIN)
    ("Polo" . SPARSER::PROTEIN) ("a major mitotic kinase" . SPARSER::KINASE)
    ("heterotrimeric G proteins/LGN/NuMA" . SPARSER::COLLECTION)
    ("The cortically localized dynein–dynactin complex" . SPARSER::BIO-COMPLEX)
    ("proteins/LGN/NuMA" . SPARSER::COLLECTION) ("NuMA" . SPARSER::PROTEIN)
    ("LGN" . SPARSER::PROTEIN)
    ("These cortical cues" . SPARSER::PROTEIN-FAMILY)
    ("MTs" . SPARSER::PROTEIN)
    ("proper mitotic spindle positioning" . SPARSER::PROTEIN)
    ("dynein–dynactin" . SPARSER::COLLECTION)
    ("dynactin" . SPARSER::PROTEIN-FAMILY) ("TIP" . SPARSER::PROTEIN)
    ("shortened astral microtubules" . SPARSER::PROTEIN)
    ("an actin-associated protein" . SPARSER::PROTEIN)
    ("a previously uncharacterized protein" . SPARSER::PROTEIN)
    ("astral microtubules" . SPARSER::PROTEIN) ("MISP" . SPARSER::PROTEIN)
    ("AMP-PNP" . SPARSER::MOLECULE) ("CS3" . SPARSER::PROTEIN)
    ("GL2" . SPARSER::PROTEIN) ("p34" . SPARSER::PROTEIN)
    ("AKAP450" . SPARSER::PROTEIN) ("CENP-E" . SPARSER::PROTEIN)
    ("Cep135" . SPARSER::PROTEIN) ("BubR1" . SPARSER::PROTEIN)
    ("24 h" . SPARSER::PROTEIN) ("3 B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BI2536" . SPARSER::DRUG) ("Ol2" . SPARSER::PROTEIN)
    ("75 kD" . SPARSER::PROTEIN) ("1 C" . SPARSER::PROTEIN)
    ("Dvl2" . SPARSER::PROTEIN) ("p150 glued" . SPARSER::PROTEIN)
    ("mitotic spindle positioning" . SPARSER::PROTEIN)
    ("cis-" . SPARSER::PROTEIN) ("ADRB2 , CRHR2 and AC9" . SPARSER::COLLECTION)
    ("ARGI" . SPARSER::PROTEIN) ("CARE and ACRN" . SPARSER::COLLECTION)
    ("this intronic SNP" . SPARSER::PROTEIN) ("PER" . SPARSER::PROTEIN)
    ("circadian rhythm genes" . SPARSER::GENE)
    ("Cis-eQTL" . SPARSER::PROTEIN-PAIR)
    ("IL15RA and IL2RA" . SPARSER::COLLECTION) ("PRKCQ" . SPARSER::PROTEIN)
    ("opted" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only one intergenic SNP" . SPARSER::PROTEIN)
    ("COL22A1 and CLOCK" . SPARSER::COLLECTION)
    ("the intergenic SNP" . SPARSER::PROTEIN)
    ("CLOCK and PER2" . SPARSER::COLLECTION) ("Cysteine" . SPARSER::AMINO-ACID)
    ("The intergenic SNP" . SPARSER::PROTEIN)
    ("ADRB2 , rs4723002 and rs226716" . SPARSER::COLLECTION)
    ("CRHR2 , and rs2230739" . SPARSER::COLLECTION)
    ("–Log" . SPARSER::COLLECTION) ("Pre-BD" . SPARSER::PROTEIN-PAIR)
    ("CARE and GACRS" . SPARSER::COLLECTION) ("CARE" . SPARSER::PROTEIN)
    ("the associated alleles" . SPARSER::ALLELE)
    ("receptor ( CRHR )" . SPARSER::RECEPTOR)
    ("-adrenergic" . SPARSER::COLLECTION) ("CRHR" . SPARSER::PROTEIN)
    ("-agonist" . SPARSER::AGONIST) ("formoterol" . SPARSER::DRUG)
    ("An intronic SNP" . SPARSER::PROTEIN)
    ("An intergenic SNP" . SPARSER::PROTEIN) ("albuterol" . SPARSER::DRUG)
    ("-agonists" . SPARSER::AGONIST) ("period 1" . SPARSER::PROTEIN)
    ("KLF6" . SPARSER::PROTEIN) ("IL15RA" . SPARSER::PROTEIN)
    ("GPR110" . SPARSER::PROTEIN) ("PER2" . SPARSER::PROTEIN)
    ("Period 2" . SPARSER::PROTEIN) ("type XXII" . SPARSER::PROTEIN)
    ("CRHR2" . SPARSER::PROTEIN) ("ZNF14" . SPARSER::PROTEIN)
    ("zinc finger protein 14" . SPARSER::PROTEIN)
    ("SPATS2L" . SPARSER::PROTEIN) ("rich 2" . SPARSER::PROTEIN)
    ("AC9" . SPARSER::PROTEIN) ("adenylyl cyclase" . SPARSER::PROTEIN)
    ("corticotropin-releasing hormone" . SPARSER::PROTEIN)
    ("ADRB2" . SPARSER::PROTEIN) ("arginase 1" . SPARSER::PROTEIN)
    ("β  2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("COL22A1" . SPARSER::PROTEIN)
    ("β 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("post-ER" . SPARSER::COLLECTION)
    ("BiP" . SPARSER::PROTEIN) ("BIP" . SPARSER::PROTEIN)
    ("KDELR" . SPARSER::PROTEIN)
    ("proteins and effectuates" . SPARSER::COLLECTION)
    ("muFLT3" . SPARSER::PROTEIN) ("muFLT3-ITD" . SPARSER::COLLECTION)
    ("semisolid media" . SPARSER::PROTEIN) ("mK5" . SPARSER::PROTEIN)
    ("stably expressing FLT3-ITD" . SPARSER::COLLECTION)
    ("expressing FLT3-ITD" . SPARSER::COLLECTION)
    ("CD135-PE" . SPARSER::COLLECTION)
    ("KDELR1 and SLC30A8" . SPARSER::COLLECTION)
    ("PU.1 and PML" . SPARSER::COLLECTION)
    ("ion channel and RBM15" . SPARSER::COLLECTION)
    ("STAT5 and AKT" . SPARSER::COLLECTION)
    ("STAT5a and STAT5b" . SPARSER::COLLECTION)
    ("the lactogenic hormones response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Renilla" . SPARSER::PROTEIN)
    ("the STAT5-responsive lactogenic hormones response element"
     . SPARSER::DNA-RESPONSE-ELEMENT)
    ("STA" . SPARSER::PROTEIN) ("endoribonuclease" . SPARSER::PROTEIN)
    ("PDGF-receptor" . SPARSER::COLLECTION)
    ("KDEL receptor" . SPARSER::PROTEIN) ("Brefeldin A" . SPARSER::MOLECULE)
    ("Asp-Glu" . SPARSER::MOLECULE) ("SLC30A8" . SPARSER::PROTEIN)
    ("VDAC3" . SPARSER::PROTEIN) ("Connexin-26" . SPARSER::PROTEIN)
    ("EP300" . SPARSER::PROTEIN) ("NBP1" . SPARSER::PROTEIN)
    ("CD135" . SPARSER::PROTEIN) ("KDELR1" . SPARSER::PROTEIN)
    ("tyrosine kinase-3" . SPARSER::PROTEIN)
    ("at least two nonspecific states" . SPARSER::BIO-STATE)
    ("nonspecific duplex DNA" . SPARSER::DNA) ("Duplex DNA" . SPARSER::DNA)
    ("transiently bound conformation" . SPARSER::BIO-CONFORMATION)
    ("the crystallographic conformation" . SPARSER::BIO-CONFORMATION)
    ("molecules or ions" . SPARSER::COLLECTION)
    ("the neutral patch" . SPARSER::PROTEIN)
    ("neutral serine or histidine side" . SPARSER::PROTEIN)
    ("serine or histidine" . SPARSER::COLLECTION)
    ("the nonspecific complex" . SPARSER::BIO-COMPLEX)
    ("duplex substrate S5" . SPARSER::MOLECULE)
    ("a 90mer DNA duplex substrate" . SPARSER::SUBSTRATE)
    ("cat" . SPARSER::PROTEIN)
    ("nonspecific and specific complexes" . SPARSER::BIO-COMPLEX)
    ("P trans , P slide , and P hop" . SPARSER::COLLECTION)
    ("methylphosphonates" . SPARSER::MOLECULE)
    ("Methylphosphonate" . SPARSER::MOLECULE)
    ("the larger AB" . SPARSER::PROTEIN) ("track" . SPARSER::PROTEIN)
    ("typical DNA binding proteins" . SPARSER::PROTEIN)
    ("a distinct weakly interacting state" . SPARSER::BIO-STATE)
    ("open and closed conformational states" . SPARSER::BIO-STATE)
    ("duplex and single stranded DNA substrates" . SPARSER::SUBSTRATE)
    ("neutral methylphosphonate" . SPARSER::MOLECULE)
    ("rare uracil" . SPARSER::NUCLEOBASE) ("NS5" . SPARSER::PROTEIN)
    ("eq 1" . SPARSER::PROTEIN) ("bp 2" . SPARSER::PROTEIN)
    ("longer DNA" . SPARSER::DNA) ("allowing more facile DNA" . SPARSER::DNA)
    ("a 30 mer duplex DNA" . SPARSER::DNA) ("mer" . SPARSER::PROTEIN)
    ("duplex or single stranded DNA" . SPARSER::DNA)
    ("helicases and DNA" . SPARSER::COLLECTION) ("Uracils" . SPARSER::DRUG)
    ("the more rigid duplex DNA polymer" . SPARSER::MOLECULE)
    ("a strong electrostatic component" . SPARSER::COMPONENT)
    ("methylphosphonate" . SPARSER::MOLECULE)
    ("ssDNA and duplex DNA" . SPARSER::COLLECTION)
    ("a conformational state" . SPARSER::BIO-STATE)
    ("ssDNA and uracils" . SPARSER::COLLECTION)
    ("uniformly spaced uracils" . SPARSER::NUCLEOBASE)
    ("deaminating neighboring cytosines" . SPARSER::NUCLEOBASE)
    ("both duplex and single stranded DNA" . SPARSER::DNA)
    ("no previously investigated duplex or single stranded substrates"
     . SPARSER::SUBSTRATE)
    ("the largest uracil" . SPARSER::NUCLEOBASE)
    ("a flexible polymer" . SPARSER::MOLECULE) ("obs" . SPARSER::PROTEIN)
    ("trap" . SPARSER::PROTEIN) ("sparse uracils" . SPARSER::NUCLEOBASE)
    ("helical duplex DNA" . SPARSER::DNA)
    ("sparsely spaced uracils" . SPARSER::NUCLEOBASE)
    ("these genomic uracils" . SPARSER::NUCLEOBASE)
    ("closely spaced cytosines" . SPARSER::NUCLEOBASE)
    ("spaced cytosines" . SPARSER::NUCLEOBASE)
    ("uracils or uracils" . SPARSER::COLLECTION)
    ("antifolate and fluoropyrimidine" . SPARSER::COLLECTION)
    ("dUTP" . SPARSER::MOLECULE) ("fluoropyrimidine" . SPARSER::DRUG)
    ("antifolate" . SPARSER::MOLECULE) ("nonspecific DNA" . SPARSER::DNA)
    ("densely spaced uracils" . SPARSER::NUCLEOBASE)
    ("spaced uracils" . SPARSER::NUCLEOBASE)
    ("sparsely or densely spaced uracil" . SPARSER::NUCLEOBASE)
    ("spaced uracil" . SPARSER::NUCLEOBASE) ("uracils" . SPARSER::NUCLEOBASE)
    ("cytidine deaminase" . SPARSER::PROTEIN)
    ("F 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("S19" . SPARSER::PROTEIN)
    ("terminal transferase" . SPARSER::PROTEIN) ("mM −1" . SPARSER::PROTEIN)
    ("DNA glycosylase" . SPARSER::PROTEIN)
    ("XLP and YQL" . SPARSER::COLLECTION) ("XLP" . SPARSER::PROTEIN)
    ("polysaccharide and lipid" . SPARSER::COLLECTION)
    ("polysaccharide" . SPARSER::POLYSACCHARIDE)
    ("H. pylori vacuolating cytotoxin A (VacA) or cytotoxin"
     . SPARSER::COLLECTION)
    ("gene A protein" . SPARSER::PROTEIN) ("VacA" . SPARSER::PROTEIN)
    ("cagA" . SPARSER::PROTEIN) ("cag" . SPARSER::PROTEIN)
    ("Table S2 and Additional file xref" . SPARSER::COLLECTION)
    ("homozygotes and SNP309T/G" . SPARSER::COLLECTION)
    ("homozygotes" . SPARSER::PROTEIN) ("MDM2 and p53" . SPARSER::COLLECTION)
    ("MDM2 SNP309G/G allele and H. pylori infection" . SPARSER::COLLECTION)
    ("age-" . SPARSER::PROTEIN) ("IFN- γ" . SPARSER::PROTEIN)
    ("trefoil factor 1" . SPARSER::PROTEIN)
    ("vacuolating cytotoxin A" . SPARSER::PROTEIN) ("24 h" . SPARSER::PROTEIN)
    ("maintaining cyclin B1" . SPARSER::PROTEIN)
    ("substrates or structures" . SPARSER::COLLECTION)
    ("Other known mitotic chromosome proteins" . SPARSER::PROTEIN)
    ("condensins or topoisomerase II" . SPARSER::COLLECTION)
    ("condensins" . SPARSER::PROTEIN-FAMILY) ("Separase" . SPARSER::PROTEIN)
    ("the N-terminal 110 amino acids of cyclin B1" . SPARSER::PROTEIN)
    ("Arg-Pro-Arg" . SPARSER::COLLECTION) ("arms" . SPARSER::PROTEIN)
    ("guanidinium" . SPARSER::MOLECULE)
    ("mitotic chromatin" . SPARSER::PROTEIN)
    ("arginines and threonine" . SPARSER::COLLECTION)
    ("cyclin B1-CDK1" . SPARSER::COLLECTION)
    ("1.39 and 1.48" . SPARSER::PROTEIN) ("1.82 and 1.85" . SPARSER::PROTEIN)
    ("DB 1" . SPARSER::PROTEIN) ("Δ3–8" . SPARSER::PROTEIN)
    ("cyclin B1 and the GFP-tagged transgenes" . SPARSER::COLLECTION)
    ("-GFP" . SPARSER::COLLECTION) ("1.83 and 1.70" . SPARSER::PROTEIN)
    ("aspartic acid and glutamic acid" . SPARSER::COLLECTION)
    ("the first 20 amino acids of cyclin B1" . SPARSER::PROTEIN)
    ("the N-terminal 50 amino acids of cyclin B1" . SPARSER::PROTEIN)
    ("the latter protein" . SPARSER::PROTEIN) ("CER " . SPARSER::PROTEIN)
    ("CER  " . SPARSER::PROTEIN)
    ("the N-terminal 41 amino acids of cyclin B1" . SPARSER::PROTEIN)
    ("the first 63 amino acids (WT 1–63 , includes the D-box), the first 110 amino acids (WT 1–110 , includes sequence N-terminal to the CRS) and the first 166 amino acids (WT 1–166 , includes the CRS but lacks the CDK1 binding domain) of cyclin B1"
     . SPARSER::PROTEIN)
    ("the first 110 amino acids (WT 1–110 , includes sequence N-terminal to the CRS) and the first 166 amino acids (WT 1–166 , includes the CRS but lacks the CDK1 binding domain)"
     . SPARSER::COLLECTION)
    ("the first 63 amino acids (WT 1–63 , includes the D-box), the first 110 amino acids (WT 1–110 , includes sequence N-terminal to the CRS) and the first 166 amino acids (WT 1–166 , includes the CRS but lacks the CDK1 binding domain)"
     . SPARSER::COLLECTION)
    ("CRS" . SPARSER::PROTEIN)
    ("the N-terminal twenty amino acids of cyclin B1" . SPARSER::PROTEIN)
    ("the first 20 amino acids of cyclin B1 (WT 1–20 )" . SPARSER::PROTEIN)
    ("The first 15 amino acids of cyclin B1 (WT 1–15 )" . SPARSER::PROTEIN)
    ("the N-terminal 109 amino acids of cyclin B1" . SPARSER::PROTEIN)
    ("fluorescent protein" . SPARSER::PROTEIN) ("CER" . SPARSER::PROTEIN)
    ("the mitotic chromatin" . SPARSER::PROTEIN)
    ("the exogenous cyclin B1-GFP" . SPARSER::COLLECTION)
    ("BS-C-1" . SPARSER::COLLECTION)
    ("the chromosome-associated fraction" . SPARSER::COMPONENT)
    ("the mitotic chromosome-enriched fraction" . SPARSER::COMPONENT)
    ("The exogenous cyclin B1-GFP" . SPARSER::COLLECTION)
    ("adenovirally expressed cyclin B1-GFP" . SPARSER::COLLECTION)
    ("expressed cyclin B1-GFP" . SPARSER::COLLECTION)
    ("cyclin B1-GFP" . SPARSER::COLLECTION)
    ("total cellular CDK1" . SPARSER::PROTEIN)
    ("total cellular cyclin B1" . SPARSER::PROTEIN)
    ("the mitotic chromosome fraction" . SPARSER::COMPONENT)
    ("cyclin B1 and CDK1" . SPARSER::COLLECTION)
    ("cyclin B1/CDK1" . SPARSER::COLLECTION) ("separase" . SPARSER::PROTEIN)
    ("condensin" . SPARSER::PROTEIN-FAMILY)
    ("importins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Plk1 and CDK" . SPARSER::COLLECTION) ("polo" . SPARSER::PROTEIN)
    ("substrates or regions" . SPARSER::COLLECTION)
    ("kinases, and polo-like" . SPARSER::COLLECTION)
    ("aurora" . SPARSER::PROTEIN) ("mitotic protein kinases" . SPARSER::KINASE)
    ("Cyclin B1–CDK1" . SPARSER::COLLECTION) ("APC3" . SPARSER::PROTEIN)
    ("BSC1" . SPARSER::PROTEIN) ("N14" . SPARSER::PROTEIN)
    ("Histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("A 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("gag-pol" . SPARSER::PROTEIN)
    ("WT 1" . SPARSER::PROTEIN) ("C-1" . SPARSER::PROTEIN)
    ("PHF8" . SPARSER::PROTEIN) ("Polo-like" . SPARSER::PROTEIN)
    ("polo-like" . SPARSER::PROTEIN) ("GENe" . SPARSER::GENE)
    ("SIRT1 variants and healthy aging" . SPARSER::COLLECTION)
    ("yrs" . SPARSER::PROTEIN)
    ("SIRT1 or using SIRT1 activators" . SPARSER::COLLECTION)
    ("SIRT1 and glucose" . SPARSER::COLLECTION)
    ("gene and human" . SPARSER::COLLECTION)
    ("SIRT1 and lifespan" . SPARSER::COLLECTION) ("PPAR γ" . SPARSER::PROTEIN)
    ("silent information regulator 2" . SPARSER::PROTEIN)
    ("dual priming oligonucleotide (DPO)" . SPARSER::MOLECULE)
    ("oligonucleotide (DPO)" . SPARSER::MOLECULE)
    ("RET/PTC" . SPARSER::COLLECTION) ("BRAFV" . SPARSER::PROTEIN)
    ("muscle)" . SPARSER::PROTEIN)
    ("just one or two MGMT alleles" . SPARSER::ALLELE)
    ("predictive biomarker" . SPARSER::MOLECULE)
    ("age, KPS and MGMT" . SPARSER::COLLECTION) ("Rank" . SPARSER::PROTEIN)
    ("MS-MLPAav" . SPARSER::PROTEIN-PAIR)
    ("Methylated MGMT promoter" . SPARSER::PROMOTER)
    ("CpGs" . SPARSER::PROTEIN) ("chemosensitizer" . SPARSER::DRUG)
    ("a minimal promoter" . SPARSER::PROMOTER)
    ("-guanine" . SPARSER::COLLECTION) ("MS-MLPA" . SPARSER::COLLECTION)
    ("DNA repair enzyme" . SPARSER::PROTEIN)
    ("alkylating agent" . SPARSER::MOLECULE)
    ("our observations turn PRMT4 as well as Mi2" . SPARSER::COLLECTION)
    ("PRMT4 and the Mi2α/β remodeller" . SPARSER::COLLECTION)
    ("PRMT4 or Mi2" . SPARSER::COLLECTION)
    ("the Mim-1 gene undergoes intensive nucleosome" . SPARSER::PROTEIN)
    ("promoter and enhancer" . SPARSER::COLLECTION)
    ("mim-1" . SPARSER::PROTEIN) ("mim" . SPARSER::PROTEIN)
    ("Nucleosome" . SPARSER::BIO-COMPLEX)
    ("PRMT4 and c-Myb" . SPARSER::COLLECTION)
    ("PRMT4, Mi2β and c-Myb" . SPARSER::COLLECTION)
    ("HEB and the HAT p300" . SPARSER::COLLECTION)
    ("Mi2β and Ikaros" . SPARSER::COLLECTION)
    ("Ikaros and HEB" . SPARSER::COLLECTION) ("HEB" . SPARSER::PROTEIN)
    ("which marks active gene promoters" . SPARSER::PROMOTER)
    ("NF-κB and KRAB" . SPARSER::COLLECTION) ("KRAB" . SPARSER::PROTEIN-FAMILY)
    ("MDa" . SPARSER::DRUG)
    ("a predominant PRMT4-containing complex" . SPARSER::BIO-COMPLEX)
    ("peak around 500 kDa" . SPARSER::PROTEIN)
    ("c-Myb and coactivate" . SPARSER::COLLECTION)
    ("c-Myb, PRMT4 and Mi2β" . SPARSER::COLLECTION)
    ("c-Myb as well as Mi2β" . SPARSER::COLLECTION)
    ("hemin" . SPARSER::MOLECULE)
    ("functionally relevant coactivators" . SPARSER::PROTEIN)
    ("PRMT4-" . SPARSER::PROTEIN) ("PI-FACS" . SPARSER::COLLECTION)
    ("Mi2α/Mi2β" . SPARSER::COLLECTION)
    ("c-Myb, PRMT4 as well as Mi2" . SPARSER::COLLECTION)
    ("Cdc7 , c-Myc and CycB1" . SPARSER::COLLECTION)
    ("PRMT4 as well as Mi2" . SPARSER::COLLECTION)
    ("activator or repressor" . SPARSER::COLLECTION)
    ("Cdc7 , c-Myc and Gata3" . SPARSER::COLLECTION)
    ("Mi2α or Mi2β" . SPARSER::COLLECTION)
    ("Cdc7 , c-Myc , Gata3 and CycB1" . SPARSER::COLLECTION)
    ("c-Myb, PRMT4, Mi2α or Mi2β" . SPARSER::COLLECTION)
    ("transcription factor and synergises" . SPARSER::COLLECTION)
    ("methyltransferase-" . SPARSER::PROTEIN)
    ("PRMT4 and Mi2β" . SPARSER::COLLECTION)
    ("PRMT1 and PRMT6" . SPARSER::COLLECTION)
    ("the chicken myelomonocytic cell line HD11" . SPARSER::PROTEIN)
    ("Mim-1 and Lysozyme" . SPARSER::COLLECTION) ("Mim-1" . SPARSER::PROTEIN)
    ("Lysozyme" . SPARSER::PROTEIN) ("Mim" . SPARSER::PROTEIN)
    ("PRMT4 and both Mi2 proteins" . SPARSER::COLLECTION)
    ("PRMT4, c-Myb and Mi2" . SPARSER::COLLECTION)
    ("c-Myb and PRMT4" . SPARSER::COLLECTION)
    ("Flag-tagged Mi2α and HA-tagged c-Myb" . SPARSER::COLLECTION)
    ("c-Myb and GST-PRMT4" . SPARSER::COLLECTION)
    ("GST-PRMTs and bacterially expressed His-tagged c-Myb"
     . SPARSER::COLLECTION)
    ("bacterially expressed His-tagged c-Myb" . SPARSER::PROTEIN)
    ("expressed His-tagged c-Myb" . SPARSER::PROTEIN)
    ("GST-PRMT6" . SPARSER::COLLECTION) ("GST-PRMTs" . SPARSER::PROTEIN-PAIR)
    ("c-Myb and co-IP" . SPARSER::COLLECTION)
    ("PRMT4, HA or IgG" . SPARSER::COLLECTION)
    ("PRMT4 as well as both Mi2 proteins" . SPARSER::COLLECTION)
    ("PRMT4-Mi2" . SPARSER::COLLECTION) ("MBD3 or HDAC1" . SPARSER::COLLECTION)
    ("GST-PRMT4" . SPARSER::COLLECTION) ("pulldown" . SPARSER::PROTEIN)
    ("Mi2β and PRMT4" . SPARSER::COLLECTION)
    ("Mi2β/CHD4" . SPARSER::COLLECTION) ("GST-PRMT1" . SPARSER::COLLECTION)
    ("PRMT1, PRMT3 and PRMT6" . SPARSER::COLLECTION)
    ("GST-pulldown" . SPARSER::PROTEIN-PAIR)
    ("overexpressed Flag-tagged Mi2α" . SPARSER::PROTEIN)
    ("Flag-Mi2α" . SPARSER::COLLECTION)
    ("PRMT4 and Mi2α" . SPARSER::COLLECTION)
    ("Components" . SPARSER::COMPONENT) ("the anti-PRMT4" . SPARSER::ANTIBODY)
    ("each chromatographic step" . SPARSER::PROTEIN)
    ("DEAE and MonoQ" . SPARSER::COLLECTION) ("MonoQ" . SPARSER::DRUG)
    ("DEAE" . SPARSER::DRUG) ("phosphocellulose" . SPARSER::DRUG)
    ("each chromatographic fraction" . SPARSER::COMPONENT)
    ("cation and anion" . SPARSER::COLLECTION)
    ("overexpressed PRMT4" . SPARSER::PROTEIN)
    ("approximately 500 kDa" . SPARSER::PROTEIN)
    ("Mi2α as well as Mi2β" . SPARSER::COLLECTION)
    ("Mi2α and Mi2β" . SPARSER::COLLECTION)
    ("CHD3 and CHD4" . SPARSER::COLLECTION) ("NUMAC" . SPARSER::BIO-COMPLEX)
    ("the nucleosomal methylation coactivator complex (NUMAC)"
     . SPARSER::BIO-COMPLEX)
    ("complex (NUMAC)" . SPARSER::BIO-COMPLEX)
    ("at least ten proteins" . SPARSER::PROTEIN)
    ("the Tudor domain-containing protein TDRD3 and the transcription elongation-associated PAF1 complex"
     . SPARSER::COLLECTION)
    ("the transcription elongation-associated PAF1 complex"
     . SPARSER::BIO-COMPLEX)
    ("PRMT4 and H3R17" . SPARSER::COLLECTION) ("TFIID" . SPARSER::PROTEIN)
    ("Bromo" . SPARSER::MOLECULE) ("PRMT1-" . SPARSER::PROTEIN)
    ("promoter-proximal nucleosomes" . SPARSER::PROTEIN)
    ("NF-κB and nuclear hormone receptors" . SPARSER::COLLECTION)
    ("histones as well as other chromatin-associated proteins"
     . SPARSER::COLLECTION)
    ("attractive targets" . SPARSER::TARGET-PROTEIN)
    ("PRMT4 and the chromatin remodeller Mi2" . SPARSER::COLLECTION)
    ("PRMT4 or Mi2α/β" . SPARSER::COLLECTION)
    ("methyltransferase and ATPase activity" . SPARSER::COLLECTION)
    ("PRMT4 and Mi2" . SPARSER::COLLECTION)
    ("PRMT4 and Mi2α/β" . SPARSER::COLLECTION)
    ("Mi2α and its close relative Mi2β" . SPARSER::COLLECTION)
    ("the repressive Mi2-containing NuRD complex" . SPARSER::BIO-COMPLEX)
    ("histones and other chromatin-associated proteins" . SPARSER::COLLECTION)
    ("other chromatin-associated proteins" . SPARSER::PROTEIN)
    ("β-Tubulin" . SPARSER::PROTEIN) ("CycB1" . SPARSER::PROTEIN)
    ("Gata3" . SPARSER::PROTEIN) ("c-Myb protein" . SPARSER::PROTEIN)
    ("HD11" . SPARSER::PROTEIN) ("MBD3" . SPARSER::PROTEIN)
    ("SNF2" . SPARSER::PROTEIN) ("PRMT6" . SPARSER::PROTEIN)
    ("PRMT3" . SPARSER::PROTEIN) ("PRMT4 " . SPARSER::PROTEIN)
    ("CHD4" . SPARSER::PROTEIN) ("CHD3" . SPARSER::PROTEIN)
    ("PAF1" . SPARSER::PROTEIN) ("TDRD3" . SPARSER::PROTEIN)
    ("TAFII250" . SPARSER::PROTEIN)
    ("coactivator associated arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("Mi2" . SPARSER::PROTEIN) ("Mi2β" . SPARSER::PROTEIN)
    ("Mi2α" . SPARSER::PROTEIN) ("multiplex DNA" . SPARSER::DNA)
    ("a well-defined inhibitor of epidermal growth factor receptor’s (EGFR)"
     . SPARSER::INHIBITOR)
    ("a well-defined inhibitor" . SPARSER::INHIBITOR)
    ("quantitative DNA" . SPARSER::DNA) ("autoantigen" . SPARSER::DRUG)
    ("TRIM54, and TRIM55" . SPARSER::COLLECTION)
    ("TRIM18/MID1" . SPARSER::COLLECTION) ("TRIM1/MID2" . SPARSER::COLLECTION)
    ("TRIM9 and TRIM67" . SPARSER::COLLECTION) ("TRIM" . SPARSER::PROTEIN)
    ("these reactive antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the human ORFeome v5.1" . SPARSER::PROTEIN) ("PND" . SPARSER::PROTEIN)
    ("CSF" . SPARSER::PROTEIN) ("Pep" . SPARSER::DRUG)
    ("P53 and PDCD4" . SPARSER::COLLECTION)
    ("IgG and RBM15" . SPARSER::COLLECTION)
    ("SH2D1A and SH2D4A" . SPARSER::COLLECTION)
    ("an irrelevant GST-fused protein" . SPARSER::PROTEIN)
    ("GST-LYN" . SPARSER::COLLECTION) ("GST-fused" . SPARSER::COLLECTION)
    ("Ribosome" . SPARSER::BIO-COMPLEX)
    ("gefitinib and dasatinib" . SPARSER::COLLECTION)
    ("proteins and other molecules" . SPARSER::COLLECTION)
    ("k 1" . SPARSER::PROTEIN) ("n 2" . SPARSER::PROTEIN)
    ("Exonuclease I" . SPARSER::PROTEIN) ("TRIM55" . SPARSER::PROTEIN)
    ("TRIM54" . SPARSER::PROTEIN) ("MID1" . SPARSER::PROTEIN)
    ("TRIM18" . SPARSER::PROTEIN) ("MID2" . SPARSER::PROTEIN)
    ("TRIM1" . SPARSER::PROTEIN) ("TRIM9" . SPARSER::PROTEIN)
    ("NOVA1" . SPARSER::PROTEIN) ("RBM15" . SPARSER::PROTEIN)
    ("PIK3R3" . SPARSER::PROTEIN) ("SH2D4A" . SPARSER::PROTEIN)
    ("SH2D1A" . SPARSER::PROTEIN) ("ORF 3" . SPARSER::PROTEIN)
    ("CHEN" . SPARSER::PROTEIN)
    ("new reagents and analytic tools" . SPARSER::COLLECTION)
    ("new reagents" . SPARSER::MOLECULE) ("SHU" . SPARSER::PROTEIN)
    ("FU, and Long-shan" . SPARSER::COLLECTION)
    ("Xue-ding" . SPARSER::COLLECTION) ("FU" . SPARSER::PROTEIN)
    ("ding" . SPARSER::PROTEIN) ("WANG" . SPARSER::PROTEIN)
    ("li" . SPARSER::PROTEIN) ("CYP3A4/ABCB1" . SPARSER::COLLECTION)
    ("ABCB1 C3435T or G2677T/A" . SPARSER::COLLECTION)
    ("a transporter (P-gp) and upstream regulators" . SPARSER::COLLECTION)
    ("drug metabolic enzymes (CYP3A4 and CYP3A5), a transporter (P-gp) and upstream regulators"
     . SPARSER::COLLECTION)
    ("PXR and NF-κB" . SPARSER::COLLECTION)
    ("CYP3A4 , CYP3A5 , NFKB1 , and NR1I2" . SPARSER::COLLECTION)
    ("CYP3A4-CYP3A5" . SPARSER::COLLECTION)
    ("CYP3A5 , CYP3A4 , and NR1I2" . SPARSER::COLLECTION)
    ("TGC" . SPARSER::PROTEIN)
    ("CYP3A5 , CYP3A4 , ABCB1 , NFKB1 , and NR1I2" . SPARSER::COLLECTION)
    ("CYP3A4 , CYP3A5 , ABCB1 , NR1I2 , and NFKB1" . SPARSER::COLLECTION)
    ("retinoid X receptor (RXR)" . SPARSER::PROTEIN)
    ("CYP3A4 and ABCB1" . SPARSER::COLLECTION)
    ("PXR-RXR" . SPARSER::COLLECTION)
    ("enzymes and transporters" . SPARSER::COLLECTION)
    ("CYP3A4 , CYP3A5 , or ABCB1" . SPARSER::COLLECTION)
    ("the key nuclear receptor" . SPARSER::PROTEIN)
    ("CYP3A4 , CYP3A5 , and ABCB1" . SPARSER::COLLECTION)
    ("PXR" . SPARSER::PROTEIN) ("CYP3A4, CYP3A5 or P-gp" . SPARSER::COLLECTION)
    ("CYP3A4, CYP3A5, and P-gp" . SPARSER::COLLECTION)
    ("CYP3A4 and CYP3A5" . SPARSER::COLLECTION)
    ("P-gp/MDR1" . SPARSER::COLLECTION) ("cytochrome" . SPARSER::PROTEIN)
    ("CNI" . SPARSER::PROTEIN) ("ABCB1 and NFKB1" . SPARSER::COLLECTION)
    ("ins/ins" . SPARSER::COLLECTION) ("ins" . SPARSER::PROTEIN)
    ("CYP3A4 , CYP3A5 , ABCB1 , NFKB1 , and NR1I2" . SPARSER::COLLECTION)
    ("Cyclosporine" . SPARSER::DRUG) ("CYP3A" . SPARSER::PROTEIN)
    ("Mycophenolate mofetil" . SPARSER::DRUG)
    ("mycophenolate mofetil" . SPARSER::DRUG)
    ("retinoid X receptor" . SPARSER::PROTEIN)
    ("pregnane X receptor" . SPARSER::PROTEIN)
    ("calcineurin inhibitor" . SPARSER::PROTEIN) ("NR1I2" . SPARSER::PROTEIN)
    ("CYP3A5" . SPARSER::PROTEIN) ("CYP3A4" . SPARSER::PROTEIN)
    ("potent viral oncogenes" . SPARSER::ONCOGENE)
    ("its identified viral oncogenes" . SPARSER::ONCOGENE)
    ("the other viral oncogenes" . SPARSER::ONCOGENE)
    ("CASP3 or IPO7" . SPARSER::COLLECTION) ("BART 1-3p" . SPARSER::COLLECTION)
    ("CASP3 and IPO7" . SPARSER::COLLECTION)
    ("a particularly tantalizing possible target" . SPARSER::TARGET-PROTEIN)
    ("IPO7 and CASP3" . SPARSER::COLLECTION) ("RISCs" . SPARSER::PROTEIN)
    ("CD2 and CGA" . SPARSER::COLLECTION)
    ("–chemokine receptor" . SPARSER::COLLECTION) ("CGA" . SPARSER::PROTEIN)
    ("gonadotrophin" . SPARSER::PROTEIN) ("cellular mRNAs" . SPARSER::PROTEIN)
    ("too many predicted targets" . SPARSER::TARGET-PROTEIN)
    ("herpesviral miRNAs" . SPARSER::MICRO-RNA)
    ("neither EBNA3A nor EBNA3C" . SPARSER::COLLECTION)
    ("two viral proteins" . SPARSER::PROTEIN) ("Oku-BL" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein BIM" . SPARSER::PROTEIN)
    ("these viral genes" . SPARSER::GENE)
    ("both a scarce miRNA ( BART 1-5p) and a plentiful miRNA ( BART 7)"
     . SPARSER::COLLECTION)
    ("a plentiful miRNA" . SPARSER::MICRO-RNA)
    ("both a scarce miRNA" . SPARSER::MICRO-RNA)
    ("viral miRNAs" . SPARSER::MICRO-RNA) ("Dante-BL" . SPARSER::COLLECTION)
    ("Sav-BL" . SPARSER::COLLECTION) ("Sav" . SPARSER::PROTEIN)
    ("LMP1 or EBNA2" . SPARSER::COLLECTION) ("BART" . SPARSER::PROTEIN)
    ("the viral miRNAs" . SPARSER::MICRO-RNA)
    ("a developmental fate" . SPARSER::PROTEIN)
    ("these viral oncogenes" . SPARSER::ONCOGENE)
    ("only one protein" . SPARSER::PROTEIN)
    ("constitutively expressing viral miRNAs" . SPARSER::MICRO-RNA)
    ("other viral oncogenes" . SPARSER::ONCOGENE)
    ("importin-7" . SPARSER::PROTEIN) ("Gag-Pol" . SPARSER::PROTEIN)
    ("pre-miRNAs" . SPARSER::RNA) ("IPO7" . SPARSER::PROTEIN)
    ("CASP3" . SPARSER::PROTEIN) ("EBNA3C" . SPARSER::PROTEIN)
    ("EBNA3A" . SPARSER::PROTEIN) ("S1-1" . SPARSER::PROTEIN)
    ("BART 1" . SPARSER::PROTEIN) ("EBNA2" . SPARSER::PROTEIN)
    ("LMP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("EBNA1" . SPARSER::PROTEIN)
    ("DNA repair notably directly binding RAD51" . SPARSER::PROTEIN)
    ("Only one SNP" . SPARSER::PROTEIN) ("UK and German" . SPARSER::COLLECTION)
    ("HNR" . SPARSER::PROTEIN) ("Duo" . SPARSER::PROTEIN)
    ("Cohort" . SPARSER::MOLECULE) ("UK and Germany" . SPARSER::COLLECTION)
    ("FGFR3/MMSET" . SPARSER::COLLECTION) ("MMSET" . SPARSER::PROTEIN)
    ("IGH" . SPARSER::PROTEIN) ("HD" . SPARSER::PROTEIN)
    ("CCND1b" . SPARSER::PROTEIN) ("CCND1a" . SPARSER::PROTEIN)
    ("10 C" . SPARSER::PROTEIN) ("cyclin D1b" . SPARSER::PROTEIN)
    ("cyclin D1a" . SPARSER::PROTEIN) ("CD138" . SPARSER::PROTEIN)
    ("metastatic GPCR" . SPARSER::PROTEIN)
    ("a desirable target" . SPARSER::TARGET-PROTEIN)
    ("an inactive GDP-bound form and an active GTP-bound form"
     . SPARSER::COLLECTION)
    ("guanine nucleotide exchange factors (GEF)" . SPARSER::GEF)
    ("PI3Kα and β inhibitors" . SPARSER::COLLECTION)
    ("CXCR4 and PAR1" . SPARSER::COLLECTION)
    ("selective inhibitors of PI3Kα or β" . SPARSER::COLLECTION)
    ("chemokines and their receptors" . SPARSER::COLLECTION)
    ("neutrophils and macrophages" . SPARSER::COLLECTION)
    ("YFP-PI3Kγ" . SPARSER::PROTEIN-PAIR)
    ("chemoattractants" . SPARSER::PROTEIN)
    ("exogenously expressed PI3Kγ" . SPARSER::PROTEIN)
    ("expressed PI3Kγ" . SPARSER::PROTEIN)
    ("PI3Kα, PI3Kβ or PI3Kγ" . SPARSER::COLLECTION)
    ("inhibitors of PI3Kα or β" . SPARSER::COLLECTION)
    ("3 μM PI3Kγ-selective inhibitor or 10 μM Ly294002 (LY)"
     . SPARSER::COLLECTION)
    ("Ly294002 (LY)" . SPARSER::MOLECULE)
    ("chemokines and growth factors" . SPARSER::COLLECTION)
    ("-proteins" . SPARSER::COLLECTION)
    ("heterotrimeric G-proteins" . SPARSER::PROTEIN)
    ("PARs" . SPARSER::PROTEIN) ("PI3Kα or PI3Kβ" . SPARSER::COLLECTION)
    ("G-protein" . SPARSER::PROTEIN) ("PK3" . SPARSER::PROTEIN)
    ("p84" . SPARSER::PROTEIN) ("p101" . SPARSER::PROTEIN)
    ("p110γ" . SPARSER::PROTEIN) ("PI3Kδ" . SPARSER::PROTEIN)
    ("AS-604850" . SPARSER::DRUG) ("PIK-75" . SPARSER::DRUG)
    ("phosphatidylinositol 3-kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXC chemokine receptor" . SPARSER::PROTEIN) ("PI3Kβ" . SPARSER::PROTEIN)
    ("PI3Kα" . SPARSER::PROTEIN) ("PI3Kγ" . SPARSER::PROTEIN)
    ("p53–pol" . SPARSER::COLLECTION)
    ("more mitochondrial p53" . SPARSER::PROTEIN)
    ("antiretroviral compounds ddC (2′,3′-dideoxycytidine) and ddI (2′,3′-dideoxyinosine)"
     . SPARSER::COLLECTION)
    ("antiretroviral compounds ddC" . SPARSER::PROTEIN)
    ("ddC" . SPARSER::PROTEIN) ("POLG2" . SPARSER::PROTEIN)
    ("ornithine transcarbamylase" . SPARSER::PROTEIN)
    ("Tumor suppressor protein" . SPARSER::PROTEIN) ("DN-" . SPARSER::PROTEIN)
    ("actin and CEACAM1" . SPARSER::COLLECTION)
    ("a β-catenin" . SPARSER::COLLECTION)
    ("CEACAM1-4L specifically pulls-down -catenin" . SPARSER::COLLECTION)
    ("con" . SPARSER::PROTEIN) ("a mild detergent NP-40" . SPARSER::DRUG)
    ("fraction and xref" . SPARSER::COLLECTION)
    ("the β-catenin-actin" . SPARSER::COLLECTION)
    ("detergents" . SPARSER::MOLECULE)
    ("the cytoskeletal detergent resistant fraction" . SPARSER::COMPONENT)
    ("β-catenin and actin" . SPARSER::COLLECTION)
    ("the β-catenin/actin" . SPARSER::COLLECTION)
    ("the β-catenin" . SPARSER::PROTEIN)
    ("the β-catenin-CEACAM1" . SPARSER::PROTEIN-PAIR)
    ("CEACAM1 expression changes β-catenin’s" . SPARSER::PROTEIN)
    ("CEACAM1 or IP" . SPARSER::COLLECTION)
    ("full-length and 90kDa" . SPARSER::COLLECTION)
    ("both 92 kDa and the 90kDa" . SPARSER::COLLECTION)
    ("CEACAM1 and β-catenin" . SPARSER::COLLECTION)
    ("GST-CEACAM1" . SPARSER::COLLECTION)
    ("CEACAM1 and SHP-1" . SPARSER::COLLECTION)
    ("pervanadate" . SPARSER::PROTEIN)
    ("the K470A mutant and the S508D mutant" . SPARSER::COLLECTION)
    ("CEACAM1-4L associated receptors" . SPARSER::PROTEIN)
    ("anti-β-catenin" . SPARSER::COLLECTION) ("90kDa" . SPARSER::PROTEIN)
    ("pan-" . SPARSER::PROTEIN)
    ("Fas-FADD-Caspase 8-Caspase 3" . SPARSER::COLLECTION)
    ("Caspase 3/8" . SPARSER::PROTEIN)
    ("pro-Caspase 3/8" . SPARSER::PROTEIN-PAIR)
    ("fluorescent labeled Caspase 3 and 8 substrates" . SPARSER::COLLECTION)
    ("fluorescent labeled Caspase 3" . SPARSER::PROTEIN)
    ("Caspase 8 and Caspase 3" . SPARSER::COLLECTION)
    ("pro-Caspase-3" . SPARSER::COLLECTION)
    ("apoptosome" . SPARSER::BIO-COMPLEX)
    ("Annexin V and PI" . SPARSER::COLLECTION)
    ("mitochondrial or DNA" . SPARSER::COLLECTION)
    ("Ac-LLnL-CHO" . SPARSER::COLLECTION) ("calpeptin" . SPARSER::MOLECULE)
    ("cyclin D1 and c-myc" . SPARSER::COLLECTION)
    ("CEACAM1 or its mutated forms" . SPARSER::COLLECTION)
    ("its mutated forms" . SPARSER::FORM) ("CEACAM1-" . SPARSER::PROTEIN)
    ("Arm" . SPARSER::PROTEIN) ("CEACAM1-β-catenin" . SPARSER::COLLECTION)
    ("T-cell and IL-2" . SPARSER::COLLECTION) ("calpain-9" . SPARSER::PROTEIN)
    ("CD66a" . SPARSER::PROTEIN) ("HK2" . SPARSER::PROTEIN)
    ("Phospho-tyrosine" . SPARSER::MOLECULE) ("SHP1" . SPARSER::PROTEIN)
    ("Cell Adhesion molecule 1" . SPARSER::PROTEIN)
    ("Carcinoembryonic Antigen" . SPARSER::PROTEIN)
    ("CEACAM1" . SPARSER::PROTEIN)
    ("-triphosphate-containing dsRNA or long dsRNA" . SPARSER::COLLECTION)
    ("the MDA5 S 88 A mutant" . SPARSER::MUTANT)
    ("exogenous PP1γ" . SPARSER::PROTEIN)
    ("RIG-I and MDA5, PP1α and PP1γ" . SPARSER::COLLECTION)
    ("MDA5, PP1α and PP1γ" . SPARSER::COLLECTION)
    ("a major eukaryotic Ser-Thr phosphatase" . SPARSER::PROTEIN)
    ("PP1α, PP1β, and PP1γ" . SPARSER::COLLECTION)
    ("RIG-I-" . SPARSER::PROTEIN) ("EMCV" . SPARSER::PROTEIN)
    ("VSV-eGFP" . SPARSER::COLLECTION)
    ("RIG-I (vesicular stomatitis virus [VSV]) or MDA5 (EMCV)"
     . SPARSER::COLLECTION)
    ("receptors (RLR)" . SPARSER::RECEPTOR)
    ("SeV or ΔNS1" . SPARSER::COLLECTION)
    ("VSV and EMCV" . SPARSER::COLLECTION)
    ("a robust IFN-β production inDdx58 −/− MEFs" . SPARSER::PROTEIN)
    ("WT MDA5 or WT RIG-I" . SPARSER::COLLECTION) ("Ddx58" . SPARSER::PROTEIN)
    ("RNA or poly" . SPARSER::COLLECTION)
    ("MDA5 or RIG-I" . SPARSER::COLLECTION) ("R/K-x" . SPARSER::PROTEIN-PAIR)
    ("viral RNA binding" . SPARSER::PROTEIN) ("NHLF" . SPARSER::PROTEIN)
    ("PP1α, PP1γ, and RIG-I" . SPARSER::COLLECTION)
    ("RIG-I(2CARD) and MDA5(2CARD)" . SPARSER::COLLECTION)
    ("RIG-I or MDA5" . SPARSER::COLLECTION)
    ("(2CARD) under these conditions ( xref and xref )" . SPARSER::COLLECTION)
    ("PP1α or PP1γ and MDA5" . SPARSER::COLLECTION)
    ("PP1γ and MDA5" . SPARSER::COLLECTION) ("GST-RIG-I" . SPARSER::COLLECTION)
    ("the other candidate phosphatases from our siRNA screen, led to a strong decrease in RIG-I CARD phosphorylation ( xref )"
     . SPARSER::PHOSPHATASE)
    ("neither PP1β nor any of the other candidate phosphatases from our siRNA screen"
     . SPARSER::COLLECTION)
    ("ectopically expressed PP1α and PP1γ" . SPARSER::COLLECTION)
    ("expressed PP1α and PP1γ" . SPARSER::COLLECTION)
    ("Exogenous PP1α or PP1γ" . SPARSER::COLLECTION)
    ("all five distinct siRNAs" . SPARSER::PROTEIN)
    ("the four unique siRNAs" . SPARSER::PROTEIN)
    ("exogenous MAVS" . SPARSER::PROTEIN)
    ("PP1α or PP1γ" . SPARSER::COLLECTION)
    ("PP1α, PP1β, or PP1γ" . SPARSER::COLLECTION)
    ("PP1α, PP1β and PP1γ" . SPARSER::COLLECTION)
    ("full-length or MDA5" . SPARSER::COLLECTION)
    ("Ser-Thr-Tyr dual specificity phosphatases" . SPARSER::PHOSPHATASE)
    ("Ser-Thr-Tyr" . SPARSER::COLLECTION)
    ("ectopically expressed MDA5 WT and S 88 A mutant" . SPARSER::COLLECTION)
    ("ectopically expressed MDA5" . SPARSER::PROTEIN)
    ("Ifih1" . SPARSER::PROTEIN) ("Mda5" . SPARSER::PROTEIN)
    ("Mda" . SPARSER::DRUG) ("Flag-MDA5 S 88 A mutant" . SPARSER::MUTANT)
    ("S 88 A mutant" . SPARSER::MUTANT) ("MAVS-CARD" . SPARSER::COLLECTION)
    ("VISA, IPS-1, or CARDIF" . SPARSER::COLLECTION)
    ("the phospho-mimetic MDA5 S 88 E and S 88 D mutants" . SPARSER::MUTANT)
    ("MDA5 S 88 A mutant" . SPARSER::MUTANT)
    ("exogenously expressed MDA5" . SPARSER::PROTEIN)
    ("expressed MDA5" . SPARSER::PROTEIN) ("exogenous MDA5" . SPARSER::PROTEIN)
    ("Flag-MDA5" . SPARSER::COLLECTION) ("S 104 A mutant" . SPARSER::MUTANT)
    ("GST-MDA5(2CARD) phospho-mimetic S 88 D and S 88 E mutants"
     . SPARSER::MUTANT)
    ("IFN-β or NF-κB" . SPARSER::COLLECTION)
    ("IFN-β and NF-κB" . SPARSER::COLLECTION)
    ("alanine or arginine" . SPARSER::COLLECTION)
    ("CARD-CARD" . SPARSER::COLLECTION) ("GST-MDA5" . SPARSER::COLLECTION)
    ("essential activators" . SPARSER::ACTIVATOR)
    ("IFN and proinflammatory cytokines" . SPARSER::COLLECTION)
    ("Nile" . SPARSER::PROTEIN)
    ("RIG-I and MDA5 sense viral RNA" . SPARSER::RNA)
    ("CARDIF" . SPARSER::PROTEIN) ("VISA" . SPARSER::PROTEIN)
    ("PP1α and PP1γ" . SPARSER::COLLECTION)
    ("MDA5 and RIG-I" . SPARSER::COLLECTION)
    ("RIG-I and MDA5" . SPARSER::COLLECTION) ("Rig-I" . SPARSER::PROTEIN)
    ("phosphoprotein phosphatase 1" . SPARSER::PROTEIN)
    ("glutathione S -transferase" . SPARSER::PROTEIN)
    ("non-structural protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRIM25" . SPARSER::PROTEIN) ("RIG-I-like receptor" . SPARSER::PROTEIN)
    ("RNA helicases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PP1γ" . SPARSER::PROTEIN) ("MDA5" . SPARSER::PROTEIN)
    ("CG and FI" . SPARSER::COLLECTION) ("FI" . SPARSER::PROTEIN)
    ("EM and CE" . SPARSER::COLLECTION) ("metastatic KRAS" . SPARSER::PROTEIN)
    ("pro-apoptotic protein p53" . SPARSER::PROTEIN)
    ("after irinotecan and sinusoidal obstruction syndrome (SOS)"
     . SPARSER::COLLECTION)
    ("SOS" . SPARSER::PROTEIN)
    ("p53, Ki-67 and survivin" . SPARSER::COLLECTION) ("DO" . SPARSER::PROTEIN)
    ("p53, survivin and Bcl-2" . SPARSER::COLLECTION)
    ("p53, survivin, and Bcl-2" . SPARSER::COLLECTION)
    ("survivin, p53 and Bcl-2" . SPARSER::COLLECTION)
    ("Biomarker" . SPARSER::MOLECULE)
    ("pre- and post-treatment" . SPARSER::COLLECTION)
    ("bevacizumab or cetuximab" . SPARSER::COLLECTION)
    ("pre and post-" . SPARSER::COLLECTION)
    ("an antiapopototic protein" . SPARSER::PROTEIN)
    ("family and p53" . SPARSER::COLLECTION)
    ("highly chemorefractory liver-dominant metastatic CRC" . SPARSER::PROTEIN)
    ("the neovascular rim" . SPARSER::PROTEIN)
    ("the hepatic arterial vasculature" . SPARSER::PROTEIN)
    ("PLLA" . SPARSER::MOLECULE) ("holmium" . SPARSER::MOLECULE)
    ("oxaliplatin, irinotecan, capecitabine and biologic"
     . SPARSER::COLLECTION)
    ("capecitabine" . SPARSER::DRUG)
    ("p53 (100% vs 69.2%; p = 0.05) and Bcl-2 (69.2% vs 53.8%; p = 0.05) expression post- 90 Y-RE"
     . SPARSER::COLLECTION)
    ("survivin (92.3% vs 53.8%; p = 0.06), p53 (100% vs 69.2%; p = 0.05) and Bcl-2 (69.2% vs 53.8%; p = 0.05) expression post- 90 Y-RE"
     . SPARSER::COLLECTION)
    ("survivin, p53, Bcl-2 and Ki-67" . SPARSER::COLLECTION)
    ("pre- and post-" . SPARSER::COLLECTION) ("post-" . SPARSER::PROTEIN)
    ("pre-" . SPARSER::PROTEIN) ("pre and post" . SPARSER::COLLECTION)
    ("5FU" . SPARSER::DRUG) ("lactic acid" . SPARSER::MOLECULE)
    ("YY" . SPARSER::MOLECULE) ("SW and XW" . SPARSER::COLLECTION)
    ("WL, and LL" . SPARSER::COLLECTION) ("WL" . SPARSER::MOLECULE)
    ("SW" . SPARSER::PROTEIN) ("norepinephrine" . SPARSER::DRUG)
    ("T-G and C-G" . SPARSER::COLLECTION) ("homozygote" . SPARSER::PROTEIN)
    ("TT-homozygote" . SPARSER::PROTEIN-PAIR)
    ("AG, GG, and GG" . SPARSER::COLLECTION) ("DNA-" . SPARSER::DNA)
    ("antipsychotic" . SPARSER::DRUG)
    ("The ovarian steroid hormone estrogen" . SPARSER::MOLECULE)
    ("risperidone" . SPARSER::DRUG)
    ("Estrogen receptor beta" . SPARSER::PROTEIN) ("T-G" . SPARSER::PROTEIN)
    ("estrogen receptor beta" . SPARSER::PROTEIN)
    ("Estrogen receptor" . SPARSER::PROTEIN)
    ("Soluble P-selectin" . SPARSER::PROTEIN)
    ("Soluble E-selectin" . SPARSER::PROTEIN)
    ("sE-selectin" . SPARSER::COLLECTION)
    ("sE" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AMI" . SPARSER::PROTEIN)
    ("MMP1 and MMP3" . SPARSER::COLLECTION)
    ("IL1β and TNFα" . SPARSER::COLLECTION)
    ("other inflammatory biomarkers" . SPARSER::MOLECULE)
    ("MMP9, and MCP1" . SPARSER::COLLECTION)
    ("selectin" . SPARSER::PROTEIN-FAMILY) ("SAA" . SPARSER::PROTEIN)
    ("fibrinogen" . SPARSER::PROTEIN)
    ("inflammatory biomarkers" . SPARSER::MOLECULE)
    ("collagen, proteoglycans and elastin" . SPARSER::COLLECTION)
    ("elastin" . SPARSER::PROTEIN) ("GATA" . SPARSER::PROTEIN)
    ("Five genetic polymorphisms around matrix metalloproteinase genes"
     . SPARSER::GENE)
    ("Interleukin 6" . SPARSER::PROTEIN) ("Serum amyloid A" . SPARSER::PROTEIN)
    ("VCAM1" . SPARSER::PROTEIN) ("P-selectin" . SPARSER::PROTEIN)
    ("MCP1" . SPARSER::PROTEIN)
    ("Monocyte chemotactic protein 1" . SPARSER::PROTEIN)
    ("serum amyloid A" . SPARSER::PROTEIN)
    ("interstitial collagenase" . SPARSER::PROTEIN)
    ("Zn 2+" . SPARSER::MOLECULE) ("Fax" . SPARSER::PROTEIN)
    ("Tel" . SPARSER::PROTEIN) ("JK" . SPARSER::PROTEIN)
    ("LG and TK" . SPARSER::COLLECTION)
    ("AF, BL, and PC" . SPARSER::COLLECTION) ("BL" . SPARSER::PROTEIN)
    ("EG and GV" . SPARSER::COLLECTION) ("orthovanadate" . SPARSER::MOLECULE)
    ("exogenous receptor" . SPARSER::PROTEIN)
    ("growth factor receptors and the associated signaling molecules"
     . SPARSER::COLLECTION)
    ("the associated signaling molecules" . SPARSER::MOLECULE)
    ("the associated focal adhesion kinase" . SPARSER::KINASE)
    ("pRb binding viral oncoproteins" . SPARSER::PROTEIN)
    ("simian virus 40 large T antigen" . SPARSER::MOLECULE)
    ("constitutively available non receptor tyrosine kinase Fyn"
     . SPARSER::PROTEIN)
    ("the studied papillomaviral oncoproteins" . SPARSER::PROTEIN)
    ("the papillomaviral oncoproteins" . SPARSER::PROTEIN)
    ("functional E6 and E7" . SPARSER::COLLECTION)
    ("p53 and pRb" . SPARSER::COLLECTION)
    ("AP1, HDAC-1, PCAF, BRCA1, CDK, and ATM" . SPARSER::COLLECTION)
    ("PCAF" . SPARSER::PROTEIN)
    ("the retinoblastoma tumor suppressor protein (pRb, p105) and the related pocket proteins p107 and pRb2/p130"
     . SPARSER::COLLECTION)
    ("growth suppressive form" . SPARSER::FORM)
    ("p107 and pRb2/p130" . SPARSER::COLLECTION)
    ("PDZ proteins and other cellular target proteins" . SPARSER::COLLECTION)
    ("exogenous oncoproteins" . SPARSER::PROTEIN)
    ("the papillomaviral oncogenes" . SPARSER::ONCOGENE)
    ("the presence papillomaviral oncoproteins" . SPARSER::PROTEIN)
    ("proliferating HFK" . SPARSER::PROTEIN)
    ("p53 or pRb" . SPARSER::COLLECTION)
    ("HPV16 E6, E7 or both oncoproteins" . SPARSER::COLLECTION)
    ("Lyn, Lck and Fgr" . SPARSER::COLLECTION)
    ("Lyn, Lck, Fgr, and Hck" . SPARSER::COLLECTION)
    ("relevant proteins" . SPARSER::PROTEIN)
    ("the functional oncoprotein" . SPARSER::PROTEIN)
    ("p53 and Rb" . SPARSER::COLLECTION)
    ("E7 or both oncogenes" . SPARSER::COLLECTION) ("HFK" . SPARSER::PROTEIN)
    ("E7 or both oncoproteins" . SPARSER::COLLECTION)
    ("the E6 and E7 viral oncoproteins" . SPARSER::PROTEIN)
    ("The major etiological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Frk" . SPARSER::PROTEIN) ("Yrk" . SPARSER::PROTEIN)
    ("receptors, and integrin" . SPARSER::COLLECTION)
    ("E6 or E7" . SPARSER::COLLECTION)
    ("papillomaviral oncoproteins" . SPARSER::PROTEIN)
    ("kinases (SFK)" . SPARSER::KINASE)
    ("Retinoblastoma protein" . SPARSER::PROTEIN)
    ("P300/CBP-associated factor" . SPARSER::PROTEIN)
    ("Na3VO4" . SPARSER::MOLECULE)
    ("Cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Activator protein 1" . SPARSER::PROTEIN) ("p130" . SPARSER::PROTEIN)
    ("p107" . SPARSER::PROTEIN) ("E6-AP" . SPARSER::PROTEIN)
    ("phospho-kinase" . SPARSER::PROTEIN) ("Src kinase" . SPARSER::PROTEIN)
    ("childhood acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("short-patch" . SPARSER::PROTEIN) ("CC and CT" . SPARSER::COLLECTION)
    ("SNP, OR1, OR2, and OR3" . SPARSER::COLLECTION)
    ("These exogenous mutagens or carcinogens" . SPARSER::COLLECTION)
    ("These exogenous mutagens" . SPARSER::MOLECULE)
    ("arylamines" . SPARSER::MOLECULE) ("ORs 1" . SPARSER::PROTEIN)
    ("THL" . SPARSER::PROTEIN) ("Natural Killer" . SPARSER::PROTEIN)
    ("Triple Mutant" . SPARSER::MUTANT) ("Cat" . SPARSER::PROTEIN)
    ("Interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Killer" . SPARSER::PROTEIN) ("IL-21 and IL-21R" . SPARSER::COLLECTION)
    ("a pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("IL-2, IL-7, and IL-15" . SPARSER::COLLECTION)
    ("a commercially available IL-21" . SPARSER::PROTEIN)
    ("IL-21 and ATR-107-A647" . SPARSER::COLLECTION)
    ("a typical competitive inhibitor" . SPARSER::INHIBITOR)
    ("STAT1, STAT3, STAT5a and STAT5b" . SPARSER::COLLECTION)
    ("STAT5a" . SPARSER::PROTEIN)
    ("a new pharmacodynamic biomarker" . SPARSER::MOLECULE)
    ("cytokine and autoantibody" . SPARSER::COLLECTION)
    ("MRL-Fas" . SPARSER::COLLECTION) ("MRL" . SPARSER::PROTEIN)
    ("JAK1 and JAK3" . SPARSER::COLLECTION)
    ("STAT1, STAT3 and STAT5" . SPARSER::COLLECTION)
    ("a heterodimeric receptor complex" . SPARSER::BIO-COMPLEX)
    ("IL-15" . SPARSER::PROTEIN) ("IL21R" . SPARSER::PROTEIN)
    ("STAT5b" . SPARSER::PROTEIN) ("IL-2R" . SPARSER::PROTEIN)
    ("Interleukin-21" . SPARSER::PROTEIN) ("IL-21R" . SPARSER::PROTEIN)
    ("LMN" . SPARSER::PROTEIN)
    ("independent prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ERCC1 and/or BRCA1" . SPARSER::COLLECTION)
    ("accurate biomarkers" . SPARSER::MOLECULE)
    ("Biomarkers" . SPARSER::MOLECULE) ("CRC or ERCC1" . SPARSER::COLLECTION)
    ("/BRCA1" . SPARSER::COLLECTION) ("ERCC1 or BRCA1" . SPARSER::COLLECTION)
    ("CRC and non-LNM" . SPARSER::COLLECTION)
    ("predictive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cisplatin [ xref ] and taxanes [ xref , xref ]" . SPARSER::COLLECTION)
    ("cisplatin and taxanes" . SPARSER::COLLECTION)
    ("BRCA1 and ERCC1" . SPARSER::COLLECTION)
    ("CRC and LNM" . SPARSER::COLLECTION)
    ("ERCC1 and BRCA1" . SPARSER::COLLECTION)
    ("Murine Leukemia Virus" . SPARSER::PROTEIN)
    ("these humoral factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("increased humoral factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-6, tumor necrosis factor-α, and angiotensin II"
     . SPARSER::COLLECTION)
    ("NF-κB and siRNA" . SPARSER::COLLECTION)
    ("preset" . SPARSER::PROTEIN-FAMILY)
    ("Nrf2, HO-1, and NQO1" . SPARSER::COLLECTION)
    ("Systolic BP" . SPARSER::PROTEIN)
    ("iron and biliverdin" . SPARSER::COLLECTION)
    ("bilirubin" . SPARSER::MOLECULE)
    ("response element (ARE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Nrf2/Keap1" . SPARSER::COLLECTION)
    ("free floating Nrf2 (fNrf2) and Keap1-binding Nrf2 (kNrf2)"
     . SPARSER::COLLECTION)
    ("Nrf2 proteins, free floating Nrf2 (fNrf2) and Keap1-binding Nrf2 (kNrf2)"
     . SPARSER::COLLECTION)
    ("numerous antioxidant and phase II" . SPARSER::COLLECTION)
    ("a basic leucine zipper transcription factor" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein-1" . SPARSER::PROTEIN)
    ("fibrotic genes" . SPARSER::GENE) ("Klotho" . SPARSER::PROTEIN)
    ("nuclear factor-κB (NF-κB) and p53 [ xref - xref ]" . SPARSER::COLLECTION)
    ("organic anion transporter" . SPARSER::PROTEIN)
    ("anion" . SPARSER::MOLECULE) ("dietary proteins" . SPARSER::PROTEIN)
    ("HO-1 and NQO1" . SPARSER::COLLECTION)
    ("Nrf2, HO-1 and NQO1" . SPARSER::COLLECTION)
    ("Nrf2 and its downstream target genes" . SPARSER::COLLECTION)
    ("Dahl salt-sensitive hypertensive indoxyl" . SPARSER::MOLECULE)
    ("Dahl salt-resistant normotensive indoxyl" . SPARSER::MOLECULE)
    ("indoxyl" . SPARSER::MOLECULE) ("a uremic toxin" . SPARSER::PROTEIN)
    ("Indoxyl" . SPARSER::MOLECULE) ("bardoxolone methyl" . SPARSER::DRUG)
    ("angiotensin II" . SPARSER::PROTEIN) ("Nrf2 " . SPARSER::PROTEIN)
    ("Nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("transforming growth factor-β1" . SPARSER::PROTEIN)
    ("nuclear factor (erythroid-derived 2)" . SPARSER::PROTEIN)
    ("normal glucose (NG)" . SPARSER::PROTEIN) ("GR" . SPARSER::PROTEIN)
    ("FOXO1 and Ac-FOXO1" . SPARSER::COLLECTION)
    ("inactive and became" . SPARSER::COLLECTION)
    ("arginines" . SPARSER::AMINO-ACID) ("peptidase (MPP)" . SPARSER::PROTEIN)
    ("MPP" . SPARSER::PROTEIN)
    ("44 kDa and a processed polypeptide" . SPARSER::COLLECTION)
    ("SA-β-gal and DAPI" . SPARSER::COLLECTION)
    ("sh-SIRT3" . SPARSER::COLLECTION) ("sh-NC" . SPARSER::COLLECTION)
    ("Ac" . SPARSER::PROTEIN)
    ("FOXO1 (Ac-FOXO1) and its target genes" . SPARSER::COLLECTION)
    ("Ac-FOXO1" . SPARSER::COLLECTION)
    ("SIRT3 and FOXO1" . SPARSER::COLLECTION)
    ("protein and FOXO1" . SPARSER::COLLECTION)
    ("normal glucose" . SPARSER::PROTEIN)
    ("white and brown fat" . SPARSER::PROTEIN)
    ("a characteristic biomarker" . SPARSER::MOLECULE)
    ("LG" . SPARSER::MOLECULE)
    ("catalase and manganese superoxide dismutase" . SPARSER::COLLECTION)
    ("CBP and p300" . SPARSER::COLLECTION) ("acetylases" . SPARSER::PROTEIN)
    ("coactivators and corepressors" . SPARSER::COLLECTION)
    ("FOXO3a, FOXO4, and FOXO6" . SPARSER::COLLECTION)
    ("dFOXO" . SPARSER::PROTEIN) ("inR" . SPARSER::PROTEIN)
    ("brown fat" . SPARSER::PROTEIN) ("Shi" . SPARSER::PROTEIN)
    ("SIRT1 and SIRT6" . SPARSER::COLLECTION)
    ("SIRT4, and SIRT5" . SPARSER::COLLECTION)
    ("SIRT3–FOXO1" . SPARSER::COLLECTION)
    ("catalase and MnSOD" . SPARSER::COLLECTION)
    ("shRNA-SIRT3" . SPARSER::COLLECTION)
    ("catalase, and manganese superoxide dismutase" . SPARSER::COLLECTION)
    ("Sirt3" . SPARSER::PROTEIN) ("Mgcl 2" . SPARSER::MOLECULE)
    ("TOMM20" . SPARSER::PROTEIN) ("Drosophila )" . SPARSER::PROTEIN)
    ("AT1" . SPARSER::PROTEIN) ("Ang II" . SPARSER::PROTEIN)
    ("sirtuin 3" . SPARSER::PROTEIN) ("Sirt 1" . SPARSER::PROTEIN)
    ("manganese superoxide dismutase" . SPARSER::PROTEIN)
    ("forkhead box protein O" . SPARSER::PROTEIN)
    ("Sirtuin 3" . SPARSER::PROTEIN)
    ("NaI and hydrogen peroxide" . SPARSER::COLLECTION)
    ("a diagnostic SPECT" . SPARSER::PROTEIN) ("SPECT" . SPARSER::PROTEIN)
    ("PYK-SPECT" . SPARSER::COLLECTION) ("ROI" . SPARSER::PROTEIN)
    ("Quinazoline" . SPARSER::MOLECULE) ("d" . SPARSER::PROTEIN)
    ("non-EGFR" . SPARSER::PROTEIN)
    ("these competitive EGFR-TK inhibitors" . SPARSER::INHIBITOR)
    ("these previous quinazoline derivatives" . SPARSER::DERIVATIVE)
    ("6b–d" . SPARSER::PROTEIN-PAIR)
    ("traditional EGFR-TK inhibitors" . SPARSER::INHIBITOR)
    ("radiopharmaceuticals" . SPARSER::DRUG)
    ("an attractive molecular target" . SPARSER::TARGET-PROTEIN)
    ("3.43 pmol/mg protein and K  d  " . SPARSER::COLLECTION)
    ("max  " . SPARSER::PROTEIN)
    ("The crude P 2 membrane fraction" . SPARSER::COMPONENT)
    ("non-EGFR-TK" . SPARSER::COLLECTION)
    ("genistein or RG13022" . SPARSER::COLLECTION)
    ("PD153035, and ZD1839" . SPARSER::COLLECTION) ("tin" . SPARSER::PROTEIN)
    ("EtOH" . SPARSER::MOLECULE) ("6b" . SPARSER::PROTEIN)
    ("b" . SPARSER::PROTEIN) ("phosphoryl" . SPARSER::MOLECULE)
    ("Van" . SPARSER::PROTEIN) ("ROR " . SPARSER::PROTEIN)
    ("a 15-" . SPARSER::PROTEIN) ("Gamma" . SPARSER::PROTEIN)
    ("FX" . SPARSER::PROTEIN) ("GF" . SPARSER::PROTEIN)
    ("PYK (0.74 kBq, 10 μL, specific activity 74 TBq/mmol) and various inhibitors (1 μM, 100 μL)"
     . SPARSER::COLLECTION)
    ("Crude P 2 membrane fractions" . SPARSER::COMPONENT)
    ("IGFR-TK" . SPARSER::COLLECTION) ("PDGFR-TK" . SPARSER::COLLECTION)
    ("HEPES" . SPARSER::MOLECULE) ("24 h" . SPARSER::PROTEIN)
    ("min—24 h" . SPARSER::PROTEIN-PAIR) ("balb/c" . SPARSER::COLLECTION)
    ("lamp" . SPARSER::PROTEIN) ("PTK" . SPARSER::PROTEIN)
    ("vanadate" . SPARSER::MOLECULE) ("trypsin" . SPARSER::PROTEIN)
    ("mL/min" . SPARSER::COLLECTION) ("MeOH" . SPARSER::MOLECULE)
    ("aqueous sodium bisulfite" . SPARSER::MOLECULE)
    ("bisulfite" . SPARSER::MOLECULE)
    ("Aqueous hydrogen peroxide" . SPARSER::DRUG) ("NaI" . SPARSER::MOLECULE)
    ("tributyltin" . SPARSER::DRUG) ("PET and SPECT" . SPARSER::COLLECTION)
    ("a desirable ligand" . SPARSER::LIGAND) ("PYK" . SPARSER::PROTEIN)
    ("PHY" . SPARSER::PROTEIN-FAMILY) ("PD 153035" . SPARSER::DRUG)
    ("RG13022" . SPARSER::DRUG) ("OSI774" . SPARSER::DRUG)
    ("ZD1839" . SPARSER::DRUG)
    ("G genetic variants and HCC risk" . SPARSER::COLLECTION)
    ("allele and genotype" . SPARSER::COLLECTION)
    ("XRCC1 variants and the risk" . SPARSER::COLLECTION)
    ("CG (235, 177 and 58 bp) and GG (235 bp, Table xref )"
     . SPARSER::COLLECTION)
    ("GA (213, 183 and 30 bp) and AA (183 and 30 bp, Table xref )"
     . SPARSER::COLLECTION)
    ("A allelic variant" . SPARSER::VARIANT) ("NP" . SPARSER::PROTEIN)
    ("Two allelic variants" . SPARSER::VARIANT)
    ("Tryptophan" . SPARSER::MOLECULE) ("gene and HCC" . SPARSER::COLLECTION)
    ("alpha-fetoprotein" . SPARSER::PROTEIN)
    ("This fusogenic peptide" . SPARSER::PEPTIDE)
    ("perforin or chloroquine" . SPARSER::COLLECTION)
    ("the pH-sensitive fusogenic peptide" . SPARSER::PEPTIDE)
    ("ER- and Her2-" . SPARSER::COLLECTION)
    ("the nucleocytoplasmic serpin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The only intracellular inhibitor" . SPARSER::INHIBITOR)
    ("the nonpolar linker SMCC" . SPARSER::PROTEIN) ("SMCC" . SPARSER::PROTEIN)
    ("neu and ER" . SPARSER::COLLECTION)
    ("the lysomotropic agent chloroquine" . SPARSER::PROTEIN)
    ("bacterially-expressed GrB fusion proteins" . SPARSER::PROTEIN)
    ("neutral pH" . SPARSER::PROTEIN) ("fusogenic peptide" . SPARSER::PEPTIDE)
    ("fully human toxin type molecules" . SPARSER::MOLECULE)
    ("clinically-effective ADCs" . SPARSER::PROTEIN)
    ("ADCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Grb" . SPARSER::PROTEIN)
    ("Pgp" . SPARSER::PROTEIN)
    ("neu and its downstream molecules Akt, mTOR and ERK"
     . SPARSER::COLLECTION)
    ("Akt, mTOR and ERK" . SPARSER::COLLECTION)
    ("ER, PR, and PI-9" . SPARSER::COLLECTION)
    ("progesterone receptor (PR) and PI-9" . SPARSER::COLLECTION)
    ("caspase-9, caspase-3, and PARP" . SPARSER::COLLECTION)
    ("caspase 3, caspase 9 and PARP" . SPARSER::COLLECTION)
    ("Iodide (PI)" . SPARSER::PROTEIN) ("Iodide" . SPARSER::PROTEIN)
    ("the fusogenic peptide 26 efficiently releases GrB fusion proteins"
     . SPARSER::PROTEIN)
    ("20 ng/mL EGF or 50 ng/mL NRG-1" . SPARSER::COLLECTION)
    ("epidermal growth factor (EGF) or neuregulin-1 (NRG-1) growth factor"
     . SPARSER::COLLECTION)
    ("Herceptin and Lapatinib" . SPARSER::COLLECTION)
    ("both Herceptin (IC 50 : 52.5 nM) and Lapatinib (IC 50 : 34.7 nM)"
     . SPARSER::COLLECTION)
    ("Herceptin or Lapatinib" . SPARSER::COLLECTION)
    ("pro-GrB" . SPARSER::COLLECTION) ("authentic GrB" . SPARSER::PROTEIN)
    ("ECD" . SPARSER::PROTEIN) ("GrB and GrB/26" . SPARSER::COLLECTION)
    ("pH-sensitive fusogenic peptide" . SPARSER::PEPTIDE)
    ("the fusogenic peptide" . SPARSER::PEPTIDE)
    ("fusogenic peptides" . SPARSER::PEPTIDE) ("light-" . SPARSER::PROTEIN)
    ("scFvs" . SPARSER::PROTEIN) ("scFv" . SPARSER::PROTEIN)
    ("FRP" . SPARSER::PROTEIN) ("Toxin" . SPARSER::PROTEIN)
    ("VLS" . SPARSER::PROTEIN) ("Lapatinib or Herceptin" . SPARSER::COLLECTION)
    ("Lapatinib" . SPARSER::DRUG) ("Ras/ERK" . SPARSER::COLLECTION)
    ("a pH-sensitive fusogenic peptide" . SPARSER::PEPTIDE)
    ("completely human chimeric fusion proteins" . SPARSER::PROTEIN)
    ("GrB" . SPARSER::PROTEIN) ("Immunotoxins" . SPARSER::DRUG)
    ("Multidrug resistance" . SPARSER::PROTEIN) ("zVAD-fmk" . SPARSER::DRUG)
    ("NRG-1" . SPARSER::PROTEIN) ("L-aspartyl" . SPARSER::MOLECULE)
    ("Granzyme B" . SPARSER::PROTEIN) ("MDR-1" . SPARSER::PROTEIN)
    ("granzyme B" . SPARSER::PROTEIN) ("PML and AKT" . SPARSER::COLLECTION)
    ("Serine and Threonine" . SPARSER::COLLECTION)
    ("AKT/PKB" . SPARSER::COLLECTION) ("PML-PP2a" . SPARSER::COLLECTION)
    ("PCas" . SPARSER::PROTEIN)
    ("pAKT(S473) and pFOXO3a(S253)" . SPARSER::COLLECTION)
    ("a profuse nuclear" . SPARSER::PROTEIN)
    ("CK2 and PML" . SPARSER::COLLECTION) ("PCa and PHp" . SPARSER::COLLECTION)
    ("an intense nuclear" . SPARSER::PROTEIN)
    ("PHp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("another pivotal factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("crucial FOXO3a" . SPARSER::PROTEIN)
    ("p27 Kip1 , Bim and VEGF" . SPARSER::COLLECTION)
    ("PML or PHLPP2" . SPARSER::COLLECTION) ("—pAKT" . SPARSER::COLLECTION)
    ("TM-FOXO3a" . SPARSER::COLLECTION)
    ("p27 Kip1 and Bim" . SPARSER::COLLECTION)
    ("—pAKT—FOXO3a" . SPARSER::COLLECTION) ("exogenous PML" . SPARSER::PROTEIN)
    ("the separate cytoplasmic and nuclear fractions" . SPARSER::COMPONENT)
    ("PML—PHLPP2" . SPARSER::COLLECTION) ("CK2—" . SPARSER::PROTEIN)
    ("PHLPP2 and PML" . SPARSER::COLLECTION) ("PML-pAKT" . SPARSER::COLLECTION)
    ("PML–PHLPP2" . SPARSER::COLLECTION) ("TBCA" . SPARSER::PROTEIN)
    ("pAKT-PML" . SPARSER::COLLECTION) ("PP2a" . SPARSER::PROTEIN)
    ("an essential homeostatic kinase" . SPARSER::KINASE)
    ("a multifunctional protein kinase" . SPARSER::PROTEIN)
    ("most importantly some crucial tumor suppressors and regulators"
     . SPARSER::COLLECTION)
    ("suppressors and regulators" . SPARSER::COLLECTION)
    ("a cardinal part" . SPARSER::COMPONENT)
    ("PML and PHLPP2" . SPARSER::COLLECTION)
    ("p21/p27/Bim" . SPARSER::COLLECTION)
    ("the recent past" . SPARSER::PROTEIN)
    ("cytoskeletal proteins" . SPARSER::PROTEIN)
    ("an ubiquitous Ser/Thr protein kinase" . SPARSER::PROTEIN)
    ("Waf1" . SPARSER::PROTEIN) ("CK2 α" . SPARSER::PROTEIN)
    ("MHS1" . SPARSER::PROTEIN) ("PHLPP2" . SPARSER::PROTEIN)
    ("p53 and PUMA" . SPARSER::COLLECTION)
    ("protein and miR-128" . SPARSER::COLLECTION)
    ("Mcl1–Bak" . SPARSER::COLLECTION)
    ("the principle extranuclear target" . SPARSER::TARGET-PROTEIN)
    ("FOXO3A and its target PUMA" . SPARSER::COLLECTION)
    ("wild-type p53 (MCF-7) and mutant p53[MDA-MB-231 (mutant p53 R280K )]"
     . SPARSER::COLLECTION)
    ("Bim and Fas ligand" . SPARSER::COLLECTION)
    ("increased FOXO3A and/or p53" . SPARSER::COLLECTION)
    ("p21, NOXA and PUMA" . SPARSER::COLLECTION)
    ("Foxo" . SPARSER::PROTEIN-FAMILY)
    ("Bak and/or PUMA siRNAs" . SPARSER::COLLECTION) ("Pre" . SPARSER::PROTEIN)
    ("respective siRNAs" . SPARSER::PROTEIN)
    ("p53, FOXO3A, Bak and PUMA" . SPARSER::COLLECTION)
    ("mutant p53 or no p53 (because of FOXO3A effect only)"
     . SPARSER::COLLECTION)
    ("Chemotherapeutic drugs" . SPARSER::DRUG) ("p53 R280K" . SPARSER::PROTEIN)
    ("Standard chemotherapeutic agents etoposide and cisplatin"
     . SPARSER::COLLECTION)
    ("etoposide and cisplatin" . SPARSER::COLLECTION)
    ("MCF7 and HCT116 p53+/+" . SPARSER::COLLECTION)
    ("cytokine/growth factor" . SPARSER::COLLECTION)
    ("SIRT1 and pAKT" . SPARSER::COLLECTION)
    ("increased acetylated FOXO3A and total FOXO3A" . SPARSER::COLLECTION)
    ("phospho-AKT and phospho-MDM2" . SPARSER::COLLECTION)
    ("AKT and MDM2" . SPARSER::COLLECTION)
    ("p21 and NOXA" . SPARSER::COLLECTION)
    ("acetylated p53 (at lysine-382) and its target PUMA"
     . SPARSER::COLLECTION)
    ("NOXA" . SPARSER::PROTEIN)
    ("p53 and its transcriptional targets" . SPARSER::COLLECTION)
    ("p53 and SIRT1" . SPARSER::COLLECTION)
    ("p53, SIRT1 and GADD45" . SPARSER::COLLECTION)
    ("IGFBP5, COL5A1, TGF β 1, RXR α and NOTCH1" . SPARSER::COLLECTION)
    ("p53 and FOXO3A" . SPARSER::COLLECTION) ("PUMA-Bak" . SPARSER::COLLECTION)
    ("MLL-AF4 acute lymphocytic leukemia" . SPARSER::PROTEIN)
    ("MLL-AF4" . SPARSER::COLLECTION) ("PUMA and Bak" . SPARSER::COLLECTION)
    ("phospho-Akt and phospho-FOXO3A" . SPARSER::COLLECTION)
    ("acetylated p53 and its transcriptional targets" . SPARSER::COLLECTION)
    ("FKHRL-1" . SPARSER::PROTEIN) ("TGFB1" . SPARSER::PROTEIN)
    ("BBC3" . SPARSER::PROTEIN) ("Bak1" . SPARSER::PROTEIN)
    ("MDM2 protein" . SPARSER::PROTEIN) ("RXR α" . SPARSER::PROTEIN)
    ("TGF β 1" . SPARSER::PROTEIN) ("COL5A1" . SPARSER::PROTEIN)
    ("AF4" . SPARSER::PROTEIN)
    ("oxaliplatin, irinotecan, fluorouracil and leucovorin"
     . SPARSER::COLLECTION)
    ("leucovorin" . SPARSER::DRUG) ("irinotecan" . SPARSER::DRUG)
    ("oxaliplatin" . SPARSER::DRUG)
    ("TTP and multivariate" . SPARSER::COLLECTION)
    ("a promising informative biomarker" . SPARSER::MOLECULE)
    ("GEM and GEM" . SPARSER::COLLECTION)
    ("GEM and Notch3" . SPARSER::COLLECTION)
    ("a prognostic predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RRM1 ( P =0.200) and RRM2 ( P =0.225)" . SPARSER::COLLECTION)
    ("dCK ( P =0.162), RRM1 ( P =0.200) and RRM2 ( P =0.225)"
     . SPARSER::COLLECTION)
    ("longer TTP" . SPARSER::PROTEIN) ("TTP and mRNA" . SPARSER::COLLECTION)
    ("RRM1 (low vs high=27.7 vs 19.3 months, P =0.215) and RRM2 (low vs high=20 vs 27.7 months, P =0.520)"
     . SPARSER::COLLECTION)
    ("the β2M internal reference gene" . SPARSER::PROTEIN)
    ("dCK , hENT1 , RRM1 , RRM2 and Notch3" . SPARSER::COLLECTION)
    ("GEM-metabolism-related enzymes" . SPARSER::ENZYME)
    ("dCK" . SPARSER::PROTEIN)
    ("the key predictive biomarkers" . SPARSER::MOLECULE)
    ("unresectable PDC" . SPARSER::PROTEIN) ("GEM" . SPARSER::PROTEIN)
    ("PDC" . SPARSER::PROTEIN) ("β2M" . SPARSER::PROTEIN)
    ("β2-microglobulin" . SPARSER::PROTEIN)
    ("equilibrative nucleoside transporter 1" . SPARSER::PROTEIN)
    ("DACH1 and SOX2" . SPARSER::COLLECTION)
    ("Sox2, Nanog, and Klf4" . SPARSER::COLLECTION)
    ("an accessory tumor suppressor" . SPARSER::SUPPRESSOR)
    ("SOX2 and DACH1" . SPARSER::COLLECTION)
    ("Low DACH1 and high EGFR" . SPARSER::COLLECTION)
    ("DACH1, SOX2 and p53" . SPARSER::COLLECTION)
    ("RAD51 and Ki67" . SPARSER::COLLECTION)
    ("DACH1 or p53 and DACH1" . SPARSER::COLLECTION)
    ("p53 and DACH1" . SPARSER::COLLECTION)
    ("DACH1 or p53" . SPARSER::COLLECTION)
    ("DACH1 and/or p53" . SPARSER::COLLECTION)
    ("a synthetic multimeric canonical p53 response element reporter gene"
     . SPARSER::PROTEIN)
    ("p21 CIP1 and Rad51" . SPARSER::COLLECTION)
    ("DACH1 and p53" . SPARSER::COLLECTION)
    ("The p53 binding-defective DACH1 mutant" . SPARSER::MUTANT)
    ("protein and p53" . SPARSER::COLLECTION)
    ("Azacytidine (AZT)" . SPARSER::DRUG) ("Azacytidine" . SPARSER::DRUG)
    ("methylase" . SPARSER::PROTEIN)
    ("Representative examples" . SPARSER::EXAMPLE)
    ("a separate cohort" . SPARSER::MOLECULE)
    ("hyperactive EGFR" . SPARSER::PROTEIN)
    ("intrinsic DNA-sequence" . SPARSER::DNA)
    ("the hyperactive EGFR" . SPARSER::PROTEIN) ("DNA-sequence" . SPARSER::DNA)
    ("Forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY) ("sin" . SPARSER::PROTEIN)
    ("tsh" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("eya" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mdm2 and Mdmx" . SPARSER::COLLECTION) ("Mdmx" . SPARSER::PROTEIN)
    ("SOX2 and fusion proteins" . SPARSER::COLLECTION)
    ("ALK and ROS" . SPARSER::COLLECTION)
    ("K-Ras and EGFR" . SPARSER::COLLECTION)
    ("DACH1, and SOX2" . SPARSER::COLLECTION) ("Dac" . SPARSER::PROTEIN)
    ("EGFR and mutant" . SPARSER::COLLECTION) ("Dach1" . SPARSER::PROTEIN)
    ("FoxG1" . SPARSER::PROTEIN) ("Klf4" . SPARSER::PROTEIN)
    ("3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("β -galactosidase" . SPARSER::PROTEIN)
    ("p21 CIP1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SOX2" . SPARSER::PROTEIN)
    ("stem cell factor" . SPARSER::PROTEIN) ("DACH1" . SPARSER::PROTEIN)
    ("Wnt–β-catenin" . SPARSER::COLLECTION)
    ("various plant-derived chemicals (phytochemicals) and their various analogues"
     . SPARSER::COLLECTION)
    ("Carnosol" . SPARSER::DRUG) ("silymarin" . SPARSER::DRUG)
    ("Curcumin and its derivative CHC007100" . SPARSER::COLLECTION)
    ("bis" . SPARSER::PROTEIN) ("TET" . SPARSER::PROTEIN)
    ("Tetrandrine" . SPARSER::DRUG) ("HQBA" . SPARSER::DRUG)
    ("benzamide" . SPARSER::DRUG) ("MMTV-Wnt1" . SPARSER::COLLECTION)
    ("PyMT" . SPARSER::PROTEIN) ("a special class" . CLASS)
    ("hydrazones" . SPARSER::MOLECULE) ("Tankyrase" . SPARSER::PROTEIN)
    ("tankyrase" . SPARSER::PROTEIN) ("CCT" . SPARSER::PROTEIN)
    ("beta-catenin/CREB-binding protein" . SPARSER::COLLECTION)
    ("cyclin D1, c-Myc and survivin" . SPARSER::COLLECTION)
    ("c-myc, cyclin D1 and survivin" . SPARSER::COLLECTION)
    ("PFK" . SPARSER::PROTEIN) ("AML and CML" . SPARSER::COLLECTION)
    ("MSCs" . SPARSER::PROTEIN) ("normal β-catenin" . SPARSER::PROTEIN)
    ("S100A4 and Tenascin" . SPARSER::COLLECTION) ("TNC" . SPARSER::PROTEIN)
    ("Tenascin" . SPARSER::PROTEIN) ("β-catenin/LEF1" . SPARSER::COLLECTION)
    ("Snail and slug" . SPARSER::COLLECTION)
    ("β-catenin/LEF-1" . SPARSER::COLLECTION) ("slug" . SPARSER::PROTEIN)
    ("EGF, TGF-β and IGF1" . SPARSER::COLLECTION)
    ("Twist, LEF-1, Ets-1, FOXC2 and Goosecoid" . SPARSER::COLLECTION)
    ("CBF-A/KAP-1" . SPARSER::COLLECTION)
    ("c-MYC and c-JUN" . SPARSER::COLLECTION)
    ("microphthalmia-associated transcription factor (MITF)"
     . SPARSER::PROTEIN)
    ("survivin and c-Jun" . SPARSER::COLLECTION)
    ("β-catenin/TCF/LEF" . SPARSER::COLLECTION) ("LBH" . SPARSER::PROTEIN)
    ("promoter, and consensus" . SPARSER::COLLECTION)
    ("CIC" . SPARSER::PROTEIN) ("AKT and β-catenin" . SPARSER::COLLECTION)
    ("tumourigenic traits" . SPARSER::PROTEIN)
    ("an invasive forms" . SPARSER::FORM)
    ("insulin and insulin-like growth factor" . SPARSER::COLLECTION)
    ("PI3K-AKT-MAPK" . SPARSER::COLLECTION)
    ("E-cadherin–β-catenin" . SPARSER::COLLECTION)
    ("the complex and subsequent degradation" . SPARSER::COLLECTION)
    ("E-cadherin and β-catenin" . SPARSER::COLLECTION)
    ("catenin/E-cadherin" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTKs) or cytoplasmic tyrosine kinases (Fer, Fyn, Yes and Src)"
     . SPARSER::COLLECTION)
    ("groucho-HDAC" . SPARSER::COLLECTION)
    ("β-catenin/LEF/TCF" . SPARSER::COLLECTION) ("groucho" . SPARSER::PROTEIN)
    ("perinuclear region and forms" . SPARSER::COLLECTION)
    ("SKP" . SPARSER::PROTEIN)
    ("GSK-3β and casein kinase 1" . SPARSER::COLLECTION)
    ("axin and GSK-3β" . SPARSER::COLLECTION) ("dsh" . SPARSER::PROTEIN)
    ("Wnt1" . SPARSER::PROTEIN) ("XAV939" . SPARSER::DRUG)
    ("ICG-001" . SPARSER::DRUG) ("PKF115-584" . SPARSER::DRUG)
    ("LEF1" . SPARSER::PROTEIN) ("FOXC2" . SPARSER::PROTEIN)
    ("KAP-1" . SPARSER::PROTEIN) ("CBF-A" . SPARSER::PROTEIN)
    ("Snail2" . SPARSER::PROTEIN) ("Snail1" . SPARSER::PROTEIN)
    ("MMP26" . SPARSER::PROTEIN)
    ("limb bud and heart development" . SPARSER::PROTEIN)
    ("microphthalmia-associated transcription factor" . SPARSER::PROTEIN)
    ("FBXW1A" . SPARSER::PROTEIN) ("CK1" . SPARSER::PROTEIN)
    ("Akt/ERK" . SPARSER::COLLECTION) ("Raf-MEK-ERK" . SPARSER::COLLECTION)
    ("MEK and a target" . SPARSER::COLLECTION)
    ("PE, MEK and ERK" . SPARSER::COLLECTION)
    ("Exogenously expressed Pin1" . SPARSER::PROTEIN)
    ("expressed Pin1" . SPARSER::PROTEIN) ("cont" . SPARSER::PROTEIN)
    ("AAV" . SPARSER::PROTEIN)
    ("CMV-enhanced cardiac specific myosin light chain (MLC) promoter"
     . SPARSER::PROMOTER)
    ("AAV-Pin1" . SPARSER::PROTEIN-PAIR) ("Akt and ERK" . SPARSER::COLLECTION)
    ("well-accepted Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("target protein conformation and activity after phosphorylation"
     . SPARSER::COLLECTION)
    ("Pin1 and Akt or MEK" . SPARSER::COLLECTION)
    ("Akt or MEK" . SPARSER::COLLECTION) ("phenylephrine" . SPARSER::DRUG)
    ("max and min" . SPARSER::COLLECTION) ("dp/dt" . SPARSER::COLLECTION)
    ("dt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("isomerase (PPI)" . SPARSER::ISOMERASE)
    ("peptidyl-prolyl" . SPARSER::COLLECTION)
    ("cis or trans" . SPARSER::COLLECTION)
    ("Almost 15 years ago" . SPARSER::PROTEIN)
    ("Akt and MEK" . SPARSER::COLLECTION)
    ("Akt, MEK and Raf-1" . SPARSER::COLLECTION)
    ("kinases and phosphatases" . SPARSER::COLLECTION)
    ("β-amyloid" . SPARSER::MOLECULE) ("Pim-1" . SPARSER::PROTEIN)
    ("Pin-1" . SPARSER::PROTEIN) ("further increase MSH2" . SPARSER::PROTEIN)
    ("MSH" . SPARSER::PROTEIN) ("Lin DP’s" . SPARSER::PROTEIN)
    ("DP" . SPARSER::PROTEIN) ("MSH2, MSH6, and PMS2" . SPARSER::COLLECTION)
    ("coR" . SPARSER::PROTEIN-FAMILY) ("hMSH2 and hMLH1" . SPARSER::COLLECTION)
    ("c-Abl and p73" . SPARSER::COLLECTION)
    ("Human mutS homolog 2 (hMSH2) and human mutL homolog 1 (hMLH1)"
     . SPARSER::COLLECTION)
    ("hMSH3 or hMSH6 and hMLH3 or hPMS2" . SPARSER::COLLECTION)
    ("hMSH6 and hMLH3 or hPMS2" . SPARSER::COLLECTION)
    ("mutL" . SPARSER::PROTEIN)
    ("MSH2 , RECQL4 and RAD51L1" . SPARSER::COLLECTION)
    ("MSH2-3" . SPARSER::COLLECTION) ("TPM1" . SPARSER::PROTEIN)
    ("Tropomyosin 1" . SPARSER::PROTEIN) ("c-Abl" . SPARSER::PROTEIN)
    ("mutS homolog 2" . SPARSER::PROTEIN) ("RAD51L1" . SPARSER::PROTEIN)
    ("RECQL4" . SPARSER::PROTEIN)
    ("our material does not present random cohort" . SPARSER::MOLECULE)
    ("resp" . SPARSER::PROTEIN) ("b-actin" . SPARSER::PROTEIN-PAIR)
    ("ALK gene and echinoderm microtubule-associated protein-like 4 ( EML4 ) gene"
     . SPARSER::PROTEIN)
    ("gene and echinoderm" . SPARSER::COLLECTION)
    ("3b" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p23" . SPARSER::PROTEIN)
    ("chr2" . SPARSER::PROTEIN) ("CC1" . SPARSER::PROTEIN)
    ("KLC1" . SPARSER::PROTEIN)
    ("anaplastic lymphoma receptor tyrosine kinase" . SPARSER::PROTEIN)
    ("Anaplastic lymphoma receptor tyrosine kinase" . SPARSER::PROTEIN)
    ("excess A fragment" . SPARSER::FRAGMENT) ("elafin" . SPARSER::PROTEIN)
    ("Cre-BP1" . SPARSER::COLLECTION)
    ("the A allele promoter" . SPARSER::PROMOTER)
    ("a famous oncogene" . SPARSER::ONCOGENE)
    ("the A allele allele" . SPARSER::ALLELE)
    ("allele allele" . SPARSER::ALLELE)
    ("zinc-dependent proteolytic enzymes" . SPARSER::ENZYME)
    ("A/G" . SPARSER::PROTEIN) ("TESS" . SPARSER::PROTEIN)
    ("the A Allele" . SPARSER::ALLELE)
    ("A Competitive DNA Fragment" . SPARSER::FRAGMENT)
    ("Fragment" . SPARSER::FRAGMENT) ("pGL3-A/G" . SPARSER::PROTEIN-PAIR)
    ("pro-MMPs" . SPARSER::COLLECTION)
    ("vascular dysplasia" . SPARSER::PROTEIN)
    ("cell surface molecules and other pericellular substances"
     . SPARSER::COLLECTION)
    ("the vascular matrix" . SPARSER::PROTEIN-FAMILY)
    ("Activin" . SPARSER::PROTEIN)
    ("Brain arteriovenous malformations (BAVM)" . SPARSER::PROTEIN)
    ("Overexpressed C-MYB" . SPARSER::PROTEIN) ("BAVM" . SPARSER::PROTEIN)
    ("brain arteriovenous malformations (BAVM)" . SPARSER::PROTEIN)
    ("C/EBP β" . SPARSER::PROTEIN) ("BP1" . SPARSER::PROTEIN)
    ("TST-1" . SPARSER::PROTEIN) ("p5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p4" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("receptor 1" . SPARSER::PROTEIN) ("ALK-1" . SPARSER::PROTEIN)
    ("c-myb" . SPARSER::PROTEIN) ("C-MYB" . SPARSER::PROTEIN)
    ("Steroid hormone receptors and their co-activators" . SPARSER::COLLECTION)
    ("at least 1 allele" . SPARSER::ALLELE)
    ("polyglutamine" . SPARSER::MOLECULE) ("NCOA3" . SPARSER::PROTEIN)
    ("SRC3" . SPARSER::PROTEIN) ("SRC1" . SPARSER::PROTEIN)
    ("Steroid hormone" . SPARSER::MOLECULE) ("AIB1" . SPARSER::PROTEIN)
    ("PRMT1 and protein" . SPARSER::COLLECTION)
    ("PRMT1 and p38" . SPARSER::COLLECTION)
    ("CARM1 (PRMT4) and PRMT5" . SPARSER::COLLECTION)
    ("TIS21/BTG2" . SPARSER::COLLECTION)
    ("transglutaminase" . SPARSER::PROTEIN)
    ("NF-E2 and ELKF" . SPARSER::COLLECTION)
    ("PRMT1/p38α" . SPARSER::COLLECTION)
    ("GATA1, NF-E2 and ELKF" . SPARSER::COLLECTION)
    ("transcription factor and BAD" . SPARSER::COLLECTION)
    ("scaffold or other regulatory proteins" . SPARSER::COLLECTION)
    ("threonine/tyrosine" . SPARSER::COLLECTION)
    ("the predominant enzyme" . SPARSER::ENZYME)
    ("TAT-PRMT1" . SPARSER::COLLECTION) ("benzidine" . SPARSER::MOLECULE)
    ("The TAT-fused PRMT1 and the control TAT-GFP proteins"
     . SPARSER::COLLECTION)
    ("TAT-GFP" . SPARSER::COLLECTION) ("TAT-fused" . SPARSER::COLLECTION)
    ("TAT" . SPARSER::PROTEIN)
    ("hnRNP K, hnRNP A1 and hnRNP A2" . SPARSER::COLLECTION)
    ("PRMT1 or p38α" . SPARSER::COLLECTION)
    ("p38α and PRMT1" . SPARSER::COLLECTION) ("p38β" . SPARSER::PROTEIN)
    ("Flag-p38β" . SPARSER::COLLECTION) ("Flag-p38α" . SPARSER::COLLECTION)
    ("p38α or p38β" . SPARSER::COLLECTION)
    ("p38α and p38β" . SPARSER::COLLECTION)
    ("threonine and tyrosine" . SPARSER::COLLECTION)
    ("ALAS2, PBGD, γ-globin and GATA1" . SPARSER::COLLECTION)
    ("araC and NaB" . SPARSER::COLLECTION)
    ("araC- or NaB-induced erythroid differentiation in K562 cells like the wild type PRMT1"
     . SPARSER::COLLECTION)
    ("araC-" . SPARSER::DRUG) ("GATA1, NF-E2 and EKLF" . SPARSER::COLLECTION)
    ("ALAS2, PBGD and γ-globin" . SPARSER::COLLECTION)
    ("γ-globin and two key enzymes" . SPARSER::COLLECTION)
    ("delta-aminolevulinate synthase 2 (ALAS2) and porphobilinogen deaminase (PBGD)"
     . SPARSER::COLLECTION)
    ("PBGD" . SPARSER::PROTEIN) ("aminolevulinate" . SPARSER::PROTEIN)
    ("the stimulatory impact" . SPARSER::PROTEIN)
    ("araC or NaB" . SPARSER::COLLECTION) ("NaB" . SPARSER::PROTEIN)
    ("butyrate" . SPARSER::PROTEIN) ("Benzidine" . SPARSER::MOLECULE)
    ("HA-PRMT1" . SPARSER::COLLECTION)
    ("the predominant protein arginine methyltransferase" . SPARSER::PROTEIN)
    ("Erythroid" . SPARSER::PROTEIN) ("Axin" . SPARSER::PROTEIN)
    ("PI3K and Src" . SPARSER::COLLECTION)
    ("factors and anti-apoptotic" . SPARSER::COLLECTION)
    ("factors and histones" . SPARSER::COLLECTION)
    ("the predominant PRMT" . SPARSER::PROTEIN) ("PRMT" . SPARSER::PROTEIN)
    ("activating transcription factor-2 (ATF-2) and cyclic AMP response element binding protein (CREB)"
     . SPARSER::COLLECTION)
    ("protein (CREB)" . SPARSER::PROTEIN)
    ("PI3 kinase/Akt" . SPARSER::COLLECTION)
    ("PRMT1 and p38α" . SPARSER::COLLECTION) ("p38α-" . SPARSER::PROTEIN)
    ("hemoglobin and the erythroid surface marker glycophorin A"
     . SPARSER::COLLECTION)
    ("factors, GATA1, NF-E2 and EKLF" . SPARSER::COLLECTION)
    ("EKLF" . SPARSER::PROTEIN) ("glycophorin" . SPARSER::PROTEIN-FAMILY)
    ("PRMT4" . SPARSER::PROTEIN) ("CARM1" . SPARSER::PROTEIN)
    ("TR3" . SPARSER::PROTEIN) ("hCAF1" . SPARSER::PROTEIN)
    ("CCR4-associated factor 1" . SPARSER::PROTEIN) ("BTG1" . SPARSER::PROTEIN)
    ("BTG2" . SPARSER::PROTEIN) ("TIS21" . SPARSER::PROTEIN)
    ("TGM2" . SPARSER::PROTEIN) ("dimethyl- arginines" . SPARSER::DRUG)
    ("hnRNP A2" . SPARSER::PROTEIN) ("hnRNP K" . SPARSER::PROTEIN)
    ("Protein Arginine Methyltransferase 1" . SPARSER::PROTEIN)
    ("porphobilinogen deaminase" . SPARSER::PROTEIN)
    ("ALAS2" . SPARSER::PROTEIN) ("synthase 2" . SPARSER::PROTEIN)
    ("delta-" . SPARSER::PROTEIN) ("hnRNP A1" . SPARSER::PROTEIN)
    ("Arg3" . SPARSER::PROTEIN) ("SIN3A" . SPARSER::PROTEIN)
    ("RUNX1" . SPARSER::PROTEIN) ("NIP45" . SPARSER::PROTEIN)
    ("Protein arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("γ-globin" . SPARSER::PROTEIN)
    ("activating transcription factor-2" . SPARSER::PROTEIN)
    ("methyltransferase activity" . SPARSER::PROTEIN)
    ("PRMT1" . SPARSER::PROTEIN)
    ("protein arginine methyltransferase 1" . SPARSER::PROTEIN)
    ("genes and enzymes" . SPARSER::COLLECTION)
    ("HBV-RNA and closed circular double-chain DNA (cccDNA) and even complete virus particles ( xref – xref )"
     . SPARSER::COLLECTION)
    ("closed circular double-chain DNA (cccDNA) and even complete virus particles ( xref – xref )"
     . SPARSER::COLLECTION)
    ("closed circular double-chain DNA" . SPARSER::DNA)
    ("HBV-related nucleic acid molecules" . SPARSER::MOLECULE)
    ("mitochondria and rough endoplasmic reticula" . SPARSER::COLLECTION)
    ("the above-menitoned four signaling proteins" . SPARSER::PROTEIN)
    ("pc-DNA3.1" . SPARSER::PROTEIN) ("pc-DNA3.1-HBx" . SPARSER::PROTEIN-PAIR)
    ("STAT3 and p-STAT3 proteins" . SPARSER::COLLECTION)
    ("JAK2 and STAT3" . SPARSER::COLLECTION)
    ("group and HBx" . SPARSER::COLLECTION) ("AI" . SPARSER::PROTEIN)
    ("Bcl-2/Bax" . SPARSER::COLLECTION)
    ("a typical pro-apoptosis protein" . SPARSER::PROTEIN)
    ("tyrosine kinase and Pyk-2" . SPARSER::COLLECTION)
    ("Ras-Raf-MAPK" . SPARSER::COLLECTION)
    ("antigen and antibody" . SPARSER::COLLECTION) ("MN" . SPARSER::PROTEIN)
    ("p-JAK2" . SPARSER::COLLECTION) ("Annexin V/PI" . SPARSER::COLLECTION)
    ("HBx" . SPARSER::PROTEIN) ("protease-3" . SPARSER::PROTEIN)
    ("Aspartic acid" . SPARSER::AMINO-ACID) ("Pyk-2" . SPARSER::PROTEIN)
    ("P13" . SPARSER::PROTEIN) ("HK-2" . SPARSER::PROTEIN)
    ("dual NVP-BEZ235 (PI3K/mTORC1 inhibitor) and lovastatin (inhibitor of ERK signaling)"
     . SPARSER::COLLECTION)
    ("dual NVP-BEZ235" . SPARSER::DRUG)
    ("AKT and mTORC1/p70S6K" . SPARSER::COLLECTION)
    ("PI3K/mTORC1" . SPARSER::COLLECTION)
    ("either humanized monoclonal anti-VEGF antibodies (Bevacizumab) or small tyrosine kinase inhibitors"
     . SPARSER::COLLECTION)
    ("either humanized monoclonal anti-VEGF antibodies" . SPARSER::ANTIBODY)
    ("sunitinib or sorafenib" . SPARSER::COLLECTION)
    ("sorafenib" . SPARSER::DRUG) ("sunitinib" . SPARSER::DRUG)
    ("vascular epithelial growth factor (VEGF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ETA and ETB" . SPARSER::COLLECTION) ("ETB" . SPARSER::PROTEIN)
    ("ETA" . SPARSER::PROTEIN) ("endothelin" . SPARSER::PROTEIN)
    ("STF" . SPARSER::PROTEIN) ("tanespimycin" . SPARSER::DRUG)
    ("MYC–MAX–MXD1" . SPARSER::COLLECTION)
    ("RET and NF1" . SPARSER::COLLECTION) ("PI3K/v-Akt" . SPARSER::COLLECTION)
    ("MMP24, DSP, SIX1, LGR5, LAPTM4B, and β-catenin" . SPARSER::COLLECTION)
    ("DSP" . SPARSER::PROTEIN) ("ENO1 , BNIP3 , or CA9" . SPARSER::COLLECTION)
    ("EGLN3 and KISS1R" . SPARSER::COLLECTION)
    ("several specifically overexpressed genes" . SPARSER::GENE)
    ("overexpressed genes" . SPARSER::GENE)
    ("PHD1, PHD2, and PHD3" . SPARSER::COLLECTION)
    ("EglN2, EglN1, and EglN3" . SPARSER::COLLECTION)
    ("EglN1" . SPARSER::PROTEIN) ("HIF-1/HIF-2α" . SPARSER::COLLECTION)
    ("TMEM127 and MAX" . SPARSER::COLLECTION)
    ("NF1 , RET , and KIF1B β" . SPARSER::COLLECTION)
    ("VHL and SDHx" . SPARSER::COLLECTION)
    ("SDHD , SDHB , SDHC , SDHA , and SDHAF2" . SPARSER::COLLECTION)
    ("SDHC" . SPARSER::PROTEIN) ("SDHB" . SPARSER::PROTEIN)
    ("SDHD" . SPARSER::PROTEIN)
    ("EDN1, EPO, GLUT1, and VEGF" . SPARSER::COLLECTION)
    ("EPO" . SPARSER::PROTEIN) ("erythropoietin" . SPARSER::PROTEIN)
    ("HIFs" . SPARSER::PROTEIN) ("bHLH–Zip" . SPARSER::COLLECTION)
    ("Zip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("bHLH" . SPARSER::PROTEIN)
    ("MAX -related thoracoabdominal PGLs" . SPARSER::PROTEIN)
    ("constitutively expressed protein" . SPARSER::PROTEIN)
    ("MYC/MAX/MXD1" . SPARSER::COLLECTION)
    ("the basic helix–loop–helix leucine zipper (bHLHZ) family"
     . SPARSER::PROTEIN-FAMILY)
    ("bilateral carotid PGLs" . SPARSER::PROTEIN)
    ("NF1 or RET" . SPARSER::COLLECTION)
    ("broadly expressed protein" . SPARSER::PROTEIN)
    ("expressed protein" . SPARSER::PROTEIN)
    ("RET and VHL" . SPARSER::COLLECTION) ("SDHA" . SPARSER::PROTEIN)
    ("SDH" . SPARSER::PROTEIN) ("catecholamines" . SPARSER::MOLECULE)
    ("neuro" . SPARSER::PROTEIN) ("RET/NF1" . SPARSER::COLLECTION)
    ("VHL , RET , NF1 , SDHx , and SDHAF2" . SPARSER::COLLECTION)
    ("PHEOs/PGLs" . SPARSER::COLLECTION) ("PGLs" . SPARSER::PROTEIN)
    ("WZB117" . SPARSER::DRUG) ("KRH102053" . SPARSER::DRUG)
    ("LAPTM4B" . SPARSER::PROTEIN) ("LGR5" . SPARSER::PROTEIN)
    ("SIX1" . SPARSER::PROTEIN) ("MMP24" . SPARSER::PROTEIN)
    ("1B" . SPARSER::PROTEIN) ("BNIP3" . SPARSER::PROTEIN)
    ("KISS1R" . SPARSER::PROTEIN) ("EglN3" . SPARSER::PROTEIN)
    ("EglN2" . SPARSER::PROTEIN) ("PHD1" . SPARSER::PROTEIN)
    ("prolyl hydroxylase" . SPARSER::PROTEIN) ("EDN1" . SPARSER::PROTEIN)
    ("MAX dimerization protein 1" . SPARSER::PROTEIN)
    ("MXD1" . SPARSER::PROTEIN) ("HIF-2 α" . SPARSER::PROTEIN)
    ("SDHAF2" . SPARSER::PROTEIN) ("TMEM127" . SPARSER::PROTEIN)
    ("BAK and synergizes" . SPARSER::COLLECTION)
    ("pro-apoptotic BCL2-like proteins" . SPARSER::PROTEIN)
    ("pro-apoptotic BCL2-like proteins and ABT-263" . SPARSER::COLLECTION)
    ("proteins and ABT-263" . SPARSER::COLLECTION)
    ("BAX/BAK" . SPARSER::COLLECTION)
    ("likely other chemotherapeutic drugs" . SPARSER::DRUG)
    ("a trivial task" . SPARSER::PROTEIN) ("CerS6" . SPARSER::PROTEIN)
    ("Cer" . SPARSER::PROTEIN)
    ("particular long-chain fatty acyl-CoA substrates" . SPARSER::SUBSTRATE)
    ("other clinically relevant drugs" . SPARSER::DRUG)
    ("MCL1/BAK" . SPARSER::COLLECTION) ("MCL1 MCL1" . SPARSER::PROTEIN)
    ("BAX and/ or BAK" . SPARSER::COLLECTION)
    ("KO or wt" . SPARSER::COLLECTION) ("soluble Bak" . SPARSER::PROTEIN)
    ("Certain BH3-only pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("C 16 -C17-ceramide Soluble Bak" . SPARSER::PROTEIN)
    ("soluble recombinant Bax or Bak" . SPARSER::COLLECTION)
    ("Bax or Bak" . SPARSER::COLLECTION) ("wt or Bak" . SPARSER::COLLECTION)
    ("BAK and ABT-263" . SPARSER::COLLECTION)
    ("BAK and/ or BAX" . SPARSER::COLLECTION)
    ("bound pro-apoptotic BCL2 proteins" . SPARSER::PROTEIN)
    ("RPMI-ER" . SPARSER::COLLECTION) ("RPMI-MCL1" . SPARSER::COLLECTION)
    ("RPMI8226" . SPARSER::PROTEIN) ("sphingoid" . SPARSER::MOLECULE)
    ("particular fatty acyl CoAs" . SPARSER::MOLECULE)
    ("CoAs" . SPARSER::MOLECULE) ("fatty acyl-CoAs" . SPARSER::MOLECULE)
    ("BAX and CerS" . SPARSER::COLLECTION)
    ("mitochondria and ER" . SPARSER::COLLECTION)
    ("U937-ER and U937-BCLx" . SPARSER::COLLECTION)
    ("green fluorescent protein (GFP)" . SPARSER::PROTEIN)
    ("an irrelevant control protein fragment (ER)" . SPARSER::FRAGMENT)
    ("fragment (ER)" . SPARSER::FRAGMENT)
    ("ABT-263 and drugs" . SPARSER::COLLECTION)
    ("the pro-apoptotic multi-domain BCL2 proteins BAK and BAX"
     . SPARSER::COLLECTION)
    ("bound pro-apoptotic BCL2-like proteins" . SPARSER::PROTEIN)
    ("/BCLw" . SPARSER::COLLECTION) ("BCL2/BCLx" . SPARSER::COLLECTION)
    ("ceramide and BAX" . SPARSER::COLLECTION)
    ("BAX and BAK" . SPARSER::COLLECTION) ("Ceramides" . SPARSER::MOLECULE)
    ("BCLw, MCL1 or BCLb" . SPARSER::COLLECTION) ("busulfan" . SPARSER::DRUG)
    ("the pro-apoptotic BCL2-like proteins BAK and BAX" . SPARSER::COLLECTION)
    ("BAK and BAX" . SPARSER::COLLECTION)
    ("BCLb/BCL2L10" . SPARSER::COLLECTION)
    ("BFL1/BCL2A1" . SPARSER::COLLECTION) ("BCLw/BCL2L2" . SPARSER::COLLECTION)
    ("/BCL2L1" . SPARSER::COLLECTION) ("BCLw" . SPARSER::PROTEIN)
    ("BCLx" . SPARSER::PROTEIN) ("ell" . SPARSER::PROTEIN)
    ("BAK" . SPARSER::PROTEIN) ("-ceramide" . SPARSER::MOLECULE)
    ("the pro-apoptotic sphingolipid ceramide" . SPARSER::MOLECULE)
    ("many chemotherapeutic drugs" . SPARSER::DRUG)
    ("proteins and bioactive sphingolipids" . SPARSER::COLLECTION)
    ("bioactive sphingolipids" . SPARSER::MOLECULE)
    ("sphingolipids" . SPARSER::MOLECULE) ("Ced-9" . SPARSER::PROTEIN)
    ("acyl-CoAs" . SPARSER::MOLECULE) ("BCL-x" . SPARSER::PROTEIN)
    ("ABt-263" . SPARSER::DRUG) ("L protein" . SPARSER::PROTEIN)
    ("sphingosine-1-phosphate" . SPARSER::DRUG)
    ("acyl-CoA" . SPARSER::MOLECULE) ("BCL2L10" . SPARSER::PROTEIN)
    ("BFL1" . SPARSER::PROTEIN) ("BCL2L2" . SPARSER::PROTEIN)
    ("ABT-263" . SPARSER::DRUG) ("CDK2–CDC6" . SPARSER::COLLECTION)
    ("ORC1 and CDT1" . SPARSER::COLLECTION)
    ("CUL1 and CUL4" . SPARSER::COLLECTION)
    ("Cdc6, Cdk1, and Cdk2" . SPARSER::COLLECTION)
    ("Cdc6 and Cdk1/2" . SPARSER::COLLECTION) ("pri" . SPARSER::PROTEIN)
    ("CDK2-3" . SPARSER::COLLECTION) ("REs" . SPARSER::PROTEIN)
    ("CDK1 and miR-302d and miR-372" . SPARSER::COLLECTION)
    ("pmir-GLO" . SPARSER::COLLECTION) ("GLO" . SPARSER::PROTEIN)
    ("CDK1 or CDK2" . SPARSER::COLLECTION)
    ("CDK1 and CDK2" . SPARSER::COLLECTION)
    ("CDC6 and pre-RC" . SPARSER::COLLECTION)
    ("exogenous CDK2" . SPARSER::PROTEIN)
    ("CDH1 and HUWE1" . SPARSER::COLLECTION)
    ("CDH1-associated form" . SPARSER::FORM)
    ("complex, APC/C and HUWE1" . SPARSER::COLLECTION)
    ("leptomycin B (LMB)" . SPARSER::MOLECULE)
    ("an accelerated nuclear" . SPARSER::PROTEIN) ("LMB" . SPARSER::MOLECULE)
    ("exogenous CDC6" . SPARSER::PROTEIN)
    ("exogenous wild-type CDC6" . SPARSER::PROTEIN)
    ("CDC6 and MCM2" . SPARSER::COLLECTION)
    ("protein (CBF)" . SPARSER::PROTEIN)
    ("CUL4B or CUL4A" . SPARSER::COLLECTION)
    ("Flag-CUL4B" . SPARSER::COLLECTION)
    ("CDC6 and CDT1" . SPARSER::COLLECTION) ("CUL4–DDB1" . SPARSER::COLLECTION)
    ("CDT1 and MCM" . SPARSER::COLLECTION) ("IdU" . SPARSER::DRUG)
    ("Cul4a" . SPARSER::PROTEIN) ("CUL4B/Cul4b" . SPARSER::COLLECTION)
    ("Cul4b" . SPARSER::PROTEIN)
    ("WDR5 and peroxiredoxin III" . SPARSER::COLLECTION)
    ("the same substrates and function" . SPARSER::COLLECTION)
    ("CUL4A and CUL4B" . SPARSER::COLLECTION)
    ("CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5, CUL7, and PARC"
     . SPARSER::COLLECTION)
    ("PARC" . SPARSER::PROTEIN)
    ("position substrate receptors (SRs) and target proteins"
     . SPARSER::COLLECTION)
    ("protein, RBX1 or RBX2" . SPARSER::COLLECTION)
    ("cullin-RING–based E3 ubiquitin ligases" . SPARSER::LIGASE)
    ("Cullins" . SPARSER::PROTEIN-FAMILY)
    ("origin DNA unwinding and recruitment" . SPARSER::COLLECTION)
    ("single-stranded DNA-binding protein (RPA)" . SPARSER::PROTEIN)
    ("CDK (cyclin-dependent kinase) and CDC7 (Dbf4-dependent kinase)"
     . SPARSER::COLLECTION)
    ("MCM" . SPARSER::PROTEIN) ("ORCs" . SPARSER::BIO-COMPLEX)
    ("CUL4B–CDK2–CDC6" . SPARSER::COLLECTION) ("ORC2" . SPARSER::PROTEIN)
    ("ORC1" . SPARSER::PROTEIN) ("pri-miRNA" . SPARSER::RNA)
    ("SKP2" . SPARSER::PROTEIN) ("3 D" . SPARSER::PROTEIN-FAMILY)
    ("leptomycin B" . SPARSER::MOLECULE) ("CRM1" . SPARSER::PROTEIN)
    ("Cul4" . SPARSER::PROTEIN) ("peroxiredoxin III" . SPARSER::PROTEIN)
    ("WDR5" . SPARSER::PROTEIN) ("CUL5" . SPARSER::PROTEIN)
    ("CUL4A" . SPARSER::PROTEIN) ("CUL1" . SPARSER::PROTEIN)
    ("RBX2" . SPARSER::PROTEIN)
    ("single-stranded DNA-binding protein" . SPARSER::PROTEIN)
    ("CDC45" . SPARSER::PROTEIN) ("CDT1" . SPARSER::PROTEIN)
    ("pre-RCs" . SPARSER::BIO-COMPLEX) ("MCM2" . SPARSER::PROTEIN)
    ("cullin family" . SPARSER::PROTEIN-FAMILY) ("CDC6" . SPARSER::PROTEIN)
    ("CUL4B" . SPARSER::PROTEIN) ("netrin-DSCAM-AMPK" . SPARSER::COLLECTION)
    ("receptor, DCC and neogenin" . SPARSER::COLLECTION)
    ("DSCAM instead of DCC" . SPARSER::COLLECTION)
    ("subunit, and netrin-1" . SPARSER::COLLECTION) ("CC" . SPARSER::MOLECULE)
    ("Compound C (CC)" . SPARSER::MOLECULE)
    ("dominant-negative mutant AMPK" . SPARSER::PROTEIN)
    ("using phospho-AMPK-specific antibody" . SPARSER::ANTIBODY)
    ("netrin-1, and AMPK" . SPARSER::COLLECTION)
    ("DSCAM and AMPK γ" . SPARSER::COLLECTION) ("Netrin" . SPARSER::PROTEIN)
    ("Myc-tagged full-length human DSCAM (DSCAM-Myc) or Myc-tagged full-length human DCC (DCC-Myc)"
     . SPARSER::COLLECTION)
    ("DCC-Myc" . SPARSER::COLLECTION) ("DSCAM-Myc" . SPARSER::COLLECTION)
    ("DSCAM and AMPKγ" . SPARSER::COLLECTION)
    ("Flag-tagged full-length human DSCAM (DSCAM-Flag) and Myc-tagged AMPKγ (AMPKγ-Myc)"
     . SPARSER::COLLECTION)
    ("DSCAM and AMPK" . SPARSER::COLLECTION)
    ("AMPKγ-Myc" . SPARSER::COLLECTION) ("DSCAM-Flag" . SPARSER::COLLECTION)
    ("DSCAM-ICD" . SPARSER::COLLECTION) ("DSAM-ICD" . SPARSER::COLLECTION)
    ("LexA" . SPARSER::PROTEIN) ("netrin" . SPARSER::PROTEIN)
    ("UNC5 and DCC" . SPARSER::COLLECTION)
    ("soma spacing, dendrite arborization and synaptic formation ( xref , xref )"
     . SPARSER::COLLECTION)
    ("fibronectin type III (FN)" . SPARSER::PROTEIN)
    ("DCC and neogenin" . SPARSER::COLLECTION) ("neogenin" . SPARSER::PROTEIN)
    ("UNC" . SPARSER::PROTEIN) ("a heterotrimeric kinase" . SPARSER::KINASE)
    ("AMP/ATP" . SPARSER::PROTEIN-PAIR)
    ("a previously unknown component" . SPARSER::COMPONENT)
    ("DCC" . SPARSER::PROTEIN) ("netrin-DSCAM" . SPARSER::COLLECTION)
    ("DSCAM" . SPARSER::PROTEIN) ("neuronal migration" . SPARSER::PROTEIN)
    ("Compound C" . SPARSER::MOLECULE) ("AMPK γ" . SPARSER::PROTEIN)
    ("netrin receptor" . SPARSER::PROTEIN) ("Netrin-1" . SPARSER::PROTEIN)
    ("fibronectin type III" . SPARSER::PROTEIN)
    ("Down Syndrome Cell Adhesion Molecule" . SPARSER::PROTEIN)
    ("UNC5A" . SPARSER::PROTEIN) ("UNC5" . SPARSER::PROTEIN)
    ("protein kinase kinase" . SPARSER::PROTEIN)
    ("calcium/calmodulin" . SPARSER::CALCIUM-CALMODULIN-COMPLEX)
    ("netrin-1" . SPARSER::PROTEIN)
    ("Down syndrome cell adhesion molecule" . SPARSER::PROTEIN)
    ("further emphasizing SRSF1’s" . SPARSER::PROTEIN)
    ("further emphasizing SRSF1" . SPARSER::PROTEIN)
    ("a powerful tumor-suppressive barrier" . SPARSER::PROTEIN)
    ("RPL5 and/or MDM2" . SPARSER::COLLECTION)
    ("previously described RPL-MDM2" . SPARSER::COLLECTION)
    ("a separate complex" . SPARSER::BIO-COMPLEX)
    ("quantitative MS" . SPARSER::PROTEIN)
    ("massively overexpressd SRSF1" . SPARSER::PROTEIN)
    ("MDM2 and very marginally induced p53 protein ( xref )"
     . SPARSER::COLLECTION)
    ("SRSF1-AAA" . SPARSER::COLLECTION) ("NRS" . SPARSER::PROTEIN)
    ("SRSF1 or ΔRRM2—but" . SPARSER::COLLECTION)
    ("RPL5 or MDM2" . SPARSER::COLLECTION)
    ("SRSF1-RP-MDM2" . SPARSER::COLLECTION)
    ("SRSF1 and TP53" . SPARSER::COLLECTION)
    ("Ras, Mos, and Cdc 6" . SPARSER::COLLECTION) ("Mos" . SPARSER::PROTEIN)
    ("Senescence-associated heterochromatic foci (SAHF)" . SPARSER::PROTEIN)
    ("overexpressed SRSF1" . SPARSER::PROTEIN)
    ("an essential barrier" . SPARSER::PROTEIN)
    ("SRSF1, actinomycin D or 5-fluorouracil" . SPARSER::COLLECTION)
    ("Flag-p53" . SPARSER::COLLECTION)
    ("SRSF1 or SRSF1-NRS" . SPARSER::COLLECTION)
    ("SRSF1-NRS" . SPARSER::COLLECTION) ("p14/ARF" . SPARSER::COLLECTION)
    ("SRSF1 and p53" . SPARSER::COLLECTION) ("RPL-MDM2" . SPARSER::COLLECTION)
    ("RPL5 and MDM2" . SPARSER::COLLECTION)
    ("SRSF1-RPL5-MDM2" . SPARSER::COLLECTION)
    ("SRSF1 and RPL11 or RPL23" . SPARSER::COLLECTION)
    ("RPL11 or RPL23" . SPARSER::COLLECTION)
    ("SRSF1-RPL5" . SPARSER::COLLECTION)
    ("SRSF1 and RPL5" . SPARSER::COLLECTION)
    ("SRSF1–RPL5" . SPARSER::COLLECTION)
    ("instead formed post-lysis" . SPARSER::COLLECTION)
    ("lysis" . SPARSER::PROTEIN) ("a quantitative form" . SPARSER::FORM)
    ("post-lysis" . SPARSER::COLLECTION) ("SRSF1/RP" . SPARSER::COLLECTION)
    ("T7-tagged SRSF1" . SPARSER::PROTEIN)
    ("SRSF1 and the RP-MDM2 complex" . SPARSER::COLLECTION)
    ("RP-MDM2" . SPARSER::COLLECTION) ("RP-MDM2-p53" . SPARSER::COLLECTION)
    ("RP" . SPARSER::PROTEIN)
    ("One such ternary complex" . SPARSER::BIO-COMPLEX)
    ("RPs" . SPARSER::PROTEIN)
    ("multiple cell-cycle regulators and tumor suppressors"
     . SPARSER::COLLECTION)
    ("RPL5-MDM2" . SPARSER::COLLECTION) ("RRM1" . SPARSER::PROTEIN)
    ("CHK1" . SPARSER::PROTEIN) ("Cdc 6" . SPARSER::PROTEIN)
    ("H-Ras" . SPARSER::PROTEIN) ("RPL23" . SPARSER::PROTEIN)
    ("IP-MS" . SPARSER::PROTEIN) ("L11" . SPARSER::PROTEIN)
    ("RPL5" . SPARSER::PROTEIN) ("SRSF1" . SPARSER::PROTEIN)
    ("available drugs" . SPARSER::DRUG) ("MITF-PGC1" . SPARSER::COLLECTION)
    ("a major regulator of mitochondrial biogenesis and function"
     . SPARSER::COLLECTION)
    ("diminished oxidative enzymes" . SPARSER::ENZYME)
    ("rotenone and the complex II inhibitor" . SPARSER::COLLECTION)
    ("Dinitrophenol" . SPARSER::MOLECULE) ("CCCP" . SPARSER::MOLECULE)
    ("-DNP" . SPARSER::DRUG) ("MITF/PGC1 α" . SPARSER::COLLECTION)
    ("PGC1α and ATP" . SPARSER::COLLECTION) ("DNP" . SPARSER::DRUG)
    ("dinitrophenol" . SPARSER::MOLECULE) ("pmel" . SPARSER::PROTEIN)
    ("a lineage-specific melanoma oncogene" . SPARSER::PROTEIN)
    ("BRAF/MEK" . SPARSER::COLLECTION)
    ("BRAF/MITF/PGC1α" . SPARSER::COLLECTION)
    ("PGC1α and MITF" . SPARSER::COLLECTION)
    ("PGC1α or MITF" . SPARSER::COLLECTION)
    ("TRPM1 and other direct targets" . SPARSER::COLLECTION)
    ("BRAF and MITF" . SPARSER::COLLECTION)
    ("the proximal PGC1α promoter" . SPARSER::PROMOTER)
    ("TFEB or TFE3" . SPARSER::COLLECTION)
    ("TFE3, TFEB and MITF" . SPARSER::COLLECTION)
    ("TFEB, TFEC, and TFE3" . SPARSER::COLLECTION)
    ("TFEB and MITF" . SPARSER::COLLECTION)
    ("TFEB, TFEC, TFE3 and MITF" . SPARSER::COLLECTION)
    ("TFEC" . SPARSER::PROTEIN)
    ("both transcription factor EB (TFEB ) and the micropthalmia-associated transcription factor (MITF )"
     . SPARSER::COLLECTION)
    ("the micropthalmia-associated transcription factor (MITF )"
     . SPARSER::PROTEIN)
    ("transcription factor EB (TFEB )" . SPARSER::PROTEIN)
    ("whose expression most closely paralleled PGC1α" . SPARSER::PROTEIN)
    ("TFEB" . SPARSER::PROTEIN) ("BRAF/MEK/ERK" . SPARSER::COLLECTION)
    ("non-melanoma" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("GABPA" . SPARSER::PROTEIN) ("TFAM" . SPARSER::PROTEIN)
    ("BRAF and MAPK" . SPARSER::COLLECTION) ("Lactate" . SPARSER::LACTATE)
    ("MitoSOX" . SPARSER::DRUG) ("a preclinical analog" . SPARSER::ANALOG)
    ("non-melanomas" . SPARSER::PROTEIN) ("PGCs" . SPARSER::PROTEIN)
    ("the peroxisome proliferator-activated receptor γ coactivator 1 (PGC-1) family"
     . SPARSER::PROTEIN-FAMILY)
    ("bromopyruvate" . SPARSER::DRUG) ("TIGAR and SCO2" . SPARSER::COLLECTION)
    ("TIGAR" . SPARSER::PROTEIN)
    ("functionally intact mitochondria" . SPARSER::PROTEIN)
    ("BRAF or MEK1/2" . SPARSER::COLLECTION)
    ("PTEN or INK4A" . SPARSER::COLLECTION)
    ("MEK1 and MEK2" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinases, ERK1 and ERK2" . SPARSER::COLLECTION)
    ("MITF and PGC1α" . SPARSER::COLLECTION)
    ("BRAF/MAPK" . SPARSER::COLLECTION) ("PGC1 α" . SPARSER::PROTEIN)
    ("TRPM1" . SPARSER::PROTEIN) ("TFE3" . SPARSER::PROTEIN)
    ("transcription factor EB" . SPARSER::PROTEIN) ("PGC1" . SPARSER::PROTEIN)
    ("PPAR-γ" . SPARSER::PROTEIN) ("GABPB2" . SPARSER::PROTEIN)
    ("NRF1" . SPARSER::PROTEIN)
    ("nuclear respiratory factor 1" . SPARSER::PROTEIN)
    ("TFB2M" . SPARSER::PROTEIN) ("TFB1M" . SPARSER::PROTEIN)
    ("MitoTracker Red" . SPARSER::MOLECULE) ("PLX4720" . SPARSER::DRUG)
    ("PPRC1" . SPARSER::PROTEIN) ("PGC1β" . SPARSER::PROTEIN)
    ("PGC-1" . SPARSER::PROTEIN) ("SCO2" . SPARSER::PROTEIN)
    ("PLX4032" . SPARSER::DRUG) ("INK4A" . SPARSER::PROTEIN)
    ("ERK1" . SPARSER::PROTEIN) ("PGC1α" . SPARSER::PROTEIN)
    ("c-FLIP, HSP27, clusterin, and GRP78" . SPARSER::COLLECTION)
    ("successful AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Clusterin, HSP27, GRP78, and c-FLIP" . SPARSER::COLLECTION)
    ("clusterin, HSP27, GRP78, and c-FLIP" . SPARSER::COLLECTION)
    ("Clusterin" . SPARSER::PROTEIN) ("HSP" . SPARSER::PROTEIN)
    ("Tim, GRP78, and HSP27" . SPARSER::COLLECTION)
    ("Tim" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypersensitive AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a more aggressive form" . SPARSER::FORM) ("doxazosin" . SPARSER::DRUG)
    ("HSP27, CLU, GRP78, and c-FLIP" . SPARSER::COLLECTION)
    ("es-LNCaP, ls-LNCaP, scr-ls-LNCaP, and si-ls-LNCaP" . SPARSER::COLLECTION)
    ("three sequence-specific siRNAs" . SPARSER::PROTEIN)
    ("siRNAs, AR-1, AR-2, and AR-3" . SPARSER::COLLECTION)
    ("es-LNCaP and ls-LNCaP" . SPARSER::COLLECTION)
    ("estrogens, progestins, and antiandrogens" . SPARSER::COLLECTION)
    ("PI3K and MAPK" . SPARSER::COLLECTION) ("progestins" . SPARSER::DRUG)
    ("a 110 kDa phosphoprotein and one of the nuclear receptor"
     . SPARSER::COLLECTION)
    ("androgenindependent state" . SPARSER::BIO-STATE)
    ("antiandrogen" . SPARSER::DRUG)
    ("HSP27, GRP78, CLU, and c-FLIP" . SPARSER::COLLECTION)
    ("AR, HSP27, CLU, GRP78, and c-FLIP" . SPARSER::COLLECTION)
    ("AR, heat shock protein 27 (HSP27), clusterin (CLU), glucose-related protein 78 (GRP78), and cellular FLICE-like inhibitory protein (c-FLIP) and their genes"
     . SPARSER::COLLECTION)
    ("cellular FLICE-like inhibitory protein (c-FLIP) and their genes"
     . SPARSER::COLLECTION)
    ("FLICE" . SPARSER::PROTEIN) ("LNCap" . SPARSER::PROTEIN)
    ("Hsp27" . SPARSER::PROTEIN)
    ("deoxyuridine triphosphate" . SPARSER::MOLECULE)
    ("GRP78 " . SPARSER::PROTEIN) ("AR-3" . SPARSER::PROTEIN)
    ("heat shock protein 27" . SPARSER::PROTEIN)
    ("inhibitors and agents" . SPARSER::COLLECTION)
    ("seemingly disparate types and locations" . SPARSER::COLLECTION)
    ("seemingly disparate types" . TYPE)
    ("a dominant-negative state" . SPARSER::BIO-STATE)
    ("cytosolic predominant mutant PTEN" . SPARSER::PROTEIN)
    ("Nuclear predominant mutant PTEN" . SPARSER::PROTEIN)
    ("these missense mutant PTEN (PTEN-M3M4, C136R) and nonsense mutant PTEN (PTEN-R233X and PTEN-R335X) proteins"
     . SPARSER::COLLECTION)
    ("PTEN-R335X" . SPARSER::PROTEIN-PAIR) ("proper PTEN" . SPARSER::PROTEIN)
    ("whose clinical analog" . SPARSER::ANALOG)
    ("M3M4, R233X and R335X" . SPARSER::COLLECTION)
    ("the lipid and protein phosphatase activity of PTEN by different mutations"
     . SPARSER::COLLECTION)
    ("perifosine" . SPARSER::PROTEIN)
    ("Mitogen Activated Protein Kinase-ERK" . SPARSER::COLLECTION)
    ("R233X" . SPARSER::PROTEIN)
    ("no observable PTEN-R233X and R335X proteins" . SPARSER::PROTEIN)
    ("PTEN-R233X and R335X" . SPARSER::COLLECTION)
    ("PTEN-R233X" . SPARSER::COLLECTION) ("Pten-M3M4" . SPARSER::COLLECTION)
    ("the stable PTEN mutant K125E and WT PTEN ( xref )" . SPARSER::COLLECTION)
    ("the proteasomal inhibitor" . SPARSER::INHIBITOR)
    ("M3M4" . SPARSER::PROTEIN) ("PTEN-M3M4" . SPARSER::COLLECTION)
    ("CHX" . SPARSER::PROTEIN) ("Polyubiquitinated" . SPARSER::PROTEIN)
    ("a dual lipid" . SPARSER::LIPID)
    ("the cytosolic-predominant mutant PTEN" . SPARSER::PROTEIN)
    ("P-ERK" . SPARSER::PROTEIN) ("WT2" . SPARSER::PROTEIN)
    ("Mitogen-Activated Protein Kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("s protein" . SPARSER::PROTEIN) ("food and tobacco" . SPARSER::COLLECTION)
    ("albumin/globin" . SPARSER::COLLECTION) ("globin" . SPARSER::PROTEIN)
    ("protein and gamma" . SPARSER::COLLECTION)
    ("inflammatory genes and an enhanced inflammatory response"
     . SPARSER::COLLECTION)
    ("transgene and 4NQO" . SPARSER::COLLECTION)
    ("gingival squamous dysplasia" . SPARSER::PROTEIN)
    ("lamin" . SPARSER::PROTEIN-FAMILY)
    ("the pro-apoptotic E2F target gene caspase 7" . SPARSER::PROTEIN)
    ("cyclin A2, and Ccne1" . SPARSER::COLLECTION)
    ("RB/E2F" . SPARSER::COLLECTION)
    ("p53, Bax, and p21 protein" . SPARSER::COLLECTION)
    ("this functional SNP" . SPARSER::PROTEIN) ("oxide" . SPARSER::MOLECULE)
    ("P72/P72" . SPARSER::COLLECTION)
    ("the p53 polymorphic variants" . SPARSER::VARIANT)
    ("NQO" . SPARSER::PROTEIN) ("the E6 viral oncoprotein" . SPARSER::PROTEIN)
    ("arginine or proline" . SPARSER::COLLECTION)
    ("caspase 7" . SPARSER::PROTEIN) ("Ccne1" . SPARSER::PROTEIN)
    ("Ccna2" . SPARSER::PROTEIN)
    ("keratinocyte growth factor" . SPARSER::PROTEIN)
    ("keratin 14" . SPARSER::PROTEIN) ("ErbB2 and Src" . SPARSER::COLLECTION)
    ("Src and ErbB2" . SPARSER::COLLECTION) ("Rexer" . SPARSER::DRUG)
    ("ErbB2 or Src" . SPARSER::COLLECTION) ("ErbB2/Src" . SPARSER::COLLECTION)
    ("-Ligand" . SPARSER::LIGAND) ("Src and ERK" . SPARSER::COLLECTION)
    ("an active ErbB2 signaling complex" . SPARSER::BIO-COMPLEX)
    ("HA, PKCδ, and Src" . SPARSER::COLLECTION)
    ("Shc and companion adaptor proteins" . SPARSER::COLLECTION)
    ("misshapen acini" . SPARSER::PROTEIN) ("Acini" . SPARSER::PROTEIN)
    ("lentiviral delivered shRNA" . SPARSER::PROTEIN)
    ("caspase-3 and Ki-67" . SPARSER::COLLECTION)
    ("ER, PR, and ErbB2" . SPARSER::COLLECTION)
    ("tamoxifen and lapatinib" . SPARSER::COLLECTION)
    ("PKCδ and Src" . SPARSER::COLLECTION)
    ("Src, and Phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("an active ErbB2/PKCδ/Src signaling complex" . SPARSER::BIO-COMPLEX)
    ("ErbB2/PKCδ/Src" . SPARSER::COLLECTION)
    ("Src, and ERK" . SPARSER::COLLECTION) ("MMTV-ErbB2" . SPARSER::COLLECTION)
    ("pERK1/2" . SPARSER::PROTEIN) ("GAB2" . SPARSER::PROTEIN)
    ("Phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mitogen Activated Protein Kinase" . SPARSER::PROTEIN)
    ("Protein Kinase C delta" . SPARSER::PROTEIN)
    ("the different conformational states" . SPARSER::BIO-STATE)
    ("the monomer and a continuous region" . SPARSER::COLLECTION)
    ("some telomerase accessory protein" . SPARSER::PROTEIN)
    ("dimeric TERT" . SPARSER::PROTEIN)
    ("the excellent fit" . SPARSER::PROTEIN-FAMILY)
    ("a dimeric complex" . SPARSER::BIO-COMPLEX)
    ("The excellent fit" . SPARSER::PROTEIN-FAMILY)
    ("the open monomer and 21" . SPARSER::COLLECTION)
    ("Independently refined monomers and composite dimers"
     . SPARSER::COLLECTION)
    ("composite dimers" . SPARSER::DIMER)
    ("two telomere substrates and telomeric DNA synthesis"
     . SPARSER::COLLECTION)
    ("the conformation of the monomers as well as the flexibility"
     . SPARSER::COLLECTION)
    ("MLF" . SPARSER::PROTEIN)
    ("a freshly prepared carbon coated grid" . SPARSER::PROTEIN)
    ("grid" . SPARSER::PROTEIN) ("glutaraldehyde" . SPARSER::MOLECULE)
    ("a dominant-negative impact" . SPARSER::PROTEIN)
    ("Colloidal gold" . SPARSER::MOLECULE)
    ("5nm colloidal gold" . SPARSER::MOLECULE)
    ("a homodimeric complex" . SPARSER::BIO-COMPLEX)
    ("two spherical lobes" . SPARSER::PROTEIN)
    ("two hTERT (127 kDa) and two hTER (153 kDa) subunits"
     . SPARSER::COLLECTION)
    ("the two accessory proteins Nop10 (7.7 kDa) and dyskerin (58 kDA)"
     . SPARSER::COLLECTION)
    ("the two accessory proteins Nop10" . SPARSER::PROTEIN)
    ("kDA" . SPARSER::PROTEIN)
    ("proteins, Nop10 and dyskerin" . SPARSER::COLLECTION)
    ("Nop10" . SPARSER::PROTEIN) ("dyskerin" . SPARSER::PROTEIN)
    ("thyroglobulin" . SPARSER::PROTEIN) ("sucrose" . SPARSER::MOLECULE)
    ("CR4" . SPARSER::PROTEIN) ("accessory proteins" . SPARSER::PROTEIN)
    ("Together TER and TERT form" . SPARSER::FORM)
    ("TER and TERT" . SPARSER::COLLECTION) ("holoenzyme" . SPARSER::PROTEIN)
    ("monomer or dimer" . SPARSER::COLLECTION)
    ("a large RNA subunit TER and a protein catalytic subunit TERT"
     . SPARSER::COLLECTION)
    ("Telomerase Activity" . SPARSER::PROTEIN) ("TIN2" . SPARSER::PROTEIN)
    ("WT/WT" . SPARSER::PROTEIN) ("Molecules" . SPARSER::MOLECULE)
    ("cytokine, and TNF" . SPARSER::COLLECTION)
    ("streptozotocin" . SPARSER::DRUG)
    ("the cytokine TNF-α and the chemokine KC" . SPARSER::COLLECTION)
    ("cytokines and nitric oxide" . SPARSER::COLLECTION)
    ("eIF2α or AROS" . SPARSER::COLLECTION)
    ("anti-nuclear antibodies (titer 1:640) and atypical ANCA (titer 1:160)"
     . SPARSER::COLLECTION)
    ("atypical ANCA" . SPARSER::PROTEIN) ("ANCA" . SPARSER::PROTEIN)
    ("the diabetes-associated TCF7L2 , IRS2 , and SOCS2 genes" . SPARSER::GENE)
    ("TCF7L2 , IRS2 , and SOCS2" . SPARSER::COLLECTION)
    ("DQ" . SPARSER::MOLECULE) ("HLA" . SPARSER::PROTEIN)
    ("Paladin" . SPARSER::PROTEIN) ("Proline" . SPARSER::AMINO-ACID)
    ("Leucine" . SPARSER::AMINO-ACID)
    ("relevant candidate genes" . SPARSER::GENE)
    ("The latter yielded myoblasts" . SPARSER::PROTEIN)
    ("proteins, Akt, ERK, and AMPK" . SPARSER::COLLECTION)
    ("BW" . SPARSER::PROTEIN) ("insulin and C-peptide" . SPARSER::COLLECTION)
    ("low basal and induced FOXP3" . SPARSER::PROTEIN)
    ("decarboxylase" . SPARSER::PROTEIN)
    ("key enzymes that coordinate the organism's" . SPARSER::ENZYME)
    ("AIRE and FOXP3" . SPARSER::COLLECTION) ("AIRE" . SPARSER::PROTEIN)
    ("nitric oxide, cytokines, and chemokines" . SPARSER::COLLECTION)
    ("interleukin-1β" . SPARSER::PROTEIN) ("KIAA1274" . SPARSER::PROTEIN)
    ("C-peptide" . SPARSER::MOLECULE) ("Bbp/ASPP2" . SPARSER::COLLECTION)
    ("NFκB peptides and p53CD" . SPARSER::COLLECTION)
    ("NFκB and Bcl-2" . SPARSER::COLLECTION)
    ("peptide and Pro" . SPARSER::COLLECTION)
    ("p53-ASPP2" . SPARSER::COLLECTION)
    ("the Fl-n-src peptide and the ASPP2 Pro peptide" . SPARSER::COLLECTION)
    ("the NFκB peptide 303–332 and ASPP2 Pro 722–737 xref"
     . SPARSER::COLLECTION)
    ("peptides and the ASPP2 Pro peptide" . SPARSER::COLLECTION)
    ("Bcl-2 or NFκB" . SPARSER::COLLECTION) ("n-Src" . SPARSER::COLLECTION)
    ("Bcl2 and NFκB" . SPARSER::COLLECTION)
    ("the Fl-n-src peptide instead of the lighter ASPP2 Pro peptide (1.7 kDa)"
     . SPARSER::COLLECTION)
    ("the ASPP2 Pro peptide and the Fl-ASPP2 n-src peptide ( xref )"
     . SPARSER::COLLECTION)
    ("fluorescein" . SPARSER::MOLECULE)
    ("its sequence-specific target DNA" . SPARSER::DNA)
    ("Bcl-2, NFκB and p53" . SPARSER::COLLECTION)
    ("a beta-Grasp" . SPARSER::COLLECTION) ("Grasp" . SPARSER::PROTEIN)
    ("ASPP2 and Bbp" . SPARSER::COLLECTION)
    ("Bbp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ASPP1 and ASPP2" . SPARSER::COLLECTION)
    ("ASPP1 and iASPP" . SPARSER::COLLECTION) ("iASPP" . SPARSER::PROTEIN)
    ("ASPP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bcl-2 and NFκB" . SPARSER::COLLECTION)
    ("Pro and p53CD" . SPARSER::COLLECTION)
    ("p53, Bcl-2 and NFkB" . SPARSER::COLLECTION)
    ("n-src" . SPARSER::COLLECTION)
    ("Bcl-2 and the p65 subunit" . SPARSER::COLLECTION)
    ("Ank-SH3" . SPARSER::COLLECTION) ("Ank" . SPARSER::PROTEIN)
    ("BH4" . SPARSER::PROTEIN-FAMILY) ("CD –" . SPARSER::PROTEIN)
    ("SP 5" . SPARSER::PROTEIN) ("ankyrin repeat" . SPARSER::PROTEIN)
    ("a beta" . SPARSER::PROTEIN) ("TP53BP2" . SPARSER::PROTEIN)
    ("ASPP1" . SPARSER::PROTEIN) ("ASPP2" . SPARSER::PROTEIN)
    ("a region around WNT4" . SPARSER::PROTEIN)
    ("1.17 and 1.17" . SPARSER::PROTEIN) ("case  " . SPARSER::PROTEIN)
    ("LCF" . SPARSER::PROTEIN) ("strong LD" . SPARSER::PROTEIN)
    ("unfortunately neither SNP" . SPARSER::PROTEIN)
    ("LINC00339 and CDC42" . SPARSER::COLLECTION)
    ("MTMR7 and SLC7A2" . SPARSER::COLLECTION) ("HAP-1" . SPARSER::PROTEIN)
    ("HAP-1  " . SPARSER::PROTEIN)
    ("this biological evidence both CDC42 and LINC00339" . SPARSER::COLLECTION)
    ("CDC42 and LINC00339" . SPARSER::COLLECTION)
    ("HSPC" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LINC00339" . SPARSER::PROTEIN)
    ("LINC00339-WNT4" . SPARSER::PROTEIN-PAIR) ("meta  " . SPARSER::PROTEIN)
    ("IBS" . SPARSER::DRUG) ("BAS" . SPARSER::PROTEIN)
    ("fetuses" . SPARSER::PROTEIN) ("pelvic pain" . SPARSER::PROTEIN)
    ("a 150 kb region around WNT4" . SPARSER::PROTEIN)
    ("RNF144B-ID4" . SPARSER::COLLECTION) ("p22" . SPARSER::PROTEIN)
    ("RND3-RBM43" . SPARSER::COLLECTION) ("LINC" . SPARSER::PROTEIN)
    ("both cyclic and chronic pelvic pain" . SPARSER::PROTEIN)
    ("ENDO1" . SPARSER::PROTEIN) ("let -7" . SPARSER::RNA)
    ("SLC7A2" . SPARSER::PROTEIN) ("MTMR7" . SPARSER::PROTEIN)
    ("Cell division cycle 42" . SPARSER::PROTEIN) ("IL33" . SPARSER::PROTEIN)
    ("CDKN2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDC42" . SPARSER::PROTEIN)
    ("ID4" . SPARSER::PROTEIN) ("RNF144B" . SPARSER::PROTEIN)
    ("RBM43" . SPARSER::PROTEIN) ("RND3" . SPARSER::PROTEIN)
    ("WNT4" . SPARSER::PROTEIN)
    ("VSV or the ICP0-null HSV-1 mutant" . SPARSER::COLLECTION)
    ("VSV or an ICP0-null mutant" . SPARSER::COLLECTION)
    ("antiviral cytokines" . SPARSER::PROTEIN)
    ("mechanisms not involving viral oncogenes" . SPARSER::ONCOGENE)
    ("viral mRNAs" . SPARSER::PROTEIN) ("eIF2α" . SPARSER::PROTEIN)
    ("these viral proteins" . SPARSER::PROTEIN)
    ("proteins, p53 and pRb" . SPARSER::COLLECTION)
    ("viral and cellular oncoproteins" . SPARSER::PROTEIN)
    ("Media" . SPARSER::PROTEIN) ("a strong inducer" . SPARSER::PROTEIN)
    ("IFN and other antiviral cytokines" . SPARSER::COLLECTION)
    ("other antiviral cytokines" . SPARSER::PROTEIN)
    ("an IFN-induced antiviral state" . SPARSER::BIO-STATE)
    ("ectopically expressed hTERT" . SPARSER::PROTEIN)
    ("expressed hTERT" . SPARSER::PROTEIN)
    ("exogenous hTERT" . SPARSER::PROTEIN)
    ("hTERT and hygromycin" . SPARSER::COLLECTION)
    ("a longer period" . SPARSER::PROTEIN) ("HEL-TERTs" . SPARSER::COLLECTION)
    ("other essential telomerase subunits" . SPARSER::FRAGMENT)
    ("expressing hTERT" . SPARSER::PROTEIN) ("IFNAR" . SPARSER::PROTEIN)
    ("cytokine and type 1" . SPARSER::COLLECTION)
    ("p53 and/or pRb" . SPARSER::COLLECTION)
    ("the simian virus 40 (SV40) large T antigen" . SPARSER::MOLECULE)
    ("E6 and E7" . SPARSER::COLLECTION)
    ("DNA primase and DNA polymerase" . SPARSER::COLLECTION)
    ("TERC" . SPARSER::PROTEIN) ("repetitive nucleoprotein" . SPARSER::PROTEIN)
    ("simian virus 40 (SV40) large T-antigen" . SPARSER::PROTEIN)
    ("the viral oncoprotein" . SPARSER::PROTEIN)
    ("HEL-TERT" . SPARSER::COLLECTION) ("HEL" . SPARSER::PROTEIN)
    ("RNA-" . SPARSER::RNA) ("viral oncogenes" . SPARSER::ONCOGENE)
    ("IFI16" . SPARSER::PROTEIN) ("E1B" . SPARSER::PROTEIN)
    ("IFIT2" . SPARSER::PROTEIN) ("IFIT1" . SPARSER::PROTEIN)
    ("ISG15" . SPARSER::PROTEIN)
    ("reverse-transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("O14746" . SPARSER::PROTEIN) ("ICP0" . SPARSER::PROTEIN)
    ("DNA primase" . SPARSER::PROTEIN) ("T-antigen" . SPARSER::PROTEIN)
    ("siRNA, HB-EGF and BTC" . SPARSER::COLLECTION)
    ("RhoA, Arf6 or flotillin1/2" . SPARSER::COLLECTION)
    ("BTC and HB-EGF" . SPARSER::COLLECTION)
    ("AR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TGF- α-" . SPARSER::PROTEIN)
    ("BTC-" . SPARSER::PROTEIN)
    ("EGF, TGF-α, HB-EGF or BTC" . SPARSER::COLLECTION)
    ("receptor and caveolin" . SPARSER::COLLECTION)
    ("caveolin" . SPARSER::PROTEIN) ("filipin" . SPARSER::MOLECULE)
    ("Filipin" . SPARSER::MOLECULE)
    ("transferrin and EGF" . SPARSER::COLLECTION)
    ("Dynamin" . SPARSER::PROTEIN) ("a fluorescent dextran" . SPARSER::DEXTRAN)
    ("EGF, TGF- α , HB-EGF or BTC" . SPARSER::COLLECTION)
    ("amiloride" . SPARSER::DRUG) ("NR6, COS7 and PANC1" . SPARSER::COLLECTION)
    ("NR6" . SPARSER::PROTEIN) ("Amiloride" . SPARSER::DRUG)
    ("EGF, TGF- α or BTC" . SPARSER::COLLECTION)
    ("EGFR and EEA1" . SPARSER::COLLECTION)
    ("EGFR and the endosomal marker EEA1" . SPARSER::COLLECTION)
    ("EGF and TGF- α" . SPARSER::COLLECTION)
    ("weak inducers" . SPARSER::MOLECULE)
    ("EGF, TGF-a, HB-EGF and BTC" . SPARSER::COLLECTION)
    ("EGF- and TGF- α" . SPARSER::COLLECTION)
    ("EGF, TGF- α , HB-EGF and BTC" . SPARSER::COLLECTION)
    ("AR and EPI" . SPARSER::COLLECTION) ("AR or EPI" . SPARSER::COLLECTION)
    ("clathrin siRNA and these ligands" . SPARSER::COLLECTION)
    ("EGF or TGF-α" . SPARSER::COLLECTION) ("CHC" . SPARSER::PROTEIN)
    ("Clathrin" . SPARSER::PROTEIN) ("HB-EGF or BTC" . SPARSER::COLLECTION)
    ("different ligands and inhibition of several endocytic pathways"
     . SPARSER::COLLECTION)
    ("TGF- α and EPI" . SPARSER::COLLECTION) ("HB-EGF-" . SPARSER::PROTEIN)
    ("epiregulin (EPI)" . SPARSER::PROTEIN)
    ("amphiregulin (AR)" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF)" . SPARSER::PROTEIN)
    ("epigen and neuregulin2-" . SPARSER::COLLECTION)
    ("neuregulin2-" . SPARSER::PROTEIN)
    ("transforming growth factor-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EPI" . SPARSER::PROTEIN) ("So far eight ligands" . SPARSER::LIGAND)
    ("receptor tyrosine kinase (RTK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HB-EGF and BTC" . SPARSER::COLLECTION)
    ("EGF and TGF-α" . SPARSER::COLLECTION) ("dynamin" . SPARSER::PROTEIN)
    ("EGF- and TGF-α-stimulated receptor" . SPARSER::COLLECTION)
    ("heparin-binding EGF-like growth factor (HB-EGF) or betacellulin (BTC)"
     . SPARSER::COLLECTION)
    ("EGF-" . SPARSER::PROTEIN) ("BTC" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF) and transforming growth factor-α (TGF-α)"
     . SPARSER::COLLECTION)
    ("IgG2A" . SPARSER::PROTEIN) ("I-EGF" . SPARSER::PROTEIN)
    ("flotillin2" . SPARSER::PROTEIN) ("Caveolin1" . SPARSER::PROTEIN)
    ("PANC1" . SPARSER::PROTEIN) ("COS7" . SPARSER::PROTEIN)
    ("TGF-a" . SPARSER::PROTEIN) ("flotillin1" . SPARSER::PROTEIN)
    ("Arf6" . SPARSER::PROTEIN) ("caveolin1" . SPARSER::PROTEIN)
    ("neuregulin2" . SPARSER::PROTEIN) ("TGF- α" . SPARSER::PROTEIN)
    ("JAK1 and TYK2" . SPARSER::COLLECTION)
    ("IL-10RA and IL-10RB" . SPARSER::COLLECTION)
    ("a multifunctional cytokine" . SPARSER::PROTEIN)
    ("IL-10 and its receptors" . SPARSER::COLLECTION)
    ("LBL" . SPARSER::PROTEIN) ("TYK2 and JAK1" . SPARSER::COLLECTION)
    ("JAK2 or JAK3" . SPARSER::COLLECTION)
    ("JAK2 and JAK3" . SPARSER::COLLECTION) ("pan-JAK" . SPARSER::COLLECTION)
    ("an alternative tyrosine kinase" . SPARSER::PROTEIN)
    ("TEL-ABL" . SPARSER::COLLECTION) ("TEL-JAK3" . SPARSER::COLLECTION)
    ("TEL-JAK2" . SPARSER::COLLECTION) ("TEL-JAK1" . SPARSER::COLLECTION)
    ("TEL" . SPARSER::PROTEIN) ("IL6R and IL23R" . SPARSER::COLLECTION)
    ("IFNAR1, IFNAR2, IL6ST, IL11RA, IL12RB1, IL12RB2 and IL27RA"
     . SPARSER::COLLECTION)
    ("IL-10, IL10RA or IL10RB" . SPARSER::COLLECTION)
    ("IL10RA and IL10RB" . SPARSER::COLLECTION)
    ("CD3 and GFP" . SPARSER::COLLECTION) ("a rare SNP" . SPARSER::PROTEIN)
    ("pro-apoptotic BCL2 family proteins" . SPARSER::PROTEIN)
    ("proteins and IAP" . SPARSER::COLLECTION)
    ("TYK2 and STAT1" . SPARSER::COLLECTION)
    ("TYK2 or STAT1" . SPARSER::COLLECTION)
    ("STAT1 and STAT2" . SPARSER::COLLECTION)
    ("NUP214-ABL" . SPARSER::COLLECTION) ("ABL" . SPARSER::PROTEIN)
    ("an attractive candidate effector" . SPARSER::EFFECTOR)
    ("STAT1 and BCL2" . SPARSER::COLLECTION)
    ("TYK2 or control siRNA ex vivo" . SPARSER::COLLECTION)
    ("TALL-1" . SPARSER::PROTEIN)
    ("multiple lentiviral shRNA" . SPARSER::PROTEIN)
    ("JAK1, JAK2, JAK3 or TYK2" . SPARSER::COLLECTION)
    ("JURKAT" . SPARSER::PROTEIN)
    ("foreign antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TLX3/HOX11L2" . SPARSER::COLLECTION) ("TLX1/HOX11" . SPARSER::COLLECTION)
    ("MYB" . SPARSER::PROTEIN)
    ("the pathogenic tyrosine kinases" . SPARSER::KINASE)
    ("TYK2 and other components" . SPARSER::COLLECTION)
    ("TYK2-STAT1-BCL2" . SPARSER::COLLECTION)
    ("TYK2-STAT1" . SPARSER::COLLECTION) ("IL-7" . SPARSER::PROTEIN)
    ("G -3" . SPARSER::PROTEIN) ("MS5" . SPARSER::PROTEIN)
    ("EA6" . SPARSER::PROTEIN) ("K-RAS" . SPARSER::PROTEIN)
    ("LMTK3" . SPARSER::PROTEIN) ("EPHA5" . SPARSER::PROTEIN)
    ("CD7" . SPARSER::PROTEIN) ("CD2" . SPARSER::PROTEIN)
    ("Il2rg" . SPARSER::PROTEIN) ("IL-10RB" . SPARSER::PROTEIN)
    ("IL-10RA" . SPARSER::PROTEIN) ("Tyk2" . SPARSER::PROTEIN)
    ("ABT-737" . SPARSER::DRUG) ("IL23R" . SPARSER::PROTEIN)
    ("IL6R" . SPARSER::PROTEIN) ("IL27RA" . SPARSER::PROTEIN)
    ("IL12RB2" . SPARSER::PROTEIN) ("IL12RB1" . SPARSER::PROTEIN)
    ("IL11RA" . SPARSER::PROTEIN) ("IFNAR2" . SPARSER::PROTEIN)
    ("IFNAR1" . SPARSER::PROTEIN) ("IL10RB" . SPARSER::PROTEIN)
    ("IL10RA" . SPARSER::PROTEIN) ("IL-10R" . SPARSER::PROTEIN)
    ("IL-23" . SPARSER::PROTEIN) ("pro-B" . SPARSER::DRUG)
    ("NUP214" . SPARSER::PROTEIN) ("IL-7R" . SPARSER::PROTEIN)
    ("STAT2" . SPARSER::PROTEIN) ("tyrosine kinase 2" . SPARSER::PROTEIN)
    ("NOTCH1" . SPARSER::PROTEIN) ("HOX11L2" . SPARSER::PROTEIN)
    ("TLX3" . SPARSER::PROTEIN) ("HOX11" . SPARSER::PROTEIN)
    ("TLX1" . SPARSER::PROTEIN) ("LYL1" . SPARSER::PROTEIN)
    ("TAL1" . SPARSER::PROTEIN) ("the homozygous mutant" . SPARSER::MUTANT)
    ("relevant target genes" . SPARSER::GENE)
    ("classical hormone nuclear receptors" . SPARSER::RECEPTOR)
    ("separate genes" . SPARSER::GENE) ("ER-α and ER-β" . SPARSER::COLLECTION)
    ("ESR1 and ESR2" . SPARSER::COLLECTION) ("ERs" . SPARSER::PROTEIN)
    ("T-A" . SPARSER::PROTEIN) ("A-F" . SPARSER::PROTEIN)
    ("ESR2" . SPARSER::PROTEIN) ("ER-β" . SPARSER::PROTEIN)
    ("ER-α" . SPARSER::PROTEIN) ("AXL and HGF" . SPARSER::COLLECTION)
    ("AXL" . SPARSER::PROTEIN) ("HER2 or MET" . SPARSER::COLLECTION)
    ("pre" . SPARSER::PROTEIN) ("e-cadherin or vimentin" . SPARSER::COLLECTION)
    ("MET and HER2 and sequenom" . SPARSER::COLLECTION)
    ("HER2 and sequenom" . SPARSER::COLLECTION)
    ("continued EGFR TKI" . SPARSER::PROTEIN)
    ("previously published EGFR mutant cohorts" . SPARSER::MOLECULE)
    ("cisplatin and etoposide" . SPARSER::COLLECTION)
    ("PIK3CA, AKT1, BRAF, HER2, MEK1, NRAS and KRAS" . SPARSER::COLLECTION)
    ("MEK1 , NRAS or KRAS" . SPARSER::COLLECTION)
    ("no residual adenocarcinoma component" . SPARSER::COMPONENT)
    ("PIK3CA, AKT1, BRAF, ERBB2, MEK1, NRAS and KRAS" . SPARSER::COLLECTION)
    ("vimentin or E-cadherin" . SPARSER::COLLECTION)
    ("synaptophysin, chromogranin, and CD56" . SPARSER::COLLECTION)
    ("chromogranin" . SPARSER::PROTEIN) ("pre-TKI" . SPARSER::PROTEIN-PAIR)
    ("the previously present EGFR" . SPARSER::PROTEIN)
    ("erlotinib and gefitinib" . SPARSER::COLLECTION)
    ("PIK3CA, AKT1, BRAF, ERBB2, KRAS, MEK1 , or NRAS" . SPARSER::COLLECTION)
    ("EGFR, AKT1, BRAF, ERBB2, KRAS, MEK1, NRAS and PIK3CA , and FISH"
     . SPARSER::COLLECTION)
    ("PIK3CA , and FISH" . SPARSER::COLLECTION)
    ("MET and HER2" . SPARSER::COLLECTION) ("e-cadherin" . SPARSER::PROTEIN)
    ("another optimal target" . SPARSER::TARGET-PROTEIN)
    ("a further downstream component" . SPARSER::COMPONENT)
    ("the downstream effectors recently shown to be mutated"
     . SPARSER::EFFECTOR)
    ("AKT1 and AKT2" . SPARSER::COLLECTION)
    ("Lyn, P-Rex2, Jag2, Map3K10, and Bcl3" . SPARSER::COLLECTION)
    ("Map3K10" . SPARSER::PROTEIN) ("Jag2" . SPARSER::PROTEIN)
    ("K10" . SPARSER::PROTEIN) ("Map3" . SPARSER::PROTEIN)
    ("P-Rex2" . SPARSER::PROTEIN) ("cc1" . SPARSER::PROTEIN)
    ("Delta-" . SPARSER::PROTEIN) ("ZNF217" . SPARSER::PROTEIN)
    ("domain 1" . SPARSER::PROTEIN) ("alpha-" . SPARSER::PROTEIN)
    ("ERK/NF-kB" . SPARSER::COLLECTION) ("MAPKs/JNK/ERK" . SPARSER::COLLECTION)
    ("JNK and ERK" . SPARSER::COLLECTION) ("Ras/MEK/ERK" . SPARSER::COLLECTION)
    ("factors, NF-kB and c-Jun" . SPARSER::COLLECTION)
    ("p65 and miR-21" . SPARSER::COLLECTION)
    ("ERK and IKK" . SPARSER::COLLECTION)
    ("c-Jun and miR-21" . SPARSER::COLLECTION)
    ("factors, NF-κB and c-Jun" . SPARSER::COLLECTION)
    ("Pdcd4, Pten and Spry1" . SPARSER::COLLECTION)
    ("PI-3K/Akt" . SPARSER::COLLECTION) ("RAS/ERK" . SPARSER::COLLECTION)
    ("Ras-MAPKs" . SPARSER::COLLECTION)
    ("JNK, ERK, Akt, NF-κB, and c-Jun" . SPARSER::COLLECTION)
    ("MAPKs, PI-3Ks, NF-κB, and c-Jun" . SPARSER::COLLECTION)
    ("pIRES-Spry1" . SPARSER::PROTEIN-PAIR)
    ("JNK and c-Jun" . SPARSER::COLLECTION)
    ("Spry1 and Pdcd4" . SPARSER::COLLECTION)
    ("p65 and c- Jun" . SPARSER::COLLECTION)
    ("arsenite, NF-κB and c-Jun" . SPARSER::COLLECTION)
    ("p65 or c-Jun" . SPARSER::COLLECTION)
    ("p65 and c-Jun" . SPARSER::COLLECTION)
    ("JNK or ERK" . SPARSER::COLLECTION) ("ERK or JNK" . SPARSER::COLLECTION)
    ("SP600125 or U0126" . SPARSER::COLLECTION)
    ("p-NF-κB-p65" . SPARSER::COLLECTION)
    ("MAPKs and PI-3Ks" . SPARSER::COLLECTION)
    ("p-c-Jun" . SPARSER::COLLECTION) ("p-NF-κB" . SPARSER::COLLECTION)
    ("p-JNK" . SPARSER::COLLECTION) ("Ras-ERK/MAPKs" . SPARSER::COLLECTION)
    ("specially Spry1 and Spry2 isoforms" . SPARSER::ISOFORM)
    ("Spry genes" . SPARSER::GENE) ("Spry1 and Spry2" . SPARSER::COLLECTION)
    ("Pdcd4, and Pdcd4" . SPARSER::COLLECTION)
    ("both a target and a regulator" . SPARSER::COLLECTION)
    ("Pdcd4 and Spry1" . SPARSER::COLLECTION)
    ("JNK/c-Jun" . SPARSER::COLLECTION) ("c- Jun" . SPARSER::PROTEIN)
    ("PI-3Ks" . SPARSER::HUMAN-PROTEIN-FAMILY) ("spry1" . SPARSER::PROTEIN)
    ("NaAsO 2" . SPARSER::DRUG) ("Spry2" . SPARSER::PROTEIN)
    ("hematopoietic progenitor kinase" . SPARSER::PROTEIN)
    ("MAP4K1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase kinase kinase kinase 1"
     . SPARSER::PROTEIN)
    ("Pdcd 4" . SPARSER::PROTEIN) ("Pdcd4" . SPARSER::PROTEIN)
    ("Spry1" . SPARSER::PROTEIN) ("EGFR and Erk1/2" . SPARSER::COLLECTION)
    ("SRC" . SPARSER::PROTEIN) ("SRCIN1 and TCAP" . SPARSER::COLLECTION)
    ("FMR1, SRCIN1 and TCAP" . SPARSER::COLLECTION)
    ("RRM2 , UBE2T and EXO1" . SPARSER::COLLECTION) ("PAM" . SPARSER::PROTEIN)
    ("The most relevant gene" . SPARSER::GENE) ("only 3 genes" . SPARSER::GENE)
    ("PIGK" . SPARSER::PROTEIN)
    ("BRCA1 , BRCA2, TP53 or CHEK2" . SPARSER::COLLECTION)
    ("pR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TN and HR" . SPARSER::COLLECTION)
    ("FMR1 and TMPO" . SPARSER::COLLECTION)
    ("SRCIN1 , TCAP , ZNF396 , IFT140 , FRY and TRAF3IP1"
     . SPARSER::COLLECTION)
    ("TMPO" . SPARSER::PROTEIN) ("whose germline UV" . SPARSER::PROTEIN)
    ("BRCA1, BRCA2 , TP53 and CHEK2" . SPARSER::COLLECTION)
    ("BRCA2 and TP53" . SPARSER::COLLECTION)
    ("BRCA2 or TP53" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 , TP53 and CHEK2" . SPARSER::COLLECTION)
    ("ER/PR" . SPARSER::COLLECTION) ("Receptor and HER2" . SPARSER::COLLECTION)
    ("Hormone" . SPARSER::PROTEIN) ("FH" . SPARSER::PROTEIN)
    ("SCNA" . SPARSER::PROTEIN) ("receptors and HER2" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 and TP53" . SPARSER::COLLECTION)
    ("cardiac muscle" . SPARSER::PROTEIN) ("SRC kinase" . SPARSER::PROTEIN)
    ("p140CAP" . SPARSER::PROTEIN) ("UBE2T" . SPARSER::PROTEIN)
    ("RRM2" . SPARSER::PROTEIN) ("ST6GALNAC5" . SPARSER::PROTEIN)
    ("ST6GALNAC3" . SPARSER::PROTEIN) ("p31" . SPARSER::PROTEIN)
    ("TRAF3IP1" . SPARSER::PROTEIN) ("IFT140" . SPARSER::PROTEIN)
    ("ZNF396" . SPARSER::PROTEIN) ("SRCIN1" . SPARSER::PROTEIN)
    ("FMR1" . SPARSER::PROTEIN) ("TM4" . SPARSER::PROTEIN)
    ("Cdk4/Cdk6" . SPARSER::COLLECTION) ("ARMS and ERMS" . SPARSER::COLLECTION)
    ("5 threonines and 10 serines" . SPARSER::COLLECTION)
    ("a polar amino acid such as aspartic acid" . SPARSER::AMINO-ACID)
    ("serine (S) or threonine (T)" . SPARSER::COLLECTION)
    ("a polar amino acid" . SPARSER::AMINO-ACID)
    ("expressed Cdk4" . SPARSER::PROTEIN) ("RD and JR-1" . SPARSER::COLLECTION)
    ("32% more active" . SPARSER::ACTIVE) ("17% less active" . SPARSER::ACTIVE)
    ("a phosphomimetic mutant" . SPARSER::MUTANT)
    ("Cdk4 or cyclin D1" . SPARSER::COLLECTION)
    ("the phosphor-specific antibody" . SPARSER::ANTIBODY)
    ("GFP-PFS430A" . SPARSER::COLLECTION) ("KS" . SPARSER::PROTEIN)
    ("GST-PAX3-FOXO1" . SPARSER::COLLECTION)
    ("Cdks" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GFP-PAX3-FOXO1" . SPARSER::COLLECTION)
    ("CPT1A and PTN" . SPARSER::COLLECTION) ("RD" . SPARSER::PROTEIN)
    ("PTN" . SPARSER::PROTEIN) ("CAS" . SPARSER::PROTEIN)
    ("PRS" . SPARSER::PROTEIN) ("/cyclin D1" . SPARSER::COLLECTION)
    ("INK4a/ARF" . SPARSER::COLLECTION) ("Pax3-foxo1" . SPARSER::COLLECTION)
    ("ectopically expressing PAX3-FOXO1" . SPARSER::COLLECTION)
    ("expressing PAX3-FOXO1" . SPARSER::COLLECTION) ("Rh30" . SPARSER::PROTEIN)
    ("Cdk4/cyclin D1" . SPARSER::COLLECTION)
    ("Ink4a/ARF" . SPARSER::COLLECTION) ("PAX3-FOXO1" . SPARSER::COLLECTION)
    ("PD0332991" . SPARSER::DRUG) ("Cdk6" . SPARSER::PROTEIN)
    ("p16 INK4a" . SPARSER::PROTEIN) ("P 250" . SPARSER::PROTEIN)
    ("glucose-6-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("CPT1A" . SPARSER::PROTEIN) ("Phenol red" . SPARSER::DRUG)
    ("foxo1" . SPARSER::PROTEIN) ("Pax3" . SPARSER::PROTEIN)
    ("Cdk4" . SPARSER::PROTEIN) ("PAX3" . SPARSER::PROTEIN)
    ("Stat5, Akt, and Erk" . SPARSER::COLLECTION)
    ("Vannucchi AM’s" . SPARSER::PROTEIN)
    ("P 25–" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immature platelets" . SPARSER::PROTEIN)
    ("Hemoglobin" . SPARSER::MOLECULE) ("EPOR" . SPARSER::PROTEIN)
    ("PLT" . SPARSER::PROTEIN) ("Ana" . SPARSER::PROTEIN)
    ("hemoglobin" . SPARSER::PROTEIN) ("TPOR" . SPARSER::PROTEIN)
    ("–P 75" . SPARSER::COLLECTION) ("MPV" . SPARSER::MOLECULE)
    ("LCR" . SPARSER::PROTEIN) ("RBC" . SPARSER::PROTEIN)
    ("CBC" . SPARSER::PROTEIN) ("MPDs" . SPARSER::PROTEIN)
    ("erythropoietin receptor" . SPARSER::PROTEIN) ("k−1" . SPARSER::PROTEIN)
    ("G-CSFR" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor receptor" . SPARSER::PROTEIN)
    ("thrombopoietin receptor" . SPARSER::PROTEIN)
    ("Janus kinase 2" . SPARSER::PROTEIN)
    ("P 75" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P 25" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Scaffold" . SPARSER::SCAFFOLD)
    ("Actin and/or Tubulin" . SPARSER::COLLECTION) ("oli" . SPARSER::PROTEIN)
    ("other constriction site-associated proteins" . SPARSER::PROTEIN)
    ("overexpressed Gas2l3" . SPARSER::PROTEIN) ("derivate" . SPARSER::PROTEIN)
    ("Spastin and the ESCRT-III complex subunit CHMP4b" . SPARSER::COLLECTION)
    ("Actin-filament" . SPARSER::COLLECTION)
    ("the protein’s" . SPARSER::PROTEIN)
    ("nearly all daughter-cell pairs overexpressing Gas2l3" . SPARSER::PROTEIN)
    ("overexpressing Gas2l3" . SPARSER::PROTEIN)
    ("Gas2l3-EGFP" . SPARSER::COLLECTION)
    ("constriction site-associated proteins" . SPARSER::PROTEIN)
    ("CHMP4b and Spastin" . SPARSER::COLLECTION) ("Spastin" . SPARSER::PROTEIN)
    ("the dense (and thus, less accessible for IF labeling) microtubules"
     . SPARSER::PROTEIN)
    ("IF" . SPARSER::PROTEIN) ("microtubules and Actin" . SPARSER::COLLECTION)
    ("CH and GAR" . SPARSER::COLLECTION)
    ("a Constriction Site-associated Protein" . SPARSER::PROTEIN)
    ("Myc-tagged Gas2l3 and either non-degradable Cyclin B1 (late mitosis [M])"
     . SPARSER::COLLECTION)
    ("Tome-1 and Securin" . SPARSER::COLLECTION)
    ("RO-3306 and roscovitine" . SPARSER::COLLECTION)
    ("roscovitine" . SPARSER::DRUG)
    ("the active APC/C Cdh1 complex" . SPARSER::BIO-COMPLEX)
    ("Geminin, Tome-1, and Gas2l3" . SPARSER::COLLECTION)
    ("-active" . SPARSER::ACTIVE) ("Cdc20 and APC/C" . SPARSER::COLLECTION)
    ("MBT" . SPARSER::PROTEIN)
    ("Cdc20 (at anaphase and early telophase) and Cdh1 (at late telophase and throughout G1)"
     . SPARSER::COLLECTION)
    ("Gas2l3 and Gas2l3-DM4" . SPARSER::COLLECTION)
    ("Gas2l3-DM3" . SPARSER::PROTEIN-PAIR) ("derivates" . SPARSER::PROTEIN)
    ("Arg and Leu" . SPARSER::COLLECTION) ("Gly and Val" . SPARSER::COLLECTION)
    ("KEN" . SPARSER::PROTEIN) ("Geminin and Tome-1" . SPARSER::COLLECTION)
    ("Emi1 or Securin" . SPARSER::COLLECTION) ("Geminin" . SPARSER::PROTEIN)
    ("a specific competitive inhibitor" . SPARSER::INHIBITOR)
    ("Securin" . SPARSER::PROTEIN)
    ("the mitotic cyclins and numerous other key cell cycle proteins"
     . SPARSER::COLLECTION)
    ("the mitotic cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hGas" . SPARSER::PROTEIN) ("commercial antibodies" . SPARSER::ANTIBODY)
    ("the mitotic Cyclin A2" . SPARSER::PROTEIN)
    ("the mitotic cyclin A2" . SPARSER::PROTEIN)
    ("GAS2, GAS2L1, and GAS2L3" . SPARSER::COLLECTION)
    ("pecific 2 - l ike protein 3" . SPARSER::PROTEIN)
    ("a Cell Cycle-regulated Protein and a Novel Substrate"
     . SPARSER::COLLECTION)
    ("a novel constriction site-associated protein and an APC/C Cdh1 target"
     . SPARSER::COLLECTION)
    ("a novel constriction site-associated protein" . SPARSER::PROTEIN)
    ("DREAM/E2F" . SPARSER::COLLECTION) ("DREAM" . SPARSER::PROTEIN)
    ("their Calponin homology (CH) and GA S2-" . SPARSER::COLLECTION)
    ("homology (CH)" . SPARSER::PROTEIN)
    ("pecific 2 - l ike (Gas2l) proteins" . SPARSER::PROTEIN)
    ("S2-" . SPARSER::MOLECULE) ("Calponin" . SPARSER::PROTEIN)
    ("filaments and microtubules" . SPARSER::COLLECTION)
    ("Plk1 and Aurora" . SPARSER::COLLECTION) ("Anillin" . SPARSER::PROTEIN)
    ("Anaphase-Promoting Complex/Cyclosome" . SPARSER::COLLECTION)
    ("Cyclosome" . SPARSER::PROTEIN) ("Cdh1" . SPARSER::PROTEIN)
    ("Cdh" . SPARSER::PROTEIN)
    ("Growth arrest-specific 2-like protein 3" . SPARSER::PROTEIN)
    ("Actin/Tubulin" . SPARSER::COLLECTION)
    ("Tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("αTubulin" . SPARSER::PROTEIN)
    ("1 L" . SPARSER::PROTEIN) ("Asc1" . SPARSER::PROTEIN)
    ("hCdh1" . SPARSER::PROTEIN) ("Cep55" . SPARSER::PROTEIN)
    ("MKLP1" . SPARSER::PROTEIN) ("CHMP4b" . SPARSER::PROTEIN)
    ("RO-3306" . SPARSER::DRUG) ("UbcH10" . SPARSER::PROTEIN)
    ("Ubch10" . SPARSER::PROTEIN) ("Cyclin B1" . SPARSER::PROTEIN)
    ("Tome-1" . SPARSER::PROTEIN) ("Cyclin A2" . SPARSER::PROTEIN)
    ("CCNA2" . SPARSER::PROTEIN) ("cyclin A2" . SPARSER::PROTEIN)
    ("GAS2" . SPARSER::PROTEIN) ("Gas2l2" . SPARSER::PROTEIN)
    ("Gas2l1" . SPARSER::PROTEIN) ("Gas2" . SPARSER::PROTEIN)
    ("2 - l" . SPARSER::PROTEIN) ("ESCRT-III" . SPARSER::PROTEIN-FAMILY)
    ("Plk1" . SPARSER::PROTEIN)
    ("Anaphase-Promoting Complex" . SPARSER::PROTEIN)
    ("Cdk1" . SPARSER::PROTEIN) ("Cdc20" . SPARSER::PROTEIN)
    ("linker protein" . SPARSER::PROTEIN) ("Gas2l3" . SPARSER::PROTEIN)
    ("Smad3 and ERK1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("ERK1/2, p38, and Smad3" . SPARSER::COLLECTION)
    ("ERK1/2 and Smad3" . SPARSER::COLLECTION)
    ("p38 and Smad3" . SPARSER::COLLECTION)
    ("p38, ERK1/2, and Smad3" . SPARSER::COLLECTION)
    ("SB203580 and PD98059" . SPARSER::COLLECTION)
    ("Smad and MAPK" . SPARSER::COLLECTION)
    ("MAPK and Smad" . SPARSER::COLLECTION)
    ("stromal TIMP-3" . SPARSER::PROTEIN)
    ("MMP-13 and CTGF" . SPARSER::COLLECTION)
    ("Smad3 and Smad7" . SPARSER::COLLECTION)
    ("type I and VII" . SPARSER::COLLECTION)
    ("collagen, aggrecan, PAI-1, and MMP-13" . SPARSER::COLLECTION)
    ("aggrecan" . SPARSER::PROTEIN) ("PAI-1 and TIMPs" . SPARSER::COLLECTION)
    ("the fibrillar collagens and fibronectin" . SPARSER::COLLECTION)
    ("collagens and fibronectin" . SPARSER::COLLECTION)
    ("proteinases and MMPs" . SPARSER::COLLECTION)
    ("p38, ERK1/2 and Smad3" . SPARSER::COLLECTION)
    ("ERK1/2 and p38" . SPARSER::COLLECTION)
    ("Smad3 and Smad4" . SPARSER::COLLECTION)
    ("MAPK and Smad3" . SPARSER::COLLECTION)
    ("PD98059 and SB203580" . SPARSER::COLLECTION)
    ("ERK1/2, and SB203580" . SPARSER::COLLECTION) ("CTGF" . SPARSER::PROTEIN)
    ("e.g. MAPK pathways p38, ERK1/2, and JNK" . SPARSER::COLLECTION)
    ("p38, ERK1/2, and JNK" . SPARSER::COLLECTION)
    ("Smad, Smad7, and Smad3DN" . SPARSER::COLLECTION)
    ("TIMP-3 or PAI-1" . SPARSER::COLLECTION)
    ("HA-Smad4" . SPARSER::COLLECTION)
    ("TIMP-3 and PAI-1" . SPARSER::COLLECTION)
    ("TIMP-3, TIMP-1, and PAI-1" . SPARSER::COLLECTION)
    ("TGF-β2 and TGF-β3" . SPARSER::COLLECTION)
    ("TIMP-1 and TIMP-3" . SPARSER::COLLECTION)
    ("Smad3, p38, and ERK1/2" . SPARSER::COLLECTION)
    ("ERK1/2, JNK, and p38 MAPKs" . SPARSER::COLLECTION)
    ("Smad2 or Smad3" . SPARSER::COLLECTION)
    ("Smad and mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("a multifunctional growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("converting enzyme (TACE)" . SPARSER::PROTEIN)
    ("ADAM-TS5 (aggrecanase-2)" . SPARSER::COLLECTION)
    ("ADAM" . SPARSER::PROTEIN) ("TACE" . SPARSER::PROTEIN)
    ("TIMP-2, TIMP-3, and TIMP-4" . SPARSER::COLLECTION)
    ("Disintegrin And Metalloprotease" . SPARSER::COLLECTION)
    ("Metalloprotease" . SPARSER::PROTEIN) ("Disintegrin" . SPARSER::PROTEIN)
    ("proteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("soluble form" . SPARSER::FORM)
    ("TIMP-1, TIMP-2, TIMP-3, and TIMP-4" . SPARSER::COLLECTION)
    ("MMPs non-covalently in 1∶1 stoichiometric complexes"
     . SPARSER::BIO-COMPLEX)
    ("TIMPs" . SPARSER::PROTEIN)
    ("proteinases and their inhibitors" . SPARSER::COLLECTION)
    ("Smad3, p38α, and ERK1/2" . SPARSER::COLLECTION)
    ("p38α and ERK1/2" . SPARSER::COLLECTION)
    ("p38 and ERK1/2" . SPARSER::COLLECTION)
    ("PD98059 and p38" . SPARSER::COLLECTION)
    ("ERK1/2 and p38 MAPK" . SPARSER::COLLECTION)
    ("Smad7 and dominant negative Smad3" . SPARSER::COLLECTION)
    ("an ECM-associated specific inhibitor" . SPARSER::INHIBITOR)
    ("proteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein phosphatase 2A" . SPARSER::PROTEIN)
    ("connective tissue growth factor" . SPARSER::PROTEIN)
    ("TGF-β3" . SPARSER::PROTEIN) ("TGF-β2" . SPARSER::PROTEIN)
    ("5 (aggrecanase-2)" . SPARSER::PROTEIN)
    ("converting enzyme" . SPARSER::PROTEIN) ("ADAM-17" . SPARSER::PROTEIN)
    ("ADAM-10" . SPARSER::PROTEIN) ("TIMP-4" . SPARSER::PROTEIN)
    ("TIMP-2" . SPARSER::PROTEIN) ("MKK3" . SPARSER::PROTEIN)
    ("p38α" . SPARSER::PROTEIN) ("TIMP-3" . SPARSER::PROTEIN)
    ("Tissue inhibitor of metalloproteinases" . SPARSER::PROTEIN)
    ("Plasmin" . SPARSER::PROTEIN) ("uPAR" . SPARSER::PROTEIN)
    ("MMPs, MMP-2 and MMP-9" . SPARSER::COLLECTION)
    ("matrix metalloproteinases (MMPs) and urokinase-type plasminogen activator (uPA)"
     . SPARSER::COLLECTION)
    ("Notch3 and COX-2" . SPARSER::COLLECTION) ("IC" . SPARSER::PROTEIN)
    ("E-cadherin and CD44v6" . SPARSER::COLLECTION)
    ("Notch1 or Notch3 and CD44v6" . SPARSER::COLLECTION)
    ("Notch3 and CD44v6" . SPARSER::COLLECTION)
    ("Notch3 and E-cadherin" . SPARSER::COLLECTION)
    ("integrins, cadherins, selectins, immunoglobulins, and proteoglycans"
     . SPARSER::COLLECTION)
    ("immunoglobulins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("selectins" . SPARSER::PROTEIN)
    ("Prognostic molecular biomarkers" . SPARSER::MOLECULE)
    ("suppressor or oncogene" . SPARSER::COLLECTION)
    ("negative and positive modifiers" . SPARSER::MOLECULE)
    ("COX-2 and p-ERK1/2" . SPARSER::COLLECTION)
    ("p-ERK1/2" . SPARSER::PROTEIN) ("COX-2 or ERK1/2" . SPARSER::COLLECTION)
    ("MMP-2, MMP-9, and uPA" . SPARSER::COLLECTION)
    ("metastasis-associated molecules" . SPARSER::MOLECULE)
    ("clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Neither Notch1 nor Notch3" . SPARSER::COLLECTION)
    ("T cell acute lymphoblastic leukemia" . SPARSER::PROTEIN)
    ("COX-2 and ERK1/2" . SPARSER::COLLECTION)
    ("Notch1 or Notch3" . SPARSER::COLLECTION)
    ("MMP-9, and urokinase-type plasminogen activator" . SPARSER::COLLECTION)
    ("anti-Notch1 or -Notch3 antibody" . SPARSER::COLLECTION)
    ("-Notch3" . SPARSER::COLLECTION)
    ("Notch1 and Notch3" . SPARSER::COLLECTION)
    ("Notch1 intracellular domain" . SPARSER::PROTEIN)
    ("Notch4" . SPARSER::PROTEIN) ("Notch2" . SPARSER::PROTEIN)
    ("NS-398" . SPARSER::DRUG) ("p-ERK1" . SPARSER::PROTEIN)
    ("extracellular signal-regulated kinase 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Stavudine" . SPARSER::DRUG)
    ("5,10-methylene tetrahydrofolate and deoxyuridine monophosphate xref"
     . SPARSER::COLLECTION)
    ("the inhibitory ternary complex" . SPARSER::BIO-COMPLEX)
    ("hemochromatosis" . SPARSER::PROTEIN)
    ("CTR or SPINK-1" . SPARSER::COLLECTION)
    ("CTR and SPINK-1" . SPARSER::COLLECTION)
    ("mitochondrially-toxic drugs" . SPARSER::DRUG)
    ("other neuropathic drugs" . SPARSER::DRUG) ("isoniazid" . SPARSER::DRUG)
    ("d4T and ddI" . SPARSER::COLLECTION) ("more toxic drugs" . SPARSER::DRUG)
    ("cystic fibrosis trans-membrane conductance regulator (CTR)"
     . SPARSER::REGULATOR)
    ("regulator (CTR)" . SPARSER::REGULATOR) ("CTR" . SPARSER::PROTEIN)
    ("ddI and hydroxyurea" . SPARSER::COLLECTION)
    ("didanosine" . SPARSER::DRUG) ("EFV" . SPARSER::MOLECULE)
    ("ddI" . SPARSER::DRUG) ("antiretroviral drugs" . SPARSER::DRUG)
    ("PY" . SPARSER::MOLECULE)
    ("zidovudine (AZT) and stavudine (d4T)" . SPARSER::COLLECTION)
    ("zidovudine" . SPARSER::DRUG) ("NRTI" . SPARSER::DRUG)
    ("TS and MTHFR" . SPARSER::COLLECTION)
    ("TS and methylene-tetrahydrofolate reductase (MTHFR) gene polymorphisms"
     . SPARSER::COLLECTION)
    ("MTHFR" . SPARSER::PROTEIN) ("tetrahydrofolate" . SPARSER::MOLECULE)
    ("stavudine" . SPARSER::DRUG) ("MTND2" . SPARSER::PROTEIN)
    ("USF-1" . SPARSER::PROTEIN)
    ("nucleoside reverse transcriptase inhibitor" . SPARSER::DRUG)
    ("d4T" . SPARSER::DRUG)
    ("PLCγ, ERK, and cyclooxygenase-2" . SPARSER::COLLECTION)
    ("ZEB1 or SNAIL" . SPARSER::COLLECTION) ("SNAIL" . SPARSER::PROTEIN)
    ("appropriate biomarkers" . SPARSER::MOLECULE)
    ("FGFR1 and EMT" . SPARSER::COLLECTION) ("FGFR3-" . SPARSER::PROTEIN)
    ("FGFR-1 or FGFR-3" . SPARSER::COLLECTION)
    ("FGFR-1 or -3" . SPARSER::COLLECTION)
    ("luciferase and red fluorescent protein (RFP)" . SPARSER::COLLECTION)
    ("red fluorescent protein (RFP)" . SPARSER::PROTEIN)
    ("bFGF or FGFR1" . SPARSER::COLLECTION)
    ("lentiviral shRNAs" . SPARSER::PROTEIN)
    ("bFGF/FGFR1" . SPARSER::COLLECTION)
    ("bFGF and FGFR1" . SPARSER::COLLECTION)
    ("FGFR1 and bFGF" . SPARSER::COLLECTION)
    ("FGFR3 or FGFR1" . SPARSER::COLLECTION)
    ("the 4 FGFRs and the dominant cancer-associated ligand (FGF-2/basic FGF)"
     . SPARSER::COLLECTION)
    ("the dominant cancer-associated ligand" . SPARSER::LIGAND)
    ("bFGF/FGFR" . SPARSER::COLLECTION)
    ("FGFR3 and FGFR1" . SPARSER::COLLECTION)
    ("wild-type FGFRs and the most common mutant form" . SPARSER::COLLECTION)
    ("very attractive candidate targets" . SPARSER::TARGET-PROTEIN)
    ("ZEB1 and vimentin" . SPARSER::COLLECTION)
    ("E-cadherin-" . SPARSER::PROTEIN) ("FGFR1 or FGFR3" . SPARSER::COLLECTION)
    ("FGFR-3" . SPARSER::PROTEIN) ("FGFR-1" . SPARSER::PROTEIN)
    ("HLA-C" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("carbon monoxide" . SPARSER::MOLECULE) ("TP63" . SPARSER::PROTEIN)
    ("cyclophilin A" . SPARSER::PROTEIN)
    ("Fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("more distal downstream targets" . SPARSER::TARGET-PROTEIN)
    ("GSK3 and FOXO" . SPARSER::COLLECTION)
    ("GSK3, FOXO1 and p70S6K" . SPARSER::COLLECTION)
    ("IRS1-PKB" . SPARSER::COLLECTION) ("severe IR" . SPARSER::PROTEIN)
    ("IRS-PI3K-PKB" . SPARSER::COLLECTION)
    ("IRS1 or IRS2" . SPARSER::COLLECTION)
    ("compensatory insulin" . SPARSER::PROTEIN)
    ("IRS1 and PKB" . SPARSER::COLLECTION)
    ("post-absorptive" . SPARSER::COLLECTION) ("absorptive" . SPARSER::PROTEIN)
    ("p42/p44" . SPARSER::COLLECTION)
    ("GSK3 and ribosomal S6 protein" . SPARSER::COLLECTION)
    ("ribosomal S6 protein" . SPARSER::PROTEIN)
    ("p42 MAPK and p44 MAPK" . SPARSER::COLLECTION)
    ("post-insulin" . SPARSER::COLLECTION)
    ("PKB and p42/44" . SPARSER::COLLECTION) ("PI3K-PKB" . SPARSER::COLLECTION)
    ("PI-3 kinase and PKB" . SPARSER::COLLECTION)
    ("p42/p44 MAPK" . SPARSER::COLLECTION) ("PI-3K/PKB" . SPARSER::COLLECTION)
    ("IRSs" . SPARSER::PROTEIN)
    ("a common pathophysiological state" . SPARSER::BIO-STATE)
    ("obesity associated IR" . SPARSER::PROTEIN)
    ("IRS1, PKB, or p42/44" . SPARSER::COLLECTION)
    ("the insulin receptor substrate 1 (IRS1) adaptor protein and downstream effectors"
     . SPARSER::COLLECTION)
    ("post-receptor" . SPARSER::COLLECTION) ("PKB beta" . SPARSER::PROTEIN)
    ("p42 MAPK" . SPARSER::PROTEIN) ("GSK-3" . SPARSER::PROTEIN)
    ("32P" . SPARSER::|32P|) ("Fatty Acid binding protein" . SPARSER::PROTEIN)
    ("ERK 1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p44 MAPK" . SPARSER::PROTEIN)
    ("p42" . SPARSER::PROTEIN) ("PI-3K" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p42/44" . SPARSER::PROTEIN)
    ("protein kinase B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the catalytically-competent PKCα molecules" . SPARSER::MOLECULE)
    ("moderately-differentiated tumors more frequently expressed PKCα protein"
     . SPARSER::PROTEIN)
    ("extracellular-matrix" . SPARSER::COLLECTION)
    ("different oncogenes and tumor suppressor genes xref"
     . SPARSER::COLLECTION)
    ("intestinal type" . TYPE)
    ("Intestinal type tumors more frequently expressed PKCα protein"
     . SPARSER::PROTEIN)
    ("promoter and tumor" . SPARSER::COLLECTION)
    ("a Significant Independent Prognostic Factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type and tumor" . SPARSER::COLLECTION)
    ("moderately-differentiated intestinal type tumors more frequently expressed PKCα protein"
     . SPARSER::PROTEIN)
    ("expressed PKCα protein" . SPARSER::PROTEIN) ("Histologic Type" . TYPE)
    ("Type" . TYPE) ("atypical forms" . SPARSER::FORM)
    ("calcium and phospholipids" . SPARSER::COLLECTION)
    ("classical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genes and oncogenes" . SPARSER::COLLECTION) ("histologic type" . TYPE)
    ("proteins, AKT2 and N-myc" . SPARSER::COLLECTION)
    ("Oncogene" . SPARSER::ONCOGENE)
    ("Hematoxylin and Eosin staining" . SPARSER::COLLECTION)
    ("endogenously expressing abundant AKT2" . SPARSER::PROTEIN)
    ("expressing abundant AKT2" . SPARSER::PROTEIN)
    ("AKT1, AKT2 or AKT3" . SPARSER::COLLECTION)
    ("AKT2 and N-myc" . SPARSER::COLLECTION)
    ("a dual inhibitor" . SPARSER::INHIBITOR)
    ("PI3K and mTOR" . SPARSER::COLLECTION)
    ("GPCRs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor (GPCR)" . SPARSER::RECEPTOR)
    ("GRP-R/AKT2/N-myc" . SPARSER::COLLECTION)
    ("GRP/GRP-R/AKT" . SPARSER::COLLECTION)
    ("AKT1 or AKT3" . SPARSER::COLLECTION) ("bombesin" . SPARSER::PROTEIN)
    ("GRP and its receptor" . SPARSER::COLLECTION)
    ("neuropeptides" . SPARSER::PROTEIN)
    ("GRP/GRP-R/AKT2" . SPARSER::COLLECTION)
    ("GRP/GRP-R" . SPARSER::COLLECTION)
    ("angiogenic factor VEGF" . SPARSER::PROTEIN)
    ("gastrin-releasing peptide (GRP) and its receptor" . SPARSER::COLLECTION)
    ("NVP-BEZ235" . SPARSER::DRUG)
    ("glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("AKT3" . SPARSER::PROTEIN) ("AKT2" . SPARSER::PROTEIN)
    ("GRP-R" . SPARSER::PROTEIN)
    ("gastrin-releasing peptide" . SPARSER::PROTEIN)
    ("additional predictive biomarkers" . SPARSER::MOLECULE)
    ("typical in-frame deletions around c" . SPARSER::PROTEIN) ("Types" . TYPE)
    ("EGFR-tyrosine kinase" . SPARSER::COLLECTION)
    ("The most common NSCLC histological types" . TYPE)
    ("Our retrospective cohort" . SPARSER::MOLECULE)
    ("H2AX and MDC1" . SPARSER::COLLECTION) ("BLM/Exo1" . SPARSER::COLLECTION)
    ("BLM (human homologue of Sgs1) and Exo1" . SPARSER::COLLECTION)
    ("Sgs1" . SPARSER::PROTEIN)
    ("a more favorable substrate" . SPARSER::SUBSTRATE)
    ("functional MDC1 and H2AX" . SPARSER::COLLECTION)
    ("Sae2 and Ctp1" . SPARSER::COLLECTION)
    ("Tel1 and Mec1/Rad3" . SPARSER::COLLECTION) ("RHR" . SPARSER::PROTEIN)
    ("HR, and CtIP" . SPARSER::COLLECTION)
    ("HR and MMEJ" . SPARSER::COLLECTION)
    ("MDC1 and H2AX" . SPARSER::COLLECTION)
    ("γH2AX and MDC1" . SPARSER::COLLECTION)
    ("Nbs1/CtIP" . SPARSER::COLLECTION) ("Nbs1/MDC1" . SPARSER::COLLECTION)
    ("the CtIP CDK- and ATM-phosphorylation mutants" . SPARSER::COLLECTION)
    ("Nbs1 and ATM" . SPARSER::COLLECTION)
    ("CtIP, and Nbs1-" . SPARSER::COLLECTION)
    ("purified Nbs1-(1–335) or Nbs1-(336-end)" . SPARSER::COLLECTION)
    ("Nbs1-R28A" . SPARSER::COLLECTION) ("-R28A" . SPARSER::PROTEIN)
    ("-R28A-GST" . SPARSER::PROTEIN-PAIR)
    ("7A-CDK or 5A-CDK" . SPARSER::COLLECTION)
    ("Nbs1 and CtIP" . SPARSER::COLLECTION) ("CtIP-" . SPARSER::PROTEIN)
    ("-RRHK" . SPARSER::COLLECTION)
    ("the corresponding FHA/BRCT mutants Nbs1-(1–335)-R28A/K160M-GST and Nbs1-(1–335)-RRHK-GST"
     . SPARSER::COLLECTION)
    ("-RRHK-GST" . SPARSER::COLLECTION) ("-GST" . SPARSER::COLLECTION)
    ("RRHK" . SPARSER::PROTEIN) ("Nbs1-" . SPARSER::PROTEIN)
    ("CtIP and the FHA/BRCT domains" . SPARSER::COLLECTION)
    ("Nbs1-RRHK" . SPARSER::COLLECTION) ("CtIP and ATM" . SPARSER::COLLECTION)
    ("Nbs1 and Mre11" . SPARSER::COLLECTION)
    ("the separate CDK and ATM mutants" . SPARSER::MUTANT)
    ("the resultant mutant CtIP-7A-CDK/T859A" . SPARSER::PROTEIN)
    ("CtIP-7A-CDK/T859A" . SPARSER::PROTEIN)
    ("CDK and ATM" . SPARSER::COLLECTION)
    ("CtIP-S10A/S163A" . SPARSER::COLLECTION)
    ("CtIP-T847A/S889A" . SPARSER::PROTEIN-PAIR)
    ("S10A/S163A" . SPARSER::PROTEIN) ("CPT and IR" . SPARSER::COLLECTION)
    ("the CtIP mutants S327A or T847A/S889A" . SPARSER::COLLECTION)
    ("SP/TP" . SPARSER::COLLECTION) ("TP" . SPARSER::PROTEIN)
    ("CtIP-S231A/T271A" . SPARSER::PROTEIN) ("TQ" . SPARSER::DRUG)
    ("expressing ATM shRNAs" . SPARSER::PROTEIN) ("IR-" . SPARSER::PROTEIN)
    ("damage-induced HR" . SPARSER::PROTEIN)
    ("CtIP and its homologues" . SPARSER::COLLECTION)
    ("Mre11, Nbs1, ATM and BRCA1" . SPARSER::COLLECTION)
    ("cell-cycle-dependent kinases CDKs" . SPARSER::PROTEIN)
    ("CDK-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CtIP and Nbs1" . SPARSER::COLLECTION)
    ("BLM and Exo1" . SPARSER::COLLECTION) ("FHA" . SPARSER::PROTEIN-FAMILY)
    ("homologous recombination (HR)–mediated DNA" . SPARSER::DNA)
    ("Nbs1 and BRCA1" . SPARSER::COLLECTION) ("CtIP" . SPARSER::PROTEIN)
    ("TiO2" . SPARSER::MOLECULE) ("non-selective" . SPARSER::PROTEIN)
    ("shH2" . SPARSER::PROTEIN) ("Dna2" . SPARSER::PROTEIN)
    ("Mec1" . SPARSER::PROTEIN) ("Tel1" . SPARSER::PROTEIN)
    ("Sae2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ctp1" . SPARSER::PROTEIN)
    ("Exo1" . SPARSER::PROTEIN)
    ("multiple viral inhibitors" . SPARSER::INHIBITOR)
    ("proteasomal inhibitors or mutants" . SPARSER::COLLECTION)
    ("inhibitors or mutants" . SPARSER::COLLECTION)
    ("other cellular proteins and target" . SPARSER::COLLECTION)
    ("CD4 and tetherin" . SPARSER::COLLECTION)
    ("tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the IL-1R or the TNFR" . SPARSER::COLLECTION) ("TNFR" . SPARSER::PROTEIN)
    ("OPVs" . SPARSER::DRUG)
    ("endogenous β-TrCP and A49 made" . SPARSER::COLLECTION)
    ("inflammatory cytokines and chemokines" . SPARSER::COLLECTION)
    ("an antiviral state" . SPARSER::BIO-STATE)
    ("IRFs and NF-κB" . SPARSER::COLLECTION) ("IRFs" . SPARSER::PROTEIN)
    ("p-IκBα/p65" . SPARSER::COLLECTION) ("IκBα/NF-κB" . SPARSER::COLLECTION)
    ("TNFα or IL-1β" . SPARSER::COLLECTION)
    ("the phospho-mimetic allele" . SPARSER::ALLELE)
    ("NF-κB-luciferase" . SPARSER::COLLECTION)
    ("the phospho-mimetic mutant S7/12E" . SPARSER::PROTEIN)
    ("S7/12E" . SPARSER::PROTEIN)
    ("alanine (S7/12A) or glutamic acid (S7/12E)" . SPARSER::COLLECTION)
    ("β-TrCP ( xref ) and these truncated alleles" . SPARSER::COLLECTION)
    ("TAP-RIG-I" . SPARSER::COLLECTION) ("TAP-β-TrCP" . SPARSER::COLLECTION)
    ("β-TrCP or retinoic acid" . SPARSER::COLLECTION)
    ("β-TrCP or TAK1" . SPARSER::COLLECTION) ("TAP" . SPARSER::PROTEIN)
    ("its usual substrates" . SPARSER::SUBSTRATE)
    ("CD4-TLR4" . SPARSER::COLLECTION) ("IL-1α or TNFα" . SPARSER::COLLECTION)
    ("LPS and CpG" . SPARSER::COLLECTION)
    ("TLR4 and TLR9" . SPARSER::COLLECTION) ("SeV" . SPARSER::PROTEIN)
    ("renilla" . SPARSER::PROTEIN)
    ("a C-terminal Flag or an N-terminal HA" . SPARSER::COLLECTION)
    ("IFNβ and CCL5" . SPARSER::COLLECTION)
    ("immunomodulators" . SPARSER::DRUG) ("rev" . SPARSER::PROTEIN)
    ("vA" . SPARSER::MOLECULE) ("AraC" . SPARSER::DRUG)
    ("WR" . SPARSER::PROTEIN) ("thymidylate" . SPARSER::MOLECULE)
    ("K7 and K1" . SPARSER::COLLECTION)
    ("TNF receptor associated factor 6 (TRAF6) and IL-1 receptor"
     . SPARSER::COLLECTION)
    ("IFNs and complement" . SPARSER::COLLECTION)
    ("many immunomodulatory proteins" . SPARSER::PROTEIN)
    ("p-IκB" . SPARSER::COLLECTION)
    ("chemokines and other pro-inflammatory molecules" . SPARSER::COLLECTION)
    ("cytokines, chemokines and other pro-inflammatory molecules"
     . SPARSER::COLLECTION)
    ("receptors (TLR)" . SPARSER::RECEPTOR) ("Vpu" . SPARSER::PROTEIN)
    ("Monoclonal antibody" . SPARSER::DRUG) ("IL-1R" . SPARSER::PROTEIN)
    ("IκBβ" . SPARSER::PROTEIN) ("Emi1" . SPARSER::PROTEIN)
    ("B14" . SPARSER::PROTEIN) ("ISG56" . SPARSER::PROTEIN)
    ("TAB3" . SPARSER::PROTEIN) ("IL-1α" . SPARSER::PROTEIN)
    ("IFNβ" . SPARSER::PROTEIN) ("virulence factor" . SPARSER::PROTEIN-FAMILY)
    ("protein C" . SPARSER::PROTEIN) ("K7" . SPARSER::PROTEIN)
    ("Protein N1" . SPARSER::PROTEIN) ("Protein B" . SPARSER::PROTEIN)
    ("IRAK2" . SPARSER::PROTEIN)
    ("TNF receptor associated factor 6" . SPARSER::PROTEIN)
    ("viral protein U" . SPARSER::PROTEIN) ("Cullin1" . SPARSER::PROTEIN)
    ("cephalostatin" . SPARSER::DRUG) ("OSBP" . SPARSER::PROTEIN)
    ("oxysterol" . SPARSER::PROTEIN) ("HFE" . SPARSER::PROTEIN)
    ("MK8033 and carboplatin-paclitaxel" . SPARSER::COLLECTION)
    ("the only known HGF receptor" . SPARSER::PROTEIN)
    ("HGF and/or c-Met" . SPARSER::COLLECTION)
    ("MK8033 and carboplatin" . SPARSER::COLLECTION)
    ("combinational carboplatin" . SPARSER::DRUG)
    ("HGF/c-Met" . SPARSER::COLLECTION) ("protein 6" . SPARSER::PROTEIN)
    ("Ubiquilin 1" . SPARSER::PROTEIN)
    ("hemochromatosis protein" . SPARSER::PROTEIN)
    ("SGK269" . SPARSER::PROTEIN) ("OSBPL6" . SPARSER::PROTEIN)
    ("LPHN3" . SPARSER::PROTEIN) ("CLTCL1" . SPARSER::PROTEIN)
    ("UBQLN1" . SPARSER::PROTEIN) ("CA125" . SPARSER::PROTEIN)
    ("MK8033" . SPARSER::DRUG) ("HGF receptor" . SPARSER::PROTEIN)
    ("PARP1 and PARG" . SPARSER::COLLECTION) ("CGCGG-3" . SPARSER::COLLECTION)
    ("the PARP1 ( xref ) and PARG ( xref ) promoters" . SPARSER::COLLECTION)
    ("PARG-" . SPARSER::PROTEIN) ("-shRNA" . SPARSER::COLLECTION)
    ("pGL4-PARP1" . SPARSER::COLLECTION)
    ("GATA-1 and GATA-2" . SPARSER::COLLECTION)
    ("NF-κB/c-Rel" . SPARSER::COLLECTION) ("PARG-siRNA" . SPARSER::COLLECTION)
    ("ON-TARGETplus" . SPARSER::PROTEIN-PAIR) ("-NAD +" . SPARSER::MOLECULE)
    ("the human PARP1 ( xref ) and PARG ( xref , xref ) genes"
     . SPARSER::COLLECTION)
    ("PARP1/PARG" . SPARSER::COLLECTION) ("GATA-2" . SPARSER::PROTEIN)
    ("Reverse transcriptase" . SPARSER::PROTEIN)
    ("ING" . SPARSER::PROTEIN-FAMILY) ("CHFR" . SPARSER::PROTEIN)
    ("BAFFR" . SPARSER::PROTEIN)
    ("potentially other promoters" . SPARSER::PROMOTER)
    ("specific non-Rel transcriptional co-factors" . SPARSER::MOLECULE)
    ("in fact eIF4E mRNA" . SPARSER::RNA)
    ("Myc and cyclinD1" . SPARSER::COLLECTION)
    ("NF-κB and C/EBP" . SPARSER::COLLECTION) ("IκB–SR" . SPARSER::COLLECTION)
    ("cRel/cRel homodimers as well as cRel/p65 heterodimers"
     . SPARSER::COLLECTION)
    ("cRel/cRel" . SPARSER::COLLECTION)
    ("c-Myc and Cyclin D1" . SPARSER::COLLECTION)
    ("post-PMA" . SPARSER::COLLECTION)
    ("p300 and Pol II" . SPARSER::COLLECTION)
    ("p50, p65 and c-Rel" . SPARSER::COLLECTION)
    ("cRel/p65" . SPARSER::COLLECTION) ("Octamer" . SPARSER::PROTEIN)
    ("cRel and p65" . SPARSER::COLLECTION)
    ("MYC and CCND1" . SPARSER::COLLECTION)
    ("GGGRNYYYCC-3" . SPARSER::COLLECTION)
    ("NF-κB and eIF4E" . SPARSER::COLLECTION) ("IκB-SR" . SPARSER::COLLECTION)
    ("Cyclin D1, VEGF, c-myc, Mcl1 and Pim1" . SPARSER::COLLECTION)
    ("Mcl1" . SPARSER::PROTEIN) ("Mcl" . SPARSER::PROTEIN)
    ("Acute Myelogenous Leukemia (AML)" . SPARSER::PROTEIN)
    ("substantially more NF-κB" . SPARSER::PROTEIN)
    ("p65 and cRel" . SPARSER::COLLECTION)
    ("NF-κB that is dysregulated preferentially in M4 and M5 AML"
     . SPARSER::COLLECTION)
    ("The eukaryotic translation initiation factor eIF4E" . SPARSER::PROTEIN)
    ("AEG-1" . SPARSER::PROTEIN) ("RPS3" . SPARSER::PROTEIN)
    ("PU.1" . SPARSER::PROTEIN) ("Histone 2B" . SPARSER::PROTEIN)
    ("Bay 11-7082" . SPARSER::DRUG) ("Sonic hedgehog" . SPARSER::PROTEIN)
    ("m 7 G" . SPARSER::MOLECULE) ("Pim1" . SPARSER::PROTEIN)
    ("eukaryotic translation initiation factor 4E" . SPARSER::PROTEIN)
    ("EIF4E" . SPARSER::PROTEIN)
    ("confounding drugs or electrolyte abnormalities" . SPARSER::COLLECTION)
    ("many diagnostic classes" . CLASS)
    ("CDKN1A and C6orf204" . SPARSER::COLLECTION)
    ("SCN10A, SCN5A , and EXOG" . SPARSER::COLLECTION)
    ("CAST" . SPARSER::PROTEIN) ("the SNP’s" . SPARSER::PROTEIN)
    ("SCN10A (rs6795970) and SCN5A (rs1805126)" . SPARSER::COLLECTION)
    ("SCN5A-SCN10A" . SPARSER::COLLECTION) ("the normal ECG" . SPARSER::DRUG)
    ("prostatic" . SPARSER::PROTEIN)
    ("CDKN1 and C6orf204" . SPARSER::COLLECTION)
    ("SCN10A and p=1" . SPARSER::COLLECTION) ("SE" . SPARSER::PROTEIN)
    ("GTCA" . SPARSER::PROTEIN) ("SLC35F1 and C6orf204" . SPARSER::COLLECTION)
    ("EXOG and XYLB1" . SPARSER::COLLECTION) ("XYLB" . SPARSER::PROTEIN)
    ("EXOG" . SPARSER::PROTEIN)
    ("the cardiac sodium channel gene" . SPARSER::PROTEIN)
    ("normal ECGs" . SPARSER::DRUG) ("ECGs" . SPARSER::DRUG)
    ("whose first ECG" . SPARSER::DRUG)
    ("PR, QRS, and QT" . SPARSER::COLLECTION)
    ("SCN10A and SCN5A" . SPARSER::COLLECTION)
    ("SCN5A and SCN10A" . SPARSER::COLLECTION) ("Nav1" . SPARSER::PROTEIN)
    ("CDKN1" . SPARSER::PROTEIN) ("SLC35F1" . SPARSER::PROTEIN)
    ("sodium channel" . SPARSER::PROTEIN) ("SCN10A" . SPARSER::PROTEIN)
    ("SCN5A" . SPARSER::PROTEIN)
    ("cisplatin, doxorubicin and TRAIL" . SPARSER::COLLECTION)
    ("whose 3D" . SPARSER::PROTEIN-FAMILY)
    ("PPM and FCP/SCP families" . SPARSER::COLLECTION)
    ("FCP/SCP" . SPARSER::COLLECTION) ("SCP" . SPARSER::PROTEIN)
    ("FCP" . SPARSER::PROTEIN) ("PPM" . SPARSER::PROTEIN)
    ("PP1α and PP1β, or PP2A" . SPARSER::COLLECTION)
    ("PP1β, or PP2A" . SPARSER::COLLECTION)
    ("family, or PPM1E/F" . SPARSER::COLLECTION)
    ("GST-AMPK" . SPARSER::COLLECTION) ("LKB1 and AMPK" . SPARSER::COLLECTION)
    ("apical proteins" . SPARSER::PROTEIN)
    ("AMPK, ACC and Raptor" . SPARSER::COLLECTION)
    ("Akt and pS792" . SPARSER::COLLECTION) ("GST-AMPKα" . SPARSER::COLLECTION)
    ("CaMKK" . SPARSER::PROTEIN) ("pSer/pThr" . SPARSER::COLLECTION)
    ("DiFMUP" . SPARSER::DRUG) ("SNAPs" . SPARSER::PROTEIN)
    ("PGC-1α and SIRT1" . SPARSER::COLLECTION) ("FCCP" . SPARSER::MOLECULE)
    ("OCR" . SPARSER::PROTEIN) ("Seahorse" . SPARSER::PROTEIN)
    ("AMPK and ACC" . SPARSER::COLLECTION) ("canine shRNA" . SPARSER::PROTEIN)
    ("ACC, Raptor and p70S6K" . SPARSER::COLLECTION)
    ("an essential subunit" . SPARSER::FRAGMENT)
    ("ATP or non-hydrolyzable derivatives of ATP" . SPARSER::COLLECTION)
    ("AMPKγ" . SPARSER::PROTEIN) ("cystathionine" . SPARSER::MOLECULE)
    ("CBS" . SPARSER::PROTEIN) ("FLAG-AMPKγ" . SPARSER::COLLECTION)
    ("NSF and SNARE" . SPARSER::COLLECTION)
    ("anti-HA or anti-FLAG" . SPARSER::COLLECTION) ("NSF" . SPARSER::PROTEIN)
    ("NAPA" . SPARSER::PROTEIN) ("AMP and ADP xref" . SPARSER::COLLECTION)
    ("the physiologically relevant AMPK phosphatase" . SPARSER::PROTEIN)
    ("drugs and physical exercise" . SPARSER::COLLECTION)
    ("fat and carbohydrate" . SPARSER::COLLECTION)
    ("ATP, ADP or AMP" . SPARSER::COLLECTION)
    ("-AMP-activated" . SPARSER::COLLECTION) ("hyh" . SPARSER::PROTEIN)
    ("hop" . SPARSER::PROTEIN) ("pThr" . SPARSER::PROTEIN)
    ("ACC and Raptor" . SPARSER::COLLECTION)
    ("cis-SNARE" . SPARSER::COLLECTION)
    ("anti-diabetic drugs and physical exercise" . SPARSER::COLLECTION)
    ("AMPKα 1" . SPARSER::PROTEIN) ("Citrate synthase" . SPARSER::PROTEIN)
    ("ZVAD-fmk" . SPARSER::DRUG) ("calyculin A" . SPARSER::MOLECULE)
    ("microcystin-LR" . SPARSER::MOLECULE) ("core2" . SPARSER::PROTEIN)
    ("pS6K" . SPARSER::PROTEIN) ("Sec17" . SPARSER::PROTEIN)
    ("SNF1" . SPARSER::PROTEIN) ("Sit4" . SPARSER::PROTEIN)
    ("PPM1E" . SPARSER::PROTEIN) ("PP1β" . SPARSER::PROTEIN)
    ("PP1α" . SPARSER::PROTEIN) ("PP6" . SPARSER::PROTEIN)
    ("PP5" . SPARSER::PROTEIN) ("PP4" . SPARSER::PROTEIN)
    ("cytochrome oxidase" . SPARSER::PROTEIN)
    ("ATP synthase" . SPARSER::PROTEIN) ("citrate synthase" . SPARSER::PROTEIN)
    ("complex I" . SPARSER::PROTEIN) ("AMPK-γ1" . SPARSER::PROTEIN)
    ("protein phosphatase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prognostic biomarkers" . SPARSER::MOLECULE)
    ("atelocollagen-mediated systemic antisense therapeutics"
     . SPARSER::THERAPEUTICS)
    ("siRNA and atelocollagen" . SPARSER::COLLECTION)
    ("indirect target" . SPARSER::TARGET-PROTEIN)
    ("the cyclin A protein" . SPARSER::PROTEIN)
    ("a potential and direct transcriptional regulator"
     . SPARSER::PROTEIN-FAMILY)
    ("cyclin A mRNA" . SPARSER::RNA)
    ("p16, p15, and p18" . SPARSER::COLLECTION)
    ("p21, p27, and p57" . SPARSER::COLLECTION) ("CKIs" . SPARSER::PROTEIN)
    ("respective CDKs" . SPARSER::PROTEIN)
    ("cyclin D1, cyclin E, and cyclin" . SPARSER::COLLECTION)
    ("YB-1, cyclin D1, and cyclin" . SPARSER::COLLECTION)
    ("YB-1 and cyclin D1 and cyclin" . SPARSER::COLLECTION)
    ("YF" . SPARSER::MOLECULE) ("si-YB-1 or si-Ctr" . SPARSER::COLLECTION)
    ("si-YB-1 and atelocollagen" . SPARSER::COLLECTION)
    ("YB-1 and cyclin D1" . SPARSER::COLLECTION)
    ("cyclin D1 and YB-1" . SPARSER::COLLECTION)
    ("cyclin A siRNA" . SPARSER::PROTEIN)
    ("cyclin D1 and cyclin A mRNA" . SPARSER::RNA)
    ("cyclin A protein" . SPARSER::PROTEIN)
    ("a prognostic biomarker" . SPARSER::MOLECULE) ("neo" . SPARSER::PROTEIN)
    ("a potent molecular target and prognostic biomarker"
     . SPARSER::COLLECTION)
    ("prognostic biomarker" . SPARSER::MOLECULE)
    ("cyclin D1 and cyclin" . SPARSER::COLLECTION)
    ("p57" . SPARSER::HUMAN-PROTEIN-FAMILY) ("citric acid" . SPARSER::MOLECULE)
    ("P-gp" . SPARSER::PROTEIN) ("YB-1" . SPARSER::PROTEIN)
    ("Y-box binding protein-1" . SPARSER::PROTEIN)
    ("MS and BRCA1" . SPARSER::COLLECTION) ("is run" . SPARSER::PROTEIN)
    ("receptor, progesterone receptor and HER-2" . SPARSER::COLLECTION)
    ("normal BRCA1" . SPARSER::PROTEIN) ("taxanes" . SPARSER::DRUG)
    ("PPC" . SPARSER::PROTEIN)
    ("cisplatin and paclitaxel" . SPARSER::COLLECTION)
    ("intraperitoneal cisplatin" . SPARSER::DRUG)
    ("vs intravenous paclitaxel" . SPARSER::DRUG)
    ("intravenous paclitaxel and cisplatin" . SPARSER::COLLECTION)
    ("paclitaxel and cisplatin" . SPARSER::COLLECTION)
    ("BRCA-1" . SPARSER::PROTEIN) ("BRCA 1" . SPARSER::PROTEIN)
    ("ABCG2, ABCB1 and ABCC1-5" . SPARSER::COLLECTION)
    ("loco" . SPARSER::PROTEIN)
    ("neither β-catenin nor Nanog" . SPARSER::COLLECTION)
    ("EGFR, β-catenin, and Nanog" . SPARSER::COLLECTION)
    ("EGFR or AKT1/2" . SPARSER::COLLECTION)
    ("EGFR and AKT" . SPARSER::COLLECTION)
    ("the most commonly prescribed chemotherapeutic drug" . SPARSER::DRUG)
    ("gefitinib or cisplatin" . SPARSER::COLLECTION)
    ("sh-β-catenin" . SPARSER::COLLECTION) ("sh-GFP" . SPARSER::COLLECTION)
    ("β-catenin [ xref ] as well as an essential factor" . SPARSER::COLLECTION)
    ("gefitinib or LY294002" . SPARSER::COLLECTION)
    ("AKT, and β-catenin" . SPARSER::COLLECTION)
    ("LY294002 and PD0325901" . SPARSER::COLLECTION)
    ("EGFR or ERK" . SPARSER::COLLECTION)
    ("gefitinib or another EGFR inhibitor PD153035" . SPARSER::COLLECTION)
    ("EGFR and its downstream effectors" . SPARSER::COLLECTION)
    ("EGFR, AKT and ERK1/2" . SPARSER::COLLECTION)
    ("gefitinib or PD153035" . SPARSER::COLLECTION)
    ("Raf/Mek/ERK" . SPARSER::COLLECTION)
    ("EGFR/PI3K/AKT" . SPARSER::COLLECTION)
    ("EGF and bFGF" . SPARSER::COLLECTION)
    ("small-interfering RNA" . SPARSER::RNA)
    ("logarithmically growing CNE1" . SPARSER::PROTEIN)
    ("Side" . SPARSER::PROTEIN)
    ("gefitinib and cisplatin" . SPARSER::COLLECTION)
    ("NPCs" . SPARSER::MOLECULE) ("EGFR or AKT" . SPARSER::COLLECTION)
    ("β-catenin and Nanog" . SPARSER::COLLECTION) ("Nanog" . SPARSER::PROTEIN)
    ("EGFR/AKT" . SPARSER::COLLECTION) ("NPC" . SPARSER::MOLECULE)
    ("B27" . SPARSER::PROTEIN) ("β-Catenin" . SPARSER::PROTEIN)
    ("ABCC1" . SPARSER::PROTEIN) ("ABCB1" . SPARSER::PROTEIN)
    ("ABCG2" . SPARSER::PROTEIN) ("Atoh1" . SPARSER::PROTEIN)
    ("PD0325901" . SPARSER::DRUG) ("CNE1" . SPARSER::PROTEIN)
    ("tenovin-6 directly target SIRT2" . SPARSER::PROTEIN)
    ("strong cytotoxic" . SPARSER::PROTEIN) ("SIRT1-" . SPARSER::PROTEIN)
    ("staurosporine or cisplatin" . SPARSER::COLLECTION)
    ("their presumptive common targets" . SPARSER::TARGET-PROTEIN)
    ("SIRT2 or ATRA" . SPARSER::COLLECTION)
    ("p53 and α-tubulin" . SPARSER::COLLECTION)
    ("wild-type RAR-α and its downstream targets" . SPARSER::COLLECTION)
    ("which lacks PML-RAR-α" . SPARSER::COLLECTION)
    ("SIRT2 or GFP" . SPARSER::COLLECTION)
    ("either SIRT1 ( xref ) or SIRT2 ( xref )" . SPARSER::COLLECTION)
    ("non-targeting shRNA (negative control) or 3 independent shRNA"
     . SPARSER::COLLECTION)
    ("SIRT1 or SIRT2" . SPARSER::COLLECTION) ("Line" . SPARSER::PROTEIN)
    ("pan-HDAC" . SPARSER::COLLECTION) ("SIRT-FOXO" . SPARSER::COLLECTION)
    ("SIRT1, SIRT2, SIRT6, and SIRT7" . SPARSER::COLLECTION)
    ("a unique NAD-dependent protein deacetylase activity" . SPARSER::PROTEIN)
    ("histone-deacetylases" . SPARSER::COLLECTION)
    ("NBs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("its partner promyelocytic leukemia (PML) or other proteins"
     . SPARSER::COLLECTION)
    ("promyelocytic leukemia (PML)" . SPARSER::PROTEIN)
    ("retinoic acid (ATRA)" . SPARSER::MOLECULE) ("ATRA" . SPARSER::DRUG)
    ("PML-RAR-α" . SPARSER::COLLECTION)
    ("the acute promyelocytic leukemia (APL) cell line NB4" . SPARSER::PROTEIN)
    ("APL" . SPARSER::PROTEIN) ("pCL10" . SPARSER::PROTEIN)
    ("caspase 2" . SPARSER::PROTEIN)
    ("granulocyte colony-stimulating factor" . SPARSER::PROTEIN)
    ("RAR-α" . SPARSER::PROTEIN) ("NB4" . SPARSER::PROTEIN)
    ("Cav-1 and PTEN" . SPARSER::COLLECTION)
    ("Hydrogen peroxide and hydroxyl radical" . SPARSER::COLLECTION)
    ("suppressor or tumor" . SPARSER::COLLECTION)
    ("hydroxyl radical and hydrogen peroxide" . SPARSER::COLLECTION)
    ("-DA, HPF and Amplex" . SPARSER::COLLECTION)
    ("Akt and phosphorylated-Akt" . SPARSER::COLLECTION)
    ("the caveolae microsomal fraction" . SPARSER::COMPONENT)
    ("hydrogen peroxide and ferrous sulfate" . SPARSER::COLLECTION)
    ("ICAM-1 and E-selectin" . SPARSER::COLLECTION)
    ("ferrous sulfate" . SPARSER::MOLECULE)
    ("exogenous hydrogen peroxide" . SPARSER::DRUG)
    ("VCAM-1, ICAM-1 and E-selectin" . SPARSER::COLLECTION)
    ("hydrogen peroxide or hydroxyl radical" . SPARSER::COLLECTION)
    ("hydrogen peroxide, and HPF" . SPARSER::COLLECTION)
    ("HPF" . SPARSER::PROTEIN)
    ("formate, and deferoxamine" . SPARSER::COLLECTION)
    ("formate" . SPARSER::MOLECULE) ("deferoxamine" . SPARSER::MOLECULE)
    ("MnTBAP" . SPARSER::DRUG) ("cellular ROS" . SPARSER::PROTEIN)
    ("-DA" . SPARSER::MOLECULE)
    ("Hydrogen Peroxide and Hydroxyl Radical" . SPARSER::COLLECTION)
    ("_XB-YFP" . SPARSER::COLLECTION) ("pDS" . SPARSER::PROTEIN)
    ("hydrogen peroxide and hydroxyl radical" . SPARSER::COLLECTION)
    ("PIP 3" . SPARSER::PIP3) ("phosphatidyl-inositol" . SPARSER::MOLECULE)
    ("β1" . SPARSER::PROTEIN)
    ("tumor necrosis factor-alpha" . SPARSER::PROTEIN)
    ("Hydrogen peroxide" . SPARSER::MOLECULE)
    ("Hydroxyl Radical" . SPARSER::MOLECULE)
    ("Hydrogen Peroxide" . SPARSER::MOLECULE)
    ("sodium chloride" . SPARSER::DRUG) ("E-selectin" . SPARSER::PROTEIN)
    ("DCFH-DA" . SPARSER::DRUG) ("VCAM-1" . SPARSER::PROTEIN)
    ("hydroxyl radical" . SPARSER::MOLECULE)
    ("ACACA and ACACB" . SPARSER::COLLECTION)
    ("ACACB and ACACA" . SPARSER::COLLECTION) ("ACACA" . SPARSER::PROTEIN)
    ("otherwise intact protein" . SPARSER::PROTEIN)
    ("EA and AA" . SPARSER::COLLECTION) ("Pimas" . SPARSER::DRUG)
    ("Accelerated DN" . SPARSER::PROTEIN) ("PPARA" . SPARSER::PROTEIN)
    ("Acacb" . SPARSER::PROTEIN)
    ("undiscovered causative variants" . SPARSER::VARIANT)
    ("palmitate or oleate" . SPARSER::COLLECTION)
    ("oleate" . SPARSER::MOLECULE)
    ("EA, Japanese and Hong" . SPARSER::COLLECTION)
    ("WFSM diabetic AAs" . SPARSER::PROTEIN)
    ("AAs and Pima" . SPARSER::COLLECTION) ("UT" . SPARSER::PROTEIN-FAMILY)
    ("traits and gene" . SPARSER::COLLECTION)
    ("DN and lipid" . SPARSER::COLLECTION)
    ("the acetyl coenzyme A carboxylase B gene ( ACACB )" . SPARSER::PROTEIN)
    ("Pima" . SPARSER::DRUG) ("gene ( ACACB )" . SPARSER::PROTEIN)
    ("ACACB" . SPARSER::PROTEIN) ("coenzyme" . SPARSER::MOLECULE)
    ("peroxisome proliferator-activated receptor alpha" . SPARSER::PROTEIN)
    ("fatty-acid" . SPARSER::MOLECULE)
    ("quantitative traits" . SPARSER::PROTEIN)
    ("incomplete LD" . SPARSER::PROTEIN)
    ("moderate and mild forms" . SPARSER::FORM)
    ("the most severe forms" . SPARSER::FORM) ("cotinine" . SPARSER::DRUG)
    ("a neurogenic inflammatory component" . SPARSER::COMPONENT)
    ("neurotransmitter and nervous system signaling pathways"
     . SPARSER::COLLECTION)
    ("NPY , NCR2 and EMR1" . SPARSER::COLLECTION)
    ("both moderate and severe CP" . SPARSER::PROTEIN)
    ("neurotransmitters" . SPARSER::MOLECULE)
    ("severe and moderate CP" . SPARSER::PROTEIN) ("fMLP" . SPARSER::PROTEIN)
    ("the moderate and severe CP" . SPARSER::PROTEIN)
    ("moderate and severe CP" . SPARSER::PROTEIN)
    ("severe CP— NPY" . SPARSER::PROTEIN) ("CP—" . SPARSER::PROTEIN)
    ("severe CP (rs12883458, rs2521634 and rs11925054) and three SNPs"
     . SPARSER::COLLECTION)
    ("the next largest cohort" . SPARSER::MOLECULE)
    ("CD14 , FCGR2A , IL1A , IL1B , IL1RN , IL4 , IL6 , IL10 , TLR4 , TNF and VDR"
     . SPARSER::COLLECTION)
    ("all four bacterial traits" . SPARSER::PROTEIN)
    ("NPY and NCR2" . SPARSER::COLLECTION)
    ("‘orange’ complex" . SPARSER::BIO-COMPLEX) ("Elav" . SPARSER::PROTEIN)
    ("CUGBP" . SPARSER::PROTEIN) ("neuropeptide" . SPARSER::PROTEIN)
    ("ERC" . SPARSER::PROTEIN) ("wingless" . SPARSER::PROTEIN)
    ("an intergenic SNP" . SPARSER::PROTEIN) ("Ninein" . SPARSER::PROTEIN)
    ("AAP" . SPARSER::PROTEIN) ("a well-defined cohort" . SPARSER::MOLECULE)
    ("CP and IL1" . SPARSER::COLLECTION)
    ("cyclo-oxygenase-2 ( COX -2) and C-reactive protein genes"
     . SPARSER::COLLECTION)
    ("matrix metalloproteinase-1, toll-like receptor ( TLR ), cyclo-oxygenase-2 ( COX -2) and C-reactive protein genes"
     . SPARSER::COLLECTION)
    ("receptor ( TLR )" . SPARSER::RECEPTOR)
    ("receptor ( VDR )" . SPARSER::RECEPTOR)
    ("receptors, chemokines, enzymes and antigen" . SPARSER::COLLECTION)
    ("severe forms" . SPARSER::FORM)
    ("both the microbial component" . SPARSER::COMPONENT)
    ("CHD" . SPARSER::PROTEIN) ("CAL" . SPARSER::PROTEIN)
    ("severe CP" . SPARSER::PROTEIN)
    ("severe CP and NCR2" . SPARSER::COLLECTION)
    ("CP and NCR2" . SPARSER::COLLECTION) ("NPY" . SPARSER::PROTEIN)
    ("NIN" . SPARSER::PROTEIN) ("EA" . SPARSER::PROTEIN)
    ("IBS 2" . SPARSER::PROTEIN) ("GLT6D1" . SPARSER::PROTEIN)
    ("glycosyltransferase 6 domain containing 1" . SPARSER::PROTEIN)
    ("N -formyl-methionyl-leucyl-phenylalanine" . SPARSER::MOLECULE)
    ("element binding protein" . SPARSER::PROTEIN) ("IL10" . SPARSER::PROTEIN)
    ("IL4" . SPARSER::PROTEIN) ("IL1RN" . SPARSER::PROTEIN)
    ("CELF2" . SPARSER::PROTEIN) ("family member 2" . SPARSER::PROTEIN)
    ("taste receptor" . SPARSER::PROTEIN) ("GPR113" . SPARSER::PROTEIN)
    ("Vav 1" . SPARSER::PROTEIN) ("hormone receptor-like 1" . SPARSER::PROTEIN)
    ("mucin-like" . SPARSER::PROTEIN)
    ("Egf-like module containing" . SPARSER::PROTEIN)
    ("natural cytotoxicity triggering receptor 2" . SPARSER::PROTEIN)
    ("ELKS/RAB6-interacting/CAST family member 2" . SPARSER::PROTEIN)
    ("member 5" . SPARSER::PROTEIN) ("Neuropeptide Y" . SPARSER::PROTEIN)
    ("GSK3B interacting protein" . SPARSER::PROTEIN)
    ("IL1A" . SPARSER::PROTEIN) ("COX -2" . SPARSER::PROTEIN)
    ("cyclo-oxygenase-2" . SPARSER::PROTEIN)
    ("matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("FCGR2A" . SPARSER::PROTEIN) ("EMR1" . SPARSER::PROTEIN)
    ("NCR2" . SPARSER::PROTEIN) ("WNT5A" . SPARSER::PROTEIN)
    ("Akt and p53" . SPARSER::COLLECTION)
    ("EGFR- and PTEN-" . SPARSER::COLLECTION) ("PTEN-" . SPARSER::PROTEIN)
    ("p53, EGFR, or PTEN" . SPARSER::COLLECTION)
    ("several chemotherapeutic drugs" . SPARSER::DRUG)
    ("ribosomal proteins" . SPARSER::PROTEIN)
    ("kinases and mTor" . SPARSER::COLLECTION)
    ("PI3K and RTK" . SPARSER::COLLECTION) ("intact PTEN" . SPARSER::PROTEIN)
    ("RIOK1 and TORC2" . SPARSER::COLLECTION)
    ("highly conserved atypical kinases" . SPARSER::KINASE)
    ("intact p53" . SPARSER::PROTEIN) ("PRAS40 and TSC2" . SPARSER::COLLECTION)
    ("TORC2 and Akt" . SPARSER::COLLECTION)
    ("doxorubicin and/or temozolomide ( xref , xref )" . SPARSER::COLLECTION)
    ("alkylator" . SPARSER::MOLECULE)
    ("p53 and the p21 cdk inhibitor" . SPARSER::COLLECTION)
    ("RpL11 and RIOK1 or RIOK2" . SPARSER::COLLECTION)
    ("cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RpL11" . SPARSER::PROTEIN)
    ("immature cytoplasmic 40S ribosomal subunits" . SPARSER::PROTEIN)
    ("RIOK1/RIOK2" . SPARSER::COLLECTION)
    ("PTEN and/or EGFR mutant" . SPARSER::COLLECTION)
    ("RIOK2 or RIOK1" . SPARSER::COLLECTION)
    ("neoplastic glia" . SPARSER::PROTEIN)
    ("RIOK1, mTor, and Rictor" . SPARSER::COLLECTION)
    ("the mTor kinase and several other signaling components"
     . SPARSER::COLLECTION)
    ("multi-protein" . SPARSER::COLLECTION) ("TORC2-Akt" . SPARSER::COLLECTION)
    ("S10 and S11" . SPARSER::COLLECTION)
    ("p110 and Akt" . SPARSER::COLLECTION) ("Ink4a/arf" . SPARSER::COLLECTION)
    ("arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ΔEGFR" . SPARSER::PROTEIN)
    ("relevant inhibitors" . SPARSER::INHIBITOR)
    ("U87MG-ΔEGFR" . SPARSER::COLLECTION) ("glia" . SPARSER::PROTEIN)
    ("warts" . SPARSER::PROTEIN)
    ("Raf , Src42A , and Taf1" . SPARSER::COLLECTION)
    ("EGFR-PI3K" . SPARSER::COLLECTION) ("Modifiers" . SPARSER::MOLECULE)
    ("Suppressor" . SPARSER::SUPPRESSOR) ("dAkt" . SPARSER::PROTEIN)
    ("Glial" . SPARSER::PROTEIN) ("available mutant alleles" . SPARSER::ALLELE)
    ("Drosophila EGFR (dEGFRλ) and the PI3K catalytic subunit p110α (dp110 CAAX )"
     . SPARSER::COLLECTION)
    ("EGFR or PI3K" . SPARSER::COLLECTION)
    ("kinase, and RIOK1" . SPARSER::COLLECTION)
    ("immature ribosomes" . SPARSER::BIO-COMPLEX)
    ("the 40S ribosomal subunit" . SPARSER::FRAGMENT)
    ("the actual in vivo substrates" . SPARSER::SUBSTRATE)
    ("nonspecific substrates" . SPARSER::SUBSTRATE)
    ("eukaryotic serine-threonine protein kinase domains"
     . SPARSER::PROTEIN-FAMILY)
    ("atypical protein kinases" . SPARSER::KINASE) ("ri" . SPARSER::MOLECULE)
    ("Akt and mTor" . SPARSER::COLLECTION) ("EGFR-Ras" . SPARSER::COLLECTION)
    ("nearly all known gliomagenic genes" . SPARSER::GENE)
    ("EGFR- and PI3K-" . SPARSER::COLLECTION) ("PI3K-" . SPARSER::PROTEIN)
    ("pharmacologic inhibitors" . SPARSER::INHIBITOR)
    ("EGFR or mTor" . SPARSER::COLLECTION)
    ("Ras, Akt, and mTor" . SPARSER::COLLECTION)
    ("EGFR and PI3K" . SPARSER::COLLECTION)
    ("neuro-glial" . SPARSER::PROTEIN-PAIR)
    ("an intragenic truncation mutant" . SPARSER::MUTANT)
    ("EGFR and PDGFRα" . SPARSER::COLLECTION)
    ("EGFR, and components" . SPARSER::COLLECTION)
    ("the RIO kinases as well as other kinases" . SPARSER::COLLECTION)
    ("RIOK1 or RIOK2" . SPARSER::COLLECTION) ("RpL" . SPARSER::PROTEIN)
    ("overexpressed RIOK2" . SPARSER::PROTEIN)
    ("RIOK1, mTor, and mTor-complex-2" . SPARSER::COLLECTION)
    ("mTor" . SPARSER::PROTEIN)
    ("the atypical kinases RIOK1 and RIOK2" . SPARSER::COLLECTION)
    ("RIOK1 and RIOK2" . SPARSER::COLLECTION) ("RTK-" . SPARSER::PROTEIN)
    ("RTK and PI3K" . SPARSER::COLLECTION) ("Pi-3" . SPARSER::PROTEIN)
    ("TLK1" . SPARSER::PROTEIN) ("CDK7" . SPARSER::PROTEIN)
    ("CDK9" . SPARSER::PROTEIN) ("STK17a" . SPARSER::PROTEIN)
    ("GDC-0941" . SPARSER::DRUG) ("MK-2206" . SPARSER::MOLECULE)
    ("Nutlin-3" . SPARSER::DRUG) ("Diamond-Blackfan anemia" . SPARSER::PROTEIN)
    ("Polo-like kinase 1" . SPARSER::PROTEIN) ("S10" . SPARSER::PROTEIN)
    ("A443654" . SPARSER::DRUG) ("BEZ-235" . SPARSER::DRUG)
    ("Ink4a" . SPARSER::PROTEIN) ("Taf1" . SPARSER::PROTEIN)
    ("Src42A" . SPARSER::PROTEIN) ("Tor2" . SPARSER::PROTEIN)
    ("protein kinase domains" . SPARSER::PROTEIN-FAMILY)
    ("PI-3 kinase" . SPARSER::PROTEIN) ("RIOK2" . SPARSER::PROTEIN)
    ("RIOK1" . SPARSER::PROTEIN) ("ICC" . SPARSER::PROTEIN)
    ("CERT, and tri/tetracyclic" . SPARSER::COLLECTION)
    ("interactive drug-SNP" . SPARSER::PROTEIN) ("CERT" . SPARSER::PROTEIN)
    ("gene and gene" . SPARSER::COLLECTION) ("ECG" . SPARSER::DRUG)
    ("warfarin" . SPARSER::DRUG) ("Therapeutics" . SPARSER::THERAPEUTICS)
    ("antidepressants" . SPARSER::DRUG) ("hypoglycemic agent" . SPARSER::DRUG)
    ("BCR-ABL1-STAT5" . SPARSER::PROTEIN-PAIR)
    ("ofBCR-ABL1" . SPARSER::COLLECTION)
    ("DNA-damage that predisposes them" . SPARSER::DNA)
    ("AsBCR-ABL1" . SPARSER::COLLECTION)
    ("STAT5, ROS and DNA" . SPARSER::COLLECTION)
    ("tetramer" . SPARSER::TETRAMER) ("MRC-cIII" . SPARSER::COLLECTION)
    ("cIII" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase [ xref , xref ] or hypoxia-responsive-element"
     . SPARSER::COLLECTION)
    ("mitochondria [ xref ], xanthine oxidase [ xref ], as well as endothelial nitric oxide synthase under specific conditions [ xref ]"
     . SPARSER::COLLECTION)
    ("JAK2-STAT5" . SPARSER::COLLECTION)
    ("GFP, STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("survival genes or cell cycle regulators [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("hydroxyl radicals or hydrogen peroxide" . SPARSER::COLLECTION)
    ("CMH" . SPARSER::MOLECULE) ("ESR" . SPARSER::PROTEIN)
    ("spin" . SPARSER::PROTEIN) ("MRC" . SPARSER::PROTEIN)
    ("Catalase and MnSOD" . SPARSER::COLLECTION)
    ("CD71 and IRP-2" . SPARSER::COLLECTION) ("DFO" . SPARSER::MOLECULE)
    ("Iron" . SPARSER::MOLECULE)
    ("internal and external factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MnSOD" . SPARSER::PROTEIN) ("Catalase" . SPARSER::PROTEIN)
    ("vABL" . SPARSER::PROTEIN) ("STAT5A or STAT5B" . SPARSER::COLLECTION)
    ("GAA" . SPARSER::PROTEIN) ("STAT5A, STAT5B or GFP" . SPARSER::COLLECTION)
    ("Stat5a and Stat5b" . SPARSER::COLLECTION)
    ("the kinases ATM and/or ATR" . SPARSER::COLLECTION)
    ("the ROS sensitive fluorescent dye DHE" . SPARSER::DRUG)
    ("DHE" . SPARSER::DRUG) ("PAX5, AID and RAD51" . SPARSER::COLLECTION)
    ("inBCR-ABL1" . SPARSER::COLLECTION)
    ("RAD51 DNA-repair proteins [ xref , xref ] or a STAT5"
     . SPARSER::COLLECTION)
    ("Stat5a" . SPARSER::PROTEIN) ("CP-" . SPARSER::PROTEIN)
    ("trigger/inducer" . SPARSER::COLLECTION)
    ("hydroxyl radicals (HO*) and lipid peroxidation products"
     . SPARSER::COLLECTION)
    ("HO" . SPARSER::PROTEIN) ("UV-light" . SPARSER::COLLECTION)
    ("imatinib, nilotinib and dasatinib" . SPARSER::COLLECTION)
    ("CP-CML" . SPARSER::COLLECTION) ("STAT5-ROS" . SPARSER::COLLECTION)
    ("CD32" . SPARSER::PROTEIN) ("CML-AP" . SPARSER::PROTEIN)
    ("NOX4" . SPARSER::PROTEIN) ("xanthine oxidase" . SPARSER::PROTEIN)
    ("INCB-018424" . SPARSER::DRUG) ("IRP-2" . SPARSER::PROTEIN)
    ("CD71" . SPARSER::PROTEIN) ("Chr1" . SPARSER::PROTEIN)
    ("Stat5b" . SPARSER::PROTEIN) ("p185" . SPARSER::PROTEIN)
    ("ABL1" . SPARSER::PROTEIN) ("p210" . SPARSER::PROTEIN)
    ("Stat5" . SPARSER::PROTEIN) ("v-ABL" . SPARSER::PROTEIN)
    ("p160" . SPARSER::PROTEIN) ("D3R-DAT" . SPARSER::PROTEIN-PAIR)
    ("a predominantly inward-facing conformation" . SPARSER::BIO-CONFORMATION)
    ("different conformational states" . SPARSER::BIO-STATE)
    ("PKC-ERK" . SPARSER::COLLECTION) ("GRKs" . SPARSER::PROTEIN)
    ("Cocaine" . SPARSER::DRUG)
    ("soluble N-ethylmaleimide-sensitive factor attachment protein receptor proteins"
     . SPARSER::RECEPTOR-PROTEIN)
    ("AMPH" . SPARSER::PROTEIN) ("the increased basal pERK" . SPARSER::PROTEIN)
    ("the basal pERK" . SPARSER::PROTEIN) ("hoc" . SPARSER::PROTEIN)
    ("percoll" . SPARSER::DRUG) ("presynaptic PKCβ" . SPARSER::PROTEIN)
    ("Quinpirole" . SPARSER::DRUG) ("post-hoc" . SPARSER::COLLECTION)
    ("quinpirole or LY379196" . SPARSER::COLLECTION)
    ("DAT and D2S" . SPARSER::COLLECTION)
    ("quinpirole and LY379196" . SPARSER::COLLECTION)
    ("quinpirole" . SPARSER::DRUG) ("D2S-activated DAT" . SPARSER::PROTEIN)
    ("PKCβ and ERK" . SPARSER::COLLECTION) ("amphetamine" . SPARSER::DRUG)
    ("DAT and D2R" . SPARSER::COLLECTION)
    ("striatal DAT and D2autoR" . SPARSER::COLLECTION)
    ("presynaptic DA transporter (DAT)" . SPARSER::PROTEIN)
    ("transporter (DAT)" . SPARSER::PROTEIN)
    ("accelerated DAT" . SPARSER::PROTEIN) ("PKCβ-ERK" . SPARSER::COLLECTION)
    ("DAT and D2autoR" . SPARSER::COLLECTION)
    ("the presynaptic dopamine transporter (DAT)" . SPARSER::PROTEIN)
    ("DAT" . SPARSER::PROTEIN) ("N-ethylmaleimide" . SPARSER::MOLECULE)
    ("sulfo-NHS" . SPARSER::DRUG) ("LY379196" . SPARSER::DRUG)
    ("extracellular signal-regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dopamine transporter" . SPARSER::PROTEIN)
    ("gestational age" . SPARSER::PROTEIN) ("maternal age" . SPARSER::PROTEIN)
    ("Hg" . SPARSER::MOLECULE) ("down-regulator" . SPARSER::PROTEIN)
    ("Aims" . SPARSER::PROTEIN) ("Factor V" . SPARSER::PROTEIN)
    ("of pregnancy" . SPARSER::PROTEIN)
    ("Plasminogen Activator Inhibitor 1" . SPARSER::PROTEIN)
    ("MMP:TIMP" . SPARSER::BIO-COMPLEX) ("NFκB and p38K" . SPARSER::COLLECTION)
    ("a multifunctional molecule" . SPARSER::MOLECULE)
    ("ERK1/2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAPK, p38K and ERK1/2" . SPARSER::COLLECTION)
    ("C/EBPβ and TIMP-1" . SPARSER::COLLECTION)
    ("astrocyte TIMP-1 and ERK1/2-targeted pharmacological inhibitors"
     . SPARSER::COLLECTION)
    ("ERK1/2 and C/EBPβ" . SPARSER::COLLECTION)
    ("pGL3-RL" . SPARSER::COLLECTION) ("pTIMP-luc" . SPARSER::COLLECTION)
    ("RL" . SPARSER::PROTEIN) ("luc" . SPARSER::PROTEIN)
    ("soma" . SPARSER::DRUG)
    ("C/EBPβ mRNA and nuclear protein levels" . SPARSER::COLLECTION)
    ("SB202190 and PD98059" . SPARSER::COLLECTION)
    ("SB203580 or U0126" . SPARSER::COLLECTION) ("HAD" . SPARSER::PROTEIN)
    ("protein kinase A-" . SPARSER::PROTEIN)
    ("ERK1/2 or p38" . SPARSER::COLLECTION)
    ("Histone deacetylase and extracellular regulated kinase"
     . SPARSER::COLLECTION)
    ("a multifunctional glycoprotein" . SPARSER::PROTEIN)
    ("the blood brain barrier, glutamate reuptake and the matrix metalloproteinase (MMP)"
     . SPARSER::COLLECTION)
    ("matrix metalloproteinase (MMP)" . SPARSER::PROTEIN)
    ("Cytokines and viral toxins" . SPARSER::COLLECTION)
    ("viral toxins" . SPARSER::MOLECULE)
    ("ERK1/2 and p38K" . SPARSER::COLLECTION)
    ("TIMP-1 and C/EBPβ" . SPARSER::COLLECTION) ("TIMP" . SPARSER::PROTEIN)
    ("immune-activated astrocytes" . SPARSER::PROTEIN)
    ("SB202190" . SPARSER::DRUG) ("Histone deacetylase" . SPARSER::PROTEIN)
    ("activator protein-1" . SPARSER::PROTEIN)
    ("Transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("C/EBPβ" . SPARSER::PROTEIN)
    ("enhancer binding protein" . SPARSER::PROTEIN)
    ("simultaneous target" . SPARSER::TARGET-PROTEIN)
    ("Sesn2" . SPARSER::PROTEIN) ("mTORC" . SPARSER::PROTEIN)
    ("ligand and its receptor" . SPARSER::COLLECTION)
    ("cdc2/cyclin B1" . SPARSER::COLLECTION)
    ("naturally occurring chemopreventive or chemotherapeutic reagents"
     . SPARSER::MOLECULE)
    ("drinking water" . SPARSER::MOLECULE) ("Chloroquine" . SPARSER::PROTEIN)
    ("cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("cyclin B1 and cdc25C" . SPARSER::COLLECTION)
    ("p21 and p15" . SPARSER::COLLECTION)
    ("cell cycle regulators and the formation of cyclin-CDK complexes trigger"
     . SPARSER::COLLECTION)
    ("Cyclins and cyclin-dependent kinase" . SPARSER::COLLECTION)
    ("cyclin-CDK" . SPARSER::COLLECTION)
    ("PARP and caspase-3" . SPARSER::COLLECTION) ("AIF" . SPARSER::PROTEIN)
    ("berberine or an EGFR kinase inhibitor" . SPARSER::COLLECTION)
    ("BrdU and PI" . SPARSER::COLLECTION)
    ("EGFR and EGFR" . SPARSER::COLLECTION)
    ("two EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab and panitumumab" . SPARSER::COLLECTION)
    ("EGFR-" . SPARSER::PROTEIN)
    ("type 1 transmembrane receptor tyrosine kinases"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53, MAPK, and NF-κB" . SPARSER::COLLECTION)
    ("colonic macrophages" . SPARSER::PROTEIN) ("dextran" . SPARSER::DEXTRAN)
    ("well-studied naturally occurring isoquinoline alkaloids"
     . SPARSER::MOLECULE)
    ("occurring isoquinoline alkaloids" . SPARSER::MOLECULE)
    ("alkaloids" . SPARSER::MOLECULE) ("EGFR, and EGFR" . SPARSER::COLLECTION)
    ("Cbl" . SPARSER::PROTEIN) ("IMCE" . SPARSER::PROTEIN)
    ("berberine" . SPARSER::MOLECULE) ("alkaloid" . SPARSER::MOLECULE)
    ("isoquinoline" . SPARSER::DRUG) ("Berberine" . SPARSER::MOLECULE)
    ("MACH 2" . SPARSER::DRUG) ("cdc25" . SPARSER::PROTEIN)
    ("PI3K-mTOR" . SPARSER::PROTEIN) ("N-myc" . SPARSER::PROTEIN)
    ("PHD3" . SPARSER::PROTEIN) ("EGLN3" . SPARSER::PROTEIN)
    ("DDIT3" . SPARSER::PROTEIN) ("cdc2" . SPARSER::PROTEIN)
    ("Gadd45" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ki67" . SPARSER::PROTEIN)
    ("cdc25C" . SPARSER::PROTEIN) ("cyclin B1" . SPARSER::PROTEIN)
    ("AG1478" . SPARSER::DRUG) ("GRB2" . SPARSER::PROTEIN)
    ("growth factor receptor-bound protein 2" . SPARSER::PROTEIN)
    ("tumour necrosis factor" . SPARSER::PROTEIN)
    ("UCSD/AML1" . SPARSER::COLLECTION) ("araC" . SPARSER::DRUG)
    ("etoposide and the anthracycline daunorubicin" . SPARSER::COLLECTION)
    ("taxol and IFN-α" . SPARSER::COLLECTION)
    ("the nearly monoclonal state" . SPARSER::BIO-STATE)
    ("Evi1" . SPARSER::PROTEIN) ("Evi" . SPARSER::PROTEIN)
    ("exogenous p21" . SPARSER::PROTEIN)
    ("siRNAs, shRNAs, or antisense" . SPARSER::COLLECTION)
    ("BCL2A1 and BCL2L1" . SPARSER::COLLECTION)
    ("BCL2 , MCL1 , BAG3 , NOXA1 , BID , BIK , BAX , BAK1 , and XIAP"
     . SPARSER::COLLECTION)
    ("BIK" . SPARSER::PROTEIN) ("BID" . SPARSER::PROTEIN)
    ("classical apoptosis regulators" . SPARSER::REGULATOR)
    ("419 unique genes" . SPARSER::GENE) ("77 unique genes" . SPARSER::GENE)
    ("EVI1 and Etoposide" . SPARSER::COLLECTION)
    ("Cytostatic Drugs" . SPARSER::DRUG)
    ("an immature state" . SPARSER::BIO-STATE) ("TPA" . SPARSER::PROTEIN)
    ("appropriate inducers" . SPARSER::MOLECULE)
    ("exponentially growing EVI1" . SPARSER::PROTEIN)
    ("ubiquinol-cytochrome c reductase-Rieske iron-sulfur polypeptide 1"
     . SPARSER::COLLECTION)
    ("DSE" . SPARSER::PROTEIN) ("the exogenous EVI1 gene" . SPARSER::PROTEIN)
    ("HNT" . SPARSER::PROTEIN) ("leukemogenic oncoproteins" . SPARSER::PROTEIN)
    ("AML1-ETO" . SPARSER::COLLECTION) ("PML-RARα" . SPARSER::COLLECTION)
    ("ETO" . SPARSER::PROTEIN)
    ("etoposide and anthracyclines" . SPARSER::COLLECTION)
    ("anthracyclines" . SPARSER::MOLECULE)
    ("E2F1 and MYC" . SPARSER::COLLECTION)
    ("JNK and caspases" . SPARSER::COLLECTION)
    ("jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transforming growth factor beta (TGF-β) and taxol" . SPARSER::COLLECTION)
    ("AKT/mTOR" . SPARSER::COLLECTION) ("CDKN1A/p21/WAF" . SPARSER::COLLECTION)
    ("WAF" . SPARSER::PROTEIN) ("EVI1 and etoposide" . SPARSER::COLLECTION)
    ("etoposide and daunorubicin" . SPARSER::COLLECTION)
    ("daunorubicin" . SPARSER::DRUG) ("antileukemic drugs" . SPARSER::DRUG)
    ("cytosine arabinoside" . SPARSER::DRUG) ("BCL2L1" . SPARSER::PROTEIN)
    ("BCL2A1" . SPARSER::PROTEIN) ("BAK1" . SPARSER::PROTEIN)
    ("NOXA1" . SPARSER::PROTEIN) ("BAG3" . SPARSER::PROTEIN)
    ("MCL1" . SPARSER::PROTEIN) ("CD52" . SPARSER::PROTEIN)
    ("UQCRFS1" . SPARSER::PROTEIN)
    ("Rieske iron-sulfur polypeptide 1" . SPARSER::PROTEIN)
    ("ubiquinol-cytochrome c reductase" . SPARSER::PROTEIN)
    ("dermatan sulfate epimerase" . SPARSER::PROTEIN)
    ("band 3" . SPARSER::PROTEIN) ("caspases 3" . SPARSER::PROTEIN)
    ("DA1" . SPARSER::PROTEIN) ("TUB 2" . SPARSER::PROTEIN)
    ("RCC1" . SPARSER::PROTEIN) ("Waf1/Cip1" . SPARSER::PROTEIN)
    ("B2M" . SPARSER::PROTEIN) ("β-2-microglobulin" . SPARSER::PROTEIN)
    ("Gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("enhanced Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("AML1" . SPARSER::PROTEIN) ("IFN-α" . SPARSER::PROTEIN)
    ("transforming growth factor beta" . SPARSER::PROTEIN)
    ("EVI1" . SPARSER::PROTEIN)
    ("ecotropic viral integration site 1" . SPARSER::PROTEIN)
    ("alcohol and tobacco" . SPARSER::COLLECTION)
    ("estrogen and NF-κB" . SPARSER::COLLECTION)
    ("diethylnitrosamine" . SPARSER::MOLECULE)
    ("the -94 Ins and -94 Del polymorphisms" . SPARSER::COLLECTION)
    ("NF-κB, AP-1, and STAT3" . SPARSER::COLLECTION) ("HBsAg" . SPARSER::DRUG)
    ("Oligonucleotides" . SPARSER::MOLECULE) ("AFP" . SPARSER::PROTEIN)
    ("NFKBIA -519, -826, or -881 polymorphic genes" . SPARSER::GENE)
    ("Ins/Ins" . SPARSER::COLLECTION)
    ("alcohol or tobacco" . SPARSER::COLLECTION)
    ("a heterodimer of the p50 and p65/Rel A subunits xref"
     . SPARSER::COLLECTION)
    ("p65/Rel" . SPARSER::COLLECTION)
    ("either NFKB1 or its inhibitory protein" . SPARSER::COLLECTION)
    ("monocytes, and astrocytes" . SPARSER::COLLECTION)
    ("Ins" . SPARSER::PROTEIN) ("NFKB1 and NFKBIA" . SPARSER::COLLECTION)
    ("NFKBIA" . SPARSER::PROTEIN)
    ("aspartate aminotransferase" . SPARSER::PROTEIN)
    ("hepatitis B surface antigen" . SPARSER::DRUG)
    ("α-fetoprotein" . SPARSER::PROTEIN)
    ("GATA binding protein 2" . SPARSER::PROTEIN)
    ("CCAAT/enhancer binding protein" . SPARSER::PROTEIN)
    ("derived factor" . SPARSER::PROTEIN) ("NFKB1" . SPARSER::PROTEIN)
    ("down stream genes and malignant phenotypes" . SPARSER::COLLECTION)
    ("dual IKKα" . SPARSER::PROTEIN) ("caspases and IκB" . SPARSER::COLLECTION)
    ("the drug’s" . SPARSER::DRUG) ("Geldanamycin" . SPARSER::DRUG)
    ("IKKβ and cJun" . SPARSER::COLLECTION)
    ("cJun or JunB" . SPARSER::COLLECTION)
    ("Jun and FosL" . SPARSER::COLLECTION)
    ("a tumor suppressive component" . SPARSER::COMPONENT)
    ("EGFR, ERK, and EGFR" . SPARSER::COLLECTION)
    ("EGFR and AP-1" . SPARSER::COLLECTION)
    ("p105 and p100" . SPARSER::COLLECTION)
    ("p50 and p52" . SPARSER::COLLECTION)
    ("p100 and nuclear p52 protein ( xref )" . SPARSER::COLLECTION)
    ("an alternate pathway inducer" . SPARSER::MOLECULE)
    ("p100 and p52" . SPARSER::COLLECTION)
    ("TNF-α and LTβ" . SPARSER::COLLECTION)
    ("RELA and NF-κB" . SPARSER::COLLECTION)
    ("Further results modulating IKKα" . SPARSER::PROTEIN)
    ("the predominant kinase" . SPARSER::KINASE)
    ("siRNA or small molecule inhibitors" . SPARSER::COLLECTION)
    ("IKK/NF-κB" . SPARSER::COLLECTION)
    ("nuclear RELB and p-p52" . SPARSER::COLLECTION)
    ("a model whereby both IKKα and IKKβ" . SPARSER::COLLECTION)
    ("IKKα/β or broader" . SPARSER::COLLECTION)
    ("wt and EE" . SPARSER::COLLECTION)
    ("IKKβ and phospho-p65" . SPARSER::COLLECTION)
    ("Pan-IKK" . SPARSER::COLLECTION) ("Wedelolactone" . SPARSER::DRUG)
    ("AAG" . SPARSER::PROTEIN) ("geldanamycin" . SPARSER::DRUG)
    ("dual IKK" . SPARSER::PROTEIN) ("IKK/EGFR/AP1" . SPARSER::COLLECTION)
    ("EGFR, JunB and FOSL" . SPARSER::COLLECTION)
    ("EGFR/AP-1" . SPARSER::COLLECTION) ("canonical IKK" . SPARSER::PROTEIN)
    ("EGFR, cJun, JunB and Fra-1/FOSL" . SPARSER::COLLECTION)
    ("AP1 and IL-8" . SPARSER::COLLECTION)
    ("HGF and TGFβ" . SPARSER::COLLECTION) ("SMADs" . SPARSER::PROTEIN)
    ("ERK/p38/MAPK" . SPARSER::COLLECTION) ("HBEGF" . SPARSER::PROTEIN)
    ("IKK or AP1" . SPARSER::COLLECTION)
    ("FOSL1, cJun, or JunB" . SPARSER::COLLECTION)
    ("known canonical NF-κB" . SPARSER::PROTEIN)
    ("IκBα, IL-1 and IL-8" . SPARSER::COLLECTION)
    ("molecules and pathways" . SPARSER::COLLECTION)
    ("Representative down-regulated genes" . SPARSER::GENE)
    ("NF-κB, cytokines and growth factor" . SPARSER::COLLECTION)
    ("p105/p50" . SPARSER::COLLECTION) ("IκB and NF-κB" . SPARSER::COLLECTION)
    ("IκBα-Luciferase" . SPARSER::COLLECTION)
    ("subunits and IκBα" . SPARSER::COLLECTION)
    ("p-IκBα" . SPARSER::COLLECTION) ("p-p100" . SPARSER::COLLECTION)
    ("ser" . SPARSER::AMINO-ACID)
    ("dimer and heterodimer" . SPARSER::COLLECTION)
    ("p-p52" . SPARSER::COLLECTION) ("NF-κB2/p100" . SPARSER::COLLECTION)
    ("p100/p52" . SPARSER::COLLECTION)
    ("alternate NF-κB2 p100 protein" . SPARSER::PROTEIN)
    ("p52 and RelB" . SPARSER::COLLECTION)
    ("p105 and its processed product p50" . SPARSER::COLLECTION)
    ("p-RELA" . SPARSER::COLLECTION) ("IKKα or β EE" . SPARSER::COLLECTION)
    ("SS-" . SPARSER::PROTEIN) ("EE" . SPARSER::PROTEIN)
    ("Alanines" . SPARSER::AMINO-ACID) ("IKKα or IKKβ" . SPARSER::COLLECTION)
    ("IKKα/β" . SPARSER::PROTEIN) ("p-IKKα/β" . SPARSER::COLLECTION)
    ("IKKα, IKKβ and phospho-IKKα/β" . SPARSER::COLLECTION)
    ("dual chemical inhibitors" . SPARSER::INHIBITOR)
    ("NF-κB/RELs" . SPARSER::COLLECTION) ("RELs" . SPARSER::PROTEIN)
    ("cJun, JunB and Fra1" . SPARSER::COLLECTION)
    ("cJun, JunB, JunD, cFos, FosB, FosL(Fra1) and FosL2(Fra2)"
     . SPARSER::COLLECTION)
    ("Jun and Fos" . SPARSER::COLLECTION) ("FosB" . SPARSER::PROTEIN)
    ("cFos" . SPARSER::PROTEIN) ("JunD" . SPARSER::PROTEIN)
    ("Fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR and its ligand TGFα" . SPARSER::COLLECTION)
    ("EGFR and AP1" . SPARSER::COLLECTION) ("MLN" . SPARSER::PROTEIN)
    ("the IKKα and IKKβ catalytic subunits and the non-catalytic subunit"
     . SPARSER::COLLECTION)
    ("a heterotrimeric complex" . SPARSER::BIO-COMPLEX)
    ("kappaB" . SPARSER::PROTEIN) ("EGFR/AP1" . SPARSER::COLLECTION)
    ("NF-κB and AP1" . SPARSER::COLLECTION)
    ("TGFα, EGFR, and AP1" . SPARSER::COLLECTION)
    ("cJun, JunB, and Fra1" . SPARSER::COLLECTION) ("cJun" . SPARSER::PROTEIN)
    ("canonical RELA and IκBα" . SPARSER::COLLECTION)
    ("RELA and IκBα" . SPARSER::COLLECTION)
    ("p52 and RELB" . SPARSER::COLLECTION) ("RELB" . SPARSER::PROTEIN)
    ("RELA" . SPARSER::PROTEIN) ("EGFR-AP1" . SPARSER::COLLECTION)
    ("NF-κB/REL" . SPARSER::COLLECTION) ("REL" . SPARSER::PROTEIN)
    ("IKKβ or EGFR" . SPARSER::COLLECTION) ("EGFR-AP-1" . SPARSER::COLLECTION)
    ("Epidermal Growth Factor Receptor-Activator Protein-1"
     . SPARSER::PROTEIN-PAIR)
    ("IKK-NF-κB" . SPARSER::COLLECTION) ("IKK2" . SPARSER::PROTEIN)
    ("17-allylamino 17-demethoxygeldanamycin" . SPARSER::DRUG)
    ("Glutamic Acid" . SPARSER::AMINO-ACID) ("S11" . SPARSER::PROTEIN)
    ("SC514" . SPARSER::DRUG) ("heat shock protein 90" . SPARSER::PROTEIN)
    ("Hsp90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("SC-514" . SPARSER::DRUG)
    ("Fra-1" . SPARSER::PROTEIN) ("EGR1" . SPARSER::PROTEIN)
    ("FOSL1" . SPARSER::PROTEIN) ("Fra2" . SPARSER::PROTEIN)
    ("FosL2" . SPARSER::PROTEIN) ("NF-kappaB" . SPARSER::PROTEIN)
    ("Fra1" . SPARSER::PROTEIN)
    ("Epidermal Growth Factor Receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Factor-κB" . SPARSER::PROTEIN) ("REV1-" . SPARSER::PROTEIN)
    ("pyrene" . SPARSER::PROTEIN)
    ("the nicotinic receptor α5 subunit" . SPARSER::FRAGMENT)
    ("collagens, and matrix" . SPARSER::COLLECTION)
    ("exocyst" . SPARSER::BIO-COMPLEX) ("Net" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("self-reported emphysema" . SPARSER::PROTEIN) ("SAS" . SPARSER::PROTEIN)
    ("IRF4 and EXOC2" . SPARSER::COLLECTION) ("HTERT" . SPARSER::PROTEIN)
    ("emphysema" . SPARSER::PROTEIN) ("hyaluronic acid" . SPARSER::MOLECULE)
    ("Exocyst complex component 2" . SPARSER::PROTEIN)
    ("Interferon regulatory factor 4" . SPARSER::PROTEIN)
    ("Rev1" . SPARSER::PROTEIN) ("chr 5" . SPARSER::PROTEIN)
    ("Dopamine transporter 1" . SPARSER::PROTEIN)
    ("dopamine D2 receptor" . SPARSER::PROTEIN) ("alpha1" . SPARSER::PROTEIN)
    ("CYP2E1" . SPARSER::PROTEIN) ("NAT 2" . SPARSER::PROTEIN)
    ("EXOC2" . SPARSER::PROTEIN) ("REV1" . SPARSER::PROTEIN)
    ("Elk-1 and AP-1sites" . SPARSER::COLLECTION)
    ("the HepG2-ADH cells effectively metabolized ethanol" . SPARSER::MOLECULE)
    ("acetaldehyde" . SPARSER::MOLECULE)
    ("Elk-1, c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("c-Jun and c-Fos" . SPARSER::COLLECTION)
    ("MCP-1 and CRR2" . SPARSER::COLLECTION) ("CRR" . SPARSER::PROTEIN)
    ("Elk-1 and AP-1" . SPARSER::COLLECTION)
    ("Elk-1 or AP-1" . SPARSER::COLLECTION) ("Luc" . SPARSER::PROTEIN)
    ("both AP-1- and Elk-1-dependent promoters ( xref )" . SPARSER::COLLECTION)
    ("AP-1-" . SPARSER::PROTEIN) ("SP 600125 or JNK1" . SPARSER::COLLECTION)
    ("JNKs" . SPARSER::PROTEIN) ("Pol III gene" . SPARSER::GENE)
    ("TBP-Luc" . SPARSER::COLLECTION)
    ("pre-tRNA Leu and 5S rRNA transcription at the ethanol concentration of 50mM"
     . SPARSER::COLLECTION)
    ("Ethanol" . SPARSER::PROTEIN)
    ("ethanol and the amounts of precursor tRNA Leu and 5S rRNA transcript"
     . SPARSER::COLLECTION)
    ("ADH" . SPARSER::PROTEIN) ("JNK1, Elk1 and AP-1" . SPARSER::COLLECTION)
    ("TBP and Pol III genes" . SPARSER::GENE)
    ("TBP and Pol" . SPARSER::COLLECTION)
    ("RNA Pol I and Pol III genes" . SPARSER::GENE)
    ("TFIIIC and RNA" . SPARSER::COLLECTION) ("TFIIIC" . SPARSER::PROTEIN)
    ("TBP and its associated factors, Brf1 and Bdp1" . SPARSER::COLLECTION)
    ("its associated factors, Brf1 and Bdp1" . SPARSER::COLLECTION)
    ("factors, Brf1 and Bdp1" . SPARSER::COLLECTION)
    ("TFIIIB" . SPARSER::PROTEIN)
    ("pRb, p53, PTEN and Maf1" . SPARSER::COLLECTION)
    ("Ras, c-Jun, and c-Myc" . SPARSER::COLLECTION)
    ("RNA and U6" . SPARSER::COLLECTION) ("Alcohol" . SPARSER::DRUG)
    ("Pol III genes" . SPARSER::GENE) ("Elk1 and AP-1" . SPARSER::COLLECTION)
    ("the TBP promoter or mutating AP-1 binding site" . SPARSER::COLLECTION)
    ("Elk1" . SPARSER::PROTEIN) ("Elk" . SPARSER::PROTEIN)
    ("a central transcription factor" . SPARSER::PROTEIN)
    ("RNA Pol III (RNA polymerase III) dependent genes" . SPARSER::GENE)
    ("alcohol-associated HCC" . SPARSER::PROTEIN) ("JNK2" . SPARSER::PROTEIN)
    ("alcohol dehydrogenase" . SPARSER::PROTEIN)
    ("SP 600125" . SPARSER::PROTEIN) ("Bdp1" . SPARSER::PROTEIN)
    ("Brf1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Maf1" . SPARSER::PROTEIN)
    ("7SK" . SPARSER::RNA) ("Pol II" . SPARSER::PROTEIN)
    ("TATA-box binding protein" . SPARSER::PROTEIN) ("vis" . SPARSER::DRUG)
    ("the canonical IκB kinases and the IKK-related kinases TBK1 and IKKε share some homology"
     . SPARSER::COLLECTION)
    ("intact TBK1" . SPARSER::PROTEIN)
    ("the S172E phosphomimetic mutant" . SPARSER::MUTANT)
    ("the monomeric proteins" . SPARSER::PROTEIN)
    ("LPS and polyI:C" . SPARSER::COLLECTION)
    ("the NEMO-related protein optineurin as well as adaptor NDP52"
     . SPARSER::COLLECTION)
    ("the catalytically active TBK1 dimer" . SPARSER::DIMER)
    ("TRAF3, NDRP1, or MIB1" . SPARSER::COLLECTION)
    ("TAK1 and the canonical IKK complex" . SPARSER::COLLECTION)
    ("NEMO and TANK" . SPARSER::COLLECTION)
    ("IL1 or specific TLRs ( xref )" . SPARSER::COLLECTION)
    ("TANK and TBK1" . SPARSER::COLLECTION)
    ("TRAF2 and TRAF6" . SPARSER::COLLECTION) ("RLR" . SPARSER::PROTEIN)
    ("STING and ER" . SPARSER::COLLECTION)
    ("TBK1 and IRF3" . SPARSER::COLLECTION)
    ("IRF3 and TBK1" . SPARSER::COLLECTION) ("IRF" . SPARSER::PROTEIN)
    ("Polyubiquitination" . SPARSER::PROTEIN) ("Lysines" . SPARSER::AMINO-ACID)
    ("E355A/R357A" . SPARSER::PROTEIN)
    ("ubiquitin or a HA-tagged mutant ubiquitin" . SPARSER::COLLECTION)
    ("GST-TBK1" . SPARSER::COLLECTION)
    ("K63-polyubiquitination" . SPARSER::COLLECTION)
    ("IRF3 ( xref ) and TBK1" . SPARSER::COLLECTION)
    ("kinase, ULD, linker and SDD" . SPARSER::COLLECTION)
    ("TBK1 and IKKβ" . SPARSER::COLLECTION)
    ("IFNB1 and RANTES" . SPARSER::COLLECTION)
    ("Flag- and V5-tagged" . SPARSER::COLLECTION)
    ("Flag-" . SPARSER::PROTEIN-FAMILY)
    ("response element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("ISRE" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("dimeric TBK1" . SPARSER::PROTEIN) ("EGR" . SPARSER::PROTEIN)
    ("an alternate crystal form" . SPARSER::FORM) ("MPD" . SPARSER::PROTEIN)
    ("the contralateral subunit" . SPARSER::FRAGMENT)
    ("the oligomeric state" . SPARSER::BIO-STATE)
    ("SEC-MALS" . SPARSER::COLLECTION) ("MALS" . SPARSER::PROTEIN)
    ("SEC" . SPARSER::PROTEIN)
    ("The pyrimidine and aniline rings" . SPARSER::COLLECTION)
    ("amide" . SPARSER::MOLECULE) ("DFG" . SPARSER::PROTEIN)
    ("lobe" . SPARSER::PROTEIN) ("β1-β5" . SPARSER::PROTEIN-PAIR)
    ("the overall superhelical twist" . SPARSER::PROTEIN)
    ("a triple-helical coiled-coil" . SPARSER::PROTEIN)
    ("coiled-coil" . SPARSER::PROTEIN) ("coil" . SPARSER::PROTEIN)
    ("kinase and ULD" . SPARSER::COLLECTION)
    ("the canonical IκB kinases and the IKK-related kinases TBK1 and IKKε"
     . SPARSER::COLLECTION)
    ("small molecule inhibitors MRT67307 ( xref ) and BX795 ( xref )"
     . SPARSER::COLLECTION)
    ("RALB" . SPARSER::PROTEIN)
    ("the tumor suppressor CYLD ( xref ; xref ) and TRAF2 ( xref )"
     . SPARSER::COLLECTION)
    ("IRF3 as well as STAT6 ( xref ; xref )" . SPARSER::COLLECTION)
    ("STING" . SPARSER::PROTEIN) ("TBK1/IKKε" . SPARSER::COLLECTION)
    ("MAVS" . SPARSER::PROTEIN) ("TRIF" . SPARSER::PROTEIN)
    ("Toll-like receptors (TLRs) or cytoplasmic RIG-1" . SPARSER::COLLECTION)
    ("IRF3 and IRF7" . SPARSER::COLLECTION) ("RLRs" . SPARSER::PROTEIN)
    ("TBK1 and IKKε" . SPARSER::COLLECTION)
    ("complex and share" . SPARSER::COLLECTION) ("TANK" . SPARSER::PROTEIN)
    ("Tank-binding kinase (TBK1) and inhibitor" . SPARSER::COLLECTION)
    ("IKKγ/NEMO" . SPARSER::COLLECTION)
    ("the atypical IκB kinases" . SPARSER::KINASE)
    ("Lysine" . SPARSER::AMINO-ACID)
    ("nearly full-length TBK1" . SPARSER::PROTEIN)
    ("the atypical IκB kinase TBK1" . SPARSER::PROTEIN)
    ("N protein" . SPARSER::PROTEIN) ("NDP52" . SPARSER::PROTEIN)
    ("NEMO-related protein" . SPARSER::PROTEIN) ("MIB1" . SPARSER::PROTEIN)
    ("TRAF3" . SPARSER::PROTEIN) ("IL1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interferon-β" . SPARSER::DRUG) ("poly I:C" . SPARSER::MOLECULE)
    ("IFNB1" . SPARSER::PROTEIN) ("cyclobutyl group" . SPARSER::MOLECULE)
    ("glutamic acid" . SPARSER::AMINO-ACID)
    ("β5" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BX795" . SPARSER::DRUG)
    ("MRT67307" . SPARSER::DRUG) ("MYD88" . SPARSER::PROTEIN)
    ("RIG-1" . SPARSER::PROTEIN) ("IKKε" . SPARSER::PROTEIN)
    ("a substantially better fit" . SPARSER::PROTEIN-FAMILY)
    ("CACNA1C and CACNA1D" . SPARSER::COLLECTION)
    ("only one SNP" . SPARSER::PROTEIN)
    ("CACNA1C, CACNA1D, CACNA1E, CACNA1S, CACNA2D2, CACNA2D4, and CACNB2"
     . SPARSER::COLLECTION)
    ("CACNA1C and CACNB2" . SPARSER::COLLECTION)
    ("an intronic SNP" . SPARSER::PROTEIN) ("p 22" . SPARSER::PROTEIN)
    ("seven multidimensional scaling components" . SPARSER::COMPONENT)
    ("trio" . SPARSER::PROTEIN) ("spec" . SPARSER::PROTEIN)
    ("PGC" . SPARSER::PROTEIN) ("ICD" . SPARSER::PROTEIN)
    ("DSM" . SPARSER::MOLECULE)
    ("subunits, CACNA1C and CACNB2" . SPARSER::COLLECTION)
    ("pp 65" . SPARSER::PROTEIN) ("CACNA2D4" . SPARSER::PROTEIN)
    ("CACNA2D2" . SPARSER::PROTEIN) ("CACNA1S" . SPARSER::PROTEIN)
    ("CACNA1E" . SPARSER::PROTEIN) ("p 64" . SPARSER::PROTEIN)
    ("p 63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pp 46" . SPARSER::PROTEIN)
    ("pp 36" . SPARSER::PROTEIN) ("SYNE1" . SPARSER::PROTEIN)
    ("AS3MT" . SPARSER::PROTEIN) ("ITIH3" . SPARSER::PROTEIN)
    ("pp 34" . SPARSER::PROTEIN) ("pp 17" . SPARSER::PROTEIN)
    ("p 13" . SPARSER::PROTEIN) ("pp 38" . SPARSER::PROTEIN)
    ("CACNB2" . SPARSER::PROTEIN) ("CACNA1C" . SPARSER::PROTEIN)
    ("Art4/Rod1" . SPARSER::COLLECTION) ("Rsp5" . SPARSER::PROTEIN)
    ("AMPK and Glut1" . SPARSER::COLLECTION)
    ("GTPase-activating protein (GAP)" . SPARSER::PROTEIN)
    ("the only previously known direct substrate" . SPARSER::SUBSTRATE)
    ("AS160/TBC1D4" . SPARSER::COLLECTION)
    ("Rab" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Glut4 and Glut1" . SPARSER::COLLECTION)
    ("protein and glucose" . SPARSER::COLLECTION)
    ("ChREBP/Mlx" . SPARSER::COLLECTION)
    ("Cy3 secondary antibody" . SPARSER::ANTIBODY)
    ("Cy5 secondary antibody" . SPARSER::ANTIBODY)
    ("HA-Glut1" . SPARSER::COLLECTION) ("Flag-Glut1" . SPARSER::COLLECTION)
    ("double-Flag-tagged Glut1" . SPARSER::PROTEIN)
    ("Glut1 and vice versa ( xref )" . SPARSER::COLLECTION)
    ("Myc-Glut1" . SPARSER::COLLECTION)
    ("facilitative glucose transporters" . SPARSER::PROTEIN)
    ("TXNIP and Rab5" . SPARSER::COLLECTION)
    ("mCherry-Rab5A" . SPARSER::COLLECTION) ("alanines" . SPARSER::AMINO-ACID)
    ("Alexa647-labeled transferrin" . SPARSER::PROTEIN)
    ("transferrin and TXNIP" . SPARSER::COLLECTION)
    ("TXNIP, transferrin and clathrin" . SPARSER::COLLECTION)
    ("CCPs" . SPARSER::PROTEIN) ("transferrin" . SPARSER::PROTEIN)
    ("GFP-TXNIP" . SPARSER::COLLECTION) ("HA-TXNIP" . SPARSER::COLLECTION)
    ("SAMS" . SPARSER::PROTEIN) ("Ser and Thr" . SPARSER::COLLECTION)
    ("bacterially-expressed GST-TXNIP" . SPARSER::COLLECTION)
    ("AMPK and ATP" . SPARSER::COLLECTION) ("GST-TXNIP" . SPARSER::COLLECTION)
    ("TXNIP and essentially all the TXNIP" . SPARSER::COLLECTION)
    ("essentially all the TXNIP" . SPARSER::PROTEIN)
    ("proteosome" . SPARSER::PROTEIN) ("-phosphatase" . SPARSER::PHOSPHATASE)
    ("AICAR, A769662 or phenformin" . SPARSER::COLLECTION)
    ("deoxyglucose" . SPARSER::MOLECULE) ("ACHN" . SPARSER::PROTEIN)
    ("acute glucose" . SPARSER::PROTEIN) ("CCP" . SPARSER::PROTEIN)
    ("arrestins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor and β-4" . SPARSER::COLLECTION)
    ("β2-adrenergic" . SPARSER::COLLECTION) ("GPCR" . SPARSER::PROTEIN)
    ("Vps26" . SPARSER::PROTEIN) ("Vps" . SPARSER::PROTEIN)
    ("MondoA/Mlx" . SPARSER::COLLECTION) ("chREBP/Mlx" . SPARSER::COLLECTION)
    ("MondoA" . SPARSER::PROTEIN) ("Mlx" . SPARSER::PROTEIN)
    ("chREBP" . SPARSER::PROTEIN) ("Txnip" . SPARSER::PROTEIN)
    ("PTEN, ASK-1 and NLRP3" . SPARSER::COLLECTION)
    ("arrestin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Calyculin A" . SPARSER::MOLECULE) ("Jen1" . SPARSER::PROTEIN)
    ("Rod1" . SPARSER::PROTEIN) ("Art4" . SPARSER::PROTEIN)
    ("Snf1" . SPARSER::PROTEIN) ("TBC1D4" . SPARSER::PROTEIN)
    ("Glut4" . SPARSER::PROTEIN) ("hexokinase activity" . SPARSER::PROTEIN)
    ("transporter activity" . SPARSER::PROTEIN) ("Rab5A" . SPARSER::PROTEIN)
    ("clathrin heavy chain" . SPARSER::PROTEIN) ("AMPK α1" . SPARSER::PROTEIN)
    ("A769662" . SPARSER::DRUG) ("ARRDC5" . SPARSER::PROTEIN)
    ("ARRDC3" . SPARSER::PROTEIN) ("β-arrestins" . SPARSER::PROTEIN)
    ("ARRDC1" . SPARSER::PROTEIN) ("VDUP1" . SPARSER::PROTEIN)
    ("NLRP3" . SPARSER::PROTEIN)
    ("Thioredoxin interacting protein" . SPARSER::PROTEIN)
    ("Nedd8–Cand1" . SPARSER::COLLECTION)
    ("CSN and Cand1" . SPARSER::COLLECTION)
    ("the available adaptor–SR" . SPARSER::PROTEIN)
    ("Cand1–cullin–Rbx" . SPARSER::COLLECTION) ("Rbx" . SPARSER::PROTEIN)
    ("receptor (SR)" . SPARSER::PROTEIN) ("cullins" . SPARSER::PROTEIN-FAMILY)
    ("several newly-synthesized F-box proteins" . SPARSER::PROTEIN)
    ("Fbxw11, Fbxo11, and Fbxo21" . SPARSER::COLLECTION)
    ("Fbxo21" . SPARSER::PROTEIN) ("Fbxo11" . SPARSER::PROTEIN)
    ("Fbxw11" . SPARSER::PROTEIN) ("newly-synthesized forms" . SPARSER::FORM)
    ("epoxomicin" . SPARSER::DRUG) ("Cry1 and Cul1" . SPARSER::COLLECTION)
    ("Fbxl3" . SPARSER::PROTEIN)
    ("the tightly-bound Cul1 partner Rbx1" . SPARSER::PROTEIN)
    ("Cul1-associated Nedd8 and CSN" . SPARSER::COLLECTION)
    ("Nedd8 and CSN" . SPARSER::COLLECTION) ("CSN" . SPARSER::PROTEIN)
    ("Cul1 (302 nM) and Cand1 (390 nM)" . SPARSER::COLLECTION)
    ("isotopically light lysine and arginine" . SPARSER::COLLECTION)
    ("‘light’" . SPARSER::PROTEIN) ("Cul1–Skp1" . SPARSER::COLLECTION)
    ("CycE–Fbxw7–Skp1" . SPARSER::COLLECTION) ("CycE" . SPARSER::PROTEIN)
    ("β-TRCP–Skp1" . SPARSER::COLLECTION)
    ("the transient ternary complex" . SPARSER::BIO-COMPLEX)
    ("Δ–Cul1–Rbx1" . SPARSER::COLLECTION) ("Cand1–Skp1" . SPARSER::COLLECTION)
    ("Ubc12" . SPARSER::PROTEIN) ("Ubc" . SPARSER::PROTEIN)
    ("GST-Rbx1–Cul1" . SPARSER::COLLECTION)
    ("their stable binary complexes" . SPARSER::BIO-COMPLEX)
    ("a transient GEF–GTPase–nucleotide ternary complex"
     . SPARSER::BIO-COMPLEX)
    ("GEF and nucleotide" . SPARSER::COLLECTION)
    ("that Cand1’s" . SPARSER::PROTEIN) ("Cand1 and CFP" . SPARSER::COLLECTION)
    ("a conventional competitive inhibitor" . SPARSER::INHIBITOR)
    ("Fbxw7–Skp1" . SPARSER::COLLECTION)
    ("preformed pure SCF Fbxw7" . SPARSER::PROTEIN)
    ("pure Cand1" . SPARSER::PROTEIN) ("Tet-" . SPARSER::PROTEIN)
    ("Rbx1 and Cul1" . SPARSER::COLLECTION) ("Skp2–Skp1" . SPARSER::COLLECTION)
    ("cyan fluorescent protein" . SPARSER::PROTEIN)
    ("–Skp1" . SPARSER::COLLECTION)
    ("the fluorescent dye TAMRA" . SPARSER::MOLECULE)
    ("SCF and other CRLs" . SPARSER::COLLECTION) ("CRL" . SPARSER::PROTEIN)
    ("a stoichiometric inhibitor" . SPARSER::INHIBITOR)
    ("associated E2s" . SPARSER::MOLECULE)
    ("Cullin-associated and neddylation-dissociated protein 1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CRLs" . SPARSER::PROTEIN) ("Cullin" . SPARSER::PROTEIN-FAMILY)
    ("a massive multi-subunit protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ubiquitin and ubiquitin" . SPARSER::COLLECTION)
    ("Nedd8, and Cand1" . SPARSER::COLLECTION) ("Nedd8" . SPARSER::PROTEIN)
    ("Protein–Skp1" . SPARSER::COLLECTION) ("Cul1–Rbx1" . SPARSER::COLLECTION)
    ("the Nedd8-deconjugated state" . SPARSER::BIO-STATE)
    ("Cand1" . SPARSER::PROTEIN) ("Cdc34" . SPARSER::PROTEIN)
    ("Protein Kinase A" . SPARSER::PROTEIN) ("Cry1" . SPARSER::PROTEIN)
    ("β-TRCP" . SPARSER::PROTEIN)
    ("Exchange Factor" . SPARSER::EXCHANGE-FACTOR) ("Skp2" . SPARSER::PROTEIN)
    ("E2s" . SPARSER::MOLECULE) ("E3s" . SPARSER::MOLECULE)
    ("ubiquitin conjugating enzyme" . SPARSER::PROTEIN-FAMILY)
    ("Fbxw7" . SPARSER::PROTEIN) ("LM, YQH and ZJY" . SPARSER::COLLECTION)
    ("SL" . SPARSER::PROTEIN)
    ("The endometrial prostaglandin E 2" . SPARSER::MOLECULE)
    ("a transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("COX-2, PGE2 and P450arom" . SPARSER::COLLECTION)
    ("-HER2/neu" . SPARSER::COLLECTION) ("HER2/neu" . SPARSER::COLLECTION)
    ("COX-2, p450arom and PGE2" . SPARSER::COLLECTION)
    ("a 185-kD transmembrane glycoprotein" . SPARSER::PROTEIN)
    ("celecoxib" . SPARSER::DRUG) ("PGE2 and P450arom" . SPARSER::COLLECTION)
    ("autocrine E 2" . SPARSER::MOLECULE)
    ("COX-2, PGE 2 and P450arom" . SPARSER::COLLECTION)
    ("-HER2" . SPARSER::COLLECTION) ("/P450arom" . SPARSER::COLLECTION)
    ("Aromatase" . SPARSER::PROTEIN) ("autocrine estrogen" . SPARSER::MOLECULE)
    ("HER-2/neu" . SPARSER::COLLECTION)
    ("COX-2 and P450arom" . SPARSER::COLLECTION)
    ("-HER-2/neu" . SPARSER::COLLECTION)
    ("COX-2/P450arom" . SPARSER::COLLECTION)
    ("prostaglandin E 2" . SPARSER::MOLECULE) ("p450arom" . SPARSER::PROTEIN)
    ("PEG 2" . SPARSER::PROTEIN) ("E 2" . SPARSER::MOLECULE)
    ("l protein" . SPARSER::PROTEIN) ("PGE 2" . SPARSER::DRUG)
    ("P450arom" . SPARSER::PROTEIN)
    ("Hematoxylin and eosin" . SPARSER::COLLECTION)
    ("Hematoxylin" . SPARSER::MOLECULE)
    ("the other associated proteins" . SPARSER::PROTEIN)
    ("JAR" . SPARSER::PROTEIN) ("dickkopf (DKK)" . SPARSER::PROTEIN-FAMILY)
    ("DKK" . SPARSER::PROTEIN) ("dickkopf" . SPARSER::PROTEIN)
    ("both severe PE" . SPARSER::PROTEIN)
    ("persistent placental hypoxia" . SPARSER::PROTEIN)
    ("the placental vasculature" . SPARSER::PROTEIN) ("CHM" . SPARSER::PROTEIN)
    ("19 Wnt ligands and 8" . SPARSER::COLLECTION)
    ("the human Wnt ligands and their receptors" . SPARSER::COLLECTION)
    ("AGA" . SPARSER::PROTEIN)
    ("hematoxylin and eosin (H&E) staining before IHC analysis"
     . SPARSER::COLLECTION)
    ("both the severe PE" . SPARSER::PROTEIN) ("severe PE" . SPARSER::PROTEIN)
    ("β-catenin and DKK1" . SPARSER::COLLECTION)
    ("/lymphoid" . SPARSER::COLLECTION)
    ("the Frizzled receptors and their co-receptors" . SPARSER::COLLECTION)
    ("beta-catenin and DKK1" . SPARSER::COLLECTION)
    ("Beta-catenin and DKK1" . SPARSER::COLLECTION) ("PAR1" . SPARSER::PROTEIN)
    ("Wnt3A" . SPARSER::PROTEIN) ("HLA-G" . SPARSER::PROTEIN)
    ("Dickkopf-1" . SPARSER::PROTEIN) ("DKK1" . SPARSER::PROTEIN)
    ("dickkopf-1" . SPARSER::PROTEIN) ("Beta-catenin" . SPARSER::PROTEIN)
    ("the mesenchymal genes" . SPARSER::GENE)
    ("RelA and RelB" . SPARSER::COLLECTION)
    ("YKL-40 and Olig2" . SPARSER::COLLECTION)
    ("Olig2 and YKL-40" . SPARSER::COLLECTION)
    ("E-Cadherin/CDH1" . SPARSER::COLLECTION) ("Occludin" . SPARSER::PROTEIN)
    ("N-cadherin, Smad2 and YKL-40" . SPARSER::COLLECTION)
    ("the mesenchymal genes N-Cadherin/CDH2" . SPARSER::COLLECTION)
    ("SMAD2 and TGFβ3" . SPARSER::COLLECTION)
    ("YKL-40/CHI3L1" . SPARSER::COLLECTION)
    ("N-Cadherin/CDH2" . SPARSER::COLLECTION)
    ("YKL-40 and OLIG2" . SPARSER::COLLECTION)
    ("Regulator" . SPARSER::REGULATOR)
    ("adherent monolayers" . SPARSER::PROTEIN)
    ("Bcl-2 and c-FLIP" . SPARSER::COLLECTION)
    ("shRelB-3" . SPARSER::COLLECTION)
    ("the mesenchymal subtype marker YKL-40" . SPARSER::PROTEIN)
    ("media (NSC)" . SPARSER::PROTEIN) ("U87 and U373" . SPARSER::COLLECTION)
    ("RelB/p52" . SPARSER::COLLECTION) ("NFκB2/p100" . SPARSER::COLLECTION)
    ("transcriptionally active RelA/p50 heterodimers" . SPARSER::HETERODIMER)
    ("RelA/p50" . SPARSER::COLLECTION)
    ("RelB, c-Rel, NFκB1 and NFκB2" . SPARSER::COLLECTION)
    ("a regulator of cancer stem cell proliferation and a candidate marker"
     . SPARSER::COLLECTION)
    ("mesenchymal genes" . SPARSER::GENE) ("Amino Acids" . SPARSER::AMINO-ACID)
    ("Glo 3" . SPARSER::PROTEIN) ("TGFB3" . SPARSER::PROTEIN)
    ("or 2 µ" . SPARSER::MOLECULE) ("Vitamin A" . SPARSER::MOLECULE)
    ("E-Cadherin" . SPARSER::PROTEIN) ("CHI3L1" . SPARSER::PROTEIN)
    ("SMAD2" . SPARSER::PROTEIN) ("N-Cadherin" . SPARSER::PROTEIN)
    ("OLIG2" . SPARSER::PROTEIN) ("collagen-I" . SPARSER::PROTEIN)
    ("protein I" . SPARSER::PROTEIN) ("NFκB2" . SPARSER::PROTEIN)
    ("YKL-40" . SPARSER::PROTEIN) ("Lymphoid" . SPARSER::PROTEIN)
    ("ß-actin" . SPARSER::COLLECTION) ("GAS" . SPARSER::PROTEIN)
    ("RAFTLIN" . SPARSER::PROTEIN) ("Protein (LCP)" . SPARSER::PROTEIN)
    ("LCP" . SPARSER::PROTEIN)
    ("SOCS2, SOCS3, IL2RA , CISH, BCL2 , BCL6 and CDK6" . SPARSER::COLLECTION)
    ("IL-2/STAT5" . SPARSER::COLLECTION)
    ("CISH, IFNG and FOXP3" . SPARSER::COLLECTION) ("IFNG" . SPARSER::PROTEIN)
    ("BCL2, BCL6, CDK6 and IL2RA" . SPARSER::COLLECTION)
    ("the gene (7 genes), enhancer (14 genes) or first exon (6 genes)"
     . SPARSER::COLLECTION)
    ("their proximal promoter" . SPARSER::PROMOTER)
    ("CISH, SOCS1, OSM, PIM-1, BCL6 and BCL2" . SPARSER::COLLECTION)
    ("IL-2 mediated genes" . SPARSER::GENE)
    ("Response Element (ISRE)" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("Interferon" . SPARSER::PROTEIN) ("TF" . SPARSER::PROTEIN)
    ("Cis" . SPARSER::PROTEIN) ("flags" . SPARSER::PROTEIN-FAMILY)
    ("MAT" . SPARSER::PROTEIN) ("cel" . SPARSER::PROTEIN)
    ("IL-2 mediated mRNA" . SPARSER::RNA)
    ("genome-wide IL-2" . SPARSER::PROTEIN)
    ("Phosphodiesterase (PDE)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Phosphodiesterase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("transcription factor-" . SPARSER::PROTEIN)
    ("tumor relevant STAT5 target genes" . SPARSER::GENE)
    ("STAT3 and STAT5" . SPARSER::COLLECTION) ("tetramers" . SPARSER::TETRAMER)
    ("STATS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor and form" . SPARSER::COLLECTION) ("JAKs" . SPARSER::PROTEIN)
    ("kinases (JAK)" . SPARSER::KINASE)
    ("IL-2 regulated genes" . SPARSER::GENE)
    ("STAT5A and STAT5B" . SPARSER::COLLECTION) ("MT-2" . SPARSER::PROTEIN)
    ("MT2" . SPARSER::PROTEIN) ("PDE4D" . SPARSER::PROTEIN)
    ("type 4" . SPARSER::PROTEIN) ("STK17B" . SPARSER::PROTEIN)
    ("CDKN2C" . SPARSER::PROTEIN) ("SOCS3" . SPARSER::PROTEIN)
    ("SOCS2" . SPARSER::PROTEIN) ("BCL6" . SPARSER::PROTEIN)
    ("PIM-1" . SPARSER::PROTEIN)
    ("Response Element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("IL2RA" . SPARSER::PROTEIN)
    ("severe combined immunodeficiency" . SPARSER::PROTEIN)
    ("PDE4B" . SPARSER::PROTEIN) ("STAT5B" . SPARSER::PROTEIN)
    ("STAT5A" . SPARSER::PROTEIN) ("ENIGMA" . SPARSER::PROTEIN)
    ("Alleles" . SPARSER::ALLELE)
    ("ascertained spliceogenic variants" . SPARSER::VARIANT)
    ("a relevant fraction" . SPARSER::COMPONENT)
    ("all non spliceogenic variants" . SPARSER::VARIANT)
    ("BRCA1 and p" . SPARSER::COLLECTION)
    ("the 5 non spliceogenic variants" . SPARSER::VARIANT)
    ("naturally occurring PTC-containing isoforms" . SPARSER::ISOFORM)
    ("occurring PTC-containing isoforms" . SPARSER::ISOFORM)
    ("SV" . SPARSER::MOLECULE) ("SSF" . SPARSER::PROTEIN)
    ("GS and SP" . SPARSER::COLLECTION) ("SP" . SPARSER::PROTEIN)
    ("GS" . SPARSER::PROTEIN-FAMILY) ("HSF" . SPARSER::PROTEIN)
    ("MES" . SPARSER::MOLECULE) ("Ri" . SPARSER::MOLECULE)
    ("the N-terminal fragment and the p" . SPARSER::COLLECTION)
    ("The BRCA2 wild-type and p" . SPARSER::COLLECTION)
    ("thrombin" . SPARSER::PROTEIN)
    ("mutant resin-bound GST-BRCA2 DBD polypeptides" . SPARSER::PROTEIN)
    ("GFP-DSS1" . SPARSER::COLLECTION) ("GST-BRCA2" . SPARSER::COLLECTION)
    ("spliceogenic UVs" . SPARSER::PROTEIN)
    ("the exonic variants" . SPARSER::VARIANT)
    ("the G allele and 5 (10%)" . SPARSER::COLLECTION)
    ("A SNP (exon 10; rs144848) and the c" . SPARSER::COLLECTION)
    ("the identified spliceogenic alleles" . SPARSER::ALLELE)
    ("an entire exon" . SPARSER::PROTEIN)
    ("the remaining spliceogenic variants" . SPARSER::VARIANT)
    ("BRCA1 and c" . SPARSER::COLLECTION)
    ("BRCA1, and c" . SPARSER::COLLECTION)
    ("the natural acceptor" . SPARSER::MOLECULE)
    ("PTC" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DSS1 and ssDNA" . SPARSER::COLLECTION)
    ("PTCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UVs" . SPARSER::PROTEIN)
    ("class 2" . SPARSER::PROTEIN) ("class 4" . SPARSER::PROTEIN)
    ("group B" . SPARSER::PROTEIN) ("group A" . SPARSER::PROTEIN)
    ("NG2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Group B" . SPARSER::PROTEIN)
    ("Group A" . SPARSER::PROTEIN) ("DSS1" . SPARSER::PROTEIN)
    ("a pro-apoptotic gene" . SPARSER::GENE)
    ("HB-EGF, DcR1 and DcR2" . SPARSER::COLLECTION) ("DcR1" . SPARSER::PROTEIN)
    ("HIF-1α and p53 transactional activated NDRG2" . SPARSER::PROTEIN)
    ("HIF-1α and p53" . SPARSER::COLLECTION)
    ("focal ischemia" . SPARSER::PROTEIN)
    ("OGD, and ischemia" . SPARSER::COLLECTION)
    ("NDRG2 and Bcl-2" . SPARSER::COLLECTION)
    ("ischemic penumbra" . SPARSER::PROTEIN)
    ("p53-specific siRNA (p53 siRNA) or scramble siRNA" . SPARSER::COLLECTION)
    ("pEGFP-C1 constructs expressing p53 (p53 vector), pEGFP-C1 (vector), p53-specific siRNA (p53 siRNA) or scramble siRNA"
     . SPARSER::COLLECTION)
    ("a pro-apoptotic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Bax and Bcl-2" . SPARSER::COLLECTION)
    ("NDRG2-specific siRNA (NDRG2 siRNA) or scramble siRNA"
     . SPARSER::COLLECTION)
    ("pEGFP-C1 constructs expressing NDRG2 (NDRG2 vector), pEGFP-C1 (vector), NDRG2-specific siRNA (NDRG2 siRNA) or scramble siRNA"
     . SPARSER::COLLECTION)
    ("Both NDRG2 mRNA ( xref ) and protein ( xref )" . SPARSER::COLLECTION)
    ("C6-originated Astrocytes" . SPARSER::PROTEIN)
    ("NDRG1, NDRG3 and NDRG4" . SPARSER::COLLECTION)
    ("NDRG" . SPARSER::PROTEIN-FAMILY)
    ("C6-originated astrocytes" . SPARSER::PROTEIN)
    ("a p53-associated regulator" . SPARSER::PROTEIN)
    ("Bax/Bcl-2" . SPARSER::COLLECTION) ("penumbra" . SPARSER::PROTEIN)
    ("DcR2" . SPARSER::PROTEIN) ("I/R" . SPARSER::PROTEIN)
    ("NDRG4" . SPARSER::PROTEIN) ("NDRG3" . SPARSER::PROTEIN)
    ("NDRG2" . SPARSER::PROTEIN)
    ("N-myc downstream-regulated gene 2" . SPARSER::PROTEIN)
    ("NU6027 and cisplatin" . SPARSER::COLLECTION) ("EM9" . SPARSER::PROTEIN)
    ("C11 and EM" . SPARSER::COLLECTION)
    ("XRCC1 and ATR" . SPARSER::COLLECTION) ("EM-C11" . SPARSER::COLLECTION)
    ("NU6027 and VE-821" . SPARSER::COLLECTION) ("SSBs" . SPARSER::PROTEIN)
    ("oxidative base" . SPARSER::PROTEIN)
    ("cisplatin and ATR" . SPARSER::COLLECTION)
    ("XRCC1 proficient CHO" . SPARSER::PROTEIN)
    ("XRCC1-LIG3" . SPARSER::COLLECTION) ("S1 B" . SPARSER::PROTEIN)
    ("–3 µ" . SPARSER::PROTEIN) ("in Chinese Hamster" . SPARSER::PROTEIN)
    ("anti -" . SPARSER::ANTIBODY)
    ("Glyceraldehyde 3-phosphate" . SPARSER::MOLECULE)
    ("VE-821" . SPARSER::DRUG) ("HR 2" . SPARSER::PROTEIN)
    ("gene 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("NU6027" . SPARSER::DRUG)
    ("LIG3" . SPARSER::PROTEIN) ("Cho" . SPARSER::PROTEIN)
    ("the MDM2 promoter and causes overexpression of MDM2"
     . SPARSER::COLLECTION)
    ("TT, OR = 1.18" . SPARSER::COLLECTION)
    ("an ubiquitin protein ligase and controls p53" . SPARSER::COLLECTION)
    ("exogenous factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("food, smoking, and Helicobacter pylori" . SPARSER::COLLECTION)
    ("TT, OR = 1" . SPARSER::COLLECTION) ("GT/TT" . SPARSER::COLLECTION)
    ("MDM 2" . SPARSER::PROTEIN)
    ("transcription factor Sp1" . SPARSER::PROTEIN)
    ("ubiquitin protein ligase" . SPARSER::PROTEIN)
    ("Torin1 and AZD8055" . SPARSER::COLLECTION)
    ("LDH, PDH and hexokinase" . SPARSER::COLLECTION)
    ("hexokinase" . SPARSER::PROTEIN)
    ("metformin and phenformin" . SPARSER::COLLECTION)
    ("the oxidative arm" . SPARSER::PROTEIN) ("pentose" . SPARSER::MOLECULE)
    ("BIM-EL" . SPARSER::COLLECTION)
    ("PRAS40 and FOXO1/3a" . SPARSER::COLLECTION)
    ("PTEN/LKB1" . SPARSER::COLLECTION) ("mTOR and MAPK" . SPARSER::COLLECTION)
    ("cyclin D1, and cyclin D3" . SPARSER::COLLECTION)
    ("Torin 1 and AZD8055" . SPARSER::COLLECTION)
    ("pS6 and AKT" . SPARSER::COLLECTION)
    ("mTORC1-mTORC2" . SPARSER::COLLECTION)
    ("pS6 or pAKT" . SPARSER::COLLECTION)
    ("ErbB2 and Cre" . SPARSER::COLLECTION)
    ("LKB1 and HER2" . SPARSER::COLLECTION)
    ("LKB1 and oncogenes" . SPARSER::COLLECTION)
    ("proteins and genes" . SPARSER::COLLECTION)
    ("dehydrogenase (PDH)" . SPARSER::PROTEIN)
    ("the essential amino acid methionine" . SPARSER::MOLECULE)
    ("the oxidative substrate α-ketoglutarate" . SPARSER::MOLECULE)
    ("amino acids (BCAA)" . SPARSER::AMINO-ACID)
    ("valine and leucine" . SPARSER::COLLECTION) ("BCAA" . SPARSER::PROTEIN)
    ("LDH and PDH" . SPARSER::COLLECTION) ("PDH" . SPARSER::PROTEIN)
    ("AMPK/mTOR" . SPARSER::COLLECTION) ("Metabolites" . SPARSER::MOLECULE)
    ("quinazoline" . SPARSER::MOLECULE) ("BIBW" . SPARSER::DRUG)
    ("the EGFR (ErbB1) and HER2" . SPARSER::COLLECTION)
    ("a next generation small molecule" . SPARSER::MOLECULE)
    ("ribonucleoside (AICAR)" . SPARSER::MOLECULE)
    ("ribonucleoside" . SPARSER::MOLECULE) ("Rapa" . SPARSER::DRUG)
    ("ErbB1/ErbB2" . SPARSER::COLLECTION)
    ("mTORC1/mTORC2" . SPARSER::COLLECTION)
    ("mTOR and ErbB2" . SPARSER::COLLECTION)
    ("ErbB2, and pS6" . SPARSER::COLLECTION)
    ("Neu/HER2-MMTV-Cre (FVB)" . SPARSER::COLLECTION)
    ("Herceptin" . SPARSER::DRUG)
    ("phosphatase and tensin homolog (PTEN)" . SPARSER::PROTEIN)
    ("Neu/HER2" . SPARSER::COLLECTION) ("LKB1 and c-Myc" . SPARSER::COLLECTION)
    ("gene (BLG)" . SPARSER::PROTEIN) ("-Cre" . SPARSER::COLLECTION)
    ("whereby several pivotal proteins" . SPARSER::PROTEIN)
    ("AMPK, AKT and S6 kinase" . SPARSER::COLLECTION)
    ("tuberin" . SPARSER::PROTEIN)
    ("STRAD and adaptor protein" . SPARSER::COLLECTION)
    ("LKB1 and ERα" . SPARSER::COLLECTION)
    ("LKB1-AMPK-mTOR" . SPARSER::COLLECTION)
    ("ErbB2-AKT-mTORC2" . SPARSER::COLLECTION)
    ("LKB1-AMPK-mTORC1" . SPARSER::COLLECTION)
    ("AZD8055 and Torin1" . SPARSER::COLLECTION)
    ("enzymes and metabolites" . SPARSER::COLLECTION)
    ("ribosomal protein S6 and AKT" . SPARSER::COLLECTION)
    ("lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Neu/HER2-MMTV-Cre (NIC)" . SPARSER::COLLECTION)
    ("Neu/HER2-MMTV-Cre" . SPARSER::COLLECTION)
    ("anti-diabetic" . SPARSER::DRUG)
    ("N-myc downstream regulated gene1" . SPARSER::PROTEIN)
    ("PRAS40" . SPARSER::PROTEIN) ("PP242" . SPARSER::DRUG)
    ("α-ketoglutarate" . SPARSER::MOLECULE)
    ("5- aminoimidazole-4-carboxamide" . SPARSER::MOLECULE)
    ("beta-lactoglobulin" . SPARSER::PROTEIN)
    ("phosphoinositide 3-kinase" . SPARSER::PROTEIN)
    ("LKB1-AMPK" . SPARSER::PROTEIN) ("Torin1" . SPARSER::DRUG)
    ("AZD8055" . SPARSER::DRUG) ("ribosomal protein S6" . SPARSER::PROTEIN)
    ("BIM and PUMA" . SPARSER::COLLECTION) ("NOX" . SPARSER::PROTEIN)
    ("PKC δ and ER" . SPARSER::COLLECTION)
    ("SMC and macrophages" . SPARSER::COLLECTION)
    ("GRP78 and GRP94" . SPARSER::COLLECTION)
    ("thapsigargin" . SPARSER::MOLECULE)
    ("IRE1 α and CHOP, and JNK" . SPARSER::COLLECTION)
    ("CHOP, and JNK" . SPARSER::COLLECTION) ("BIM" . SPARSER::PROTEIN)
    ("-TRAF2-JNK" . SPARSER::COLLECTION) ("eIF2" . SPARSER::PROTEIN)
    ("eIF" . SPARSER::PROTEIN) ("PERK, IRE1 α and ATF6" . SPARSER::COLLECTION)
    ("IRE1/JNK" . SPARSER::COLLECTION)
    ("a cell permeable form" . SPARSER::FORM)
    ("PEG-catalase" . SPARSER::COLLECTION) ("UI" . SPARSER::PROTEIN)
    ("PEG" . SPARSER::PROTEIN) ("catalase" . SPARSER::PROTEIN)
    ("a pro-apoptotic PKC δ catalytic fragment" . SPARSER::FRAGMENT)
    ("ApoB" . SPARSER::PROTEIN)
    ("human vascular smooth muscle" . SPARSER::PROTEIN)
    ("either GFP (AdGFP) or a PKC δ –GFP (AdPKC δ –GFP) fusion protein ( xref )"
     . SPARSER::COLLECTION)
    ("–GFP" . SPARSER::COLLECTION) ("antimycin" . SPARSER::DRUG)
    ("the pro-apoptotic protein Bak" . SPARSER::PROTEIN)
    ("GADD" . SPARSER::PROTEIN) ("serine–threonine" . SPARSER::COLLECTION)
    ("SMC" . SPARSER::PROTEIN) ("chaperones" . SPARSER::PROTEIN)
    ("redox or calcium" . SPARSER::COLLECTION) ("PERK" . SPARSER::PROTEIN)
    ("/JNK" . SPARSER::COLLECTION) ("OxLDL" . SPARSER::PROTEIN)
    ("oxLDL" . SPARSER::PROTEIN) ("thiobarbituric acid" . SPARSER::MOLECULE)
    ("α -actin" . SPARSER::PROTEIN) ("z-VAD-FMK" . SPARSER::DRUG)
    ("H 2 DCFDA" . SPARSER::DRUG) ("GRP94" . SPARSER::PROTEIN)
    ("GRP78" . SPARSER::PROTEIN) ("Asp–Glu" . SPARSER::MOLECULE)
    ("CL-2" . SPARSER::PROTEIN) ("p 53" . SPARSER::PROTEIN)
    ("TRAF2" . SPARSER::PROTEIN) ("IRE1" . SPARSER::PROTEIN)
    ("VAS2870" . SPARSER::DRUG) ("18 h" . SPARSER::PROTEIN)
    ("superoxide anion" . SPARSER::MOLECULE) ("TNF α" . SPARSER::PROTEIN)
    ("C/EBP homologous protein" . SPARSER::PROTEIN)
    ("activating transcription factor 6" . SPARSER::PROTEIN)
    ("RNA-dependent protein kinase" . SPARSER::PROTEIN)
    ("IRE1 α" . SPARSER::PROTEIN) ("PKC δ" . SPARSER::PROTEIN)
    ("the EBV viral homologue" . SPARSER::PROTEIN)
    ("Bcl-2 and BHRF1" . SPARSER::COLLECTION)
    ("proteins, Bcl-xL and BHRF1" . SPARSER::COLLECTION)
    ("apoptotic or antiapoptotic proteins" . SPARSER::PROTEIN)
    ("doxorubicin or etoposide" . SPARSER::COLLECTION)
    ("cytochrome c and pro-apoptotic Bax" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("the soluble cytosolic fraction" . SPARSER::COMPONENT)
    ("two different siRNA, si-VRK2-06 ( xref ) and si-VRK2-M ( xref )"
     . SPARSER::COLLECTION)
    ("cytochrome c and PARP" . SPARSER::COLLECTION)
    ("the proximal BAX gene promoter" . SPARSER::PROMOTER)
    ("BCL2 and Bcl-xl" . SPARSER::COLLECTION)
    ("Bcl-xL or Bax" . SPARSER::COLLECTION)
    ("Bcl-xL and Bax" . SPARSER::COLLECTION)
    ("VRK2A and Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-xL–Bax" . SPARSER::COLLECTION) ("VRK2A–Bcl-xL" . SPARSER::COLLECTION)
    ("Bcl-2 or Bax" . SPARSER::COLLECTION) ("VRK2A" . SPARSER::PROTEIN)
    ("the associated endogenous proteins" . SPARSER::PROTEIN)
    ("GST-VRK2A" . SPARSER::COLLECTION)
    ("the proapoptotic Bax" . SPARSER::PROTEIN)
    ("Bcl-xL, Bcl-2 and Bax" . SPARSER::COLLECTION)
    ("Ras and B-Raf" . SPARSER::COLLECTION)
    ("signalosomes" . SPARSER::BIO-COMPLEX) ("VRK" . SPARSER::PROTEIN-FAMILY)
    ("a viral homologue" . SPARSER::PROTEIN)
    ("Bid, or inhibitors" . SPARSER::COLLECTION)
    ("camptothecin or doxorubicin" . SPARSER::COLLECTION)
    ("annexinV" . SPARSER::PROTEIN)
    ("cytochrome C and caspase" . SPARSER::COLLECTION)
    ("its proximal promoter" . SPARSER::PROMOTER) ("BAX" . SPARSER::PROTEIN)
    ("Bcl-2, Bax, Bad, PUMA or Binp-3L" . SPARSER::COLLECTION)
    ("whose VRK2A isoform" . SPARSER::ISOFORM)
    ("Ser-Thr" . SPARSER::COLLECTION) ("β -actin" . SPARSER::PROTEIN)
    ("Cytochrome oxidase" . SPARSER::PROTEIN)
    ("p8" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DiOC 6" . SPARSER::DRUG)
    ("sensitive to apoptosis" . SPARSER::PROTEIN) ("IL-1 β" . SPARSER::PROTEIN)
    ("JIP-1" . SPARSER::PROTEIN) ("NFAT1" . SPARSER::PROTEIN)
    ("DiOC6" . SPARSER::DRUG) ("Membrane-bound" . SPARSER::PROTEIN)
    ("KSR1" . SPARSER::PROTEIN) ("interleukin-1 β" . SPARSER::PROTEIN)
    ("JIP1" . SPARSER::PROTEIN) ("GTPase Ran" . SPARSER::PROTEIN)
    ("VRK1" . SPARSER::PROTEIN) ("Bnip3" . SPARSER::PROTEIN)
    ("cytochrome C" . SPARSER::PROTEIN) ("VRK2" . SPARSER::PROTEIN)
    ("an as yet unknown functional variant" . SPARSER::VARIANT)
    ("nucleosomal histones" . SPARSER::PROTEIN)
    ("canonical HDACs" . SPARSER::PROTEIN) ("AHA" . SPARSER::MOLECULE)
    ("HDAC9 and SMM" . SPARSER::COLLECTION)
    ("all arterial beds strong HDAC9" . SPARSER::PROTEIN)
    ("CCA" . SPARSER::PROTEIN) ("intima-media" . SPARSER::COLLECTION)
    ("PG-M" . SPARSER::PROTEIN) ("leukocyte common antigen" . SPARSER::PROTEIN)
    ("PECAM1" . SPARSER::PROTEIN) ("isoform 6" . SPARSER::PROTEIN)
    ("isoform 1" . SPARSER::PROTEIN)
    ("an essential DNA replication factor Mcm10" . SPARSER::PROTEIN)
    ("respective protein" . SPARSER::PROTEIN)
    ("Mcm10/SIRT1" . SPARSER::COLLECTION) ("higher DNA-damage" . SPARSER::DNA)
    ("DNA2 and FEN1" . SPARSER::COLLECTION) ("cohesin" . SPARSER::PROTEIN)
    ("Cdt1 and Mcm2–7" . SPARSER::COLLECTION)
    ("oligosaccharide" . SPARSER::MOLECULE) ("OB" . SPARSER::PROTEIN)
    ("Mcm10–SIRT1" . SPARSER::COLLECTION)
    ("multiple possible targets" . SPARSER::TARGET-PROTEIN)
    ("Mcm10, ID and CTD" . SPARSER::COLLECTION)
    ("SIRT1 and Mcm10" . SPARSER::COLLECTION)
    ("the control siRNA entered G2/M" . SPARSER::PROTEIN)
    ("Mcm2" . SPARSER::PROTEIN)
    ("the nuclear soluble Mcm10" . SPARSER::PROTEIN) ("mix" . SPARSER::PROTEIN)
    ("the conserved ID and the metazoan-specific CTD" . SPARSER::COLLECTION)
    ("four single lysines and six pairs" . SPARSER::COLLECTION)
    ("NIA" . SPARSER::PROTEIN) ("ID and CTD" . SPARSER::COLLECTION)
    ("Purified FL Mcm10 and its NTD, ID and CTD (see xref D)"
     . SPARSER::COLLECTION)
    ("NTD, ID and CTD" . SPARSER::COLLECTION) ("Mcm10-" . SPARSER::PROTEIN)
    ("SIRT2, SIRT5, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("SIRT1–Mcm10" . SPARSER::COLLECTION) ("SIRTs" . SPARSER::PROTEIN)
    ("Flag-SIRT1" . SPARSER::COLLECTION) ("SIRT" . SPARSER::PROTEIN)
    ("anti-Mcm10 or anti-Flag" . SPARSER::COLLECTION)
    ("antibodies, and complexes" . SPARSER::COLLECTION)
    ("Mcm10-SIRTs" . SPARSER::PROTEIN-PAIR)
    ("the most robust deacetylases" . SPARSER::PROTEIN)
    ("SIRT1 and SIRT2" . SPARSER::COLLECTION)
    ("Mcm10 and sirtuin" . SPARSER::COLLECTION)
    ("SIRT1, SIRT2, SIRT5, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("p53, E2F1, FOXO1 and FOXO3a" . SPARSER::COLLECTION)
    ("Ku70, WRN, NBS and XPA" . SPARSER::COLLECTION) ("NBS" . SPARSER::PROTEIN)
    ("WRN" . SPARSER::PROTEIN) ("Mcm10 and Sir2" . SPARSER::COLLECTION)
    ("SIRT3, SIRT4 and SIRT5" . SPARSER::COLLECTION)
    ("SIRT1, SIRT6 and SIRT7" . SPARSER::COLLECTION)
    ("histone deacetylase (HDAC)" . SPARSER::PROTEIN)
    ("a soluble complex" . SPARSER::BIO-COMPLEX)
    ("And1/Ctf4" . SPARSER::COLLECTION) ("primase" . SPARSER::PROTEIN)
    ("DNA and replisome protein components ( xref )" . SPARSER::COLLECTION)
    ("Cdc45 and additional initiator proteins" . SPARSER::COLLECTION)
    ("Mcm10, Cdc45 and additional initiator proteins" . SPARSER::COLLECTION)
    ("cyclin-dependent kinases and the Cdc7/Dbf4 kinase complex"
     . SPARSER::COLLECTION)
    ("Cdc7/Dbf4" . SPARSER::COLLECTION)
    ("Cdc6, Cdt1 and Mcm2–7" . SPARSER::COLLECTION)
    ("preRCs" . SPARSER::BIO-COMPLEX)
    ("a macromolecular protein complex" . SPARSER::BIO-COMPLEX)
    ("preRC" . SPARSER::BIO-COMPLEX) ("Mcm10 and SIRT1" . SPARSER::COLLECTION)
    ("The eukaryotic DNA replication initiation factor Mcm10"
     . SPARSER::PROTEIN)
    ("replisome" . SPARSER::BIO-COMPLEX)
    ("DNA replication factor" . SPARSER::PROTEIN) ("FEN1" . SPARSER::PROTEIN)
    ("DNA2" . SPARSER::PROTEIN) ("HDAC11" . SPARSER::PROTEIN)
    ("HBO1" . SPARSER::PROTEIN) ("Two domains" . SPARSER::PROTEIN)
    ("ID 1" . SPARSER::PROTEIN) ("Polynucleotide Kinase" . SPARSER::PROTEIN)
    ("nonyl phenoxypolyethoxylethanol" . SPARSER::MOLECULE)
    ("Acetyl-CoA" . SPARSER::MOLECULE) ("p300 HAT" . SPARSER::PROTEIN)
    ("D-1" . SPARSER::PROTEIN) ("aa 1" . SPARSER::PROTEIN)
    ("hSIRT1" . SPARSER::PROTEIN) ("SIRT5" . SPARSER::PROTEIN)
    ("SIRT4" . SPARSER::PROTEIN) ("SIRT3" . SPARSER::PROTEIN)
    ("SIRT7" . SPARSER::PROTEIN) ("SIRT6" . SPARSER::PROTEIN)
    ("Ctf4" . SPARSER::PROTEIN) ("And1" . SPARSER::PROTEIN)
    ("Dbf4" . SPARSER::PROTEIN) ("Cdc7" . SPARSER::PROTEIN)
    ("pre-replicative complex" . SPARSER::BIO-COMPLEX)
    ("Mcm10" . SPARSER::PROTEIN) ("RT and hTERT" . SPARSER::COLLECTION)
    ("the enzyme's" . SPARSER::PROTEIN) ("TERTs" . SPARSER::PROTEIN)
    ("maximal telomerase activity" . SPARSER::PROTEIN)
    ("a processive enzyme" . SPARSER::ENZYME)
    ("hTR and WT hTERT" . SPARSER::COLLECTION)
    ("hTERT and hTR" . SPARSER::COLLECTION)
    ("hTR and mutant" . SPARSER::COLLECTION)
    ("overexpressed telomerase components" . SPARSER::COMPONENT)
    ("dTTP" . SPARSER::MOLECULE) ("dGTPs" . SPARSER::DGTP)
    ("dGTP" . SPARSER::DGTP) ("dATP" . SPARSER::DATP)
    ("TRF" . SPARSER::PROTEIN) ("hTERT-" . SPARSER::PROTEIN)
    ("hTERTs" . SPARSER::PROTEIN) ("telomerases" . SPARSER::PROTEIN)
    ("hTR and the various hTERTs" . SPARSER::COLLECTION)
    ("telomerase activity or DNA" . SPARSER::COLLECTION)
    ("TRAP" . SPARSER::PROTEIN) ("hTR" . SPARSER::PROTEIN)
    ("valine and tryptophan" . SPARSER::COLLECTION)
    ("the pharmacological nonnucleosidic compound BIBR1532" . SPARSER::DRUG)
    ("Telomerases" . SPARSER::PROTEIN)
    ("hTERT and HIV-1 RT" . SPARSER::COLLECTION) ("RAP" . SPARSER::PROTEIN)
    ("substrate or primer" . SPARSER::COLLECTION) ("TRBD" . SPARSER::PROTEIN)
    ("the telomerase reverse transcriptase (TERT) and the telomerase RNA (TR)"
     . SPARSER::COLLECTION)
    ("RNA (TR)" . SPARSER::RNA)
    ("reverse transcriptase (RT)" . SPARSER::PROTEIN)
    ("shelterin" . SPARSER::PROTEIN) ("SFEs" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase (TERT) and an integrally associated RNA"
     . SPARSER::COLLECTION)
    ("an integrally associated RNA" . SPARSER::RNA)
    ("ribonucleoprotein" . SPARSER::PROTEIN)
    ("telomerase RNA component" . SPARSER::RNA) ("HA5" . SPARSER::PROTEIN)
    ("BIBR1532" . SPARSER::DRUG) ("front-line" . SPARSER::PROTEIN)
    ("the drug's" . SPARSER::DRUG)
    ("the pathogeneic trigger" . SPARSER::PROTEIN)
    ("A plausible case" . SPARSER::PROTEIN)
    ("certain ribosomal proteins" . SPARSER::PROTEIN)
    ("phosphatase or Cdc14-like" . SPARSER::COLLECTION)
    ("caffeine-" . SPARSER::MOLECULE)
    ("the Fucci dual-color FACS and the DAPI" . SPARSER::COLLECTION)
    ("caffeine or UCN-01" . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and Rad3-related protein (ATR)"
     . SPARSER::COLLECTION)
    ("ataxia telangiectasia and Rad3-related protein (ATR)"
     . SPARSER::COLLECTION)
    ("protein (ATR)" . SPARSER::PROTEIN) ("Caffeine" . SPARSER::MOLECULE)
    ("protein–checkpoint kinase 1" . SPARSER::COLLECTION)
    ("a 2- or 4-h" . SPARSER::COLLECTION)
    ("a 2-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Simultaneous flow cytometry" . SPARSER::PROTEIN)
    ("nucleolar components" . SPARSER::COMPONENT)
    ("the aforementioned nucleostemin" . SPARSER::PROTEIN)
    ("nucleostemin" . SPARSER::PROTEIN)
    ("–checkpoint kinase 1" . SPARSER::COLLECTION)
    ("ATR and Chk1" . SPARSER::COLLECTION) ("H2A.X" . SPARSER::PROTEIN)
    ("RNA polymerase I" . SPARSER::PROTEIN)
    ("Diamond–Blackfan anemia" . SPARSER::PROTEIN)
    ("Cdc14" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UCN-01" . SPARSER::DRUG)
    ("cdk2/cyclin-A" . SPARSER::COLLECTION)
    ("Cdk2/cyclin-A" . SPARSER::COLLECTION) ("/Aurora-A" . SPARSER::COLLECTION)
    ("centrin and Aurora-A" . SPARSER::COLLECTION)
    ("HU and shRNA" . SPARSER::COLLECTION) ("HU" . SPARSER::DRUG)
    ("the centrosomal protein centrin and the mitotic kinase Aurora-A"
     . SPARSER::COLLECTION)
    ("the mitotic kinase Aurora-A" . SPARSER::PROTEIN)
    ("the centrosomal protein centrin" . SPARSER::PROTEIN)
    ("centrin" . SPARSER::PROTEIN) ("Cdk2 and Aurora-A" . SPARSER::COLLECTION)
    ("Aurora-A mitotic kinase" . SPARSER::KINASE)
    ("oncogene and tumor" . SPARSER::COLLECTION)
    ("conventional chemotherapeutic drugs" . SPARSER::DRUG)
    ("Alisertib" . SPARSER::DRUG) ("defective p53" . SPARSER::PROTEIN)
    ("cyclin-A/Cdk2" . SPARSER::COLLECTION) ("DNp" . SPARSER::DRUG)
    ("cdk2" . SPARSER::PROTEIN) ("Aurora A" . SPARSER::PROTEIN)
    ("RNA polymerase" . SPARSER::PROTEIN) ("DRaf-1" . SPARSER::PROTEIN)
    ("SU9516" . SPARSER::DRUG) ("Aurora-A" . SPARSER::PROTEIN)
    ("cyclin-A" . SPARSER::PROTEIN) ("Smo and Sufu" . SPARSER::COLLECTION)
    ("Sufu" . SPARSER::PROTEIN) ("K-ras or B-raf" . SPARSER::COLLECTION)
    ("itraconazole" . SPARSER::DRUG)
    ("Phospho-mimetic Gli1" . SPARSER::PROTEIN)
    ("aPKC and Gli1" . SPARSER::COLLECTION)
    ("HA:Gli1 or HA:Gli1" . SPARSER::COLLECTION)
    ("HA:Gli1" . SPARSER::BIO-COMPLEX) ("HIS" . SPARSER::AMINO-ACID)
    ("Gli2 or Gli3" . SPARSER::COLLECTION) ("Gli2" . SPARSER::PROTEIN)
    ("SAG" . SPARSER::PROTEIN) ("cyclopamine or PSI" . SPARSER::COLLECTION)
    ("Pard6A-aPKC" . SPARSER::COLLECTION) ("Par6A" . SPARSER::PROTEIN)
    ("Flag:Gli1" . SPARSER::BIO-COMPLEX)
    ("cyclopamine, gli1 and apkciota" . SPARSER::COLLECTION)
    ("gli1 and apkciota" . SPARSER::COLLECTION) ("Shh" . SPARSER::PROTEIN)
    ("aPKC and P-aPKC" . SPARSER::COLLECTION)
    ("both total and activated aPKC" . SPARSER::PROTEIN)
    ("gli1 or apkc" . SPARSER::COLLECTION) ("cyclopamine" . SPARSER::DRUG)
    ("inhibitor (PSI)" . SPARSER::INHIBITOR)
    ("aPKC or MIM" . SPARSER::COLLECTION)
    ("aPKC and MIM" . SPARSER::COLLECTION)
    ("Pard3 and Pard6A" . SPARSER::COLLECTION)
    ("aPKC and Pard3" . SPARSER::COLLECTION)
    ("kinase, and Pard3" . SPARSER::COLLECTION)
    ("scaffold protein and aPKC" . SPARSER::COLLECTION)
    ("Pard3" . SPARSER::PROTEIN) ("aPKC and Smo" . SPARSER::COLLECTION)
    ("Smo" . SPARSER::PROTEIN) ("Smoothened" . SPARSER::PROTEIN)
    ("BCC" . SPARSER::PROTEIN) ("DNA Polymerase" . SPARSER::PROTEIN)
    ("RNAse H" . SPARSER::PROTEIN) ("DNA Polymerase I" . SPARSER::PROTEIN)
    ("DNA Ligase" . SPARSER::PROTEIN) ("site 2" . SPARSER::PROTEIN)
    ("site 1" . SPARSER::PROTEIN) ("H 10" . SPARSER::PROTEIN)
    ("KI67" . SPARSER::PROTEIN) ("Pard6a" . SPARSER::PROTEIN)
    ("B-raf" . SPARSER::PROTEIN) ("arsenic trioxide" . SPARSER::MOLECULE)
    ("Gli3" . SPARSER::PROTEIN) ("pard6a" . SPARSER::PROTEIN)
    ("Go6983" . SPARSER::DRUG) ("gli1" . SPARSER::PROTEIN)
    ("gamma-tubulin" . SPARSER::PROTEIN) ("Pard6A" . SPARSER::PROTEIN)
    ("centrosome-associated protein" . SPARSER::PROTEIN)
    ("atypical Protein Kinase" . SPARSER::PROTEIN)
    ("mesalamine" . SPARSER::DRUG)
    ("blood-based peripheral biomarkers" . SPARSER::MOLECULE)
    ("a separate (validation) cohort" . SPARSER::MOLECULE)
    ("calprotectin and CRP" . SPARSER::COLLECTION)
    ("calprotectin" . SPARSER::PROTEIN)
    ("any peripheral biomarker" . SPARSER::MOLECULE)
    ("RR 1" . SPARSER::PROTEIN)
    ("clear cell papillary RCC or chRCC" . SPARSER::COLLECTION)
    ("RCC or chRCC" . SPARSER::COLLECTION)
    ("EMT, or EMT and FGFR2" . SPARSER::COLLECTION)
    ("EMT and FGFR2" . SPARSER::COLLECTION)
    ("ESRP1/GRHL2" . SPARSER::COLLECTION)
    ("FGFR2-IIIb and -IIIc" . SPARSER::COLLECTION) ("GSEA" . SPARSER::PROTEIN)
    ("clear cell papillary RCC and chromophobe RCC" . SPARSER::PROTEIN)
    ("RCC and chromophobe" . SPARSER::COLLECTION)
    ("p53 and PTEN" . SPARSER::COLLECTION)
    ("VHL and hypoxia" . SPARSER::COLLECTION) ("HOXB" . SPARSER::PROTEIN)
    ("vimentin (VIM)" . SPARSER::PROTEIN)
    ("mesenchymal markers N-cadherin" . SPARSER::PROTEIN)
    ("claudins" . SPARSER::PROTEIN)
    ("FGFR2 IIIb and IIIc" . SPARSER::COLLECTION)
    ("ESRP1 or GRHL2" . SPARSER::COLLECTION)
    ("possible regulators" . SPARSER::REGULATOR)
    ("normal IIIb" . SPARSER::DRUG) ("ESRP1 and GRHL2" . SPARSER::COLLECTION)
    ("Isoform" . SPARSER::PROTEIN) ("the predominant form" . SPARSER::FORM)
    ("whose major FGFR2 isoform type" . TYPE)
    ("mesenchymal and hypoxic genes" . SPARSER::GENE)
    ("the mesenchymal marker vimentin, chRCC and RO" . SPARSER::COLLECTION)
    ("vimentin, chRCC and RO" . SPARSER::COLLECTION)
    ("papillary RCC" . SPARSER::PROTEIN) ("RO" . SPARSER::PROTEIN)
    ("pRCC" . SPARSER::PROTEIN)
    ("a soluble dominant negative FGFR2 IIIb mutant" . SPARSER::MUTANT)
    ("epithelial IIIb" . SPARSER::DRUG)
    ("FGFR1 and FGFR3" . SPARSER::COLLECTION)
    ("FGFR2 IIIb or IIIc" . SPARSER::COLLECTION)
    ("sulphate" . SPARSER::MOLECULE)
    ("At least 18 FGF ligands" . SPARSER::LIGAND) ("FGFRs" . SPARSER::PROTEIN)
    ("FGFs" . SPARSER::PROTEIN)
    ("transmembrane receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SF3B1" . SPARSER::PROTEIN) ("MDS" . SPARSER::PROTEIN)
    ("PKM" . SPARSER::PROTEIN) ("pyruvate" . SPARSER::PROTEIN)
    ("FGF-2" . SPARSER::PROTEIN) ("Type 3" . SPARSER::PROTEIN)
    ("Type 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AP1M2" . SPARSER::PROTEIN)
    ("CD82" . SPARSER::PROTEIN) ("HOXA4" . SPARSER::PROTEIN)
    ("COL23A1" . SPARSER::PROTEIN) ("CDH2" . SPARSER::PROTEIN)
    ("CLDN4" . SPARSER::PROTEIN) ("KRT7" . SPARSER::PROTEIN)
    ("keratin 7" . SPARSER::PROTEIN) ("GRHL2" . SPARSER::PROTEIN)
    ("ESRP1" . SPARSER::PROTEIN) ("FGFR4" . SPARSER::PROTEIN)
    ("FGF-1" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 2" . SPARSER::PROTEIN)
    ("SF3" . SPARSER::PROTEIN) ("SLC39A14" . SPARSER::PROTEIN)
    ("PKM2" . SPARSER::PROTEIN) ("FGFR2 IIIb" . SPARSER::PROTEIN)
    ("FGFR2-IIIc" . SPARSER::PROTEIN) ("FGFR2-IIIb" . SPARSER::PROTEIN)
    ("MAPK and Hedgehog" . SPARSER::COLLECTION)
    ("PI3 kinase/AKT" . SPARSER::COLLECTION)
    ("BRAF and NRAS" . SPARSER::COLLECTION)
    ("dacarbazine or paclitaxel" . SPARSER::COLLECTION)
    ("dacarbazine" . SPARSER::DRUG) ("Trametinib" . SPARSER::DRUG)
    ("trametinib" . SPARSER::DRUG)
    ("selumetinib and temozolomide" . SPARSER::COLLECTION)
    ("selumetinib or temozolomide" . SPARSER::COLLECTION)
    ("Selumetinib" . SPARSER::DRUG) ("vemurafenib" . SPARSER::DRUG)
    ("kinase and MEK" . SPARSER::COLLECTION)
    ("MAP2K1, PTEN, CDKN2A, PITCH1, and GRIN2A" . SPARSER::COLLECTION)
    ("MEK and BRAF" . SPARSER::COLLECTION)
    ("NF1 and EGFR" . SPARSER::COLLECTION) ("MITF" . SPARSER::PROTEIN)
    ("CDKN2A, EPHA6, GRIN2A, MAP2K1, NOTCH2, PTPRD , ARID1A , and PTCH1"
     . SPARSER::COLLECTION)
    ("PTPRD" . SPARSER::PROTEIN) ("ipilimumab" . SPARSER::DRUG)
    ("a BRAF or NRAS-mutated melanoma" . SPARSER::COLLECTION)
    ("MEK-ERK" . SPARSER::COLLECTION) ("usually BRAF V600E" . SPARSER::PROTEIN)
    ("phosphorylated-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("bid" . SPARSER::PROTEIN) ("selumetinib" . SPARSER::DRUG)
    ("MEK162" . SPARSER::DRUG) ("PTCH1" . SPARSER::PROTEIN)
    ("NOTCH2" . SPARSER::PROTEIN) ("GRIN2A" . SPARSER::PROTEIN)
    ("ARRY-142886" . SPARSER::DRUG)
    ("Mcl-1 (NF-κB target gene) and phospho-S6 ribosomal protein (mTOR target)"
     . SPARSER::COLLECTION)
    ("Ki67 and CD31" . SPARSER::COLLECTION) ("neutrophil" . SPARSER::PROTEIN)
    ("MTD" . SPARSER::PROTEIN)
    ("Alanine transaminase (ALT) and aspartate transaminase (AST)"
     . SPARSER::COLLECTION)
    ("transaminase (AST)" . SPARSER::PROTEIN)
    ("transaminase (ALT)" . SPARSER::PROTEIN) ("AST" . SPARSER::PROTEIN)
    ("ALT" . SPARSER::PROTEIN) ("Alanine" . SPARSER::AMINO-ACID)
    ("Balb/c" . SPARSER::COLLECTION) ("octanol" . SPARSER::MOLECULE)
    ("acceptors" . SPARSER::MOLECULE) ("Wt" . SPARSER::PROTEIN)
    ("IL-8, VEGF, ICAM1 and MMP-9" . SPARSER::COLLECTION)
    ("Bcl-xL/XIAP/Survivin" . SPARSER::COLLECTION)
    ("Mcl-1, Bcl-xL, XIAP and Survivin" . SPARSER::COLLECTION)
    ("Bcl-xL, XIAP and Survivin" . SPARSER::COLLECTION)
    ("XIAP and Survivin" . SPARSER::COLLECTION)
    ("Survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mcl-1 and Bcl-xL" . SPARSER::COLLECTION)
    ("E2F, PCNA and Cyclin D1" . SPARSER::COLLECTION)
    ("S6K and eIF4EBP1" . SPARSER::COLLECTION)
    ("PARP/H2B" . SPARSER::COLLECTION) ("AsPC" . SPARSER::PROTEIN)
    ("IκBα, S6K and eIF4EBP1" . SPARSER::COLLECTION)
    ("eIF4EBP1" . SPARSER::PROTEIN)
    ("p-IKKβ/mTOR/p-S6K/p-eIF4EBP" . SPARSER::COLLECTION)
    ("p-IKKβ/p-IκBα/NF-κB" . SPARSER::COLLECTION)
    ("IL-1 and TNFα" . SPARSER::COLLECTION)
    ("TRKA and IKKβ" . SPARSER::COLLECTION) ("prolactin" . SPARSER::PROTEIN)
    ("TRKA, IKKβ, EPHA6 and Nek3" . SPARSER::COLLECTION)
    ("TRKA" . SPARSER::PROTEIN)
    ("IKKβ and targets NF-κB and mTOR pathway proteins" . SPARSER::COLLECTION)
    ("IKKβ and Kras" . SPARSER::COLLECTION)
    ("mTOR/p-S6K/p-eIF4EBP" . SPARSER::COLLECTION)
    ("mTOR and NF-κB" . SPARSER::COLLECTION)
    ("IκBα, S6K and eIF4EBP" . SPARSER::COLLECTION)
    ("NF-κB and mTOR" . SPARSER::COLLECTION)
    ("p-eIF4EBP" . SPARSER::PROTEIN-PAIR) ("p-S6K" . SPARSER::PROTEIN)
    ("p-IκBα/NF-κB" . SPARSER::COLLECTION)
    ("the canonical NF-κB" . SPARSER::PROTEIN) ("PR3" . SPARSER::PROTEIN)
    ("Nek3" . SPARSER::PROTEIN) ("EPHA6" . SPARSER::PROTEIN)
    ("Ribosomal protein" . SPARSER::PROTEIN)
    ("ribonuclease A" . SPARSER::PROTEIN) ("C−T" . SPARSER::PROTEIN)
    ("Ikbα" . SPARSER::PROTEIN) ("4EBP-1" . SPARSER::PROTEIN)
    ("anti-phospho" . SPARSER::PROTEIN) ("P81" . SPARSER::PROTEIN)
    ("TPCA1" . SPARSER::DRUG) ("tuberous sclerosis 1" . SPARSER::PROTEIN)
    ("βTrCP" . SPARSER::PROTEIN) ("eIF4EBP" . SPARSER::PROTEIN-FAMILY)
    ("Wnt or Hedgehog" . SPARSER::COLLECTION)
    ("CD133 and ALDH" . SPARSER::COLLECTION)
    ("overexpressing constitutively active NICD" . SPARSER::PROTEIN)
    ("SAGE" . SPARSER::PROTEIN)
    ("effectors and inhibitors" . SPARSER::COLLECTION)
    ("sixfold less Annexin V" . SPARSER::PROTEIN)
    ("cisplatin or docetaxel" . SPARSER::COLLECTION)
    ("GFP and Ds-red" . SPARSER::COLLECTION) ("-dim" . SPARSER::COLLECTION)
    ("soluble DLL4" . SPARSER::PROTEIN) ("Hes1 and Hey1" . SPARSER::COLLECTION)
    ("Notch-2 and Notch-4" . SPARSER::COLLECTION)
    ("Notch-1 and Notch-3" . SPARSER::COLLECTION)
    ("the minimal essential CMV promoter" . SPARSER::PROMOTER)
    ("GFP and Luciferase" . SPARSER::COLLECTION) ("GSIs" . SPARSER::PROTEIN)
    ("NICD" . SPARSER::PROTEIN) ("sea" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GFP-dim" . SPARSER::COLLECTION) ("dim" . SPARSER::PROTEIN-FAMILY)
    ("GFP-bright" . SPARSER::COLLECTION)
    ("inhibitor (GSI)" . SPARSER::INHIBITOR) ("GSI" . SPARSER::PROTEIN)
    ("Notch1" . SPARSER::PROTEIN) ("MRK003" . SPARSER::DRUG)
    ("Intracellular Domain 1" . SPARSER::PROTEIN) ("DLL4" . SPARSER::PROTEIN)
    ("Hey1" . SPARSER::PROTEIN) ("Hes1" . SPARSER::PROTEIN)
    ("Notch-3" . SPARSER::PROTEIN) ("Notch-1" . SPARSER::PROTEIN)
    ("Notch-4" . SPARSER::PROTEIN) ("Notch-2" . SPARSER::PROTEIN)
    ("MRK-003" . SPARSER::DRUG) ("γ-secretase" . SPARSER::PROTEIN)
    ("gamma secretase" . SPARSER::PROTEIN) ("Notch3" . SPARSER::PROTEIN)
    ("Gamma secretase" . SPARSER::PROTEIN) ("Hes-1" . SPARSER::PROTEIN)
    ("gamma-secretase" . SPARSER::PROTEIN) ("ILE" . SPARSER::AMINO-ACID)
    ("ARG" . SPARSER::PROTEIN) ("LEU" . SPARSER::AMINO-ACID)
    ("GLY" . SPARSER::PROTEIN) ("THR" . SPARSER::PROTEIN)
    ("CYS" . SPARSER::PROTEIN) ("FAST" . SPARSER::PROTEIN)
    ("Bank" . SPARSER::PROTEIN)
    ("whose bioactive conformation" . SPARSER::BIO-CONFORMATION)
    ("inhibitor TAF089" . SPARSER::PROTEIN) ("TAF" . SPARSER::PROTEIN)
    ("the comprehensive pharmacophore map" . SPARSER::PROTEIN)
    ("The comprehensive pharmacophore map" . SPARSER::PROTEIN)
    ("A comprehensive pharmacophore map" . SPARSER::PROTEIN)
    ("Water" . SPARSER::MOLECULE)
    ("anti-neoplastic and anti-metastatic drugs" . SPARSER::COLLECTION)
    ("dominant-negative fragments" . SPARSER::FRAGMENT)
    ("integrin and growth factor receptors" . SPARSER::COLLECTION)
    ("PB-VS" . SPARSER::COLLECTION) ("PF-573228" . SPARSER::DRUG)
    ("receptor protein" . SPARSER::RECEPTOR-PROTEIN)
    ("mitochondria-associated Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("Bcl-2 and Bcl-XL" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-XL" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-8" . SPARSER::COLLECTION)
    ("caspases-3 and -7" . SPARSER::COLLECTION)
    ("Bcl-2 or Bcl-xL" . SPARSER::COLLECTION) ("Reagent" . SPARSER::MOLECULE)
    ("The mitochondria and cytosol proteins" . SPARSER::COLLECTION)
    ("mouse monoclonal anticytochrome c antibodies" . SPARSER::ANTIBODY)
    ("Deoxycholate" . SPARSER::MOLECULE)
    ("Mitochondria and cytosolic protein" . SPARSER::COLLECTION)
    ("Sucrose" . SPARSER::MOLECULE) ("IgG or anti" . SPARSER::COLLECTION)
    ("PVDF" . SPARSER::DRUG) ("polyacrylamide" . SPARSER::DRUG)
    ("pepstatin" . SPARSER::DRUG) ("leupeptin" . SPARSER::DRUG)
    ("NaF" . SPARSER::PROTEIN) ("EGTA" . SPARSER::PROTEIN)
    ("ice" . SPARSER::PROTEIN) ("paraformaldehyde" . SPARSER::DRUG)
    ("streptomycin" . SPARSER::DRUG) ("Mitochondria" . SPARSER::PROTEIN)
    ("Goat anti-caspase-8 and rabbit anti-PARP antibodies"
     . SPARSER::COLLECTION)
    ("Goat anti-caspase-8" . SPARSER::ANTIBODY) ("Goat" . SPARSER::PROTEIN)
    ("mouse anti-cytochrome c and caspase-6" . SPARSER::COLLECTION)
    ("anti-cytochrome c and caspase-6" . SPARSER::COLLECTION)
    ("G-Rh2-promoted caspase-8" . SPARSER::PROTEIN)
    ("casaspe-3" . SPARSER::COLLECTION)
    ("the pro-apoptotic protein Bid" . SPARSER::PROTEIN)
    ("ligand (TRAIL)" . SPARSER::MOLECULE)
    ("the increased mitochondrial Bax and/or Bak" . SPARSER::COLLECTION)
    ("treated isolated mitochondria" . SPARSER::PROTEIN)
    ("proteins, Bcl-2 and Bcl-xL" . SPARSER::COLLECTION)
    ("the monomeric form" . SPARSER::FORM)
    ("caspase-3 and caspase-7" . SPARSER::COLLECTION)
    ("mitochondrial and caspase-8" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-9" . SPARSER::COLLECTION)
    ("z-DEVD-fmk" . SPARSER::COLLECTION)
    ("caspase-3 and -7" . SPARSER::COLLECTION)
    ("The multi-domain pro-apoptotic molecules Bax and Bak"
     . SPARSER::COLLECTION)
    ("pro-caspase 9" . SPARSER::COLLECTION)
    ("caspase-activating protein" . SPARSER::COLLECTION)
    ("Fas and tumor necrosis factor" . SPARSER::COLLECTION)
    ("WAF1/CIP1" . SPARSER::COLLECTION) ("cyclin E-Cdk2" . SPARSER::COLLECTION)
    ("ginsenoside" . SPARSER::MOLECULE) ("Ginsenosides" . SPARSER::MOLECULE)
    ("Bak and Bax" . SPARSER::COLLECTION) ("Rh2" . SPARSER::PROTEIN)
    ("Rh" . SPARSER::MOLECULE) ("Ginsenoside" . SPARSER::MOLECULE)
    ("caspases-3" . SPARSER::PROTEIN) ("caspase-6" . SPARSER::PROTEIN)
    ("Caspase-6" . SPARSER::PROTEIN) ("Apaf-1" . SPARSER::PROTEIN)
    ("MMTV-HER2" . SPARSER::COLLECTION) ("CTC" . SPARSER::PROTEIN)
    ("Akt-Wnt" . SPARSER::COLLECTION) ("HER2 and RANK" . SPARSER::COLLECTION)
    ("DsRed" . SPARSER::PROTEIN) ("AQUA" . SPARSER::MOLECULE)
    ("HER2 and ALDH1" . SPARSER::COLLECTION)
    ("trastuzumab, the cytotoxic chemotherapy docetaxel, or both"
     . SPARSER::COLLECTION)
    ("the mammary fat" . SPARSER::PROTEIN) ("HER2−" . SPARSER::PROTEIN)
    ("CD24−" . SPARSER::PROTEIN) ("CD24-" . SPARSER::PROTEIN)
    ("HER2 and ALDH" . SPARSER::COLLECTION) ("claudin" . SPARSER::PROTEIN)
    ("aldehyde dehydrogenase (ALDH)" . SPARSER::PROTEIN)
    ("ALDH" . SPARSER::PROTEIN)
    ("trastuzumab and lapatinib" . SPARSER::COLLECTION)
    ("I-κB" . SPARSER::PROTEIN) ("CK8" . SPARSER::PROTEIN)
    ("ALDH1" . SPARSER::PROTEIN) ("aldehyde dehydrogenase" . SPARSER::PROTEIN)
    ("antisense/SMI" . SPARSER::COLLECTION) ("apex" . SPARSER::PROTEIN)
    ("NF-κB and SP1" . SPARSER::COLLECTION)
    ("p53 and AP-2a" . SPARSER::COLLECTION)
    ("factors, NF-κB, SP1, p53 and AP-2" . SPARSER::COLLECTION)
    ("stress-activated kinases" . SPARSER::KINASE)
    ("Bcl-2, Bim or Bax" . SPARSER::COLLECTION)
    ("Mef2, Nur77, AP1, AP2, SP1, Myc/Max, Stat1, p53 and NF-κB"
     . SPARSER::COLLECTION)
    ("Stat" . SPARSER::PROTEIN) ("BimS and BimEL" . SPARSER::COLLECTION)
    ("BimEL" . SPARSER::PROTEIN) ("BimS" . SPARSER::PROTEIN)
    ("at least 3 isoforms" . SPARSER::ISOFORM)
    ("all prosurvival Bcl-2 proteins" . SPARSER::PROTEIN)
    ("proapoptotic Bim" . SPARSER::PROTEIN)
    ("Bim and Bcl-2" . SPARSER::COLLECTION)
    ("apical caspase-9 and subsequent executioner caspase-3"
     . SPARSER::COLLECTION)
    ("pharmacological caspase-3 and general caspase inhibitors"
     . SPARSER::COLLECTION)
    ("subsequent executioner caspase-3" . SPARSER::PROTEIN)
    ("apical caspase-9" . SPARSER::PROTEIN)
    ("normal vascular endothelial" . SPARSER::PROTEIN)
    ("inhibitors (SMI)" . SPARSER::INHIBITOR) ("SMI" . SPARSER::PROTEIN)
    ("BimL" . SPARSER::PROTEIN)
    ("BH3-only proapoptotic Bim" . SPARSER::PROTEIN)
    ("cellular Bcl-2" . SPARSER::PROTEIN) ("Bax/Bim" . SPARSER::COLLECTION)
    ("Bim, Bid, and Puma" . SPARSER::COLLECTION)
    ("receptors, and NF-κB" . SPARSER::COLLECTION)
    ("Bim/Bax" . SPARSER::COLLECTION) ("proapoptotic Bid" . SPARSER::PROTEIN)
    ("antiapoptotic Bcl-2" . SPARSER::PROTEIN)
    ("proapoptotic Bim and Bax" . SPARSER::COLLECTION)
    ("cellular pro- and antiapoptotic Bcl-2 proteins ( xref )"
     . SPARSER::COLLECTION)
    ("cellular pro-" . SPARSER::PROTEIN)
    ("both stress-activated MAPKs p38 and JNK" . SPARSER::COLLECTION)
    ("wt and p53−/−" . SPARSER::COLLECTION) ("Caspases" . SPARSER::PROTEIN)
    ("wt, p53−/−, and Bax" . SPARSER::COLLECTION)
    ("pramanicin" . SPARSER::DRUG) ("mixtures" . SPARSER::MOLECULE)
    ("a racemic mixture" . SPARSER::MOLECULE)
    ("vascular endothelial and Jurkat" . SPARSER::COLLECTION)
    ("Analogs" . SPARSER::ANALOG) ("Cytotoxic" . SPARSER::PROTEIN)
    ("Bax and Bim" . SPARSER::COLLECTION)
    ("p38 and Bcl-2" . SPARSER::COLLECTION) ("alkene" . SPARSER::MOLECULE)
    ("Bak and transmembrane death receptors" . SPARSER::COLLECTION)
    ("transcriptionally upregulating Bax, Bid, Puma, Noxa, Bak and transmembrane death receptors"
     . SPARSER::COLLECTION)
    ("protein or death receptor" . SPARSER::COLLECTION)
    ("pro- and antiapoptotic Bcl-2 proteins" . SPARSER::COLLECTION)
    ("Bim, Bid, Noxa, Bad and Puma" . SPARSER::COLLECTION)
    ("Noxa" . SPARSER::PROTEIN) ("apoptogenic molecules" . SPARSER::MOLECULE)
    ("inflammatory cytokines and growth factors" . SPARSER::COLLECTION)
    ("damage cellular macromolecules" . SPARSER::MOLECULE)
    ("macromolecules" . SPARSER::MOLECULE)
    ("Upstream serine/threonine kinases MAP kinase kinase kinases (MEKKs) and MAP kinase kinases (MKKs)"
     . SPARSER::COLLECTION)
    ("MKKs" . SPARSER::PROTEIN) ("MEKKs" . SPARSER::PROTEIN)
    ("stress-activated MAPKs p38 and JNK" . SPARSER::COLLECTION)
    ("cytokines or death receptor" . SPARSER::COLLECTION)
    ("p38 and JNK" . SPARSER::COLLECTION)
    ("both stress-related kinases p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK)"
     . SPARSER::COLLECTION)
    ("kinase (JNK)" . SPARSER::KINASE) ("Bcl-2/Bim/Bax" . SPARSER::COLLECTION)
    ("cellular Bim and Bax" . SPARSER::COLLECTION)
    ("Bim and Bax" . SPARSER::COLLECTION) ("JNK and p38" . SPARSER::COLLECTION)
    ("caspase-9 and -3" . SPARSER::COLLECTION) ("Pramanicin" . SPARSER::DRUG)
    ("Procaspase-8" . SPARSER::PROTEIN) ("Myc/Max" . SPARSER::PROTEIN)
    ("AP2" . SPARSER::PROTEIN) ("Mef2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nur77" . SPARSER::PROTEIN) ("Z-IETD-FMK" . SPARSER::DRUG)
    ("Z-LEHD-FMK" . SPARSER::DRUG) ("Z-VAD-FMK" . SPARSER::DRUG)
    ("P-p38" . SPARSER::PROTEIN) ("pyrrolidin-2-one" . SPARSER::MOLECULE)
    ("FN 2" . SPARSER::PROTEIN) ("NO 3" . SPARSER::PROTEIN)
    ("18 H" . SPARSER::PROTEIN) ("C 11" . SPARSER::PROTEIN)
    ("N C" . SPARSER::PROTEIN) ("Cl 2" . SPARSER::PROTEIN)
    ("CH 2" . SPARSER::MOLECULE) ("CH 3" . SPARSER::MOLECULE)
    ("CD 3" . SPARSER::PROTEIN) ("Mcl-1" . SPARSER::PROTEIN)
    ("Cytochrome c" . SPARSER::PROTEIN)
    ("MAP kinase kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinase kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("extracellular regulated kinase" . SPARSER::PROTEIN)
    ("Cao" . SPARSER::MOLECULE) ("HNC or MMP1" . SPARSER::COLLECTION)
    ("other fibrillar collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("at least 26 proteases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("essentially all extracelluar matrix (ECM) components"
     . SPARSER::COMPONENT)
    ("zinc-dependent endopeptidases" . SPARSER::PROTEIN)
    ("collagen, and fibronectin" . SPARSER::COLLECTION)
    ("HNC" . SPARSER::PROTEIN) ("endopeptidase" . SPARSER::PROTEIN)
    ("Matrix Metalloproteinase" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase-1" . SPARSER::PROTEIN)
    ("robust fibrogenic EMT" . SPARSER::PROTEIN)
    ("ZEB1/ZEB2" . SPARSER::COLLECTION)
    ("PDCD4 and RECK" . SPARSER::COLLECTION) ("PTEN/Akt" . SPARSER::COLLECTION)
    ("a functionally outmost important miRNA" . SPARSER::MICRO-RNA)
    ("the investigated fibrogenic EMT biomarkers" . SPARSER::MOLECULE)
    ("MAPK/NF-κB" . SPARSER::COLLECTION)
    ("a pleiotropic acting miRNA" . SPARSER::MICRO-RNA)
    ("the miR-21-mediated PDCD4-" . SPARSER::PROTEIN)
    ("PDCD4-" . SPARSER::PROTEIN)
    ("TAC ( xref ) and LAD ( xref )" . SPARSER::COLLECTION)
    ("NF-kB/MAPK" . SPARSER::COLLECTION)
    ("IL-1β and TNF-α" . SPARSER::COLLECTION)
    ("a far more potent EMT-inducer" . SPARSER::COLLECTION)
    ("EMT-inducer" . SPARSER::COLLECTION)
    ("adult fibrogenic EMT" . SPARSER::PROTEIN)
    ("fibrogenic cardiac EMT" . SPARSER::PROTEIN)
    ("PDCD4 or SPRY1" . SPARSER::COLLECTION) ("ANOVAs" . SPARSER::PROTEIN)
    ("PDCD4 and/or SPRY1" . SPARSER::COLLECTION)
    ("PDCD4, SPRY1, and RECK" . SPARSER::COLLECTION)
    ("PDCD4, SPRY1, and reversion-inducing-cysteine-rich"
     . SPARSER::COLLECTION)
    ("PDCD4 and SPRY1" . SPARSER::COLLECTION)
    ("TAC and LAD" . SPARSER::COLLECTION)
    ("ANP, BNP, α-SMA and TGF-β" . SPARSER::COLLECTION)
    ("BNP" . SPARSER::PROTEIN) ("ANP" . SPARSER::PROTEIN)
    ("namely both TAC" . SPARSER::PROTEIN) ("LAD" . SPARSER::PROTEIN)
    ("TAC" . SPARSER::PROTEIN) ("TNF-α and TGF-β" . SPARSER::COLLECTION)
    ("IL-1β-, TNF-α- or TGF-β" . SPARSER::COLLECTION)
    ("TNF-α-" . SPARSER::PROTEIN) ("IL-1β-" . SPARSER::PROTEIN)
    ("Twist-1 and Snail" . SPARSER::COLLECTION)
    ("TNF-α or TGF-β" . SPARSER::COLLECTION)
    ("Classic transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("Twist-1, Snail and Slug" . SPARSER::COLLECTION)
    ("mesenchymal markers S100A4 and α-SMA" . SPARSER::COLLECTION)
    ("the epicardial marker WT1" . SPARSER::PROTEIN)
    ("S100A4 and α-SMA" . SPARSER::COLLECTION)
    ("IL-1β, TNF-α, and TGF-β" . SPARSER::COLLECTION)
    ("cytokines or growth factors" . SPARSER::COLLECTION)
    ("Fibrogenic EMT" . SPARSER::PROTEIN)
    ("α-smooth muscle actin (α-SMA) and CD31 ( xref )" . SPARSER::COLLECTION)
    ("CD45, Troponin T, α-smooth muscle actin (α-SMA) and CD31 ( xref )"
     . SPARSER::COLLECTION)
    ("E-cadherin, Tbx18, Raldh2, and Islet-1" . SPARSER::COLLECTION)
    ("Tbx" . SPARSER::PROTEIN-FAMILY)
    ("cardiac fibrogenic EMT" . SPARSER::PROTEIN)
    ("cardiac EMT" . SPARSER::PROTEIN)
    ("clinically relevant targets" . SPARSER::TARGET-PROTEIN)
    ("EMC" . SPARSER::PROTEIN) ("fibrogenic EMT" . SPARSER::PROTEIN)
    ("Smad7" . SPARSER::PROTEIN)
    ("Phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("SPRY2" . SPARSER::PROTEIN) ("metalloproteinase 1" . SPARSER::PROTEIN)
    ("Twist-1" . SPARSER::PROTEIN) ("S100A4" . SPARSER::PROTEIN)
    ("Islet-1" . SPARSER::PROTEIN) ("Raldh2" . SPARSER::PROTEIN)
    ("Wilms Tumor protein" . SPARSER::PROTEIN) ("TIMP-1" . SPARSER::PROTEIN)
    ("anti-S" . SPARSER::ANTIBODY) ("Nkx2.5" . SPARSER::PROTEIN)
    ("WT1" . SPARSER::PROTEIN) ("Islet1" . SPARSER::PROTEIN)
    ("NH 4 Cl" . SPARSER::MOLECULE) ("Sprouty homolog 1" . SPARSER::PROTEIN)
    ("SPRY1" . SPARSER::PROTEIN) ("Sprouty Homolog 1" . SPARSER::PROTEIN)
    ("a predictive and prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("KRAS, BRAF, or PIK3C2A" . SPARSER::COLLECTION)
    ("PI3K-PTEN-AKT" . SPARSER::COLLECTION)
    ("RAS-RAF-MAPK" . SPARSER::COLLECTION)
    ("an independent prognostic biomarker" . SPARSER::MOLECULE)
    ("important prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CISH" . SPARSER::PROTEIN)
    ("mAbs, panitumumab and cetuximab" . SPARSER::COLLECTION)
    ("HR " . SPARSER::PROTEIN) ("metastatic CRC" . SPARSER::PROTEIN)
    ("panitumumab or cetuximab" . SPARSER::COLLECTION)
    ("anti-EGFR monoclonal antibodies" . SPARSER::ANTIBODY)
    ("PIK3C2A" . SPARSER::PROTEIN) ("anti–EGFR" . SPARSER::PROTEIN)
    ("the entire RB1" . SPARSER::PROTEIN)
    ("MLPA and QMFPCR" . SPARSER::COLLECTION)
    ("unilateral retinoblastoma" . SPARSER::PROTEIN)
    ("ITM2B and CHC1L" . SPARSER::COLLECTION) ("hot" . SPARSER::PROTEIN)
    ("a mutated allele" . SPARSER::ALLELE)
    ("the hereditary form" . SPARSER::FORM)
    ("Retinoblastoma" . SPARSER::PROTEIN)
    ("isolated unilateral retinoblastoma" . SPARSER::PROTEIN)
    ("RB1-" . SPARSER::PROTEIN) ("DLEU1" . SPARSER::PROTEIN)
    ("CHC1" . SPARSER::PROTEIN) ("ITM2B" . SPARSER::PROTEIN)
    ("MMP1 (-1607 1G/2G) and MMP9 () polymorphisms" . SPARSER::COLLECTION)
    ("The precise impact" . SPARSER::PROTEIN)
    ("MMPs and their inhibitors" . SPARSER::COLLECTION)
    ("prostaglandin" . SPARSER::PROTEIN)
    ("MMP9 and PACG" . SPARSER::COLLECTION)
    ("the 2G allele and patients" . SPARSER::COLLECTION)
    ("MMP1 , MMP7 , and MMP9" . SPARSER::COLLECTION)
    ("glutamine" . SPARSER::AMINO-ACID)
    ("latent MMPs and their inhibitors" . SPARSER::COLLECTION)
    ("latent MMPs" . SPARSER::PROTEIN) ("matrilysin" . SPARSER::PROTEIN)
    ("collagenases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Matrix" . SPARSER::PROTEIN-FAMILY) ("FN2" . SPARSER::PROTEIN)
    ("β-blockers" . SPARSER::DRUG) ("MMP-7" . SPARSER::PROTEIN)
    ("MMP27" . SPARSER::PROTEIN) ("MMP20" . SPARSER::PROTEIN)
    ("MMP12" . SPARSER::PROTEIN) ("MMP10" . SPARSER::PROTEIN)
    ("MMP8" . SPARSER::PROTEIN) ("MMP7" . SPARSER::PROTEIN)
    ("MMP1" . SPARSER::PROTEIN)
    ("nuclear and/or cytoplasmic p27 Kip1" . SPARSER::COLLECTION)
    ("ODC and possibly intra-cellular polyamines" . SPARSER::COLLECTION)
    ("possibly intra-cellular polyamines" . SPARSER::MOLECULE)
    ("the only other publicly available NB tumor cohort" . SPARSER::MOLECULE)
    ("polyamines and p27 Kip1" . SPARSER::COLLECTION)
    ("p27 Kip1 or sc control siRNA" . SPARSER::COLLECTION)
    ("Akt/PKB-GSK3-β" . SPARSER::COLLECTION) ("Doxycycline" . SPARSER::DRUG)
    ("DFMO-treatment" . SPARSER::DRUG) ("DFMO or left" . SPARSER::COLLECTION)
    ("polyamines and MYCN" . SPARSER::COLLECTION)
    ("Polyamine" . SPARSER::MOLECULE)
    ("spermidine (spd) and spermine (spm) levels" . SPARSER::COLLECTION)
    ("spm" . SPARSER::PROTEIN) ("spermine" . SPARSER::MOLECULE)
    ("putrescine" . SPARSER::MOLECULE) ("spermidine" . SPARSER::MOLECULE)
    ("p27 Kip1 and ODC" . SPARSER::COLLECTION) ("HG" . SPARSER::MOLECULE)
    ("stathmin" . SPARSER::PROTEIN)
    ("p27 Kip1 and the RhoA small GTPases" . SPARSER::COLLECTION)
    ("CDK/cyclin" . SPARSER::COLLECTION) ("eflornithine" . SPARSER::DRUG)
    ("difluoromethylornithine" . SPARSER::DRUG)
    ("Akt/PKB (Ser473) and GSK3-β (Ser9)" . SPARSER::COLLECTION)
    ("polyamine" . SPARSER::MOLECULE)
    ("the cyclin-dependent kinase inhibitor p27 Kip1 protein and causes p27 Kip1"
     . SPARSER::COLLECTION)
    ("DFMO" . SPARSER::DRUG) ("polyamines" . SPARSER::MOLECULE)
    ("ODC" . SPARSER::PROTEIN) ("MYCN" . SPARSER::PROTEIN)
    ("glycogen synthase kinase-3" . SPARSER::PROTEIN)
    ("4–1" . SPARSER::PROTEIN) ("MAS5" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase inhibitor 1" . SPARSER::PROTEIN)
    ("ODC1" . SPARSER::PROTEIN) ("sodium hydroxide" . SPARSER::MOLECULE)
    ("Ornithine decarboxylase" . SPARSER::PROTEIN)
    ("GSK3-β" . SPARSER::PROTEIN) ("Kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin-dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("ornithine decarboxylase" . SPARSER::PROTEIN)
    ("Lgl ( xref ; xref ; xref ) and Par1 ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("Lgl" . SPARSER::PROTEIN) ("the apical complex" . SPARSER::BIO-COMPLEX)
    ("Crb3 and Par6–aPKC ( xref )" . SPARSER::COLLECTION)
    ("the apical membrane Cdc42" . SPARSER::PROTEIN)
    ("the soluble protein Morg1" . SPARSER::PROTEIN)
    ("the Par6–aPKC binary complex and the Par3-containing complex"
     . SPARSER::COLLECTION)
    ("Par3 as well as Pals1" . SPARSER::COLLECTION)
    ("The main apical polarity proteins" . SPARSER::PROTEIN)
    ("Bazooka, Par6, and aPKC" . SPARSER::COLLECTION)
    ("Pals1/Stardust" . SPARSER::COLLECTION) ("Bazooka" . SPARSER::PROTEIN)
    ("the Pals1-associated TJ protein Patj" . SPARSER::PROTEIN)
    ("EERLI-COOH" . SPARSER::COLLECTION)
    ("an intrinsic Par6-PDZ–binding protein" . SPARSER::PROTEIN)
    ("Par6 and Cdc42" . SPARSER::COLLECTION)
    ("the basolateral protein β-catenin" . SPARSER::PROTEIN)
    ("Morg1-" . SPARSER::PROTEIN)
    ("an apical membrane–initiating factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Morg1 or Cdc42" . SPARSER::COLLECTION)
    ("RACK1 and a subunit" . SPARSER::COLLECTION)
    ("PAP or lumen" . SPARSER::COLLECTION) ("HA–PKCι" . SPARSER::PROTEIN-PAIR)
    ("aPKC-PS" . SPARSER::COLLECTION)
    ("the apical marker gp135 as well as F-actin" . SPARSER::COLLECTION)
    ("pre-apical patch" . SPARSER::PROTEIN)
    ("the apical marker gp135" . SPARSER::PROTEIN) ("PAP" . SPARSER::MOLECULE)
    ("The basolateral marker β-catenin" . SPARSER::PROTEIN)
    ("the apical marker gp135 and F-actin" . SPARSER::COLLECTION)
    ("gp135 and F-actin" . SPARSER::COLLECTION)
    ("a spherical cyst" . SPARSER::PROTEIN)
    ("Crb3, and Cdc42" . SPARSER::COLLECTION)
    ("Cdc42–Par6" . SPARSER::COLLECTION)
    ("the dominant-negative form" . SPARSER::FORM)
    ("the apical transmembrane protein Crb3" . SPARSER::PROTEIN)
    ("Par6 and Crb3" . SPARSER::COLLECTION) ("Crb3-" . SPARSER::PROTEIN)
    ("Par6–Crb3" . SPARSER::COLLECTION) ("Par6β-" . SPARSER::PROTEIN)
    ("wild-type Par6β or a mutant protein" . SPARSER::COLLECTION)
    ("GFP–Crb3" . SPARSER::COLLECTION)
    ("Crb3 as well as Cdc42" . SPARSER::COLLECTION)
    ("basolateral proteins" . SPARSER::PROTEIN)
    ("the basolateral marker β-catenin" . SPARSER::PROTEIN)
    ("HA–Morg1" . SPARSER::COLLECTION) ("canine Morg1" . SPARSER::PROTEIN)
    ("Par6β" . SPARSER::PROTEIN) ("Morg1 and Cdc42" . SPARSER::COLLECTION)
    ("GST–Par6β" . SPARSER::COLLECTION) ("MBP–Morg1" . SPARSER::COLLECTION)
    ("the apical protein Crb3" . SPARSER::PROTEIN)
    ("Crb3 and Cdc42" . SPARSER::COLLECTION)
    ("Its dominant homologue" . SPARSER::PROTEIN) ("Patj" . SPARSER::PROTEIN)
    ("the Par6–aPKC binary complex" . SPARSER::BIO-COMPLEX)
    ("Par3, Par6, and aPKC" . SPARSER::COLLECTION)
    ("Par6 and aPKC" . SPARSER::COLLECTION) ("Stardust" . SPARSER::PROTEIN)
    ("PSD95/Dlg/ZO-1" . SPARSER::COLLECTION)
    ("Cdc42/Rac" . SPARSER::COLLECTION) ("Dlg" . SPARSER::PROTEIN)
    ("CRIB" . SPARSER::DRUG) ("Phox and Bem1p" . SPARSER::COLLECTION)
    ("Phox" . SPARSER::PROTEIN) ("PB1" . SPARSER::PROTEIN)
    ("the apical transmembrane protein Crumbs3" . SPARSER::PROTEIN)
    ("cyst" . SPARSER::PROTEIN) ("Morg1" . SPARSER::PROTEIN)
    ("Par6–aPKC" . SPARSER::COLLECTION) ("anti-Par" . SPARSER::DRUG)
    ("type IV collagen" . SPARSER::PROTEIN) ("For 3" . SPARSER::PROTEIN)
    ("YL1" . SPARSER::PROTEIN) ("anti–β" . SPARSER::PROTEIN)
    ("CRB3" . SPARSER::PROTEIN) ("Par1" . SPARSER::PROTEIN)
    ("L27" . SPARSER::PROTEIN) ("annexin 2" . SPARSER::PROTEIN)
    ("PP2A" . SPARSER::PROTEIN) ("PKCι" . SPARSER::PROTEIN)
    ("GM130" . SPARSER::PROTEIN) ("gp135" . SPARSER::PROTEIN)
    ("2 B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("WDR83" . SPARSER::PROTEIN)
    ("Crb3" . SPARSER::PROTEIN) ("Par3" . SPARSER::PROTEIN)
    ("Pals1" . SPARSER::PROTEIN) ("ZO-1" . SPARSER::PROTEIN)
    ("PSD95" . SPARSER::PROTEIN) ("Bem1" . SPARSER::PROTEIN)
    ("atypical protein kinase" . SPARSER::PROTEIN)
    ("Crumbs3" . SPARSER::PROTEIN)
    ("Atypical protein kinase" . SPARSER::PROTEIN)
    ("tight junction" . SPARSER::PROTEIN)
    ("IL-4 and IFNγ" . SPARSER::COLLECTION)
    ("NFAT, AP1 and NFκB" . SPARSER::COLLECTION)
    ("CD44 and CD62L" . SPARSER::COLLECTION)
    ("CD25, CD69 and CD44" . SPARSER::COLLECTION)
    ("AP1 and NFAT" . SPARSER::COLLECTION)
    ("NFκB, NFAT and AP1" . SPARSER::COLLECTION)
    ("IL-2RA and PKCθ" . SPARSER::COLLECTION) ("GM-CFS" . SPARSER::COLLECTION)
    ("CFS" . SPARSER::PROTEIN) ("GM" . SPARSER::PROTEIN)
    ("soluble anti-CD28" . SPARSER::PROTEIN)
    ("the ex vivo apoptotic stimuli anti-CD3 or FasL" . SPARSER::COLLECTION)
    ("anti-CD3 or FasL" . SPARSER::COLLECTION) ("1b" . SPARSER::PROTEIN)
    ("AICD and/or Fasl" . SPARSER::COLLECTION)
    ("CD3 or FasL" . SPARSER::COLLECTION) ("AICD" . SPARSER::PROTEIN)
    ("PDBu" . SPARSER::MOLECULE) ("PKB/Akt" . SPARSER::COLLECTION)
    ("PKB" . SPARSER::PROTEIN) ("PKCα or PKCβ" . SPARSER::COLLECTION)
    ("receptor and insulin receptor" . SPARSER::COLLECTION)
    ("overexpressed PKCα" . SPARSER::PROTEIN)
    ("NFκB, AP1, and NFAT" . SPARSER::COLLECTION)
    ("PKC, PKCθ and PKCα" . SPARSER::COLLECTION)
    ("PKCα and PKCθ" . SPARSER::COLLECTION)
    ("PKCα and PKCβ" . SPARSER::COLLECTION) ("IL-2RA" . SPARSER::PROTEIN)
    ("IL5" . SPARSER::PROTEIN) ("Con A" . SPARSER::PROTEIN)
    ("18 h" . SPARSER::PROTEIN) ("l -glutamine" . SPARSER::MOLECULE)
    ("respiratory epithelial NOS2" . SPARSER::PROTEIN)
    ("isoforms or differences" . SPARSER::COLLECTION)
    ("glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [ xref ] and Rac1 [ xref ]"
     . SPARSER::COLLECTION)
    ("COX2 [ xref ], cPLA2α [ xref ], glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [ xref ] and Rac1 [ xref ]"
     . SPARSER::COLLECTION)
    ("glyceraldehyde-3-phosphate dehydrogenase (GAPDH)" . SPARSER::PROTEIN)
    ("several previously characterized NOS2-interacting proteins"
     . SPARSER::PROTEIN)
    ("possible targets" . SPARSER::TARGET-PROTEIN)
    ("HSP90 [ xref , xref ] and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2)"
     . SPARSER::COLLECTION)
    ("HOP" . SPARSER::PROTEIN)
    ("DICER, ICAM-1, SIRT1 and TNFAIP2" . SPARSER::COLLECTION)
    ("DICER" . SPARSER::PROTEIN) ("B30.2/SPRY" . SPARSER::PROTEIN)
    ("B30.2/SPRY-NOS2" . SPARSER::PROTEIN-PAIR)
    ("substrate-" . SPARSER::SUBSTRATE) ("oxygenase" . SPARSER::PROTEIN)
    ("HSP70/CHIP" . SPARSER::COLLECTION)
    ("its associated factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBXO45, SPSB1 and SPSB2" . SPARSER::COLLECTION)
    ("NOS2 and the SPSB proteins" . SPARSER::COLLECTION)
    ("FBXO45 and NOS2" . SPARSER::COLLECTION)
    ("wt-NOS2-FLAG" . SPARSER::COLLECTION)
    ("NOS2-FBXO45" . SPARSER::COLLECTION)
    ("previously described NOS2-interacting proteins" . SPARSER::PROTEIN)
    ("FBXO45 and SPSB2" . SPARSER::COLLECTION)
    ("FBXO45 and SPSB" . SPARSER::COLLECTION)
    ("F-box/SPRY domain-containing protein 1 (FBXO45) and S-phase kinase-associated protein 1 (SKP1; xref )"
     . SPARSER::COLLECTION)
    ("S-phase kinase-associated protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HUWE1 and Myc-binding protein 2 (MYCBP2)" . SPARSER::COLLECTION)
    ("RO52, HERC1, HUWE1 and Myc-binding protein 2 (MYCBP2)"
     . SPARSER::COLLECTION)
    ("SPSB1, SPSB2 and SPSB4" . SPARSER::COLLECTION)
    ("ubiquitin, and TUBE2" . SPARSER::COLLECTION) ("K63-" . SPARSER::PROTEIN)
    ("TUBE1- and TUBE2-agarose" . SPARSER::COLLECTION)
    ("NOS2 and ubiquitin" . SPARSER::COLLECTION)
    ("wt-NOS2" . SPARSER::COLLECTION) ("TUBE1-" . SPARSER::PROTEIN)
    ("the proteasome-associated ubiquitin receptor ADRM1" . SPARSER::PROTEIN)
    ("nitroso-protein" . SPARSER::COLLECTION)
    ("nitrosyl-protein" . SPARSER::COLLECTION) ("nitrite" . SPARSER::MOLECULE)
    ("a constitutively bound activator" . SPARSER::ACTIVATOR)
    ("NOS2 and HSP90" . SPARSER::COLLECTION) ("Calmodulin" . SPARSER::PROTEIN)
    ("subunits (PSB9, PSB10 and PSB11) and the interferon-inducible proteasome-associated activator PSME2"
     . SPARSER::COLLECTION)
    ("the interferon-inducible proteasome-associated activator PSME2"
     . SPARSER::PROTEIN)
    ("The proteasome-associated proteins ADRM1 and UCHL5"
     . SPARSER::COLLECTION)
    ("ADRM1 and UCHL5" . SPARSER::COLLECTION)
    ("numerous mRNP complex-associated proteins" . SPARSER::PROTEIN)
    ("had seven associated proteins" . SPARSER::PROTEIN)
    ("DDX20, GEMI2, GEMI4, GEMI5, LG3BP, SMN1, and STRAP"
     . SPARSER::COLLECTION)
    ("mRNP" . SPARSER::PROTEIN) ("STRAP" . SPARSER::PROTEIN)
    ("SMN" . SPARSER::PROTEIN)
    ("immunoproteasome subunits (PSB9 and PSB10) and sirtuin 1 (SIRT1; xref )"
     . SPARSER::COLLECTION)
    ("tryptophanyl-tRNA synthase, immunoproteasome subunits (PSB9 and PSB10) and sirtuin 1 (SIRT1; xref )"
     . SPARSER::COLLECTION)
    ("PSB" . SPARSER::PROTEIN) ("synthase" . SPARSER::PROTEIN)
    ("tRNA" . SPARSER::RNA) ("fell" . SPARSER::PROTEIN)
    ("ICAM1 and TNFAIP2" . SPARSER::COLLECTION)
    ("an associated heavy isotope form" . SPARSER::FORM)
    ("keratins" . SPARSER::PROTEIN)
    ("the ectopically-expressed NOS2" . SPARSER::PROTEIN)
    ("LPS, IFNγ, TNFα and IL-1β" . SPARSER::COLLECTION)
    ("Light" . SPARSER::PROTEIN)
    ("300 NOS2-associated proteins" . SPARSER::PROTEIN)
    ("SPSB1 and SPSB2" . SPARSER::COLLECTION)
    ("STUB1/CHIP" . SPARSER::COLLECTION) ("GeLC-MS/MS" . SPARSER::COLLECTION)
    ("HSP90, HPS70 and tubulin" . SPARSER::COLLECTION)
    ("HSP60, HSP70, HSP90 and calmodulin" . SPARSER::COLLECTION)
    ("IgG- or anti-Flag" . SPARSER::COLLECTION)
    ("IgG-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("guanidine" . SPARSER::MOLECULE)
    ("NOS2, COX-2 and cPLA2α" . SPARSER::COLLECTION)
    ("NOS2 and cPLA2α" . SPARSER::COLLECTION)
    ("tetrahydrobiopterin" . SPARSER::DRUG)
    ("interferon regulatory factor 1, and NOS2" . SPARSER::COLLECTION)
    ("Activators" . SPARSER::ACTIVATOR)
    ("a 10-fold larger V max" . SPARSER::PROTEIN)
    ("NOS1 and NOS3" . SPARSER::COLLECTION) ("max" . SPARSER::PROTEIN)
    ("CAM" . SPARSER::PROTEIN) ("NOS1, NOS2 and NOS3" . SPARSER::COLLECTION)
    ("beta-adrenergic" . SPARSER::COLLECTION) ("adrenergic" . SPARSER::PROTEIN)
    ("MYCBP2 and SKP1" . SPARSER::COLLECTION) ("SPRY" . SPARSER::PROTEIN)
    ("Multi-protein" . SPARSER::COLLECTION) ("Multi" . SPARSER::PROTEIN)
    ("NOS2-protein" . SPARSER::COLLECTION) ("SERCA2" . SPARSER::PROTEIN)
    ("sarcoplasmic/endoplasmic reticulum calcium ATPase 2" . SPARSER::PROTEIN)
    ("phosphoprotein 1" . SPARSER::PROTEIN) ("HSC70" . SPARSER::PROTEIN)
    ("HERC1" . SPARSER::PROTEIN) ("RO52" . SPARSER::PROTEIN)
    ("SPSB4" . SPARSER::PROTEIN) ("TUBE1" . SPARSER::PROTEIN)
    ("NO 2" . SPARSER::MOLECULE) ("HSP90β" . SPARSER::PROTEIN)
    ("α-actinin-4" . SPARSER::PROTEIN) ("PSME2" . SPARSER::PROTEIN)
    ("interferon-inducible" . SPARSER::PROTEIN) ("PSB11" . SPARSER::DRUG)
    ("ADRM1" . SPARSER::PROTEIN) ("SMN1" . SPARSER::PROTEIN)
    ("LG3" . SPARSER::PROTEIN) ("DDX20" . SPARSER::PROTEIN)
    ("sirtuin 1" . SPARSER::PROTEIN) ("TNFAIP2" . SPARSER::PROTEIN)
    ("SPSB2" . SPARSER::PROTEIN) ("SPSB1" . SPARSER::PROTEIN)
    ("UCHL5" . SPARSER::PROTEIN) ("STUB1" . SPARSER::PROTEIN)
    ("STIP1 homology and U box-containing protein 1" . SPARSER::PROTEIN)
    ("HSP70" . SPARSER::PROTEIN) ("HSP60" . SPARSER::PROTEIN)
    ("e6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("interleukin-1 beta" . SPARSER::PROTEIN)
    ("interferon gamma" . SPARSER::PROTEIN) ("l 15" . SPARSER::PROTEIN)
    ("prostaglandin E2" . SPARSER::MOLECULE) ("cPLA2α" . SPARSER::PROTEIN)
    ("cytosolic phospholipase A2" . SPARSER::PROTEIN)
    ("cyclooxygenase 2" . SPARSER::PROTEIN) ("L-arginine" . SPARSER::MOLECULE)
    ("interferon regulatory factor 1" . SPARSER::PROTEIN)
    ("NOS1" . SPARSER::PROTEIN) ("SKP1" . SPARSER::PROTEIN)
    ("MYCBP2" . SPARSER::PROTEIN) ("FBXO45" . SPARSER::PROTEIN)
    ("NOS2" . SPARSER::PROTEIN) ("pediatric and adult HGAs" . SPARSER::PROTEIN)
    ("KIT and KDR" . SPARSER::COLLECTION) ("KDR" . SPARSER::PROTEIN)
    ("PDGFRA/CEP4" . SPARSER::COLLECTION) ("only 12 HGAs" . SPARSER::PROTEIN)
    ("pediatric HGAs" . SPARSER::PROTEIN)
    ("irradiation-induced HGAs" . SPARSER::PROTEIN)
    ("pediatric HGA" . SPARSER::PROTEIN) ("HGAs" . SPARSER::PROTEIN)
    ("IDH1 mutant AA and secondary GBM" . SPARSER::COLLECTION)
    ("larger patient cohorts" . SPARSER::MOLECULE)
    ("the frontal lobes" . SPARSER::PROTEIN) ("lobes" . SPARSER::PROTEIN)
    ("a significant prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pediatric GBM cohort" . SPARSER::MOLECULE)
    ("pediatric AA" . SPARSER::MOLECULE) ("/CEP4" . SPARSER::COLLECTION)
    ("AAs" . SPARSER::PROTEIN)
    ("both adult and pediatric cohorts" . SPARSER::MOLECULE)
    ("HGA" . SPARSER::PROTEIN)
    ("a significant independent prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGFR2" . SPARSER::PROTEIN) ("De-" . SPARSER::MOLECULE)
    ("CEP4" . SPARSER::PROTEIN) ("IDH1" . SPARSER::PROTEIN)
    ("IL-1β and NF-κB" . SPARSER::COLLECTION) ("nfkb1" . SPARSER::PROTEIN)
    ("CLOCK" . SPARSER::PROTEIN) ("CIRBP null MEFs" . SPARSER::PROTEIN)
    ("IKK- and NF-κB" . SPARSER::COLLECTION) ("IKK-" . SPARSER::PROTEIN)
    ("other secondary cytokines" . SPARSER::PROTEIN)
    ("IL-8 and TNFAIP6" . SPARSER::COLLECTION)
    ("IL-1β, IL-8 and TNFAIP6" . SPARSER::COLLECTION)
    ("inflammatory cytokines and NF-κB" . SPARSER::COLLECTION)
    ("cytokines and NF-κB" . SPARSER::COLLECTION)
    ("UVC and hypoxia" . SPARSER::COLLECTION)
    ("cisplatin and UVB" . SPARSER::COLLECTION)
    ("stress-induced GRP" . SPARSER::PROTEIN)
    ("UVC or LPS" . SPARSER::COLLECTION) ("UVB-" . SPARSER::PROTEIN)
    ("150 J/m 2 UVB or 10 µM cisplatin" . SPARSER::COLLECTION)
    ("CIRBP and IL1B" . SPARSER::COLLECTION)
    ("UVB and cisplatin" . SPARSER::COLLECTION)
    ("a commonly used chemotherapeutic drug" . SPARSER::DRUG)
    ("UVB" . SPARSER::PROTEIN) ("light (UVB)" . SPARSER::PROTEIN)
    ("a convenient model DNA" . SPARSER::DNA)
    ("pro-IL-1β" . SPARSER::COLLECTION)
    ("IL8 or TNFAIP6" . SPARSER::COLLECTION)
    ("CIRBP or IL1B" . SPARSER::COLLECTION)
    ("CIRBP, IL1B, IL8 and TNFAIP6" . SPARSER::COLLECTION)
    ("IL1B, IL8, TNFAIP6, HMOX1 and HSPB6" . SPARSER::COLLECTION)
    ("UVC and LPS" . SPARSER::COLLECTION)
    ("the chemotherapeutic agent cisplatin and bacterial lipopolysaccaride (LPS) but not moderate hypothermia"
     . SPARSER::COLLECTION)
    ("the chemotherapeutic agent cisplatin" . SPARSER::MOLECULE)
    ("UV (UVB)" . SPARSER::PROTEIN) ("UV (UVC)" . SPARSER::PROTEIN)
    ("thioredoxin (TXN)" . SPARSER::PROTEIN)
    ("RPA2 and Ataxia telangiectasia mutated and Rad3" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia mutated and Rad3" . SPARSER::COLLECTION)
    ("TXN" . SPARSER::PROTEIN) ("Arsenite" . SPARSER::DRUG)
    ("light and hypothermia" . SPARSER::COLLECTION)
    ("arsenite" . SPARSER::DRUG) ("cold-induced CIRBP" . SPARSER::PROTEIN)
    ("CHO" . SPARSER::PROTEIN) ("orthologs" . SPARSER::PROTEIN)
    ("RRM" . SPARSER::PROTEIN)
    ("Cold-inducible RNA binding protein (CIRBP)" . SPARSER::PROTEIN)
    ("GRP" . SPARSER::PROTEIN) ("hnRNP" . SPARSER::PROTEIN)
    ("CIRBP and NF-κB" . SPARSER::COLLECTION)
    ("CIRBP and NFκB" . SPARSER::COLLECTION)
    ("IL1B, IL8 and TNFAIP6" . SPARSER::COLLECTION)
    ("IL8 and TNFAIP6" . SPARSER::COLLECTION) ("UVC" . SPARSER::PROTEIN)
    ("ribosomes" . SPARSER::BIO-COMPLEX)
    ("short wavelength ultraviolet light (UVC)" . SPARSER::PROTEIN)
    ("cold inducible RNA binding protein (CIRBP)" . SPARSER::PROTEIN)
    ("CIRBP" . SPARSER::PROTEIN)
    ("clock circadian regulator" . SPARSER::PROTEIN)
    ("Tumor necrosis factor" . SPARSER::PROTEIN)
    ("sodium arsenite" . SPARSER::DRUG) ("BMS-345541" . SPARSER::DRUG)
    ("IKK-2" . SPARSER::PROTEIN) ("HSPB6" . SPARSER::PROTEIN)
    ("Il-1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Il-1β" . SPARSER::PROTEIN)
    ("β–actin" . SPARSER::PROTEIN) ("RPA2" . SPARSER::PROTEIN)
    ("TNFAIP6" . SPARSER::PROTEIN) ("IL1B" . SPARSER::PROTEIN)
    ("cold inducible RNA binding protein" . SPARSER::PROTEIN)
    ("the nontoxic phytochemical curcumin" . SPARSER::DRUG)
    ("neurofibromin and its regulatory target pathways PI3K and MEK"
     . SPARSER::COLLECTION)
    ("functionally relevant targets" . SPARSER::TARGET-PROTEIN)
    ("IKK/IκBα" . SPARSER::COLLECTION)
    ("AKT, IκBα and STAT3" . SPARSER::COLLECTION)
    ("XIAP or MCL-1" . SPARSER::COLLECTION)
    ("XIAP, survivin and BCL-2" . SPARSER::COLLECTION)
    ("survivin, MCL-1 and HIF1α" . SPARSER::COLLECTION)
    ("survivin and HIF1α" . SPARSER::COLLECTION)
    ("survivin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("XIAP, claspin and HIF1α" . SPARSER::COLLECTION)
    ("claspin" . SPARSER::PROTEIN)
    ("PARP, caspase 8 and caspase 9" . SPARSER::COLLECTION)
    ("curcumin and TRAIL" . SPARSER::COLLECTION)
    ("genistein, curcumin, capsaicin or resveratrol" . SPARSER::COLLECTION)
    ("capsaicin" . SPARSER::DRUG) ("genistein" . SPARSER::PROTEIN)
    ("PI3K (LY294002) and MEK(U0126) inhibitors" . SPARSER::COLLECTION)
    ("MEK and PI3K" . SPARSER::COLLECTION)
    ("c-MYC and MAD1" . SPARSER::COLLECTION)
    ("AKT and ERK" . SPARSER::COLLECTION) ("PI3K or MEK" . SPARSER::COLLECTION)
    ("PI3K and MEK" . SPARSER::COLLECTION) ("ERK or AKT" . SPARSER::COLLECTION)
    ("MEK (U0126) and PI3K (LY294002)" . SPARSER::COLLECTION)
    ("the previous results NF1-GRD" . SPARSER::COLLECTION)
    ("ERK and AKT" . SPARSER::COLLECTION) ("DR4 and DR5" . SPARSER::COLLECTION)
    ("substances" . SPARSER::SUBSTANCE) ("Neurofibromin" . SPARSER::PROTEIN)
    ("GTP-ase" . SPARSER::NUCLEOTIDE) ("exogenous ROS" . SPARSER::PROTEIN)
    ("phytochemical" . SPARSER::DRUG) ("MYC/MAX/MAD" . SPARSER::COLLECTION)
    ("MAD" . SPARSER::PROTEIN) ("MAX" . SPARSER::PROTEIN)
    ("MEK/ERK" . SPARSER::COLLECTION) ("NF1-GRD" . SPARSER::COLLECTION)
    ("GRD" . SPARSER::PROTEIN) ("neurofibromin" . SPARSER::PROTEIN)
    ("a rare aggressive form" . SPARSER::FORM) ("HIF1α" . SPARSER::PROTEIN)
    ("caspase 9" . SPARSER::PROTEIN) ("BIS-TRIS" . SPARSER::MOLECULE)
    ("Caspase 8" . SPARSER::PROTEIN) ("MCL-1" . SPARSER::PROTEIN)
    ("β-Actin" . SPARSER::PROTEIN) ("Ly294002" . SPARSER::MOLECULE)
    ("DR4" . SPARSER::PROTEIN) ("MAD1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DR5" . SPARSER::PROTEIN) ("p53 and CHK-2" . SPARSER::COLLECTION)
    ("ATM or other miR-18a target genes" . SPARSER::COLLECTION)
    ("Additional prognostic biomarkers" . SPARSER::MOLECULE)
    ("progressive cerebellar ataxia" . SPARSER::PROTEIN)
    ("The most evident example" . SPARSER::EXAMPLE)
    ("an inactive homodimer or multimer" . SPARSER::COLLECTION)
    ("homodimer or multimer" . SPARSER::COLLECTION)
    ("Genotoxin" . SPARSER::MOLECULE) ("Target" . SPARSER::TARGET-PROTEIN)
    ("complex (RISC)" . SPARSER::BIO-COMPLEX) ("RISC" . SPARSER::PROTEIN)
    ("CHK-2" . SPARSER::PROTEIN)
    ("3-(4,5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("Checkpoint kinase 2" . SPARSER::PROTEIN)
    ("Anti-phospho" . SPARSER::PROTEIN) ("TLR4 and IL-8" . SPARSER::COLLECTION)
    ("multiple bacterial components" . SPARSER::COMPONENT)
    ("TLR4 and Gly" . SPARSER::COLLECTION)
    ("at least three proteins" . SPARSER::PROTEIN)
    ("TLR4 and COX-2" . SPARSER::COLLECTION)
    ("TLR5 and TLR2" . SPARSER::COLLECTION) ("CDO" . SPARSER::PROTEIN)
    ("the glycosylated receptors (Gly-TLR4 and Gly-TLR2) and the non-glycosylated receptors (Non-Gly-TLR4 and Non-Gly-TLR2)"
     . SPARSER::COLLECTION)
    ("TLR4 and TLR2" . SPARSER::COLLECTION)
    ("TLR5 and COX-2" . SPARSER::COLLECTION)
    ("COX-2 and IL-8" . SPARSER::COLLECTION) ("flagellin" . SPARSER::PROTEIN)
    ("TLR4 and other proinflammatory molecules" . SPARSER::COLLECTION)
    ("cyclooxygenase-2 (COX-2) and interleukin (IL)" . SPARSER::COLLECTION)
    ("TLR4 and its co-receptor myeloid differentiation factor (MD)-2"
     . SPARSER::COLLECTION)
    ("Enteric" . SPARSER::PROTEIN) ("IL-8 and COX-2" . SPARSER::COLLECTION)
    ("TLR2 and TLR5" . SPARSER::COLLECTION)
    ("glycosylated TLR4 (Gly-TLR4) and surface TLR4" . SPARSER::COLLECTION)
    ("enteric" . SPARSER::PROTEIN) ("Serum albumin" . SPARSER::PROTEIN)
    ("alpha-tubulin" . SPARSER::PROTEIN) ("Cox-2" . SPARSER::PROTEIN)
    ("LC20" . SPARSER::PROTEIN) ("CDB1" . SPARSER::PROTEIN)
    ("α-Tubulin" . SPARSER::PROTEIN)
    ("bacterial lipoproteins" . SPARSER::PROTEIN-FAMILY)
    ("cyclooxygenase-2" . SPARSER::PROTEIN) ("TLR5" . SPARSER::PROTEIN)
    ("best-fit" . SPARSER::PROTEIN-FAMILY)
    ("carrying at least one 5G allele" . SPARSER::ALLELE)
    ("plasmin" . SPARSER::PROTEIN) ("Stata" . SPARSER::PROTEIN)
    ("trim" . SPARSER::HUMAN-PROTEIN-FAMILY) ("t " . SPARSER::PROTEIN)
    ("meta" . SPARSER::PROTEIN)
    ("urinary plasminogen activators" . SPARSER::ACTIVATOR)
    ("the principal inhibitor" . SPARSER::INHIBITOR)
    ("glyco-protein" . SPARSER::COLLECTION) ("plasminogen" . SPARSER::PROTEIN)
    ("AI 2" . SPARSER::PROTEIN) ("aI 2" . SPARSER::PROTEIN)
    ("serine proteinase" . SPARSER::PROTEIN)
    ("potentially more effective therapeutic targets"
     . SPARSER::TARGET-PROTEIN)
    ("transcriptionally active AR-target genes" . SPARSER::GENE)
    ("pre-RC and replication" . SPARSER::COLLECTION)
    ("E2F-1 and Rb" . SPARSER::COLLECTION)
    ("enzymes and proteins" . SPARSER::COLLECTION)
    ("Orc2, Cdt1, and Mcm7" . SPARSER::COLLECTION)
    ("cyproterone" . SPARSER::DRUG)
    ("PCNA and ribonucleotide reductase" . SPARSER::COLLECTION)
    ("cyclin E and p27" . SPARSER::COLLECTION) ("AR-IPs" . SPARSER::COLLECTION)
    ("IPs" . SPARSER::PROTEIN)
    ("proliferating cell nuclear antigen (PCNA), an auxiliary protein of DNA polymerase, and the catalytic subunit of ribonucleotide reductase (RNR2)"
     . SPARSER::COLLECTION)
    ("an auxiliary protein" . SPARSER::PROTEIN)
    ("deoxyribonucleotides" . SPARSER::MOLECULE)
    ("ribonucleotides" . SPARSER::MOLECULE)
    ("a mitotic cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cdc6 or AR" . SPARSER::COLLECTION) ("AR-Cdc6" . SPARSER::COLLECTION)
    ("the most abundantly expressed proteins, prostate-specific antigen (PSA),"
     . SPARSER::PROTEIN)
    ("Cdc6-IP" . SPARSER::COLLECTION) ("TdR" . SPARSER::PROTEIN)
    ("isoleucine" . SPARSER::AMINO-ACID)
    ("Functional AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Trypan" . SPARSER::DRUG)
    ("prostate specific antigen (PSA)" . SPARSER::PROTEIN)
    ("siRNA or shRNA" . SPARSER::COLLECTION)
    ("proteins and enzymes" . SPARSER::COLLECTION)
    ("pre-RC and DNA replication machinery" . SPARSER::COLLECTION)
    ("origin recognition complex (ORC)" . SPARSER::PROTEIN)
    ("mega" . SPARSER::MOLECULE) ("ORC" . SPARSER::BIO-COMPLEX)
    ("Mcm" . SPARSER::PROTEIN) ("RLF" . SPARSER::PROTEIN)
    ("ribozyme" . SPARSER::RNA) ("shRNA or siRNA" . SPARSER::COLLECTION)
    ("cyclin E and cyclin" . SPARSER::COLLECTION)
    ("AR-IP" . SPARSER::COLLECTION) ("Cdc6, and Casodex" . SPARSER::COLLECTION)
    ("AR and Cdc6" . SPARSER::COLLECTION) ("E2F-1" . SPARSER::PROTEIN)
    ("Mcm7" . SPARSER::PROTEIN) ("Orc2" . SPARSER::PROTEIN)
    ("RNR2" . SPARSER::PROTEIN) ("lamin B" . SPARSER::PROTEIN-FAMILY)
    ("prostate-specific antigen" . SPARSER::PROTEIN)
    ("Pre-RC" . SPARSER::BIO-COMPLEX) ("anti-androgen" . SPARSER::DRUG)
    ("Kip-1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Lamin B" . SPARSER::PROTEIN-FAMILY)
    ("prostate specific antigen" . SPARSER::PROTEIN)
    ("Cdc45" . SPARSER::PROTEIN)
    ("origin recognition complex" . SPARSER::PROTEIN)
    ("Cdt1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ribonucleotide reductase" . SPARSER::PROTEIN) ("Cdc6" . SPARSER::PROTEIN)
    ("pre-RC" . SPARSER::BIO-COMPLEX) ("LIV-1 and EMT" . SPARSER::COLLECTION)
    ("an attractive new therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("LIV-1 and E-cadherin" . SPARSER::COLLECTION)
    ("Snail and Slug" . SPARSER::COLLECTION) ("ZIP" . SPARSER::PROTEIN)
    ("SLC39A6" . SPARSER::PROTEIN) ("LIV-1" . SPARSER::PROTEIN)
    ("CHI" . SPARSER::PROTEIN) ("Dimer" . SPARSER::DIMER)
    ("thanatophoric dysplasia type 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("disulfide" . SPARSER::MOLECULE) ("TD1" . SPARSER::PROTEIN)
    ("robust fits" . SPARSER::PROTEIN-FAMILY)
    ("the receptor and the constantK 2" . SPARSER::COLLECTION)
    ("K 1 and K 2" . SPARSER::COLLECTION)
    ("the mutant dimeric receptors" . SPARSER::PROTEIN)
    ("dimeric fractions" . SPARSER::COMPONENT)
    ("100% dimeric fraction" . SPARSER::COMPONENT)
    ("monomeric and cross-linked mutant FGFR3" . SPARSER::PROTEIN)
    ("a membrane-impermeable crosslinker" . SPARSER::PROTEIN)
    ("dimeric receptors" . SPARSER::PROTEIN)
    ("their liganded dimeric state" . SPARSER::BIO-STATE)
    ("is 1.7±0.16" . SPARSER::PROTEIN)
    ("the all-liganded dimeric state" . SPARSER::BIO-STATE)
    ("the liganded dimeric state" . SPARSER::BIO-STATE)
    ("the immature FGFR3" . SPARSER::PROTEIN) ("Endo" . SPARSER::PROTEIN)
    ("anti-phospho-FGFR" . SPARSER::PROTEIN-PAIR) ("Santa" . SPARSER::PROTEIN)
    ("wild-type FGFR3 and the A391E mutant" . SPARSER::COLLECTION)
    ("fgf1" . SPARSER::PROTEIN)
    ("heparin or heparan sulfate proteoglycan" . SPARSER::COLLECTION)
    ("fgf" . SPARSER::PROTEIN) ("P250" . SPARSER::PROTEIN)
    ("ΔΔG " . SPARSER::PROTEIN) ("K 1" . SPARSER::PROTEIN)
    ("heparan sulfates" . SPARSER::MOLECULE) ("BS 3" . SPARSER::PROTEIN)
    ("heparan sulfate proteoglycan" . SPARSER::PROTEIN)
    ("Fibroblast growth factor receptor 3" . SPARSER::PROTEIN)
    ("fibroblast growth factor 1" . SPARSER::PROTEIN)
    ("progressive leukemia" . SPARSER::PROTEIN)
    ("Akt and p38 MAPK" . SPARSER::COLLECTION)
    ("Akt and Erk" . SPARSER::COLLECTION)
    ("BCR-ABL-positive acute lymphoblastic leukemia (ALL)" . SPARSER::PROTEIN)
    ("Akt, p38MAPK, and Erk" . SPARSER::COLLECTION)
    ("lonafarnib" . SPARSER::DRUG) ("nilotinib" . SPARSER::DRUG)
    ("KP" . SPARSER::PROTEIN) ("ERK/Akt/STAT" . SPARSER::COLLECTION)
    ("ITD" . SPARSER::PROTEIN) ("ILK/Akt" . SPARSER::COLLECTION)
    ("kinase (ILK)" . SPARSER::KINASE) ("ILK" . SPARSER::PROTEIN)
    ("Akt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("stromal-derived cytokines" . SPARSER::PROTEIN)
    ("Ras/MEK/MAPK" . SPARSER::COLLECTION)
    ("cytoprotective cytokines" . SPARSER::PROTEIN)
    ("FLT3-positive AML#2" . SPARSER::PROTEIN)
    ("FLT3-ITD" . SPARSER::COLLECTION)
    ("cytoprotective HS-5-derived SCM" . SPARSER::PROTEIN-FAMILY)
    ("Cytoprotective SCM" . SPARSER::PROTEIN)
    ("PKC412 or AC220" . SPARSER::COLLECTION) ("Partial" . SPARSER::PROTEIN)
    ("selective Akt inhibitors and the highly potent and selective FLT3 inhibitor"
     . SPARSER::COLLECTION)
    ("Part" . SPARSER::COMPONENT)
    ("FLT3 Inhibitor and Akt Inhibitor Combination" . SPARSER::COLLECTION)
    ("stromal-secreted cytokines" . SPARSER::PROTEIN)
    ("PKC412 and Akt" . SPARSER::COLLECTION)
    ("AT7867, GSK690693, and MK2206" . SPARSER::COLLECTION)
    ("library-derived inhibitors" . SPARSER::INHIBITOR)
    ("three dual Src/Abl inhibitors- dasatinib, KIN112, and KIN113-"
     . SPARSER::COLLECTION)
    ("dasatinib, KIN112, and KIN113-" . SPARSER::COLLECTION)
    ("inhibitors-" . SPARSER::INHIBITOR) ("Src/Abl" . SPARSER::COLLECTION)
    ("Abl" . SPARSER::PROTEIN)
    ("FLT3-positive cells co-cultured" . SPARSER::PROTEIN)
    ("co-cultured" . SPARSER::PROTEIN)
    ("FLT3-expressing Cells co-cultured" . SPARSER::PROTEIN)
    ("Jak" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cytoprotective and cytokine-abundant stromal-conditioned media (SCM)"
     . SPARSER::PROTEIN)
    ("Dr" . SPARSER::MOLECULE) ("KIN" . SPARSER::PROTEIN)
    ("SCM" . SPARSER::PROTEIN) ("dasatinib" . SPARSER::DRUG)
    ("quizartinib" . SPARSER::DRUG) ("midostaurin" . SPARSER::DRUG)
    ("a mutated form" . SPARSER::FORM) ("kinase-3" . SPARSER::COLLECTION)
    ("SCF, IL-6, IL-8, IL-11, M-CSF and GM-CSF" . SPARSER::COLLECTION)
    ("selective Akt inhibitors and FLT3 inhibitors" . SPARSER::COLLECTION)
    ("PKC412 and AC220" . SPARSER::COLLECTION) ("GSK690693" . SPARSER::DRUG)
    ("GSK 690693" . SPARSER::DRUG) ("p38a" . SPARSER::PROTEIN)
    ("SB 203580" . SPARSER::DRUG) ("VX-702" . SPARSER::DRUG)
    ("derived growth factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FLK-2" . SPARSER::PROTEIN) ("STK-1" . SPARSER::PROTEIN)
    ("IL-11" . SPARSER::PROTEIN) ("AC220" . SPARSER::DRUG)
    ("PKC412" . SPARSER::DRUG) ("protein, and SOCS1" . SPARSER::COLLECTION)
    ("miR-155 and STAT3" . SPARSER::COLLECTION)
    ("JAK2/STAT3" . SPARSER::COLLECTION)
    ("homodimer or heterodimer" . SPARSER::COLLECTION)
    ("STATs" . SPARSER::PROTEIN) ("SOCS1 and STAT3" . SPARSER::COLLECTION)
    ("miR-155 ASO or their NC" . SPARSER::COLLECTION)
    ("miR-155, SOCS1 and STAT3" . SPARSER::COLLECTION)
    ("which targets SOCS1" . SPARSER::PROTEIN)
    ("SOCS1 and LR" . SPARSER::COLLECTION)
    ("miR-155 and itsdownstream" . SPARSER::COLLECTION)
    ("ASO" . SPARSER::PROTEIN)
    ("the related clinicopathological factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P-P" . SPARSER::PROTEIN) ("MiR-155" . SPARSER::PROTEIN)
    ("SOCS1" . SPARSER::PROTEIN)
    ("suppressor of cytokine signaling 1" . SPARSER::PROTEIN)
    ("miR-155" . SPARSER::PROTEIN)
    ("AP-1, Sp1, STAT-3, and NF-κB" . SPARSER::COLLECTION)
    ("LDs" . SPARSER::PROTEIN) ("Lipid" . SPARSER::LIPID)
    ("α-SMA and ColIAI" . SPARSER::COLLECTION)
    ("α-SMA and Col1A1" . SPARSER::COLLECTION)
    ("JNK, p38 MAPK, Src, and ERK" . SPARSER::COLLECTION)
    ("AP-1, STAT-3, Sp1, and NF-κB" . SPARSER::COLLECTION)
    ("E6-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("v-src" . SPARSER::COLLECTION)
    ("TGF-β1 promoter-luciferase and endogenous TGF-β1 mRNA"
     . SPARSER::COLLECTION)
    ("NF-κB inhibitors and dominant negative forms" . SPARSER::COLLECTION)
    ("NF-κB or STAT-3" . SPARSER::COLLECTION)
    ("NF-κB and STAT-3" . SPARSER::COLLECTION)
    ("NS3, and NS5A" . SPARSER::COLLECTION)
    ("STAT-3, Sp1, NF-κB, and AP-1" . SPARSER::COLLECTION)
    ("Secreted bioactive TGF-β1" . SPARSER::PROTEIN)
    ("collagens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("profibrogenic molecules" . SPARSER::MOLECULE)
    ("TGF-β1, furin, and TSP-1" . SPARSER::COLLECTION)
    ("α-smooth muscle actin (α-SMA) and collagen type 1 α 1 (Col1A1) mRNA"
     . SPARSER::COLLECTION)
    ("TGF-β1, TSP-1, and furin" . SPARSER::COLLECTION)
    ("furin and TSP-1" . SPARSER::COLLECTION)
    ("TGF-β1, Furin, and TSP-1" . SPARSER::COLLECTION)
    ("Furin" . SPARSER::PROTEIN)
    ("approximately 2.6 fold more bioactive TGF-β1" . SPARSER::PROTEIN)
    ("PAI" . SPARSER::PROTEIN) ("The bioactive TGF-β1" . SPARSER::PROTEIN)
    ("MLEC" . SPARSER::PROTEIN) ("media (CM)" . SPARSER::PROTEIN)
    ("TAM" . SPARSER::PROTEIN) ("PI3K and JAK" . SPARSER::COLLECTION)
    ("anti-c-Jun and anti-Sp1" . SPARSER::COLLECTION)
    ("c-Jun and Sp1" . SPARSER::COLLECTION) ("pyrrolidine" . SPARSER::DRUG)
    ("AM" . SPARSER::PROTEIN) ("BAPTA" . SPARSER::MOLECULE)
    ("chelator" . SPARSER::MOLECULE)
    ("STAT-3, NF-κB, and AP-1" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos and Sp1" . SPARSER::COLLECTION)
    ("c-Jun, c-Fos, and Sp1" . SPARSER::COLLECTION)
    ("IkBα, STAT-3 and AP-1" . SPARSER::COLLECTION)
    ("AP-1, Sp1, NF-kB, and STAT-3" . SPARSER::COLLECTION)
    ("IkBα and NF-kB" . SPARSER::COLLECTION)
    ("IkBα and STAT-3" . SPARSER::COLLECTION)
    ("NF-kB and STAT-3" . SPARSER::COLLECTION) ("Mithramycin" . SPARSER::DRUG)
    ("Tanshinone" . SPARSER::DRUG)
    ("protein, AP-1, Sp1, NF-kB, and STAT-3" . SPARSER::COLLECTION)
    ("phTG6" . SPARSER::PROTEIN)
    ("HCV nonstructural (NS) proteins" . SPARSER::PROTEIN)
    ("NS3, NS3/4A, and NS5A" . SPARSER::COLLECTION)
    ("AP-1, Sp1, NF-κB, and STAT-3" . SPARSER::COLLECTION)
    ("JNK, p38 MAPK, ERK, Src, PI3K and JAK" . SPARSER::COLLECTION)
    ("Nrf2, NF-κB, AP-1, Sp1, HIF-1α, ATF6, SREBPs, and STAT-3"
     . SPARSER::COLLECTION)
    ("protein, and STAT-3" . SPARSER::COLLECTION) ("USF" . SPARSER::PROTEIN)
    ("bioactive TGF-β1" . SPARSER::PROTEIN)
    ("the major profibrogenic cytokine" . SPARSER::PROTEIN)
    ("viral proteases" . SPARSER::PROTEIN) ("E1, and E2" . SPARSER::COLLECTION)
    ("p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B" . SPARSER::COLLECTION)
    ("ribosome" . SPARSER::BIO-COMPLEX)
    ("alpha smooth muscle actin (α-SMA) and type 1 collagen"
     . SPARSER::COLLECTION)
    ("HCV-induced bioactive TGF-β1" . SPARSER::PROTEIN)
    ("secreted bioactive TGF-β1" . SPARSER::PROTEIN)
    ("HSCs" . SPARSER::PROTEIN) ("AP-1 and Sp1" . SPARSER::COLLECTION)
    ("AP-1, Sp1, NF-κB and STAT-3" . SPARSER::COLLECTION)
    ("Col1A1" . SPARSER::PROTEIN) ("IkBα" . SPARSER::PROTEIN)
    ("JAK 2" . SPARSER::PROTEIN) ("SU6656" . SPARSER::PROTEIN)
    ("lipid droplet" . SPARSER::PROTEIN) ("Lipid Droplet" . SPARSER::PROTEIN)
    ("TSP-1" . SPARSER::PROTEIN) ("p3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATF6" . SPARSER::PROTEIN) ("ZF9" . SPARSER::PROTEIN)
    ("EGR-1" . SPARSER::PROTEIN) ("NS5B" . SPARSER::PROTEIN)
    ("NS4A" . SPARSER::PROTEIN) ("E1" . SPARSER::MOLECULE)
    ("TGF-b" . SPARSER::PROTEIN) ("STAT-3" . SPARSER::PROTEIN)
    ("transforming growth factor-beta 1" . SPARSER::PROTEIN)
    ("receptor (RXR)" . SPARSER::RECEPTOR)
    ("-retinoic acid" . SPARSER::MOLECULE) ("/SREBP-1" . SPARSER::COLLECTION)
    ("-liganded" . SPARSER::MOLECULE) ("RXR" . SPARSER::PROTEIN)
    ("retinoic" . SPARSER::PROTEIN) ("liganded" . SPARSER::MOLECULE)
    ("GC and CCAAT" . SPARSER::COLLECTION) ("lovastatin" . SPARSER::DRUG)
    ("GFP or active" . SPARSER::COLLECTION)
    ("a peroxisomal marker protein" . SPARSER::PROTEIN)
    ("protein (ALDRP)" . SPARSER::PROTEIN)
    ("commercially available antibodies" . SPARSER::ANTIBODY)
    ("active mutant β -catenin (4A) and wild-type TCF-4" . SPARSER::COLLECTION)
    ("IgG or β -catenin" . SPARSER::COLLECTION)
    ("β -catenin/TCF" . SPARSER::COLLECTION) ("Mut" . SPARSER::PROTEIN)
    ("DN-TCF-4" . SPARSER::COLLECTION) ("-TCF-4" . SPARSER::COLLECTION)
    ("β -catenin/TCF-4" . SPARSER::COLLECTION)
    ("LEF-1/TCF" . SPARSER::COLLECTION)
    ("sterol regulatory element-binding proteins" . SPARSER::PROTEIN)
    ("SREBPs" . SPARSER::PROTEIN-FAMILY) ("Groucho" . SPARSER::PROTEIN)
    ("factor/T-cell" . SPARSER::COLLECTION) ("Abcd1" . SPARSER::PROTEIN)
    ("Abcd" . SPARSER::PROTEIN-FAMILY) ("ALDRP or ABCD2" . SPARSER::COLLECTION)
    ("ALDRP" . SPARSER::PROTEIN) ("iPS" . SPARSER::PROTEIN)
    ("a slowly progressive form" . SPARSER::FORM)
    ("namely severe childhood cerebral form" . SPARSER::FORM)
    ("AMN" . SPARSER::PROTEIN) ("ABCD2-GFP" . SPARSER::COLLECTION)
    ("β -catenin and the promoter" . SPARSER::COLLECTION)
    ("-catenin" . SPARSER::COLLECTION)
    ("β -catenin and TCF-4" . SPARSER::COLLECTION)
    ("protein (ALDP)" . SPARSER::PROTEIN)
    ("the peroxisomal ATP-binding cassette (ABC) transporter subfamily D member 1 protein"
     . SPARSER::PROTEIN)
    ("ALDP" . SPARSER::PROTEIN) ("adrenoleukodystrophy" . SPARSER::PROTEIN)
    ("SREBP1" . SPARSER::PROTEIN) ("PMP70" . SPARSER::PROTEIN)
    ("TBE1" . SPARSER::PROTEIN) ("Myc-tagged" . SPARSER::PROTEIN)
    ("TCF-3" . SPARSER::PROTEIN) ("LEF-1" . SPARSER::PROTEIN)
    ("TCF-1" . SPARSER::PROTEIN) ("a β" . SPARSER::PROTEIN)
    ("β -catenin" . SPARSER::PROTEIN) ("ABCD2" . SPARSER::PROTEIN)
    ("subfamily D" . SPARSER::PROTEIN) ("ABCD1" . SPARSER::PROTEIN)
    ("codon 12-mutated KRAS" . SPARSER::PROTEIN)
    ("a permanent form" . SPARSER::FORM) ("protein–" . SPARSER::PROTEIN)
    ("an accessory protein" . SPARSER::PROTEIN) ("RasGAP" . SPARSER::PROTEIN)
    ("this mutated form" . SPARSER::FORM)
    ("wild-type KRAS or the c" . SPARSER::COLLECTION)
    ("mutant and the wild-type KRAS" . SPARSER::COLLECTION)
    ("ΔΔG" . SPARSER::PROTEIN)
    ("Gly13Asp mutant and wild-type KRAS" . SPARSER::COLLECTION)
    ("wild-type KRAS and its mutants" . SPARSER::COLLECTION)
    ("the explicit solvent" . SPARSER::MOLECULE)
    ("traditional anti-EGFR drugs" . SPARSER::DRUG)
    ("larger amino acid side" . SPARSER::PROTEIN)
    ("aspartate and valine" . SPARSER::COLLECTION)
    ("valine" . SPARSER::AMINO-ACID) ("aspartate" . SPARSER::MOLECULE)
    ("activating protein (GAP)" . SPARSER::PROTEIN)
    ("KRAS-" . SPARSER::PROTEIN)
    ("cetuximab or panitumumab" . SPARSER::COLLECTION)
    ("the growth factor and other receptor" . SPARSER::COLLECTION)
    ("c-Raf" . SPARSER::COLLECTION)
    ("a membrane-associated GTPase" . SPARSER::GTPASE)
    ("These monoclonal antibodies" . SPARSER::ANTIBODY)
    ("cetuximab (Erbitux®, ImClone Systems) and panitumumab (Vectibix®, Amgen)"
     . SPARSER::COLLECTION)
    ("panitumumab" . SPARSER::DRUG) ("Erbitux" . SPARSER::DRUG)
    ("mCRC" . SPARSER::PROTEIN)
    ("wild-type (WT) KRAS and its mutants (MT)" . SPARSER::COLLECTION)
    ("mutants (MT)" . SPARSER::MUTANT) ("PMF" . SPARSER::PROTEIN)
    ("RAS-GTP" . SPARSER::PROTEIN) ("p21 ras" . SPARSER::PROTEIN)
    ("B-factor" . SPARSER::PROTEIN) ("activating protein" . SPARSER::PROTEIN)
    ("destructive impact" . SPARSER::PROTEIN)
    ("the deterministic part" . SPARSER::COMPONENT)
    ("the stochastic steady state solution ofas" . SPARSER::PROTEIN)
    ("respect toin stochastic case" . SPARSER::PROTEIN)
    ("the deterministic case" . SPARSER::PROTEIN) ("ofas" . SPARSER::PROTEIN)
    ("fix" . SPARSER::PROTEIN) ("stochastic CLE" . SPARSER::PROTEIN)
    ("CLE" . SPARSER::PROTEIN) ("p300 and HDAC1" . SPARSER::COLLECTION)
    ("Mdm2-p53-p300" . SPARSER::COLLECTION) ("Mdm2-p300" . SPARSER::COLLECTION)
    ("Mdm2-HDAC1" . SPARSER::COLLECTION)
    ("the predominant negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("p53 and Mdm2" . SPARSER::COLLECTION)
    ("Star" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PRD" . SPARSER::PROTEIN)
    ("deterministic case" . SPARSER::PROTEIN)
    ("each oscillatory state" . SPARSER::BIO-STATE)
    ("p53 and p300" . SPARSER::COLLECTION)
    ("various oscillatory states" . SPARSER::BIO-STATE)
    ("damped" . SPARSER::MOLECULE)
    ("proteins, p300 and HDAC1" . SPARSER::COLLECTION)
    ("p53-Mdm2-p300-HDAC1" . SPARSER::COLLECTION) ("SMAR1" . SPARSER::PROTEIN)
    ("p19ARF" . SPARSER::PROTEIN) ("BMP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("well-powered HRpQCT cohorts" . SPARSER::MOLECULE)
    ("RANKL and ESR1" . SPARSER::COLLECTION)
    ("an alternative plausible candidate gene" . SPARSER::PROTEIN)
    ("BMPs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PRDC" . SPARSER::PROTEIN)
    ("denosumab" . SPARSER::DRUG) ("RANK/RANKL/OPG" . SPARSER::COLLECTION)
    ("distinct phenotypic traits" . SPARSER::PROTEIN)
    ("RANK" . SPARSER::PROTEIN)
    ("the one side and cortical and trabecular vBMDs" . SPARSER::COLLECTION)
    ("bone microstructural traits" . SPARSER::PROTEIN)
    ("RANKL , LOC285735 , OPG and ESR1" . SPARSER::COLLECTION)
    ("the trabecular vBMD-associated SNP" . SPARSER::PROTEIN)
    ("dexamethasone, BMP-2 and PGE2" . SPARSER::COLLECTION)
    ("dexamethasone" . SPARSER::PROTEIN) ("GCTA" . SPARSER::PROTEIN)
    ("Trabecular vBMD SNP" . SPARSER::PROTEIN)
    ("trabecular bone fraction" . SPARSER::COMPONENT)
    ("SE " . SPARSER::PROTEIN) ("het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("The identified cortical vBMD SNP" . SPARSER::PROTEIN)
    ("The two cortical vBMD RANKL" . SPARSER::PROTEIN)
    ("RANKL , OPG and ESR1" . SPARSER::COLLECTION)
    ("GOOD cohorts" . SPARSER::MOLECULE)
    ("rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genome-wide significant genetic variants" . SPARSER::VARIANT)
    ("Standard peripheral QCT" . SPARSER::PROTEIN) ("QCT" . SPARSER::PROTEIN)
    ("RANKL , LOC285735 , OPG , and ESR1" . SPARSER::COLLECTION)
    ("the GOOD cohort" . SPARSER::MOLECULE)
    ("FMN2/GREM2" . SPARSER::COLLECTION) ("OPG" . SPARSER::PROTEIN)
    ("trabecular vBMD, and bone microstructural traits" . SPARSER::PROTEIN)
    ("MACH2" . SPARSER::DRUG)
    ("bone morphogenetic proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt16" . SPARSER::PROTEIN) ("WNT16" . SPARSER::PROTEIN)
    ("PGE2" . SPARSER::DRUG) ("BMP-2" . SPARSER::PROTEIN)
    ("formin 2" . SPARSER::PROTEIN) ("AKAP1" . SPARSER::PROTEIN)
    ("TNFRSF11B" . SPARSER::PROTEIN) ("TNFSF11" . SPARSER::PROTEIN)
    ("GREM2" . SPARSER::PROTEIN) ("FMN2" . SPARSER::PROTEIN)
    ("C6orf97" . SPARSER::PROTEIN) ("Gli" . SPARSER::PROTEIN)
    ("ITCH and ATM" . SPARSER::COLLECTION)
    ("an essential promoter" . SPARSER::PROMOTER)
    ("ATM and JNK1" . SPARSER::COLLECTION) ("ATM-ITCH" . SPARSER::COLLECTION)
    ("JNK1-ITCH" . SPARSER::COLLECTION) ("Jnk1" . SPARSER::PROTEIN)
    ("Jnk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NCS and Adriamycin" . SPARSER::COLLECTION)
    ("ATM and c-Jun" . SPARSER::COLLECTION)
    ("JunB and c-Jun" . SPARSER::COLLECTION)
    ("ATM and ITCH" . SPARSER::COLLECTION)
    ("ATM-ITCH-FLIP" . SPARSER::COLLECTION)
    ("the ITCHS161A unphosphorylatable mutant" . SPARSER::MUTANT)
    ("GST-HECT" . SPARSER::COLLECTION)
    ("JNK1 and trigger" . SPARSER::COLLECTION)
    ("unphosphorylatable mutants" . SPARSER::MUTANT) ("NCS" . SPARSER::PROTEIN)
    ("Neocarzinostatin" . SPARSER::PROTEIN)
    ("the enzymatically competent ITCH" . SPARSER::PROTEIN)
    ("ITCH-wt" . SPARSER::COLLECTION) ("Ubiquitin-HA" . SPARSER::COLLECTION)
    ("Ligase" . SPARSER::LIGASE) ("proteins, and ITCH" . SPARSER::COLLECTION)
    ("ATM kinase or its catalytically inactive mutant" . SPARSER::COLLECTION)
    ("Ub-HA" . SPARSER::COLLECTION) ("ITCH-Myc-wt" . SPARSER::COLLECTION)
    ("c-FLIP-L and c-FLIP-S" . SPARSER::COLLECTION)
    ("c-Jun and c-FLIP-L" . SPARSER::COLLECTION) ("HECT" . SPARSER::PROTEIN)
    ("c-FLIP-L, c-Jun and JunB, p73 and p63" . SPARSER::COLLECTION)
    ("JunB, p73 and p63" . SPARSER::COLLECTION) ("JunB" . SPARSER::PROTEIN)
    ("RNF20-RNF40" . SPARSER::COLLECTION) ("MDM2/MDM4" . SPARSER::COLLECTION)
    ("a relevant target" . SPARSER::TARGET-PROTEIN) ("Itch" . SPARSER::PROTEIN)
    ("Atm" . SPARSER::PROTEIN) ("c-FLIP-L and c-Jun" . SPARSER::COLLECTION)
    ("SQ" . SPARSER::MOLECULE) ("Hedgehog" . SPARSER::PROTEIN)
    ("ITCH" . SPARSER::PROTEIN) ("trypsin inhibitor" . SPARSER::PROTEIN)
    ("CA5" . SPARSER::PROTEIN) ("prK5" . SPARSER::PROTEIN)
    ("S46" . SPARSER::PROTEIN) ("c- FLIP-L" . SPARSER::PROTEIN)
    ("Ubiquitin Ligase" . SPARSER::PROTEIN) ("Gli1" . SPARSER::PROTEIN)
    ("p63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RNF40" . SPARSER::PROTEIN)
    ("RNF20" . SPARSER::PROTEIN) ("HIPK2" . SPARSER::PROTEIN)
    ("Ubiquitin ligase" . SPARSER::PROTEIN) ("Siah-1" . SPARSER::PROTEIN)
    ("MDM4" . SPARSER::PROTEIN) ("Ataxia Telangiectasia" . SPARSER::PROTEIN)
    ("c-FLIP-L" . SPARSER::PROTEIN)
    ("Ataxia Telangiectasia Mutated" . SPARSER::PROTEIN)
    ("a functionally active heterodimer" . SPARSER::HETERODIMER)
    ("only p65 −/− MEFs" . SPARSER::PROTEIN) ("IκBα-SR" . SPARSER::COLLECTION)
    ("BRCA1, p65, and p50" . SPARSER::COLLECTION)
    ("p65, p50 and BRCA1" . SPARSER::COLLECTION)
    ("BRCA1-p65-p50" . SPARSER::COLLECTION) ("Chip" . SPARSER::PROTEIN)
    ("BRCA1 and p50" . SPARSER::COLLECTION)
    ("p50 or p65" . SPARSER::COLLECTION)
    ("BRCA1, p65 and p50" . SPARSER::COLLECTION)
    ("the active NF-κB DNA binding complex" . SPARSER::BIO-COMPLEX)
    ("subunits, RelB, RelC or p52" . SPARSER::COLLECTION)
    ("p50/p65" . SPARSER::COLLECTION)
    ("BRCA1 or any of the NF-κB family members p65 (RelA)"
     . SPARSER::COLLECTION)
    ("RelB, RelC, p50 or p52" . SPARSER::COLLECTION)
    ("BCL2 or XIAP" . SPARSER::COLLECTION) ("RelC" . SPARSER::PROTEIN)
    ("BRCA1, p65 or p50" . SPARSER::COLLECTION) ("Scr" . SPARSER::PROTEIN)
    ("cisplatin or mitomycin C" . SPARSER::COLLECTION)
    ("p65, p50 or BRCA1" . SPARSER::COLLECTION)
    ("p65/p50" . SPARSER::COLLECTION)
    ("BRCA1, p50 and p65" . SPARSER::COLLECTION)
    ("Bcl2, XIAP and IκBα" . SPARSER::COLLECTION)
    ("p65 or p50" . SPARSER::COLLECTION)
    ("etoposide, camptothecin, cisplatin or mitomycin C" . SPARSER::COLLECTION)
    ("etoposide, camptothecin, mitomycin C and cisplatin"
     . SPARSER::COLLECTION)
    ("Bcl2 and XIAP" . SPARSER::COLLECTION)
    ("target and negative regulator" . SPARSER::COLLECTION)
    ("mitomycin C or cisplatin" . SPARSER::COLLECTION)
    ("mitomycin C, or cisplatin" . SPARSER::COLLECTION)
    ("the DNA damagers etoposide (topoisomerase II inhibitor) or camptothecin (topoisomerase I inhibitor)"
     . SPARSER::COLLECTION)
    ("HCC-BR" . SPARSER::COLLECTION) ("IAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATM/NEMO" . SPARSER::COLLECTION)
    ("PIDD (p53-induced death domain protein) and PARP-1"
     . SPARSER::COLLECTION)
    ("RIP1 (receptor interacting protein 1), PIDD (p53-induced death domain protein) and PARP-1"
     . SPARSER::COLLECTION)
    ("PIDD" . SPARSER::PROTEIN) ("p52/p100" . SPARSER::COLLECTION)
    ("p50/p105" . SPARSER::COLLECTION) ("Swi/Snf" . SPARSER::COLLECTION)
    ("hGCN5/TRRAP" . SPARSER::COLLECTION) ("p300/CBP" . SPARSER::COLLECTION)
    ("Snf" . SPARSER::PROTEIN) ("Swi" . SPARSER::PROTEIN)
    ("HATs" . SPARSER::PROTEIN)
    ("p53, c-Myc, STAT1 and Oct-1" . SPARSER::COLLECTION)
    ("p21 and GADD45" . SPARSER::COLLECTION) ("psoriasin" . SPARSER::PROTEIN)
    ("BRCA1-p50" . SPARSER::COLLECTION)
    ("etoposide and camptothecin" . SPARSER::COLLECTION)
    ("BRCA1 and p65" . SPARSER::COLLECTION)
    ("etoposide or camptothecin" . SPARSER::COLLECTION)
    ("BRCA1 and NF-κB" . SPARSER::COLLECTION)
    ("BCL2 and XIAP" . SPARSER::COLLECTION) ("Caspase-3" . SPARSER::PROTEIN)
    ("Bay11-7082" . SPARSER::DRUG) ("TGF-beta" . SPARSER::PROTEIN)
    ("p53-induced death domain protein" . SPARSER::PROTEIN)
    ("receptor interacting protein 1" . SPARSER::PROTEIN)
    ("RIP1" . SPARSER::PROTEIN) ("PIASγ" . SPARSER::PROTEIN)
    ("BRD7" . SPARSER::PROTEIN) ("hGCN5" . SPARSER::PROTEIN)
    ("Oct-1" . SPARSER::PROTEIN)
    ("RNA helicase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GADD45" . SPARSER::PROTEIN) ("PARP 1" . SPARSER::PROTEIN)
    ("AR-corepressors" . SPARSER::COLLECTION)
    ("corepressors" . SPARSER::PROTEIN)
    ("the most efficacious antiandrogens" . SPARSER::DRUG)
    ("AR and ERG" . SPARSER::COLLECTION)
    ("AR and the ETS proteins" . SPARSER::COLLECTION)
    ("PSA, NKX3.1 and TMPRSS2" . SPARSER::COLLECTION)
    ("exogenous FLAG" . SPARSER::PROTEIN-FAMILY)
    ("NDRG1 , SLC16A6 , NKX3.1 and SLC45A3" . SPARSER::COLLECTION)
    ("SLC16A6" . SPARSER::PROTEIN) ("SLC" . SPARSER::PROTEIN)
    ("two separate siRNAs" . SPARSER::PROTEIN)
    ("ETS1 or ETS2" . SPARSER::COLLECTION)
    ("a dominant-negative inhibitor" . SPARSER::INHIBITOR)
    ("a serine- and aspartic acid-rich (SAR) domain" . SPARSER::COLLECTION)
    ("serine-" . SPARSER::AMINO-ACID) ("hook" . SPARSER::PROTEIN-FAMILY)
    ("CSX" . SPARSER::PROTEIN) ("Casodex" . SPARSER::DRUG)
    ("PSA, KLF5 and MMTV" . SPARSER::COLLECTION)
    ("PSA-luciferase" . SPARSER::COLLECTION)
    ("PSA- luciferase and MMTV-luciferase reporter genes ( xref )"
     . SPARSER::COLLECTION)
    ("MMTV-luciferase" . SPARSER::COLLECTION) ("PSA-" . SPARSER::PROTEIN)
    ("Flag-ELF3" . SPARSER::COLLECTION)
    ("AR or fragments" . SPARSER::COLLECTION)
    ("GST-ELF3" . SPARSER::COLLECTION) ("AR and ELF3" . SPARSER::COLLECTION)
    ("a biologically relevant regulator" . SPARSER::PROTEIN)
    ("ELF3 and the androgen receptor" . SPARSER::COLLECTION)
    ("AR/ELF3" . SPARSER::COLLECTION)
    ("ETV1 , ERG, ETV4, and TMPRSS2" . SPARSER::COLLECTION)
    ("PCs" . SPARSER::PROTEIN) ("NF-κB, SP1 and AP-1" . SPARSER::COLLECTION)
    ("receptor and DNA" . SPARSER::COLLECTION) ("Cofactors" . SPARSER::PROTEIN)
    ("weak androgens and anti-androgens" . SPARSER::COLLECTION)
    ("androgens and anti-androgens" . SPARSER::COLLECTION)
    ("GnRH" . SPARSER::PROTEIN) ("ELF3 and AR" . SPARSER::COLLECTION)
    ("RPLP0" . SPARSER::PROTEIN) ("nV5" . SPARSER::PROTEIN)
    ("βgal" . SPARSER::PROTEIN) ("l-glutamine" . SPARSER::MOLECULE)
    ("SLC45A3" . SPARSER::PROTEIN) ("NKX3.1" . SPARSER::PROTEIN)
    ("16A" . SPARSER::PROTEIN) ("NDRG1" . SPARSER::PROTEIN)
    ("ETS2" . SPARSER::PROTEIN) ("aspartic acid" . SPARSER::AMINO-ACID)
    ("KLF5" . SPARSER::PROTEIN) ("ETV4" . SPARSER::PROTEIN)
    ("ETV1" . SPARSER::PROTEIN) ("ESE-1" . SPARSER::PROTEIN)
    ("anti-androgens" . SPARSER::DRUG)
    ("nuclear hormone receptor" . SPARSER::PROTEIN) ("ELF3" . SPARSER::PROTEIN)
    ("p53 and BRCA2" . SPARSER::COLLECTION)
    ("Palb2 and BRCA2" . SPARSER::COLLECTION) ("broken DNA" . SPARSER::DNA)
    ("BRCA2/FancD1" . SPARSER::COLLECTION)
    ("BRCA2-siRNA" . SPARSER::PROTEIN-PAIR)
    ("ɛ3, Hmg20b and FancB" . SPARSER::COLLECTION)
    ("FA/BRCA" . SPARSER::COLLECTION) ("gene or pathway" . SPARSER::COLLECTION)
    ("the BRCA2-associated proteins Hmg20b and Rdm1" . SPARSER::COLLECTION)
    ("Hmg20b and Rdm1" . SPARSER::COLLECTION)
    ("Xrcc2 and Xrcc3" . SPARSER::COLLECTION)
    ("BRCA and FA" . SPARSER::COLLECTION) ("Hmg20b" . SPARSER::PROTEIN)
    ("MEFs and MECs" . SPARSER::COLLECTION)
    ("FA and BRCA1/2" . SPARSER::COLLECTION)
    ("at least four genes" . SPARSER::GENE)
    ("RAD51C/FANCO" . SPARSER::COLLECTION)
    ("PALB2/FANCN" . SPARSER::COLLECTION) ("BRIP1/FANCJ" . SPARSER::COLLECTION)
    ("BRCA2/FANCD1" . SPARSER::COLLECTION)
    ("replication-associated HR" . SPARSER::PROTEIN)
    ("MRE11 and RAD50" . SPARSER::COLLECTION)
    ("MRE11-RAD50-Nibrin" . SPARSER::COLLECTION) ("Nibrin" . SPARSER::PROTEIN)
    ("ATM, MRE11, RAD50, BLM, Palb2, or Rad51" . SPARSER::COLLECTION)
    ("FANCD1/BRCA2" . SPARSER::COLLECTION)
    ("exogenous PALB2" . SPARSER::PROTEIN)
    ("exogenous murine Palb2" . SPARSER::PROTEIN) ("FancB" . SPARSER::PROTEIN)
    ("FancD2 and FancI" . SPARSER::COLLECTION) ("MECs" . SPARSER::PROTEIN)
    ("NU1025-induced γH2AX foci" . SPARSER::PROTEIN)
    ("HR proteins and the RecQ helicase BLM" . SPARSER::COLLECTION)
    ("FA and BRCA" . SPARSER::COLLECTION)
    ("Xrcc2 or Palb2" . SPARSER::COLLECTION) ("Palb2" . SPARSER::PROTEIN)
    ("—log 2" . SPARSER::COLLECTION)
    ("five representative genes" . SPARSER::GENE)
    ("two representative genes" . SPARSER::GENE)
    ("HR and SSA" . SPARSER::COLLECTION)
    ("polymerases, helicases and nucleases" . SPARSER::COLLECTION)
    ("ATM and/or ATR" . SPARSER::COLLECTION)
    ("the ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR) inhibitor caffeine differentially"
     . SPARSER::COLLECTION)
    ("ATM and Rad3-related (ATR) inhibitor caffeine differentially"
     . SPARSER::COLLECTION)
    ("ataxia telangiectasia mutated (ATM)" . SPARSER::PROTEIN)
    ("caffeine" . SPARSER::MOLECULE) ("cs" . SPARSER::PROTEIN)
    ("PK" . SPARSER::PROTEIN) ("EJ-EGFP and ΔEGFP/3" . SPARSER::COLLECTION)
    ("fanconi anemia (FA) and BRCA" . SPARSER::COLLECTION)
    ("a plausible target" . SPARSER::TARGET-PROTEIN)
    ("FANCN and RAD51C" . SPARSER::COLLECTION) ("FANCO" . SPARSER::PROTEIN)
    ("FANCN" . SPARSER::PROTEIN) ("FancD2" . SPARSER::PROTEIN)
    ("a small interfering RNA-library targeting" . SPARSER::RNA)
    ("a small interfering RNA-library" . SPARSER::RNA)
    ("small interfering RNA-library" . SPARSER::RNA)
    ("interfering RNA-library" . SPARSER::RNA) ("RNA-library" . SPARSER::RNA)
    ("frequent loss of heterozygosity" . SPARSER::PROTEIN)
    ("LFS" . SPARSER::PROTEIN) ("F10" . SPARSER::PROTEIN)
    ("RPA34" . SPARSER::PROTEIN) ("FL2" . SPARSER::PROTEIN)
    ("L -glutamine" . SPARSER::MOLECULE) ("DMBT1" . SPARSER::PROTEIN)
    ("MRG15" . SPARSER::PROTEIN) ("Mad2l2" . SPARSER::PROTEIN)
    ("Rev7" . SPARSER::PROTEIN) ("FancD1" . SPARSER::PROTEIN)
    ("ɛ3" . SPARSER::MOLECULE) ("Rad52" . SPARSER::PROTEIN)
    ("Rdm1" . SPARSER::PROTEIN) ("Xrcc3" . SPARSER::PROTEIN)
    ("DNA-PKcs" . SPARSER::PROTEIN) ("BRCA2 protein" . SPARSER::PROTEIN)
    ("Log2" . SPARSER::PROTEIN) ("KU-55933" . SPARSER::DRUG)
    ("NU7441" . SPARSER::MOLECULE) ("FANCD1" . SPARSER::PROTEIN)
    ("Replication protein" . SPARSER::PROTEIN)
    ("fanconi anemia" . SPARSER::PROTEIN) ("a viable RdRP" . SPARSER::PROTEIN)
    ("A functional RdRP" . SPARSER::PROTEIN) ("RdRP" . SPARSER::PROTEIN)
    ("lncRNAs" . SPARSER::RNA) ("pAKT" . SPARSER::PROTEIN-FAMILY)
    ("first developed U6 expressed single stranded RNAs" . SPARSER::RNA)
    ("ssRNAs" . SPARSER::RNA) ("RNAse" . SPARSER::PROTEIN)
    ("ODN" . SPARSER::PROTEIN) ("EZH2 and H3K27me3" . SPARSER::COLLECTION)
    ("H3K27me3, DNMT3a and EZH2" . SPARSER::COLLECTION)
    ("DNMT3a and PTENpg1" . SPARSER::COLLECTION)
    ("EZH2 and PTENpg1" . SPARSER::COLLECTION)
    ("EZH2 and DNMT3a" . SPARSER::COLLECTION) ("SiRNA" . SPARSER::PROTEIN)
    ("DNMT3a, EZH2 and G9A" . SPARSER::COLLECTION) ("ncRNAs" . SPARSER::RNA)
    ("OAS1 and IL6" . SPARSER::COLLECTION) ("ncRNA" . SPARSER::RNA)
    ("Run" . SPARSER::PROTEIN)
    ("siRNAs ( pg1as α siRNA) or shRNAs ( pg1as α shRNA)"
     . SPARSER::COLLECTION)
    ("PTEN and PTENpg1" . SPARSER::COLLECTION) ("TSS" . SPARSER::PROTEIN)
    ("EST" . SPARSER::PROTEIN)
    ("the pluripotency-associated transcription factor OCT4"
     . SPARSER::PROTEIN)
    ("lncRNA" . SPARSER::RNA)
    ("phosphatase and tensin homolog ( PTEN )" . SPARSER::PROTEIN)
    ("DNMT3a and EZH2" . SPARSER::COLLECTION)
    ("a previously unidentified PTENpg1 encoded antisense RNA" . SPARSER::RNA)
    ("IMPDH2" . SPARSER::PROTEIN) ("Not1" . SPARSER::PROTEIN)
    ("G9a" . SPARSER::PROTEIN) ("set 3" . SPARSER::PROTEIN)
    ("set 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Polymerase II" . SPARSER::PROTEIN) ("Protein A" . SPARSER::PROTEIN)
    ("RNA dependent RNA polymerase" . SPARSER::PROTEIN)
    ("RNase H" . SPARSER::PROTEIN) ("H3K27me3" . SPARSER::MOLECULE)
    ("AGO2" . SPARSER::PROTEIN) ("Argonaute 2" . SPARSER::PROTEIN)
    ("AGO1" . SPARSER::PROTEIN) ("Argonaute 1" . SPARSER::PROTEIN)
    ("Histone deacetylase 1" . SPARSER::PROTEIN) ("OAS1" . SPARSER::PROTEIN)
    ("IFNα" . SPARSER::PROTEIN) ("G9A" . SPARSER::PROTEIN)
    ("DNA methyltransferase 3" . SPARSER::PROTEIN) ("pg1" . SPARSER::PROTEIN)
    ("RNA Polymerase II" . SPARSER::PROTEIN) ("H3K4" . SPARSER::PROTEIN)
    ("OCT4" . SPARSER::PROTEIN) ("PTEN2" . SPARSER::PROTEIN)
    ("beta isoform" . SPARSER::PROTEIN) ("EZH2" . SPARSER::PROTEIN)
    ("DNMT3a" . SPARSER::PROTEIN)
    ("prior erlotinib and/or bevacizumab" . SPARSER::COLLECTION)
    ("erlotinib and cetuximab" . SPARSER::COLLECTION)
    ("bevacizumab and cetuximab" . SPARSER::COLLECTION)
    ("EGFR mutations L848R and G873E and PIK3CA mutation E542K (n=1)"
     . SPARSER::COLLECTION)
    ("EGFR, PIK3CA, PTEN, and p53" . SPARSER::COLLECTION)
    ("EGFR or VEGF" . SPARSER::COLLECTION) ("PR/CR" . SPARSER::COLLECTION)
    ("cetuximab and erlotinib" . SPARSER::COLLECTION)
    ("inhibitors and antibodies" . SPARSER::COLLECTION)
    ("had received prior bevacizumab and/or erlotinib" . SPARSER::COLLECTION)
    ("PRs" . SPARSER::PROTEIN)
    ("bevacizumab, cetuximab, and erlotinib" . SPARSER::COLLECTION)
    ("prior sequential erlotinib and bevacizumab" . SPARSER::COLLECTION)
    ("erlotinib or bevacizumab" . SPARSER::COLLECTION)
    ("received prior concurrent erlotinib and bevacizumab"
     . SPARSER::COLLECTION)
    ("Prior EGFR inhibitor or VEGF Inhibitor Therapy" . SPARSER::COLLECTION)
    ("DLT" . SPARSER::PROTEIN) ("dual EGFR inhibitors" . SPARSER::INHIBITOR)
    ("erlotinib and bevacizumab" . SPARSER::COLLECTION)
    ("anti-VEGF or anti-EGFR" . SPARSER::COLLECTION)
    ("CR/PR" . SPARSER::COLLECTION) ("VEGF and EGFR" . SPARSER::COLLECTION)
    ("erlotinib and cetuximab or gefitinib and cetuximab"
     . SPARSER::COLLECTION)
    ("cetuximab or gefitinib and cetuximab" . SPARSER::COLLECTION)
    ("gefitinib and cetuximab" . SPARSER::COLLECTION)
    ("paclitaxel and carboplatin" . SPARSER::COLLECTION)
    ("Bevacizumab" . SPARSER::DRUG)
    ("vascular endothelial growth factor (VEGF) and its receptor VEGFR [ xref ]"
     . SPARSER::COLLECTION)
    ("VEGFR" . SPARSER::PROTEIN)
    ("antibodies and kinase" . SPARSER::COLLECTION)
    ("had received prior erlotinib and/or bevacizumab" . SPARSER::COLLECTION)
    ("erlotinib, cetuximab, and bevacizumab" . SPARSER::COLLECTION)
    ("RP2" . SPARSER::PROTEIN) ("SGLT1" . SPARSER::PROTEIN)
    ("anti-angiogenic" . SPARSER::DRUG) ("EGFR antibody" . SPARSER::PROTEIN)
    ("Nrf2 and/or INrf2" . SPARSER::COLLECTION)
    ("antioxidants and anti-apoptotic proteins" . SPARSER::COLLECTION)
    ("Fyn and Src and SCFβ-TrCP" . SPARSER::COLLECTION)
    ("Src and SCFβ-TrCP" . SPARSER::COLLECTION)
    ("p21 and BRCA2" . SPARSER::COLLECTION) ("oncoproteins" . SPARSER::PROTEIN)
    ("curcumin" . SPARSER::DRUG) ("amine" . SPARSER::MOLECULE)
    ("pentachlorophenol and 4-vinylcyclohexene diepoxide [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("pentachlorophenol" . SPARSER::MOLECULE) ("ovalbumin" . SPARSER::PROTEIN)
    ("acetaminophen" . SPARSER::DRUG)
    ("antioxidants and anti-inflammatory proteins" . SPARSER::COLLECTION)
    ("electrophiles and ROS" . SPARSER::COLLECTION)
    ("enzymes and other cytoprotective proteins" . SPARSER::COLLECTION)
    ("other cytoprotective proteins" . SPARSER::PROTEIN)
    ("Nrf2/HO-1" . SPARSER::COLLECTION) ("catechin" . SPARSER::MOLECULE)
    ("Curcumin" . SPARSER::DRUG)
    ("antioxidant and anti-inflammatory" . SPARSER::COLLECTION)
    ("acrolein" . SPARSER::MOLECULE) ("Prothymosin" . SPARSER::PROTEIN)
    ("K-Ras, B-Raf and Myc" . SPARSER::COLLECTION)
    ("GSK3β and β-TrCP" . SPARSER::COLLECTION)
    ("INrf2 and PKCδ" . SPARSER::COLLECTION)
    ("Nrf2 and INrf2/Cul3-RBX1 complex" . SPARSER::COLLECTION)
    ("Cul3 and Rbx1" . SPARSER::COLLECTION)
    ("INrf2 and INrf2" . SPARSER::COLLECTION)
    ("Nrf2 and INrf2" . SPARSER::COLLECTION)
    ("INrf2/Cul3-Rbx1" . SPARSER::COLLECTION)
    ("proteins and Bach1:Maf" . SPARSER::COLLECTION)
    ("Bach1:Maf" . SPARSER::BIO-COMPLEX)
    ("Nrf2 and Bach1" . SPARSER::COLLECTION)
    ("Fyn and Bach1" . SPARSER::COLLECTION)
    ("Maf or c-Jun" . SPARSER::COLLECTION) ("runs" . SPARSER::PROTEIN-FAMILY)
    ("Cul3-Rbx1" . SPARSER::COLLECTION)
    ("GSK3β phosphorylated Nrf2" . SPARSER::PROTEIN)
    ("Nrf2 [ xref ] and Bach1" . SPARSER::COLLECTION)
    ("Fgr" . SPARSER::PROTEIN) ("INrf2/Cul3-RBX1" . SPARSER::COLLECTION)
    ("Antioxidants" . SPARSER::DRUG)
    ("INrf2 (Inhibitor of Nrf2) or KEAP1 ( Kelch -like E CH- a ssociated p rotein1)"
     . SPARSER::COLLECTION)
    ("a homodimeric protein" . SPARSER::PROTEIN) ("CH-" . SPARSER::PROTEIN)
    ("CH" . SPARSER::PROTEIN) ("Maf or Jun" . SPARSER::COLLECTION)
    ("Jun" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Maf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Nrf1 and Nrf2" . SPARSER::COLLECTION) ("Nrf1" . SPARSER::PROTEIN)
    ("CNC" . SPARSER::PROTEIN) ("Factors and INrf2" . SPARSER::COLLECTION)
    ("TGA" . SPARSER::PROTEIN)
    ("NQO2 and other cytoprotective genes" . SPARSER::COLLECTION)
    ("other cytoprotective genes" . SPARSER::GENE)
    ("cytoprotective proteins" . SPARSER::PROTEIN)
    ("GSH and proteins" . SPARSER::COLLECTION)
    ("ROS and metal ions" . SPARSER::COLLECTION)
    ("metallothioneins and ferritins" . SPARSER::COLLECTION)
    ("ferritins" . SPARSER::PROTEIN) ("Glutathione" . SPARSER::DRUG)
    ("catabolism" . SPARSER::PROTEIN)
    ("H 2 O 2 and lipid hydroperoxides" . SPARSER::COLLECTION)
    ("electrophiles" . SPARSER::MOLECULE) ("MT3" . SPARSER::PROTEIN)
    ("reactive semiquinones" . SPARSER::MOLECULE)
    ("NQO1 and NQO2" . SPARSER::COLLECTION)
    ("semiquinones" . SPARSER::MOLECULE) ("quinones" . SPARSER::MOLECULE)
    ("the cytoprotective proteins" . SPARSER::PROTEIN)
    ("NRH:quinone oxidoreductase" . SPARSER::BIO-COMPLEX)
    ("metallothioneins" . SPARSER::PROTEIN)
    ("Cytoprotective proteins" . SPARSER::PROTEIN)
    ("Nrf2:INrf2 or Keap1 system" . SPARSER::COLLECTION)
    ("phenolic antioxidants" . SPARSER::DRUG) ("Quercetin" . SPARSER::MOLECULE)
    ("Honokiol" . SPARSER::DRUG) ("flavonoid" . SPARSER::MOLECULE)
    ("Silymarin and its major constituent" . SPARSER::COLLECTION)
    ("Silymarin" . SPARSER::DRUG) ("TRAMP" . SPARSER::PROTEIN)
    ("Sulforaphane" . SPARSER::PROTEIN)
    ("-epigallocatechin gallate" . SPARSER::DRUG)
    ("quercetin" . SPARSER::MOLECULE) ("EGCG" . SPARSER::DRUG)
    ("honokiol" . SPARSER::DRUG) ("silibinin" . SPARSER::DRUG)
    ("sulforaphane" . SPARSER::DRUG) ("Phytochemicals" . SPARSER::DRUG)
    ("chromanol" . SPARSER::MOLECULE) ("tocotrienols" . SPARSER::MOLECULE)
    ("The phenolic antioxidants BHA (tert-butyl-4-hydroxyanisole) and BHT [3,5-di-tert-butyl-4-hydroxytoluene]"
     . SPARSER::COLLECTION)
    ("The phenolic antioxidants BHA" . SPARSER::MOLECULE)
    ("hydroxytoluene" . SPARSER::MOLECULE) ("BHA" . SPARSER::MOLECULE)
    ("a few representative phenolic antioxidants" . SPARSER::DRUG)
    ("naturally occurring phytochemicals" . SPARSER::DRUG)
    ("occurring phytochemicals" . SPARSER::DRUG)
    ("Phenolic antioxidants" . SPARSER::DRUG) ("Chemical" . SPARSER::MOLECULE)
    ("hydroperoxides and quinone" . SPARSER::COLLECTION)
    ("quinone" . SPARSER::PROTEIN) ("hydroperoxides" . SPARSER::MOLECULE)
    ("INrf2 and Nrf2" . SPARSER::COLLECTION)
    ("AKT and PI3K" . SPARSER::COLLECTION)
    ("INrf2, Fyn and Bach1" . SPARSER::COLLECTION)
    ("phytochemicals" . SPARSER::DRUG) ("Chemicals" . SPARSER::MOLECULE)
    ("Cul3/Rbx1" . SPARSER::COLLECTION)
    ("proteins and proteasomes" . SPARSER::COLLECTION)
    ("Nrf2:INrf2" . SPARSER::BIO-COMPLEX) ("α-tocopherols" . SPARSER::MOLECULE)
    ("B-Raf" . SPARSER::PROTEIN) ("β-TrCP" . SPARSER::PROTEIN)
    ("subfamily A" . SPARSER::PROTEIN) ("RBX1" . SPARSER::PROTEIN)
    ("p45 NF-E2" . SPARSER::PROTEIN) ("Nrf3" . SPARSER::PROTEIN)
    ("cap ‘n’ collar" . SPARSER::PROTEIN) ("NF-E2" . SPARSER::PROTEIN)
    ("HO-1" . SPARSER::PROTEIN) ("NQO2" . SPARSER::PROTEIN)
    ("anti-neoplastic" . SPARSER::DRUG)
    ("epigallocatechin gallate" . SPARSER::DRUG)
    ("tert-butyl" . SPARSER::MOLECULE) ("Bach1" . SPARSER::PROTEIN)
    ("α-tocopherol" . SPARSER::MOLECULE) ("Rbx1" . SPARSER::PROTEIN)
    ("Cul3" . SPARSER::PROTEIN) ("Keap1" . SPARSER::PROTEIN)
    ("INrf2" . SPARSER::PROTEIN) ("Nrf2" . SPARSER::PROTEIN)
    ("that OGT and miRNA’s" . SPARSER::COLLECTION)
    ("OGT and miRNA" . SPARSER::COLLECTION)
    ("CD40LG, OGT and perhaps miRNA’s" . SPARSER::MICRO-RNA)
    ("CD40LG, OGT and perhaps" . SPARSER::COLLECTION)
    ("the other 13 X-linked miRNA’s" . SPARSER::MICRO-RNA)
    ("LCK and CBL" . SPARSER::COLLECTION) ("LCK and FYN" . SPARSER::COLLECTION)
    ("FYN" . SPARSER::PROTEIN) ("18 miRNA’s" . SPARSER::MICRO-RNA)
    ("Jurkat" . SPARSER::PROTEIN) ("Elf" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and NFAT" . SPARSER::COLLECTION)
    ("c-Myc and eNOS" . SPARSER::COLLECTION)
    ("the posttranslational fate" . SPARSER::PROTEIN)
    ("NAGA" . SPARSER::PROTEIN)
    ("CD40LG, EDA, OGT and CXCR3" . SPARSER::COLLECTION)
    ("hormonal factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("only 15 CG" . SPARSER::PROTEIN) ("the 18 miRNA’s" . SPARSER::MICRO-RNA)
    ("finally selected miRNA’s" . SPARSER::MICRO-RNA)
    ("finally selected miRNA" . SPARSER::MICRO-RNA)
    ("overexpressed miRNA’s" . SPARSER::MICRO-RNA)
    ("Overexpressed miRNA’s" . SPARSER::MICRO-RNA)
    ("These miRNA’s" . SPARSER::MICRO-RNA)
    ("18 X-linked miRNA’s" . SPARSER::MICRO-RNA)
    ("comparing miRNA’s" . SPARSER::MICRO-RNA)
    ("167 miRNA’s" . SPARSER::MICRO-RNA) ("miRNA’s" . SPARSER::MICRO-RNA)
    ("80 X chromosome and 824 autosomal miRNA" . SPARSER::COLLECTION)
    ("824 autosomal miRNA" . SPARSER::MICRO-RNA)
    ("X-linked miRNA’s" . SPARSER::MICRO-RNA)
    ("active and inactive" . SPARSER::COLLECTION)
    ("an autosomal gene" . SPARSER::GENE)
    ("inactive and active" . SPARSER::COLLECTION)
    ("the relevant gene promoters" . SPARSER::PROMOTER)
    ("OGT and CXCR3" . SPARSER::COLLECTION)
    ("immune relevant genes" . SPARSER::GENE)
    ("CXCR3 and OGT" . SPARSER::COLLECTION)
    ("anhidrotic ectodermal dysplasia" . SPARSER::PROTEIN)
    ("anhidrotic" . SPARSER::PROTEIN)
    ("serines and threonines" . SPARSER::COLLECTION)
    ("threonines" . SPARSER::AMINO-ACID)
    ("CXCR3 , OGT and CD40LG" . SPARSER::COLLECTION)
    ("EDA (Xq12-q13.1) and CD40LG (Xq26)" . SPARSER::COLLECTION)
    ("EDA" . SPARSER::PROTEIN) ("PMA and ionomycin" . SPARSER::COLLECTION)
    ("Dnmt" . SPARSER::PROTEIN)
    ("X-linked immune-related mRNAs and miRNA" . SPARSER::COLLECTION)
    ("mRNAs and miRNA" . SPARSER::COLLECTION)
    ("cytotoxic and pro-inflammatory" . SPARSER::COLLECTION)
    ("procainamide and hydralazine" . SPARSER::COLLECTION)
    ("perforin, IFN-γ, and KIR" . SPARSER::COLLECTION)
    ("cytotoxic and pro-inflammatory cells" . SPARSER::COLLECTION)
    ("KIR" . SPARSER::PROTEIN) ("perforin" . SPARSER::PROTEIN)
    ("hydralazine" . SPARSER::DRUG) ("procainamide" . SPARSER::DRUG)
    ("SAH" . SPARSER::PROTEIN) ("Dnmt3a and Dnmt3b" . SPARSER::COLLECTION)
    ("methyltransferases" . SPARSER::PROTEIN)
    ("a transcriptionally repressive conformation" . SPARSER::BIO-CONFORMATION)
    ("cytosines" . SPARSER::NUCLEOBASE) ("XO" . SPARSER::PROTEIN)
    ("just estrogen" . SPARSER::MOLECULE) ("Estrogen" . SPARSER::MOLECULE)
    ("CBL" . SPARSER::PROTEIN) ("OGT" . SPARSER::PROTEIN)
    ("azacytidine" . SPARSER::DRUG) ("mRNA and miRNA" . SPARSER::COLLECTION)
    ("ZAP70" . SPARSER::PROTEIN) ("HUWE1" . SPARSER::PROTEIN)
    ("O-GlcNAc" . SPARSER::PROTEIN) ("TLR7" . SPARSER::PROTEIN)
    ("Let-7" . SPARSER::RNA) ("Let 7" . SPARSER::RNA)
    ("E3 ubiquitin-protein ligase CBL" . SPARSER::PROTEIN)
    ("c-CBL" . SPARSER::PROTEIN) ("CD70" . SPARSER::PROTEIN)
    ("TNFSF7" . SPARSER::PROTEIN) ("membrane protein" . SPARSER::PROTEIN)
    ("ectodysplasin A" . SPARSER::PROTEIN) ("O -GlcNAc" . SPARSER::PROTEIN)
    ("N -acetylglucosamine" . SPARSER::MOLECULE) ("UDP-" . SPARSER::PROTEIN)
    ("N-acetylglucosamine" . SPARSER::MOLECULE) ("DNMT1" . SPARSER::PROTEIN)
    ("Gene2" . SPARSER::PROTEIN) ("S-adenosylhomocysteine" . SPARSER::MOLECULE)
    ("S-adenosylmethionine" . SPARSER::DRUG) ("Dnmt1" . SPARSER::PROTEIN)
    ("Dnmt3b" . SPARSER::PROTEIN) ("Dnmt3a" . SPARSER::PROTEIN)
    ("let-7" . SPARSER::RNA) ("DNA methyltransferase" . SPARSER::PROTEIN)
    ("CD40LG" . SPARSER::PROTEIN) ("X chromosome" . SPARSER::PROTEIN)
    ("extrinsic growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RabGAP5 and p85α" . SPARSER::COLLECTION)
    ("a new twist" . SPARSER::PROTEIN)
    ("Rab5-Vps15/Vps34" . SPARSER::COLLECTION)
    ("active growth factor receptor signaling complexes"
     . SPARSER::BIO-COMPLEX)
    ("p110β/p85" . SPARSER::COLLECTION) ("CAAX" . SPARSER::PROTEIN)
    ("Rab5 and the p110β-CAAX mutant" . SPARSER::COLLECTION)
    ("p110β-CAAX" . SPARSER::COLLECTION)
    ("effectively target proteins" . SPARSER::PROTEIN)
    ("p110β or a non-targeting control shRNA" . SPARSER::COLLECTION)
    ("the hormonal factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("toxin, and hydrocortisone" . SPARSER::COLLECTION)
    ("hydrocortisone" . SPARSER::DRUG)
    ("the dominant-negative Rab5 S43N mutant" . SPARSER::MUTANT)
    ("LC3-II ( xref ) and GFP-LC3 autophagic puncta ( xref )"
     . SPARSER::COLLECTION)
    ("GFP-LC3 autophagic puncta" . SPARSER::PROTEIN)
    ("p110β-" . SPARSER::PROTEIN)
    ("lysophosphatidic acid (LPA)" . SPARSER::LPA)
    ("the only Class IA isoform" . SPARSER::ISOFORM)
    ("always form heterodimers" . SPARSER::HETERODIMER)
    ("Akt and S6K" . SPARSER::COLLECTION)
    ("mCherry and GFP" . SPARSER::COLLECTION) ("Bcr" . SPARSER::PROTEIN)
    ("inhibitor (GDI)" . SPARSER::INHIBITOR)
    ("GEF or guanine" . SPARSER::COLLECTION) ("GDI" . SPARSER::PROTEIN)
    ("monomeric GTPases" . SPARSER::GTPASE)
    ("guanine nucleotide exchange factor (GEF)" . SPARSER::GEF)
    ("GAP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Vps34 and EEA1" . SPARSER::COLLECTION) ("R5BD" . SPARSER::PROTEIN)
    ("a dominant-negative Rab5 S43N mutant" . SPARSER::MUTANT)
    ("Rab5-DN" . SPARSER::COLLECTION) ("GST-R5BD" . SPARSER::COLLECTION)
    ("an inactive GDP-bound state and an active GTP-bound form that binds and activates its effectors ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("autophagic GFP-LC3 puncta and LC3-II" . SPARSER::COLLECTION)
    ("puncta and LC3-II" . SPARSER::COLLECTION)
    ("Vps34-Vps15" . SPARSER::COLLECTION)
    ("Vps34, Vps15, or Beclin 1" . SPARSER::COLLECTION)
    ("Vps34-Vps15-Beclin 1-Atg14L" . SPARSER::COLLECTION)
    ("p110β and Rab5" . SPARSER::COLLECTION)
    ("Vps34/Vps15" . SPARSER::COLLECTION)
    ("Vps34-Beclin 1" . SPARSER::COLLECTION) ("Akt/mTOR" . SPARSER::COLLECTION)
    ("metazoans" . SPARSER::PROTEIN-FAMILY)
    ("Rab5-Vps34" . SPARSER::COLLECTION) ("p110β-Rab5" . SPARSER::COLLECTION)
    ("IA" . SPARSER::MOLECULE) ("metazoan" . SPARSER::PROTEIN-FAMILY)
    ("GTPγS" . SPARSER::PROTEIN) ("TGX-221" . SPARSER::DRUG)
    ("K-Ras" . SPARSER::PROTEIN) ("IRS-2" . SPARSER::PROTEIN)
    ("RabGAP5" . SPARSER::PROTEIN)
    ("GTPase-activating protein" . SPARSER::PROTEIN)
    ("EEA1" . SPARSER::PROTEIN) ("Rabaptin5" . SPARSER::PROTEIN)
    ("bafilomycin A1" . SPARSER::DRUG) ("LC3-II" . SPARSER::PROTEIN)
    ("GFP-LC3" . SPARSER::PROTEIN) ("Atg14L" . SPARSER::PROTEIN)
    ("p110α" . SPARSER::PROTEIN) ("Beclin 1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-phosphate" . SPARSER::MOLECULE)
    ("Vps15" . SPARSER::PROTEIN) ("p110" . SPARSER::PROTEIN)
    ("Vps34" . SPARSER::PROTEIN) ("PI3Ks" . SPARSER::PROTEIN)
    ("phosphoinositide 3" . SPARSER::PROTEIN) ("p110β" . SPARSER::PROTEIN)
    ("Lynch syndrome-associated CRCs" . SPARSER::PROTEIN)
    ("the A allele" . SPARSER::ALLELE) ("MLH1 and MSH2" . SPARSER::COLLECTION)
    ("MLH1, MSH2, MSH6 and PMS2" . SPARSER::COLLECTION)
    ("p12" . SPARSER::PROTEIN)
    ("at least 15 independent common genetic variants" . SPARSER::VARIANT)
    ("p14" . SPARSER::PROTEIN) ("Colon Cancer" . SPARSER::PROTEIN)
    ("the variant A allele" . SPARSER::ALLELE) ("Tobacco" . SPARSER::DRUG)
    ("the histo-pathological subtypes" . SPARSER::PROTEIN)
    ("clock" . SPARSER::PROTEIN) ("Telomerase" . SPARSER::PROTEIN)
    ("TERT and GG" . SPARSER::COLLECTION) ("GT" . SPARSER::PROTEIN)
    ("TERT (rs2736100) and A allele (29.0% in cases and 33.3% in controls)"
     . SPARSER::COLLECTION)
    ("TERT (rs2736100) and CLPTM1L (rs401681) genes" . SPARSER::COLLECTION)
    ("the telomerase reverse transcriptase (TERT) and cleft lip and palate trans-membrane 1 like (CLPTM1L) genes"
     . SPARSER::COLLECTION)
    ("telomerase reverse transcriptase (TERT)" . SPARSER::PROTEIN)
    ("smoke (ETS)" . SPARSER::MOLECULE)
    ("TERT and CLPTM1L" . SPARSER::COLLECTION)
    ("Telomerase reverse transcriptase (TERT) and cleft lip and palate trans-membrane 1 like (CLPTM1L) genes"
     . SPARSER::COLLECTION)
    ("cleft lip and palate trans-membrane 1 like (CLPTM1L) genes"
     . SPARSER::COLLECTION)
    ("ribonucleoprotein complex" . SPARSER::BIO-COMPLEX)
    ("– 3" . SPARSER::PROTEIN) ("CLPTM1L" . SPARSER::PROTEIN)
    ("1 like" . SPARSER::PROTEIN)
    ("Telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("desirable selective forms" . SPARSER::FORM)
    ("TLRs" . SPARSER::PROTEIN-FAMILY) ("PKCα and PKCε" . SPARSER::COLLECTION)
    ("PKCθ or PKCα" . SPARSER::COLLECTION)
    ("PKCθ and PKCα" . SPARSER::COLLECTION)
    ("PKCθ and other PKCs" . SPARSER::COLLECTION) ("imatinib" . SPARSER::DRUG)
    ("ATP competitive inhibitors" . SPARSER::INHIBITOR)
    ("CD69 and CD25" . SPARSER::COLLECTION)
    ("IL-8 and TNFβ" . SPARSER::COLLECTION) ("IgG2a/2b" . SPARSER::COLLECTION)
    ("NF-κB, NFAT and AP1" . SPARSER::COLLECTION)
    ("PKCθ and other T cell-expressed PKCs" . SPARSER::COLLECTION)
    ("an attractive drug target" . SPARSER::TARGET-PROTEIN)
    ("a strong case" . SPARSER::PROTEIN) ("GLK" . SPARSER::PROTEIN)
    ("FOXO3a/ERα/p27Kip1" . SPARSER::COLLECTION)
    ("p21 and p27" . SPARSER::COLLECTION) ("Imatinib" . SPARSER::DRUG)
    ("receptor (VDR)" . SPARSER::RECEPTOR) ("VDR" . SPARSER::PROTEIN)
    ("RA, and celiac" . SPARSER::COLLECTION)
    ("this costimulatory receptor" . SPARSER::PROTEIN)
    ("pharmacological PKCθ inhibitors or Prkcq gene deletion"
     . SPARSER::COLLECTION)
    ("TGFβ and IL-2" . SPARSER::COLLECTION)
    ("Foxo1 and Foxo3a" . SPARSER::COLLECTION)
    ("Akt-Foxo1" . SPARSER::PROTEIN-PAIR)
    ("FoxP3, TGFβ and IL-10" . SPARSER::COLLECTION)
    ("-CD28" . SPARSER::COLLECTION) ("CN-A β" . SPARSER::PROTEIN-PAIR)
    ("IKKβ and Bcl10" . SPARSER::COLLECTION)
    ("an essential master transcription factor" . SPARSER::PROTEIN)
    ("VII" . SPARSER::PROTEIN) ("AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("-NFAT" . SPARSER::COLLECTION) ("PKCθ-JNK" . SPARSER::COLLECTION)
    ("Cd28" . SPARSER::PROTEIN)
    ("Ras, MAP kinases, AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("the major costimulatory receptor" . SPARSER::PROTEIN)
    ("PKCθ-Lck" . SPARSER::COLLECTION) ("sphingomyelin" . SPARSER::MOLECULE)
    ("PKCθ and WASp" . SPARSER::COLLECTION) ("WASp" . SPARSER::PROTEIN)
    ("Wiscott" . SPARSER::PROTEIN) ("a new APC" . SPARSER::PROTEIN)
    ("PKCε and PKCη" . SPARSER::COLLECTION) ("PKCθ" . SPARSER::PROTEIN)
    ("Th2 or Th17" . SPARSER::COLLECTION) ("PKCθ-CD28" . SPARSER::COLLECTION)
    ("this trimolecular complex" . SPARSER::BIO-COMPLEX)
    ("other costimulatory receptors" . SPARSER::PROTEIN)
    ("distal SMAC" . SPARSER::PROTEIN) ("peripheral SMAC" . SPARSER::PROTEIN)
    ("proteins and lipids" . SPARSER::COLLECTION) ("SMAC" . SPARSER::PROTEIN)
    ("IFNγ, TNFα and IL-6" . SPARSER::COLLECTION) ("ConA-" . SPARSER::PROTEIN)
    ("directional cytokine" . SPARSER::PROTEIN)
    ("protein (WIP)" . SPARSER::PROTEIN) ("WIP and WASP" . SPARSER::COLLECTION)
    ("WIP" . SPARSER::PROTEIN) ("WASP" . SPARSER::PROTEIN)
    ("IFNγ and TNFα" . SPARSER::COLLECTION)
    ("natural killer (NK)" . SPARSER::PROTEIN) ("NKT" . SPARSER::PROTEIN)
    ("allogeneic BMT" . SPARSER::PROTEIN) ("-leukemia" . SPARSER::COLLECTION)
    ("BMT" . SPARSER::PROTEIN) ("Prkcq and Prkca" . SPARSER::COLLECTION)
    ("Prkca" . SPARSER::PROTEIN) ("a special case" . SPARSER::PROTEIN)
    ("receptor (TLR)" . SPARSER::RECEPTOR)
    ("antibody and type 1" . SPARSER::COLLECTION)
    ("CTL and antibody" . SPARSER::COLLECTION) ("VSV" . SPARSER::PROTEIN)
    ("CTL" . SPARSER::PROTEIN)
    ("an active nuclear complex" . SPARSER::BIO-COMPLEX)
    ("centrosomes" . SPARSER::PROTEIN)
    ("biologically relevant nuclear" . SPARSER::PROTEIN)
    ("EL" . SPARSER::PROTEIN)
    ("Bcl2-associated death promoter (BAD)" . SPARSER::PROMOTER)
    ("promoter (BAD)" . SPARSER::PROMOTER)
    ("Bcl2 and Bcl" . SPARSER::COLLECTION) ("CTLs" . SPARSER::PROTEIN)
    ("Itk and Tec" . SPARSER::COLLECTION) ("interactors" . SPARSER::PROTEIN)
    ("Itk" . SPARSER::PROTEIN) ("SPAK" . SPARSER::PROTEIN)
    ("ERK and JNK" . SPARSER::COLLECTION) ("Bcl10-MALT1" . SPARSER::COLLECTION)
    ("IKKα and IKKβ" . SPARSER::COLLECTION)
    ("membrane-associated guanylate kinase (MAGUK) protein-1"
     . SPARSER::PROTEIN)
    ("Bcl10" . SPARSER::PROTEIN) ("MAGUK" . SPARSER::PROTEIN-FAMILY)
    ("CARD" . SPARSER::PROTEIN) ("NF-κB, AP-1, and NFAT" . SPARSER::COLLECTION)
    ("anti-CD3/CD28" . SPARSER::COLLECTION) ("neomycin" . SPARSER::DRUG)
    ("CD25 and CD69" . SPARSER::COLLECTION) ("ester-" . SPARSER::MOLECULE)
    ("NF-κB and AP-1" . SPARSER::COLLECTION)
    ("phospholipase C-γ1" . SPARSER::PROTEIN)
    ("AP-1, NF-κB and NFAT" . SPARSER::COLLECTION)
    ("additional enzymes and adaptor proteins" . SPARSER::COLLECTION)
    ("ZAP-70 and Tec-family" . SPARSER::COLLECTION)
    ("antigen-major histocompatibility complex (MHC)" . SPARSER::COLLECTION)
    ("antigen-major histocompatibility complex" . SPARSER::COLLECTION)
    ("sac" . SPARSER::PROTEIN) ("killer" . SPARSER::PROTEIN)
    ("PKCθ displays two main conformational states" . SPARSER::BIO-STATE)
    ("shot" . SPARSER::PROTEIN)
    ("phorbol esters and Ca 2+ ionophores" . SPARSER::COLLECTION)
    ("ionophores" . SPARSER::MOLECULE)
    ("the second messenger diacylglycerol (DAG) or phorbol esters"
     . SPARSER::COLLECTION)
    ("membrane-localized phosphatidylserine or other phospholipids"
     . SPARSER::COLLECTION)
    ("diacylglycerol (DAG)" . SPARSER::DAG)
    ("phosphatidylserine" . SPARSER::PROTEIN)
    ("novel PKCs (nPKC; δ, ε, η, and θ) and atypical PKCs (aPKC; ζ and ι/λ)"
     . SPARSER::COLLECTION)
    ("atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lipid and Ca 2+" . SPARSER::COLLECTION) ("esters" . SPARSER::MOLECULE)
    ("an increasingly attractive immunomodulatory drug target"
     . SPARSER::TARGET-PROTEIN)
    ("calcineurin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("costimulatory receptors" . SPARSER::PROTEIN) ("fungi" . SPARSER::PROTEIN)
    ("experimental Th2" . SPARSER::PROTEIN)
    ("NF-κB, AP-1 and NFAT" . SPARSER::COLLECTION) ("Prkcq" . SPARSER::PROTEIN)
    ("TLR9" . SPARSER::PROTEIN) ("Bcr-Abl" . SPARSER::PROTEIN)
    ("TNFβ" . SPARSER::PROTEIN) ("p27Kip1" . SPARSER::PROTEIN)
    ("Foxo3a" . SPARSER::PROTEIN) ("Foxo1" . SPARSER::PROTEIN)
    ("C20" . SPARSER::PROTEIN) ("Rap1" . SPARSER::PROTEIN)
    ("GEF2" . SPARSER::PROTEIN) ("concanavalin A" . SPARSER::DRUG)
    ("anti-CD28" . SPARSER::PROTEIN) ("micro-RNA" . SPARSER::MICRO-RNA)
    ("MSK-1" . SPARSER::PROTEIN) ("Ste20" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP kinases" . SPARSER::HUMAN-PROTEIN-FAMILY) ("IKKγ" . SPARSER::PROTEIN)
    ("CARD11" . SPARSER::PROTEIN) ("guanylate kinase" . SPARSER::PROTEIN)
    ("CD69" . SPARSER::PROTEIN) ("IP 3" . SPARSER::IP3)
    ("PLC-γ1" . SPARSER::PROTEIN) ("TCR-ζ" . SPARSER::PROTEIN)
    ("ι/λ" . SPARSER::PROTEIN) ("Protein kinase" . SPARSER::PROTEIN)
    ("CYL" . SPARSER::PROTEIN)
    ("KCL and HYK conceived and designed" . SPARSER::COLLECTION)
    ("KCL" . SPARSER::MOLECULE)
    ("Human chorionic gonadotropin" . SPARSER::PROTEIN)
    ("Androgen receptor-associated protein" . SPARSER::PROTEIN)
    ("Uracil" . SPARSER::DRUG) ("Gonadotropin" . SPARSER::PROTEIN)
    ("Deoxyribonucleoside" . SPARSER::MOLECULE) ("dNTP" . SPARSER::MOLECULE)
    ("Dihydrotestosterone" . SPARSER::DRUG)
    ("AR, SOX9 and AMH" . SPARSER::COLLECTION)
    ("AR, AMH and SOX9" . SPARSER::COLLECTION) ("PCOS" . SPARSER::PROTEIN)
    ("Androgens" . SPARSER::DRUG)
    ("testosterone and androstenedione" . SPARSER::COLLECTION)
    ("estradiol, testosterone, and androstenedione" . SPARSER::COLLECTION)
    ("gonadotropin and LH" . SPARSER::COLLECTION)
    ("LH, estradiol and androstenedione" . SPARSER::COLLECTION)
    ("hormonally-regulated genes" . SPARSER::GENE)
    ("androgen receptor and anti-Müllerian" . SPARSER::COLLECTION)
    ("DHT (0, 1 x 10 -9 M, 1 x 10 -8 M, 1 x 10 -7 M, or 1 x 10 -6 M) or rLH (0, 0.5 IU/mL, 1 IU/mL, 1.5 IU/mL, or 2 IU/mL)"
     . SPARSER::COLLECTION)
    ("androgen or rLH" . SPARSER::COLLECTION)
    ("AR or AMH" . SPARSER::COLLECTION) ("IU/mL" . SPARSER::COLLECTION)
    ("ARA54 and ARA70" . SPARSER::COLLECTION)
    ("SOX9 and AMH" . SPARSER::COLLECTION)
    ("AMH, SOX9 and AR" . SPARSER::COLLECTION)
    ("ARA70 and ARA54" . SPARSER::COLLECTION)
    ("LHR, AR, SOX9, and AMH" . SPARSER::COLLECTION)
    ("receptor (LHR)" . SPARSER::RECEPTOR)
    ("AR, SOX9, AMH, ARA54 and ARA70" . SPARSER::COLLECTION)
    ("androgen and AMH" . SPARSER::COLLECTION)
    ("androstenedione, testosterone, estradiol and progesterone"
     . SPARSER::COLLECTION)
    ("mIU/mL" . SPARSER::COLLECTION) ("mL" . SPARSER::PROTEIN)
    ("estradiol and progesterone" . SPARSER::COLLECTION)
    ("LH and androgen" . SPARSER::COLLECTION)
    ("luteinizing hormone receptor (LHR)" . SPARSER::PROTEIN)
    ("coactivators, SOX9, and AMH" . SPARSER::COLLECTION)
    ("GnRHa" . SPARSER::MOLECULE)
    ("endocrine and paracrine" . SPARSER::COLLECTION)
    ("AMH/SOX9" . SPARSER::COLLECTION) ("FSH" . SPARSER::PROTEIN)
    ("intrafollicular AMH" . SPARSER::PROTEIN)
    ("group (HMG)" . SPARSER::MOLECULE) ("SOX" . SPARSER::PROTEIN)
    ("aromatase" . SPARSER::PROTEIN)
    ("the AR-associated protein" . SPARSER::PROTEIN)
    ("Androgen" . SPARSER::PROTEIN) ("Ovarian androgens" . SPARSER::DRUG)
    ("ART" . SPARSER::PROTEIN) ("LHR and AR" . SPARSER::COLLECTION)
    ("AR, AMH, and SOX9" . SPARSER::COLLECTION)
    ("LHR, AR, AMH, and SOX9" . SPARSER::COLLECTION)
    ("androstenedione, testosterone, and estradiol" . SPARSER::COLLECTION)
    ("androstenedione" . SPARSER::PROTEIN)
    ("androgen and rLH" . SPARSER::COLLECTION)
    ("AR and AMH" . SPARSER::COLLECTION)
    ("AR-associated protein" . SPARSER::PROTEIN) ("LHR" . SPARSER::PROTEIN)
    ("androgen/androgen receptor (AR)" . SPARSER::COLLECTION)
    ("androgen/androgen receptor" . SPARSER::COLLECTION)
    ("Sry" . SPARSER::PROTEIN) ("AMH" . SPARSER::PROTEIN)
    ("Ribonucleic acid" . SPARSER::RNA)
    ("Luteinizing hormone receptor" . SPARSER::PROTEIN)
    ("Androgen receptor" . SPARSER::PROTEIN) ("co-factors" . SPARSER::MOLECULE)
    ("Ha- ras" . SPARSER::PROTEIN) ("ARA70" . SPARSER::PROTEIN)
    ("ARA54" . SPARSER::PROTEIN) ("TK and BS" . SPARSER::COLLECTION)
    ("an extrachromosomal viral DNA" . SPARSER::DNA)
    ("non-integrated viral DNA" . SPARSER::DNA) ("viral mRNA" . SPARSER::RNA)
    ("x" . SPARSER::PROTEIN) ("exogenous DNA" . SPARSER::DNA)
    ("viral and cellular factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("expressed rare-cutting endonucleases" . SPARSER::PROTEIN)
    ("x-ray" . SPARSER::COLLECTION) ("ray" . SPARSER::PROTEIN)
    ("ATM [ xref , xref ] and ATR [ xref ]" . SPARSER::COLLECTION)
    ("a 96-amino acid virion-associated nuclear protein" . SPARSER::PROTEIN)
    ("an accessory gene" . SPARSER::GENE)
    ("the structurally intact viral DNA" . SPARSER::DNA)
    ("the proviral DNA" . SPARSER::DNA)
    ("contained proviral DNA" . SPARSER::DNA)
    ("these viral RNA" . SPARSER::RNA) ("a viral protein" . SPARSER::PROTEIN)
    ("Tax" . SPARSER::PROTEIN) ("AZT" . SPARSER::DRUG)
    ("azidothymidine" . SPARSER::DRUG) ("a pivotal step" . SPARSER::PROTEIN)
    ("integrated viral DNA" . SPARSER::DNA)
    ("etoposide or bleomycin" . SPARSER::COLLECTION)
    ("etoposide and bleomycin" . SPARSER::COLLECTION)
    ("bleomycin" . SPARSER::DRUG)
    ("adenine and cytidine" . SPARSER::COLLECTION) ("pAC" . SPARSER::PROTEIN)
    ("Ppo" . SPARSER::PROTEIN)
    ("monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("raltegravir (RAL)" . SPARSER::DRUG) ("Lau" . SPARSER::MOLECULE)
    ("the viral DNA and the CA-3" . SPARSER::COLLECTION)
    ("the viral DNA" . SPARSER::DNA)
    ("the reverse-transcribed double-stranded viral DNA" . SPARSER::DNA)
    ("a 288-amino-acid and 32-kDa HIV-1 protein" . SPARSER::PROTEIN)
    ("Integrase" . SPARSER::PROTEIN) ("viral DNA" . SPARSER::DNA)
    ("cART" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protein (ATM)" . SPARSER::PROTEIN) ("RAL" . SPARSER::PROTEIN)
    ("raltegravir" . SPARSER::DRUG) ("integrase" . SPARSER::PROTEIN)
    ("X-gal" . SPARSER::MOLECULE) ("4-hydroxytamoxifen" . SPARSER::DRUG)
    ("β-globin" . SPARSER::PROTEIN) ("NL4" . SPARSER::PROTEIN)
    ("I-R" . SPARSER::PROTEIN) ("S6B" . SPARSER::PROTEIN)
    ("MT-4" . SPARSER::PROTEIN) ("KU55933" . SPARSER::DRUG)
    ("NBS1" . SPARSER::PROTEIN) ("integrase activity" . SPARSER::PROTEIN)
    ("PFL and YCC" . SPARSER::COLLECTION) ("PFL" . SPARSER::PROTEIN)
    ("LW" . SPARSER::PROTEIN)
    ("Paclitaxel, Docetaxel, Vincristine, and Doxorubicin"
     . SPARSER::COLLECTION)
    ("gene and telomerase activity" . SPARSER::COLLECTION)
    ("Vincristine" . SPARSER::DRUG) ("Paclitaxel" . SPARSER::DRUG)
    ("telomerase activity or hTERT" . SPARSER::COLLECTION)
    ("GCs" . SPARSER::PROTEIN) ("TAX, CDDP, and MMC" . SPARSER::COLLECTION)
    ("5-FU and ADM" . SPARSER::COLLECTION)
    ("different tumor histological types" . TYPE)
    ("CDDP and 5-FU" . SPARSER::COLLECTION)
    ("TAX, CDDP and 5-FU" . SPARSER::COLLECTION)
    ("ADM and MMC" . SPARSER::COLLECTION) ("ADM" . SPARSER::PROTEIN)
    ("CDDP" . SPARSER::DRUG) ("TAX" . SPARSER::PROTEIN)
    ("Telomerase activity or hTERT" . SPARSER::COLLECTION)
    ("TTAGGG repetitive DNA" . SPARSER::DNA) ("-diphenyl" . SPARSER::DRUG)
    ("diphenyl" . SPARSER::DRUG) ("the histological type" . TYPE)
    ("the chemotherapeutic drugs" . SPARSER::DRUG)
    ("tumor histological types and a worse tumor grade" . SPARSER::COLLECTION)
    ("Adriamycin and Mitomycin" . SPARSER::COLLECTION)
    ("tumor histological types" . TYPE)
    ("Taxol, Cisplatin and 5-Fluorouracil" . SPARSER::COLLECTION)
    ("Adriamycin" . SPARSER::DRUG) ("Cisplatin" . SPARSER::DRUG)
    ("Taxol" . SPARSER::DRUG) ("Telomerase activity" . SPARSER::PROTEIN)
    ("telomerase reverse transcriptase" . SPARSER::PROTEIN)
    ("a larger patient cohort" . SPARSER::MOLECULE)
    ("healthy BMMb and FLT3 ITD AML" . SPARSER::PROTEIN)
    ("pediatric AML" . SPARSER::PROTEIN)
    ("an adverse impact" . SPARSER::PROTEIN)
    ("an independent prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS/RAF/MAPK" . SPARSER::COLLECTION) ("Etoposide" . SPARSER::PROTEIN)
    ("age and secondary AML" . SPARSER::COLLECTION)
    ("FLT3 WT AML and healthy BMMbs ( xref )" . SPARSER::COLLECTION)
    ("FLT3 ITD AML, FLT3 WT AML and healthy BMMbs ( xref )"
     . SPARSER::COLLECTION)
    ("the first two principal components" . SPARSER::COMPONENT)
    ("p-Chk2" . SPARSER::COLLECTION) ("p-STAT1" . SPARSER::COLLECTION)
    ("p-STAT5" . SPARSER::COLLECTION) ("Component" . SPARSER::COMPONENT)
    ("Daunorubicin" . SPARSER::DRUG) ("Staurosporine" . SPARSER::DRUG)
    ("healthy BM and FLT3 ITD AML" . SPARSER::PROTEIN)
    ("ERK, AKT, and STAT5" . SPARSER::COLLECTION)
    ("PI3K, RAS, and JAK" . SPARSER::COLLECTION)
    ("secondary AML" . SPARSER::PROTEIN)
    ("two sequential cohorts" . SPARSER::MOLECULE)
    ("RAS/RAF/ERK" . SPARSER::COLLECTION) ("/FLT3" . SPARSER::COLLECTION)
    ("SCT" . SPARSER::PROTEIN)
    ("cytogenetically normal AML" . SPARSER::PROTEIN)
    ("receptor and NPM1" . SPARSER::COLLECTION)
    ("a nucleolar phosphoprotein" . SPARSER::PROTEIN)
    ("phosphoprotein" . SPARSER::PROTEIN) ("Nucleophosmin" . SPARSER::PROTEIN)
    ("FLT3 and NPM1" . SPARSER::COLLECTION)
    ("FLT3 and nucleophosmin" . SPARSER::COLLECTION)
    ("nucleophosmin" . SPARSER::PROTEIN)
    ("two separate cohorts" . SPARSER::MOLECULE)
    ("a multiparametric flow cytometry" . SPARSER::PROTEIN)
    ("pS6" . SPARSER::PROTEIN) ("TK1" . SPARSER::PROTEIN)
    ("log 2" . SPARSER::PROTEIN) ("CD15" . SPARSER::DRUG)
    ("G-CSF" . SPARSER::PROTEIN) ("RARα" . SPARSER::PROTEIN)
    ("IL-27" . SPARSER::PROTEIN) ("FLT3 ligand" . SPARSER::PROTEIN)
    ("PI3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FMS-like tyrosine kinase 3" . SPARSER::PROTEIN)
    ("an intriguing viral protein" . SPARSER::PROTEIN)
    ("two accessory genes" . SPARSER::GENE)
    ("vif and vpr" . SPARSER::COLLECTION)
    ("vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 and a Vif mutant" . SPARSER::COLLECTION)
    ("Cdc2/CyclinB" . SPARSER::COLLECTION) ("CyclinB" . SPARSER::PROTEIN)
    ("a tumor suppressor gene and the regulator of cell cycle"
     . SPARSER::COLLECTION)
    ("Vpr" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neural precursor cell expressed developmentally down-regulated protein 4 (Nedd4) and atrophin-interacting protein 4 (AIP4)"
     . SPARSER::COLLECTION)
    ("atrophin" . SPARSER::PROTEIN) ("Cul5–EloB" . SPARSER::PROTEIN-PAIR)
    ("polyubiquitinate" . SPARSER::PROTEIN)
    ("Vif AND CBFβ" . SPARSER::COLLECTION)
    ("chimeric APOBEC3G" . SPARSER::PROTEIN)
    ("Vif and APOBEC3G" . SPARSER::COLLECTION) ("PROTEINS" . SPARSER::PROTEIN)
    ("Cx" . SPARSER::PROTEIN-FAMILY) ("SOCS" . SPARSER::PROTEIN)
    ("EloB" . SPARSER::PROTEIN) ("Elongin" . SPARSER::PROTEIN)
    ("cellular APOBEC3G" . SPARSER::PROTEIN) ("vif" . SPARSER::PROTEIN)
    ("Vif and APOBEC3" . SPARSER::COLLECTION)
    ("Tetherin/BST-2" . SPARSER::COLLECTION)
    ("Tetherin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Vif" . SPARSER::PROTEIN)
    ("Cdc2" . SPARSER::PROTEIN) ("protein R" . SPARSER::PROTEIN)
    ("AIP4" . SPARSER::PROTEIN) ("protein 4" . SPARSER::PROTEIN)
    ("Nedd4" . SPARSER::PROTEIN)
    ("neural precursor cell expressed developmentally down-regulated protein 4"
     . SPARSER::PROTEIN)
    ("Gag protein" . SPARSER::PROTEIN)
    ("core-binding factor subunit beta" . SPARSER::PROTEIN)
    ("APOBEC3F" . SPARSER::PROTEIN) ("chelating agent" . SPARSER::MOLECULE)
    ("Cul5" . SPARSER::PROTEIN) ("Cullin 5" . SPARSER::PROTEIN)
    ("CEM15" . SPARSER::PROTEIN)
    ("Virion infectivity factor" . SPARSER::PROTEIN)
    ("APOBEC3" . SPARSER::PROTEIN) ("SAMHD1" . SPARSER::PROTEIN)
    ("BST-2" . SPARSER::PROTEIN) ("TRIM5α" . SPARSER::PROTEIN)
    ("APOBEC3G" . SPARSER::PROTEIN)
    ("virion infectivity factor" . SPARSER::PROTEIN)
    ("otherwise effective anti-EGFR drugs" . SPARSER::DRUG)
    ("at least EGFRvIII" . SPARSER::PROTEIN)
    ("EGFRvIII and wtEGFR" . SPARSER::COLLECTION)
    ("EGFR and PDGFR" . SPARSER::COLLECTION)
    ("AKT, MAPK and Stat3" . SPARSER::COLLECTION)
    ("PTEN, p53 and RB" . SPARSER::COLLECTION)
    ("dominant-negative EGFR" . SPARSER::PROTEIN)
    ("Vimentin, snail and twist" . SPARSER::COLLECTION)
    ("Vimentin" . SPARSER::PROTEIN)
    ("vimentin, snail and twist" . SPARSER::COLLECTION)
    ("Akt and MAPK" . SPARSER::COLLECTION)
    ("Akt, MAPK and Stat3" . SPARSER::COLLECTION)
    ("HIF1A and VEGFA" . SPARSER::COLLECTION) ("pimonidazole" . SPARSER::DRUG)
    ("CD533" . SPARSER::PROTEIN)
    ("dominant-negative EGFR protein" . SPARSER::PROTEIN)
    ("EGFR-CD533" . SPARSER::COLLECTION)
    ("a dominant-negative receptor" . SPARSER::PROTEIN)
    ("MRI and histology" . SPARSER::COLLECTION) ("BBB" . SPARSER::PROTEIN)
    ("a clinically relevant anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("covered significantly smaller area fractions" . SPARSER::COMPONENT)
    ("pAkt, pMAPK and pStat3" . SPARSER::COLLECTION)
    ("nestin and sox2" . SPARSER::COLLECTION)
    ("nestin, sox2 and CD133" . SPARSER::COLLECTION)
    ("VEGFA, ANGPT1, ANGPT2 and bFGF" . SPARSER::COLLECTION)
    ("the vascular marker vWF" . SPARSER::PROTEIN) ("vWF" . SPARSER::PROTEIN)
    ("barrier (BBB)" . SPARSER::PROTEIN) ("EGFRvIII" . SPARSER::PROTEIN)
    ("a dominant-negative EGFR" . SPARSER::PROTEIN)
    ("angiopoietin-2" . SPARSER::PROTEIN) ("ANGPT2" . SPARSER::PROTEIN)
    ("ANGPT1" . SPARSER::PROTEIN) ("beta-Actin" . SPARSER::PROTEIN)
    ("AC133" . SPARSER::PROTEIN) ("angiopoietin1" . SPARSER::PROTEIN)
    ("angiopoietin2" . SPARSER::PROTEIN) ("sox2" . SPARSER::PROTEIN)
    ("Kit 2" . SPARSER::PROTEIN) ("ML4" . SPARSER::PROTEIN)
    ("and 1 " . SPARSER::PROTEIN) ("OGD and tFCI" . SPARSER::COLLECTION)
    ("SP600125 or AG14361" . SPARSER::COLLECTION)
    ("PARP1 and JNK" . SPARSER::COLLECTION)
    ("p53 or ATM" . SPARSER::COLLECTION)
    ("thioredoxin/ASK1" . SPARSER::COLLECTION)
    ("a larger fraction" . SPARSER::COMPONENT)
    ("A smaller fraction" . SPARSER::COMPONENT)
    ("the predominant functional form" . SPARSER::FORM)
    ("a rational target" . SPARSER::TARGET-PROTEIN)
    ("p53 and JNK" . SPARSER::COLLECTION) ("overexpressors" . SPARSER::PROTEIN)
    ("phospho-p53 and mitochondrial" . SPARSER::COLLECTION)
    ("NeuN and PARS" . SPARSER::COLLECTION) ("NeuN" . SPARSER::PROTEIN)
    ("PRX2 overexpressors" . SPARSER::PROTEIN)
    ("neuronal PRX2" . SPARSER::PROTEIN)
    ("AG14361 and SP600125" . SPARSER::COLLECTION)
    ("JNK and PARP1" . SPARSER::COLLECTION)
    ("JNK and p53" . SPARSER::COLLECTION) ("ATM and p53" . SPARSER::COLLECTION)
    ("ASK1 and JNK" . SPARSER::COLLECTION) ("PARS" . SPARSER::PROTEIN)
    ("ASK1 and c-Jun" . SPARSER::COLLECTION)
    ("PARP1, and ASK1" . SPARSER::COLLECTION)
    ("ASK1/JNK" . SPARSER::COLLECTION)
    ("JNK and PARP1 or p53" . SPARSER::COLLECTION)
    ("PARP1 or p53" . SPARSER::COLLECTION)
    ("AG14361 and MK801" . SPARSER::COLLECTION) ("NMDA" . SPARSER::MOLECULE)
    ("ATM, H2AX and p53" . SPARSER::COLLECTION)
    ("shRNA and PRX2" . SPARSER::COLLECTION)
    ("NAD + and cause energy failure" . SPARSER::COLLECTION)
    ("the potent cell membrane-permeable PARP1 inhibitor AG14361"
     . SPARSER::DRUG)
    ("staurosporine or camptothecin-induced death ( xref )"
     . SPARSER::COLLECTION)
    ("staurosporine" . SPARSER::DRUG) ("PRX1 or PRX2" . SPARSER::COLLECTION)
    ("PRX1 and PRX2" . SPARSER::COLLECTION)
    ("aid rational drug" . SPARSER::DRUG)
    ("JNK, PARP1, and p53" . SPARSER::COLLECTION) ("PARP1-" . SPARSER::PROTEIN)
    ("PRX" . SPARSER::PROTEIN) ("effectively control H 2 O 2" . SPARSER::DRUG)
    ("PRXs" . SPARSER::PROTEIN) ("peroxiredoxins" . SPARSER::PROTEIN)
    ("peroxynitrites and hydroxyl radicals" . SPARSER::COLLECTION)
    ("base and deoxyribose" . SPARSER::COLLECTION)
    ("H2AX and p53" . SPARSER::COLLECTION)
    ("peroxynitrites" . SPARSER::MOLECULE) ("deoxyribose" . SPARSER::MOLECULE)
    ("AG14361 and p53" . SPARSER::COLLECTION)
    ("p53 or Bax" . SPARSER::COLLECTION)
    ("PARP1, p53, Bax, and caspase" . SPARSER::COLLECTION)
    ("OGD" . SPARSER::PROTEIN)
    ("transient focal cerebral ischemia" . SPARSER::PROTEIN)
    ("oxygen-glucose" . SPARSER::PROTEIN) ("p53 and Bax" . SPARSER::COLLECTION)
    ("p53-" . SPARSER::PROTEIN) ("glutamate receptor" . SPARSER::PROTEIN)
    ("MK801" . SPARSER::MOLECULE) ("Sirtuin 1" . SPARSER::PROTEIN)
    ("PRX1" . SPARSER::PROTEIN) ("neuronal)" . SPARSER::PROTEIN)
    ("apoptosis signal-regulating kinase 1" . SPARSER::PROTEIN)
    ("apoptosis-inducing" . SPARSER::PROTEIN)
    ("hydroxyl radicals" . SPARSER::MOLECULE) ("AG14361" . SPARSER::DRUG)
    ("PRX2" . SPARSER::PROTEIN) ("peroxiredoxin2" . SPARSER::PROTEIN)
    ("PARP1" . SPARSER::PROTEIN) ("enigma" . SPARSER::PROTEIN)
    ("Prominin-1/CD133" . SPARSER::COLLECTION)
    ("Neither c-Myc nor Akt" . SPARSER::COLLECTION)
    ("calbindin, synaptophysin or PLP" . SPARSER::COLLECTION)
    ("CD133, nestin, Olig2 and Musashi-1" . SPARSER::COLLECTION)
    ("CSC or TIC" . SPARSER::COLLECTION) ("TIC" . SPARSER::PROTEIN)
    ("CSC" . SPARSER::PROTEIN) ("Bad and Caspase 9" . SPARSER::COLLECTION)
    ("Bad" . SPARSER::PROTEIN) ("pro-apoptotic proteins" . SPARSER::PROTEIN)
    ("Bax and Bak" . SPARSER::COLLECTION)
    ("CD133, Olig2 and Musashi-1" . SPARSER::COLLECTION)
    ("both c-Myc as well as Akt" . SPARSER::COLLECTION)
    ("active c-Myc and/or Akt" . SPARSER::COLLECTION)
    ("p53 −/− cortical astrocytes" . SPARSER::PROTEIN)
    ("p53 and Pten" . SPARSER::COLLECTION)
    ("Ras and Akt" . SPARSER::COLLECTION) ("PTEN/Akt-1" . SPARSER::COLLECTION)
    ("RB1-p16INK4a" . SPARSER::COLLECTION)
    ("p53-MDM2-p14ARF" . SPARSER::COLLECTION)
    ("cortical astrocytes" . SPARSER::PROTEIN)
    ("MAC-1 immunoreactive macrophages" . SPARSER::PROTEIN)
    ("primary cortical astrocytes" . SPARSER::PROTEIN)
    ("70kDa" . SPARSER::PROTEIN) ("Ak/c-Myc" . SPARSER::COLLECTION)
    ("c-Myc or both oncogenes ( xref )" . SPARSER::COLLECTION)
    ("Akt, c-Myc or both oncogenes ( xref )" . SPARSER::COLLECTION)
    ("CD133 and Olig2" . SPARSER::COLLECTION)
    ("c-Myc as well as Akt" . SPARSER::COLLECTION)
    ("nestin-IR" . SPARSER::COLLECTION)
    ("strong GFAP-IR" . SPARSER::COLLECTION)
    ("c-Myc or both oncogenes" . SPARSER::COLLECTION)
    ("Musashi-1, nestin, CD133 and Olig2" . SPARSER::COLLECTION)
    ("side and p53MYC and p53MA" . SPARSER::COLLECTION)
    ("a larger growth fraction" . SPARSER::COMPONENT)
    ("Ki67-LIs" . SPARSER::COLLECTION) ("LIs" . SPARSER::PROTEIN)
    ("LI" . SPARSER::PROTEIN) ("Ki67-LI" . SPARSER::PROTEIN-PAIR)
    ("Ki67-IR" . SPARSER::COLLECTION)
    ("AKT and/or c-Myc" . SPARSER::COLLECTION)
    ("neuronal or oligodendroglial genes" . SPARSER::GENE)
    ("c-Myc and/or Akt" . SPARSER::COLLECTION)
    ("oligodendroglial (PLP, MBP) genes" . SPARSER::GENE)
    ("MBP" . SPARSER::PROTEIN) ("PLP" . SPARSER::PROTEIN)
    ("calbindin" . SPARSER::PROTEIN) ("synaptophysin" . SPARSER::PROTEIN)
    ("GFAP and c-Myc" . SPARSER::COLLECTION) ("GFAP-IR" . SPARSER::COLLECTION)
    ("Astrocytes" . SPARSER::PROTEIN) ("sharp" . SPARSER::PROTEIN)
    ("GFAP" . SPARSER::PROTEIN) ("star" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either EGFP, c-Myc, Akt or both oncogenes" . SPARSER::COLLECTION)
    ("Akt or both oncogenes" . SPARSER::COLLECTION)
    ("c-Myc, Akt or both oncogenes" . SPARSER::COLLECTION)
    ("constitutively active Akt or both c-Myc and myr-Akt"
     . SPARSER::COLLECTION)
    ("c-Myc and myr-Akt" . SPARSER::COLLECTION)
    ("ARF/p53" . SPARSER::COLLECTION)
    ("p53 and phosphatase and tensin homolog (PTEN)" . SPARSER::COLLECTION)
    ("p53 and phosphatase and tensin homolog" . SPARSER::COLLECTION)
    ("c-Myc or Akt" . SPARSER::COLLECTION)
    ("isocitrate-dehydrogenase" . SPARSER::COLLECTION)
    ("dehydrogenase" . SPARSER::PROTEIN) ("isocitrate" . SPARSER::PROTEIN)
    ("c-Myc and Akt" . SPARSER::COLLECTION)
    ("myr-Akt and c-Myc" . SPARSER::COLLECTION) ("myr" . SPARSER::MOLECULE)
    ("transmembrane protein" . SPARSER::PROTEIN)
    ("Prominin-1" . SPARSER::PROTEIN) ("Akt-1" . SPARSER::PROTEIN)
    ("RB1" . SPARSER::PROTEIN) ("p14ARF" . SPARSER::PROTEIN)
    ("Rag2" . SPARSER::PROTEIN) ("proliferation-associated" . SPARSER::PROTEIN)
    ("NF68" . SPARSER::PROTEIN) ("GAP43" . SPARSER::PROTEIN)
    ("Olig2" . SPARSER::PROTEIN) ("Musashi-1" . SPARSER::PROTEIN)
    ("Enhanced Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("glial fibrillary acidic protein" . SPARSER::PROTEIN)
    ("neurofibromin 1" . SPARSER::PROTEIN)
    ("ERK1/2 and further upregulated MMP-2" . SPARSER::COLLECTION)
    ("further upregulated MMP-2" . SPARSER::PROTEIN)
    ("subunits, hCGα and hCGβ" . SPARSER::COLLECTION)
    ("hCGβ/ERK1/2/MMP-2" . SPARSER::COLLECTION)
    ("hCGβ and VEGF" . SPARSER::COLLECTION) ("DH" . SPARSER::PROTEIN)
    ("CON" . SPARSER::PROTEIN)
    ("vitamin D and Vitamin D" . SPARSER::COLLECTION)
    ("essential proteases" . SPARSER::PROTEIN)
    ("intact hCG" . SPARSER::PROTEIN) ("hCG" . SPARSER::PROTEIN)
    ("HCGs" . SPARSER::PROTEIN)
    ("heterodimeric glycoproteins" . SPARSER::PROTEIN)
    ("Human chorionic gonadotropins" . SPARSER::PROTEIN)
    ("hCGs" . SPARSER::PROTEIN) ("gonadotropins" . SPARSER::PROTEIN)
    ("ERK1/2 and MMP-2" . SPARSER::COLLECTION) ("R-250" . SPARSER::PROTEIN)
    ("luteinizing hormone receptor" . SPARSER::PROTEIN)
    ("DNA ligase" . SPARSER::PROTEIN) ("vitamin D" . SPARSER::MOLECULE)
    ("Extracellular signal-regulated kinase1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DU145" . SPARSER::PROTEIN) ("hCGβ" . SPARSER::PROTEIN)
    ("the EGFR mutational state" . SPARSER::BIO-STATE)
    ("EGFR mutational state" . SPARSER::BIO-STATE)
    ("the extracted DNA and the quantity" . SPARSER::COLLECTION)
    ("developmental targeted drugs" . SPARSER::DRUG)
    ("ALK/EML4-ALK" . SPARSER::COLLECTION)
    ("afatinib, and dacomitinib" . SPARSER::COLLECTION)
    ("dacomitinib" . SPARSER::DRUG)
    ("another irreversible TKI" . SPARSER::PROTEIN)
    ("Dacomitinib" . SPARSER::DRUG)
    ("erlotinib and the second-generation TKI afatinib" . SPARSER::COLLECTION)
    ("LUX" . SPARSER::PROTEIN) ("Afatinib" . SPARSER::DRUG)
    ("good RR" . SPARSER::PROTEIN) ("Neratinib" . SPARSER::DRUG)
    ("methionine" . SPARSER::AMINO-ACID)
    ("gefitinib or erlotinib" . SPARSER::COLLECTION)
    ("EGFR mutational subtypes" . SPARSER::PROTEIN)
    ("PFS and RR" . SPARSER::COLLECTION) ("RR and PFS" . SPARSER::COLLECTION)
    ("IRESSA" . SPARSER::DRUG) ("RRs" . SPARSER::MOLECULE)
    ("third-line" . SPARSER::PROTEIN) ("BR" . SPARSER::PROTEIN)
    ("Gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("Gefitinib" . SPARSER::DRUG)
    ("cisplatin and vinorelbine" . SPARSER::COLLECTION)
    ("cetuximab" . SPARSER::DRUG)
    ("inhibitors, and NSCLCs" . SPARSER::COLLECTION)
    ("EGFR/HER2" . SPARSER::COLLECTION) ("EGFR and HER2" . SPARSER::COLLECTION)
    ("this membrane-associated receptor" . SPARSER::PROTEIN)
    ("glycine" . SPARSER::AMINO-ACID)
    ("a possible target" . SPARSER::TARGET-PROTEIN)
    ("second-line" . SPARSER::PROTEIN)
    ("carboplatin and paclitaxel" . SPARSER::COLLECTION)
    ("cisplatin or carboplatin" . SPARSER::COLLECTION)
    ("docetaxel" . SPARSER::DRUG) ("vinorelbine" . SPARSER::DRUG)
    ("carboplatin" . SPARSER::DRUG) ("IIIB" . SPARSER::DRUG)
    ("a predictive factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a functional EGFR" . SPARSER::PROTEIN) ("EGFR-TK" . SPARSER::COLLECTION)
    ("RAS/RAF1/MAP2K1/MAPK1" . SPARSER::COLLECTION)
    ("PIK3CA/AKT1/MTOR" . SPARSER::COLLECTION)
    ("HER3 (ErbB3) and HER4 (ErbB4)" . SPARSER::COLLECTION)
    ("EGFR (HER1/ErbB1), HER2 (ErbB2), HER3 (ErbB3) and HER4 (ErbB4)"
     . SPARSER::COLLECTION)
    ("HER or ErbB" . SPARSER::COLLECTION) ("HER1/ErbB1" . SPARSER::COLLECTION)
    ("TKs" . SPARSER::PROTEIN) ("ADC" . SPARSER::PROTEIN)
    ("TTF-1" . SPARSER::PROTEIN) ("P40" . SPARSER::PROTEIN)
    ("P63" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PF-00299804" . SPARSER::DRUG)
    ("BIBW2992" . SPARSER::DRUG) ("HKI-272" . SPARSER::DRUG)
    ("MAPK1" . SPARSER::PROTEIN) ("MAP2K1" . SPARSER::PROTEIN)
    ("RAF1" . SPARSER::PROTEIN) ("HER4" . SPARSER::PROTEIN)
    ("HER3" . SPARSER::PROTEIN) ("RhoGDI" . SPARSER::PROTEIN)
    ("ceramide" . SPARSER::MOLECULE) ("Akt or AS160" . SPARSER::COLLECTION)
    ("Rac1 or PAK1" . SPARSER::COLLECTION) ("Intralipid" . SPARSER::DRUG)
    ("GLUT4, Akt, and PAK1" . SPARSER::COLLECTION)
    ("food and water" . SPARSER::COLLECTION) ("VO" . SPARSER::MOLECULE)
    ("RER" . SPARSER::PROTEIN) ("an intraperitoneal ITT" . SPARSER::MOLECULE)
    ("ITT" . SPARSER::MOLECULE) ("muscle-specific KO" . SPARSER::PROTEIN)
    ("GLUT4, GLUT1, and actin" . SPARSER::COLLECTION)
    ("insulin and Rac1" . SPARSER::COLLECTION)
    ("a hyperinsulinemic-euglycemic clamp" . SPARSER::PROTEIN)
    ("VL" . SPARSER::PROTEIN) ("EDL" . SPARSER::PROTEIN)
    ("Rac1 and PAK" . SPARSER::COLLECTION) ("p-PAK" . SPARSER::COLLECTION)
    ("postprandial glucose" . SPARSER::PROTEIN) ("intralipid" . SPARSER::DRUG)
    ("insulin and glucose" . SPARSER::COLLECTION)
    ("Rac1 and PAK1" . SPARSER::COLLECTION)
    ("Rac1 and its downstream target" . SPARSER::COLLECTION)
    ("kinase (PAK)" . SPARSER::KINASE) ("AS160" . SPARSER::PROTEIN)
    ("cdc42" . SPARSER::PROTEIN) ("latrunculin B" . SPARSER::DRUG)
    ("DDB2-" . SPARSER::PROTEIN)
    ("XPA, XPB, XPC, XPD, XPF, XPG and DDB2" . SPARSER::COLLECTION)
    ("XPD" . SPARSER::PROTEIN) ("XPB" . SPARSER::PROTEIN)
    ("ATR, ATM, Chk1, Chk2, and BRCA1" . SPARSER::COLLECTION)
    ("ATM-Chk2-BRCA1" . SPARSER::COLLECTION)
    ("NER, DDB2 and XPC" . SPARSER::COLLECTION)
    ("spontaneous HR" . SPARSER::PROTEIN) ("Chk1-" . SPARSER::PROTEIN)
    ("both NER complex and RPA complex" . SPARSER::COLLECTION)
    ("Chk1 and SMC1" . SPARSER::COLLECTION) ("RPA-ATRIP" . SPARSER::COLLECTION)
    ("ATRIP" . SPARSER::PROTEIN) ("XPC or DDB2" . SPARSER::COLLECTION)
    ("DDB2/XPC" . SPARSER::COLLECTION) ("DDB1-DDB2-XPC" . SPARSER::COLLECTION)
    ("BRCA1/Rad51" . SPARSER::COLLECTION) ("Chk1/Chk2" . SPARSER::COLLECTION)
    ("NER and checkpoint components" . SPARSER::COLLECTION)
    ("phospho-BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("H2AX and BRCA1" . SPARSER::COLLECTION)
    ("p53 and p21 proteins" . SPARSER::COLLECTION)
    ("ATR, ATM, and H2AX" . SPARSER::COLLECTION) ("siRNAs" . SPARSER::PROTEIN)
    ("ATM-Chk2" . SPARSER::COLLECTION)
    ("H2AX and phospho-Chk1" . SPARSER::COLLECTION)
    ("functional DDB2 and XPC" . SPARSER::COLLECTION)
    ("siRNA-, or ATM" . SPARSER::COLLECTION) ("siRNA-" . SPARSER::PROTEIN)
    ("antibody, and XPC" . SPARSER::COLLECTION)
    ("HA-XPC" . SPARSER::COLLECTION) ("FLAG-DDB2" . SPARSER::COLLECTION)
    ("ATR or ATM" . SPARSER::COLLECTION) ("siRNA or ATM" . SPARSER::COLLECTION)
    ("the well-defined foci" . SPARSER::PROTEIN)
    ("ATR, ATM, and γH2AX" . SPARSER::COLLECTION)
    ("ATR, pATM, and γH2AX" . SPARSER::COLLECTION) ("Foci" . SPARSER::PROTEIN)
    ("DDB2 (XP-E) or XPC (XP-C)" . SPARSER::COLLECTION)
    ("ATR or pATM" . SPARSER::COLLECTION)
    ("antibodies, and XPC" . SPARSER::COLLECTION)
    ("XPC, SNF5, and ATM" . SPARSER::COLLECTION)
    ("SNF5, and SNF5" . SPARSER::COLLECTION) ("ATR/ATM" . SPARSER::COLLECTION)
    ("pATM and γ-H2AX" . SPARSER::COLLECTION)
    ("CPD and 6-4PP" . SPARSER::COLLECTION)
    ("pATM, ATR, and γH2AX" . SPARSER::COLLECTION) ("pATM" . SPARSER::PROTEIN)
    ("the lesion-specific antibodies" . SPARSER::ANTIBODY)
    ("CPD, and 6-4PP" . SPARSER::COLLECTION) ("MRN" . SPARSER::COLLECTION)
    ("an essential step" . SPARSER::PROTEIN)
    ("Mre11-Rad50-Nbs1" . SPARSER::COLLECTION)
    ("Chk1 and Chk2" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, and Rad51" . SPARSER::COLLECTION)
    ("BRCA1 and H2AX" . SPARSER::COLLECTION) ("SSB" . SPARSER::PROTEIN)
    ("ATR (Ataxia telangiectasia- and Rad3- related) and ATM (Ataxia telangiectasia mutated)"
     . SPARSER::COLLECTION)
    ("the principal checkpoint kinases" . SPARSER::KINASE)
    ("Ataxia telangiectasia- and Rad3-" . SPARSER::COLLECTION)
    ("Ataxia telangiectasia-" . SPARSER::PROTEIN)
    ("trichothiodystrophy" . SPARSER::PROTEIN)
    ("complete NER" . SPARSER::PROTEIN) ("XPF and XPG" . SPARSER::COLLECTION)
    ("endonucleases" . SPARSER::PROTEIN)
    ("XPA, XPG, and TFIIH" . SPARSER::COLLECTION) ("TFIIH" . SPARSER::PROTEIN)
    ("XPG" . SPARSER::PROTEIN) ("XPA" . SPARSER::PROTEIN)
    ("DDB1-CUL4-ROC1" . SPARSER::COLLECTION)
    ("DDB1 and DDB2" . SPARSER::COLLECTION)
    ("XPC-RAD23B" . SPARSER::COLLECTION) ("DDB" . SPARSER::DRUG)
    ("global genome NER" . SPARSER::PROTEIN) ("TC-NER" . SPARSER::COLLECTION)
    ("UV-induced bulky DNA adducts cyclobutane pyrimidine dimers (CPD)"
     . SPARSER::DIMER)
    ("dimers (CPD)" . SPARSER::DIMER) ("pyrimidone" . SPARSER::MOLECULE)
    ("CPD" . SPARSER::PROTEIN) ("cyclobutane" . SPARSER::MOLECULE)
    ("DDR" . SPARSER::PROTEIN) ("ATR-" . SPARSER::PROTEIN)
    ("Chk1, Chk2, H2AX, and BRCA1" . SPARSER::COLLECTION)
    ("DDB2 or XPC" . SPARSER::COLLECTION)
    ("DDB2 and XPC" . SPARSER::COLLECTION) ("XPC" . SPARSER::PROTEIN)
    ("ATR and ATM" . SPARSER::COLLECTION) ("SMC1" . SPARSER::PROTEIN)
    ("p21 proteins" . SPARSER::PROTEIN) ("p-ATM" . SPARSER::PROTEIN)
    ("SNF5" . SPARSER::PROTEIN) ("γ-H2AX" . SPARSER::PROTEIN)
    ("XP-C" . SPARSER::PROTEIN) ("Cdc25A" . SPARSER::PROTEIN)
    ("Cdc25" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Ataxia telangiectasia" . SPARSER::PROTEIN)
    ("Cockayne syndrome" . SPARSER::PROTEIN) ("Cullin 4A" . SPARSER::PROTEIN)
    ("CUL4" . SPARSER::PROTEIN) ("cullin 4A" . SPARSER::PROTEIN)
    ("RAD23B" . SPARSER::PROTEIN) ("DDB1" . SPARSER::PROTEIN)
    ("DDB2" . SPARSER::PROTEIN) ("special p" . SPARSER::PROTEIN)
    ("the prominent p" . SPARSER::PROTEIN) ("MH" . SPARSER::PROTEIN)
    ("CTA" . SPARSER::PROTEIN) ("CAA" . SPARSER::PROTEIN)
    ("ACB" . SPARSER::PROTEIN) ("mutagen" . SPARSER::MOLECULE)
    ("pyrimidine and a 3" . SPARSER::COLLECTION) ("Py" . SPARSER::MOLECULE)
    ("acceptor" . SPARSER::MOLECULE) ("only five p" . SPARSER::PROTEIN)
    ("the principal DNA base" . SPARSER::PROTEIN) ("dA" . SPARSER::MOLECULE)
    ("Adenine" . SPARSER::NUCLEOBASE)
    ("the pre-mutated adenine" . SPARSER::NUCLEOBASE)
    ("AA and TP53" . SPARSER::COLLECTION) ("JD Wang's" . SPARSER::PROTEIN)
    ("analogs" . SPARSER::ANALOG) ("AAI and AAII" . SPARSER::COLLECTION)
    ("AAI" . SPARSER::PROTEIN) ("ochratoxin A (OTA)" . SPARSER::MOLECULE)
    ("OTA" . SPARSER::MOLECULE) ("environmental mutagens" . SPARSER::MOLECULE)
    ("UV or tobacco" . SPARSER::COLLECTION)
    ("the mutated guanines" . SPARSER::NUCLEOBASE) ("AGT" . SPARSER::PROTEIN)
    ("AGG" . SPARSER::MOLECULE) ("guanines" . SPARSER::NUCLEOBASE)
    ("certain environmental mutagens" . SPARSER::MOLECULE)
    ("mutagens" . SPARSER::MOLECULE) ("AA-I" . SPARSER::PROTEIN)
    ("ochratoxin A" . SPARSER::MOLECULE) ("RKP" . SPARSER::PROTEIN)
    ("BH" . SPARSER::PROTEIN)
    ("a unique tumor target" . SPARSER::TARGET-PROTEIN)
    ("IL-13 and undergoes" . SPARSER::COLLECTION)
    ("Bacterial toxins" . SPARSER::MOLECULE) ("immunotoxins" . SPARSER::DRUG)
    ("monoclonal antibodies and fusion toxins" . SPARSER::COLLECTION)
    ("toxins" . SPARSER::MOLECULE)
    ("IL-13Rα1 and IL-4Rα" . SPARSER::COLLECTION)
    ("growth factors and cytokines" . SPARSER::COLLECTION)
    ("CreER" . SPARSER::PROTEIN) ("Immunotoxin" . SPARSER::DRUG)
    ("an irrelevant IL2-PE immunotoxin" . SPARSER::DRUG)
    ("IL2-PE" . SPARSER::COLLECTION) ("K14-CreER" . SPARSER::COLLECTION)
    ("tam" . SPARSER::PROTEIN) ("Tamoxifen" . SPARSER::MOLECULE)
    ("the murine sarcoma cell line MCA304" . SPARSER::PROTEIN)
    ("MCA" . SPARSER::PROTEIN) ("only few molecules" . SPARSER::MOLECULE)
    ("RCC" . SPARSER::PROTEIN)
    ("IL-13 receptors and cause selective cytotoxicitiy" . SPARSER::COLLECTION)
    ("a bacterial toxin" . SPARSER::PROTEIN)
    ("TGFBR1 and PTEN" . SPARSER::COLLECTION)
    ("IL-13Rα2, IL-13Rα1, and IL-4Rα" . SPARSER::COLLECTION)
    ("cytotoxin" . SPARSER::PROTEIN)
    ("Akt, NF-κB, and Stat3" . SPARSER::COLLECTION)
    ("keratin" . SPARSER::PROTEIN) ("IL-13 and TGF-β" . SPARSER::COLLECTION)
    ("a unique receptor" . SPARSER::PROTEIN) ("IL-13-PE" . SPARSER::COLLECTION)
    ("immunotoxin" . SPARSER::DRUG) ("Tgfbr1/Pten" . SPARSER::COLLECTION)
    ("cKO" . SPARSER::PROTEIN)
    ("Transforming Growth Factor-β Receptor 1 (TGFβRI) and Phosphatase and Tensin homolog (PTEN)"
     . SPARSER::COLLECTION)
    ("RI" . SPARSER::PROTEIN) ("elongation factor 2" . SPARSER::PROTEIN)
    ("IL13Rα2" . SPARSER::PROTEIN) ("IL2" . SPARSER::PROTEIN)
    ("recombinase activity" . SPARSER::PROTEIN) ("TGFBR1" . SPARSER::PROTEIN)
    ("Gr-1" . SPARSER::PROTEIN) ("GR-1" . SPARSER::PROTEIN)
    ("IL-4Rα" . SPARSER::PROTEIN) ("IL-13Rα1" . SPARSER::PROTEIN)
    ("Stat3" . SPARSER::PROTEIN) ("a Beta" . SPARSER::PROTEIN)
    ("K14" . SPARSER::PROTEIN) ("TGF-β1" . SPARSER::PROTEIN)
    ("tumor antigen" . SPARSER::DRUG) ("IL-13Rα2" . SPARSER::PROTEIN)
    ("Tgfbr1" . SPARSER::PROTEIN)
    ("Phosphatase and Tensin homolog" . SPARSER::PROTEIN)
    ("Receptor 1" . SPARSER::PROTEIN)
    ("Transforming Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor necrosis factor-" . SPARSER::PROTEIN) ("HRP" . SPARSER::PROTEIN)
    ("pro-apoptotic Bax gene" . SPARSER::PROTEIN)
    ("the major IL-17" . SPARSER::PROTEIN)
    ("leukemia inhibitor factor, and bone morphogenic protein 2"
     . SPARSER::PROTEIN)
    ("an essential transcription factor" . SPARSER::PROTEIN)
    ("synoviolin" . SPARSER::PROTEIN) ("ligand (RANKL)" . SPARSER::MOLECULE)
    ("RANKL" . SPARSER::PROTEIN) ("degradative enzymes" . SPARSER::ENZYME)
    ("IL-8 and stromal cell-derived factor-1" . SPARSER::COLLECTION)
    ("IL-6 and IL-8" . SPARSER::COLLECTION)
    ("IL-17 antibodies or soluble IL-17 receptor" . SPARSER::COLLECTION)
    ("soluble IL-17 receptor" . SPARSER::RECEPTOR)
    ("IL-17, and IL-17" . SPARSER::COLLECTION)
    ("phosphorylated STAT3 ( p -STAT3 705 and p -STAT3 727) and Bcl-2"
     . SPARSER::COLLECTION)
    ("-STAT3" . SPARSER::COLLECTION) ("intense Bcl-2" . SPARSER::PROTEIN)
    ("neither Bcl-2 nor Bax" . SPARSER::COLLECTION)
    ("PI and Annexin V" . SPARSER::COLLECTION)
    ("RA and OA" . SPARSER::COLLECTION)
    ("pro-apoptotic Bax mRNA" . SPARSER::RNA)
    ("the principal components" . SPARSER::COMPONENT)
    ("pro-apoptotic Bax and anti-apoptotic Bcl-2" . SPARSER::PROTEIN)
    ("Bax and anti-apoptotic" . SPARSER::COLLECTION)
    ("a highly inflammatory cytokine" . SPARSER::PROTEIN)
    ("interleukin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-17/STAT3" . SPARSER::COLLECTION) ("FLS" . SPARSER::PROTEIN)
    ("nitroprusside (SNP)" . SPARSER::DRUG) ("nitroprusside" . SPARSER::DRUG)
    ("The pro-apoptotic Bax" . SPARSER::PROTEIN)
    ("Bcl-2 and phosphoSTAT3" . SPARSER::COLLECTION)
    ("Bcl-2 and Bax" . SPARSER::COLLECTION) ("FLSs" . SPARSER::PROTEIN)
    ("STA-21" . SPARSER::DRUG) ("protein 2" . SPARSER::PROTEIN)
    ("Cyr61" . SPARSER::PROTEIN) ("NF-Kb" . SPARSER::PROTEIN)
    ("SDF-1" . SPARSER::PROTEIN) ("derived factor-1" . SPARSER::PROTEIN)
    ("Caspases 3" . SPARSER::PROTEIN) ("STA21" . SPARSER::DRUG)
    ("IL-17RA" . SPARSER::PROTEIN) ("Bcl2" . SPARSER::PROTEIN)
    ("member 6" . SPARSER::PROTEIN) ("H-ras" . SPARSER::PROTEIN)
    ("interleukin-17" . SPARSER::PROTEIN) ("MLP" . SPARSER::PROTEIN)
    ("FC" . SPARSER::PROTEIN)
    ("prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MBP-1 or HDAC1" . SPARSER::COLLECTION)
    ("MBP-1/HDAC1/ERBB2" . SPARSER::COLLECTION)
    ("ERBB2 and the c-MYC P2 promoter" . SPARSER::COLLECTION)
    ("BRM, BRG1, and SUV39H1" . SPARSER::COLLECTION)
    ("forkhead" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the multifunctional transcription factor YY1" . SPARSER::PROTEIN)
    ("AP-2 and Ets" . SPARSER::COLLECTION)
    ("the ERBB2 gene proximal promoter" . SPARSER::PROMOTER)
    ("strong HDAC1 and MBP-1 nuclear" . SPARSER::PROTEIN)
    ("MBP-1, HDAC1 and ErbB2" . SPARSER::COLLECTION)
    ("MBP-1 and ErbB2" . SPARSER::COLLECTION)
    ("HDAC1 and MBP-1" . SPARSER::COLLECTION) ("AcH" . SPARSER::PROTEIN)
    ("exogenous Flag-MBP-1" . SPARSER::COLLECTION)
    ("exogenous MBP-1 and endogenous HDAC1 protein" . SPARSER::COLLECTION)
    ("the larger fragment" . SPARSER::FRAGMENT)
    ("gene (MD)" . SPARSER::PROTEIN) ("MP" . SPARSER::PROTEIN)
    ("the ERBB2 proximal promoter" . SPARSER::PROMOTER)
    ("pG" . SPARSER::MOLECULE) ("exogenous MBP-1" . SPARSER::PROTEIN)
    ("the exogenous MBP-1 protein" . SPARSER::PROTEIN)
    ("Green Fluorescent Protein(GFP)" . SPARSER::PROTEIN)
    ("Myc and ErbB2" . SPARSER::COLLECTION)
    ("c-MYC and ERBB2" . SPARSER::COLLECTION)
    ("ERBB2 and c-MYC" . SPARSER::COLLECTION)
    ("Flag-MBP-1" . SPARSER::COLLECTION)
    ("MBP-1, HDAC1 and ERBB2" . SPARSER::COLLECTION)
    ("MBP-1 and the ERBB2 gene" . SPARSER::COLLECTION)
    ("ErbB2 and Ki67" . SPARSER::COLLECTION) ("NS1-BP" . SPARSER::COLLECTION)
    ("MIP-2/sedlin" . SPARSER::COLLECTION) ("sedlin" . SPARSER::PROTEIN)
    ("alpha-enolase and MBP-1" . SPARSER::COLLECTION)
    ("protein (TBP)" . SPARSER::PROTEIN) ("TBP" . SPARSER::PROTEIN)
    ("c-MYC and D-type" . SPARSER::COLLECTION)
    ("Ras/Erk" . SPARSER::COLLECTION)
    ("target, and immunohistochemistry" . SPARSER::COLLECTION)
    ("MBP-1 and HDAC1" . SPARSER::COLLECTION)
    ("gene and chromatin" . SPARSER::COLLECTION)
    ("MBP-1 and ERBB2" . SPARSER::COLLECTION)
    ("only one other direct target" . SPARSER::TARGET-PROTEIN)
    ("GATA4" . SPARSER::PROTEIN) ("DNA-binding protein" . SPARSER::PROTEIN)
    ("PEA3" . SPARSER::PROTEIN) ("of 45" . SPARSER::PROTEIN)
    ("HDAC-1" . SPARSER::PROTEIN) ("ERP5" . SPARSER::PROTEIN)
    ("ERP3" . SPARSER::PROTEIN) ("ERP1" . SPARSER::PROTEIN)
    ("MPB-1" . SPARSER::PROTEIN) ("Histone H4" . SPARSER::PROTEIN)
    ("anti-ErbB2" . SPARSER::DRUG)
    ("beta-galactosidase activity" . SPARSER::PROTEIN)
    ("beta-galactosidase" . SPARSER::PROTEIN) ("MBP1" . SPARSER::PROTEIN)
    ("Notch 1" . SPARSER::PROTEIN) ("NS1" . SPARSER::PROTEIN)
    ("histone deacetylase 1" . SPARSER::PROTEIN) ("MIP-2" . SPARSER::PROTEIN)
    ("alpha-enolase" . SPARSER::PROTEIN) ("Myc protein" . SPARSER::PROTEIN)
    ("COX2" . SPARSER::PROTEIN) ("MBP-1" . SPARSER::PROTEIN)
    ("ERBB2" . SPARSER::PROTEIN) ("XPOT, RASSF3 and GNS" . SPARSER::COLLECTION)
    ("the only other established NTG gene ( OPTN )" . SPARSER::PROTEIN)
    ("gene ( OPTN )" . SPARSER::PROTEIN)
    ("XPOT , RASSF3 , or GNS" . SPARSER::COLLECTION)
    ("the chromosome 12q14 duplication strongly supports TBK1"
     . SPARSER::PROTEIN)
    ("anti-RASSF3 and anti-XPOT" . SPARSER::COLLECTION)
    ("XPOT and RASSF3" . SPARSER::COLLECTION)
    ("GNS, XPOT, RASSF3, and TBK1" . SPARSER::COLLECTION)
    ("XPOT, RASSF3, and GNS" . SPARSER::COLLECTION)
    ("XPOT , RASSF3 , and GNS" . SPARSER::COLLECTION)
    ("sulfatase" . SPARSER::PROTEIN) ("glucosamine" . SPARSER::MOLECULE)
    ("TBK1 and exportin" . SPARSER::COLLECTION) ("exportin" . SPARSER::PROTEIN)
    ("MYOC" . SPARSER::PROTEIN) ("myocilin" . SPARSER::PROTEIN)
    ("GLC" . SPARSER::MOLECULE) ("These Mendelian forms" . SPARSER::FORM)
    ("RASSF3 and XPOT" . SPARSER::COLLECTION)
    ("XPOT, TBK1, RASSF3, and GNS" . SPARSER::COLLECTION)
    ("TBK1 and GNS" . SPARSER::COLLECTION)
    ("TBK1 , XPOT , RASSF3 , and GNS" . SPARSER::COLLECTION)
    ("GNS" . SPARSER::PROTEIN) ("XPOT" . SPARSER::PROTEIN)
    ("vascular endothelial" . SPARSER::PROTEIN)
    ("potassium chloride" . SPARSER::MOLECULE) ("LC3" . SPARSER::PROTEIN)
    ("TANK binding kinase 1" . SPARSER::PROTEIN) ("GLC1G" . SPARSER::PROTEIN)
    ("GLC1F" . SPARSER::PROTEIN) ("GLC1E" . SPARSER::PROTEIN)
    ("GLC1A" . SPARSER::PROTEIN) ("open angle" . SPARSER::PROTEIN)
    ("RASSF3" . SPARSER::PROTEIN) ("TBK1" . SPARSER::PROTEIN)
    ("GLC1P" . SPARSER::MOLECULE) ("azathioprine" . SPARSER::DRUG)
    ("TNF and IFN-γ" . SPARSER::COLLECTION) ("complete TEM" . SPARSER::PROTEIN)
    ("professional APCs or planar bilayers" . SPARSER::COLLECTION)
    ("Vav and Rac both reduced TCR-driven TEM" . SPARSER::PROTEIN)
    ("DOCK2 and Tiam" . SPARSER::COLLECTION) ("Tiam" . SPARSER::PROTEIN-FAMILY)
    ("homeostatic chemokines" . SPARSER::PROTEIN)
    ("substantially (total T cells from human blood) naïve" . SPARSER::PROTEIN)
    ("Rac1 and Rac2" . SPARSER::COLLECTION)
    ("target or non-specific" . SPARSER::COLLECTION)
    ("Hph-EGFP-Vav" . SPARSER::COLLECTION) ("Hph-EGFP" . SPARSER::COLLECTION)
    ("LAT and SLP-76" . SPARSER::COLLECTION)
    ("LFA-1 and talin" . SPARSER::COLLECTION)
    ("very weak, and activated LFA-1" . SPARSER::PROTEIN)
    ("Vav, Rac, and myosin" . SPARSER::COLLECTION)
    ("Blebbistatin" . SPARSER::DRUG) ("blebbistatin" . SPARSER::DRUG)
    ("the only myosin II isoform" . SPARSER::ISOFORM)
    ("Myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("reduced TCR-driven TEM" . SPARSER::PROTEIN)
    ("Vav, Rac1 and Cdc42" . SPARSER::COLLECTION) ("Hph-1" . SPARSER::PROTEIN)
    ("Hph" . SPARSER::PROTEIN)
    ("TCR-but not chemokine-driven TEM" . SPARSER::PROTEIN)
    ("a ternary complex" . SPARSER::BIO-COMPLEX)
    ("kindlin-3 and LFA-1" . SPARSER::COLLECTION)
    ("Talin and kindlin-3" . SPARSER::COLLECTION) ("Talin" . SPARSER::PROTEIN)
    ("LFA-1-ICAM-1" . SPARSER::COLLECTION)
    ("both chemokine-and TCR-driven TEM" . SPARSER::PROTEIN)
    ("piceatannol and Syk" . SPARSER::COLLECTION)
    ("piceatannol" . SPARSER::DRUG)
    ("chemokine- and TCR-driven TEM" . SPARSER::COLLECTION)
    ("chemokine-" . SPARSER::PROTEIN) ("CIITA" . SPARSER::PROTEIN)
    ("Vav and its target small G protein Rac" . SPARSER::COLLECTION)
    ("membrane-permeable recombinant proteins" . SPARSER::PROTEIN)
    ("Vav and Rac" . SPARSER::COLLECTION)
    ("LFA-1, talin, and RACK1" . SPARSER::COLLECTION)
    ("ZAP-70 and LAT" . SPARSER::COLLECTION)
    ("LFA-1 as well as the linker proteins" . SPARSER::COLLECTION)
    ("namely talin and kindlin 3" . SPARSER::COLLECTION)
    ("The principal integrin" . SPARSER::PROTEIN)
    ("talin and kindlin" . SPARSER::COLLECTION)
    ("CD11a/CD18" . SPARSER::COLLECTION) ("kindlin" . SPARSER::PROTEIN-FAMILY)
    ("talin" . SPARSER::PROTEIN)
    ("TCR-driven TEM (such as TEP formation) and chemokine-driven TEM (such as filopodia formation)"
     . SPARSER::COLLECTION)
    ("Rho and Cdc42" . SPARSER::COLLECTION)
    ("both cytosolic tyrosine kinases (such as ZAP-70 in T cells) and small Rho family G proteins"
     . SPARSER::COLLECTION)
    ("Rac and/or Cdc42" . SPARSER::COLLECTION)
    ("activated trimeric G proteins" . SPARSER::PROTEIN)
    ("exchange factor (GEF)" . SPARSER::EXCHANGE-FACTOR)
    ("TCR-associated adaptor proteins" . SPARSER::PROTEIN)
    ("LAT and SLP76" . SPARSER::COLLECTION) ("LAT" . SPARSER::PROTEIN)
    ("syk" . SPARSER::PROTEIN)
    ("the TCR-associated CD3 protein subunits" . SPARSER::FRAGMENT)
    ("lck or fyn" . SPARSER::COLLECTION) ("fyn" . SPARSER::PROTEIN)
    ("lck" . SPARSER::PROTEIN) ("src" . SPARSER::PROTEIN)
    ("polio virus receptor (CD155) or nectin-2 (CD112)" . SPARSER::COLLECTION)
    ("several EC junctional molecules" . SPARSER::MOLECULE)
    ("chemokine-driven TEM" . SPARSER::PROTEIN)
    ("superantigen" . SPARSER::MOLECULE)
    ("both MHC Class I and Class II molecules" . SPARSER::COLLECTION)
    ("CD8 or CD4" . SPARSER::COLLECTION) ("proteoglycans" . SPARSER::PROTEIN)
    ("CD45RA−" . SPARSER::PROTEIN) ("CD62L−" . SPARSER::PROTEIN)
    ("CCR7−" . SPARSER::PROTEIN) ("multi-step" . SPARSER::COLLECTION)
    ("Chemokine-driven TEM" . SPARSER::PROTEIN)
    ("Vav, Rac and mysosin" . SPARSER::COLLECTION)
    ("Chemokine" . SPARSER::PROTEIN) ("TCR-driven TEM" . SPARSER::PROTEIN)
    ("Vav, Rac and myosin" . SPARSER::COLLECTION)
    ("inflammatory chemokines" . SPARSER::PROTEIN) ("TEM" . SPARSER::PROTEIN)
    ("DOCK2" . SPARSER::PROTEIN) ("CXCL12" . SPARSER::PROTEIN)
    ("CCL21" . SPARSER::PROTEIN) ("CD3 zeta chain" . SPARSER::PROTEIN)
    ("SLP-76" . SPARSER::PROTEIN) ("myosin II" . SPARSER::PROTEIN)
    ("kindlin-3" . SPARSER::PROTEIN) ("CD3 complex" . SPARSER::PROTEIN)
    ("Hph1" . SPARSER::PROTEIN)
    ("myosin light chain kinase" . SPARSER::PROTEIN)
    ("ML-7" . SPARSER::MOLECULE) ("β2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("scaffold protein" . SPARSER::PROTEIN) ("CD18" . SPARSER::PROTEIN)
    ("CD11a" . SPARSER::PROTEIN) ("small G protein" . SPARSER::PROTEIN)
    ("SLP76" . SPARSER::PROTEIN) ("CD112" . SPARSER::PROTEIN)
    ("nectin-2" . SPARSER::PROTEIN) ("CD155" . SPARSER::PROTEIN)
    ("CD99" . SPARSER::PROTEIN)
    ("endothelial cell adhesion molecule" . SPARSER::PROTEIN)
    ("TSST-1" . SPARSER::PROTEIN) ("CD62L" . SPARSER::PROTEIN)
    ("ZAP-70" . SPARSER::PROTEIN) ("innovative drug" . SPARSER::DRUG)
    ("FGFR–FRS2–Shp2" . SPARSER::COLLECTION) ("FGFR" . SPARSER::PROTEIN)
    ("Shp2 or Grb2" . SPARSER::COLLECTION)
    ("FGFR2 and FGFR1" . SPARSER::COLLECTION)
    ("Grb2 and Shp2" . SPARSER::COLLECTION)
    ("FGFR2 and Grb2" . SPARSER::COLLECTION)
    ("the pivotal regulator" . SPARSER::PROTEIN)
    ("this heterotetrameric complex Grb2" . SPARSER::PROTEIN)
    ("dimeric Grb2" . SPARSER::PROTEIN)
    ("the Shp2 inhibitor (NSC87877) and receptor phosphorylation level"
     . SPARSER::COLLECTION)
    ("pERK" . SPARSER::PROTEIN)
    ("WT Shp2 and the C459S and Y542F mutants" . SPARSER::COLLECTION)
    ("the nonphosphorylatable Y542F mutant Shp2" . SPARSER::PROTEIN)
    ("receptor and adaptor protein" . SPARSER::COLLECTION)
    ("RFP-Grb2" . SPARSER::COLLECTION)
    ("FGFR2 (FGFR2 cyto residues 400–821) and full-length Grb2 N-terminally"
     . SPARSER::COLLECTION)
    ("the receptor-bound/dephosphorylated state and the unbound/phosphorylated state"
     . SPARSER::COLLECTION)
    ("extracellular ligand" . SPARSER::LIGAND)
    ("its FGFR2-phosphorylated state and Shp2-dephosphorylated state"
     . SPARSER::COLLECTION)
    ("The nonphosphorylatable Y542F Shp2 mutant" . SPARSER::MUTANT)
    ("N-terminal CFP-tagged Grb2 (CFP-Grb2) and N-terminal RFP-tagged Shp2 (RFP-Shp2)"
     . SPARSER::COLLECTION)
    ("Shp2 and Grb2 is" . SPARSER::COLLECTION)
    ("RFP-Shp2" . SPARSER::COLLECTION) ("CFP-Grb2" . SPARSER::COLLECTION)
    ("CFP" . SPARSER::PROTEIN)
    ("an FGFR2 kinase inhibitor (SU5402) or a Shp2 inhibitor (NSC87877)"
     . SPARSER::COLLECTION)
    ("strep-Grb2" . SPARSER::COLLECTION) ("GFP-FGFR2" . SPARSER::COLLECTION)
    ("a nonphosphorylatable phenylalanine" . SPARSER::AMINO-ACID)
    ("two phosphorylatable tyrosines" . SPARSER::AMINO-ACID)
    ("around Shp2 phosphatase" . SPARSER::PROTEIN)
    ("FGFR2, and FGFR2" . SPARSER::COLLECTION)
    ("Phosphatase" . SPARSER::PHOSPHATASE) ("Shp2–FGFR2" . SPARSER::COLLECTION)
    ("Shp2 and FGFR2" . SPARSER::COLLECTION)
    ("FGFR2–Shp2" . SPARSER::COLLECTION) ("GFP and RFP" . SPARSER::COLLECTION)
    ("Shp2-RFP" . SPARSER::COLLECTION) ("RFP" . SPARSER::PROTEIN)
    ("FLIM" . SPARSER::PROTEIN)
    ("receptor and phosphatase" . SPARSER::COLLECTION)
    ("Shp1" . SPARSER::PROTEIN) ("Shp" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PTPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Grb2–FGFR2" . SPARSER::COLLECTION) ("FGFR2-GFP" . SPARSER::COLLECTION)
    ("a passive adaptor protein" . SPARSER::PROTEIN)
    ("auxiliary adaptor proteins" . SPARSER::PROTEIN)
    ("fgfr2" . SPARSER::PROTEIN) ("SH2" . SPARSER::PROTEIN)
    ("linking RTKs" . SPARSER::PROTEIN)
    ("the RTK fibroblast growth factor receptor 2 (FGFR2) and the SH2 domain–containing protein tyrosine phosphatase 2 (Shp2)"
     . SPARSER::COLLECTION)
    ("signaling-incompetent state" . SPARSER::BIO-STATE)
    ("FGFR2–Grb2" . SPARSER::COLLECTION) ("both FGFR2’s" . SPARSER::PROTEIN)
    ("kinase and Shp2’s" . SPARSER::COLLECTION)
    ("kinase and Shp2" . SPARSER::COLLECTION)
    ("FGFR2 and Shp2" . SPARSER::COLLECTION)
    ("nonsignaling state and its Shp2-dephosphorylated state"
     . SPARSER::COLLECTION)
    ("kinase and phosphatase" . SPARSER::COLLECTION) ("1 D" . SPARSER::PROTEIN)
    ("1 A" . SPARSER::PROTEIN) ("FGFR substrate 2" . SPARSER::PROTEIN)
    ("FGFR1" . SPARSER::PROTEIN) ("son-of-sevenless" . SPARSER::PROTEIN)
    ("SU5402" . SPARSER::DRUG)
    ("extracellular signal–regulated kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FGF9" . SPARSER::PROTEIN) ("NSC87877" . SPARSER::DRUG)
    ("PTPN11" . SPARSER::PROTEIN) ("C-SH3" . SPARSER::PROTEIN)
    ("Growth factor" . SPARSER::GROWTH-FACTOR)
    ("fibroblast growth factor receptor 2" . SPARSER::PROTEIN)
    ("growth factor receptor–bound protein 2" . SPARSER::PROTEIN)
    ("Shp2" . SPARSER::PROTEIN) ("FGFR2" . SPARSER::PROTEIN)
    ("Grb2" . SPARSER::PROTEIN)
    ("ezrin, moesin, RhoA, RhoB and Cdc42" . SPARSER::COLLECTION)
    ("a good prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RhoB and Cdc42" . SPARSER::COLLECTION) ("Pan" . SPARSER::PROTEIN)
    ("Fritz" . SPARSER::PROTEIN)
    ("external growth factors" . SPARSER::GROWTH-FACTOR)
    ("the apical part" . SPARSER::COMPONENT)
    ("a negative prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RhoA and RhoB" . SPARSER::COLLECTION) ("Moesin" . SPARSER::PROTEIN)
    ("the ERM (ezrin, moesin) and Rho (RhoA, RhoB, Cdc42) protein families"
     . SPARSER::COLLECTION)
    ("ezrin or moesin" . SPARSER::COLLECTION) ("IIB" . SPARSER::PROTEIN)
    ("ER, PgR or HER-2" . SPARSER::COLLECTION)
    ("receptors and HER-2" . SPARSER::COLLECTION)
    ("ezrin and moesin" . SPARSER::COLLECTION)
    ("Ezrin and moesin" . SPARSER::COLLECTION)
    ("ERM and Rho" . SPARSER::COLLECTION)
    ("RhoA, DRFs and ROCKs" . SPARSER::COLLECTION)
    ("diaphanous-related formins (DRFs) and Rho-activated kinases (ROCKs)"
     . SPARSER::COLLECTION)
    ("diaphanous-related formins" . SPARSER::PROTEIN)
    ("ROCKs" . SPARSER::PROTEIN-FAMILY) ("formins" . SPARSER::PROTEIN)
    ("CD43, CD44, ICAM-1, ICAM-2, EGFR and MET" . SPARSER::COLLECTION)
    ("membrane-cytoskeleton-associated complexes" . SPARSER::BIO-COMPLEX)
    ("Ezrin, radixin and moesin" . SPARSER::COLLECTION)
    ("radixin" . SPARSER::PROTEIN) ("Ezrin" . SPARSER::PROTEIN)
    ("Gallen International Expert Consensus group" . SPARSER::MOLECULE)
    ("Conventional prognostic and predictive factors"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ER and PgR" . SPARSER::COLLECTION) ("receptor (ER)" . SPARSER::RECEPTOR)
    ("PgR" . SPARSER::PROTEIN)
    ("RhoB, P  = 0.004 and Cdc42" . SPARSER::COLLECTION)
    ("ERM/Rho" . SPARSER::COLLECTION)
    ("ERM (ezrin, moesin) and Rho (RhoA, RhoB and Cdc42) proteins"
     . SPARSER::COLLECTION)
    ("RhoA, RhoB and Cdc42" . SPARSER::COLLECTION)
    ("moesin" . SPARSER::PROTEIN) ("ezrin" . SPARSER::PROTEIN)
    ("ERM" . SPARSER::PROTEIN) ("a 15 " . SPARSER::PROTEIN)
    ("ICAM-2" . SPARSER::PROTEIN) ("CD43" . SPARSER::PROTEIN)
    ("a pivotal factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the mutated allele" . SPARSER::ALLELE)
    ("previously known cMPN family" . SPARSER::PROTEIN-FAMILY)
    ("phenotypic modifiers" . SPARSER::MOLECULE)
    ("vera (PV)" . SPARSER::PROTEIN) ("ET" . SPARSER::PROTEIN)
    ("PV" . SPARSER::PROTEIN) ("vera" . SPARSER::PROTEIN)
    ("CML" . SPARSER::PROTEIN)
    ("the G allele and the development" . SPARSER::COLLECTION)
    ("a tumor suppressor as well as a tumor promoter depending on the cellular context [ xref – xref ]"
     . SPARSER::COLLECTION)
    ("vasoactive factors and extracellular matrix proteins"
     . SPARSER::COLLECTION)
    ("vasoactive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a histone acetyltransferase and a transcriptional co-activator"
     . SPARSER::COLLECTION)
    ("p300 and RLIP76" . SPARSER::COLLECTION) ("BRAVO" . SPARSER::PROTEIN)
    ("Hope" . SPARSER::PROTEIN) ("siRNA or p300" . SPARSER::COLLECTION)
    ("p300 and cMYB" . SPARSER::COLLECTION) ("cMYB/p300" . SPARSER::COLLECTION)
    ("cMYB or p300" . SPARSER::COLLECTION) ("TC" . SPARSER::PROTEIN)
    ("GGG" . SPARSER::MOLECULE) ("mutated nucleotides" . SPARSER::NUCLEOTIDE)
    ("c-ETS" . SPARSER::COLLECTION) ("LRF" . SPARSER::PROTEIN)
    ("transcription-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("smallest fragment" . SPARSER::FRAGMENT)
    ("Renilla-luciferase" . SPARSER::COLLECTION) ("pRL" . SPARSER::PROTEIN)
    ("insulin/glucose" . SPARSER::COLLECTION) ("-ATPase" . SPARSER::COLLECTION)
    ("dinitrophenyl" . SPARSER::DRUG)
    ("a multifunctional protein" . SPARSER::PROTEIN)
    ("RLIP" . SPARSER::PROTEIN)
    ("Transcription factor cMYB and the coactivator p300"
     . SPARSER::COLLECTION)
    ("the proximal promoter" . SPARSER::PROMOTER)
    ("a strong cis" . SPARSER::PROTEIN) ("cMYB" . SPARSER::PROTEIN)
    ("the RLIP76 promoter using deletion mapping and mutational analysis"
     . SPARSER::COLLECTION)
    ("Ral" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Mu4" . SPARSER::PROTEIN)
    ("Mu2" . SPARSER::PROTEIN) ("TTF1" . SPARSER::PROTEIN)
    ("transcription factor-1" . SPARSER::PROTEIN)
    ("p11" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P300" . SPARSER::PROTEIN)
    ("monoamine oxidase B" . SPARSER::PROTEIN) ("DNP-SG" . SPARSER::MOLECULE)
    ("ABC transporter" . SPARSER::PROTEIN) ("RalBP1" . SPARSER::PROTEIN)
    ("Transcription factor" . SPARSER::PROTEIN) ("RLIP76" . SPARSER::PROTEIN)
    ("soluble forms" . SPARSER::FORM) ("multi" . SPARSER::PROTEIN)
    ("MCI/AD" . SPARSER::COLLECTION) ("microglia" . SPARSER::PROTEIN)
    ("the next closest genes" . SPARSER::GENE)
    ("acetylcholinesterase" . SPARSER::PROTEIN)
    ("rivastigmine" . SPARSER::DRUG) ("cholinesterase" . SPARSER::PROTEIN)
    ("mortem" . SPARSER::PROTEIN)
    ("the extensive linkage disequilibrium (LD) structure around APOE"
     . SPARSER::PROTEIN)
    ("toxic Aβ oligomers" . SPARSER::MOLECULE)
    ("oligomers" . SPARSER::MOLECULE) ("Florbetapir" . SPARSER::DRUG)
    ("APOE or BCHE" . SPARSER::COLLECTION)
    ("both the APOE ε4 allele and the minor allele (G)" . SPARSER::COLLECTION)
    ("APOE and BCHE" . SPARSER::COLLECTION)
    ("ITGA6 (integrin, alpha 6; chromosome 2) and ITGA1 (integrin, alpha 1; chromosome 5) as well as SNPs"
     . SPARSER::COLLECTION)
    ("ITGA1 (integrin, alpha 1; chromosome 5) as well as SNPs"
     . SPARSER::COLLECTION)
    ("APOC1 , TOMM40 , and PVRL2" . SPARSER::COLLECTION)
    ("HC, EMCI, LMCI, or AD" . SPARSER::COLLECTION)
    ("tracers" . SPARSER::MOLECULE) ("ApoE" . SPARSER::PROTEIN)
    ("apolipoprotein" . SPARSER::MOLECULE) ("MCI" . SPARSER::PROTEIN)
    ("Butyrylcholinesterase" . SPARSER::PROTEIN)
    ("EFNA5 , EDIL3 , ITGA1 , PIK3R1 , NFIB , and ARID1B"
     . SPARSER::COLLECTION)
    ("NUAK1 and C12orf75" . SPARSER::COLLECTION) ("orf" . SPARSER::PROTEIN)
    ("NFIB" . SPARSER::PROTEIN) ("butyrylcholinesterase" . SPARSER::PROTEIN)
    ("BCHE" . SPARSER::PROTEIN) ("florbetapir" . SPARSER::DRUG)
    ("SERPINI2" . SPARSER::PROTEIN) ("regulatory subunit 1" . SPARSER::PROTEIN)
    ("alpha 1" . SPARSER::PROTEIN) ("alpha 6" . SPARSER::PROTEIN)
    ("PVRL2" . SPARSER::PROTEIN) ("TOMM40" . SPARSER::PROTEIN)
    ("APOC1" . SPARSER::PROTEIN) ("PSEN2" . SPARSER::PROTEIN)
    ("PSEN1" . SPARSER::PROTEIN) ("presenilin-1" . SPARSER::PROTEIN)
    ("NUAK1" . SPARSER::PROTEIN) ("ARID1B" . SPARSER::PROTEIN)
    ("PIK3R1" . SPARSER::PROTEIN) ("ITGA1" . SPARSER::PROTEIN)
    ("EDIL3" . SPARSER::PROTEIN) ("EFNA5" . SPARSER::PROTEIN)
    ("ITGA6" . SPARSER::PROTEIN) ("amyloid-β" . SPARSER::MOLECULE)
    ("Yan" . SPARSER::PROTEIN) ("DY" . SPARSER::MOLECULE)
    ("RPG" . SPARSER::PROTEIN) ("LN and LTS" . SPARSER::COLLECTION)
    ("NSCL" . SPARSER::PROTEIN) ("LNA" . SPARSER::PROTEIN)
    ("Formalin" . SPARSER::MOLECULE) ("Clamps" . SPARSER::PROTEIN-FAMILY)
    ("CLMP" . SPARSER::PROTEIN)
    ("sodium citrate (pH 6.0) and EDTA (pH 9.0)" . SPARSER::COLLECTION)
    ("uncommon types" . TYPE) ("Kappa " . SPARSER::PROTEIN-FAMILY)
    ("PPV" . SPARSER::MOLECULE)
    ("EDTA (pH 8.0) and EDTA (pH 9.0)" . SPARSER::COLLECTION)
    ("sodium citrate (pH 6.0), EDTA (pH 8.0) and EDTA (pH 9.0)"
     . SPARSER::COLLECTION)
    ("developed mutation specific rabbit monoclonal antibodies"
     . SPARSER::ANTIBODY)
    ("Tyrosine kinase" . SPARSER::PROTEIN)
    ("Epidermal growth factor" . SPARSER::PROTEIN) ("AE3" . SPARSER::PROTEIN)
    ("LH and ZQ" . SPARSER::COLLECTION)
    ("LH, AQQ and ZQ" . SPARSER::COLLECTION)
    ("c-fos and integrin" . SPARSER::COLLECTION)
    ("FAK and paxillin" . SPARSER::COLLECTION)
    ("diverse extracellular" . SPARSER::PROTEIN)
    ("fos" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PRL-3 and c-fos" . SPARSER::COLLECTION) ("Integrin" . SPARSER::PROTEIN)
    ("especially integrin subunits" . SPARSER::FRAGMENT)
    ("PRL-PTP" . SPARSER::COLLECTION) ("PTP" . SPARSER::PROTEIN)
    ("PRL" . SPARSER::PROTEIN)
    ("PRL-3, c-fos and integrin" . SPARSER::COLLECTION)
    ("Sp1 and c-jun" . SPARSER::COLLECTION)
    ("c-fos, c-jun and Sp1" . SPARSER::COLLECTION)
    ("PRL-3 and integrin" . SPARSER::COLLECTION)
    ("Paxillin" . SPARSER::PROTEIN)
    ("cadherins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hematoxylin and eosin" . SPARSER::COLLECTION)
    ("PRL-1 or PRL-2" . SPARSER::COLLECTION)
    ("the most two efficiently PRL-3 targeting shRNA" . SPARSER::PROTEIN)
    ("screening 8 unique shRNA" . SPARSER::PROTEIN)
    ("an ovarian cancer early biomarker" . SPARSER::MOLECULE)
    ("PRLs" . SPARSER::PROTEIN)
    ("heterodimeric cell adhesion receptors" . SPARSER::RECEPTOR)
    ("Integrins" . SPARSER::PROTEIN)
    ("a promising therapeutic target and potential early biomarker"
     . SPARSER::COLLECTION)
    ("EGFP-PRL-3" . SPARSER::COLLECTION)
    ("RNA and protein" . SPARSER::COLLECTION) ("S178" . SPARSER::PROTEIN)
    ("G-I" . SPARSER::PROTEIN) ("PRL-2" . SPARSER::PROTEIN)
    ("PRL-1" . SPARSER::PROTEIN) ("ITGA2" . SPARSER::PROTEIN)
    ("PTP4A3" . SPARSER::PROTEIN) ("phospho-JNK" . SPARSER::PROTEIN)
    ("in Chinese hamster" . SPARSER::PROTEIN) ("αIIbβ3" . SPARSER::PROTEIN)
    ("c-fos" . SPARSER::PROTEIN)
    ("protein tyrosine phosphatase" . SPARSER::PROTEIN)
    ("PRL-3" . SPARSER::PROTEIN)
    ("Phosphatase of regenerating liver-3" . SPARSER::PROTEIN)
    ("an indispensable downstream target" . SPARSER::TARGET-PROTEIN)
    ("a unique antagonist" . SPARSER::MOLECULE)
    ("peripheral serotonin" . SPARSER::MOLECULE)
    ("FOXO3a and its target genes" . SPARSER::COLLECTION)
    ("serotonin and FOXO3a" . SPARSER::COLLECTION)
    ("especially peripheral serotonin" . SPARSER::MOLECULE)
    ("FOXO3a and AKT" . SPARSER::COLLECTION) ("EdU" . SPARSER::DRUG)
    ("-siRNA" . SPARSER::COLLECTION) ("siRNA" . SPARSER::PROTEIN)
    ("NC-siRNA" . SPARSER::COLLECTION) ("AFX/FOXO4" . SPARSER::COLLECTION)
    ("FKHRL1/FOXO3" . SPARSER::COLLECTION) ("FKHR/FOXO1" . SPARSER::COLLECTION)
    ("AFX" . SPARSER::PROTEIN) ("FKHR" . SPARSER::PROTEIN)
    ("platelets" . SPARSER::PROTEIN)
    ("a neurotransmitter and vasoactive substance [ xref , xref ]"
     . SPARSER::COLLECTION)
    ("vasoactive substance" . SPARSER::SUBSTANCE)
    ("substance" . SPARSER::SUBSTANCE) ("neurotransmitter" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor (VEGF) and insulin growth factor-1 (IGF-1)"
     . SPARSER::COLLECTION)
    ("TGF-" . SPARSER::PROTEIN) ("AKT and FOXO3a" . SPARSER::COLLECTION)
    ("Serotonin" . SPARSER::MOLECULE)
    ("Peripheral serotonin" . SPARSER::MOLECULE)
    ("serotonin" . SPARSER::MOLECULE)
    ("hypoxia inducible factor" . SPARSER::PROTEIN) ("CCK8" . SPARSER::PROTEIN)
    ("5-HT  2B" . SPARSER::PROTEIN) ("CCK-8" . SPARSER::MOLECULE)
    ("DAF-2" . SPARSER::PROTEIN) ("DAF-16" . SPARSER::PROTEIN)
    ("FOXO6" . SPARSER::PROTEIN) ("FOXO4" . SPARSER::PROTEIN)
    ("FKHRL1" . SPARSER::PROTEIN) ("class O" . SPARSER::PROTEIN)
    ("5-HT" . SPARSER::PROTEIN) ("serotonin receptor" . SPARSER::PROTEIN)
    ("5-HT 2B" . SPARSER::PROTEIN) ("5-HT2B receptor" . SPARSER::PROTEIN)
    ("soluble mediators" . SPARSER::PROTEIN)
    ("chemotactic ligands" . SPARSER::LIGAND)
    ("MIP1β/CCL4" . SPARSER::COLLECTION)
    ("Chemokines and their receptors" . SPARSER::COLLECTION)
    ("TDM" . SPARSER::PROTEIN) ("trehalose" . SPARSER::MOLECULE)
    ("PIM" . SPARSER::PROTEIN) ("LM" . SPARSER::PROTEIN)
    ("LAM" . SPARSER::PROTEIN) ("glycolipids" . SPARSER::MOLECULE)
    ("TLR3 and TLR4" . SPARSER::COLLECTION) ("TLR-2" . SPARSER::PROTEIN)
    ("MTB" . SPARSER::PROTEIN) ("larger cohorts" . SPARSER::MOLECULE)
    ("IFN-γ and adenosine deaminase" . SPARSER::COLLECTION)
    ("ADA" . SPARSER::PROTEIN) ("Mediators" . SPARSER::PROTEIN)
    ("The fibrogenic PDGF-BB" . SPARSER::PROTEIN)
    ("Mycobacterial antigen-stimulated lymphocytes release IFN-γ"
     . SPARSER::PROTEIN)
    ("PDGFRB" . SPARSER::PROTEIN) ("-BB" . SPARSER::COLLECTION)
    ("PDGFD" . SPARSER::PROTEIN) ("PDGFC" . SPARSER::PROTEIN)
    ("PDGFB" . SPARSER::PROTEIN) ("PDGFA" . SPARSER::PROTEIN)
    ("TB and non-TB" . SPARSER::COLLECTION)
    ("other soluble mediators" . SPARSER::PROTEIN)
    ("macrophages and neutrophils" . SPARSER::COLLECTION)
    ("Akt and p38" . SPARSER::COLLECTION)
    ("TLR3 −/− or TLR4 −/− mice" . SPARSER::COLLECTION)
    ("PRR" . SPARSER::PROTEIN) ("PAMPs" . SPARSER::PROTEIN)
    ("PRRs" . SPARSER::PROTEIN) ("SB203580 and LY294002" . SPARSER::COLLECTION)
    ("SB203580 or LY294002" . SPARSER::COLLECTION)
    ("p38 inhibitor (SB203580, 10 µM) or NF-κB inhibitor (BAY11-7082, 10 µM)"
     . SPARSER::COLLECTION)
    ("p38, ERK and JNK" . SPARSER::COLLECTION)
    ("human PBMC monocyte-derived macrophage (MDM)" . SPARSER::PROTEIN)
    ("MDM" . SPARSER::PROTEIN)
    ("Both BCG and H37Rv infection" . SPARSER::COLLECTION)
    ("CCL1 and PDGF-BB" . SPARSER::COLLECTION)
    ("BCG or H37Rv infection" . SPARSER::COLLECTION)
    ("BCG or M" . SPARSER::COLLECTION)
    ("its primary receptor CCR5 instead of CCR1 or CCR2" . SPARSER::COLLECTION)
    ("CCR1 or CCR2" . SPARSER::COLLECTION)
    ("CCR1 and CCR2" . SPARSER::COLLECTION)
    ("Pleural IFN-γ" . SPARSER::PROTEIN)
    ("IFN-γ and PDGF-BB" . SPARSER::COLLECTION)
    ("I-309/CCL1" . SPARSER::COLLECTION) ("PAH" . SPARSER::PROTEIN)
    ("pleural TB" . SPARSER::PROTEIN)
    ("CCR1, CCR2B and CCR5" . SPARSER::COLLECTION)
    ("other proinflammatory cytokines" . SPARSER::PROTEIN)
    ("a proinflammatory chemokine" . SPARSER::PROTEIN) ("IFNs" . SPARSER::DRUG)
    ("a significantly higher expressed chemokine" . SPARSER::PROTEIN)
    ("RANTES/CCL5" . SPARSER::COLLECTION)
    ("MIP-1alpha/CCL3" . SPARSER::COLLECTION)
    ("IL-8/CXCL8" . SPARSER::COLLECTION) ("I-TAC/CXCL11" . SPARSER::COLLECTION)
    ("MIG/CXCL9" . SPARSER::COLLECTION) ("IP-10/CXCL10" . SPARSER::COLLECTION)
    ("IFN" . SPARSER::PROTEIN)
    ("fractalkine/neurotactin" . SPARSER::COLLECTION)
    ("neurotactin" . SPARSER::PROTEIN) ("fractalkine" . SPARSER::PROTEIN)
    ("lymphotactin" . SPARSER::PROTEIN) ("Chemokines" . SPARSER::PROTEIN)
    ("both systemic and pulmonary vasculature" . SPARSER::PROTEIN)
    ("Mtb" . SPARSER::PROTEIN) ("pleural chest pain" . SPARSER::PROTEIN)
    ("pain" . SPARSER::PROTEIN) ("TLR2/PI3K/Akt" . SPARSER::COLLECTION)
    ("TLR2" . SPARSER::PROTEIN)
    ("human PBMC monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("MDMs" . SPARSER::PROTEIN) ("Rv" . SPARSER::MOLECULE)
    ("BCG" . SPARSER::DRUG) ("lymphatic TB" . SPARSER::PROTEIN)
    ("TB" . SPARSER::PROTEIN) ("M-CSF" . SPARSER::PROTEIN)
    ("colony stimulating factor" . SPARSER::PROTEIN) ("H11" . SPARSER::PROTEIN)
    ("oleic acid" . SPARSER::MOLECULE)
    ("Phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("CCL4" . SPARSER::PROTEIN) ("MIP1β" . SPARSER::PROTEIN)
    ("MIP1" . SPARSER::PROTEIN) ("PhoS1" . SPARSER::PROTEIN)
    ("MyD88" . SPARSER::PROTEIN) ("adenosine deaminase" . SPARSER::PROTEIN)
    ("PDGF-B" . SPARSER::PROTEIN) ("TLR4" . SPARSER::PROTEIN)
    ("TLR3" . SPARSER::PROTEIN) ("PD98059" . SPARSER::MOLECULE)
    ("BAY11-7082" . SPARSER::DRUG) ("SP600125" . SPARSER::PROTEIN)
    ("THP1" . SPARSER::PROTEIN)
    ("phorbol-12-myristate-13-acetate" . SPARSER::DRUG)
    ("mcp- 2" . SPARSER::DRUG) ("ccl8" . SPARSER::PROTEIN)
    ("mcp-2" . SPARSER::DRUG) ("CCR2" . SPARSER::PROTEIN)
    ("CCL1" . SPARSER::PROTEIN) ("I-309" . SPARSER::PROTEIN)
    ("CCR2B" . SPARSER::PROTEIN) ("CCR1" . SPARSER::PROTEIN)
    ("monocyte chemotactic protein 1" . SPARSER::PROTEIN)
    ("CCL5" . SPARSER::PROTEIN) ("CCL3" . SPARSER::PROTEIN)
    ("MIP-1alpha" . SPARSER::PROTEIN)
    ("macrophage inflammatory protein" . SPARSER::PROTEIN)
    ("CXCL8" . SPARSER::PROTEIN) ("interleukin-8" . SPARSER::PROTEIN)
    ("I-TAC" . SPARSER::PROTEIN) ("IP-10" . SPARSER::PROTEIN)
    ("CX3C" . SPARSER::PROTEIN) ("H37" . SPARSER::PROTEIN)
    ("CCL8" . SPARSER::PROTEIN) ("CsA" . SPARSER::PROTEIN)
    ("RhoA and MLC" . SPARSER::COLLECTION)
    ("RhoA and its downstream effector pathway ROCK-MLC" . SPARSER::COLLECTION)
    ("ROCK-MLC" . SPARSER::COLLECTION) ("pemetrexed" . SPARSER::DRUG)
    ("experimental proteinuria" . SPARSER::PROTEIN)
    ("a toxic molecule" . SPARSER::MOLECULE)
    ("severe proteinuria" . SPARSER::PROTEIN)
    ("central actin" . SPARSER::PROTEIN)
    ("RhoA-ROCK-MLC" . SPARSER::COLLECTION)
    ("Targets" . SPARSER::TARGET-PROTEIN)
    ("Akt and p70S6K" . SPARSER::COLLECTION)
    ("actin-myosin" . SPARSER::COLLECTION)
    ("the central actin" . SPARSER::PROTEIN)
    ("the cytoskeletal organization EV" . SPARSER::DRUG)
    ("paxillin" . SPARSER::PROTEIN)
    ("the functional glomerular filtration barrier" . SPARSER::PROTEIN)
    ("ROCK and MLC" . SPARSER::COLLECTION) ("EV" . SPARSER::DRUG)
    ("mTORC1 and mTORC2" . SPARSER::COLLECTION)
    ("a prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunosuppressants" . SPARSER::DRUG)
    ("the prosurvival kinase Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mTOR, raptor, and mLST8" . SPARSER::COLLECTION)
    ("p70S6K and 4E-BP1" . SPARSER::COLLECTION) ("raptor" . SPARSER::PROTEIN)
    ("the catalytical subunit" . SPARSER::FRAGMENT)
    ("serine-threonine" . SPARSER::COLLECTION)
    ("the downstream pathway Rho-associated protein kinase (ROCK) and myosin light chain (MLC)"
     . SPARSER::COLLECTION)
    ("the downstream pathway Rho-associated protein kinase (ROCK)"
     . SPARSER::PROTEIN)
    ("RhoA and the effector pathway Rho-associated protein kinase (ROCK) and myosin light chain (MLC)"
     . SPARSER::COLLECTION)
    ("the effector pathway Rho-associated protein kinase (ROCK) and myosin light chain (MLC)"
     . SPARSER::COLLECTION)
    ("the effector pathway Rho-associated protein kinase (ROCK)"
     . SPARSER::PROTEIN)
    ("MLC" . SPARSER::PROTEIN) ("ROCK" . SPARSER::PROTEIN-FAMILY)
    ("everolimus (EV)" . SPARSER::DRUG) ("PAN" . SPARSER::PROTEIN)
    ("immunosuppressant" . SPARSER::DRUG)
    ("the glomerular filtration barrier" . SPARSER::PROTEIN)
    ("glutathione S-transferase" . SPARSER::PROTEIN)
    ("alpha-Tubulin" . SPARSER::PROTEIN) ("B34" . SPARSER::PROTEIN)
    ("Y-27632" . SPARSER::MOLECULE) ("4E-BP1" . SPARSER::PROTEIN)
    ("mLST8" . SPARSER::PROTEIN)
    ("myosin light chain" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MTCH2/MIMP" . SPARSER::COLLECTION) ("MIMP" . SPARSER::PROTEIN)
    ("FLASH" . SPARSER::PROTEIN) ("CL and caspase-8" . SPARSER::COLLECTION)
    ("essentially pure DOPC" . SPARSER::DRUG)
    ("caspase-8, tBid and caspase-8" . SPARSER::COLLECTION)
    ("a lamellar state" . SPARSER::BIO-STATE) ("DOPC " . SPARSER::DRUG)
    ("CL-protein" . SPARSER::PROTEIN-PAIR)
    ("procaspase-8 and Bid" . SPARSER::COLLECTION)
    ("caspase-8 and caspase-8" . SPARSER::COLLECTION)
    ("water" . SPARSER::MOLECULE)
    ("Bid and the caspase-8+ Bid complex" . SPARSER::COLLECTION)
    ("caspase-8, Bid and the caspase-8+ Bid complex" . SPARSER::COLLECTION)
    ("tracer" . SPARSER::MOLECULE) ("neither DOPC-only" . SPARSER::DRUG)
    ("-liposomes" . SPARSER::COLLECTION)
    ("general caspase inhibitors (z-VAD-fmk and Boc-D-fmk) or a specific caspase-8 inhibitor (z-IETD-fmk)"
     . SPARSER::COLLECTION)
    ("fmk" . SPARSER::PROTEIN) ("Boc" . SPARSER::PROTEIN)
    ("fluorescent Bid" . SPARSER::PROTEIN) ("Cytometry" . SPARSER::PROTEIN)
    ("the soluble p7 part" . SPARSER::COMPONENT)
    ("caspase-8/Bid" . SPARSER::COLLECTION) ("Green" . SPARSER::PROTEIN)
    ("tBid, caspase-8, and caspase-8" . SPARSER::COLLECTION)
    ("caspase-8+ Bid and/or tBid" . SPARSER::COLLECTION)
    ("caspase-8, caspase-8+ Bid and/or tBid" . SPARSER::COLLECTION)
    ("Bid and caspase-8" . SPARSER::COLLECTION)
    ("tBid and caspase-8" . SPARSER::COLLECTION)
    ("a mixture of DOPC and CL" . SPARSER::COLLECTION)
    ("procaspase-8 and Bid or tBid" . SPARSER::COLLECTION)
    ("Bid or tBid" . SPARSER::COLLECTION)
    ("Caspase-8 and Bid" . SPARSER::COLLECTION)
    ("DOPC-only or CL + -LUVs" . SPARSER::COLLECTION)
    ("mimetic liposomes" . SPARSER::PROTEIN) ("DOPC-only" . SPARSER::DRUG)
    ("PE" . SPARSER::PROTEIN) ("phosphatidylethanolamine" . SPARSER::MOLECULE)
    ("phosphatidylcholine" . SPARSER::MOLECULE)
    ("p43–p55" . SPARSER::COLLECTION)
    ("caspase-8 and cardiolipin" . SPARSER::COLLECTION)
    ("liposomes" . SPARSER::PROTEIN) ("Fas-receptor" . SPARSER::COLLECTION)
    ("caspase-8 and CL" . SPARSER::COLLECTION)
    ("the basic components" . SPARSER::COMPONENT) ("CL" . SPARSER::MOLECULE)
    ("a supramolecular complex" . SPARSER::BIO-COMPLEX)
    ("p43–p10" . SPARSER::COLLECTION) ("tafazzin" . SPARSER::PROTEIN)
    ("Bax/Bak" . SPARSER::COLLECTION) ("MOMP" . SPARSER::PROTEIN)
    ("Bak" . SPARSER::PROTEIN) ("tBid" . SPARSER::PROTEIN)
    ("type I or type II" . SPARSER::COLLECTION)
    ("a heterotetrameric complex" . SPARSER::BIO-COMPLEX)
    ("p18 and p10" . SPARSER::COLLECTION)
    ("p43–p10/p43–p10" . SPARSER::COLLECTION) ("p55/p55" . SPARSER::COLLECTION)
    ("pro-apoptotic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteins, FADD and caspase-8" . SPARSER::COLLECTION)
    ("FADD/MORT1" . SPARSER::COLLECTION) ("FADD" . SPARSER::PROTEIN)
    ("agonistic anti-CD95 antibodies" . SPARSER::ANTIBODY)
    ("complex (DISC)" . SPARSER::BIO-COMPLEX) ("DISC" . SPARSER::BIO-COMPLEX)
    ("APO-1/Fas" . SPARSER::COLLECTION) ("caspases" . SPARSER::PROTEIN)
    ("receptors and mitochondria" . SPARSER::COLLECTION)
    ("cardiolipin, caspase-8 and Bid" . SPARSER::COLLECTION)
    ("Laurdan" . SPARSER::DRUG)
    ("caspase-8, Bid and cardiolipin" . SPARSER::COLLECTION)
    ("immature cardiolipin" . SPARSER::MOLECULE)
    ("cardiolipin" . SPARSER::MOLECULE)
    ("an anchor and an essential activating platform" . SPARSER::COLLECTION)
    ("Cardiolipin" . SPARSER::MOLECULE)
    ("caspase-8 and Bid" . SPARSER::COLLECTION) ("Bid" . SPARSER::PROTEIN)
    ("MTCH2" . SPARSER::PROTEIN) ("Rab5" . SPARSER::PROTEIN)
    ("Bcl-XL" . SPARSER::PROTEIN) ("z-IETD-fmk" . SPARSER::DRUG)
    ("BH2" . SPARSER::MOLECULE) ("BH1" . SPARSER::PROTEIN)
    ("procaspase-8" . SPARSER::PROTEIN) ("Casp8" . SPARSER::PROTEIN)
    ("P 18" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P 10" . SPARSER::PROTEIN)
    ("P 55" . SPARSER::PROTEIN)
    ("X-linked inhibitor of apoptosis" . SPARSER::PROTEIN)
    ("p43" . SPARSER::PROTEIN) ("p55" . SPARSER::PROTEIN)
    ("MORT1" . SPARSER::PROTEIN) ("CD95 ligand" . SPARSER::PROTEIN)
    ("APO-1" . SPARSER::PROTEIN) ("CD95" . SPARSER::PROTEIN)
    ("Caspase-8" . SPARSER::PROTEIN) ("PR and SD" . SPARSER::COLLECTION)
    ("numerous intratumoral foci" . SPARSER::PROTEIN)
    ("the intratumoral EGFR" . SPARSER::PROTEIN)
    ("the microdissected intratumoral foci" . SPARSER::PROTEIN)
    ("SD" . SPARSER::PROTEIN)
    ("first-line or multi-line" . SPARSER::COLLECTION)
    ("multi-line" . SPARSER::PROTEIN-PAIR)
    ("IIIb (locally advanced) and 35" . SPARSER::COLLECTION)
    ("histological type and stage" . SPARSER::COLLECTION)
    ("type and stage" . SPARSER::COLLECTION) ("IIIb" . SPARSER::DRUG)
    ("Histologic subtypes" . SPARSER::PROTEIN)
    ("EGFR, MET , and PDGFRA" . SPARSER::COLLECTION)
    ("EGFR as well as other genetic aberrances" . SPARSER::COLLECTION)
    ("growth factor receptor-tyrosine kinase" . SPARSER::COLLECTION)
    ("EGFR-TKIs" . SPARSER::COLLECTION) ("ARMS" . SPARSER::PROTEIN)
    ("C-met" . SPARSER::PROTEIN) ("K-ras" . SPARSER::PROTEIN)
    ("E19" . SPARSER::PROTEIN) ("EGFR-TKI" . SPARSER::PROTEIN)
    ("IGF-1R" . SPARSER::PROTEIN) ("C-MET" . SPARSER::PROTEIN)
    ("distinct MMPs" . SPARSER::PROTEIN) ("endopeptidases" . SPARSER::PROTEIN)
    ("cyclin D1 ( xref ) and c-Myc ( xref )" . SPARSER::COLLECTION)
    ("STAT3- or STAT3-C-induced" . SPARSER::COLLECTION)
    ("STAT3-" . SPARSER::PROTEIN) ("CCND3 and KRAS" . SPARSER::COLLECTION)
    ("CCND3, KRAS and CDKN1A" . SPARSER::COLLECTION)
    ("STAT3-PTTG" . SPARSER::COLLECTION)
    ("cyclin D3 and Kras" . SPARSER::COLLECTION)
    ("The shorter PTTG promoter" . SPARSER::PROMOTER)
    ("STAT3 and STAT3-C" . SPARSER::COLLECTION)
    ("STAT3 or STAT3-C" . SPARSER::COLLECTION)
    ("wild type STAT3 and constitutively active STAT3 (STAT3-C)"
     . SPARSER::COLLECTION)
    ("promoter and actives" . SPARSER::COLLECTION)
    ("IL-6 and S3I-201" . SPARSER::COLLECTION)
    ("phospho-STAT3 and PTTG" . SPARSER::COLLECTION)
    ("Upregulated immunoreactive STAT3 and PTTG" . SPARSER::COLLECTION)
    ("STAT3 and PTTG" . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF) ( xref ) and matrix metalloproteinase-2 (MMP-2)"
     . SPARSER::COLLECTION)
    ("c-Myc ( xref ), cyclin D1 ( xref ), vascular endothelial growth factor (VEGF) ( xref ) and matrix metalloproteinase-2 (MMP-2)"
     . SPARSER::COLLECTION)
    ("vascular endothelial growth factor (VEGF)"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("beta-catenin/TCF" . SPARSER::COLLECTION)
    ("estrogen, insulin, b-FGF and epidermal growth factor (EGF)"
     . SPARSER::COLLECTION)
    ("estrogen, insulin, b-FGF and epidermal growth factor"
     . SPARSER::COLLECTION)
    ("c-Myc ( xref ) and cyclin D3 ( xref )" . SPARSER::COLLECTION)
    ("Pituitary tumor transforming gene (PTTG) and signal transducer and activator of transcription 3 (STAT3)"
     . SPARSER::COLLECTION)
    ("STAT3-DN" . SPARSER::COLLECTION)
    ("Total STAT3 and Tyr705 phosphorylated STAT3" . SPARSER::COLLECTION)
    ("Pituitary tumor transforming gene (PTTG)" . SPARSER::PROTEIN)
    ("securin" . SPARSER::PROTEIN) ("PTTG" . SPARSER::PROTEIN)
    ("Reverse Transcriptase" . SPARSER::PROTEIN) ("MMP-13" . SPARSER::PROTEIN)
    ("MMP-10" . SPARSER::PROTEIN) ("MMP-3" . SPARSER::PROTEIN)
    ("pGL 3" . SPARSER::PROTEIN) ("S3I-201" . SPARSER::MOLECULE)
    ("beta-catenin" . SPARSER::PROTEIN) ("cyclin D3" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 3" . SPARSER::PROTEIN)
    ("Pituitary tumor transforming gene" . SPARSER::PROTEIN)
    ("NF-κB and IGF1R" . SPARSER::COLLECTION) ("ANKH" . SPARSER::PROTEIN)
    ("IGF1 and IGF1R" . SPARSER::COLLECTION)
    ("a key regulatory transcription factor" . SPARSER::PROTEIN)
    ("CBF" . SPARSER::PROTEIN) ("ALP" . SPARSER::PROTEIN)
    ("bioactive molecules that have been implicated in the aging of tissue proteins and the development"
     . SPARSER::COLLECTION)
    ("-CGGATCCCCCCG-3" . SPARSER::COLLECTION)
    ("IκBα and p65" . SPARSER::COLLECTION)
    ("IL-8 and TNF" . SPARSER::COLLECTION) ("AGE-BSA" . SPARSER::COLLECTION)
    ("alizarin" . SPARSER::DRUG) ("NF-κB/IGF1R" . SPARSER::COLLECTION)
    ("AGE" . SPARSER::PROTEIN)
    ("a pivotal pathogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lipids or nucleic acids" . SPARSER::COLLECTION)
    ("lipids" . SPARSER::LIPID) ("sugar" . SPARSER::MOLECULE)
    ("bone-associated proteins" . SPARSER::PROTEIN) ("PDTC" . SPARSER::DRUG)
    ("IκBα and Flag-tagged p65" . SPARSER::COLLECTION)
    ("osteocalcin and Cbfα1" . SPARSER::COLLECTION)
    ("Cbf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("osteocalcin" . SPARSER::PROTEIN)
    ("Calcium" . SPARSER::CALCIUM) ("Alizarin" . SPARSER::DRUG)
    ("Aim" . SPARSER::PROTEIN)
    ("Insulin-like growth factor-1" . SPARSER::PROTEIN)
    ("CCA-3" . SPARSER::PROTEIN)
    ("EGFR and other receptors" . SPARSER::COLLECTION)
    ("antidepressant" . SPARSER::DRUG) ("nestin-" . SPARSER::PROTEIN)
    ("cAMP or depolarization" . SPARSER::COLLECTION)
    ("EGFR and TrkB" . SPARSER::COLLECTION)
    ("EGF or TGFα" . SPARSER::COLLECTION)
    ("c-Src or Fyn" . SPARSER::COLLECTION) ("BDNF-" . SPARSER::PROTEIN)
    ("Neurotrophins and ligands" . SPARSER::COLLECTION)
    ("Neurotrophins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sonic hedgehog and FGF2" . SPARSER::COLLECTION)
    ("morphogens" . SPARSER::PROTEIN)
    ("the different cortical layers form" . SPARSER::FORM)
    ("dominant-negative forms" . SPARSER::FORM)
    ("BSA or EGF" . SPARSER::COLLECTION) ("BSA and EGF" . SPARSER::COLLECTION)
    ("EGF or bovine serum albumin (BSA)" . SPARSER::COLLECTION)
    ("BrdU-" . SPARSER::DRUG) ("TrkB/TrkC" . SPARSER::COLLECTION)
    ("avidin" . SPARSER::PROTEIN) ("TrkB and pTrk" . SPARSER::COLLECTION)
    ("occludin" . SPARSER::PROTEIN) ("tunicamycin" . SPARSER::MOLECULE)
    ("galactosidase" . SPARSER::PROTEIN) ("PNGase" . SPARSER::PROTEIN)
    ("PP1 and PP2" . SPARSER::COLLECTION)
    ("c-Src and Fyn" . SPARSER::COLLECTION) ("lentiviral gene" . SPARSER::GENE)
    ("PP1 (at 1 μM) and PP2 (at 100 nM)" . SPARSER::COLLECTION)
    ("Src kinases, PP1 (at 1 μM) and PP2 (at 100 nM)" . SPARSER::COLLECTION)
    ("lentiviral shRNA" . SPARSER::PROTEIN)
    ("TrkA and TrkC" . SPARSER::COLLECTION) ("TrkA" . SPARSER::PROTEIN)
    ("around 170 kDa" . SPARSER::PROTEIN)
    ("the SHC site–specific antibody ( xref ) and a phospho-tyrosine antibody ( xref )"
     . SPARSER::COLLECTION)
    ("Akt and Erk1/2" . SPARSER::COLLECTION) ("pAkt" . SPARSER::PROTEIN-FAMILY)
    ("TrkB and other Trk receptors" . SPARSER::COLLECTION)
    ("pTrk-Shc" . SPARSER::PROTEIN-PAIR)
    ("TrkB and EGFR" . SPARSER::COLLECTION)
    ("nestin and Pax6" . SPARSER::COLLECTION) ("pTrk" . SPARSER::PROTEIN)
    ("nestin ( xref ) and Pax6" . SPARSER::COLLECTION)
    ("Pax6-" . SPARSER::PROTEIN) ("nestin" . SPARSER::PROTEIN)
    ("pTrk-SHC" . SPARSER::COLLECTION) ("pTrk-PLCγ" . SPARSER::COLLECTION)
    ("family, and phospho-tyrosine" . SPARSER::COLLECTION)
    ("Trk" . SPARSER::PROTEIN) ("Bdnf" . SPARSER::PROTEIN)
    ("neurotrophins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHC/FRS2" . SPARSER::COLLECTION) ("doublecortin" . SPARSER::PROTEIN)
    ("Ligand" . SPARSER::LIGAND) ("SHC" . SPARSER::PROTEIN)
    ("cues and growth factors" . SPARSER::COLLECTION) ("VI" . SPARSER::PROTEIN)
    ("BDNF and NT-3" . SPARSER::COLLECTION)
    ("brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3)"
     . SPARSER::COLLECTION)
    ("neurotrophic factor (BDNF)" . SPARSER::PROTEIN)
    ("TrkB and TrkC" . SPARSER::COLLECTION)
    ("BDNF or NT-3" . SPARSER::COLLECTION) ("BDNF" . SPARSER::PROTEIN)
    ("TrkC" . SPARSER::PROTEIN) ("TrkB" . SPARSER::PROTEIN)
    ("neurotrophic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mitogens" . SPARSER::MITOGEN) ("U18" . SPARSER::PROTEIN)
    ("AC-3" . SPARSER::PROTEIN) ("Protein-G" . SPARSER::PROTEIN)
    ("B12" . SPARSER::PROTEIN) ("E7" . SPARSER::PROTEIN-FAMILY)
    ("K23" . SPARSER::PROTEIN) ("Erk2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1" . SPARSER::PROTEIN) ("Ntrk2" . SPARSER::PROTEIN)
    ("FGF2" . SPARSER::PROTEIN) ("sonic hedgehog" . SPARSER::PROTEIN)
    ("PD153035" . SPARSER::DRUG) ("beta1 subunit" . SPARSER::PROTEIN)
    ("c-Src" . SPARSER::PROTEIN) ("G protein–coupled" . SPARSER::PROTEIN)
    ("PP2" . SPARSER::PROTEIN) ("PP1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MAP2" . SPARSER::PROTEIN) ("Pax6" . SPARSER::PROTEIN)
    ("phospho-tyrosine" . SPARSER::MOLECULE) ("Ntf3" . SPARSER::PROTEIN)
    ("P4" . SPARSER::HUMAN-PROTEIN-FAMILY) ("FRS2" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor substrate 2" . SPARSER::PROTEIN)
    ("transforming protein" . SPARSER::PROTEIN) ("NT-3" . SPARSER::PROTEIN)
    ("neurotrophin-3" . SPARSER::PROTEIN)
    ("neurotrophic factor" . SPARSER::PROTEIN)
    ("masks" . SPARSER::HUMAN-PROTEIN-FAMILY) ("taxol" . SPARSER::DRUG)
    ("PTEN and BRCA1" . SPARSER::COLLECTION)
    ("an alternate path" . SPARSER::PROTEIN)
    ("The heterozygous BRCA2" . SPARSER::PROTEIN)
    ("PTEN and p53" . SPARSER::COLLECTION)
    ("BRCA1, PTEN and p53" . SPARSER::COLLECTION) ("HOC" . SPARSER::PROTEIN)
    ("PEA2" . SPARSER::PROTEIN) ("HEY" . SPARSER::PROTEIN)
    ("a functional BRCA1" . SPARSER::PROTEIN)
    ("a premature stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gene or protein" . SPARSER::COLLECTION) ("PEO1" . SPARSER::PROTEIN)
    ("olaparib and veliparib" . SPARSER::COLLECTION)
    ("olaparib" . SPARSER::DRUG) ("ABT888" . SPARSER::DRUG)
    ("AZD2281" . SPARSER::DRUG) ("s 5a" . SPARSER::PROTEIN)
    ("L15" . SPARSER::PROTEIN) ("HOC1" . SPARSER::PROTEIN)
    ("P-glycoprotein" . SPARSER::PROTEIN) ("LAF" . SPARSER::PROTEIN)
    ("AMG" . SPARSER::PROTEIN) ("RM" . SPARSER::PROTEIN)
    ("SK" . SPARSER::PROTEIN) ("CTB" . SPARSER::PROTEIN)
    ("PB" . SPARSER::PROTEIN) ("DV" . SPARSER::MOLECULE)
    ("Variant" . SPARSER::VARIANT) ("varieties" . SPARSER::VARIETY)
    ("TP73 and AD" . SPARSER::COLLECTION)
    ("AD and any variants" . SPARSER::COLLECTION)
    ("an unproven SNP" . SPARSER::PROTEIN) ("APOE" . SPARSER::PROTEIN)
    ("labile over-phosphorylated forms" . SPARSER::FORM)
    ("labile" . SPARSER::PROTEIN) ("Pathological forms" . SPARSER::FORM)
    ("insoluble forms" . SPARSER::FORM) ("BL6" . SPARSER::PROTEIN)
    ("Sv" . SPARSER::MOLECULE) ("the respective cohorts" . SPARSER::MOLECULE)
    ("tempo" . SPARSER::DRUG)
    ("the same APP transgene and the same Trp73 null allele"
     . SPARSER::COLLECTION)
    ("novel or enhanced phenotypic traits" . SPARSER::PROTEIN)
    ("P73 and Aβ" . SPARSER::COLLECTION)
    ("pro- and anti-apoptotic" . SPARSER::COLLECTION)
    ("anesthetic" . SPARSER::DRUG)
    ("AT8, AT180, and CP13" . SPARSER::COLLECTION)
    ("tau or APP" . SPARSER::COLLECTION) ("transgenes" . SPARSER::PROTEIN)
    ("pentobarbital" . SPARSER::DRUG) ("anaesthetic" . SPARSER::DRUG)
    ("insoluble hyperphosphorylated tau" . SPARSER::PROTEIN)
    ("the hemizygous state" . SPARSER::BIO-STATE)
    ("any abnormal tau" . SPARSER::PROTEIN)
    ("insoluble fractions" . SPARSER::COMPONENT)
    ("our own cohorts" . SPARSER::MOLECULE)
    ("PHF1 or AT180" . SPARSER::COLLECTION)
    ("the soluble tau fractions" . SPARSER::COMPONENT)
    ("an obvious impact" . SPARSER::PROTEIN)
    ("detergent insoluble fractions" . SPARSER::COMPONENT)
    ("AT8 and AT180" . SPARSER::COLLECTION)
    ("MC1 and PHF1" . SPARSER::COLLECTION)
    ("AT8 and CP13" . SPARSER::COLLECTION)
    ("AT8, CP13 and PHF1" . SPARSER::COLLECTION)
    ("Sparse amyloid" . SPARSER::PROTEIN) ("cusp" . SPARSER::PROTEIN)
    ("any associated dystrophic" . SPARSER::PROTEIN)
    ("MC1 and AT180" . SPARSER::COLLECTION) ("Tau" . SPARSER::PROTEIN)
    ("the former case" . SPARSER::PROTEIN)
    ("tau transgenes" . SPARSER::PROTEIN) ("MC1" . SPARSER::PROTEIN)
    ("AT8, CP13, AT180 and PHF1" . SPARSER::COLLECTION)
    ("CP" . SPARSER::PROTEIN) ("Cohorts" . SPARSER::MOLECULE)
    ("dystrophic" . SPARSER::PROTEIN) ("APP and tau" . SPARSER::COLLECTION)
    ("AD and 544 non-demented" . SPARSER::COLLECTION)
    ("heterozygous or homozygous form" . SPARSER::FORM)
    ("amyloid" . SPARSER::PROTEIN) ("tau" . SPARSER::PROTEIN)
    ("TAp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("PHF-1" . SPARSER::PROTEIN)
    ("t-tau" . SPARSER::PROTEIN) ("TG 3" . SPARSER::PROTEIN)
    ("PHF1" . SPARSER::PROTEIN) ("AT8" . SPARSER::PROTEIN)
    ("d53" . SPARSER::PROTEIN) ("d35" . SPARSER::PROTEIN)
    ("p73" . SPARSER::PROTEIN) ("N-terminally" . SPARSER::PROTEIN)
    ("p53 family" . SPARSER::HUMAN-PROTEIN-FAMILY) ("P73" . SPARSER::PROTEIN)
    ("EG, JBB, AB and LB" . SPARSER::COLLECTION) ("LB" . SPARSER::PROTEIN)
    ("EG" . SPARSER::PROTEIN) ("MB" . SPARSER::PROTEIN)
    ("KC" . SPARSER::PROTEIN) ("Protein-protein" . SPARSER::COLLECTION)
    ("MEAX" . SPARSER::PROTEIN) ("Hyaline" . SPARSER::PROTEIN)
    ("HBM" . SPARSER::PROTEIN)
    ("LGMD proteins and other proteins" . SPARSER::COLLECTION)
    ("TCAP and p53" . SPARSER::COLLECTION) ("PYGM" . SPARSER::PROTEIN)
    ("ubiquitin-protein" . SPARSER::COLLECTION) ("POMP" . SPARSER::PROTEIN)
    ("causative genes" . SPARSER::GENE) ("FLN" . SPARSER::PROTEIN)
    ("the causative mutated genes" . SPARSER::GENE)
    ("the sarcomeric proteins ACTN2, MYBPC1, MYOM1 and MYOM2"
     . SPARSER::COLLECTION)
    ("ACTN2, MYBPC1, MYOM1 and MYOM2" . SPARSER::COLLECTION)
    ("TTN, ACTN2 and DES" . SPARSER::COLLECTION)
    ("myoblasts" . SPARSER::PROTEIN) ("sarcoglycans" . SPARSER::PROTEIN-FAMILY)
    ("mechanical-resistant dimers and nebulin-like domains play"
     . SPARSER::COLLECTION)
    ("actin and the thin filament" . SPARSER::COLLECTION)
    ("mechanical-resistant dimers" . SPARSER::DIMER)
    ("ankyrin" . SPARSER::PROTEIN) ("Fibronectin" . SPARSER::PROTEIN)
    ("enzyme, transcription factor or ATP" . SPARSER::COLLECTION)
    ("2239 proteins and 3304 PPIs" . SPARSER::COLLECTION)
    ("497 proteins and 705 PPIs (Additional file xref : Table S1)"
     . SPARSER::COLLECTION)
    ("FLNC and protein transport protein Sec31A" . SPARSER::COLLECTION)
    ("the causative genes" . SPARSER::GENE)
    ("phosphorylase (PYGM)" . SPARSER::PROTEIN)
    ("phosphorylase" . SPARSER::PROTEIN) ("enolase" . SPARSER::PROTEIN)
    ("TTN, DYSF and SGCG" . SPARSER::COLLECTION)
    ("three additional LGMD proteins, plectin (LGMD2M), myotillin (LGMD1A) and lamin A/C (LGMD1B)"
     . SPARSER::COLLECTION)
    ("plectin" . SPARSER::PROTEIN) ("NMD and non-NMD" . SPARSER::COLLECTION)
    ("this last group" . SPARSER::MOLECULE)
    ("more hereditary NMD" . SPARSER::PROTEIN) ("NMD" . SPARSER::PROTEIN)
    ("BP or CC" . SPARSER::COLLECTION) ("BP, CC and MF" . SPARSER::COLLECTION)
    ("components (CC)" . SPARSER::COMPONENT) ("MF" . SPARSER::PROTEIN)
    ("BP" . SPARSER::PROTEIN) ("DES/DYSF" . SPARSER::COLLECTION)
    ("Prey" . SPARSER::HUMAN-PROTEIN-FAMILY) ("leucine" . SPARSER::AMINO-ACID)
    ("SGCG" . SPARSER::PROTEIN) ("a secondary antibody" . SPARSER::ANTIBODY)
    ("PLA" . SPARSER::PROTEIN)
    ("kinesin family member 1B (KIF1B, 0.566) and optineurin (OPTN, 0.733)"
     . SPARSER::COLLECTION)
    ("NEB" . SPARSER::PROTEIN) ("nebulin" . SPARSER::PROTEIN)
    ("DGKD" . SPARSER::PROTEIN) ("OPTN" . SPARSER::PROTEIN)
    ("optineurin" . SPARSER::PROTEIN) ("FLNC" . SPARSER::PROTEIN)
    ("filamin" . SPARSER::PROTEIN) ("DES" . SPARSER::PROTEIN)
    ("kinesin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kinectin" . SPARSER::PROTEIN)
    ("protein, and SNAPIN" . SPARSER::COLLECTION)
    ("the available antibodies" . SPARSER::ANTIBODY)
    ("SNAP-associated protein (SNAPIN) and telethonin (TCAP)"
     . SPARSER::COLLECTION)
    ("SNAP-associated protein (SNAPIN)" . SPARSER::PROTEIN)
    ("myotube" . SPARSER::PROTEIN) ("TCAP" . SPARSER::PROTEIN)
    ("SNAPIN" . SPARSER::PROTEIN) ("abl" . SPARSER::PROTEIN)
    ("Ankyrin repeat and Nebulin" . SPARSER::COLLECTION)
    ("EGF/laminin" . SPARSER::COLLECTION) ("Nebulin" . SPARSER::PROTEIN)
    ("the secondary/tertiary bait protein and the protein it"
     . SPARSER::COLLECTION)
    ("SIDs" . SPARSER::PROTEIN-FAMILY) ("SID" . SPARSER::PROTEIN)
    ("adult and fetal human skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("prey" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("titin (TTN) and dysferlin (DYSF)" . SPARSER::COLLECTION)
    ("DYSF" . SPARSER::PROTEIN) ("TTN" . SPARSER::PROTEIN)
    ("titin" . SPARSER::PROTEIN)
    ("signal peptides and transcriptional trans-activation domains"
     . SPARSER::COLLECTION)
    ("13 LGMD-causing proteins and related proteins" . SPARSER::COLLECTION)
    ("preys" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex and α-dystrophycan" . SPARSER::COLLECTION)
    ("dystrophin-glycoprotein" . SPARSER::COLLECTION)
    ("LGMD2G/telethonin" . SPARSER::COLLECTION)
    ("LGMD2B/dysferlin" . SPARSER::COLLECTION)
    ("telethonin" . SPARSER::PROTEIN) ("sarcoglycan" . SPARSER::PROTEIN-FAMILY)
    ("dysferlin" . SPARSER::PROTEIN) ("LGMD2G" . SPARSER::PROTEIN)
    ("LGMD2B" . SPARSER::PROTEIN) ("sarcomeric proteins" . SPARSER::PROTEIN)
    ("limb" . SPARSER::PROTEIN) ("NEM6" . SPARSER::PROTEIN)
    ("Autosomal dominant" . SPARSER::PROTEIN) ("ACO1" . SPARSER::PROTEIN)
    ("SUCLG2" . SPARSER::PROTEIN) ("RNF167" . SPARSER::PROTEIN)
    ("ring finger protein 167" . SPARSER::PROTEIN) ("CAPN3" . SPARSER::PROTEIN)
    ("calpain 3" . SPARSER::PROTEIN) ("two domains" . SPARSER::PROTEIN)
    ("POMT2" . SPARSER::PROTEIN) ("POMT1" . SPARSER::PROTEIN)
    ("POMGnT1" . SPARSER::PROTEIN) ("beta-1" . SPARSER::PROTEIN)
    ("SEC31A" . SPARSER::PROTEIN)
    ("protein transport protein Sec31A" . SPARSER::PROTEIN)
    ("MYBPC2" . SPARSER::PROTEIN) ("MYBPC1" . SPARSER::PROTEIN)
    ("myosin-binding protein C" . SPARSER::PROTEIN) ("ENO3" . SPARSER::PROTEIN)
    ("type 5" . SPARSER::PROTEIN) ("lamin A/C" . SPARSER::PROTEIN)
    ("myomesin2" . SPARSER::PROTEIN)
    ("diacylglycerol kinase delta" . SPARSER::PROTEIN)
    ("kinesin family member 1B" . SPARSER::PROTEIN)
    ("adaptor protein" . SPARSER::PROTEIN) ("enolase 1" . SPARSER::PROTEIN)
    ("Ankyrin repeat" . SPARSER::PROTEIN)
    ("Fibronectin type III" . SPARSER::PROTEIN) ("C2H2" . SPARSER::MOLECULE)
    ("Zinc Finger" . SPARSER::PROTEIN) ("protein it" . SPARSER::PROTEIN)
    ("RCOR3" . SPARSER::PROTEIN) ("Chi-2" . SPARSER::PROTEIN)
    ("TOPRO-3" . SPARSER::MOLECULE) ("Bis-Tris" . SPARSER::MOLECULE)
    ("reducing agent" . SPARSER::MOLECULE) ("NPHP3" . SPARSER::PROTEIN)
    ("MYOM2" . SPARSER::PROTEIN) ("EEF1G" . SPARSER::PROTEIN)
    ("DNAJB6" . SPARSER::PROTEIN) ("CMYA5" . SPARSER::PROTEIN)
    ("KTN1" . SPARSER::PROTEIN) ("KIF1B" . SPARSER::PROTEIN)
    ("KBTBD10" . SPARSER::PROTEIN) ("ENO1" . SPARSER::PROTEIN)
    ("APPL1" . SPARSER::PROTEIN) ("MYOM1" . SPARSER::PROTEIN)
    ("ACTN2" . SPARSER::PROTEIN) ("ABI1" . SPARSER::PROTEIN)
    ("splicing factor" . SPARSER::PROTEIN) ("L40" . SPARSER::PROTEIN)
    ("LGMD2" . SPARSER::PROTEIN) ("LGMD1" . SPARSER::PROTEIN)
    ("spinocerebellar ataxia" . SPARSER::PROTEIN)
    ("P72 and A2" . SPARSER::COLLECTION)
    ("masking" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GA" . SPARSER::PROTEIN)
    ("allele and cancer" . SPARSER::COLLECTION)
    ("P72" . SPARSER::HUMAN-PROTEIN-FAMILY) ("1A2" . SPARSER::PROTEIN)
    ("1A1" . SPARSER::PROTEIN) ("PIN3" . SPARSER::PROTEIN)
    ("da" . SPARSER::MOLECULE) ("Da" . SPARSER::MOLECULE)
    ("reproductive age" . SPARSER::PROTEIN) ("CEB" . SPARSER::PROTEIN)
    ("reactive oxygen" . SPARSER::MOLECULE)
    ("the lengthy period" . SPARSER::PROTEIN) ("Pal" . SPARSER::PROTEIN)
    ("oocytes" . SPARSER::PROTEIN) ("telomerase activity" . SPARSER::PROTEIN)
    ("nanoparticles" . SPARSER::MOLECULE)
    ("epigenetically silenced miR-200-mediated EMT" . SPARSER::PROTEIN)
    ("ovarian EMT" . SPARSER::PROTEIN)
    ("TWIST1 and ZEB1" . SPARSER::COLLECTION)
    ("an epithelial barrier" . SPARSER::PROTEIN) ("OSE" . SPARSER::PROTEIN)
    ("the most aggressive cancer types" . TYPE)
    ("nanoparticle" . SPARSER::MOLECULE)
    ("SNAI2 (58% reduction in HeyA8-IP1 and 68% reduction in SKOV3-IP1 models; p<0.05, xref ) and VIM (30% reduction in both models, p<0.05, xref )"
     . SPARSER::COLLECTION)
    ("DOPC" . SPARSER::DRUG) ("SKOV3-IP1 and HeyA8-IP1" . SPARSER::COLLECTION)
    ("DNAs" . SPARSER::DNA)
    ("SNAI2, E-cadherin, and VIM" . SPARSER::COLLECTION)
    ("TMAs" . SPARSER::MOLECULE) ("CDH1 and SNAI2" . SPARSER::COLLECTION)
    ("increased E-cadherin, decreased SNAI2 and VIM, and longer overall survival duration"
     . SPARSER::COLLECTION)
    ("cortical F-actin" . SPARSER::BIO-COMPLEX)
    ("a robust inducer" . SPARSER::PROTEIN)
    ("miR-506 directly targets SNAI2" . SPARSER::PROTEIN)
    ("SNAI2 and miR-506" . SPARSER::COLLECTION) ("pGL3-" . SPARSER::PROTEIN)
    ("pGL3-ctrl" . SPARSER::COLLECTION) ("ctrl" . SPARSER::PROTEIN)
    ("the mesenchymal markers SNAI2 and VIM" . SPARSER::COLLECTION)
    ("Ctrl" . SPARSER::PROTEIN)
    ("35 mesenchymal signature genes" . SPARSER::GENE)
    ("SLUG" . SPARSER::PROTEIN) ("aka" . SPARSER::PROTEIN)
    ("SPARC" . SPARSER::PROTEIN) ("family, and miRNAs" . SPARSER::COLLECTION)
    ("only 219 miRNA-associated genes" . SPARSER::GENE)
    ("the mesenchymal markers SNAI2 and FN1" . SPARSER::COLLECTION)
    ("SNAI2 and FN1" . SPARSER::COLLECTION)
    ("FN1, VIM, SNAI1, SNAI2 , and ZEB1" . SPARSER::COLLECTION)
    ("thin" . SPARSER::PROTEIN) ("the miRNA-associated genes" . SPARSER::GENE)
    ("the 219 miRNA-associated genes" . SPARSER::GENE)
    ("miRNA-associated genes" . SPARSER::GENE)
    ("219 miRNA-associated genes" . SPARSER::GENE)
    ("the 2,942 TCGA mesenchymal subtype-associated genes" . SPARSER::GENE)
    ("MiRNA-associated genes" . SPARSER::GENE) ("MiRNA" . SPARSER::MICRO-RNA)
    ("The methylation-associated genes" . SPARSER::GENE)
    ("the 26 CNA-associated genes" . SPARSER::GENE)
    ("nine methylation-associated genes" . SPARSER::GENE)
    ("These miRNA-associated genes" . SPARSER::GENE)
    ("SNAI2 and ZEB2" . SPARSER::COLLECTION)
    ("clinically relevant subtypes" . SPARSER::PROTEIN)
    ("TCGA mesenchymal signature gene" . SPARSER::PROTEIN)
    ("Almost 1000 miRNAs" . SPARSER::MICRO-RNA) ("MiRNAs" . SPARSER::MICRO-RNA)
    ("Nanoparticle" . SPARSER::MOLECULE)
    ("SNAI2 and VIM" . SPARSER::COLLECTION) ("ip1" . SPARSER::PROTEIN)
    ("TWIST1" . SPARSER::PROTEIN) ("IP1" . SPARSER::PROTEIN)
    ("COL4A2" . SPARSER::PROTEIN) ("COL4A1" . SPARSER::PROTEIN)
    ("LAMC1" . SPARSER::PROTEIN) ("SNAI1" . SPARSER::PROTEIN)
    ("FN1" . SPARSER::PROTEIN) ("CDH1" . SPARSER::PROTEIN)
    ("IL20RA" . SPARSER::PROTEIN) ("SNAI2" . SPARSER::PROTEIN)
    ("enzalutamide and abiraterone" . SPARSER::COLLECTION)
    ("enzalutamide" . SPARSER::DRUG)
    ("any currently available antiandrogens or ADT strategies"
     . SPARSER::COLLECTION)
    ("antiandrogens or ADT strategies" . SPARSER::COLLECTION)
    ("any currently available antiandrogens" . SPARSER::DRUG)
    ("antiandrogens" . SPARSER::DRUG)
    ("a vital and viable therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("the central ketone" . SPARSER::MOLECULE) ("ketone" . SPARSER::MOLECULE)
    ("CBP/p300" . SPARSER::COLLECTION) ("enhancers" . SPARSER::PROTEIN)
    ("a chlorinated bisphenol A diglycidyl ether (BADGE)" . SPARSER::MOLECULE)
    ("ether (BADGE)" . SPARSER::MOLECULE) ("ether" . SPARSER::MOLECULE)
    ("bisphenol" . SPARSER::MOLECULE)
    ("subsequent intelligent drug" . SPARSER::DRUG)
    ("a nearly ideal drug target" . SPARSER::TARGET-PROTEIN)
    ("NCoR/TAB2" . SPARSER::COLLECTION)
    ("the transcriptional co-repressor NCoR and its binding partner TAB2"
     . SPARSER::COLLECTION)
    ("NCoR" . SPARSER::PROTEIN) ("LL" . SPARSER::PROTEIN)
    ("two smaller subdomains" . SPARSER::PROTEIN)
    ("subdomains" . SPARSER::PROTEIN)
    ("Trp-His-Thr-Leu-Phe" . SPARSER::COLLECTION) ("TAU" . SPARSER::PROTEIN)
    ("TAUs" . SPARSER::PROTEIN) ("androgen/AR" . SPARSER::COLLECTION)
    ("MLPA" . SPARSER::PROTEIN) ("naïve" . SPARSER::PROTEIN)
    ("mRNAs and proteins" . SPARSER::COLLECTION)
    ("hormone-naïve" . SPARSER::COLLECTION)
    ("metastatic castration-recurrent PCa" . SPARSER::PROTEIN)
    ("TMPRSS2:Ets" . SPARSER::BIO-COMPLEX)
    ("TMPRSS2-Ets" . SPARSER::COLLECTION) ("AT" . SPARSER::PROTEIN)
    ("both HSP90 and the nuclear" . SPARSER::COLLECTION)
    ("and 1/2/3/2b" . SPARSER::COLLECTION) ("RACE" . SPARSER::PROTEIN)
    ("UBE2C, CDCA5, ZWINT, TPX2, and CDC25C" . SPARSER::COLLECTION)
    ("ZWINT" . SPARSER::PROTEIN) ("LNCaP" . SPARSER::PROTEIN)
    ("currently best characterized ARV" . SPARSER::VARIANT)
    ("AR 1/2/3/2b" . SPARSER::COLLECTION) ("AR 1" . SPARSER::PROTEIN)
    ("CE1" . SPARSER::PROTEIN) ("reagents" . SPARSER::MOLECULE)
    ("ARV" . SPARSER::VARIANT) ("Stop" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("variant (ARV)" . SPARSER::VARIANT) ("VARIANTS" . SPARSER::VARIANT)
    ("ACTIVE" . SPARSER::ACTIVE)
    ("pathogenic AR splice variants" . SPARSER::VARIANT)
    ("abiraterone and MDV3100" . SPARSER::COLLECTION)
    ("abiraterone" . SPARSER::DRUG)
    ("Enzalutamide (formerly MDV3100) and abiraterone acetate"
     . SPARSER::COLLECTION)
    ("Enzalutamide" . SPARSER::DRUG) ("adrenal androgens" . SPARSER::DRUG)
    ("bicalutamide or flutamide" . SPARSER::COLLECTION)
    ("gonadotropin" . SPARSER::PROTEIN) ("flutamide" . SPARSER::DRUG)
    ("bicalutamide" . SPARSER::DRUG) ("AF-2/BF-3" . SPARSER::COLLECTION)
    ("PCa and androgen" . SPARSER::COLLECTION) ("BF" . SPARSER::PROTEIN)
    ("NR" . SPARSER::PROTEIN) ("DHT and forms" . SPARSER::COLLECTION)
    ("its structural homology" . SPARSER::PROTEIN) ("PCa" . SPARSER::PROTEIN)
    ("AR/DHT" . SPARSER::COLLECTION)
    ("heat shock proteins and high molecular weight immunophilins"
     . SPARSER::COLLECTION)
    ("testosterone and dihydrotestosterone (DHT)" . SPARSER::COLLECTION)
    ("testosterone and dihydrotestosterone" . SPARSER::COLLECTION)
    ("DHT" . SPARSER::PROTEIN) ("dihydrotestosterone" . SPARSER::DRUG)
    ("testosterone" . SPARSER::MOLECULE) ("androgens" . SPARSER::DRUG)
    ("CTD" . SPARSER::PROTEIN) ("bipartite" . SPARSER::PROTEIN)
    ("AF" . SPARSER::PROTEIN)
    ("truncated AR variants (ARVs) and their corresponding genomic origins"
     . SPARSER::COLLECTION)
    ("androgen" . SPARSER::PROTEIN) ("EPI-001" . SPARSER::DRUG)
    ("MEKK1" . SPARSER::PROTEIN) ("TAB2" . SPARSER::PROTEIN)
    ("TAU1" . SPARSER::DRUG) ("CDC25C" . SPARSER::PROTEIN)
    ("TPX2" . SPARSER::PROTEIN) ("CDCA5" . SPARSER::PROTEIN)
    ("UBE2C" . SPARSER::PROTEIN) ("AR-V7" . SPARSER::PROTEIN)
    ("CE4" . SPARSER::PROTEIN) ("2b" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("abiraterone acetate" . SPARSER::DRUG) ("MDV3100" . SPARSER::DRUG)
    ("FKBP52" . SPARSER::PROTEIN) ("BF-3" . SPARSER::PROTEIN)
    ("SRC-2" . SPARSER::PROTEIN)
    ("doxorubicin and dicuomarol" . SPARSER::COLLECTION)
    ("Mdm2-p53" . SPARSER::COLLECTION)
    ("camptothecin or doxorubicin, and p53γ" . SPARSER::COLLECTION)
    ("doxorubicin, and p53γ" . SPARSER::COLLECTION)
    ("p21 (CIP1/WAF1) and Bax" . SPARSER::COLLECTION)
    ("TGF-β, epidermal growth factor, insulin-like growth factor and fibroblast growth factor"
     . SPARSER::COLLECTION)
    ("p53-Mdm2" . SPARSER::COLLECTION)
    ("bortezomib and chloroquine" . SPARSER::COLLECTION)
    ("chloroquine" . SPARSER::PROTEIN) ("Tigar" . SPARSER::PROTEIN)
    ("Puma" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Camptothecin and doxorubicin" . SPARSER::COLLECTION)
    ("Bax and p21" . SPARSER::COLLECTION) ("Camptothecin" . SPARSER::DRUG)
    ("camptothecin- and doxorubicin-treated H1299 p53β" . SPARSER::COLLECTION)
    ("camptothecin-" . SPARSER::DRUG)
    ("doxorubicin and camptothecin" . SPARSER::COLLECTION)
    ("Ara-C and camptothecin" . SPARSER::COLLECTION)
    ("the cytotoxic antibiotic and topoisomerase II inhibitor doxorubicin (Dox) and the topoisomerase I inhibitor camptothecin (CPT)"
     . SPARSER::COLLECTION)
    ("camptothecin (CPT)" . SPARSER::DRUG)
    ("antibiotic and topoisomerase II" . SPARSER::COLLECTION)
    ("CPT" . SPARSER::PROTEIN) ("antibiotic" . SPARSER::DRUG)
    ("cytidine" . SPARSER::MOLECULE) ("DDI" . SPARSER::DRUG)
    ("3 H-thymidine DNA-incorporation" . SPARSER::DNA)
    ("H-thymidine DNA-incorporation" . SPARSER::DNA)
    ("DNA-incorporation" . SPARSER::DNA)
    ("at least 12 different p53 protein isoforms" . SPARSER::ISOFORM)
    ("dicoumarol" . SPARSER::DRUG) ("bortezomib" . SPARSER::DRUG)
    ("Bax and Mdm2" . SPARSER::COLLECTION) ("CIP1/WAF1" . SPARSER::COLLECTION)
    ("camptothecin and doxorubicin" . SPARSER::COLLECTION)
    ("camptothecin" . SPARSER::DRUG) ("carboxy" . SPARSER::MOLECULE)
    ("IL2R" . SPARSER::PROTEIN) ("ddH 2" . SPARSER::PROTEIN)
    ("- 3" . SPARSER::PROTEIN) ("s 5A" . SPARSER::PROTEIN)
    ("topoisomerase I" . SPARSER::PROTEIN) ("TP73" . SPARSER::PROTEIN)
    ("TP53INP1" . SPARSER::PROTEIN) ("ARG2" . SPARSER::PROTEIN)
    ("NAD(P)H" . SPARSER::MOLECULE) ("CIP1" . SPARSER::PROTEIN)
    ("allele or genotype" . SPARSER::COLLECTION)
    ("the interactive impact" . SPARSER::PROTEIN) ("Allele" . SPARSER::ALLELE)
    ("XRCC1 (rs1799782∶Arg194Trp and rs25487∶Arg399Gln) and XRCC3 (rs861539∶Thr241Met) genes"
     . SPARSER::COLLECTION)
    ("XRCC1 and XRCC3" . SPARSER::COLLECTION) ("MDR" . SPARSER::PROTEIN)
    ("XRCC1 (Arg194Trp and Arg399Gln) and XRCC3 (Thr241Met) genes"
     . SPARSER::COLLECTION)
    ("Arg-Gln" . SPARSER::MOLECULE) ("Arg-Arg" . SPARSER::MOLECULE)
    ("dominant and recessive" . SPARSER::PROTEIN) ("1 µL" . SPARSER::PROTEIN)
    ("carboxy-fluorescein" . SPARSER::DRUG)
    ("any required receptors and/or signaling molecules" . SPARSER::COLLECTION)
    ("ribonuclease" . SPARSER::PROTEIN)
    ("wortmannin and LY294002" . SPARSER::COLLECTION)
    ("striatal DA and its metabolites HVA" . SPARSER::COLLECTION)
    ("striatal DA" . SPARSER::MOLECULE) ("metabolite" . SPARSER::MOLECULE)
    ("HVA" . SPARSER::MOLECULE) ("DA" . SPARSER::MOLECULE)
    ("AAV2" . SPARSER::PROTEIN) ("puncta" . SPARSER::PROTEIN)
    ("AAV2-GFP or AAV2-angiogenin" . SPARSER::COLLECTION)
    ("AAV2-Ang" . SPARSER::COLLECTION)
    ("AAV2-angiogenin" . SPARSER::PROTEIN-PAIR)
    ("AAV2-GFP" . SPARSER::COLLECTION) ("Ang" . SPARSER::PROTEIN)
    ("LDH" . SPARSER::PROTEIN) ("angiogenin or mutant" . SPARSER::COLLECTION)
    ("Wildtype angiogenin (100 nM) and mutant K40I angiogenin (100 nM)"
     . SPARSER::COLLECTION)
    ("angiogenin or MPP+" . SPARSER::COLLECTION)
    ("DN-Akt" . SPARSER::COLLECTION) ("PI3K-Akt" . SPARSER::COLLECTION)
    ("stress-associated protein kinase/c-Jun N-terminal kinase"
     . SPARSER::KINASE)
    ("SAPK/JNK" . SPARSER::COLLECTION)
    ("protein kinase/c-Jun" . SPARSER::COLLECTION)
    ("SAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phenylpyridine" . SPARSER::MOLECULE) ("rotenone" . SPARSER::PROTEIN)
    ("both sporadic and familial forms" . SPARSER::FORM)
    ("Angiogenin" . SPARSER::PROTEIN)
    ("The potent angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dopamine and its metabolites" . SPARSER::COLLECTION)
    ("striatum" . SPARSER::PROTEIN) ("dopamine" . SPARSER::PROTEIN)
    ("MPTP" . SPARSER::PROTEIN) ("tetrahydropyridine" . SPARSER::MOLECULE)
    ("an ALS-associated mutant" . SPARSER::MUTANT)
    ("exogenous angiogenin" . SPARSER::PROTEIN)
    ("neurotoxin" . SPARSER::PROTEIN)
    ("The angiogenic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ALS" . SPARSER::PROTEIN) ("angiogenin" . SPARSER::PROTEIN)
    ("Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("homovanillic acid" . SPARSER::MOLECULE)
    ("Green Fluorescent Protein" . SPARSER::PROTEIN)
    ("α-actin" . SPARSER::PROTEIN) ("P30" . SPARSER::DRUG)
    ("SOD1" . SPARSER::PROTEIN) ("superoxide dismutase 1" . SPARSER::PROTEIN)
    ("MPP+" . SPARSER::MOLECULE) ("alpha-synuclein" . SPARSER::PROTEIN)
    ("HIF-1α and its downstream effectors" . SPARSER::COLLECTION)
    ("HIF-1α and its downstream proteins CAIX and Glut-1"
     . SPARSER::COLLECTION)
    ("Hur" . SPARSER::PROTEIN) ("Cetuximab" . SPARSER::DRUG)
    ("PX" . SPARSER::PROTEIN) ("the invasive state" . SPARSER::BIO-STATE)
    ("hypoxia and HIF-1α" . SPARSER::COLLECTION)
    ("HIF-1α and its downstream targets" . SPARSER::COLLECTION)
    ("CAIX and Glut-1" . SPARSER::COLLECTION)
    ("CAIX and Glut1" . SPARSER::COLLECTION)
    ("BRCA1 and BRCA2 and non- BRCA" . SPARSER::COLLECTION)
    ("Examples" . SPARSER::EXAMPLE) ("ER, PR and HER2" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and non-BRCA" . SPARSER::COLLECTION)
    ("BRCA2 and non- BRCA" . SPARSER::COLLECTION)
    ("ER, PR, HER2, HIF-1α, CAIX and Glut-1" . SPARSER::COLLECTION)
    ("BRCA1 , BRCA2 and non-BRCA" . SPARSER::COLLECTION)
    ("BRCA-" . SPARSER::PROTEIN-FAMILY)
    ("Carbonic anhydrase IX (CAIX) and Glucose transporter-1 (Glut-1)"
     . SPARSER::COLLECTION)
    ("Glucose" . SPARSER::PROTEIN)
    ("subunits, HIF-1α and HIF-1β" . SPARSER::COLLECTION)
    ("the invasive part" . SPARSER::COMPONENT)
    ("HIF-1α, CAIX and Glut-1" . SPARSER::COLLECTION)
    ("Glut-1" . SPARSER::PROTEIN) ("CAIX" . SPARSER::PROTEIN)
    ("RNA binding protein" . SPARSER::PROTEIN) ("ME2" . SPARSER::PROTEIN)
    ("HIF-2α" . SPARSER::PROTEIN) ("Glut1" . SPARSER::PROTEIN)
    ("Carbonic anhydrase IX" . SPARSER::PROTEIN) ("HIF-1β" . SPARSER::PROTEIN)
    ("Hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("aggressive ACC" . SPARSER::PROTEIN) ("Ctr and shβ" . SPARSER::COLLECTION)
    ("stau" . SPARSER::PROTEIN) ("staurosporin" . SPARSER::MOLECULE)
    ("Cyclin A and CDK2" . SPARSER::COLLECTION)
    ("LEF/TCF" . SPARSER::COLLECTION) ("Flash" . SPARSER::PROTEIN)
    ("Wnt/β-catenin-LEF/TCF" . SPARSER::COLLECTION)
    ("shRNA-β-catenin" . SPARSER::COLLECTION)
    ("β-catenin-LEF/TCF" . SPARSER::COLLECTION)
    ("relevant therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("molecular prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("continous β-catenin" . SPARSER::PROTEIN)
    ("CTNNB1 and AXIN2" . SPARSER::COLLECTION) ("Ctr" . SPARSER::PROTEIN)
    ("cc3" . SPARSER::PROTEIN) ("caspase3" . SPARSER::PROTEIN)
    ("CTNNB 1" . SPARSER::PROTEIN) ("CYP11B1" . SPARSER::PROTEIN)
    ("Catenin (cadherin-associated protein)" . SPARSER::PROTEIN)
    ("AXIN2" . SPARSER::PROTEIN) ("βcatenin" . SPARSER::PROTEIN)
    ("moderate and low penetrance alleles" . SPARSER::ALLELE)
    ("FANCC and BLM" . SPARSER::COLLECTION) ("FANCC" . SPARSER::PROTEIN)
    ("pathogenic variants" . SPARSER::VARIANT)
    ("a previously identified moderate susceptibility indel variant"
     . SPARSER::VARIANT)
    ("several families and a second group" . SPARSER::COLLECTION)
    ("variants or variants" . SPARSER::COLLECTION)
    ("these seven variants as well as the previous four candidates"
     . SPARSER::COLLECTION)
    ("the previous group" . SPARSER::MOLECULE) ("SLBP" . SPARSER::PROTEIN)
    ("p " . SPARSER::PROTEIN) ("BRCAX" . SPARSER::PROTEIN)
    ("Fanconi" . SPARSER::PROTEIN-FAMILY)
    ("a plausible BC related allele" . SPARSER::ALLELE)
    ("an elevated diagnostic age" . SPARSER::PROTEIN)
    ("FANCM" . SPARSER::PROTEIN) ("BRCA1/BRCA2" . SPARSER::COLLECTION)
    ("1.1 and 1.3" . SPARSER::PROTEIN)
    ("PALB2 , BRIP1 , RAD51C and XRCC2" . SPARSER::COLLECTION)
    ("ATM , CHEK2, RAD51D and RAD51B" . SPARSER::COLLECTION)
    ("P53 , PTEN or STK11" . SPARSER::COLLECTION)
    ("a known moderate susceptibility indel variant ( CHEK2 1100delC) and a catalogue"
     . SPARSER::COLLECTION)
    ("delC" . SPARSER::PROTEIN)
    ("P53 , PTEN , STK11 , PALB2 or ATM" . SPARSER::COLLECTION)
    ("WNT8A" . SPARSER::PROTEIN)
    ("stem-loop binding protein" . SPARSER::PROTEIN)
    ("heat shock protein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HSP90B1" . SPARSER::PROTEIN) ("SOSTDC1" . SPARSER::PROTEIN)
    ("I-1" . SPARSER::PROTEIN) ("RAD51B" . SPARSER::PROTEIN)
    ("RAD51D" . SPARSER::PROTEIN) ("XRCC2" . SPARSER::PROTEIN)
    ("RAD51C" . SPARSER::PROTEIN) ("BRIP1" . SPARSER::PROTEIN)
    ("Fanconi Anemia" . SPARSER::PROTEIN)
    ("PI3K and Akt" . SPARSER::COLLECTION) ("Alkaline" . SPARSER::PROTEIN)
    ("the angiogenic factor VEGF" . SPARSER::PROTEIN)
    ("photofrin and light" . SPARSER::COLLECTION)
    ("at least 100 genes" . SPARSER::GENE)
    ("caspase-9, and active" . SPARSER::COLLECTION)
    ("Caspase" . SPARSER::PROTEIN)
    ("Mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PDT or miR-99a" . SPARSER::COLLECTION)
    ("caspase-9 and caspase-3" . SPARSER::COLLECTION)
    ("FGFR3, PI3K, and Akt" . SPARSER::COLLECTION)
    ("alkaline" . SPARSER::PROTEIN)
    ("angiogenic factors (VEGF and b-FGF), a growth factor receptor (EGFR), and invasive factors (MMP-2 and MMP-9)"
     . SPARSER::COLLECTION)
    ("growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VEGF and b-FGF" . SPARSER::COLLECTION)
    ("angiogenic factors, growth factors, and invasive factors"
     . SPARSER::COLLECTION)
    ("factors, growth factors, and invasive factors" . SPARSER::COLLECTION)
    ("invasive factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("angiogenic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("condensation, and membrane-bound" . SPARSER::COLLECTION)
    ("PDT and miR-99a" . SPARSER::COLLECTION)
    ("sub-lethal light" . SPARSER::PROTEIN)
    ("an exogenous PS" . SPARSER::PROTEIN) ("most aggressive type" . TYPE)
    ("highly cytotoxic singlet oxygen and other reactive oxygen species xref"
     . SPARSER::COLLECTION)
    ("highly cytotoxic singlet oxygen" . SPARSER::MOLECULE)
    ("photosensitizer (PS)" . SPARSER::DRUG) ("PS" . SPARSER::PROTEIN)
    ("photosensitizer" . SPARSER::DRUG) ("Photofrin" . SPARSER::DRUG)
    ("PDT" . SPARSER::PROTEIN) ("photofrin" . SPARSER::DRUG)
    ("anti-VEGF" . SPARSER::DRUG) ("caspase-9" . SPARSER::PROTEIN)
    ("b-FGF" . SPARSER::DRUG)
    ("basic fibroblast growth factor" . SPARSER::PROTEIN)
    ("l 12" . SPARSER::PROTEIN) ("von Willebrand factor" . SPARSER::PROTEIN)
    ("Vascular Endothelial Growth Factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fluorescein Isothiocyanate" . SPARSER::MOLECULE)
    ("PMT4" . SPARSER::PROTEIN) ("FGFR3" . SPARSER::PROTEIN)
    ("fibroblast growth factor receptor 3" . SPARSER::PROTEIN)
    ("U87MG" . SPARSER::PROTEIN)
    ("cell membrane-associated fraction" . SPARSER::COMPONENT)
    ("Wnt and hedgehog" . SPARSER::COLLECTION) ("hedgehog" . SPARSER::PROTEIN)
    ("task" . SPARSER::PROTEIN) ("TS and TK" . SPARSER::COLLECTION)
    ("thymidylate synthase (TS) and thymidine kinase (TK)"
     . SPARSER::COLLECTION)
    ("TS" . SPARSER::PROTEIN) ("RR" . SPARSER::PROTEIN)
    ("gemcitabine and AR-A014418" . SPARSER::COLLECTION)
    ("exogenous (transfected) NF-κB" . SPARSER::PROTEIN)
    ("Cdc42 and GSK3β" . SPARSER::COLLECTION)
    ("F-actin and microtubule" . SPARSER::COLLECTION)
    ("Rac1 and Cdc42" . SPARSER::COLLECTION)
    ("IQGAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GAPs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK3β, FAK and Rac1" . SPARSER::COLLECTION)
    ("the active fractions of FAK and Rac1 and the expression"
     . SPARSER::COLLECTION)
    ("FAK and Rac1" . SPARSER::COLLECTION) ("snail" . SPARSER::PROTEIN)
    ("GSK3β and its active form" . SPARSER::COLLECTION)
    ("sham" . SPARSER::DRUG)
    ("MMP-2 and FAK and tyrosine" . SPARSER::COLLECTION)
    ("FAK and tyrosine" . SPARSER::COLLECTION)
    ("GSK3β/FAK/Rac1" . SPARSER::COLLECTION) ("p-FAK" . SPARSER::COLLECTION)
    ("GSK3β and Rac1" . SPARSER::COLLECTION)
    ("E-cadherin, N-cadherin and vimentin" . SPARSER::COLLECTION)
    ("CDK4 or CDK6" . SPARSER::COLLECTION)
    ("AR-A014418 and gemcitabine" . SPARSER::COLLECTION)
    ("Gemcitabine" . SPARSER::DRUG) ("p-β-catenin" . SPARSER::COLLECTION)
    ("GSK3β and the Y216-phosphorylated active form (p-GSK3β Y216 )"
     . SPARSER::COLLECTION)
    ("the S9-phosphorylated inactive form" . SPARSER::FORM)
    ("p-GSK3β" . SPARSER::COLLECTION) ("aberrant GSK3β" . SPARSER::PROTEIN)
    ("angiogenic factor/receptor" . SPARSER::COLLECTION)
    ("factor/receptor" . SPARSER::COLLECTION)
    ("infusional gemcitabine" . SPARSER::DRUG)
    ("Rac1 and F-actin" . SPARSER::COLLECTION) ("gemcitabine" . SPARSER::DRUG)
    ("LY2090314" . SPARSER::DRUG) ("thymidylate synthase" . SPARSER::PROTEIN)
    ("Ribonucleotide reductase" . SPARSER::PROTEIN)
    ("IQGAP1" . SPARSER::PROTEIN) ("Vav1" . SPARSER::PROTEIN)
    ("GTPase-activating" . SPARSER::PROTEIN) ("p-Rb" . SPARSER::PROTEIN)
    ("Matrix Metalloproteinase-2" . SPARSER::PROTEIN)
    ("chemo-attractant" . SPARSER::PROTEIN) ("AR-A014418" . SPARSER::DRUG)
    ("S33" . SPARSER::PROTEIN) ("penicillin G" . SPARSER::MOLECULE)
    ("matrix metalloproteinase-2" . SPARSER::PROTEIN)
    ("Glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("the TSH-associated variants" . SPARSER::VARIANT)
    ("the genetic map" . SPARSER::PROTEIN)
    ("VAV3 , NKX2–3 , TPO and FOXA2" . SPARSER::COLLECTION)
    ("GRAIL" . SPARSER::PROTEIN) ("HPA" . SPARSER::PROTEIN)
    ("kynurenine" . SPARSER::MOLECULE) ("KYNA" . SPARSER::PROTEIN)
    ("DIO1 and FOXE1" . SPARSER::COLLECTION)
    ("DIO1 , FOXE1 and LHX3" . SPARSER::COLLECTION)
    ("IGFBP5 , INSR and NR3C2" . SPARSER::COLLECTION)
    ("GH/IGF" . SPARSER::COLLECTION)
    ("growth hormone/insulin-like growth factor" . SPARSER::COLLECTION)
    ("GH" . SPARSER::PROTEIN) ("PDE10A and CAPZB" . SPARSER::COLLECTION)
    ("the associated variants" . SPARSER::VARIANT)
    ("genes and mechanisms" . SPARSER::COLLECTION)
    ("PDE8B , PDE10A , and MAF/LOC440389" . SPARSER::COLLECTION)
    ("FBX" . SPARSER::PROTEIN)
    ("PDE8B , PDE10, CAPZB, VEGFA , NR3C2, FGF7 , NFIA and ITPK1"
     . SPARSER::COLLECTION)
    ("PDE" . SPARSER::PROTEIN) ("PDE8B and CAPZB" . SPARSER::COLLECTION)
    ("PDE8B , CAPZB and FGF7" . SPARSER::COLLECTION)
    ("PDE8B , CAPZB , FGF7 , PDE10A, NFIA and ITPK1" . SPARSER::COLLECTION)
    ("TSH- and FT4-associated SNPs" . SPARSER::COLLECTION)
    ("the global impact" . SPARSER::PROTEIN)
    ("PDE8B , MAF/LOC440389 , VEGFA , IGFBP5 , NFIA , MIR1179 , MBIP and GLIS3"
     . SPARSER::COLLECTION)
    ("TSH-" . SPARSER::PROTEIN) ("calpain" . SPARSER::PROTEIN)
    ("acyltransferase" . SPARSER::PROTEIN)
    ("lysophosphatidylcholine" . SPARSER::MOLECULE) ("TLL" . SPARSER::PROTEIN)
    ("NRP" . SPARSER::PROTEIN) ("neuropilin" . SPARSER::PROTEIN)
    ("PDE8B and PDE10A" . SPARSER::COLLECTION)
    ("PDE8B , PDE10A and MAF/LOC440389" . SPARSER::COLLECTION)
    ("iodine" . SPARSER::MOLECULE) ("Iodine" . SPARSER::MOLECULE)
    ("FOXE1 ( forkhead box E1 , P  = 1.50×10 −11 ) and AADAT ( aminoadipate aminotransferase , P  = 5.20×10 −9 )"
     . SPARSER::COLLECTION)
    ("SAM" . SPARSER::PROTEIN) ("glycosyltransferase" . SPARSER::PROTEIN)
    ("CAPZB ( P  = 3.60×10 −21 , r 2  = 1 with the reported rs10917469) and NR3C2 ( P  = 9.28×10 −16 , r 2  = 0.90 with the reported rs10028213)"
     . SPARSER::COLLECTION)
    ("PDE8B ( P  = 1.95×10 −56 , r 2  = 0.94 with the reported rs4704397), CAPZB ( P  = 3.60×10 −21 , r 2  = 1 with the reported rs10917469) and NR3C2 ( P  = 9.28×10 −16 , r 2  = 0.90 with the reported rs10028213)"
     . SPARSER::COLLECTION)
    ("GW" . SPARSER::PROTEIN) ("deiodinase" . SPARSER::PROTEIN)
    ("iodothyronine" . SPARSER::MOLECULE)
    ("phosphodiesterase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TRH" . SPARSER::PROTEIN) ("HPT" . SPARSER::PROTEIN)
    ("pro-hormone" . SPARSER::COLLECTION) ("triiodothyronine" . SPARSER::DRUG)
    ("CAPZB, MAF/LOC440389 , and NR3C2" . SPARSER::COLLECTION)
    ("CAPZB" . SPARSER::PROTEIN)
    ("TSH ( PDE10A , VEGFA , IGFBP5 , NFIA , SOX9, PRDM11, FGF7 , INSR , ABO , MIR1179 , NRG1 , MBIP , ITPK1 , SASH1, GLIS3 ) and FT4 ( LHX3 , FOXE1, AADAT, NETO1/FBXO15, LPCAT2/CAPNS2 )"
     . SPARSER::COLLECTION)
    ("LPCAT2/CAPNS2" . SPARSER::COLLECTION)
    ("NETO1/FBXO15" . SPARSER::COLLECTION) ("AADAT" . SPARSER::PROTEIN)
    ("MBIP" . SPARSER::PROTEIN) ("ABO" . SPARSER::PROTEIN)
    ("INSR" . SPARSER::PROTEIN) ("NFIA" . SPARSER::PROTEIN)
    ("VEGFA" . SPARSER::PROTEIN) ("TSH and FT4" . SPARSER::COLLECTION)
    ("FT" . SPARSER::PROTEIN) ("TSH" . SPARSER::PROTEIN)
    ("ELK3" . SPARSER::PROTEIN) ("SIVA1" . SPARSER::PROTEIN)
    ("FOXA2" . SPARSER::PROTEIN) ("growth hormone" . SPARSER::PROTEIN)
    ("cAMP-dependent" . SPARSER::PROTEIN)
    ("mineralocorticoid receptor" . SPARSER::PROTEIN)
    ("subunit 2" . SPARSER::PROTEIN)
    ("aminoadipate aminotransferase" . SPARSER::PROTEIN)
    ("forkhead box E1" . SPARSER::PROTEIN)
    ("LIM homeobox 3" . SPARSER::PROTEIN)
    ("GLIS family zinc finger 3" . SPARSER::PROTEIN)
    ("MAP3K12 binding inhibitory protein 1" . SPARSER::PROTEIN)
    ("neuregulin 1" . SPARSER::PROTEIN)
    ("inositol-tetrakisphosphate 1-kinase" . SPARSER::PROTEIN)
    ("fibroblast growth factor 7" . SPARSER::PROTEIN)
    ("nuclear factor I / A" . SPARSER::PROTEIN)
    ("sex determining region Y" . SPARSER::PROTEIN)
    ("insulin-like growth factor binding protein" . SPARSER::PROTEIN)
    ("Vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("type 10A" . SPARSER::PROTEIN)
    ("v-maf musculoaponeurotic fibrosarcoma oncogene homolog"
     . SPARSER::PROTEIN)
    ("group C" . SPARSER::PROTEIN)
    ("nuclear receptor subfamily 3" . SPARSER::PROTEIN)
    ("capping protein (actin filament) muscle Z-line" . SPARSER::PROTEIN)
    ("type 8B" . SPARSER::PROTEIN)
    ("thyrotropin releasing hormone" . SPARSER::PROTEIN)
    ("thyroid stimulating hormone" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DIO1" . SPARSER::PROTEIN) ("NR3C2" . SPARSER::PROTEIN)
    ("PDE8B" . SPARSER::PROTEIN) ("CAPNS2" . SPARSER::PROTEIN)
    ("LPCAT2" . SPARSER::PROTEIN) ("FBXO15" . SPARSER::PROTEIN)
    ("NETO1" . SPARSER::PROTEIN) ("FOXE1" . SPARSER::PROTEIN)
    ("LHX3" . SPARSER::PROTEIN) ("GLIS3" . SPARSER::PROTEIN)
    ("ITPK1" . SPARSER::PROTEIN) ("FGF7" . SPARSER::PROTEIN)
    ("PRDM11" . SPARSER::PROTEIN) ("SOX9" . SPARSER::PROTEIN)
    ("IGFBP5" . SPARSER::PROTEIN) ("PDE10A" . SPARSER::PROTEIN)
    ("PSA" . SPARSER::PROTEIN) ("predates" . SPARSER::DRUG)
    ("TK" . SPARSER::PROTEIN) ("erlotinib or gefitinib" . SPARSER::COLLECTION)
    ("Prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NCCN" . SPARSER::PROTEIN) ("TKIs" . SPARSER::PROTEIN)
    ("gefitinib, erlotinib, and afatinib" . SPARSER::COLLECTION)
    ("first-line" . SPARSER::PROTEIN) ("afatinib" . SPARSER::DRUG)
    ("gefitinib and erlotinib" . SPARSER::COLLECTION)
    ("gefitinib" . SPARSER::DRUG) ("RET and ROS1" . SPARSER::COLLECTION)
    ("RET" . SPARSER::PROTEIN) ("EGFR, KRAS, and ALK" . SPARSER::COLLECTION)
    ("PFS" . SPARSER::PROTEIN) ("-mutant" . SPARSER::MUTANT)
    ("inhibitors (TKI)" . SPARSER::INHIBITOR) ("TKI" . SPARSER::PROTEIN)
    ("PIK3CA" . SPARSER::PROTEIN) ("ROS1" . SPARSER::PROTEIN)
    ("FISH and Sanger" . SPARSER::COLLECTION) ("LK" . SPARSER::PROTEIN)
    ("weak green" . SPARSER::PROTEIN)
    ("adenocarcinoma underwent ALK FISH" . SPARSER::PROTEIN)
    ("bright" . SPARSER::PROTEIN) ("Pemetrexed" . SPARSER::DRUG)
    ("Subsequent FISH" . SPARSER::PROTEIN)
    ("FISH and ALK" . SPARSER::COLLECTION)
    ("FISH and an EGFR c" . SPARSER::COLLECTION)
    ("830 cases underwent ALK FISH" . SPARSER::PROTEIN)
    ("State" . SPARSER::BIO-STATE) ("LMS and JLH" . SPARSER::COLLECTION)
    ("LMS" . SPARSER::PROTEIN) ("DAB" . SPARSER::MOLECULE)
    ("horseradish peroxidase–conjugated secondary antibodies"
     . SPARSER::ANTIBODY)
    ("the primary mouse monoclonal anti-ALK antibody" . SPARSER::ANTIBODY)
    ("citrate" . SPARSER::MOLECULE) ("peroxidase" . SPARSER::PROTEIN)
    ("Peroxidase" . SPARSER::PROTEIN) ("ethanol" . SPARSER::PROTEIN)
    ("formamide" . SPARSER::DRUG) ("Protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Solution" . SPARSER::MOLECULE) ("hematoxylin" . SPARSER::MOLECULE)
    ("pen" . SPARSER::PROTEIN)
    ("FISH and negative ALK IHC" . SPARSER::COLLECTION)
    ("FISH and IHC" . SPARSER::COLLECTION) ("EML4-ALK" . SPARSER::COLLECTION)
    ("Des" . SPARSER::PROTEIN) ("ALK and KIF5B" . SPARSER::COLLECTION)
    ("TFG" . SPARSER::PROTEIN) ("crizotinib" . SPARSER::DRUG)
    ("ALK-" . SPARSER::PROTEIN)
    ("FISH and EGFR and KRAS" . SPARSER::COLLECTION)
    ("EGFR and KRAS" . SPARSER::COLLECTION) ("ACA" . SPARSER::PROTEIN)
    ("CD246" . SPARSER::PROTEIN) ("KIF5B" . SPARSER::PROTEIN)
    ("EML4" . SPARSER::PROTEIN) ("MCH" . SPARSER::PROTEIN)
    ("EP" . SPARSER::PROTEIN) ("JAK2/TYK2" . SPARSER::COLLECTION)
    ("TWEAK or ligands" . SPARSER::COLLECTION)
    ("neuregulin and HB-EGF" . SPARSER::COLLECTION)
    ("TWEAK" . SPARSER::PROTEIN)
    ("that are mitogenic in various cell types" . SPARSER::COLLECTION)
    ("MAPK-Erk1/2" . SPARSER::COLLECTION)
    ("c-myc and IL-6 receptor" . SPARSER::COLLECTION)
    ("gp130/gp80" . SPARSER::COLLECTION)
    ("hypoxia and pro-inflammatory" . SPARSER::COLLECTION)
    ("JAK1 and STAT3" . SPARSER::COLLECTION)
    ("STAT3 and Erk1/2" . SPARSER::COLLECTION) ("Stattic" . SPARSER::DRUG)
    ("HL-" . SPARSER::PROTEIN) ("hypoxia and hypoxia" . SPARSER::COLLECTION)
    ("Hypoxia and IL-1β" . SPARSER::COLLECTION)
    ("normoxia and IL-1β" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin D2" . SPARSER::COLLECTION)
    ("IL-6 or IL-1β" . SPARSER::COLLECTION) ("Bclx" . SPARSER::PROTEIN)
    ("Hypoxia and pro-inflammatory" . SPARSER::COLLECTION)
    ("normoxia or hypoxia" . SPARSER::COLLECTION)
    ("TNF-α or IL-1β" . SPARSER::COLLECTION)
    ("normoxia and hypoxia" . SPARSER::COLLECTION)
    ("TNF- α or IL-1β" . SPARSER::COLLECTION) ("p " . SPARSER::PROTEIN)
    ("the trophic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the associated Janus Kinase (JAK)" . SPARSER::KINASE)
    ("Kinase (JAK)" . SPARSER::KINASE) ("p-STAT3" . SPARSER::COLLECTION)
    ("IL-6/gp130" . SPARSER::COLLECTION)
    ("the late post-MI healing phase IL-6" . SPARSER::PROTEIN)
    ("the adipose vascular stromal fraction" . SPARSER::COMPONENT)
    ("CD105, CD90, CD44, CD29 or CD73" . SPARSER::COLLECTION)
    ("trophic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CM" . SPARSER::PROTEIN) ("media or IL-6" . SPARSER::COLLECTION)
    ("JAK/STAT" . SPARSER::COLLECTION) ("Mitogen" . SPARSER::MITOGEN)
    ("Activator" . SPARSER::ACTIVATOR)
    ("hypoxia and/or IL-1β" . SPARSER::COLLECTION) ("aMI" . SPARSER::MOLECULE)
    ("TYK2" . SPARSER::PROTEIN) ("gp80" . SPARSER::PROTEIN)
    ("IL-6 receptor" . SPARSER::PROTEIN) ("TNF- α" . SPARSER::PROTEIN)
    ("AG490" . SPARSER::DRUG) ("JAK1" . SPARSER::PROTEIN)
    ("TBS-1" . SPARSER::PROTEIN) ("Beta-2" . SPARSER::PROTEIN)
    ("mitomycin-C" . SPARSER::DRUG)
    ("mitogen activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("gp130" . SPARSER::PROTEIN) ("CD73" . SPARSER::PROTEIN)
    ("CD29" . SPARSER::PROTEIN) ("CD90" . SPARSER::PROTEIN)
    ("CD105" . SPARSER::PROTEIN) ("hope" . SPARSER::PROTEIN)
    ("the unique effector" . SPARSER::EFFECTOR)
    ("Noncanonical NF-κB members RelB and p52" . SPARSER::COLLECTION)
    ("RelB and p52" . SPARSER::COLLECTION) ("NIK" . SPARSER::PROTEIN)
    ("T-cell ICOS and B-cell ICOSL" . SPARSER::COLLECTION)
    ("ICOSL" . SPARSER::PROTEIN) ("ICOS" . SPARSER::PROTEIN)
    ("RelB:p52" . SPARSER::BIO-COMPLEX) ("p52-RelB" . SPARSER::COLLECTION)
    ("IκB or a chemical inhibitor" . SPARSER::COLLECTION)
    ("a nondegradable form" . SPARSER::FORM)
    ("IL-4 and TGF-β" . SPARSER::COLLECTION)
    ("TNF-receptor" . SPARSER::COLLECTION) ("OX40" . SPARSER::PROTEIN)
    ("these two group’s" . SPARSER::MOLECULE)
    ("c-Rel and p65" . SPARSER::COLLECTION)
    ("RelA or RelB" . SPARSER::COLLECTION)
    ("RelA, and RelB" . SPARSER::COLLECTION)
    ("RelA (p65) and RelB" . SPARSER::COLLECTION) ("LT" . SPARSER::PROTEIN)
    ("‘enhanceosome’" . SPARSER::PROTEIN) ("enhanceosome" . SPARSER::PROTEIN)
    ("NFAT and STAT" . SPARSER::COLLECTION)
    ("c-Rel:p65" . SPARSER::BIO-COMPLEX) ("IL-17a" . SPARSER::PROTEIN)
    ("Il17a" . SPARSER::PROTEIN) ("gene, Rorg and share" . SPARSER::COLLECTION)
    ("RORγt and RORγ" . SPARSER::COLLECTION) ("ROR" . SPARSER::PROTEIN)
    ("c-Rel-" . SPARSER::PROTEIN) ("EAE" . SPARSER::PROTEIN)
    ("stop" . SPARSER::HUMAN-PROTEIN-FAMILY) ("lox" . SPARSER::PROTEIN)
    ("IKK and NF-κB" . SPARSER::COLLECTION) ("Ubc13-IKK" . SPARSER::COLLECTION)
    ("mTOR/Akt" . SPARSER::COLLECTION) ("Cre-Lox" . SPARSER::COLLECTION)
    ("Lox" . SPARSER::PROTEIN) ("CARMA1/MALT1/BCL10" . SPARSER::COLLECTION)
    ("CREB, CBFβ, and STAT5" . SPARSER::COLLECTION)
    ("AP1, NFAT, and SMAD3" . SPARSER::COLLECTION) ("AP1" . SPARSER::PROTEIN)
    ("CNS1, CNS2, and CNS3" . SPARSER::COLLECTION) ("OT" . SPARSER::PROTEIN)
    ("a proximal Lck promoter" . SPARSER::PROMOTER)
    ("TAK1-" . SPARSER::PROTEIN)
    ("TAK1, BCL10, CARMA1, PKCθ, and IKKβ" . SPARSER::COLLECTION)
    ("NF-κB, NF-AT, and mammalian target of rapamycin" . SPARSER::COLLECTION)
    ("/AKT" . SPARSER::COLLECTION) ("two-step" . SPARSER::PROTEIN)
    ("food, or allergens" . SPARSER::COLLECTION)
    ("allergens" . SPARSER::MOLECULE)
    ("STAT6, GATA3, and c-Maf" . SPARSER::COLLECTION)
    ("NFAT, AP-1 and NF-κB" . SPARSER::COLLECTION)
    ("a homodimer or a heterodimer" . SPARSER::COLLECTION)
    ("p65:c-Rel" . SPARSER::BIO-COMPLEX) ("p50 or c-Rel" . SPARSER::COLLECTION)
    ("RelA and STAT4" . SPARSER::COLLECTION)
    ("T-bet, STAT4 and STAT1" . SPARSER::COLLECTION)
    ("IL-12 and IFN-γ" . SPARSER::COLLECTION)
    ("T-bet and GATA3" . SPARSER::COLLECTION)
    ("DCs or macrophages" . SPARSER::COLLECTION) ("DCs" . SPARSER::PROTEIN)
    ("IL-5, IL-6, IL-9, IL-13, and IL-25" . SPARSER::COLLECTION)
    ("RORγt and RORα" . SPARSER::COLLECTION)
    ("proinflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-17A, IL-17F, and IL-22" . SPARSER::COLLECTION)
    ("interleukin-4 (IL-4) and other cytokines" . SPARSER::COLLECTION)
    ("interferon-γ" . SPARSER::PROTEIN) ("APCs" . SPARSER::PROTEIN)
    ("the T-cell receptor (TCR) and the co-receptor CD28"
     . SPARSER::COLLECTION)
    ("activation-associated cell surface molecules" . SPARSER::MOLECULE)
    ("antimicrobial factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immunomodulatory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p65:p50" . SPARSER::BIO-COMPLEX)
    ("promoter or enhancer" . SPARSER::COLLECTION)
    ("kinase (IKK)" . SPARSER::KINASE) ("IKK" . SPARSER::PROTEIN)
    ("p65, c-Rel, and RelB" . SPARSER::COLLECTION)
    ("Rel-homology" . SPARSER::COLLECTION) ("RHD" . SPARSER::PROTEIN)
    ("regulators and effectors" . SPARSER::COLLECTION)
    ("IL-21" . SPARSER::PROTEIN) ("CXCR5" . SPARSER::PROTEIN)
    ("TRAF6" . SPARSER::PROTEIN) ("BAY 11–7082" . SPARSER::DRUG)
    ("costimulatory molecule" . SPARSER::PROTEIN) ("LTβR" . SPARSER::PROTEIN)
    ("LTβ" . SPARSER::PROTEIN) ("IL-17" . SPARSER::PROTEIN)
    ("Ubc13" . SPARSER::PROTEIN) ("MALT1" . SPARSER::PROTEIN)
    ("STAT5" . SPARSER::PROTEIN) ("SMAD3" . SPARSER::PROTEIN)
    ("CNS1" . SPARSER::PROTEIN) ("P14" . SPARSER::PROTEIN)
    ("CARMA1" . SPARSER::PROTEIN) ("BCL10" . SPARSER::PROTEIN)
    ("TAK1" . SPARSER::PROTEIN) ("NF-AT" . SPARSER::PROTEIN)
    ("CD25" . SPARSER::PROTEIN) ("GATA-3" . SPARSER::PROTEIN)
    ("c-Maf" . SPARSER::PROTEIN) ("STAT6" . SPARSER::PROTEIN)
    ("STAT4" . SPARSER::PROTEIN)
    ("signal transducer and activator of transcription 4" . SPARSER::PROTEIN)
    ("IL-25" . SPARSER::PROTEIN) ("IL-9" . SPARSER::PROTEIN)
    ("IL-5" . SPARSER::PROTEIN) ("RORα" . SPARSER::PROTEIN)
    ("RORγt" . SPARSER::PROTEIN) ("protein 3" . SPARSER::PROTEIN)
    ("forkhead box" . SPARSER::PROTEIN) ("GATA3" . SPARSER::PROTEIN)
    ("T-bet" . SPARSER::PROTEIN) ("IL-22" . SPARSER::PROTEIN)
    ("IL-17F" . SPARSER::PROTEIN) ("IL-17A" . SPARSER::PROTEIN)
    ("interleukin-4" . SPARSER::PROTEIN) ("IFN-γ" . SPARSER::PROTEIN)
    ("major histocompatibility complex" . SPARSER::PROTEIN)
    ("interleukin-2" . SPARSER::PROTEIN)
    ("adhesion molecule" . SPARSER::PROTEIN) ("co-receptor" . SPARSER::PROTEIN)
    ("p100" . SPARSER::PROTEIN) ("Th2" . SPARSER::PROTEIN)
    ("methylated BRCA1 promoter" . SPARSER::PROMOTER)
    ("the infiltrating ductal type" . TYPE)
    ("a significantly faster pace" . SPARSER::PROTEIN)
    ("pace" . SPARSER::PROTEIN) ("methylated promoter" . SPARSER::PROMOTER)
    ("ER, PR, and HER-2" . SPARSER::COLLECTION)
    ("cytosine" . SPARSER::NUCLEOBASE) ("BRCA1 or BRCA2" . SPARSER::COLLECTION)
    ("germ-line" . SPARSER::PROTEIN)
    ("environmental chemicals" . SPARSER::MOLECULE)
    ("PR-" . SPARSER::HUMAN-PROTEIN-FAMILY) ("p  " . SPARSER::PROTEIN)
    ("estrogen-receptor" . SPARSER::PROTEIN) ("CA-3" . SPARSER::PROTEIN)
    ("APC/CTNNB1" . SPARSER::COLLECTION)
    ("a synonymous coding SNP" . SPARSER::PROTEIN)
    ("SF2/ASF" . SPARSER::COLLECTION) ("ASF" . SPARSER::PROTEIN)
    ("cadherin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("known clinical prognostic factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SNP-SNP" . SPARSER::COLLECTION) ("CEA" . SPARSER::PROTEIN)
    ("Wnt/APC/CTNNB1" . SPARSER::COLLECTION)
    ("a multifunctional signaling protein" . SPARSER::PROTEIN)
    ("transmembrane Frizzled receptors and their co-receptors"
     . SPARSER::COLLECTION)
    ("axin" . SPARSER::PROTEIN) ("Frizzled" . SPARSER::PROTEIN)
    ("/β-catenin" . SPARSER::COLLECTION) ("new biomarkers" . SPARSER::MOLECULE)
    ("APC and CTNNB1" . SPARSER::COLLECTION) ("SF2" . SPARSER::PROTEIN)
    ("OCT1" . SPARSER::PROTEIN) ("Carcinoembryonic antigen" . SPARSER::PROTEIN)
    ("glycogen synthase" . SPARSER::PROTEIN-FAMILY)
    ("casein kinase 1" . SPARSER::PROTEIN)
    ("carcinoembryonic antigen" . SPARSER::PROTEIN)
    ("NADPH" . SPARSER::PROTEIN) ("triphosphatase" . SPARSER::PROTEIN)
    ("AP-2, or TLE1" . SPARSER::COLLECTION)
    ("a dual regulator" . SPARSER::PROTEIN)
    ("Ets-1/PARP-1" . SPARSER::COLLECTION)
    ("PARP-1 and Ets-1" . SPARSER::COLLECTION)
    ("good biomarkers" . SPARSER::MOLECULE) ("BRCA1-" . SPARSER::PROTEIN)
    ("Blot" . SPARSER::PROTEIN) ("mark" . SPARSER::PROTEIN)
    ("PJ-34 and doxorubicin" . SPARSER::COLLECTION)
    ("doxorubicin or paclitaxel" . SPARSER::COLLECTION)
    ("MDR1 and Ets-1" . SPARSER::COLLECTION)
    ("p53, c-Jun, ERK-2 and PARP-1" . SPARSER::COLLECTION)
    ("PJ-34 or MG-132" . SPARSER::COLLECTION)
    ("eGFP-Ets-1" . SPARSER::COLLECTION) ("-Ets-1" . SPARSER::COLLECTION)
    ("eGFP" . SPARSER::PROTEIN)
    ("two other well-studied PARP-1 inhibitors" . SPARSER::INHIBITOR)
    ("veliparib" . SPARSER::DRUG) ("a palindromic EBS" . SPARSER::PROTEIN)
    ("a well-studied Ets-1 target gene" . SPARSER::PROTEIN)
    ("PARG" . SPARSER::PROTEIN) ("peptide (SBP)" . SPARSER::PEPTIDE)
    ("SBP" . SPARSER::PROTEIN) ("approximately 27 kDa" . SPARSER::PROTEIN)
    ("approximately 51 kDa" . SPARSER::PROTEIN) ("PNT" . SPARSER::PROTEIN)
    ("simply called Ets-1 and a dominant-negative isoform"
     . SPARSER::COLLECTION)
    ("a dominant-negative isoform" . SPARSER::PROTEIN)
    ("anti-Ets-1 and anti-PARP-1" . SPARSER::COLLECTION)
    ("Ets-1 and PARP-1" . SPARSER::COLLECTION)
    ("oncoprotein" . SPARSER::PROTEIN) ("EWS-Fli1" . SPARSER::COLLECTION)
    ("EWS" . SPARSER::PROTEIN) ("parp1" . SPARSER::PROTEIN)
    ("parp" . SPARSER::PROTEIN) ("PARP-1 and ETS family" . SPARSER::COLLECTION)
    ("Ese-1" . SPARSER::PROTEIN)
    ("the MMP3 (stromelysin-1) and TP53 genes" . SPARSER::COLLECTION)
    ("two palindromic EBS" . SPARSER::PROTEIN) ("uPA" . SPARSER::PROTEIN)
    ("collagenase" . SPARSER::PROTEIN) ("EBS" . SPARSER::PROTEIN)
    ("ETS" . SPARSER::PROTEIN) ("mL −1" . SPARSER::PROTEIN)
    ("Erk-2" . SPARSER::PROTEIN) ("ets-1" . SPARSER::PROTEIN)
    ("NADPH oxidase" . SPARSER::PROTEIN) ("p47phox" . SPARSER::PROTEIN)
    ("RNF146" . SPARSER::PROTEIN) ("TLE1" . SPARSER::PROTEIN)
    ("MDR1" . SPARSER::PROTEIN)
    ("enhanced green fluorescent protein" . SPARSER::PROTEIN)
    ("ABT-888" . SPARSER::DRUG) ("PJ-34" . SPARSER::DRUG)
    ("anti-PAR" . SPARSER::DRUG) ("TMPRSS2" . SPARSER::PROTEIN)
    ("Elk-1" . SPARSER::PROTEIN) ("Fli1" . SPARSER::PROTEIN)
    ("AP-2" . SPARSER::PROTEIN) ("NAD+" . SPARSER::MOLECULE)
    ("MMP3" . SPARSER::PROTEIN)
    ("urokinase-type plasminogen activator" . SPARSER::PROTEIN)
    ("stromelysin-1" . SPARSER::PROTEIN) ("ADP-ribosyl" . SPARSER::MOLECULE)
    ("PARP-1" . SPARSER::PROTEIN) ("Ets-1" . SPARSER::PROTEIN)
    ("Traf2, Traf6, Bcl3, and Rip1" . SPARSER::COLLECTION)
    ("Rip1" . SPARSER::PROTEIN) ("NEMO" . SPARSER::PROTEIN)
    ("Fluorescent GDP or GTP" . SPARSER::COLLECTION)
    ("GDP or GTP" . SPARSER::COLLECTION) ("RhoA and GTP" . SPARSER::COLLECTION)
    ("GST-RhoA" . SPARSER::COLLECTION)
    ("lysine-63 (K63)-linked polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CYLD shRNA and Flag-LARG" . SPARSER::COLLECTION)
    ("Flag-LARG" . SPARSER::COLLECTION)
    ("p115RhoGEF or PDZ-RhoGEF" . SPARSER::COLLECTION)
    ("CYLD and LARG" . SPARSER::COLLECTION) ("Myc-LARG" . SPARSER::COLLECTION)
    ("Flag-tagged tumor necrosis factor receptor-associated factor 2"
     . SPARSER::PROTEIN)
    ("Flag-RhoA" . SPARSER::COLLECTION) ("Traf" . SPARSER::PROTEIN-FAMILY)
    ("Drugs" . SPARSER::DRUG)
    ("nocodazole and cytochalasin D" . SPARSER::COLLECTION)
    ("nocodazole" . SPARSER::DRUG) ("GFP-CYLD" . SPARSER::COLLECTION)
    ("CYLD-LARG" . SPARSER::COLLECTION)
    ("Leukemia-associated RhoGEF (LARG)" . SPARSER::PROTEIN)
    ("p115RhoGEF and PDZ-RhoGEF" . SPARSER::COLLECTION)
    ("p115RhoGEF" . SPARSER::PROTEIN) ("RGS" . SPARSER::PROTEIN)
    ("Leukemia" . SPARSER::PROTEIN)
    ("a GDP-bound inactive state and a GTP-bound active state"
     . SPARSER::COLLECTION)
    ("LARG-RhoA" . SPARSER::COLLECTION)
    ("leukemia-associated RhoGEF (LARG)" . SPARSER::PROTEIN)
    ("LARG" . SPARSER::PROTEIN) ("RhoGEF" . SPARSER::PROTEIN)
    ("CYLD" . SPARSER::PROTEIN) ("RhoA, Cdc42, and Rac1" . SPARSER::COLLECTION)
    ("triphosphatases" . SPARSER::PROTEIN) ("Bcl3" . SPARSER::PROTEIN)
    ("factor 2" . SPARSER::PROTEIN)
    ("tumor necrosis factor receptor" . SPARSER::PROTEIN)
    ("Pak1" . SPARSER::PROTEIN)
    ("glutathione-S-transferase" . SPARSER::PROTEIN)
    ("P3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("cytochalasin D" . SPARSER::DRUG)
    ("p115" . SPARSER::PROTEIN) ("mental retardation" . SPARSER::PROTEIN)
    ("Mdm2-Daxx-Hausp" . SPARSER::COLLECTION)
    ("Daxx and Hausp" . SPARSER::COLLECTION)
    ("Daxx-Hausp" . SPARSER::COLLECTION)
    ("the principal p53 antagonist Mdm2" . SPARSER::PROTEIN)
    ("Daxx or Daxx" . SPARSER::COLLECTION)
    ("Daxx S712A and wild-type Daxx" . SPARSER::COLLECTION)
    ("Daxx and Mdm2" . SPARSER::COLLECTION) ("PML" . SPARSER::PROTEIN)
    ("KD" . SPARSER::PROTEIN) ("pSer" . SPARSER::PROTEIN)
    ("ATM and Daxx" . SPARSER::COLLECTION)
    ("both exogenous and endogenous Daxx" . SPARSER::PROTEIN)
    ("HT1080" . SPARSER::PROTEIN)
    ("exogenous wild-type Daxx and Daxx S424A" . SPARSER::COLLECTION)
    ("Daxx and Daxx" . SPARSER::COLLECTION) ("pS" . SPARSER::PROTEIN)
    ("fish" . SPARSER::PROTEIN) ("VS" . SPARSER::PROTEIN)
    ("MAS" . SPARSER::PROTEIN) ("the genotoxic drug etoposide" . SPARSER::DRUG)
    ("Mdm2 and p53" . SPARSER::COLLECTION) ("Mdm2-Daxx" . SPARSER::COLLECTION)
    ("Mdm2 and the deubiquitinase Hausp (herpesvirus-associated ubiquitin-specific protease; also known as USP7)"
     . SPARSER::COLLECTION)
    ("ATM and its downstream kinase Chk2" . SPARSER::COLLECTION)
    ("Daxx-Mdm2" . SPARSER::COLLECTION) ("Hausp/USP7" . SPARSER::COLLECTION)
    ("Hausp" . SPARSER::PROTEIN) ("deubiquitinase" . SPARSER::DEUBIQUITINASE)
    ("Daxx" . SPARSER::PROTEIN) ("2SA" . SPARSER::PROTEIN)
    ("promyelocytic leukemia protein" . SPARSER::PROTEIN)
    ("pRK5" . SPARSER::PROTEIN) ("RASSF1A" . SPARSER::PROTEIN)
    ("herpesvirus-associated ubiquitin-specific protease" . SPARSER::PROTEIN)
    ("ataxia telangiectasia mutated" . SPARSER::PROTEIN)
    ("Hdm2" . SPARSER::PROTEIN) ("PI 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("USP7" . SPARSER::PROTEIN) ("Mdm2" . SPARSER::PROTEIN)
    ("gene and protein" . SPARSER::COLLECTION)
    ("a crucial inducer" . SPARSER::PROTEIN)
    ("EGFR and/or CK-II" . SPARSER::COLLECTION)
    ("hypoxia and EGF" . SPARSER::COLLECTION) ("CK" . SPARSER::PROTEIN)
    ("casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR/MAPK" . SPARSER::COLLECTION) ("EGFR-ERK1/2" . SPARSER::COLLECTION)
    ("ERK-MAP kinase" . SPARSER::COLLECTION)
    ("tubulin and cortactin" . SPARSER::COLLECTION)
    ("TGFβ-receptor" . SPARSER::COLLECTION) ("TGF" . SPARSER::PROTEIN)
    ("metalloproteinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("EGFR-HDAC6-TGFβ/Smad3" . SPARSER::COLLECTION)
    ("TGFβ and Smad3" . SPARSER::COLLECTION)
    ("EGFR and TGFβ" . SPARSER::COLLECTION)
    ("EGF and TGFβ" . SPARSER::COLLECTION)
    ("EGFR and TGFβR1" . SPARSER::COLLECTION)
    ("EGFR kinase activity almost completely prevented hypoxia-induced HDAC6 deacetylase activity"
     . SPARSER::PROTEIN)
    ("AG-1478, or Ly364947" . SPARSER::COLLECTION)
    ("EGFR or TGFβR1" . SPARSER::COLLECTION)
    ("Tyrphostin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("antibodies or anti-EGFR" . SPARSER::COLLECTION)
    ("phosphotyrosine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("TGFβ or EGF" . SPARSER::COLLECTION) ("EGF or TGFβ" . SPARSER::COLLECTION)
    ("HDAC and α-tubulin" . SPARSER::COLLECTION) ("VPA" . SPARSER::PROTEIN)
    ("HDAC6 and HDAC6" . SPARSER::COLLECTION) ("tubacin" . SPARSER::DRUG)
    ("HDAC6-targeted shRNA or control shRNA" . SPARSER::COLLECTION)
    ("HDAC6 and Smad3" . SPARSER::COLLECTION)
    ("Ly364947 or SIS3" . SPARSER::COLLECTION)
    ("a cell-permeable selective inhibitor of TGFβ-dependent Smad3 phosphorylation and Smad3-mediated cellular signaling xref"
     . SPARSER::COLLECTION)
    ("a cell-permeable selective inhibitor" . SPARSER::INHIBITOR)
    ("p-Smad2" . SPARSER::COLLECTION) ("p-Smad3" . SPARSER::COLLECTION)
    ("Smad2 and Smad3" . SPARSER::COLLECTION)
    ("Smads" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a multimeric Smad complex" . SPARSER::BIO-COMPLEX)
    ("bioactive TGFβ1" . SPARSER::PROTEIN) ("PDX" . SPARSER::PROTEIN)
    ("CA1" . SPARSER::PROTEIN) ("pro-TGFβ" . SPARSER::COLLECTION)
    ("furin" . SPARSER::PROTEIN) ("actin and cortactin" . SPARSER::COLLECTION)
    ("p90RSK" . SPARSER::PROTEIN-FAMILY) ("RSK" . SPARSER::PROTEIN)
    ("metalloproteases and other components" . SPARSER::COLLECTION)
    ("metalloproteases" . SPARSER::PROTEIN)
    ("TGFβ and EGF" . SPARSER::COLLECTION)
    ("tubulin, cortactin, heat shock proteins and catenin"
     . SPARSER::COLLECTION)
    ("catenin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proteases, integrins and growth factor receptors" . SPARSER::COLLECTION)
    ("proteases, growth factors and receptors" . SPARSER::COLLECTION)
    ("Smad" . SPARSER::HUMAN-PROTEIN-FAMILY) ("R-Smads" . SPARSER::PROTEIN)
    ("HSP90" . SPARSER::HUMAN-PROTEIN-FAMILY) ("β–tubulin" . SPARSER::PROTEIN)
    ("Smad 3" . SPARSER::PROTEIN) ("MT1-MMP" . SPARSER::PROTEIN)
    ("precursor protein" . SPARSER::PROTEIN)
    ("secreted growth factor" . SPARSER::PROTEIN) ("LY364947" . SPARSER::DRUG)
    ("TGFβR" . SPARSER::PROTEIN) ("Smad 2" . SPARSER::PROTEIN)
    ("Smad2" . SPARSER::PROTEIN) ("α1-antitrypsin" . SPARSER::PROTEIN)
    ("TGFβ1" . SPARSER::PROTEIN) ("proprotein convertase" . SPARSER::PROTEIN)
    ("LT1" . SPARSER::PROTEIN) ("Ly364947" . SPARSER::DRUG)
    ("SIS3" . SPARSER::PROTEIN) ("AG-1478" . SPARSER::DRUG)
    ("smad3" . SPARSER::PROTEIN) ("IF 1" . SPARSER::PROTEIN)
    ("S6 kinase" . SPARSER::PROTEIN-FAMILY) ("p90" . SPARSER::PROTEIN)
    ("Alpha-tubulin" . SPARSER::PROTEIN)
    ("heat shock proteins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("growth factor receptors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF-1" . SPARSER::PROTEIN) ("Smad3" . SPARSER::PROTEIN)
    ("HDAC6" . SPARSER::PROTEIN) ("histone deacetylase 6" . SPARSER::PROTEIN)
    ("three-step" . SPARSER::PROTEIN)
    ("the BLM and RAD51 polymorphic variants" . SPARSER::VARIANT)
    ("neu" . SPARSER::PROTEIN) ("ERB" . SPARSER::PROTEIN)
    ("ER-" . SPARSER::PROTEIN) ("ER and PR" . SPARSER::COLLECTION)
    ("four polymorphic variants" . SPARSER::VARIANT)
    ("the polymorphic variant" . SPARSER::VARIANT)
    ("the polymorphic variants" . SPARSER::VARIANT)
    ("helicase and RNase" . SPARSER::COLLECTION) ("RNase" . SPARSER::PROTEIN)
    ("HRDC" . SPARSER::PROTEIN) ("The polymorphic variant" . SPARSER::VARIANT)
    ("PR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genes or proteins" . SPARSER::COLLECTION)
    ("RAD51 and other proteins" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2, RAD51 and other proteins" . SPARSER::COLLECTION)
    ("BRCA1, BRCA2 and RAD51" . SPARSER::COLLECTION)
    ("DNA-repair" . SPARSER::DNA)
    ("two important homologous recombination genes" . SPARSER::GENE)
    ("ataxia telangiectasia and Werner" . SPARSER::COLLECTION)
    ("pro- and anti-recombinogenic" . SPARSER::COLLECTION)
    ("many homologous recombination proteins" . SPARSER::PROTEIN)
    ("BRCA1 and MRN" . SPARSER::COLLECTION)
    ("BLAP75/RMI1" . SPARSER::COLLECTION) ("topoisomerase" . SPARSER::PROTEIN)
    ("NBN" . SPARSER::PROTEIN)
    ("RAD51 recombinase and BLM" . SPARSER::COLLECTION)
    ("gene and tumor" . SPARSER::COLLECTION)
    ("BLM and RAD51" . SPARSER::COLLECTION) ("p  " . SPARSER::PROTEIN)
    ("the RAD51 and BLM genes and clinical characteristics"
     . SPARSER::COLLECTION)
    ("estrogen and progesterone" . SPARSER::COLLECTION)
    ("ssDNA" . SPARSER::PROTEIN) ("protein and ATP" . SPARSER::COLLECTION)
    ("RAD51-ssDNA" . SPARSER::COLLECTION)
    ("the central homologous recombination protein" . SPARSER::PROTEIN)
    ("SSA" . SPARSER::PROTEIN) ("RAD51 and BLM" . SPARSER::COLLECTION)
    ("gene and breast" . SPARSER::COLLECTION)
    ("ataxia telangiectasia" . SPARSER::PROTEIN) ("RMI1" . SPARSER::PROTEIN)
    ("BLAP75" . SPARSER::PROTEIN) ("RAD50" . SPARSER::PROTEIN)
    ("MRE11" . SPARSER::PROTEIN) ("SO 4" . SPARSER::PROTEIN)
    ("OR 2" . SPARSER::PROTEIN) ("Twist and microRNAs" . SPARSER::COLLECTION)
    ("EMT-regulator" . SPARSER::COLLECTION)
    ("Twist, Snail, Slug, and ZEB2" . SPARSER::COLLECTION)
    ("a pharmacologic inhibitor" . SPARSER::INHIBITOR)
    ("Chen" . SPARSER::PROTEIN) ("ER and N-cadherin" . SPARSER::COLLECTION)
    ("ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("both death receptors and chemotherapeutic drugs" . SPARSER::COLLECTION)
    ("doxorubicin, paclitaxel and fulvestrant" . SPARSER::COLLECTION)
    ("fulvestrant and mitoxantrone" . SPARSER::COLLECTION)
    ("mitoxantrone" . SPARSER::DRUG) ("fulvestrant" . SPARSER::DRUG)
    ("the mesenchymal surface protein N-cadherin" . SPARSER::PROTEIN)
    ("Twist, Snail, Slug and ZEB2" . SPARSER::COLLECTION)
    ("Gal-CHOP" . SPARSER::COLLECTION) ("Gal" . SPARSER::PROTEIN)
    ("p38 and ATF" . SPARSER::COLLECTION)
    ("which targets ETS1, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("Slug and Lef" . SPARSER::COLLECTION)
    ("ETS1, ZEB1 and ZEB2" . SPARSER::COLLECTION)
    ("Global microRNA" . SPARSER::MICRO-RNA) ("TN" . SPARSER::PROTEIN)
    ("TNF-NF-κB" . SPARSER::COLLECTION)
    ("NF-κB and ATF2" . SPARSER::COLLECTION)
    ("TNF and TRAIL" . SPARSER::COLLECTION)
    ("MAPKs, and p38" . SPARSER::COLLECTION)
    ("MAPKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEKs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk1/2, JNK, p38 and Erk5/BMK" . SPARSER::COLLECTION)
    ("BMK" . SPARSER::PROTEIN)
    ("tumor necrosis factor, TNF and Fas" . SPARSER::COLLECTION)
    ("multiple microRNAs and p38 signaling" . SPARSER::COLLECTION)
    ("Twist, Snail, Slug and ZEB and protein and mRNA" . SPARSER::COLLECTION)
    ("ZEB and protein and mRNA" . SPARSER::COLLECTION)
    ("ZEB" . SPARSER::PROTEIN) ("Slug" . SPARSER::PROTEIN)
    ("Twist" . SPARSER::PROTEIN) ("ATF and NF-κB" . SPARSER::COLLECTION)
    ("ATF" . SPARSER::PROTEIN)
    ("miRNA and p38 mitogen-activated protein kinase (MAPK) signaling"
     . SPARSER::COLLECTION)
    ("c-Met" . SPARSER::PROTEIN) ("miR-10b" . SPARSER::MOLECULE)
    ("ZEB2" . SPARSER::PROTEIN) ("ZEB1" . SPARSER::PROTEIN)
    ("MEF2C" . SPARSER::PROTEIN) ("Death receptor" . SPARSER::PROTEIN)
    ("P38α" . SPARSER::PROTEIN) ("Gal-4" . SPARSER::PROTEIN)
    ("ATF2" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("N-cadherin" . SPARSER::PROTEIN) ("RWJ67657" . SPARSER::DRUG)
    ("hormone-sensitive" . SPARSER::PROTEIN)
    ("MAK, MSC, HSL, SYN and WHK" . SPARSER::COLLECTION)
    ("SYN" . SPARSER::PROTEIN) ("HSL" . SPARSER::PROTEIN)
    ("MSC" . SPARSER::PROTEIN) ("MAK" . SPARSER::PROTEIN)
    ("JP, DHS, ICH and SYH" . SPARSER::COLLECTION) ("SYH" . SPARSER::PROTEIN)
    ("DHS" . SPARSER::PROTEIN) ("JP" . SPARSER::PROTEIN)
    ("NF-κB and its downstream molecule STAT3" . SPARSER::COLLECTION)
    ("NF-κB/STAT3" . SPARSER::COLLECTION) ("Janus" . SPARSER::PROTEIN-FAMILY)
    ("STAT3 and RelA" . SPARSER::COLLECTION)
    ("STAT3 and pSTAT3" . SPARSER::COLLECTION)
    ("a clear regulatory path" . SPARSER::PROTEIN)
    ("some cytokines [ xref ] and tyrosine kinases [ xref ]"
     . SPARSER::COLLECTION)
    ("RelA and STAT3" . SPARSER::COLLECTION)
    ("mesenchymal markers Snail and MMP9" . SPARSER::COLLECTION)
    ("representative EMT marker proteins" . SPARSER::PROTEIN)
    ("NF-κB (Figure xref A) or STAT3 (Figure xref B)" . SPARSER::COLLECTION)
    ("distinct nuclear" . SPARSER::PROTEIN)
    ("NF-κB and pSTAT3" . SPARSER::COLLECTION)
    ("NF-κB, pSTAT3 and MMP9" . SPARSER::COLLECTION)
    ("supersuppressive mutant form" . SPARSER::FORM)
    ("NF-κB p65 (RelA) and phospho-Tyr705-STAT3 (pSTAT3) or matrix metalloproteinase"
     . SPARSER::COLLECTION)
    ("growth factors and oncogenic proteins" . SPARSER::COLLECTION)
    ("cytokines, growth factors and oncogenic proteins" . SPARSER::COLLECTION)
    ("NF-κB2/p52" . SPARSER::COLLECTION) ("RelA/p65" . SPARSER::COLLECTION)
    ("Snail and MMP9" . SPARSER::COLLECTION) ("Snail" . SPARSER::PROTEIN)
    ("NF-κB and STAT3" . SPARSER::COLLECTION)
    ("IκBα, and STAT3" . SPARSER::COLLECTION)
    ("NF-κB and signal transducers and activators" . SPARSER::COLLECTION)
    ("transducers and activators" . SPARSER::COLLECTION)
    ("transducers" . SPARSER::PROTEIN)
    ("Matrix metalloproteinase" . SPARSER::PROTEIN)
    ("β-galactosidase" . SPARSER::PROTEIN) ("IκBs" . SPARSER::PROTEIN)
    ("NF-κB2" . SPARSER::PROTEIN) ("c-Rel" . SPARSER::PROTEIN)
    ("STAT3" . SPARSER::PROTEIN) ("factor-κB" . SPARSER::PROTEIN)
    ("several red blood cell quantitative traits" . SPARSER::PROTEIN)
    ("a transmembrane tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("PDGFRA and axial" . SPARSER::COLLECTION) ("CHB" . SPARSER::PROTEIN)
    ("Antibody" . SPARSER::ANTIBODY)
    ("surveyed five Asian cohorts" . SPARSER::MOLECULE)
    ("STARS" . SPARSER::PROTEIN) ("Fan" . SPARSER::PROTEIN)
    ("genome-wide significant variants" . SPARSER::VARIANT)
    ("Han" . SPARSER::PROTEIN) ("MTOR" . SPARSER::PROTEIN)
    ("Sharp" . SPARSER::PROTEIN)
    ("the previously discovered PDGFRA variants" . SPARSER::VARIANT)
    ("MACH" . SPARSER::PROTEIN) ("PDGFRA" . SPARSER::PROTEIN)
    ("alpha isoform" . SPARSER::PROTEIN) ("mach2" . SPARSER::DRUG)
    ("platelet-derived growth factor receptor alpha" . SPARSER::PROTEIN)
    ("p36" . SPARSER::PROTEIN) ("FRAP1" . SPARSER::PROTEIN)
    ("FKBP12-rapamycin complex-associated protein" . SPARSER::PROTEIN)
    ("ATR and WS" . SPARSER::COLLECTION)
    ("an essential protein" . SPARSER::PROTEIN)
    ("p38 and SIPS" . SPARSER::COLLECTION) ("synergizes" . SPARSER::PROTEIN)
    ("p53/p21" . SPARSER::COLLECTION)
    ("the principal component" . SPARSER::COMPONENT) ("CdkI" . SPARSER::DRUG)
    ("p16 INK4A and p21" . SPARSER::COLLECTION)
    ("the p38 inhibitors corrected this (not shown)" . SPARSER::INHIBITOR)
    ("GM18366 hTert and GM18366 puro" . SPARSER::COLLECTION)
    ("hTert or puromycin" . SPARSER::COLLECTION) ("hTert" . SPARSER::PROTEIN)
    ("both puro and an shRNA" . SPARSER::COLLECTION)
    ("puro" . SPARSER::PROTEIN) ("p-caveolin-1" . SPARSER::COLLECTION)
    ("24kDa" . SPARSER::PROTEIN) ("21kDa" . SPARSER::PROTEIN)
    ("NDFs and p38" . SPARSER::COLLECTION)
    ("WAF1 and p16 INK4A" . SPARSER::COLLECTION) ("CdkIs" . SPARSER::DRUG)
    ("p-cofilin" . SPARSER::COLLECTION) ("LIM" . SPARSER::PROTEIN)
    ("MEC3" . SPARSER::PROTEIN)
    ("The immediate p38 target MK2" . SPARSER::PROTEIN)
    ("p-HSP27" . SPARSER::COLLECTION)
    ("FITC-phalloidin showed many cells that were enlarged with numerous visible F-actin stress fibers ( xref )"
     . SPARSER::MOLECULE)
    ("FITC-phalloidin" . SPARSER::MOLECULE)
    ("BIRB 796–treated NDFs" . SPARSER::PROTEIN) ("NDFs" . SPARSER::PROTEIN)
    ("PDs" . SPARSER::PROTEIN) ("Inhibitors" . SPARSER::INHIBITOR)
    ("ATR and WRNp" . SPARSER::COLLECTION) ("Casper" . SPARSER::PROTEIN)
    ("aphidicolin" . SPARSER::PROTEIN)
    ("the pubertal growth spurt" . SPARSER::PROTEIN)
    ("spurt" . SPARSER::PROTEIN) ("severe microcephaly" . SPARSER::PROTEIN)
    ("microcephaly" . SPARSER::PROTEIN)
    ("a rare viable hypomorphic allele" . SPARSER::ALLELE)
    ("an essential gene" . SPARSER::GENE)
    ("the stress-associated p38 mitogen-activated protein (MAP) kinase"
     . SPARSER::KINASE)
    ("SIPS" . SPARSER::PROTEIN) ("WS" . SPARSER::PROTEIN)
    ("p16 INK4A and caveolin-1" . SPARSER::COLLECTION)
    ("Seckel" . SPARSER::PROTEIN)
    ("stress-associated p38 mitogen-activated protein kinase"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATR-Seckel" . SPARSER::COLLECTION)
    ("actin depolymerizing factor" . SPARSER::PROTEIN)
    ("Isl1" . SPARSER::PROTEIN) ("LIN-11" . SPARSER::PROTEIN)
    ("MK2" . SPARSER::PROTEIN) ("p-p38" . SPARSER::PROTEIN)
    ("F-Actin" . SPARSER::BIO-COMPLEX) ("Y14" . SPARSER::PROTEIN)
    ("JNK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("BIRB 796" . SPARSER::DRUG)
    ("Protein Kinase" . SPARSER::PROTEIN)
    ("MAP kinase" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HSP27" . SPARSER::PROTEIN)
    ("B-RAF or N-RAS" . SPARSER::COLLECTION) ("NGF" . SPARSER::PROTEIN)
    ("pro- or anti-apoptotic" . SPARSER::COLLECTION) ("EBP" . SPARSER::PROTEIN)
    ("zinc finger (PLZF)" . SPARSER::PROTEIN) ("PLZF" . SPARSER::PROTEIN)
    ("VEGF, GROa, ANG-2 and IL-8" . SPARSER::COLLECTION)
    ("p27 Kip1 , ETS-1 and c-KIT" . SPARSER::COLLECTION)
    ("GROa" . SPARSER::PROTEIN) ("Homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("confirmed lower HOXB7 and higher c-FOS" . SPARSER::COLLECTION)
    ("HOXB7 and c-FOS" . SPARSER::COLLECTION)
    ("c-JUN and c-FLIP" . SPARSER::COLLECTION)
    ("c-FOS/c-JUN" . SPARSER::COLLECTION)
    ("HOXB7, PBX2 and c-FOS" . SPARSER::COLLECTION)
    ("cycloheximide (CHX)" . SPARSER::PROTEIN)
    ("Dsi-PBX2" . SPARSER::COLLECTION) ("Dsi" . SPARSER::PROTEIN)
    ("HOXB7 as well as PBX2" . SPARSER::COLLECTION)
    ("an unrelated irrelevant antibody" . SPARSER::ANTIBODY)
    ("PBX2 and HOXB7" . SPARSER::COLLECTION)
    ("pan-caspase" . SPARSER::COLLECTION)
    ("pro-caspase-7" . SPARSER::COLLECTION) ("aldehyde" . SPARSER::MOLECULE)
    ("annexin V and 7AAD" . SPARSER::COLLECTION)
    ("a competitive inhibitor" . SPARSER::INHIBITOR)
    ("-FOS" . SPARSER::COLLECTION) ("FOS" . SPARSER::PROTEIN)
    ("MiR-221&222 directly target c-FOS" . SPARSER::PROTEIN)
    ("an irrelevant antibody" . SPARSER::ANTIBODY)
    ("anti-HOXB7 or anti-PBX2" . SPARSER::COLLECTION)
    ("BS1 and BS2" . SPARSER::COLLECTION) ("pGL" . SPARSER::PROTEIN)
    ("BSs" . SPARSER::PROTEIN) ("Dsi-scr" . SPARSER::COLLECTION)
    ("Dsi-HOXB7" . SPARSER::COLLECTION) ("scr" . SPARSER::PROTEIN)
    ("HOXB7 or PBX2" . SPARSER::COLLECTION)
    ("HOXB7 and PBX2" . SPARSER::COLLECTION)
    ("an anti-PBX2" . SPARSER::ANTIBODY)
    ("HOX proteins and their PBX cofactors" . SPARSER::COLLECTION)
    ("PBX1 and PBX2" . SPARSER::COLLECTION)
    ("HOXB7 and HOX" . SPARSER::COLLECTION)
    ("called micro RNAs" . SPARSER::RNA)
    ("HOXB7 and/or miR-221&222" . SPARSER::COLLECTION)
    ("HOX and PBX" . SPARSER::COLLECTION) ("“HOX/PBX" . SPARSER::COLLECTION)
    ("bFGF" . SPARSER::PROTEIN) ("PBX and MEIS" . SPARSER::COLLECTION)
    ("HOXA5 and HOXA10" . SPARSER::COLLECTION)
    ("the most aggressive form" . SPARSER::FORM)
    ("HOX/PBX" . SPARSER::COLLECTION) ("PBX" . SPARSER::PROTEIN-FAMILY)
    ("HOX" . SPARSER::PROTEIN) ("HOXB7/PBX2" . SPARSER::COLLECTION)
    ("N-RAS" . SPARSER::PROTEIN) ("B-RAF" . SPARSER::PROTEIN)
    ("activator protein" . SPARSER::PROTEIN) ("ETS1" . SPARSER::PROTEIN)
    ("zinc finger" . SPARSER::PROTEIN) ("c-KIT" . SPARSER::PROTEIN)
    ("ETS-1" . SPARSER::PROTEIN) ("p27 Kip1" . SPARSER::PROTEIN)
    ("ANG-2" . SPARSER::PROTEIN) ("c-FLIP" . SPARSER::PROTEIN)
    ("c-JUN" . SPARSER::PROTEIN) ("z-VAD-fmk" . SPARSER::DRUG)
    ("caspase-7" . SPARSER::PROTEIN) ("caspase-3" . SPARSER::PROTEIN)
    ("C-FOS" . SPARSER::PROTEIN) ("PBX1" . SPARSER::PROTEIN)
    ("Z-VAD-fmk" . SPARSER::DRUG) ("BS2" . SPARSER::PROTEIN)
    ("BS1" . SPARSER::PROTEIN) ("DVL-1" . SPARSER::PROTEIN)
    ("pSG5" . SPARSER::PROTEIN) ("B16" . SPARSER::PROTEIN)
    ("S100β" . SPARSER::PROTEIN) ("HOXC11" . SPARSER::PROTEIN)
    ("HOXA10" . SPARSER::PROTEIN) ("HOXA5" . SPARSER::PROTEIN)
    ("c-FOS" . SPARSER::PROTEIN) ("PBX2" . SPARSER::PROTEIN)
    ("HOXB7" . SPARSER::PROTEIN) ("antihypertensives" . SPARSER::DRUG)
    ("transaminase" . SPARSER::PROTEIN) ("sib" . SPARSER::DRUG)
    ("angiopoietin" . SPARSER::PROTEIN)
    ("both unipotent preadipocytes" . SPARSER::PROTEIN)
    ("whose encoded protein" . SPARSER::PROTEIN)
    ("glucose and triglyceride" . SPARSER::COLLECTION)
    ("GERA" . SPARSER::PROTEIN-FAMILY) ("AME" . SPARSER::DRUG)
    ("renin–angiotensin–aldosterone" . SPARSER::COLLECTION)
    ("catecholamine" . SPARSER::MOLECULE) ("angiotensin" . SPARSER::PROTEIN)
    ("renin" . SPARSER::PROTEIN)
    ("glucose and potassium" . SPARSER::COLLECTION)
    ("thiazides" . SPARSER::MOLECULE) ("AMEs" . SPARSER::DRUG)
    ("thiazide" . SPARSER::MOLECULE)
    ("whereby each variant allele" . SPARSER::ALLELE)
    ("glucose and triglycerides" . SPARSER::COLLECTION)
    ("Antihypertensive" . SPARSER::DRUG) ("triglycerides" . SPARSER::MOLECULE)
    ("HCTZ" . SPARSER::DRUG) ("antihypertensive" . SPARSER::DRUG)
    ("Hydrochlorothiazide" . SPARSER::DRUG)
    ("G protein-coupled" . SPARSER::PROTEIN)
    ("branched chain" . SPARSER::PROTEIN) ("MGAT1" . SPARSER::PROTEIN)
    ("glycoprotein beta" . SPARSER::PROTEIN)
    ("coactivator 1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma" . SPARSER::PROTEIN)
    ("cholinergic receptor muscarinic 3" . SPARSER::PROTEIN)
    ("growth differentiation factor 3" . SPARSER::PROTEIN)
    ("PHLDB1" . SPARSER::PROTEIN) ("member 1" . SPARSER::PROTEIN)
    ("family B" . SPARSER::PROTEIN)
    ("pleckstrin homology-like domain" . SPARSER::PROTEIN)
    ("GLUT4" . SPARSER::PROTEIN)
    ("myocyte enhancer factor 2C" . SPARSER::PROTEIN)
    ("lipoprotein lipase" . SPARSER::PROTEIN) ("NELL1" . SPARSER::PROTEIN)
    ("p15" . SPARSER::PROTEIN)
    ("multiple histological subtypes" . SPARSER::PROTEIN)
    ("hamartomatous-polyposis-related genes" . SPARSER::GENE)
    ("APC or other adenomatous polyposis-related genes" . SPARSER::COLLECTION)
    ("other adenomatous polyposis-related genes" . SPARSER::GENE)
    ("SMAD4/BMPR1A" . SPARSER::COLLECTION)
    ("type 2B and type 1" . SPARSER::COLLECTION) ("Eng" . SPARSER::PROTEIN)
    ("SMAD4 and STK11" . SPARSER::COLLECTION)
    ("MAP, AFAP or FAP" . SPARSER::COLLECTION) ("FAP" . SPARSER::PROTEIN)
    ("AFAP" . SPARSER::PROTEIN)
    ("hamartomatous polyposis-related genes" . SPARSER::GENE)
    ("Factors" . SPARSER::HUMAN-PROTEIN-FAMILY) ("met" . SPARSER::PROTEIN)
    ("20 (3.3%) BMPR1A and 21 (3.5%) SMAD4 ( xref )" . SPARSER::COLLECTION)
    ("ENG , 13 (2.2%) PTEN , 13 (2.2%) STK11 , 20 (3.3%) BMPR1A and 21 (3.5%) SMAD4 ( xref )"
     . SPARSER::COLLECTION)
    ("PTEN, BMPR1A, SMAD4, STK11 and ENG" . SPARSER::COLLECTION)
    ("hamartomatous polyposis related genes PTEN , BMPR1A, SMAD4, STK11 and ENG"
     . SPARSER::COLLECTION)
    ("PTEN , BMPR1A, SMAD4, STK11 and ENG" . SPARSER::COLLECTION)
    ("PTEN and BMPR1A" . SPARSER::COLLECTION)
    ("STK11/LKB1" . SPARSER::COLLECTION) ("PJS" . SPARSER::PROTEIN)
    ("CRCs" . SPARSER::PROTEIN) ("more histologic types" . TYPE)
    ("PTEN , BMPR1A , SMAD4 , and STK11" . SPARSER::COLLECTION)
    ("PTEN , BMPR1A, SMAD4, ENG, and STK11" . SPARSER::COLLECTION)
    ("ENG" . SPARSER::PROTEIN) ("AIMS" . SPARSER::PROTEIN)
    ("OR 1" . SPARSER::PROTEIN) ("type 2B" . SPARSER::PROTEIN)
    ("STK11" . SPARSER::PROTEIN) ("SMAD4" . SPARSER::PROTEIN)
    ("BMPR1A" . SPARSER::PROTEIN)
    ("the EGFR and/or its ligands" . SPARSER::COLLECTION)
    ("functional EGFRs" . SPARSER::PROTEIN)
    ("both erbB4 and the EGFR" . SPARSER::COLLECTION)
    ("either TGFα or other EGFR ligands" . SPARSER::COLLECTION)
    ("HB-EGF or betacellulin" . SPARSER::COLLECTION)
    ("TGFα and amphiregulin" . SPARSER::COLLECTION) ("erbB" . SPARSER::PROTEIN)
    ("EGFRs and the EGFR ligand TGFα" . SPARSER::COLLECTION)
    ("EGFRs and TGFα" . SPARSER::COLLECTION)
    ("EGFR and TGFα" . SPARSER::COLLECTION)
    ("Prominent punctate" . SPARSER::PROTEIN) ("punctate" . SPARSER::PROTEIN)
    ("a mouse monoclonal anti-TGFα antibody and a rabbit polyclonal antibody"
     . SPARSER::COLLECTION)
    ("a mouse monoclonal anti-TGFα antibody" . SPARSER::ANTIBODY)
    ("TGFα and EGFRs" . SPARSER::COLLECTION)
    ("TGF-α and EGFR" . SPARSER::COLLECTION)
    ("EGF, epigen, HB-EGF, betacellulin and epiregulin" . SPARSER::COLLECTION)
    ("target both the EGFR and erbB4" . SPARSER::COLLECTION)
    ("Epiregulin" . SPARSER::PROTEIN)
    ("the ligands capable of activating both the EGFR and erbB4"
     . SPARSER::LIGAND)
    ("Betacellulin and epiregulin" . SPARSER::COLLECTION)
    ("betacellulin and epiregulin" . SPARSER::COLLECTION)
    ("Betacellulin" . SPARSER::PROTEIN)
    ("EGFR and erbB4" . SPARSER::COLLECTION) ("Epigen" . SPARSER::PROTEIN)
    ("EGF and TGFα" . SPARSER::COLLECTION) ("Amphiregulin" . SPARSER::PROTEIN)
    ("both the EGFR and the related membrane tyrosine kinase erbB4"
     . SPARSER::COLLECTION)
    ("EGF, TGFα, amphiregulin and epigen" . SPARSER::COLLECTION)
    ("HB-EGF, betacellulin, and epiregulin" . SPARSER::COLLECTION)
    ("Ligands" . SPARSER::LIGAND) ("ethylnitrosourea" . SPARSER::MOLECULE)
    ("fibronectin and poly-L-lysine/laminin substrates" . SPARSER::COLLECTION)
    ("fibronectin" . SPARSER::PROTEIN) ("Substrate" . SPARSER::SUBSTRATE)
    ("2 distinct EGFR" . SPARSER::PROTEIN)
    ("the parent line" . SPARSER::PROTEIN)
    ("GFP or EGFR" . SPARSER::COLLECTION)
    ("shRNA and GFP" . SPARSER::COLLECTION)
    ("targeting human EGFR mRNA or a nonsense sequence" . SPARSER::COLLECTION)
    ("erbB3 and erbB4" . SPARSER::COLLECTION)
    ("cytoplasmic signaling molecules and proteases" . SPARSER::COLLECTION)
    ("a rabbit monoclonal anti-EGFR antibody" . SPARSER::ANTIBODY)
    ("YST" . SPARSER::PROTEIN) ("STS" . SPARSER::PROTEIN)
    ("mast cell" . SPARSER::PROTEIN) ("Nf1" . SPARSER::PROTEIN)
    ("HER1 and erbB1" . SPARSER::COLLECTION)
    ("amphiregulin, and epigen" . SPARSER::COLLECTION)
    ("epigen" . SPARSER::PROTEIN) ("amphiregulin" . SPARSER::PROTEIN)
    ("epiregulin" . SPARSER::PROTEIN) ("betacellulin" . SPARSER::PROTEIN)
    ("a chemotactic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exogenous EGF" . SPARSER::PROTEIN) ("EGFRs" . SPARSER::PROTEIN)
    ("laminin receptor" . SPARSER::PROTEIN) ("TGF-α" . SPARSER::PROTEIN)
    ("Growth factors" . SPARSER::GROWTH-FACTOR) ("erbB2" . SPARSER::PROTEIN)
    ("or 2" . SPARSER::MOLECULE) ("erbB4" . SPARSER::PROTEIN)
    ("erbB3" . SPARSER::PROTEIN) ("m1" . SPARSER::MOLECULE)
    ("neuregulin-1" . SPARSER::PROTEIN) ("anti-EGFR" . SPARSER::PROTEIN)
    ("erbB1" . SPARSER::PROTEIN) ("HER1" . SPARSER::PROTEIN)
    ("tumor-suppressive genes" . SPARSER::GENE)
    ("IBD-associated dysplasia" . SPARSER::PROTEIN)
    ("frank carcinoma, and vice versa" . SPARSER::PROTEIN)
    ("biologic" . SPARSER::DRUG)
    ("IBD-associated colon cancer" . SPARSER::PROTEIN)
    ("ileal" . SPARSER::PROTEIN) ("CRC" . SPARSER::PROTEIN)
    ("sporadic colon cancer" . SPARSER::PROTEIN)
    ("p21-3" . SPARSER::COLLECTION) ("NSM" . SPARSER::PROTEIN)
    ("miR-224-dysregulated genes" . SPARSER::GENE)
    ("biological targets" . SPARSER::TARGET-PROTEIN)
    ("Doxorubicin" . SPARSER::PROTEIN) ("Dicer-KO" . SPARSER::COLLECTION)
    ("Dicer" . SPARSER::PROTEIN) ("HCT" . SPARSER::PROTEIN)
    ("IBD or GI" . SPARSER::COLLECTION)
    ("This larger cohort" . SPARSER::MOLECULE)
    ("IBD-dysplasia" . SPARSER::COLLECTION) ("dysplasia" . SPARSER::PROTEIN)
    ("a larger cohort" . SPARSER::MOLECULE) ("dysplasias" . SPARSER::PROTEIN)
    ("MiRs" . SPARSER::MICRO-RNA) ("IBD-dysplasias" . SPARSER::COLLECTION)
    ("Akt and NF-κB" . SPARSER::COLLECTION) ("miRs" . SPARSER::MICRO-RNA)
    ("IBD" . SPARSER::PROTEIN) ("regulator of cell cycle" . SPARSER::PROTEIN)
    ("pGL4" . SPARSER::PROTEIN) ("messenger RNA" . SPARSER::RNA)
    ("polymerase and other HCV-specific enzyme inhibitors"
     . SPARSER::COLLECTION)
    ("a rational therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("interferon and interferon" . SPARSER::COLLECTION)
    ("protein and NS5A" . SPARSER::COLLECTION)
    ("dsRNA and viral RNA" . SPARSER::COLLECTION)
    ("aminopurine" . SPARSER::MOLECULE) ("PKR-" . SPARSER::PROTEIN)
    ("shRNAs" . SPARSER::PROTEIN)
    ("IL8, TNF-alpha and interferon beta" . SPARSER::COLLECTION)
    ("DsRNA" . SPARSER::RNA) ("dsRNA" . SPARSER::RNA)
    ("NFkB" . SPARSER::PROTEIN) ("IkB" . SPARSER::PROTEIN)
    ("homodimers and heterodimers" . SPARSER::COLLECTION)
    ("Rel" . SPARSER::PROTEIN)
    ("interferon beta and interferon" . SPARSER::COLLECTION)
    ("RelA, cRel, RelB, p50 and p52" . SPARSER::COLLECTION)
    ("RelB" . SPARSER::PROTEIN) ("cRel" . SPARSER::PROTEIN)
    ("IRF3/IRF7" . SPARSER::COLLECTION) ("ATF-2/c-Jun" . SPARSER::COLLECTION)
    ("PKR or PKR" . SPARSER::COLLECTION)
    ("antiviral interferon" . SPARSER::PROTEIN)
    ("interferon alpha and ribavirin" . SPARSER::COLLECTION)
    ("ribavirin" . SPARSER::DRUG) ("interferon" . SPARSER::PROTEIN)
    ("PKR" . SPARSER::PROTEIN) ("p91" . SPARSER::PROTEIN)
    ("Beta-actin" . SPARSER::PROTEIN) ("S21" . SPARSER::PROTEIN)
    ("S17" . SPARSER::PROTEIN) ("beta-actin" . SPARSER::PROTEIN)
    ("Type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Interferon beta" . SPARSER::PROTEIN) ("IPS-1" . SPARSER::PROTEIN)
    ("IFN-beta" . SPARSER::PROTEIN) ("RIG-I" . SPARSER::PROTEIN)
    ("IFN beta" . SPARSER::PROTEIN) ("IFN β" . SPARSER::PROTEIN)
    ("core protein" . SPARSER::PROTEIN) ("IFN-β" . SPARSER::PROTEIN)
    ("IL8" . SPARSER::PROTEIN) ("eIF2alpha" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("immediate early" . SPARSER::PROTEIN) ("p52" . SPARSER::PROTEIN)
    ("IRF7" . SPARSER::PROTEIN) ("IRF3" . SPARSER::PROTEIN)
    ("ATF-2" . SPARSER::PROTEIN) ("NS5A" . SPARSER::PROTEIN)
    ("NS4B" . SPARSER::PROTEIN) ("NS3" . SPARSER::PROTEIN)
    ("NS2" . SPARSER::PROTEIN) ("interferon beta" . SPARSER::PROTEIN)
    ("STAT1" . SPARSER::PROTEIN) ("interferon alpha" . SPARSER::PROTEIN)
    ("Protein kinase R" . SPARSER::PROTEIN)
    ("the E3 ubiquitin ligase and
P-body component TRIM21"
     . SPARSER::COLLECTION)
    ("TRIM21 or its substrates" . SPARSER::COLLECTION)
    ("a USP52-associated protein" . SPARSER::PROTEIN)
    ("MEX" . SPARSER::PROTEIN) ("protecting HIF1A mRNA" . SPARSER::RNA)
    ("hydrolase" . SPARSER::PROTEIN) ("UCH" . SPARSER::PROTEIN)
    ("elegans" . SPARSER::PROTEIN) ("AMD and miRMD" . SPARSER::COLLECTION)
    ("CCR4–CAF1" . SPARSER::COLLECTION)
    ("HIF1A mRNA and USP52 protein" . SPARSER::COLLECTION)
    ("Ago1 and GW182" . SPARSER::COLLECTION)
    ("active polysomes" . SPARSER::BIO-COMPLEX)
    ("polysomes" . SPARSER::BIO-COMPLEX) ("GFP–DCP1A" . SPARSER::COLLECTION)
    ("USP52 and the essential P-body component GW182" . SPARSER::COLLECTION)
    ("the essential P-body component GW182" . SPARSER::PROTEIN)
    ("PCBP1 and PAN3" . SPARSER::COLLECTION) ("–MS/MS" . SPARSER::COLLECTION)
    ("specific USP52-associated proteins" . SPARSER::PROTEIN)
    ("new USP52-associated
proteins"
     . SPARSER::PROTEIN)
    ("polysome" . SPARSER::BIO-COMPLEX)
    ("HIF1A and
HIF2A"
     . SPARSER::COLLECTION)
    ("ERG and CTNNB1" . SPARSER::COLLECTION)
    ("the unrelated
genes ERG (Ets-related gene) and CTNNB1 (β-catenin)"
     . SPARSER::COLLECTION)
    ("Ets" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CHIP" . SPARSER::PROTEIN)
    ("RCC4 cells lack
functional VHL"
     . SPARSER::PROTEIN)
    ("cullin" . SPARSER::PROTEIN-FAMILY)
    ("TCEB2/elongin" . SPARSER::COLLECTION) ("elongin" . SPARSER::PROTEIN)
    ("TCE" . SPARSER::DRUG) ("PHD2 and VEGF" . SPARSER::COLLECTION)
    ("GLUT1 and LDHA" . SPARSER::COLLECTION) ("USP52 " . SPARSER::PROTEIN)
    ("si1-" . SPARSER::PROTEIN) ("si1 or si3" . SPARSER::COLLECTION)
    ("si1 and si3" . SPARSER::COLLECTION) ("si1" . SPARSER::PROTEIN)
    ("siRNA library
targeting all known and assumed components of the ubiquitin and ubiquitin-like systems"
     . SPARSER::COLLECTION)
    ("siRNA library
targeting all known and assumed components"
     . SPARSER::COMPONENT)
    ("LDHA" . SPARSER::PROTEIN) ("transporter" . SPARSER::PROTEIN)
    ("NB" . SPARSER::PROTEIN) ("MAB" . SPARSER::DRUG)
    ("EDTA" . SPARSER::MOLECULE) ("NaCl" . SPARSER::PROTEIN)
    ("KOH" . SPARSER::MOLECULE) ("Hepes" . SPARSER::MOLECULE)
    ("Antibodies" . SPARSER::ANTIBODY) ("USP52 and LSM1" . SPARSER::COLLECTION)
    ("Max" . SPARSER::PROTEIN)
    ("USP52 , GW182 , LSM1 and PAN3" . SPARSER::COLLECTION)
    ("USP52" . SPARSER::PROTEIN) ("luciferase–" . SPARSER::PROTEIN)
    ("pyrophosphate" . SPARSER::MOLECULE) ("luciferin" . SPARSER::MOLECULE)
    ("glycerol" . SPARSER::PROTEIN) ("dithiothreitol" . SPARSER::PROTEIN)
    ("DTT" . SPARSER::MOLECULE) ("pH " . SPARSER::PROTEIN)
    ("Luciferase" . SPARSER::PROTEIN) ("protein and RNA" . SPARSER::COLLECTION)
    ("Hypoxia" . SPARSER::PROTEIN) ("cycloheximide" . SPARSER::PROTEIN)
    ("5 μg/ml blasticidin and
100 μg/ml hygromycin"
     . SPARSER::COLLECTION)
    ("FLAG–USP52" . SPARSER::COLLECTION) ("hygromycin" . SPARSER::MOLECULE)
    ("blasticidin" . SPARSER::MOLECULE) ("YFP" . SPARSER::PROTEIN)
    ("Sigma" . SPARSER::PROTEIN) ("puromycin" . SPARSER::DRUG)
    ("v/v" . SPARSER::COLLECTION) ("CCR4–NOT1" . SPARSER::COLLECTION)
    ("PAN2–PAN3" . SPARSER::COLLECTION) ("exonuclease" . SPARSER::PROTEIN)
    ("antisense" . SPARSER::PROTEIN) ("TTP" . SPARSER::PROTEIN)
    ("AMD" . SPARSER::PROTEIN)
    ("AREs" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("hydroxyproline" . SPARSER::MOLECULE) ("PHDs" . SPARSER::PROTEIN)
    ("GW182 or LSM1" . SPARSER::COLLECTION)
    ("protein and HIF1A" . SPARSER::COLLECTION)
    ("the pseudo-DUB (deubiquitinating enzyme)/deadenylase USP52
(ubiquitin-specific protease 52)/PAN2"
     . SPARSER::COLLECTION)
    ("/PAN2" . SPARSER::COLLECTION) ("USP" . SPARSER::PROTEIN)
    ("DUB" . SPARSER::PROTEIN) ("HLA-A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CAF1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Ago1" . SPARSER::PROTEIN)
    ("decapping enzyme" . SPARSER::PROTEIN) ("DCP1A" . SPARSER::PROTEIN)
    ("Texas-Red" . SPARSER::DRUG) ("PAN3 " . SPARSER::PROTEIN)
    ("PCBP1" . SPARSER::PROTEIN)
    ("tripartite motif-containing 21" . SPARSER::PROTEIN)
    ("TRIM21" . SPARSER::PROTEIN)
    ("its
3"
     . SPARSER::PROTEIN)
    ("S3B" . SPARSER::PROTEIN) ("S3A" . SPARSER::PROTEIN)
    ("RNA polymerase II" . SPARSER::PROTEIN) ("CTNNB1" . SPARSER::PROTEIN)
    ("activated C-kinase" . SPARSER::PROTEIN) ("RACK1" . SPARSER::PROTEIN)
    ("NEDD8" . SPARSER::PROTEIN) ("TCEB2" . SPARSER::PROTEIN)
    ("elongation factor" . SPARSER::PROTEIN) ("1D" . SPARSER::PROTEIN)
    ("KIAA0710" . SPARSER::PROTEIN) ("PHD2" . SPARSER::PROTEIN)
    ("carbonic anhydrase IX" . SPARSER::PROTEIN) ("CA9" . SPARSER::PROTEIN)
    ("1C" . SPARSER::PROTEIN) ("S1B" . SPARSER::PROTEIN)
    ("tumour
necrosis factor"
     . SPARSER::PROTEIN)
    ("cullin 2" . SPARSER::PROTEIN) ("CUL2" . SPARSER::PROTEIN)
    ("lactate dehydrogenase A" . SPARSER::PROTEIN) ("GLUT1" . SPARSER::PROTEIN)
    ("green fluorescent protein" . SPARSER::PROTEIN)
    ("P40)" . SPARSER::PROTEIN) ("HIF2A" . SPARSER::PROTEIN)
    ("for 3 " . SPARSER::PROTEIN) ("MLN4924" . SPARSER::DRUG)
    ("T-REx" . SPARSER::PROTEIN-FAMILY)
    ("yellow fluorescent protein" . SPARSER::PROTEIN)
    ("nuclease
activity"
     . SPARSER::PROTEIN)
    ("NOT1" . SPARSER::PROTEIN) ("CCR4" . SPARSER::PROTEIN)
    ("nuclease activity" . SPARSER::PROTEIN)
    ("poly(A)-binding protein" . SPARSER::PROTEIN)
    ("PABPC1" . SPARSER::PROTEIN) ("PAN3" . SPARSER::PROTEIN)
    ("factor
1"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("HIF1B" . SPARSER::PROTEIN) ("von Hippel–Lindau" . SPARSER::PROTEIN)
    ("LSM1" . SPARSER::PROTEIN) ("GW182" . SPARSER::PROTEIN)
    ("PAN2" . SPARSER::PROTEIN) ("HIF1A" . SPARSER::PROTEIN)
    ("son" . SPARSER::PROTEIN) ("EEE" . SPARSER::MOLECULE)
    ("Sur" . SPARSER::PROTEIN) ("car" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("aux" . SPARSER::PROTEIN) ("Par" . SPARSER::PROTEIN)
    ("chez" . SPARSER::PROTEIN-FAMILY) ("Trastuzumab" . SPARSER::DRUG)
    ("mise" . SPARSER::PROTEIN) ("ont" . SPARSER::MOLECULE)
    ("Aux" . SPARSER::PROTEIN) ("par" . SPARSER::PROTEIN)
    ("nos" . SPARSER::PROTEIN) ("cas" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sur" . SPARSER::PROTEIN) ("pT3" . SPARSER::PROTEIN)
    ("HER 2" . SPARSER::PROTEIN)
    ("all currently known variants" . SPARSER::VARIANT)
    ("FDR" . SPARSER::PROTEIN) ("heterozygotes" . SPARSER::PROTEIN)
    ("temsirolimus" . SPARSER::DRUG) ("NCT" . SPARSER::PROTEIN)
    ("an antidiabetic drug" . SPARSER::DRUG)
    ("At least two existing small molecules" . SPARSER::MOLECULE)
    ("metformin" . SPARSER::DRUG)
    ("an attractive target" . SPARSER::TARGET-PROTEIN)
    ("AMPKs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("everolimus" . SPARSER::DRUG)
    ("rituximab" . SPARSER::DRUG) ("AICAR" . SPARSER::PROTEIN)
    ("SLL" . SPARSER::PROTEIN) ("Rapamycin" . SPARSER::DRUG)
    ("AMPK and NHL" . SPARSER::COLLECTION)
    ("PRKAG2 and PRKAA1" . SPARSER::COLLECTION)
    ("NHL and AMPK" . SPARSER::COLLECTION)
    ("PRKAG1 and haplotypes" . SPARSER::COLLECTION)
    ("PRKAA2 and PRKAG3" . SPARSER::COLLECTION)
    ("PRKAB1 (p=0.001) and PRKAB2 (p=0.021)" . SPARSER::COLLECTION)
    ("GDS" . SPARSER::PROTEIN) ("genesis" . SPARSER::PROTEIN)
    ("lipid and glycogen synthesis and pathways that regulate cell growth"
     . SPARSER::COLLECTION)
    ("glycogen" . SPARSER::PROTEIN) ("ATP and AMP" . SPARSER::COLLECTION)
    ("PRKAB1 or PRKAB2" . SPARSER::COLLECTION)
    ("PRKAG1 , PRKAG2 , or PRKAG3" . SPARSER::COLLECTION)
    ("PRKAA1 or PRKAA2" . SPARSER::COLLECTION)
    ("a heterotrimeric protein" . SPARSER::PROTEIN)
    ("protein kinase(AMPK)" . SPARSER::PROTEIN)
    ("suppressors and oncogenes" . SPARSER::COLLECTION)
    ("Impact" . SPARSER::PROTEIN)
    ("the follicular and diffuse large B cell lymphoma histologic subtypes"
     . SPARSER::PROTEIN)
    ("subunits, PRKAA2 and PRKAG3" . SPARSER::COLLECTION)
    ("NHL" . SPARSER::PROTEIN)
    ("The heterotrimeric AMP-activated protein kinase (AMPK) complex"
     . SPARSER::BIO-COMPLEX)
    ("CRTC2" . SPARSER::PROTEIN) ("Type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXP1" . SPARSER::PROTEIN) ("PRKAG2" . SPARSER::PROTEIN)
    ("PRKAG1" . SPARSER::PROTEIN) ("PRKAB2" . SPARSER::PROTEIN)
    ("PRKAB1" . SPARSER::PROTEIN) ("PRKAA1" . SPARSER::PROTEIN)
    ("PRKAG3" . SPARSER::PROTEIN) ("PRKAA2" . SPARSER::PROTEIN)
    ("CD22, SHP-1 and SHIP-1" . SPARSER::COLLECTION)
    ("Lyn and genetic polymorphisms" . SPARSER::COLLECTION)
    ("Lyn as well as the ITIM-containing receptor FcγRIIb"
     . SPARSER::COLLECTION)
    ("the anergic state" . SPARSER::BIO-STATE)
    ("Lyn, SHP-1 and SHIP1" . SPARSER::COLLECTION)
    ("SHP-1/SHIP1" . SPARSER::COLLECTION)
    ("neither Lyn −/− nor E613R B cells" . SPARSER::COLLECTION)
    ("CD45 and CD4" . SPARSER::COLLECTION)
    ("Lyn and Lck" . SPARSER::COLLECTION)
    ("CD4-associated Lck" . SPARSER::PROTEIN)
    ("a hypermorphic variant" . SPARSER::VARIANT) ("BAFF" . SPARSER::PROTEIN)
    ("proteinuria" . SPARSER::PROTEIN) ("CD45 and Lyn" . SPARSER::COLLECTION)
    ("ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Erk" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the inhibitory tyrosine of Lyn" . SPARSER::PROTEIN)
    ("the inhibitory tyrosine of Lyn (Y507)" . SPARSER::PROTEIN)
    ("pY" . SPARSER::PROTEIN) ("Lyn, Fyn, and Blk" . SPARSER::COLLECTION)
    ("a hyper-morphic allele" . SPARSER::ALLELE)
    ("Lyn and Fyn" . SPARSER::COLLECTION)
    ("a simple hypomorphic allele" . SPARSER::ALLELE)
    ("CD3/CD4" . SPARSER::COLLECTION)
    ("the activation loop tyrosine of Lck" . SPARSER::PROTEIN)
    ("zeta" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("inhibitory tyrosines of Lck" . SPARSER::PROTEIN)
    ("the activation loop tyrosine of Fyn" . SPARSER::PROTEIN)
    ("a hypomorphic allele" . SPARSER::ALLELE)
    ("Lck and Fyn" . SPARSER::COLLECTION)
    ("a hyper-morphic variant" . SPARSER::VARIANT) ("HE" . SPARSER::PROTEIN)
    ("the inhibitory tyrosines of Lck and Lyn" . SPARSER::COLLECTION)
    ("Lck and Lyn" . SPARSER::COLLECTION)
    ("a hypermorphic allele" . SPARSER::ALLELE)
    ("The inhibitory tyrosine of the T-cell-specific SFK Lck (Y505)"
     . SPARSER::PROTEIN)
    ("Lck" . SPARSER::PROTEIN)
    ("an autoinhibitory conformation" . SPARSER::BIO-CONFORMATION)
    ("SHP-1, SHIP1, or Lyn" . SPARSER::COLLECTION)
    ("Fyn and Blk" . SPARSER::COLLECTION) ("Blk" . SPARSER::PROTEIN)
    ("Fyn" . SPARSER::PROTEIN) ("protein and lipid" . SPARSER::COLLECTION)
    ("SHP-1 and SHIP1" . SPARSER::COLLECTION)
    ("phosphatases" . SPARSER::PHOSPHATASE)
    ("kinases, Syk and Zap70" . SPARSER::COLLECTION)
    ("the BCR or the T cell receptor (TCR)" . SPARSER::COLLECTION)
    ("ITAMs" . SPARSER::PROTEIN) ("Src and Syk" . SPARSER::COLLECTION)
    ("Syk" . SPARSER::PROTEIN) ("AgR" . SPARSER::PROTEIN)
    ("Antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("hypo-morphic allele" . SPARSER::ALLELE)
    ("receptor (BCR)" . SPARSER::RECEPTOR) ("Lyn" . SPARSER::PROTEIN)
    ("the inhibitory tyrosine of the Src family kinases (SFKs)"
     . SPARSER::KINASE)
    ("BCR" . SPARSER::PROTEIN) ("Shp-1" . SPARSER::PROTEIN)
    ("co-receptors" . SPARSER::PROTEIN) ("anti-IgM" . SPARSER::PROTEIN)
    ("Indo-1 dye" . SPARSER::MOLECULE) ("CD3ε" . SPARSER::PROTEIN)
    ("G10" . SPARSER::PROTEIN) ("Erk 1" . SPARSER::PROTEIN)
    ("pErk1/2" . SPARSER::PROTEIN) ("CD23" . SPARSER::PROTEIN)
    ("CD22" . SPARSER::PROTEIN) ("CD21" . SPARSER::PROTEIN)
    ("CD5" . SPARSER::PROTEIN) ("N-ethyl-N-nitrosourea" . SPARSER::MOLECULE)
    ("CD148" . SPARSER::PROTEIN) ("SHIP1" . SPARSER::PROTEIN)
    ("negative regulators" . SPARSER::NEGATIVE-REGULATOR)
    ("Zap70" . SPARSER::PROTEIN)
    ("adiponectin, leptin, TGs, and IGF-I" . SPARSER::COLLECTION)
    ("TGs" . SPARSER::PROTEIN) ("normal BAT" . SPARSER::PROTEIN)
    ("BAT and thatLKB1" . SPARSER::COLLECTION)
    ("AMPK and SREBP-1c" . SPARSER::COLLECTION)
    ("the predominant SREBP-1 isoform" . SPARSER::ISOFORM)
    ("lipogenic enzymes" . SPARSER::ENZYME)
    ("ChIP and luciferase" . SPARSER::COLLECTION)
    ("C/EBPα-KO" . SPARSER::COLLECTION) ("Sirt6-KO" . SPARSER::COLLECTION)
    ("LKB1-IRS1" . SPARSER::COLLECTION) ("SREs" . SPARSER::PROTEIN-FAMILY)
    ("separate cytoplasmic and nuclear proteins" . SPARSER::PROTEIN)
    ("SREBP1a or SREBP2" . SPARSER::COLLECTION)
    ("flag" . SPARSER::PROTEIN-FAMILY) ("SREBP" . SPARSER::PROTEIN-FAMILY)
    ("LKB1/AMPK" . SPARSER::COLLECTION)
    ("LKB1–AMPK–Fbw8–IRS1" . SPARSER::COLLECTION)
    ("PPARγ and Fabp4" . SPARSER::COLLECTION)
    ("AMPKα1- and -α2–deficient" . SPARSER::COLLECTION)
    ("AMPKα1-" . SPARSER::PROTEIN) ("ACC" . SPARSER::PROTEIN)
    ("p-AMPKα" . SPARSER::COLLECTION)
    ("AMPK, Fbw8, and IRS1" . SPARSER::COLLECTION)
    ("Fabp4, PPARγ, and C/EBPα" . SPARSER::COLLECTION)
    ("p-FoxO1" . SPARSER::COLLECTION) ("p-IRS1" . SPARSER::COLLECTION)
    ("p" . SPARSER::PROTEIN) ("synthetase (FAS)" . SPARSER::PROTEIN)
    ("Fabp4 and fatty acid" . SPARSER::COLLECTION) ("LKB" . SPARSER::PROTEIN)
    ("FAS" . SPARSER::PROTEIN) ("synthetase" . SPARSER::PROTEIN)
    ("lacZ or Cre" . SPARSER::COLLECTION) ("lacZ" . SPARSER::PROTEIN)
    ("IRS1/Akt" . SPARSER::COLLECTION)
    ("CUL7 and the Fbw8-substrate-targeting subunit ( xref )"
     . SPARSER::COLLECTION)
    ("CUL7 and Fbw8" . SPARSER::COLLECTION)
    ("insulin/Akt" . SPARSER::COLLECTION) ("Insulin/Akt" . SPARSER::COLLECTION)
    ("C/EBPα and PPARγ" . SPARSER::COLLECTION) ("CoA" . SPARSER::MOLECULE)
    ("adiponectin, leptin, and IGF-1" . SPARSER::COLLECTION)
    ("glucose and lipid" . SPARSER::COLLECTION)
    ("adipocytokines" . SPARSER::PROTEIN-FAMILY)
    ("adipocytes" . SPARSER::PROTEIN) ("gonadal" . SPARSER::PROTEIN-FAMILY)
    ("p-AMPK" . SPARSER::COLLECTION) ("/Cre" . SPARSER::COLLECTION)
    ("defective vasculature" . SPARSER::PROTEIN)
    ("Lkb1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("phenformin" . SPARSER::DRUG)
    ("STE20-related adaptor (STRAD) protein and mouse protein"
     . SPARSER::COLLECTION)
    ("STRAD" . SPARSER::PROTEIN) ("Stk11" . SPARSER::PROTEIN)
    ("CUL7 or Fbw8" . SPARSER::COLLECTION) ("ROC1" . SPARSER::PROTEIN)
    ("Akt1 and Akt2" . SPARSER::COLLECTION)
    ("Irs1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Irs" . SPARSER::PROTEIN)
    ("BAT" . SPARSER::PROTEIN) ("IRS" . SPARSER::PROTEIN)
    ("PPARγ and C/EBPα" . SPARSER::COLLECTION)
    ("PPARγ or C/EBPα" . SPARSER::COLLECTION)
    ("coactivators" . SPARSER::PROTEIN)
    ("leptin, adiponectin, and tumor necrosis factor-α" . SPARSER::COLLECTION)
    ("adiponectin" . SPARSER::PROTEIN) ("leptin" . SPARSER::PROTEIN)
    ("SRE" . SPARSER::PROTEIN) ("sterol" . SPARSER::PROTEIN)
    ("CCAAT" . SPARSER::PROTEIN) ("peroxisome" . SPARSER::PROTEIN)
    ("Fabp4-Cre" . SPARSER::COLLECTION) ("IGF-I" . SPARSER::PROTEIN)
    ("Sirt6" . SPARSER::PROTEIN) ("SREBP2" . SPARSER::PROTEIN)
    ("SREBP1a" . SPARSER::PROTEIN) ("SREBP1c" . SPARSER::PROTEIN)
    ("Transcription Factor" . SPARSER::PROTEIN)
    ("LKB1–AMPK" . SPARSER::PROTEIN) ("acetyl-CoA" . SPARSER::MOLECULE)
    ("phosphoinositide-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p85" . SPARSER::HUMAN-PROTEIN-FAMILY) ("UCP1" . SPARSER::PROTEIN)
    ("SRE1" . SPARSER::PROTEIN) ("anti–" . SPARSER::ANTIBODY)
    ("AMPKα1" . SPARSER::PROTEIN) ("SREBP-2" . SPARSER::PROTEIN)
    ("SREBP-1c" . SPARSER::PROTEIN) ("SREBP-1a" . SPARSER::PROTEIN)
    ("IRS1 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("uncoupling protein 1" . SPARSER::PROTEIN) ("SREBP-1" . SPARSER::PROTEIN)
    ("FoxO1" . SPARSER::PROTEIN) ("K1" . SPARSER::PROTEIN)
    ("p-S6" . SPARSER::PROTEIN) ("AMPKα" . SPARSER::PROTEIN-FAMILY)
    ("β-cell" . SPARSER::PROTEIN) ("MO25" . SPARSER::PROTEIN)
    ("STE20" . SPARSER::PROTEIN)
    ("serine/threonine protein kinase" . SPARSER::PROTEIN)
    ("liver kinase B1" . SPARSER::PROTEIN)
    ("regulator of cullins 1" . SPARSER::PROTEIN) ("CUL7" . SPARSER::PROTEIN)
    ("Cullin 7" . SPARSER::PROTEIN) ("IRS4" . SPARSER::PROTEIN)
    ("IRS2" . SPARSER::PROTEIN) ("C/EBPα" . SPARSER::PROTEIN)
    ("transcriptional activators" . SPARSER::PROTEIN-FAMILY)
    ("Fbw8" . SPARSER::PROTEIN) ("IRS1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("insulin receptor substrate 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Fabp4" . SPARSER::PROTEIN) ("LKB1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Liver kinase B1" . SPARSER::PROTEIN)
    ("all associated genes" . SPARSER::GENE)
    ("microphthalmia" . SPARSER::PROTEIN)
    ("The two bone morphogenic genes" . SPARSER::GENE)
    ("laminins" . SPARSER::PROTEIN-FAMILY) ("RAR" . SPARSER::PROTEIN)
    ("RORB" . SPARSER::PROTEIN)
    ("a novel refractive error susceptibility gene" . SPARSER::PROTEIN)
    ("a nicotinic cholinergic receptor" . SPARSER::PROTEIN)
    ("a voltage-sensitive calcium channel regulator" . SPARSER::REGULATOR)
    ("calmodulin" . SPARSER::PROTEIN) ("CHRNG" . SPARSER::PROTEIN)
    ("GDP/GTP" . SPARSER::PROTEIN-PAIR)
    ("molecules and ions" . SPARSER::COLLECTION)
    ("the sensory retina" . SPARSER::DRUG)
    ("PRSS56, LOC100506035 , and SHISA6" . SPARSER::COLLECTION)
    ("0.992 and 1.050" . SPARSER::PROTEIN)
    ("associated alleles" . SPARSER::ALLELE)
    ("GJD2 and RASGRF1" . SPARSER::COLLECTION)
    ("tissue type" . SPARSER::PROTEIN) ("− 3" . SPARSER::PROTEIN)
    ("SP2" . SPARSER::PROTEIN) ("a1b" . SPARSER::PROTEIN)
    ("ZIC2" . SPARSER::PROTEIN) ("CHD7" . SPARSER::PROTEIN)
    ("transforming growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BMP3" . SPARSER::PROTEIN) ("CYP26A1" . SPARSER::PROTEIN)
    ("orphan receptor" . SPARSER::PROTEIN)
    ("Retinol dehydrogenase 5" . SPARSER::PROTEIN)
    ("Retinoic acid" . SPARSER::MOLECULE) ("MYO1D" . SPARSER::PROTEIN)
    ("cholinergic receptor" . SPARSER::PROTEIN) ("KCNJ2" . SPARSER::PROTEIN)
    ("calcium channel" . SPARSER::PROTEIN) ("CACNA1D" . SPARSER::PROTEIN)
    ("CD55" . SPARSER::PROTEIN) ("potassium channel" . SPARSER::PROTEIN)
    ("RBFOX1" . SPARSER::PROTEIN) ("A2BP1" . SPARSER::PROTEIN)
    ("H3K27ac" . SPARSER::MOLECULE) ("SHISA6" . SPARSER::PROTEIN)
    ("RASGRF1" . SPARSER::PROTEIN) ("GJD2" . SPARSER::PROTEIN)
    ("PRSS56" . SPARSER::PROTEIN) ("SIX6" . SPARSER::PROTEIN)
    ("BMP2" . SPARSER::PROTEIN) ("LAMA2" . SPARSER::PROTEIN)
    ("RDH5" . SPARSER::PROTEIN) ("KCNQ5" . SPARSER::PROTEIN)
    ("GRIA4" . SPARSER::PROTEIN) ("gelsolin" . SPARSER::PROTEIN)
    ("crosslinker" . SPARSER::PROTEIN) ("ADF" . SPARSER::PROTEIN)
    ("fascin" . SPARSER::PROTEIN)
    ("subsequent filament" . SPARSER::PROTEIN-FAMILY)
    ("the thermally-driven filament" . SPARSER::PROTEIN-FAMILY)
    ("bare filaments" . SPARSER::PROTEIN-FAMILY)
    ("subunits and filament" . SPARSER::COLLECTION)
    ("twist and subunit" . SPARSER::COLLECTION) ("tilt" . SPARSER::DRUG)
    ("twist" . SPARSER::PROTEIN) ("subunit and filament" . SPARSER::COLLECTION)
    ("solvent or ion" . SPARSER::COLLECTION)
    ("a typical globular protein" . SPARSER::PROTEIN)
    ("Ion" . SPARSER::MOLECULE) ("Actin" . SPARSER::PROTEIN)
    ("cofilin and filament-associated cations ( xref )" . SPARSER::COLLECTION)
    ("filament-associated cations" . SPARSER::MOLECULE)
    ("Salt" . SPARSER::MOLECULE) ("Ref" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Solvent" . SPARSER::MOLECULE)
    ("salts and/or protein (cofilin and actin)" . SPARSER::COLLECTION)
    ("cofilin and actin" . SPARSER::COLLECTION) ("salts" . SPARSER::DRUG)
    ("solvent" . SPARSER::MOLECULE)
    ("two distinct vacant states" . SPARSER::BIO-STATE)
    ("more reliable fits" . SPARSER::PROTEIN-FAMILY)
    ("fits" . SPARSER::PROTEIN-FAMILY)
    ("vertebrate cofilin and vertebrate actin" . SPARSER::COLLECTION)
    ("int" . SPARSER::PROTEIN) ("grasp" . SPARSER::PROTEIN)
    ("semi-flexible polymers" . SPARSER::MOLECULE)
    ("filaments and filament" . SPARSER::COLLECTION)
    ("Filament" . SPARSER::PROTEIN-FAMILY)
    ("linear double-stranded helical filaments" . SPARSER::PROTEIN-FAMILY)
    ("net" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Cofilin" . SPARSER::PROTEIN)
    ("essential regulatory proteins" . SPARSER::PROTEIN)
    ("cofilins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("villin 1" . SPARSER::PROTEIN) ("IGFR/mTORC1" . SPARSER::COLLECTION)
    ("inulin" . SPARSER::MOLECULE) ("hyperglycemia" . SPARSER::PROTEIN)
    ("mutant and wildtype" . SPARSER::COLLECTION)
    ("Wnt/LRP6" . SPARSER::COLLECTION) ("IGF-mTOR" . SPARSER::COLLECTION)
    ("insulin as well as growth factors" . SPARSER::COLLECTION)
    ("Raptor-mTOR" . SPARSER::COLLECTION)
    ("Wnt-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA-bending proteins ( xref ) and FOXO1" . SPARSER::COLLECTION)
    ("a pluripotent transcription factor" . SPARSER::PROTEIN)
    ("High mobility group protein HMGI (Y) and FOXO1" . SPARSER::COLLECTION)
    ("The IR and its downstream effectors" . SPARSER::COLLECTION)
    ("IGFR and SUMO-1" . SPARSER::COLLECTION)
    ("proteosomal inhibitor MG-132" . SPARSER::DRUG)
    ("IR and IGFR" . SPARSER::COLLECTION) ("tyr" . SPARSER::PROTEIN)
    ("thr" . SPARSER::PROTEIN) ("significantly higher S6K" . SPARSER::PROTEIN)
    ("PBS or Wnt-3a" . SPARSER::COLLECTION) ("HEK" . SPARSER::PROTEIN)
    ("preadipocytes" . SPARSER::PROTEIN)
    ("mRNA or protein" . SPARSER::COLLECTION)
    ("HMGA" . SPARSER::PROTEIN-FAMILY) ("HMGI" . SPARSER::PROTEIN)
    ("IRS-1 and AKT" . SPARSER::COLLECTION)
    ("IRS-1, AKT and GSK3β" . SPARSER::COLLECTION)
    ("/min" . SPARSER::COLLECTION) ("NGT" . SPARSER::PROTEIN)
    ("dl" . SPARSER::MOLECULE) ("DM" . SPARSER::PROTEIN)
    ("glucose and insulin" . SPARSER::COLLECTION)
    ("Skeletal muscle and skin biopsies" . SPARSER::COLLECTION)
    ("Skeletal muscle" . SPARSER::PROTEIN)
    ("skeletal muscle and skin fibroblast biopsies" . SPARSER::COLLECTION)
    ("LDL, and triglyceride" . SPARSER::COLLECTION)
    ("triglyceride" . SPARSER::MOLECULE) ("Insulin" . SPARSER::PROTEIN)
    ("Wnts and their downstream signaling proteins" . SPARSER::COLLECTION)
    ("Wnts" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("genes and pathways" . SPARSER::COLLECTION)
    ("a monogenic form" . SPARSER::FORM) ("TCF/LEF" . SPARSER::COLLECTION)
    ("LEF" . SPARSER::PROTEIN) ("TCF" . SPARSER::PROTEIN)
    ("the cell-surface receptor frizzled and its coreceptors LRP5/6"
     . SPARSER::COLLECTION)
    ("coreceptors" . SPARSER::PROTEIN) ("frizzled" . SPARSER::PROTEIN)
    ("Wnt/β-catenin" . SPARSER::COLLECTION)
    ("Wnt/LRP6/TCF7L2" . SPARSER::COLLECTION)
    ("insulin receptor (IR)" . SPARSER::PROTEIN)
    ("Wnt and insulin" . SPARSER::COLLECTION)
    ("skeletal muscles" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Wnt-coreceptor" . SPARSER::COLLECTION) ("coreceptor" . SPARSER::PROTEIN)
    ("s 2" . SPARSER::MOLECULE) ("wnt3a" . SPARSER::PROTEIN)
    ("RPL30" . SPARSER::PROTEIN) ("micrococcal nuclease" . SPARSER::PROTEIN)
    ("GSK-3β" . SPARSER::PROTEIN) ("Wnt-5a" . SPARSER::PROTEIN)
    ("TCF-4" . SPARSER::PROTEIN) ("m2" . SPARSER::MOLECULE)
    ("S6K1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TCF4" . SPARSER::PROTEIN)
    ("SUMO-1" . SPARSER::PROTEIN) ("S6K" . SPARSER::PROTEIN)
    ("Wnt-3a" . SPARSER::PROTEIN) ("Wnt 3a" . SPARSER::PROTEIN)
    ("HMGA1" . SPARSER::PROTEIN) ("Wnt5a" . SPARSER::PROTEIN)
    ("Wnt3a" . SPARSER::PROTEIN) ("IRS-1" . SPARSER::PROTEIN)
    ("m 2" . SPARSER::MOLECULE) ("LRP5/6" . SPARSER::PROTEIN)
    ("Wnt5B" . SPARSER::PROTEIN) ("TCF7L2" . SPARSER::PROTEIN)
    ("insulin receptor" . SPARSER::PROTEIN)
    ("type 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LRP6" . SPARSER::PROTEIN)
    ("mTOR and lysoNa" . SPARSER::COLLECTION)
    ("mTOR and the components" . SPARSER::COLLECTION)
    ("ion channels and transporters" . SPARSER::COLLECTION)
    ("transporters" . SPARSER::PROTEIN) ("endolysosome" . SPARSER::PROTEIN)
    ("TPCs and mTORC1" . SPARSER::COLLECTION)
    ("pH and amino acid" . SPARSER::COLLECTION)
    ("hypoxia and ischemia" . SPARSER::COLLECTION)
    ("Na + and other ions" . SPARSER::COLLECTION)
    ("TPC, and lysoNa" . SPARSER::COLLECTION) ("ions" . SPARSER::MOLECULE)
    ("TPC and/or its associated proteins" . SPARSER::COLLECTION)
    ("its associated proteins" . SPARSER::PROTEIN)
    ("the mutant's" . SPARSER::MUTANT)
    ("lysine and arginine" . SPARSER::COLLECTION)
    ("cations" . SPARSER::MOLECULE) ("available ATP" . SPARSER::ATP)
    ("similar voltage-sensitive proteins" . SPARSER::PROTEIN)
    ("voltage-gated ion channels and voltage-sensitive enzymes ( xref )"
     . SPARSER::COLLECTION)
    ("voltage-sensitive enzymes" . SPARSER::ENZYME)
    ("Lysosomal" . SPARSER::PROTEIN) ("NALCN" . SPARSER::PROTEIN)
    ("lysoNa" . SPARSER::PROTEIN) ("endolysosomes" . SPARSER::PROTEIN)
    ("Ren" . SPARSER::PROTEIN) ("TPC1 and/or TPC2" . SPARSER::COLLECTION)
    ("measureable lysoNa ATP" . SPARSER::ATP) ("pF" . SPARSER::PROTEIN)
    ("KO" . SPARSER::PROTEIN) ("the ATP-sensitivity ( xref )" . SPARSER::ATP)
    ("the ATP-sensitivity" . SPARSER::ATP)
    ("tpc2 or both tpc1 and tpc2" . SPARSER::COLLECTION)
    ("tpc1 , tpc2 or both tpc1 and tpc2" . SPARSER::COLLECTION)
    ("Rag" . SPARSER::PROTEIN)
    ("glucose and amino acids" . SPARSER::COLLECTION)
    ("Nutrient" . SPARSER::MOLECULE)
    ("TPC complex-associated subunits" . SPARSER::PROTEIN)
    ("LysoNa ATP 's" . SPARSER::ATP)
    ("TPC2 and the lysosome-localized proteins RagB ( xref )"
     . SPARSER::COLLECTION)
    ("V-ATPase ( xref ) or lamptors ( xref )" . SPARSER::COLLECTION)
    ("RagB" . SPARSER::PROTEIN) ("TPC1 or TPC2" . SPARSER::COLLECTION)
    ("proteins and mTOR" . SPARSER::COLLECTION)
    ("Complexes" . SPARSER::BIO-COMPLEX)
    ("mTORC1 and Rictor-containing" . SPARSER::COLLECTION)
    ("rapamycin and Torin 1" . SPARSER::COLLECTION)
    ("soluble proteins" . SPARSER::PROTEIN) ("lyosNa ATP 's" . SPARSER::ATP)
    ("MEF" . SPARSER::PROTEIN) ("dorsomorphin" . SPARSER::MOLECULE)
    ("protein kinase (AMPK)" . SPARSER::PROTEIN)
    ("lysoNa ATP and the channel" . SPARSER::COLLECTION)
    ("the nonhydrolyzable analog ATPγS" . SPARSER::PROTEIN)
    ("analog" . SPARSER::ANALOG) ("lysoNa ATP 's" . SPARSER::ATP)
    ("Organellar PIP 2" . SPARSER::PROTEIN)
    ("The ATP-sensitivity" . SPARSER::ATP) ("ATP-sensitivity" . SPARSER::ATP)
    ("ATP or ATP-Mg" . SPARSER::COLLECTION) ("TPC" . SPARSER::PROTEIN)
    ("ATP's" . SPARSER::ATP)
    ("TRPML1 (a 6-transmembrane spanning endolysosomal Na + -permeable cation channel in the TRP family) and TPC1/TPC2 proteins (endolysosomal channels of 12-transmembrane spanning proteins with similarity to that of voltage-gated Na + and Ca 2+ channels)"
     . SPARSER::COLLECTION)
    ("known ion channels, TRPML1 (a 6-transmembrane spanning endolysosomal Na + -permeable cation channel in the TRP family) and TPC1/TPC2 proteins (endolysosomal channels of 12-transmembrane spanning proteins with similarity to that of voltage-gated Na + and Ca 2+ channels)"
     . SPARSER::COLLECTION)
    ("TPC1/TPC2" . SPARSER::COLLECTION) ("TRP" . SPARSER::PROTEIN)
    ("Form" . SPARSER::FORM) ("a major cation" . SPARSER::MOLECULE)
    ("mV" . SPARSER::PROTEIN) ("run" . SPARSER::PROTEIN)
    ("glass" . SPARSER::MOLECULE)
    ("a Novel ATP-sensitive Na + -permeable Channel lysoNa ATP" . SPARSER::ATP)
    ("tpc1 and tpc2" . SPARSER::COLLECTION) ("tpc2" . SPARSER::PROTEIN)
    ("tpc1" . SPARSER::PROTEIN)
    ("two well-conserved proteins" . SPARSER::PROTEIN)
    ("adenosine triphosphate (ATP)" . SPARSER::MOLECULE)
    ("TPCs" . SPARSER::PROTEIN) ("pH" . SPARSER::PROTEIN)
    ("lysosomal" . SPARSER::PROTEIN) ("TPC1 and TPC2" . SPARSER::COLLECTION)
    ("NAADP" . SPARSER::MOLECULE) ("diC8" . SPARSER::DRUG)
    ("MgSO4" . SPARSER::DRUG) ("V-ATPase" . SPARSER::PROTEIN-FAMILY)
    ("mTORC2" . SPARSER::PROTEIN) ("Torin 1" . SPARSER::DRUG)
    ("AMPK 1" . SPARSER::PROTEIN) ("AMP-activated" . SPARSER::PROTEIN)
    ("ATPγS" . SPARSER::PROTEIN) ("PIP 2" . SPARSER::PROTEIN)
    ("voltage-gated" . SPARSER::PROTEIN) ("cation channel" . SPARSER::PROTEIN)
    ("TRPML1" . SPARSER::PROTEIN) ("K +" . SPARSER::MOLECULE)
    ("ion channel" . SPARSER::PROTEIN-FAMILY)
    ("mammalian target of rapamycin" . SPARSER::PROTEIN)
    ("ion channels" . SPARSER::PROTEIN-FAMILY) ("TPC2" . SPARSER::PROTEIN)
    ("TPC1" . SPARSER::PROTEIN) ("cues" . SPARSER::PROTEIN-FAMILY)
    ("small molecule activators or re" . SPARSER::COLLECTION)
    ("PPARs, and HIC1" . SPARSER::COLLECTION)
    ("Yet another miRNA" . SPARSER::MICRO-RNA)
    ("both Sirt1 and hypoxia-inducible factor (HIF)-1alpha"
     . SPARSER::COLLECTION)
    ("Sirt1, and miR-199a" . SPARSER::COLLECTION) ("HIF" . SPARSER::PROTEIN)
    ("palmitate" . SPARSER::PROTEIN)
    ("farnesoid X receptor (FXR)" . SPARSER::PROTEIN)
    ("FXR" . SPARSER::PROTEIN) ("nucleotides" . SPARSER::NUCLEOTIDE)
    ("RNA-recognition" . SPARSER::RNA) ("HuR" . SPARSER::PROTEIN)
    ("CtBP" . SPARSER::PROTEIN) ("PPARγ-Sirt1" . SPARSER::COLLECTION)
    ("yet another transcription factor" . SPARSER::PROTEIN)
    ("PPAR" . SPARSER::PROTEIN)
    ("Peroxisome proliferator-activated receptors" . SPARSER::PROTEIN)
    ("PPARs" . SPARSER::PROTEIN) ("Peroxisome" . SPARSER::PROTEIN)
    ("Sirt1 and FOXO1" . SPARSER::COLLECTION) ("ChREBP" . SPARSER::PROTEIN)
    ("CREB" . SPARSER::PROTEIN) ("derivative" . SPARSER::DERIVATIVE)
    ("splitomicin" . SPARSER::DRUG)
    ("yet another family" . SPARSER::PROTEIN-FAMILY)
    ("Splitomicin" . SPARSER::DRUG) ("resveratrol-Sirt1" . SPARSER::COLLECTION)
    ("a powerful antioxidant" . SPARSER::PROTEIN)
    ("Resveratrol" . SPARSER::PROTEIN) ("resveratrol" . SPARSER::PROTEIN)
    ("Sirt1 and DBC1" . SPARSER::COLLECTION)
    ("DBC1-Sirt1" . SPARSER::COLLECTION) ("ESA" . SPARSER::PROTEIN)
    ("DBC1" . SPARSER::PROTEIN) ("AROS" . SPARSER::PROTEIN)
    ("SNO-GAPDH" . SPARSER::COLLECTION) ("SNO" . SPARSER::PROTEIN)
    ("thiol" . SPARSER::MOLECULE) ("SENP" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("protease (SENP)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("sentrin" . SPARSER::PROTEIN) ("SUMO" . SPARSER::PROTEIN)
    ("Sirt1-p53" . SPARSER::COLLECTION) ("Sirt1-Set7/9" . SPARSER::COLLECTION)
    ("Sirt1 and Set7/9" . SPARSER::COLLECTION)
    ("Setd7 or Set7/9" . SPARSER::COLLECTION) ("Set7/9" . SPARSER::PROTEIN)
    ("lysine or arginine" . SPARSER::COLLECTION)
    ("the intrinsic deacetylase activity" . SPARSER::PROTEIN)
    ("cAMP/PKA" . SPARSER::COLLECTION) ("p53 and p65" . SPARSER::COLLECTION)
    ("Kappa" . SPARSER::PROTEIN-FAMILY)
    ("Casein" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Two pro-survival dual specificity tyrosine phosphorylation-regulated kinases"
     . SPARSER::KINASE)
    ("DYRK1A and DYRK3" . SPARSER::COLLECTION) ("DYRKs" . SPARSER::PROTEIN)
    ("JNK1-Sirt1" . SPARSER::COLLECTION) ("JUN" . SPARSER::PROTEIN)
    ("enzymes, and Sirt1" . SPARSER::COLLECTION)
    ("an essential substrate" . SPARSER::SUBSTRATE)
    ("the multifunctional enzyme" . SPARSER::ENZYME)
    ("NAD" . SPARSER::MOLECULE)
    ("the most ubiquitous PARPs" . SPARSER::MOLECULE)
    ("Parp1 or Parp2" . SPARSER::COLLECTION) ("Parp2" . SPARSER::PROTEIN)
    ("Parp1" . SPARSER::PROTEIN) ("Parp" . SPARSER::PROTEIN)
    ("polymerases, or PARPs" . SPARSER::COLLECTION)
    ("PARPs" . SPARSER::MOLECULE) ("mononucleotide" . SPARSER::MOLECULE)
    ("NAD + and activity of Sirt1" . SPARSER::COLLECTION)
    ("Nampt" . SPARSER::PROTEIN) ("cellular NAD +" . SPARSER::MOLECULE)
    ("tryptophan" . SPARSER::AMINO-ACID) ("electrons" . SPARSER::MOLECULE)
    ("Acetyl" . SPARSER::MOLECULE) ("proteins and NAD +" . SPARSER::COLLECTION)
    ("RNA binding" . SPARSER::PROTEIN)
    ("farnesoid X receptor" . SPARSER::PROTEIN) ("miR-34a" . SPARSER::MOLECULE)
    ("Chk2" . SPARSER::PROTEIN) ("HIC1" . SPARSER::PROTEIN)
    ("PPARγ" . SPARSER::PROTEIN) ("PPARβ" . SPARSER::PROTEIN)
    ("PPARα" . SPARSER::PROTEIN) ("FOXO3A" . SPARSER::PROTEIN)
    ("response elements" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("response element" . SPARSER::DNA-RESPONSE-ELEMENT)
    ("protein kinase A" . SPARSER::PROTEIN) ("EX-527" . SPARSER::DRUG)
    ("FOXO3" . SPARSER::PROTEIN) ("forkhead box O1" . SPARSER::PROTEIN)
    ("peroxisome proliferator-activated receptor gamma coactivator 1-alpha"
     . SPARSER::PROTEIN)
    ("glyceraldehyde-3-phosphate dehydrogenase" . SPARSER::PROTEIN)
    ("Set7" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Setd7" . SPARSER::PROTEIN)
    ("SET domain" . SPARSER::PROTEIN) ("Protein kinase A" . SPARSER::PROTEIN)
    ("NFκB" . SPARSER::PROTEIN) ("DYRK3" . SPARSER::PROTEIN)
    ("DYRK1A" . SPARSER::PROTEIN) ("deacetylase activity" . SPARSER::PROTEIN)
    ("JNK1" . SPARSER::PROTEIN) ("CD38" . SPARSER::PROTEIN)
    ("nicotinamide phosphoribosyltransferase" . SPARSER::PROTEIN)
    ("biologically relevant genes" . SPARSER::GENE)
    ("critical cytoskeleton-associated membrane-bound molecular scaffolds"
     . SPARSER::SCAFFOLD)
    ("scaffolds" . SPARSER::SCAFFOLD) ("dystrophin" . SPARSER::PROTEIN)
    ("UTRN" . SPARSER::PROTEIN) ("a retinal protein" . SPARSER::PROTEIN)
    ("both the retinal and renal vasculature" . SPARSER::PROTEIN)
    ("von Hippel Lindau Disease and Sturge-Weber-Krabble"
     . SPARSER::COLLECTION)
    ("these smaller cohorts" . SPARSER::MOLECULE)
    ("gene ( HDAC9 ) gene" . SPARSER::PROTEIN) ("Case" . SPARSER::PROTEIN)
    ("albumin/creatinine" . SPARSER::COLLECTION)
    ("creatinine" . SPARSER::PROTEIN) ("albumin" . SPARSER::PROTEIN)
    ("SNP and rs12374816" . SPARSER::COLLECTION) ("MAF " . SPARSER::PROTEIN)
    ("MESA and ARIC" . SPARSER::COLLECTION) ("LD" . SPARSER::PROTEIN)
    ("RS" . SPARSER::PROTEIN) ("MESA and BMES" . SPARSER::COLLECTION)
    ("MESA" . SPARSER::PROTEIN) ("Figures S5 and S6" . SPARSER::COLLECTION)
    ("six community-based cohorts" . SPARSER::MOLECULE)
    ("vascular smooth muscle" . SPARSER::PROTEIN)
    ("the blood–retinal barrier" . SPARSER::PROTEIN)
    ("smooth muscle" . SPARSER::PROTEIN) ("dot-blot" . SPARSER::PROTEIN)
    ("peripapillary chorioretinal degeneration" . SPARSER::PROTEIN)
    ("TEAD1" . SPARSER::PROTEIN) ("promyelocytic leukemia" . SPARSER::PROTEIN)
    ("RD3" . SPARSER::PROTEIN) ("von Hippel Lindau Disease" . SPARSER::PROTEIN)
    ("(beta " . SPARSER::PROTEIN) ("S2" . SPARSER::MOLECULE)
    ("HDAC9" . SPARSER::PROTEIN) ("histone deacetylase 9" . SPARSER::PROTEIN)
    ("NAR" . SPARSER::PROTEIN) ("hydroxyurea" . SPARSER::DRUG)
    ("PARI" . SPARSER::PROTEIN) ("FANCJ" . SPARSER::PROTEIN)
    ("pro- and anti-recombinase" . SPARSER::COLLECTION)
    ("pro-" . SPARSER::PROTEIN) ("Fbh1" . SPARSER::PROTEIN)
    ("the fluorescent substrate" . SPARSER::SUBSTRATE)
    ("Ub-FBH1" . SPARSER::COLLECTION) ("FBH1 and non-Ub" . SPARSER::COLLECTION)
    ("Only FBH1 molecules" . SPARSER::MOLECULE) ("TUBE2" . SPARSER::PROTEIN)
    ("reagent" . SPARSER::MOLECULE) ("TAMRA" . SPARSER::MOLECULE)
    ("TMR-TUBE2" . SPARSER::COLLECTION) ("TUBE" . SPARSER::PROTEIN)
    ("TMR" . SPARSER::PROTEIN) ("ligases" . SPARSER::LIGASE)
    ("Ub and non-Ub" . SPARSER::COLLECTION) ("Ub" . SPARSER::PROTEIN)
    ("bek" . SPARSER::PROTEIN) ("ON" . SPARSER::PROTEIN)
    ("Ca 2+ and ATP" . SPARSER::COLLECTION)
    ("FBH1–RAD51" . SPARSER::COLLECTION) ("NTA" . SPARSER::MOLECULE)
    ("NTD" . SPARSER::PROTEIN) ("PD1 and RFL" . SPARSER::COLLECTION)
    ("t" . SPARSER::PROTEIN) ("RFL" . SPARSER::PROTEIN)
    ("bio" . SPARSER::PROTEIN) ("dT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FBH1–bio" . SPARSER::COLLECTION)
    ("its DNA-dependent ATPase and duplex DNA" . SPARSER::COLLECTION)
    ("BAP" . SPARSER::PROTEIN) ("BirA" . SPARSER::PROTEIN)
    ("FBH1 and RAD51" . SPARSER::COLLECTION)
    ("Cul1 and Roc1 components" . SPARSER::COLLECTION)
    ("the Skp1, Cul1 and Roc1 components" . SPARSER::COLLECTION)
    ("helicases and helicase-like" . SPARSER::COLLECTION)
    ("DNA and separation" . SPARSER::COLLECTION)
    ("Pro- and anti-recombinogenic" . SPARSER::COLLECTION)
    ("Pro-" . SPARSER::AMINO-ACID) ("an anti-recombinase" . SPARSER::ANTIBODY)
    ("filament" . SPARSER::PROTEIN-FAMILY) ("nucleoprotein" . SPARSER::PROTEIN)
    ("RTEL1" . SPARSER::PROTEIN) ("DNA repair protein" . SPARSER::PROTEIN)
    ("RAD51 recombinase" . SPARSER::PROTEIN) ("PD1" . SPARSER::PROTEIN)
    ("Mg 2+" . SPARSER::MOLECULE) ("d -glucose" . SPARSER::MOLECULE)
    ("glucose oxidase" . SPARSER::PROTEIN)
    ("nicotinamide adenine dinucleotide" . SPARSER::MOLECULE)
    ("Mono-Q" . SPARSER::DRUG) ("d -1" . SPARSER::PROTEIN)
    ("phenylmethanesulfonyl fluoride" . SPARSER::MOLECULE)
    ("Tween20" . SPARSER::MOLECULE) ("Cul1" . SPARSER::PROTEIN)
    ("Skp1" . SPARSER::PROTEIN) ("SF1" . SPARSER::PROTEIN)
    ("adenosine triphosphate" . SPARSER::MOLECULE) ("Srs2" . SPARSER::PROTEIN)
    ("FBH1" . SPARSER::PROTEIN) ("BRG1 and Sox10" . SPARSER::COLLECTION)
    ("YY1, NFAT and NF-κB" . SPARSER::COLLECTION)
    ("YY1 ( xref ) and NFAT ( xref )" . SPARSER::COLLECTION)
    ("NFAT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("both NF-κB ( xref ) as well as BRG1 ATPase activity ( xref )"
     . SPARSER::COLLECTION)
    ("the axonal ligand neuregulin1 (NRG1) type III"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the transcription factor NF-κB and the chromatin" . SPARSER::COLLECTION)
    ("CREST" . SPARSER::PROTEIN) ("REST" . SPARSER::PROTEIN)
    ("NRSF" . SPARSER::PROTEIN) ("factors and chromatin" . SPARSER::COLLECTION)
    ("BRG1, MyoD and MEF2" . SPARSER::COLLECTION)
    ("myogenin" . SPARSER::PROTEIN) ("skeletal muscle" . SPARSER::PROTEIN)
    ("Cdk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("nodal" . SPARSER::PROTEIN)
    ("the axonal signal neuregulin1 type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("acetyltransferases (HAT)" . SPARSER::PROTEIN)
    ("histones and DNA" . SPARSER::COLLECTION) ("HAT" . SPARSER::PROTEIN)
    ("acetyltransferases" . SPARSER::PROTEIN) ("Rat" . SPARSER::PROTEIN)
    ("SN" . SPARSER::PROTEIN) ("type III and ATP" . SPARSER::COLLECTION)
    ("p65 and BRG1" . SPARSER::COLLECTION)
    ("BRG1 or p65" . SPARSER::COLLECTION)
    ("BRG1 and p65" . SPARSER::COLLECTION) ("neuregulin" . SPARSER::PROTEIN)
    ("NF-κB and increases BRG1 ATPase activity" . SPARSER::COLLECTION)
    ("ChIP both the p65 subunit" . SPARSER::FRAGMENT)
    ("both BRG1 and the p65 subunit" . SPARSER::COLLECTION)
    ("NF-κB and BRG1" . SPARSER::COLLECTION)
    ("an active DNA-binding complex" . SPARSER::BIO-COMPLEX)
    ("BRG1 and the p65 subunit" . SPARSER::COLLECTION)
    ("BRM-NF-κB" . SPARSER::COLLECTION) ("NF-κB-BRG1" . SPARSER::COLLECTION)
    ("BRG1-NF-κB" . SPARSER::COLLECTION) ("DRG" . SPARSER::PROTEIN)
    ("The anti-BRG1" . SPARSER::ANTIBODY)
    ("BRG1 and NF-κB" . SPARSER::COLLECTION)
    ("EGR2/Krox20" . SPARSER::COLLECTION)
    ("either control heterozygous mutants" . SPARSER::MUTANT)
    ("Dhh" . SPARSER::PROTEIN) ("food" . SPARSER::MOLECULE)
    ("ataxia and hindlimb" . SPARSER::COLLECTION)
    ("Dhh-Cre" . SPARSER::COLLECTION) ("flox/flox" . SPARSER::COLLECTION)
    ("Brg1" . SPARSER::PROTEIN) ("cko" . SPARSER::PROTEIN)
    ("flox" . SPARSER::PROTEIN) ("recombinase" . SPARSER::PROTEIN)
    ("CRE" . SPARSER::PROTEIN) ("myelinating rat" . SPARSER::PROTEIN)
    ("p65/RelA" . SPARSER::COLLECTION) ("RelA" . SPARSER::PROTEIN)
    ("dimer" . SPARSER::DIMER) ("BRM and BRG1" . SPARSER::COLLECTION)
    ("MyoD and MEF2" . SPARSER::COLLECTION) ("MyoD" . SPARSER::PROTEIN)
    ("the highly homologous BRG1 or BRM ATPases" . SPARSER::PROTEIN)
    ("BRG1 or BRM" . SPARSER::COLLECTION) ("ATPases" . SPARSER::PROTEIN)
    ("BRM" . SPARSER::PROTEIN)
    ("chromatin associated factors and transcription regulators ( xref ; xref )"
     . SPARSER::COLLECTION)
    ("chromatin associated factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("NF-κB and both proteins" . SPARSER::COLLECTION)
    ("the central helicase" . SPARSER::PROTEIN)
    ("BRG1/SMARCA4" . SPARSER::COLLECTION) ("myelin" . SPARSER::PROTEIN)
    ("YY1" . SPARSER::PROTEIN) ("Ca2+" . SPARSER::CALCIUM-ION)
    ("Caspase 3" . SPARSER::PROTEIN)
    ("cyclin dependent kinase inhibitor p27" . SPARSER::PROTEIN)
    ("HDAC 1" . SPARSER::PROTEIN) ("Neuregulin 1" . SPARSER::PROTEIN)
    ("EGR2" . SPARSER::PROTEIN) ("P11" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("desert hedgehog" . SPARSER::PROTEIN) ("ATP dependent" . SPARSER::PROTEIN)
    ("Topro3" . SPARSER::MOLECULE) ("P5" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-Mercaptoethanol" . SPARSER::MOLECULE) ("N2" . SPARSER::PROTEIN)
    ("NRG 1" . SPARSER::PROTEIN) ("Caspase3" . SPARSER::PROTEIN)
    ("Krox20" . SPARSER::PROTEIN) ("Sox2" . SPARSER::PROTEIN)
    ("chromatin remodeling factor" . SPARSER::PROTEIN)
    ("POU domain" . SPARSER::PROTEIN) ("Oct6" . SPARSER::PROTEIN)
    ("MEF2" . SPARSER::PROTEIN)
    ("transcriptional regulators" . SPARSER::PROTEIN-FAMILY)
    ("Sox10" . SPARSER::PROTEIN) ("type III" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("neuregulin1" . SPARSER::PROTEIN) ("BRAF/NRAS" . SPARSER::COLLECTION)
    ("lip" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a pigmentary component" . SPARSER::COMPONENT)
    ("RAS/RAF/MEK/ERK" . SPARSER::COLLECTION)
    ("EGFP-NRAS" . SPARSER::COLLECTION) ("EGFP" . SPARSER::PROTEIN)
    ("inactive (guanosine diphosphate bound) and active (guanosine triphosphate bound)"
     . SPARSER::COLLECTION)
    ("RAF and phosphatidylinositol 3-kinase" . SPARSER::COLLECTION)
    ("RAF/MEK/ERK" . SPARSER::COLLECTION) ("post-mortem" . SPARSER::COLLECTION)
    ("c" . SPARSER::PROTEIN) ("NRAS , BRAF , and Tp53" . SPARSER::COLLECTION)
    ("–3 " . SPARSER::PROTEIN) ("ml −1" . SPARSER::PROTEIN)
    ("chr1" . SPARSER::PROTEIN) ("guanosine triphosphate" . SPARSER::MOLECULE)
    ("loss of heterozygosity" . SPARSER::PROTEIN)
    ("RAS family" . SPARSER::PROTEIN)
    ("melanocortin 1 receptor" . SPARSER::PROTEIN)
    ("Loss of heterozygosity" . SPARSER::PROTEIN) ("Tp53" . SPARSER::PROTEIN)
    ("Qin" . SPARSER::PROTEIN) ("chelators" . SPARSER::MOLECULE)
    ("p53 conformational state" . SPARSER::BIO-STATE)
    ("methylcholanthrene" . SPARSER::MOLECULE) ("NADH" . SPARSER::MOLECULE)
    ("pro-apoptotic gene" . SPARSER::GENE)
    ("familiar and sporadic AD" . SPARSER::PROTEIN) ("SIN" . SPARSER::PROTEIN)
    ("Tyrosine" . SPARSER::AMINO-ACID)
    ("two-specific conformational antibodies" . SPARSER::ANTIBODY)
    ("only neurite elongation" . SPARSER::PROTEIN)
    ("wild-type p53 conformation and pro-apoptotic activity"
     . SPARSER::COLLECTION)
    ("pif" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Retinoic" . SPARSER::PROTEIN)
    ("a weak GAP-43" . SPARSER::PROTEIN) ("pifithrin-" . SPARSER::DRUG)
    ("Pif" . SPARSER::HUMAN-PROTEIN-FAMILY) ("pifithrin" . SPARSER::DRUG)
    ("β -III tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p53 unfolded conformation" . SPARSER::BIO-CONFORMATION)
    ("H 2 O 2 and doxorubicin" . SPARSER::COLLECTION)
    ("p53AIP1-luciferase" . SPARSER::COLLECTION)
    ("the corresponding p53 conformational isoforms" . SPARSER::ISOFORM)
    ("HNE-p53" . SPARSER::COLLECTION)
    ("anti-HNE or anti-3NT" . SPARSER::COLLECTION)
    ("cryptic" . SPARSER::PROTEIN) ("PAb" . SPARSER::PROTEIN)
    ("nitrated" . SPARSER::MOLECULE) ("peroxynitrite" . SPARSER::MOLECULE)
    ("NT" . SPARSER::PROTEIN) ("nitrotyrosine" . SPARSER::MOLECULE)
    ("HNE" . SPARSER::PROTEIN)
    ("finally smear bands around 15-8 kDa" . SPARSER::PROTEIN)
    ("immature protein" . SPARSER::PROTEIN)
    ("CTFs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AD" . SPARSER::PROTEIN)
    ("ischemia" . SPARSER::PROTEIN)
    ("a pleiotropic protein" . SPARSER::PROTEIN)
    ("amyloid precursor protein (APP) and its metabolites"
     . SPARSER::COLLECTION)
    ("metabolites" . SPARSER::PROTEIN) ("APP" . SPARSER::PROTEIN)
    ("SH-SY5Y" . SPARSER::PROTEIN) ("housekeeping gene" . SPARSER::PROTEIN)
    ("AIP1" . SPARSER::PROTEIN) ("G-3" . SPARSER::PROTEIN)
    ("TWEEN 20" . SPARSER::MOLECULE) ("anti- β" . SPARSER::PROTEIN)
    ("and 1 " . SPARSER::PROTEIN) ("dimethyl sulfoxide" . SPARSER::MOLECULE)
    ("for 3 " . SPARSER::PROTEIN)
    ("3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide"
     . SPARSER::MOLECULE)
    ("NQO1" . SPARSER::PROTEIN) ("quinone oxidoreductase" . SPARSER::PROTEIN)
    ("pro-oxidant" . SPARSER::MOLECULE) ("retinoic acid" . SPARSER::MOLECULE)
    ("p53AIP1" . SPARSER::PROTEIN) ("H 2 O 2" . SPARSER::DRUG)
    ("C11" . SPARSER::PROTEIN) ("PS1" . SPARSER::PROTEIN)
    ("GAP-43" . SPARSER::PROTEIN)
    ("growth-associated protein 43" . SPARSER::PROTEIN)
    ("β -amyloid" . SPARSER::MOLECULE)
    ("amyloid precursor protein" . SPARSER::PROTEIN)
    ("MSH2 and MSH3" . SPARSER::COLLECTION) ("DNA-damage" . SPARSER::DNA)
    ("proteins and chromatin" . SPARSER::COLLECTION)
    ("dynamic duo" . SPARSER::PROTEIN) ("duo" . SPARSER::PROTEIN)
    ("Pms2" . SPARSER::PROTEIN) ("cause mutational TNR" . SPARSER::PROTEIN)
    ("Pathogenic TNR" . SPARSER::PROTEIN) ("TNR" . SPARSER::PROTEIN)
    ("Ku70, and MutLα" . SPARSER::COLLECTION)
    ("DNA-PK-cs" . SPARSER::PROTEIN-PAIR)
    ("UNG, APE1 and MMR" . SPARSER::COLLECTION)
    ("AID and MMR" . SPARSER::COLLECTION) ("CSR" . SPARSER::PROTEIN)
    ("IG" . SPARSER::MOLECULE) ("MSH2, and MutSα" . SPARSER::COLLECTION)
    ("Pol" . SPARSER::PROTEIN) ("UNG" . SPARSER::PROTEIN)
    ("uracil" . SPARSER::NUCLEOBASE) ("dC" . SPARSER::MOLECULE)
    ("deoxycytosine" . SPARSER::MOLECULE) ("AID" . SPARSER::PROTEIN)
    ("each new antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SHM" . SPARSER::DRUG) ("Ig" . SPARSER::MOLECULE)
    ("MSH2 and MLH1" . SPARSER::COLLECTION)
    ("FANCD2, and MMR" . SPARSER::COLLECTION) ("FA-BRCA" . SPARSER::COLLECTION)
    ("MMR or DNA" . SPARSER::COLLECTION) ("ERCC1-XPF" . SPARSER::COLLECTION)
    ("XPF" . SPARSER::PROTEIN) ("ICL" . SPARSER::PROTEIN)
    ("psoralen" . SPARSER::DRUG) ("melphalan" . SPARSER::DRUG)
    ("cisplatinum" . SPARSER::DRUG) ("mustards" . SPARSER::DRUG)
    ("BCNU" . SPARSER::DRUG) ("Bis" . SPARSER::PROTEIN)
    ("complex (BASC)" . SPARSER::BIO-COMPLEX)
    ("BLM and MSH6" . SPARSER::COLLECTION) ("RecQ" . SPARSER::PROTEIN)
    ("BS" . SPARSER::PROTEIN)
    ("the Bloom syndrome helicase (BLM) and MSH6" . SPARSER::COLLECTION)
    ("helicase (BLM)" . SPARSER::PROTEIN) ("BLM" . SPARSER::PROTEIN)
    ("helicase" . SPARSER::PROTEIN) ("Ku70-MSH6" . SPARSER::COLLECTION)
    ("neocarzinostatin" . SPARSER::PROTEIN) ("intact MMR" . SPARSER::PROTEIN)
    ("O 6 meG or deficient MMR" . SPARSER::COLLECTION)
    ("Xrcc2, Brca2, or rad51d" . SPARSER::COLLECTION)
    ("rad51d" . SPARSER::PROTEIN) ("Brca2" . SPARSER::PROTEIN)
    ("temozolomide (TMZ)" . SPARSER::DRUG) ("TMZ" . SPARSER::DRUG)
    ("temozolomide" . SPARSER::DRUG) ("MMR and HR" . SPARSER::COLLECTION)
    ("Inappropriate base" . SPARSER::PROTEIN)
    ("Mre11/Rad50/Nbs1" . SPARSER::COLLECTION)
    ("MMR And DNA" . SPARSER::COLLECTION) ("ATR-Chk1" . SPARSER::COLLECTION)
    ("MSH6, MSH2, and MSH3" . SPARSER::COLLECTION)
    ("RPA and the Rad9-Rad1-Hus1 (9-1-1) complex" . SPARSER::COLLECTION)
    ("MSH2 and ATR" . SPARSER::COLLECTION)
    ("monofunctional alkylators" . SPARSER::MOLECULE)
    ("thymine" . SPARSER::MOLECULE) ("MMR and MGMT" . SPARSER::COLLECTION)
    ("proficient MMR" . SPARSER::PROTEIN) ("guanine" . SPARSER::PROTEIN)
    ("methyltransferase (MGMT)" . SPARSER::PROTEIN) ("MGMT" . SPARSER::PROTEIN)
    ("methylguanine" . SPARSER::MOLECULE)
    ("other monofunctional alkylators" . SPARSER::MOLECULE)
    ("alkylators" . SPARSER::MOLECULE) ("MSH6 and MYH" . SPARSER::COLLECTION)
    ("hMYH" . SPARSER::PROTEIN) ("MYH and MutSα" . SPARSER::COLLECTION)
    ("MYH" . SPARSER::PROTEIN) ("MutY" . SPARSER::PROTEIN)
    ("epoxide, and cisplatin" . SPARSER::COLLECTION)
    ("epoxide" . SPARSER::MOLECULE) ("phenanthrene" . SPARSER::DRUG)
    ("pyrimidines" . SPARSER::DRUG) ("pyrimidine" . SPARSER::DRUG)
    ("MSH6 and MSH2" . SPARSER::COLLECTION)
    ("ubiquitin-proteosome" . SPARSER::PROTEIN-PAIR)
    ("E2F1 and E2F3" . SPARSER::COLLECTION) ("SP1" . SPARSER::PROTEIN)
    ("Mismatch" . SPARSER::PROTEIN)
    ("chemicals or nutrient" . SPARSER::COLLECTION)
    ("nutrient" . SPARSER::MOLECULE)
    ("MSH6 and the other key MMR proteins (MSH2, MLH1, MSH3, PMS2)"
     . SPARSER::COLLECTION)
    ("MMR and DNA" . SPARSER::COLLECTION) ("PKC and CK2" . SPARSER::COLLECTION)
    ("this fragile molecule" . SPARSER::MOLECULE)
    ("exogenous hMSH6" . SPARSER::PROTEIN) ("ATM/ATR" . SPARSER::COLLECTION)
    ("CK2, CDK, MAPK, and Aurora" . SPARSER::COLLECTION)
    ("Aurora" . SPARSER::PROTEIN) ("Msh2 and Msh6" . SPARSER::COLLECTION)
    ("importin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("This alternate SPS nuclear" . SPARSER::PROTEIN)
    ("pSPS" . SPARSER::PROTEIN) ("Ser-Pro-Ser" . SPARSER::COLLECTION)
    ("MSH6 And Mutsα" . SPARSER::COLLECTION)
    ("Msh6 and Msh3" . SPARSER::COLLECTION) ("Msh3" . SPARSER::PROTEIN)
    ("p21 Cip1/WAF1" . SPARSER::COLLECTION)
    ("foci, and MMR" . SPARSER::COLLECTION)
    ("the subsequent MMR proteins" . SPARSER::PROTEIN)
    ("aid" . SPARSER::PROTEIN) ("Msh6 and PCNA" . SPARSER::COLLECTION)
    ("PCNA and MSH6" . SPARSER::COLLECTION)
    ("PCNA and hMutSα" . SPARSER::COLLECTION) ("SAX" . SPARSER::PROTEIN)
    ("-PCNA" . SPARSER::COLLECTION)
    ("both hMSH6 (aa 4–11) and hMSH3 (aa 21–28)" . SPARSER::COLLECTION)
    ("MSH6 And PCNA" . SPARSER::COLLECTION)
    ("p53 and the Cdk2 kinase inhibitor p21" . SPARSER::COLLECTION)
    ("almost exclusively studied using synthetic duplex DNA" . SPARSER::DNA)
    ("chromatin and chromatin-associated proteins" . SPARSER::COLLECTION)
    ("chromatin-associated proteins" . SPARSER::PROTEIN)
    ("HMG" . SPARSER::PROTEIN) ("duplex DNA" . SPARSER::DNA)
    ("MSH6 and HMGB1" . SPARSER::COLLECTION)
    ("nucleosome loading and chromosome compaction" . SPARSER::COLLECTION)
    ("efficient MMR" . SPARSER::PROTEIN) ("PIP" . SPARSER::PROTEIN)
    ("basic amino acids" . SPARSER::AMINO-ACID)
    ("MSH6 And Chromatin" . SPARSER::COLLECTION)
    ("MSH6-MSH2" . SPARSER::COLLECTION) ("mutated alleles" . SPARSER::ALLELE)
    ("Msh2 or Msh6" . SPARSER::COLLECTION)
    ("The ternary MutSα •MutLα •heterduplex DNA complex"
     . SPARSER::BIO-COMPLEX)
    ("hMSH2 and hMSH6" . SPARSER::COLLECTION)
    ("intrinsic ATPase activity" . SPARSER::PROTEIN) ("ABC" . SPARSER::PROTEIN)
    ("ADP and MSH6" . SPARSER::COLLECTION)
    ("only one molecule" . SPARSER::MOLECULE)
    ("MutL and ATP" . SPARSER::COLLECTION)
    ("the MutSα -MutLα ternary complex" . SPARSER::BIO-COMPLEX)
    ("-MutLα" . SPARSER::COLLECTION) ("DNase" . SPARSER::PROTEIN)
    ("cisplatin" . SPARSER::DRUG) ("MutS and MSH6" . SPARSER::COLLECTION)
    ("eukaryotic MSH6" . SPARSER::PROTEIN)
    ("MSH2 or MSH3" . SPARSER::COLLECTION)
    ("Full length MSH2 and a major fragment" . SPARSER::COLLECTION)
    ("oligomer" . SPARSER::MOLECULE) ("clamp" . SPARSER::PROTEIN)
    ("the bacterial MutS complex" . SPARSER::BIO-COMPLEX)
    ("essential for 3" . SPARSER::PROTEIN)
    ("mismatch, PCNA, RFC and DNA polymerase" . SPARSER::COLLECTION)
    ("MutLα, PCNA and RFC" . SPARSER::COLLECTION) ("nick" . SPARSER::PROTEIN)
    ("RFC" . SPARSER::PROTEIN) ("larger IDLs" . SPARSER::MOLECULE)
    ("IDLs" . SPARSER::MOLECULE) ("available hMSH2" . SPARSER::PROTEIN)
    ("the petite arm" . SPARSER::PROTEIN) ("Protein (GTBP)" . SPARSER::PROTEIN)
    ("MSH2 and MSH6" . SPARSER::COLLECTION)
    ("The eukaryotic MutSα complex" . SPARSER::BIO-COMPLEX)
    ("an equivalent sequence-specific MutH endonuclease" . SPARSER::PROTEIN)
    ("endonuclease" . SPARSER::PROTEIN) ("adenines" . SPARSER::NUCLEOBASE)
    ("a unique MMR protein" . SPARSER::PROTEIN)
    ("Bacterial MMR" . SPARSER::PROTEIN) ("GATC" . SPARSER::PROTEIN)
    ("yet distinct protein subunits, MutSα (MSH2+MSH6), MutSα (MSH2+MSH3) and MutLα (MLH1+PMS2)"
     . SPARSER::COLLECTION)
    ("eukaryotic homologues" . SPARSER::PROTEIN)
    ("homodimeric proteins" . SPARSER::PROTEIN)
    ("bacterial and eukaryotic MMR" . SPARSER::PROTEIN)
    ("Homologous human genes" . SPARSER::GENE)
    ("MSH2 , MSH6 , MSH3 , MLH1 and PMS2" . SPARSER::COLLECTION)
    ("MLH1" . SPARSER::PROTEIN) ("omologous genes" . SPARSER::GENE)
    ("mlh3" . SPARSER::PROTEIN) ("ut" . SPARSER::PROTEIN-FAMILY)
    ("bacterial MutS and MutL proteins" . SPARSER::PROTEIN)
    ("Several eukaryotic homologues" . SPARSER::PROTEIN)
    ("MutS and MutL" . SPARSER::COLLECTION)
    ("The essential proteins" . SPARSER::PROTEIN)
    ("eukaryotic MMR" . SPARSER::PROTEIN)
    ("this unique protein" . SPARSER::PROTEIN) ("meG" . SPARSER::PROTEIN)
    ("hMLH1 and hPMS2" . SPARSER::COLLECTION) ("GTBP" . SPARSER::PROTEIN)
    ("bacterial MutL" . SPARSER::PROTEIN)
    ("the mid 1990s yeast and human homologues" . SPARSER::PROTEIN)
    ("HNPCC" . SPARSER::PROTEIN) ("MutS" . SPARSER::PROTEIN)
    ("MutL" . SPARSER::PROTEIN) ("homologues" . SPARSER::PROTEIN)
    ("DNA-PK" . SPARSER::PROTEIN) ("APE1" . SPARSER::PROTEIN)
    ("ERCC1" . SPARSER::PROTEIN) ("Ku70" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("rad51" . SPARSER::PROTEIN) ("Xrcc2" . SPARSER::PROTEIN)
    ("G 2 /M" . SPARSER::PROTEIN) ("Nbs1" . SPARSER::PROTEIN)
    ("Rad50" . SPARSER::PROTEIN) ("Mre11" . SPARSER::PROTEIN)
    ("Chk1" . SPARSER::PROTEIN) ("Rad9" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("9-1-1 complex" . SPARSER::|9-1-1|) ("Rad9-Rad1-Hus1" . SPARSER::PROTEIN)
    ("E2F7" . SPARSER::PROTEIN) ("PO 4" . SPARSER::PROTEIN)
    ("CK2" . SPARSER::PROTEIN) ("WAF1" . SPARSER::PROTEIN)
    ("hMSH3" . SPARSER::PROTEIN) ("Cdk2" . SPARSER::PROTEIN)
    ("Nhp6" . SPARSER::PROTEIN) ("CAF-1" . SPARSER::PROTEIN)
    ("histone 3" . SPARSER::PROTEIN) ("msh6" . SPARSER::PROTEIN)
    ("Msh2" . SPARSER::PROTEIN) ("ATPase activity" . SPARSER::PROTEIN)
    ("Msh6" . SPARSER::PROTEIN) ("Amino acids" . SPARSER::AMINO-ACID)
    ("Domain 1" . SPARSER::PROTEIN) ("HMGB1" . SPARSER::PROTEIN)
    ("DNA binding protein" . SPARSER::PROTEIN) ("EXO1" . SPARSER::PROTEIN)
    ("endonuclease activity" . SPARSER::PROTEIN) ("MutLα" . SPARSER::PROTEIN)
    ("PMS2" . SPARSER::PROTEIN) ("MSH3" . SPARSER::PROTEIN)
    ("pms1" . SPARSER::PROTEIN) ("msh 6" . SPARSER::PROTEIN)
    ("MSH2" . SPARSER::PROTEIN) ("MSH6" . SPARSER::PROTEIN)
    ("hPMS2" . SPARSER::PROTEIN) ("hMLH1" . SPARSER::PROTEIN)
    ("hMSH2" . SPARSER::PROTEIN) ("hMSH6" . SPARSER::PROTEIN)
    ("a microRNA's" . SPARSER::MICRO-RNA)
    ("MDM2 and PTEN" . SPARSER::COLLECTION) ("carmustine" . SPARSER::DRUG)
    ("HIF-1α and VEGF" . SPARSER::COLLECTION)
    ("PTEN/PI3K/AKT" . SPARSER::COLLECTION)
    ("PTEN and MDM2" . SPARSER::COLLECTION) ("normoxia" . SPARSER::PROTEIN)
    ("a key transcription factor" . SPARSER::PROTEIN)
    ("bevacizumab" . SPARSER::DRUG)
    ("Docetaxel, Carmustine and Temozolomide" . SPARSER::COLLECTION)
    ("Carmustine" . SPARSER::DRUG) ("agarose" . SPARSER::MOLECULE)
    ("EGF and FGF" . SPARSER::COLLECTION) ("FGF" . SPARSER::PROTEIN)
    ("Fragments" . SPARSER::FRAGMENT) ("PTEN/HIF-1α" . SPARSER::COLLECTION)
    ("Docetaxel" . SPARSER::DRUG) ("PTEN-HIF-1α-VEGF" . SPARSER::COLLECTION)
    ("HIF-1α and vascular endothelial growth factor" . SPARSER::COLLECTION)
    ("the chemotherapeutic Temozolomide" . SPARSER::DRUG)
    ("Temozolomide" . SPARSER::DRUG) ("U87 and U343" . SPARSER::COLLECTION)
    ("Von Hippel-Lindau (VHL) and phosphatase and tensin homolog (PTEN)"
     . SPARSER::COLLECTION)
    ("VHL" . SPARSER::PROTEIN) ("TICs" . SPARSER::PROTEIN)
    ("paralogs" . SPARSER::PROTEIN) ("MiR" . SPARSER::MICRO-RNA)
    ("mRNAs" . SPARSER::PROTEIN)
    ("miRNA and a passenger strand [ xref ]" . SPARSER::COLLECTION)
    ("chemotherapeutic drugs" . SPARSER::DRUG) ("face" . SPARSER::PROTEIN)
    ("Dimethyl sulfoxide" . SPARSER::MOLECULE) ("N1" . SPARSER::PROTEIN)
    ("fibroblast growth factor" . SPARSER::PROTEIN-FAMILY)
    ("miR-200a" . SPARSER::MOLECULE)
    ("phosphatase and tensin homolog" . SPARSER::PROTEIN)
    ("Von Hippel-Lindau" . SPARSER::PROTEIN) ("HIF-1α" . SPARSER::PROTEIN)
    ("hypoxia inducible factor-1" . SPARSER::PROTEIN)
    ("CD133" . SPARSER::PROTEIN) ("HIF1" . SPARSER::PROTEIN)
    ("FP" . SPARSER::PROTEIN) ("Group" . SPARSER::MOLECULE)
    ("AGO" . SPARSER::PROTEIN)
    ("trastuzumab and their combination" . SPARSER::COLLECTION)
    ("lapatinib [ xref , xref ] or pertuzumab [ xref ]" . SPARSER::COLLECTION)
    ("pertuzumab" . SPARSER::DRUG)
    ("the crucial biomarker" . SPARSER::MOLECULE) ("vs" . SPARSER::PROTEIN)
    ("trastuzumab or lapatinib" . SPARSER::COLLECTION)
    ("lapatinib and trastuzumab" . SPARSER::COLLECTION)
    ("HRs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("lapatinib" . SPARSER::DRUG)
    ("HER2 or ER" . SPARSER::COLLECTION)
    ("relevant mediators" . SPARSER::PROTEIN) ("AIB" . SPARSER::DRUG)
    ("HERA" . SPARSER::PROTEIN) ("HER2-" . SPARSER::PROTEIN)
    ("anthracycline" . SPARSER::MOLECULE) ("Adjuvant" . SPARSER::DRUG)
    ("estrogen receptor (ER)" . SPARSER::PROTEIN)
    ("a predictive biomarker" . SPARSER::MOLECULE) ("HER" . SPARSER::PROTEIN)
    ("pCR" . SPARSER::PROTEIN) ("cHER" . SPARSER::PROTEIN)
    ("formalin" . SPARSER::MOLECULE) ("HER2 and ESR1" . SPARSER::COLLECTION)
    ("HER2 and estrogen receptor" . SPARSER::COLLECTION)
    ("estrogen receptor 1" . SPARSER::PROTEIN) ("B47" . SPARSER::PROTEIN)
    ("PAX2" . SPARSER::PROTEIN) ("gene 2" . SPARSER::PROTEIN)
    ("RPL37A" . SPARSER::PROTEIN) ("OAZ1" . SPARSER::PROTEIN)
    ("CALM2" . SPARSER::PROTEIN) ("ESR1" . SPARSER::PROTEIN)
    ("CDK2 and Pin1" . SPARSER::COLLECTION)
    ("CDK2/ERalpha" . SPARSER::COLLECTION)
    ("PI3K and CDK2" . SPARSER::COLLECTION)
    ("Serine/Threonine" . SPARSER::COLLECTION)
    ("Threonine" . SPARSER::AMINO-ACID) ("Serines" . SPARSER::AMINO-ACID)
    ("lysines" . SPARSER::AMINO-ACID) ("aa" . SPARSER::MOLECULE)
    ("FBS or estradiol" . SPARSER::COLLECTION) ("cofactors" . SPARSER::PROTEIN)
    ("estrogens" . SPARSER::MOLECULE) ("Endocrine" . SPARSER::PROTEIN)
    ("an essential component" . SPARSER::COMPONENT)
    ("endocrine" . SPARSER::PROTEIN) ("Pin1/ERalpha" . SPARSER::COLLECTION)
    ("extracellular-regulated kinase" . SPARSER::COLLECTION)
    ("CTSD and TFF1" . SPARSER::COLLECTION) ("CTSD" . SPARSER::PROTEIN)
    ("E2 or a vehicle" . SPARSER::COLLECTION) ("ERalpha-" . SPARSER::PROTEIN)
    ("pVP" . SPARSER::MOLECULE) ("3% charcoal-stripped FBS" . SPARSER::PROTEIN)
    ("serines" . SPARSER::AMINO-ACID) ("FLV" . SPARSER::DRUG)
    ("flavopiridol" . SPARSER::DRUG) ("CDK4 and CDK6" . SPARSER::COLLECTION)
    ("Glo" . SPARSER::PROTEIN) ("CDK6/CycD1" . SPARSER::COLLECTION)
    ("CDK4/CycD1" . SPARSER::COLLECTION) ("CDK2/CycA" . SPARSER::COLLECTION)
    ("CycA" . SPARSER::PROTEIN) ("CDK1 or CDK4" . SPARSER::COLLECTION)
    ("CDK1, CDK2 and CDK4" . SPARSER::COLLECTION)
    ("ERalpha and Pin1" . SPARSER::COLLECTION) ("MT" . SPARSER::PROTEIN)
    ("Ser-Pro" . SPARSER::COLLECTION) ("Pro" . SPARSER::AMINO-ACID)
    ("peptidyl-prolyl-isomerase" . SPARSER::COLLECTION)
    ("only CD peptide" . SPARSER::PEPTIDE) ("×-His" . SPARSER::COLLECTION)
    ("GST and GST-Pin1 proteins ( xref )" . SPARSER::COLLECTION)
    ("Histidine" . SPARSER::AMINO-ACID) ("EF" . SPARSER::PROTEIN)
    ("GST-PP" . SPARSER::COLLECTION) ("GST-Pin1" . SPARSER::COLLECTION)
    ("PP" . SPARSER::PROTEIN) ("PPIase" . SPARSER::PROTEIN)
    ("FBS and estradiol" . SPARSER::COLLECTION)
    ("a macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("hormone or growth factor" . SPARSER::COLLECTION)
    ("FBS- or estrogen-stimulated ERalpha" . SPARSER::COLLECTION)
    ("FBS-" . SPARSER::PROTEIN) ("SMRT" . SPARSER::PROTEIN)
    ("cis/trans" . SPARSER::COLLECTION) ("prolyl" . SPARSER::PROTEIN)
    ("cis and trans" . SPARSER::COLLECTION) ("trans" . SPARSER::PROTEIN-FAMILY)
    ("HER2 and insulin-like growth factor receptor" . SPARSER::COLLECTION)
    ("estrogen" . SPARSER::MOLECULE) ("Pin1-ERalpha" . SPARSER::COLLECTION)
    ("Pin1 and ERalpha" . SPARSER::COLLECTION) ("hormone-" . SPARSER::PROTEIN)
    ("ERalpha-Pin1" . SPARSER::COLLECTION) ("ERalpha" . SPARSER::PROTEIN)
    ("isomerase" . SPARSER::PROTEIN) ("tamoxifen" . SPARSER::MOLECULE)
    ("the estrogen receptor and its ligand" . SPARSER::COLLECTION)
    ("estradiol" . SPARSER::MOLECULE) ("AF1" . SPARSER::PROTEIN)
    ("HER-2" . SPARSER::PROTEIN) ("regulated kinase" . SPARSER::PROTEIN)
    ("phenol-red" . SPARSER::DRUG)
    ("Cyclin Dependent Kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-estradiol" . SPARSER::MOLECULE) ("pGL2" . SPARSER::PROTEIN)
    ("MgCl2" . SPARSER::MOLECULE) ("CDK6" . SPARSER::PROTEIN)
    ("CycD1" . SPARSER::PROTEIN) ("TFF1" . SPARSER::PROTEIN)
    ("a 20 µ" . SPARSER::PROTEIN) ("GAL4" . SPARSER::PROTEIN)
    ("TG-3" . SPARSER::PROTEIN) ("CD-" . SPARSER::PROTEIN)
    ("VP16" . SPARSER::DRUG) ("PIN1" . SPARSER::PROTEIN)
    ("CDK1" . SPARSER::PROTEIN) ("U0126" . SPARSER::DRUG)
    ("AG825" . SPARSER::DRUG) ("A20" . SPARSER::PROTEIN)
    ("SRC-3" . SPARSER::PROTEIN) ("Thr-Pro" . SPARSER::MOLECULE)
    ("IGF1-R" . SPARSER::PROTEIN)
    ("insulin-like growth factor receptor" . SPARSER::PROTEIN)
    ("AF-2" . SPARSER::PROTEIN) ("AF-1" . SPARSER::PROTEIN)
    ("anti-estrogen" . SPARSER::DRUG) ("Pin1" . SPARSER::PROTEIN)
    ("Anti-estrogens" . SPARSER::DRUG) ("Luminal" . SPARSER::DRUG)
    ("NSG" . SPARSER::PROTEIN-FAMILY) ("shp53-MYC" . SPARSER::PROTEIN-PAIR)
    ("shp53-RAS" . SPARSER::PROTEIN-PAIR) ("MMTVD1-K2" . SPARSER::PROTEIN-PAIR)
    ("CCND1 and MYC" . SPARSER::COLLECTION)
    ("MYC, or RAS" . SPARSER::COLLECTION) ("p53-shRNA" . SPARSER::COLLECTION)
    ("48R-shp16-D1/K2-RAS" . SPARSER::PROTEIN-PAIR)
    ("shp16, shp53, MYC, and RAS" . SPARSER::COLLECTION)
    ("K2-MYC" . SPARSER::PROTEIN-PAIR) ("RAS, or MYC" . SPARSER::COLLECTION)
    ("K2-RAS" . SPARSER::PROTEIN-PAIR) ("p16-" . SPARSER::PROTEIN)
    ("MYC or RAS" . SPARSER::COLLECTION)
    ("p53 and p21 protein" . SPARSER::COLLECTION)
    ("p53 and p21" . SPARSER::COLLECTION) ("p53-p21" . SPARSER::COLLECTION)
    ("48R-shp16, 48R-shp53, and 48R-shp16-shp53" . SPARSER::COLLECTION)
    ("exogenous MYC" . SPARSER::PROTEIN) ("functional p16" . SPARSER::PROTEIN)
    ("MYC and RAS" . SPARSER::COLLECTION) ("HME" . SPARSER::PROTEIN)
    ("CDK4 and CDK2" . SPARSER::COLLECTION) ("mink" . SPARSER::PROTEIN)
    ("CCND1/CDK4" . SPARSER::COLLECTION)
    ("Cyclins and cyclin-dependent kinases" . SPARSER::COLLECTION)
    ("p16-RB" . SPARSER::COLLECTION) ("Post" . SPARSER::PROTEIN)
    ("a stress-induced senescence barrier" . SPARSER::PROTEIN)
    ("RB" . SPARSER::PROTEIN) ("p53 or replacing MYC" . SPARSER::COLLECTION)
    ("exogenous MYC and mutant RAS" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16 and p53" . SPARSER::COLLECTION)
    ("MYC and mutant" . SPARSER::COLLECTION) ("MYC" . SPARSER::PROTEIN)
    ("CCND1/CDK2" . SPARSER::COLLECTION) ("type VII" . SPARSER::PROTEIN)
    ("NP40" . SPARSER::MOLECULE) ("pMD2" . SPARSER::MOLECULE)
    ("RasV12" . SPARSER::DRUG) ("nutlin-3" . SPARSER::DRUG)
    ("CDK4/6" . SPARSER::PROTEIN) ("p21 protein" . SPARSER::PROTEIN)
    ("K2" . SPARSER::PROTEIN) ("p16 protein" . SPARSER::PROTEIN)
    ("c-MYC" . SPARSER::PROTEIN)
    ("cytokine- or chemo-kine-mediated" . SPARSER::COLLECTION)
    ("cytokine-" . SPARSER::PROTEIN) ("PA" . SPARSER::PROTEIN)
    ("heterozygous AG" . SPARSER::PROTEIN)
    ("esophageal SCCs" . SPARSER::PROTEIN)
    ("26 primary human esophageal SCCs" . SPARSER::PROTEIN)
    ("SCCs" . SPARSER::PROTEIN) ("protein–protein" . SPARSER::COLLECTION)
    ("ion" . SPARSER::MOLECULE)
    ("cytokine and chemokine" . SPARSER::COLLECTION)
    ("agonists" . SPARSER::AGONIST) ("AA" . SPARSER::MOLECULE)
    ("TE" . SPARSER::PROTEIN) ("ECA" . SPARSER::PROTEIN)
    ("arginine" . SPARSER::AMINO-ACID) ("histidine" . SPARSER::AMINO-ACID)
    ("CAC" . SPARSER::PROTEIN) ("a susceptible SNP" . SPARSER::PROTEIN)
    ("diacylglycerol and inositol 1,4,5-trisphosphate" . SPARSER::COLLECTION)
    ("calcium" . SPARSER::CALCIUM) ("PtdIns" . SPARSER::PROTEIN)
    ("phosphoinositide" . SPARSER::PROTEIN) ("AG or GG" . SPARSER::COLLECTION)
    ("AG" . SPARSER::PROTEIN) ("epsilon" . SPARSER::PROTEIN)
    ("G Protein" . SPARSER::PROTEIN) ("Gα 13" . SPARSER::PROTEIN)
    ("G protein" . SPARSER::PROTEIN) ("PLCE1" . SPARSER::PROTEIN)
    ("CO 3" . SPARSER::PROTEIN) ("K 2" . SPARSER::PROTEIN)
    ("IP 6" . SPARSER::DRUG) ("fatty acid" . SPARSER::MOLECULE)
    ("Ras family" . SPARSER::PROTEIN) ("PLCE 1" . SPARSER::PROTEIN)
    ("Phospholipase C" . SPARSER::PROTEIN)
    ("Akt and Runx2" . SPARSER::COLLECTION)
    ("three separate genes" . SPARSER::GENE)
    ("Akt1, Akt2 and Akt3" . SPARSER::COLLECTION)
    ("chondrocytes and osteoblasts" . SPARSER::COLLECTION)
    ("chondrocytes" . SPARSER::PROTEIN)
    ("PKA, PKC and Akt" . SPARSER::COLLECTION)
    ("MAPK/ERK" . SPARSER::COLLECTION) ("PKA" . SPARSER::PROTEIN)
    ("a multifunctional osteogenic regulator" . SPARSER::PROTEIN)
    ("a representative target promoter" . SPARSER::PROMOTER)
    ("Runx2-CBFβ" . SPARSER::COLLECTION)
    ("MMP9 and MMP13" . SPARSER::COLLECTION) ("MCF7" . SPARSER::PROTEIN)
    ("FLAG-Runx2" . SPARSER::COLLECTION)
    ("GST-tagged full length Runx2 or the GST-tagged DNA binding domain both form"
     . SPARSER::COLLECTION)
    ("phospho-serine/threonine" . SPARSER::COLLECTION)
    ("active (CA)" . SPARSER::ACTIVE)
    ("dominant negative (DN) Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("this peptide and three" . SPARSER::COLLECTION)
    ("serine or threonine" . SPARSER::COLLECTION)
    ("PI3K and Runx2" . SPARSER::COLLECTION)
    ("LY294002 or triciribine" . SPARSER::COLLECTION)
    ("PI3Kinase/Akt" . SPARSER::COLLECTION)
    ("a cell-permeable tricyclic nucleoside" . SPARSER::MOLECULE)
    ("nucleoside" . SPARSER::MOLECULE) ("triciribine" . SPARSER::MOLECULE)
    ("MMP9, MMP13 and VEGF" . SPARSER::COLLECTION)
    ("MMP9 , MMP13 and VEGF" . SPARSER::COLLECTION)
    ("metastasis-related genes and the invasive potential"
     . SPARSER::COLLECTION)
    ("Runx2 and Akt" . SPARSER::COLLECTION) ("MMTV-PyMT" . SPARSER::COLLECTION)
    ("MMTV" . SPARSER::PROTEIN) ("Runx3" . SPARSER::PROTEIN)
    ("Runt" . SPARSER::PROTEIN) ("girdin" . SPARSER::PROTEIN)
    ("Akt genes or mutations" . SPARSER::COLLECTION)
    ("CBFβ-Runx2" . SPARSER::COLLECTION) ("runt" . SPARSER::PROTEIN)
    ("Akt3" . SPARSER::PROTEIN) ("Akt2" . SPARSER::PROTEIN)
    ("phospho-serine" . SPARSER::PHOSPHORYLATED-AMINO-ACID)
    ("PI3 kinase" . SPARSER::PROTEIN) ("PI3Kinase" . SPARSER::PROTEIN)
    ("B23" . SPARSER::PROTEIN) ("set 1" . SPARSER::PROTEIN)
    ("HEMA 3" . SPARSER::PROTEIN) ("MARK3" . SPARSER::PROTEIN)
    ("MMP 13" . SPARSER::PROTEIN) ("polynucleotide kinase" . SPARSER::PROTEIN)
    ("32 P" . SPARSER::|32P|) ("PDK1" . SPARSER::PROTEIN)
    ("Runx1" . SPARSER::PROTEIN) ("IGF1" . SPARSER::PROTEIN)
    ("YB- 1" . SPARSER::PROTEIN) ("protein-1" . SPARSER::PROTEIN)
    ("CBFβ" . SPARSER::PROTEIN) ("MMP13" . SPARSER::PROTEIN)
    ("Runx2" . SPARSER::PROTEIN) ("Akt/PKB" . SPARSER::PROTEIN)
    ("PCNA or FANCD2" . SPARSER::COLLECTION)
    ("eta or mt" . SPARSER::COLLECTION) ("FANCD2-IP" . SPARSER::COLLECTION)
    ("Flag-wt" . SPARSER::COLLECTION) ("GFP-wt" . SPARSER::COLLECTION)
    ("ub" . SPARSER::PROTEIN) ("CUE" . SPARSER::PROTEIN-FAMILY)
    ("eta and FANCD2" . SPARSER::COLLECTION) ("aims" . SPARSER::PROTEIN)
    ("SF-eta" . SPARSER::COLLECTION) ("SF-H2B" . SPARSER::COLLECTION)
    ("H2B-pol" . SPARSER::COLLECTION) ("PCNA and FANCD2" . SPARSER::COLLECTION)
    ("eta and PCNA" . SPARSER::COLLECTION) ("sepharose" . SPARSER::MOLECULE)
    ("a heterodimeric complex" . SPARSER::BIO-COMPLEX)
    ("FANCD2 and FANCI" . SPARSER::COLLECTION)
    ("helicases and polymerases" . SPARSER::COLLECTION)
    ("polymerases" . SPARSER::PROTEIN) ("helicases" . SPARSER::PROTEIN)
    ("ID" . SPARSER::PROTEIN) ("FANCI" . SPARSER::PROTEIN)
    ("UV" . SPARSER::PROTEIN) ("neither FANCD2 nor PCNA" . SPARSER::COLLECTION)
    ("post-UV" . SPARSER::PROTEIN-PAIR)
    ("FANCD2 and pol" . SPARSER::COLLECTION)
    ("PCNA and pol" . SPARSER::COLLECTION)
    ("FANCD2 and PCNA" . SPARSER::COLLECTION) ("GFP-IP" . SPARSER::COLLECTION)
    ("Flag-wtFANCD2-IP" . SPARSER::COLLECTION)
    ("GFP-wt-pol" . SPARSER::COLLECTION) ("GFP-pol-eta" . SPARSER::COLLECTION)
    ("mtFANCD2" . SPARSER::PROTEIN) ("Flag-mtFANCD2" . SPARSER::COLLECTION)
    ("GFP-pol" . SPARSER::COLLECTION) ("monoubiquitin" . SPARSER::PROTEIN)
    ("formaldehyde" . SPARSER::MOLECULE) ("wtFANCD2" . SPARSER::PROTEIN)
    ("Flag-wtFANCD2 or Flag-mtFANCD2" . SPARSER::COLLECTION)
    ("GFP-fused" . SPARSER::COLLECTION) ("Flag-wtFANCD2" . SPARSER::COLLECTION)
    ("ICLs" . SPARSER::PROTEIN) ("diepoxybutane" . SPARSER::MOLECULE)
    ("FANCA" . SPARSER::PROTEIN) ("XPV" . SPARSER::PROTEIN)
    ("TLS" . SPARSER::PROTEIN) ("eta and wtFANCD2" . SPARSER::COLLECTION)
    ("histone H2B-fused" . SPARSER::COLLECTION) ("MMC" . SPARSER::PROTEIN)
    ("eta" . SPARSER::PROTEIN) ("pol" . SPARSER::PROTEIN)
    ("M 2" . SPARSER::MOLECULE) ("eta)" . SPARSER::PROTEIN)
    ("DNA polymerase eta" . SPARSER::PROTEIN) ("XP-A" . SPARSER::PROTEIN)
    ("Mitomycin C" . SPARSER::DRUG)
    ("histone H2B" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DNA polymerase" . SPARSER::PROTEIN) ("FANCD2" . SPARSER::PROTEIN)
    ("protein D" . SPARSER::PROTEIN) ("Fanconi anemia" . SPARSER::PROTEIN)
    ("HK" . SPARSER::PROTEIN) ("Bcl-2–associated X protein" . SPARSER::PROTEIN)
    ("CBP" . SPARSER::PROTEIN) ("TMA" . SPARSER::MOLECULE)
    ("Tris" . SPARSER::MOLECULE) ("PBS" . SPARSER::PROTEIN)
    ("sulfate" . SPARSER::MOLECULE) ("dodecyl" . SPARSER::MOLECULE)
    ("PMSF" . SPARSER::MOLECULE) ("Polymerase" . SPARSER::PROTEIN)
    ("FACS" . SPARSER::PROTEIN)
    ("the nucleolar protein MYBBP1A" . SPARSER::PROTEIN)
    ("these nucleolar factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the nucleolar proteins NPM, NCL, NS, and ARF" . SPARSER::COLLECTION)
    ("NPM, NCL, NS, and ARF" . SPARSER::COLLECTION) ("ARF" . SPARSER::PROTEIN)
    ("NCL" . SPARSER::PROTEIN) ("NPM" . SPARSER::PROTEIN)
    ("other nucleolar proteins" . SPARSER::PROTEIN)
    ("NF–κB and CRY1" . SPARSER::COLLECTION)
    ("Prep1 or PGC-1α" . SPARSER::COLLECTION) ("Prep1" . SPARSER::PROTEIN)
    ("Prep" . SPARSER::PROTEIN) ("MYBBP1A and p53" . SPARSER::COLLECTION)
    ("Bax , PUMA , and p21" . SPARSER::COLLECTION)
    ("p53 or MYBBP1A" . SPARSER::COLLECTION)
    ("sip" . SPARSER::HUMAN-PROTEIN-FAMILY) ("sh" . SPARSER::PROTEIN-FAMILY)
    ("chip" . SPARSER::PROTEIN) ("RT" . SPARSER::PROTEIN)
    ("p53 and histone acetyltransferase p300" . SPARSER::COLLECTION)
    ("p21 , Bax , and PUMA" . SPARSER::COLLECTION) ("PUMA" . SPARSER::PROTEIN)
    ("Bax" . SPARSER::PROTEIN) ("Anoikis" . SPARSER::PROTEIN)
    ("ultraviolet light or γ-irradiation" . SPARSER::COLLECTION)
    ("light or γ-irradiation" . SPARSER::COLLECTION)
    ("p53 and MYBBP1A" . SPARSER::COLLECTION)
    ("a nucleolar protein" . SPARSER::PROTEIN) ("Myb" . SPARSER::PROTEIN)
    ("anoikis" . SPARSER::PROTEIN)
    ("Peroxisome proliferator-activated receptor gamma coactivator 1-alpha"
     . SPARSER::PROTEIN)
    ("CREB-binding protein" . SPARSER::PROTEIN)
    ("tween 20" . SPARSER::MOLECULE)
    ("Fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("p300" . SPARSER::PROTEIN) ("HDM2" . SPARSER::PROTEIN)
    ("RPL11" . SPARSER::PROTEIN) ("CRY1" . SPARSER::PROTEIN)
    ("NF–κB" . SPARSER::PROTEIN) ("PGC-1α" . SPARSER::PROTEIN)
    ("c-Myb" . SPARSER::PROTEIN) ("Nonidet P-40" . SPARSER::DRUG)
    ("fluorescein isothiocyanate" . SPARSER::MOLECULE)
    ("1A" . SPARSER::PROTEIN) ("p10" . SPARSER::PROTEIN)
    ("Anti-β" . SPARSER::PROTEIN)
    ("histone acetyltransferase p300" . SPARSER::PROTEIN)
    ("MYBBP1A" . SPARSER::PROTEIN)
    ("protein 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Tumor suppressor p53" . SPARSER::PROTEIN) ("HLi" . SPARSER::MOLECULE)
    ("RV" . SPARSER::PROTEIN) ("LC and JPV" . SPARSER::COLLECTION)
    ("LC" . SPARSER::PROTEIN) ("CR" . SPARSER::PROTEIN)
    ("CB" . SPARSER::PROTEIN) ("LLP" . SPARSER::PROTEIN)
    ("LH" . SPARSER::PROTEIN) ("CG" . SPARSER::PROTEIN)
    ("Bovine Serum Albumin" . SPARSER::PROTEIN) ("MMP" . SPARSER::PROTEIN)
    ("WAVE/Arp2/3" . SPARSER::COLLECTION) ("WAVE" . SPARSER::PROTEIN)
    ("Rac3/ERK2/NF-κB" . SPARSER::COLLECTION)
    ("hyperactive Rac3" . SPARSER::PROTEIN) ("Mira" . SPARSER::PROTEIN)
    ("IL-6, IL-8 and GROα" . SPARSER::COLLECTION)
    ("ERK-2/NF-κB" . SPARSER::COLLECTION)
    ("IL-6, IL-8 and GRO" . SPARSER::COLLECTION)
    ("IL-6, IL-8, GRO, GRO-α and IL-10" . SPARSER::COLLECTION)
    ("ERK/NF-κB" . SPARSER::COLLECTION) ("p50 and p65" . SPARSER::COLLECTION)
    ("FLIP" . SPARSER::PROTEIN) ("Rac3/ERK/NF-κB" . SPARSER::COLLECTION)
    ("ERK and phospho-ERK" . SPARSER::COLLECTION)
    ("MMP-2 and MMP-9" . SPARSER::COLLECTION) ("Cox" . SPARSER::PROTEIN)
    ("Rho or Cdc42" . SPARSER::COLLECTION)
    ("Rho- and Rac-GTPases" . SPARSER::COLLECTION)
    ("Rho-" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IL-8 (34%) and IL-10 (44%)" . SPARSER::COLLECTION)
    ("GRO (19% compared to the control), GROα (65%), IL-6 (47%), IL-8 (34%) and IL-10 (44%)"
     . SPARSER::COLLECTION)
    ("p65 and p50" . SPARSER::COLLECTION)
    ("essentially ERK-2 protein" . SPARSER::PROTEIN)
    ("ERK-1 and ERK-2" . SPARSER::COLLECTION) ("anti" . SPARSER::PROTEIN)
    ("ERK and NF-κB" . SPARSER::COLLECTION)
    ("siRNA anti-Rac3" . SPARSER::ANTIBODY)
    ("Matrigel, and VM" . SPARSER::COLLECTION)
    ("anti-Rac3 and control siRNA" . SPARSER::COLLECTION)
    ("activated RhoA (Figure  xref D) and Cdc42 (data not shown)"
     . SPARSER::COLLECTION)
    ("RhoA and Cdc42" . SPARSER::COLLECTION)
    ("an aggressive line" . SPARSER::PROTEIN)
    ("these highly homologous proteins" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factors, or GEFs" . SPARSER::COLLECTION)
    ("active and negative" . SPARSER::COLLECTION)
    ("Rac1 and Rac3" . SPARSER::COLLECTION)
    ("focal complexes" . SPARSER::BIO-COMPLEX)
    ("Rac and Rho" . SPARSER::COLLECTION)
    ("Rho, Rac and Cdc42" . SPARSER::COLLECTION)
    ("Rho and Rac" . SPARSER::COLLECTION)
    ("Rac3/ERK-2/NF-κB" . SPARSER::COLLECTION) ("GRO" . SPARSER::PROTEIN)
    ("NF-κB and ERK" . SPARSER::COLLECTION) ("MCF-10A" . SPARSER::PROTEIN)
    ("RhoA and Rac1" . SPARSER::COLLECTION)
    ("Tumor Necrosis Factor" . SPARSER::PROTEIN)
    ("Matrix MetalloProteinase" . SPARSER::PROTEIN)
    ("Serum Albumin" . SPARSER::PROTEIN) ("ERK2" . SPARSER::PROTEIN)
    ("protein expressed in" . SPARSER::PROTEIN) ("TRAF-2" . SPARSER::PROTEIN)
    ("TRAF-1" . SPARSER::PROTEIN) ("NF- κB" . SPARSER::PROTEIN)
    ("IκB" . SPARSER::PROTEIN) ("phospho-ERK" . SPARSER::PROTEIN)
    ("MMP-2" . SPARSER::PROTEIN) ("GROα" . SPARSER::PROTEIN)
    ("ERK-1" . SPARSER::PROTEIN) ("18 h" . SPARSER::PROTEIN)
    ("growth-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MnCl 2" . SPARSER::DRUG) ("MgSO 4" . SPARSER::DRUG)
    ("anti-Histone" . SPARSER::PROTEIN) ("IKKα" . SPARSER::PROTEIN)
    ("p65" . SPARSER::PROTEIN) ("p50" . SPARSER::PROTEIN)
    ("p105" . SPARSER::PROTEIN) ("anti-ERK" . SPARSER::PROTEIN)
    ("Reverse-Transcriptase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("F12" . SPARSER::PROTEIN) ("Estrogen Receptor" . SPARSER::PROTEIN)
    ("Rac2" . SPARSER::PROTEIN) ("ERK-2" . SPARSER::PROTEIN)
    ("Rac3" . SPARSER::PROTEIN) ("DG" . SPARSER::PROTEIN)
    ("AC, IM and BPM" . SPARSER::COLLECTION) ("IM" . SPARSER::PROTEIN)
    ("IDH" . SPARSER::PROTEIN) ("DS and ST" . SPARSER::COLLECTION)
    ("MEK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Active" . SPARSER::ACTIVE)
    ("tyrosine and threonine" . SPARSER::COLLECTION)
    ("RAF and MAP/ERK kinases" . SPARSER::COLLECTION)
    ("growth factors, cytokines and proto-oncogenes" . SPARSER::COLLECTION)
    ("MAP/ERK" . SPARSER::COLLECTION) ("RAF" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RAS" . SPARSER::HUMAN-PROTEIN-FAMILY) ("topo" . SPARSER::PROTEIN)
    ("an attractive therapeutic target" . SPARSER::TARGET-PROTEIN)
    ("platinum and taxane" . SPARSER::COLLECTION) ("taxane" . SPARSER::DRUG)
    ("p53 and MAPK" . SPARSER::COLLECTION) ("HPFs" . SPARSER::PROTEIN)
    ("OSC" . SPARSER::PROTEIN)
    ("the tumor group and the age" . SPARSER::COLLECTION)
    ("type I and type II" . SPARSER::COLLECTION)
    ("a cell-cycle-related protein" . SPARSER::PROTEIN)
    ("TopoII" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase (MAPK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("platinum" . SPARSER::MOLECULE) ("des" . SPARSER::PROTEIN)
    ("das" . SPARSER::DRUG) ("Gruppe" . SPARSER::MOLECULE)
    ("Von" . SPARSER::PROTEIN) ("von" . SPARSER::PROTEIN)
    ("als" . SPARSER::PROTEIN) ("KRAS or BRAF" . SPARSER::COLLECTION)
    ("p53 and topoII" . SPARSER::COLLECTION)
    ("alpha) and Ki67" . SPARSER::COLLECTION)
    ("KRAS and BRAF" . SPARSER::COLLECTION) ("topoII" . SPARSER::PROTEIN)
    ("Topoisomerase II" . SPARSER::PROTEIN)
    ("Mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("nuclear pore" . SPARSER::BIO-COMPLEX)
    ("nuclear pores" . SPARSER::BIO-COMPLEX)
    ("proto-oncogenes" . SPARSER::PROTO-ONCOGENE) ("MEK-1" . SPARSER::PROTEIN)
    ("AZD6244" . SPARSER::DRUG) ("CA 125" . SPARSER::PROTEIN)
    ("k-ras" . SPARSER::PROTEIN) ("MIB-1" . SPARSER::PROTEIN)
    ("alpha)" . SPARSER::PROTEIN) ("topoisomerase II" . SPARSER::PROTEIN)
    ("cellular glucose" . SPARSER::PROTEIN) ("lactate" . SPARSER::MOLECULE)
    ("glucose" . SPARSER::PROTEIN)
    ("repressor of Trx and metastasis" . SPARSER::COLLECTION)
    ("Trx" . SPARSER::PROTEIN) ("Y397-FAK and FAK" . SPARSER::COLLECTION)
    ("Inhibitor" . SPARSER::INHIBITOR) ("TXNIP and FAK" . SPARSER::COLLECTION)
    ("fluorouracil" . SPARSER::DRUG) ("FAK and TXNIP" . SPARSER::COLLECTION)
    ("Vitamin D Or 5-Fluorouracil" . SPARSER::COLLECTION)
    ("Fluorouracil" . SPARSER::DRUG) ("Doxycyclin" . SPARSER::MOLECULE)
    ("TXNIP mRNA, promoter activity and protein level in cancer cells that is important for cancer cell survival and intracellular signaling"
     . SPARSER::COLLECTION)
    ("WNT" . SPARSER::HUMAN-PROTEIN-FAMILY) ("repressor" . SPARSER::REPRESSOR)
    ("thioredoxin (TRX)" . SPARSER::PROTEIN) ("TRX" . SPARSER::PROTEIN)
    ("thioredoxin" . SPARSER::PROTEIN) ("PMA" . SPARSER::PROTEIN)
    ("phorbol" . SPARSER::DRUG)
    ("Thioredoxin-interacting protein (TXNIP) or Vitamin D3 up-regulated protein 1 (VDUP-1)"
     . SPARSER::COLLECTION)
    ("FAK-CD (FRNK)" . SPARSER::PROTEIN) ("FRNK" . SPARSER::PROTEIN)
    ("thioredoxin-interacting protein (TXNIP) and FAK" . SPARSER::COLLECTION)
    ("doxycyclin-" . SPARSER::MOLECULE) ("doxycyclin" . SPARSER::MOLECULE)
    ("TXNIP" . SPARSER::PROTEIN) ("Kinase (FAK)" . SPARSER::KINASE)
    ("Kinase" . SPARSER::KINASE) ("cyclin D" . SPARSER::PROTEIN)
    ("vitamin D3" . SPARSER::MOLECULE) ("PI-3" . SPARSER::PROTEIN)
    ("Vitamin D" . SPARSER::MOLECULE) ("thymidine kinase" . SPARSER::PROTEIN)
    ("Dual-luciferase" . SPARSER::PROTEIN) ("caspase-8" . SPARSER::PROTEIN)
    ("cyclin A 2" . SPARSER::PROTEIN) ("TGF-beta 1" . SPARSER::PROTEIN)
    ("Vitamin D3" . SPARSER::MOLECULE) ("VDUP-1" . SPARSER::PROTEIN)
    ("Vitamin D3 up-regulated protein 1" . SPARSER::PROTEIN)
    ("Thioredoxin-interacting protein" . SPARSER::PROTEIN)
    ("three domains" . SPARSER::PROTEIN)
    ("thioredoxin-interacting protein" . SPARSER::PROTEIN)
    ("HGF/c-MET" . SPARSER::COLLECTION) ("Exogenous HGF" . SPARSER::PROTEIN)
    ("Fas/MET" . SPARSER::COLLECTION) ("FasL" . SPARSER::PROTEIN)
    ("Fas" . SPARSER::PROTEIN) ("EGF/EGFR" . SPARSER::COLLECTION)
    ("autocrine-activated c-MET" . SPARSER::PROTEIN)
    ("p-ELK" . SPARSER::COLLECTION) ("p-ERK" . SPARSER::COLLECTION)
    ("p-JAK" . SPARSER::COLLECTION) ("p-p53" . SPARSER::COLLECTION)
    ("anaplastic lymphoma kinase (ALK)" . SPARSER::PROTEIN)
    ("ALK" . SPARSER::PROTEIN)
    ("an orally bioavailable small-molecule kinase inhibitor"
     . SPARSER::INHIBITOR)
    ("their respective ligands" . SPARSER::LIGAND)
    ("Erlotinib" . SPARSER::DRUG) ("erlotinib" . SPARSER::DRUG)
    ("HGF/EGF" . SPARSER::COLLECTION) ("MRI" . SPARSER::PROTEIN)
    ("ELK" . SPARSER::PROTEIN) ("high HGF and low HGF" . SPARSER::COLLECTION)
    ("AAD" . SPARSER::PROTEIN) ("AnnexinV" . SPARSER::PROTEIN)
    ("p-EGFR" . SPARSER::COLLECTION) ("p-MET" . SPARSER::COLLECTION)
    ("SF" . SPARSER::PROTEIN)
    ("a clinically applicable, potent and selective ATP competitive small molecule kinase inhibitor"
     . SPARSER::INHIBITOR)
    ("METi" . SPARSER::PROTEIN)
    ("Four selective kinase inhibitors (PF-02341066, ARQ197, JNJ-38877605, PF-04217903) and four broad-spectrum kinase inhibitors (XL184, PM470, MGCD265, MK-2461)"
     . SPARSER::COLLECTION)
    ("MK" . SPARSER::PROTEIN) ("PM" . SPARSER::PROTEIN)
    ("Clinically translatable c-MET inhibitors" . SPARSER::INHIBITOR)
    ("ligand and receptor" . SPARSER::COLLECTION)
    ("endogenous c-MET and/or HGF" . SPARSER::COLLECTION)
    ("exogenous HGF" . SPARSER::PROTEIN) ("ERK/JAK/p53" . SPARSER::COLLECTION)
    ("GSCs" . SPARSER::PROTEIN)
    ("clinically applicable c-MET inhibitors" . SPARSER::INHIBITOR)
    ("The receptor tyrosine kinase (RTK) c-MET and its ligand hepatocyte growth factor (HGF)"
     . SPARSER::COLLECTION)
    ("hepatocyte growth factor (HGF)" . SPARSER::PROTEIN)
    ("Fas ligand" . SPARSER::PROTEIN) ("death receptor" . SPARSER::PROTEIN)
    ("p-RSK" . SPARSER::PROTEIN) ("PHA-665752" . SPARSER::DRUG)
    ("SGX523" . SPARSER::MOLECULE) ("annexin-V" . SPARSER::PROTEIN)
    ("RSK3" . SPARSER::PROTEIN) ("S15" . SPARSER::PROTEIN)
    ("ERK 1" . SPARSER::PROTEIN) ("U87" . SPARSER::PROTEIN)
    ("PF-2341066" . SPARSER::DRUG) ("MGCD265" . SPARSER::DRUG)
    ("XL184" . SPARSER::DRUG) ("hepatocyte growth factor" . SPARSER::PROTEIN)
    ("a mutational hotspot and CDK4 families" . SPARSER::PROTEIN-FAMILY)
    ("the most frequent histologic type" . TYPE)
    ("a highly penetrant melanoma risk gene" . SPARSER::PROTEIN)
    ("MPM and SPM" . SPARSER::COLLECTION)
    ("all remaining non-synonymous MC1R variants and 86insA"
     . SPARSER::COLLECTION)
    ("synonymous amino acid" . SPARSER::AMINO-ACID) ("insA" . SPARSER::PROTEIN)
    ("NM and LMM" . SPARSER::COLLECTION) ("NM" . SPARSER::PROTEIN)
    ("The predominant histologic type" . TYPE) ("SSM" . SPARSER::PROTEIN)
    ("SPM and MPM" . SPARSER::COLLECTION) ("melanoma (SPM)" . SPARSER::PROTEIN)
    ("SPM" . SPARSER::PROTEIN) ("Age" . SPARSER::PROTEIN)
    ("available DNA" . SPARSER::DNA) ("RHC" . SPARSER::PROTEIN)
    ("sun" . SPARSER::PROTEIN)
    ("Only 12 melanoma prone families" . SPARSER::PROTEIN-FAMILY)
    ("Cys" . SPARSER::AMINO-ACID)
    ("a heterodimeric Ser/Thr protein kinase" . SPARSER::PROTEIN)
    ("proteins, p16 INK4A and p14 ARF" . SPARSER::COLLECTION)
    ("MPMs" . SPARSER::MOLECULE) ("MIM" . SPARSER::PROTEIN)
    ("MPM" . SPARSER::MOLECULE) ("Melanoma" . SPARSER::PROTEIN)
    ("CDKN2A and CDK4" . SPARSER::COLLECTION)
    ("catalytic subunit" . SPARSER::PROTEIN) ("p14 ARF" . SPARSER::PROTEIN)
    ("p16 INK4A" . SPARSER::PROTEIN)
    ("cyclin dependent kinase inhibitor 2A" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MC1R" . SPARSER::PROTEIN) ("CDKN2A" . SPARSER::PROTEIN)
    ("EM" . SPARSER::PROTEIN) ("VC" . SPARSER::MOLECULE)
    ("LS" . SPARSER::PROTEIN) ("SS" . SPARSER::PROTEIN)
    ("PC" . SPARSER::PROTEIN) ("RAGE" . SPARSER::PROTEIN)
    ("TLC" . SPARSER::PROTEIN) ("Enzyme" . SPARSER::ENZYME)
    ("lipocalin, Extracellular newly identified RAGE-binding protein and Heparin-binding EGF-like growth factor"
     . SPARSER::COLLECTION)
    ("lipocalin" . SPARSER::PROTEIN) ("Neutrophil" . SPARSER::PROTEIN)
    ("Fibrinogen" . SPARSER::PROTEIN) ("KRAS and EGFR" . SPARSER::COLLECTION)
    ("A soluble fragment" . SPARSER::FRAGMENT)
    ("either obstructive or restrictive type" . TYPE)
    ("FEV" . SPARSER::PROTEIN) ("the obstructive or restrictive type" . TYPE)
    ("Sera" . SPARSER::PROTEIN) ("kB" . SPARSER::PROTEIN)
    ("oxidants and carcinogens" . SPARSER::COLLECTION)
    ("the main aetiological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("smoke" . SPARSER::MOLECULE) ("cigarette" . SPARSER::DRUG)
    ("Cigarette" . SPARSER::DRUG) ("COPD" . SPARSER::PROTEIN)
    ("asbestos" . SPARSER::MOLECULE) ("predate" . SPARSER::DRUG)
    ("cigarettes" . SPARSER::DRUG) ("tobacco" . SPARSER::DRUG)
    ("Cyclooxygenase-2" . SPARSER::PROTEIN)
    ("Heparin-binding EGF-like growth factor" . SPARSER::PROTEIN)
    ("Extracellular newly identified RAGE-binding protein" . SPARSER::PROTEIN)
    ("Epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("COX-2" . SPARSER::PROTEIN) ("GK, EB and SR" . SPARSER::COLLECTION)
    ("EB" . SPARSER::PROTEIN) ("SR" . SPARSER::PROTEIN)
    ("GK" . SPARSER::PROTEIN)
    ("proteins, CHEK1 and BUB1" . SPARSER::COLLECTION)
    ("a favourable prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("androgen receptor (AR)" . SPARSER::PROTEIN)
    ("CHEK1, AR and LYN" . SPARSER::COLLECTION)
    ("log-rank" . SPARSER::COLLECTION) ("Log-rank" . SPARSER::COLLECTION)
    ("Log" . SPARSER::PROTEIN) ("CHEK2, CDC7 and BUB1" . SPARSER::COLLECTION)
    ("Dai" . SPARSER::PROTEIN)
    ("AR , CHEK1 , CHEK2 , PGR , VIM , LYN , IRAK1 , IGF1R and DAB2"
     . SPARSER::COLLECTION)
    ("AR and the non-differentially" . SPARSER::COLLECTION)
    ("‘Gene’" . SPARSER::GENE) ("path" . SPARSER::PROTEIN)
    ("genes and 32" . SPARSER::COLLECTION)
    ("the GeneCards biological process GO" . SPARSER::PROTEIN)
    ("STC2 and LCN2" . SPARSER::COLLECTION)
    ("The relevant GO" . SPARSER::PROTEIN) ("vimentin" . SPARSER::PROTEIN)
    ("progesterone" . SPARSER::PROTEIN) ("Phosphoprotein" . SPARSER::PROTEIN)
    ("factors and receptors" . SPARSER::COLLECTION)
    ("phosphoproteins" . SPARSER::PROTEIN)
    ("a 25 kDa secretory protein" . SPARSER::PROTEIN)
    ("iron" . SPARSER::MOLECULE)
    ("CLU (clusterin) and LCN2 (lipocalin 2)" . SPARSER::COLLECTION)
    ("clusterin" . SPARSER::PROTEIN) ("inadequate oxygen" . SPARSER::MOLECULE)
    ("a secreted homodimeric glycoprotein" . SPARSER::PROTEIN)
    ("kallikrein" . SPARSER::PROTEIN)
    ("a nucleophilic serine residue" . SPARSER::MOLECULE)
    ("proteases" . SPARSER::PROTEIN) ("Serine" . SPARSER::AMINO-ACID)
    ("IRAK1, BUB1 , CDC7 , CHEK1 and CHEK2" . SPARSER::COLLECTION)
    ("yet another important cell cycle protein" . SPARSER::PROTEIN)
    ("ATM and ATR" . SPARSER::COLLECTION) ("meiotic" . SPARSER::DRUG)
    ("ATR" . SPARSER::PROTEIN)
    ("CDC7 (cell-division cycle 7 homolog of S. cerevisiae ) and BUB1 (budding uninhibited by benzimidazoles 1 homolog of S. cerevisiae )"
     . SPARSER::COLLECTION)
    ("benzimidazoles" . SPARSER::DRUG)
    ("IGFBP7 and LCN2" . SPARSER::COLLECTION)
    ("IRAK1 , STC2 , CDC7 , CHEK1 , KLK6 , BUB1 and CHEK2"
     . SPARSER::COLLECTION)
    ("IGF1R , DAB2 , IGFBP7 , FOXL2 , LCN2 , CLU , LYN , PGR , AR and VIM"
     . SPARSER::COLLECTION)
    ("VIM" . SPARSER::PROTEIN) ("PGR" . SPARSER::PROTEIN)
    ("CLU" . SPARSER::PROTEIN)
    ("transcription factor and hub" . SPARSER::COLLECTION)
    ("hub" . SPARSER::PROTEIN) ("CpG" . SPARSER::PROTEIN)
    ("pfp" . SPARSER::PROTEIN) ("pfp  " . SPARSER::PROTEIN)
    ("disease-associated genes" . SPARSER::GENE)
    ("differentially and non-differentially" . SPARSER::COLLECTION)
    ("diseased-associated genes" . SPARSER::GENE)
    ("CHEK1, AR, and LYN" . SPARSER::COLLECTION) ("LYN" . SPARSER::PROTEIN)
    ("AR" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IRAK1 , CHEK1 and BUB1" . SPARSER::COLLECTION)
    ("mitogen-activated protein kinase kinase kinase 7" . SPARSER::PROTEIN)
    ("MAP3K7" . SPARSER::PROTEIN) ("p44" . SPARSER::PROTEIN)
    ("steroid hormone" . SPARSER::MOLECULE)
    ("androgen receptor" . SPARSER::PROTEIN)
    ("progesterone receptor" . SPARSER::PROTEIN)
    ("forkhead box L2" . SPARSER::PROTEIN)
    ("TGF-β" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lipocalin 2" . SPARSER::PROTEIN) ("Stanniocalcin 2" . SPARSER::PROTEIN)
    ("serine residue" . SPARSER::MOLECULE)
    ("cancer 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("checkpoint kinase 2" . SPARSER::PROTEIN)
    ("checkpoint kinase 1" . SPARSER::PROTEIN)
    ("homolog of" . SPARSER::PROTEIN) ("caspase 8" . SPARSER::PROTEIN)
    ("insulin-like growth factor" . SPARSER::PROTEIN)
    ("LCN2" . SPARSER::PROTEIN) ("FOXL2" . SPARSER::PROTEIN)
    ("IGFBP7" . SPARSER::PROTEIN) ("DAB2" . SPARSER::PROTEIN)
    ("IGF1R" . SPARSER::PROTEIN) ("CHEK2" . SPARSER::PROTEIN)
    ("KLK6" . SPARSER::PROTEIN) ("CDC7" . SPARSER::PROTEIN)
    ("STC2" . SPARSER::PROTEIN) ("4 -1" . SPARSER::PROTEIN)
    ("ERα" . SPARSER::PROTEIN) ("estrogen receptor" . SPARSER::PROTEIN)
    ("c-Fos" . SPARSER::PROTEIN) ("BUB1" . SPARSER::PROTEIN)
    ("CHEK1" . SPARSER::PROTEIN) ("IRAK1" . SPARSER::PROTEIN)
    ("VCL , CHN1 and CALD1" . SPARSER::COLLECTION)
    ("families" . SPARSER::PROTEIN-FAMILY) ("Cajal" . SPARSER::PROTEIN)
    ("telomerase" . SPARSER::PROTEIN) ("TCAB1" . SPARSER::PROTEIN)
    ("their actual targets" . SPARSER::TARGET-PROTEIN)
    ("typical targets" . SPARSER::TARGET-PROTEIN) ("TRAIL" . SPARSER::PROTEIN)
    ("previously identified FOXO1" . SPARSER::PROTEIN)
    ("NF-kB and STAT" . SPARSER::COLLECTION)
    ("repressors" . SPARSER::REPRESSOR) ("FoxP3" . SPARSER::PROTEIN)
    ("IL-3" . SPARSER::PROTEIN) ("CTLA-4" . SPARSER::PROTEIN)
    ("TNFSF10" . SPARSER::PROTEIN) ("CDKN1B" . SPARSER::PROTEIN)
    ("sestrin 3" . SPARSER::PROTEIN) ("INK4a" . SPARSER::PROTEIN)
    ("NF-kB" . SPARSER::PROTEIN)
    ("CHPT1 , GALC and SPHK1 or ACER3" . SPARSER::COLLECTION)
    ("SPHK1 or ACER3" . SPARSER::COLLECTION) ("AS or RG" . SPARSER::COLLECTION)
    ("GALC" . SPARSER::PROTEIN) ("sphingolipid" . SPARSER::MOLECULE)
    ("Ship1" . SPARSER::PROTEIN) ("INPP4B and INPP5D" . SPARSER::COLLECTION)
    ("INPPL1, INPP5B and INPP5F" . SPARSER::COLLECTION)
    ("long chain" . SPARSER::PROTEIN) ("ACER3" . SPARSER::PROTEIN)
    ("SPHK1" . SPARSER::PROTEIN) ("CHPT1" . SPARSER::PROTEIN)
    ("SHIP-1" . SPARSER::PROTEIN) ("INPP5F" . SPARSER::PROTEIN)
    ("INPP5B" . SPARSER::PROTEIN) ("INPPL1" . SPARSER::PROTEIN)
    ("INPP5D" . SPARSER::PROTEIN) ("INPP4B" . SPARSER::PROTEIN)
    ("phosphatidylinositol-3,4,5-trisphosphate" . SPARSER::PIP3)
    ("only one probeset/exon" . SPARSER::COLLECTION)
    ("probeset/exon" . SPARSER::COLLECTION)
    ("mitogen activated protein kinases and cyclin-dependent kinases"
     . SPARSER::COLLECTION)
    ("Family" . SPARSER::PROTEIN-FAMILY)
    ("mitogen activated protein kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Myc" . SPARSER::PROTEIN)
    ("Vinculin ( VCL ) and caldesmon 1 ( CALD1 )" . SPARSER::COLLECTION)
    ("Vinculin" . SPARSER::PROTEIN)
    ("ATM , PRMT5 and VCL" . SPARSER::COLLECTION)
    ("CALD1 , LCK and MXI1" . SPARSER::COLLECTION)
    ("vinculin" . SPARSER::PROTEIN) ("NRP1" . SPARSER::PROTEIN)
    ("neuropilin-1" . SPARSER::PROTEIN) ("caldesmon 1" . SPARSER::PROTEIN)
    ("p30" . SPARSER::PROTEIN) ("MXI1" . SPARSER::PROTEIN)
    ("CALD1" . SPARSER::PROTEIN) ("PRMT5" . SPARSER::PROTEIN)
    ("alphaM" . SPARSER::PROTEIN) ("ITGAM" . SPARSER::PROTEIN)
    ("ITGAL" . SPARSER::PROTEIN)
    ("PTPN6 (SHP-1) and PPP3CA (calcineurin A)" . SPARSER::COLLECTION)
    ("VAV1 , VAV3 , TIAM1 and TIAM2" . SPARSER::COLLECTION)
    ("Shc" . SPARSER::PROTEIN) ("PTPRC" . SPARSER::PROTEIN)
    ("guanosine" . SPARSER::MOLECULE)
    ("Both CD3G (encoding the γ component of the CD3 TCR complex) and CD4"
     . SPARSER::COLLECTION)
    ("an essential kinase" . SPARSER::KINASE) ("CD3G" . SPARSER::PROTEIN)
    ("LCK" . SPARSER::PROTEIN) ("MAC-1" . SPARSER::PROTEIN)
    ("ITGB2" . SPARSER::PROTEIN) ("VLA-4" . SPARSER::PROTEIN)
    ("ITGA4" . SPARSER::PROTEIN) ("LFA-1" . SPARSER::PROTEIN)
    ("DOK5" . SPARSER::PROTEIN) ("DOK2" . SPARSER::PROTEIN)
    ("calcineurin A" . SPARSER::PROTEIN) ("PPP3CA" . SPARSER::PROTEIN)
    ("SHP-1" . SPARSER::PROTEIN) ("PTPN6" . SPARSER::PROTEIN)
    ("protein phosphatases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("TIAM2" . SPARSER::PROTEIN) ("TIAM1" . SPARSER::PROTEIN)
    ("VAV3" . SPARSER::PROTEIN) ("VAV1" . SPARSER::PROTEIN)
    ("RG and 24 genes" . SPARSER::COLLECTION)
    ("BCL-2, BCL-3, and BCL-9L" . SPARSER::COLLECTION)
    ("p16INK4a and p18INK4b" . SPARSER::COLLECTION)
    ("BCL-11B" . SPARSER::COLLECTION)
    ("other typical FOXO1" . SPARSER::PROTEIN)
    ("SESN3 , CDKN1A , SAT1 , and VCL" . SPARSER::COLLECTION)
    ("KIP" . SPARSER::PROTEIN) ("VCL" . SPARSER::PROTEIN)
    ("INK4b" . SPARSER::PROTEIN) ("p18" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16INK4a" . SPARSER::PROTEIN) ("BCL-9" . SPARSER::PROTEIN)
    ("BCL-3" . SPARSER::PROTEIN) ("BCL-2" . SPARSER::PROTEIN)
    ("11B" . SPARSER::PROTEIN) ("SAT1" . SPARSER::PROTEIN)
    ("SESN3" . SPARSER::PROTEIN) ("CDKN1A" . SPARSER::PROTEIN)
    ("NOS3" . SPARSER::PROTEIN) ("MAPK3" . SPARSER::PROTEIN)
    ("FAIM3 , TNFSF8 and TNFRSF10D" . SPARSER::COLLECTION)
    ("TNF/TNF-R" . SPARSER::COLLECTION)
    ("cytokine–cytokine receptor" . SPARSER::COLLECTION)
    ("hsa" . SPARSER::PROTEIN) ("SNARE" . SPARSER::PROTEIN)
    ("receptor and protein kinase" . SPARSER::COLLECTION)
    ("receptors and ECM" . SPARSER::COLLECTION) ("GO" . SPARSER::PROTEIN)
    ("TNFRSF10D" . SPARSER::PROTEIN) ("TNFSF8" . SPARSER::PROTEIN)
    ("FAIM3" . SPARSER::PROTEIN) ("TNF-R" . SPARSER::PROTEIN)
    ("Jak–STAT" . SPARSER::PROTEIN) ("cytokine receptor" . SPARSER::PROTEIN)
    ("NUAK2" . SPARSER::PROTEIN) ("CDKL5" . SPARSER::PROTEIN)
    ("SGK3" . SPARSER::PROTEIN) ("TESK2" . SPARSER::PROTEIN)
    ("CLK1" . SPARSER::PROTEIN) ("MAP3K3" . SPARSER::PROTEIN)
    ("purine" . SPARSER::DRUG)
    ("DTL (about 45% down) and SLFN5 (about 130% up)" . SPARSER::COLLECTION)
    ("DTL" . SPARSER::PROTEIN) ("chimerin 1" . SPARSER::PROTEIN)
    ("WD repeat domain 79" . SPARSER::PROTEIN)
    ("tripartite motif containing 47" . SPARSER::PROTEIN)
    ("genes (RG)" . SPARSER::GENE) ("differential exon" . SPARSER::PROTEIN)
    ("log" . SPARSER::PROTEIN)
    ("sets interrogating all currently known exon" . SPARSER::PROTEIN)
    ("RIN" . SPARSER::PROTEIN) ("a commercial inhibitor" . SPARSER::INHIBITOR)
    ("CD3/CD28" . SPARSER::COLLECTION) ("CD28" . SPARSER::PROTEIN)
    ("RG and AS" . SPARSER::COLLECTION) ("ionomycin" . SPARSER::DRUG)
    ("splice accessory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phosphatase" . SPARSER::PHOSPHATASE) ("SHIP" . SPARSER::PROTEIN)
    ("certain splicing accessory factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("LY294002 or wortmannin" . SPARSER::COLLECTION)
    ("wortmannin" . SPARSER::PROTEIN)
    ("Vav, GSK-3b, and FOXO1" . SPARSER::COLLECTION) ("Vav" . SPARSER::PROTEIN)
    ("sphingomyelinases" . SPARSER::PROTEIN)
    ("receptor (TCR)" . SPARSER::RECEPTOR)
    ("Soluble mediators" . SPARSER::PROTEIN)
    ("II molecules" . SPARSER::MOLECULE) ("viral peptides" . SPARSER::PEPTIDE)
    ("AS/RG" . SPARSER::COLLECTION) ("cytokine-receptor" . SPARSER::COLLECTION)
    ("-receptor" . SPARSER::COLLECTION) ("ECM" . SPARSER::PROTEIN)
    ("AS and RG" . SPARSER::COLLECTION) ("RG" . SPARSER::PROTEIN)
    ("Exon" . SPARSER::PROTEIN) ("Differentially" . SPARSER::PROTEIN)
    ("splice regulatory proteins and a T cell inhibitory protein isoform"
     . SPARSER::COLLECTION)
    ("MV" . SPARSER::PROTEIN) ("CD44" . SPARSER::PROTEIN)
    ("CHN1" . SPARSER::PROTEIN) ("WRAP53" . SPARSER::PROTEIN)
    ("SLFN5" . SPARSER::PROTEIN) ("TRIM47" . SPARSER::PROTEIN)
    ("log2" . SPARSER::PROTEIN) ("SIP110" . SPARSER::PROTEIN)
    ("GSK-3b" . SPARSER::PROTEIN) ("Cbl-b" . SPARSER::PROTEIN)
    ("PI3" . SPARSER::PROTEIN) ("Jak-STAT" . SPARSER::PROTEIN)
    ("pre-mRNA" . SPARSER::RNA)
    ("phosphatidylinositol-3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("BAD, PDCD4, Caspase9, p21 Cip1 , p27 kip1 , and p53"
     . SPARSER::COLLECTION)
    ("p21 Cip1 , p27 kip1 , and p53" . SPARSER::COLLECTION)
    ("p21 Cip1 and p27 kip1" . SPARSER::COLLECTION)
    ("CagA−" . SPARSER::PROTEIN) ("Cag" . SPARSER::PROTEIN)
    ("CagA" . SPARSER::PROTEIN) ("XIAP" . SPARSER::PROTEIN)
    ("Akt and IκBα" . SPARSER::COLLECTION) ("fated" . SPARSER::PROTEIN)
    ("serine/threonine" . SPARSER::COLLECTION) ("homologue" . SPARSER::PROTEIN)
    ("HA-Ub" . SPARSER::PROTEIN-PAIR)
    ("p53, p21 Cip1 , p27 kip1 , Caspase9, PDCD4, BAD, and IκBα"
     . SPARSER::COLLECTION)
    ("VCP-" . SPARSER::PROTEIN) ("HA" . SPARSER::PROTEIN)
    ("polyubiquitination" . SPARSER::PROTEIN)
    ("mitochondria" . SPARSER::PROTEIN)
    ("proteins, and DAPI" . SPARSER::COLLECTION) ("FK" . SPARSER::PROTEIN)
    ("proteins and ubiquitin" . SPARSER::COLLECTION) ("UPS" . SPARSER::PROTEIN)
    ("polyubiquitinated" . SPARSER::PROTEIN) ("proteasomes" . SPARSER::PROTEIN)
    ("Akt or VCP" . SPARSER::COLLECTION)
    ("the triple mutant S352AS746AS748A" . SPARSER::PROTEIN)
    ("S352AS746AS748A" . SPARSER::PROTEIN)
    ("the triple mutant VCP-Flag S352AS746AS748A" . SPARSER::PROTEIN)
    ("VCP-Flag S352AS746AS748A" . SPARSER::PROTEIN)
    ("VCP-Flag S352A/S746A" . SPARSER::PROTEIN)
    ("Tri-mut" . SPARSER::COLLECTION) ("Tri" . SPARSER::PROTEIN)
    ("AS" . SPARSER::PROTEIN) ("VCP-Akt" . SPARSER::COLLECTION)
    ("-Akt" . SPARSER::COLLECTION) ("Ser/Thr" . SPARSER::COLLECTION)
    ("VCP and Akt" . SPARSER::COLLECTION)
    ("IκBα, Caspase9, BAD, PDCD4, p53, p21 Cip1 , and p27 kip1"
     . SPARSER::COLLECTION)
    ("BAD" . SPARSER::PROTEIN) ("ERK/MAPK" . SPARSER::COLLECTION)
    ("hypoxia" . SPARSER::PROTEIN) ("aldosterone" . SPARSER::PROTEIN)
    ("n  " . SPARSER::PROTEIN) ("classes" . CLASS) ("IPA" . SPARSER::MOLECULE)
    ("Swiss-Prot" . SPARSER::COLLECTION) ("Prot" . SPARSER::PROTEIN)
    ("LTQ" . SPARSER::MOLECULE) ("SDS" . SPARSER::PROTEIN)
    ("VCP-Flag" . SPARSER::COLLECTION) ("Flag" . SPARSER::PROTEIN-FAMILY)
    ("chaperone" . SPARSER::PROTEIN) ("prone" . SPARSER::PROTEIN-FAMILY)
    ("large complexes containing ubiquitinated proteins and transport"
     . SPARSER::COLLECTION)
    ("polyubiquitin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("AAA" . SPARSER::PROTEIN) ("fate" . SPARSER::PROTEIN)
    ("Akt and VCP" . SPARSER::COLLECTION) ("protein (VCP)" . SPARSER::PROTEIN)
    ("VCP" . SPARSER::PROTEIN) ("Akt1" . SPARSER::PROTEIN)
    ("PDCD 4" . SPARSER::PROTEIN) ("BCL2" . SPARSER::PROTEIN)
    ("perinuclear region" . SPARSER::PROTEIN) ("p27 kip1" . SPARSER::PROTEIN)
    ("p21 Cip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Caspase9" . SPARSER::PROTEIN) ("14-3-3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Polo-Like kinase" . SPARSER::PROTEIN)
    ("glucocorticoid receptor" . SPARSER::PROTEIN) ("SP5" . SPARSER::PROTEIN)
    ("a 20" . SPARSER::PROTEIN) ("IκBα" . SPARSER::PROTEIN)
    ("Caspase 9" . SPARSER::PROTEIN) ("PDCD4" . SPARSER::PROTEIN)
    ("programmed cell death 4" . SPARSER::PROTEIN) ("MG-132" . SPARSER::DRUG)
    ("N 2" . SPARSER::PROTEIN) ("vacuolating cytotoxin" . SPARSER::PROTEIN)
    ("TA1" . SPARSER::PROTEIN)
    ("phosphatidylinositol 3-kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP-dependent" . SPARSER::PROTEIN)
    ("matrix metalloproteinase and urokinase" . SPARSER::COLLECTION)
    ("urokinase" . SPARSER::PROTEIN) ("GGAA" . SPARSER::PROTEIN)
    ("factor/lymphoid" . SPARSER::COLLECTION)
    ("an essential factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("si-Ets1" . SPARSER::COLLECTION) ("si-CCND1" . SPARSER::COLLECTION)
    ("Ets1 and downstream MMP-9" . SPARSER::COLLECTION)
    ("cyclin D1, Ets1 and downstream MMP-9" . SPARSER::COLLECTION)
    ("matrigel" . SPARSER::PROTEIN)
    ("cyclin D1, Ets1 and MMP-9" . SPARSER::COLLECTION)
    ("cyclin D1, pRB, Ets1 and MMP-9" . SPARSER::COLLECTION)
    ("NC" . SPARSER::PROTEIN) ("pRB" . SPARSER::PROTEIN)
    ("cyclin D1 ( P <0.0001, xref ) or Ets1 ( P <0.0001, xref )"
     . SPARSER::COLLECTION)
    ("TNM" . SPARSER::MOLECULE)
    ("miR-9 directly targets cyclin D1 and v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets1)"
     . SPARSER::COLLECTION)
    ("miR-9 directly targets cyclin D1" . SPARSER::PROTEIN)
    ("v" . SPARSER::PROTEIN) ("NF-kappa" . SPARSER::COLLECTION)
    ("kappa" . SPARSER::PROTEIN-FAMILY) ("MicroRNA" . SPARSER::MICRO-RNA)
    ("oxidase" . SPARSER::PROTEIN) ("miR-15b and miR-16" . SPARSER::COLLECTION)
    ("miRNAs and their target genes" . SPARSER::COLLECTION)
    ("cyclin D1 or Ets1" . SPARSER::COLLECTION)
    ("Ets1 and their downstream targets" . SPARSER::COLLECTION)
    ("cyclin D1, Ets1 and their downstream targets" . SPARSER::COLLECTION)
    ("AGS" . SPARSER::PROTEIN) ("cyclin D1 and Ets1" . SPARSER::COLLECTION)
    ("cyclin D1 and v-ets" . SPARSER::COLLECTION)
    ("v-ets" . SPARSER::COLLECTION) ("ets" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("dual-luciferase" . SPARSER::PROTEIN) ("miR-125b" . SPARSER::MOLECULE)
    ("ETS family" . SPARSER::PROTEIN) ("RB protein" . SPARSER::PROTEIN)
    ("cyclin dependent kinase 4" . SPARSER::PROTEIN)
    ("factor 1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("β-catenin" . SPARSER::PROTEIN) ("CCND1" . SPARSER::PROTEIN)
    ("CD31" . SPARSER::PROTEIN) ("GES-1" . SPARSER::PROTEIN)
    ("CDX2" . SPARSER::PROTEIN) ("caudal type homeobox 2" . SPARSER::PROTEIN)
    ("cytochrome c" . SPARSER::PROTEIN)
    ("enhancer of zeste homolog 2" . SPARSER::PROTEIN)
    ("multidrug resistance" . SPARSER::PROTEIN)
    ("cysteine-rich protein" . SPARSER::PROTEIN)
    ("miR-15b" . SPARSER::MOLECULE) ("Ets1" . SPARSER::PROTEIN)
    ("homolog 1" . SPARSER::PROTEIN)
    ("single-factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Met" . SPARSER::AMINO-ACID)
    ("its histological subtypes" . SPARSER::PROTEIN) ("Sun" . SPARSER::PROTEIN)
    ("MAF" . SPARSER::PROTEIN) ("Wang" . SPARSER::PROTEIN)
    ("other as-yet-unidentified causal genes" . SPARSER::GENE)
    ("chemicals" . SPARSER::MOLECULE) ("MDA and UCSF" . SPARSER::COLLECTION)
    ("MDA" . SPARSER::DRUG) ("these polymorphic variants" . SPARSER::VARIANT)
    ("XRCC1 protein and other base excision repair proteins"
     . SPARSER::COLLECTION)
    ("polymerase (PARP)" . SPARSER::PROTEIN)
    ("DNA polymerase beta, and DNA ligase III" . SPARSER::COLLECTION)
    ("MMR" . SPARSER::PROTEIN) ("mismatch" . SPARSER::PROTEIN)
    ("NER" . SPARSER::PROTEIN)
    ("the most frequent and malignant histologic type" . TYPE)
    ("IV" . SPARSER::PROTEIN) ("Arg/Gln" . SPARSER::COLLECTION)
    ("Gln/Gln" . SPARSER::COLLECTION) ("STATA" . SPARSER::PROTEIN)
    ("XRCC3" . SPARSER::PROTEIN) ("DNA ligase III" . SPARSER::PROTEIN)
    ("DNA polymerase beta" . SPARSER::PROTEIN)
    ("ADP-ribose" . SPARSER::MOLECULE)
    ("scaffolding protein" . SPARSER::PROTEIN) ("XRCC1" . SPARSER::PROTEIN)
    ("X-ray repair" . SPARSER::PROTEIN)
    ("iNOS and ICAM-1" . SPARSER::COLLECTION)
    ("LPS or cytokines" . SPARSER::COLLECTION) ("cGMP" . SPARSER::PROTEIN)
    ("superoxide" . SPARSER::MOLECULE) ("oxidants" . SPARSER::MOLECULE)
    ("nitric oxide (NO)" . SPARSER::MOLECULE) ("oxidant" . SPARSER::PROTEIN)
    ("TNF" . SPARSER::PROTEIN) ("Cdc42 and Vav2" . SPARSER::COLLECTION)
    ("FRG" . SPARSER::PROTEIN) ("Rac1 and cortactin" . SPARSER::COLLECTION)
    ("Rac and Cdc42" . SPARSER::COLLECTION)
    ("cortactin-Arp2/3" . SPARSER::COLLECTION)
    ("the peripheral actin rim" . SPARSER::PROTEIN)
    ("endothelial barrier" . SPARSER::PROTEIN) ("rim" . SPARSER::PROTEIN)
    ("gap" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Inflammatory mediators" . SPARSER::PROTEIN) ("shRNA" . SPARSER::PROTEIN)
    ("NSC" . SPARSER::PROTEIN) ("Cav-1-shRNA" . SPARSER::PROTEIN-PAIR)
    ("Barrier" . SPARSER::PROTEIN) ("Monolayers" . SPARSER::PROTEIN)
    ("increased peripheral F-actin" . SPARSER::BIO-COMPLEX)
    ("the peripheral F-actin" . SPARSER::BIO-COMPLEX)
    ("cm 2" . SPARSER::PROTEIN) ("cAMP" . SPARSER::PROTEIN)
    ("monolayers" . SPARSER::PROTEIN)
    ("Rac1 and caveolin-1" . SPARSER::COLLECTION)
    ("Cortactin" . SPARSER::PROTEIN) ("‘inactive’" . SPARSER::INACTIVE)
    ("‘active’" . SPARSER::ACTIVE)
    ("microvascular endothelial barrier" . SPARSER::PROTEIN)
    ("the sub-endothelial matrix" . SPARSER::PROTEIN-FAMILY)
    ("RhoA, Rac1, and Cdc42" . SPARSER::COLLECTION)
    ("actin and/or membrane-binding proteins" . SPARSER::COLLECTION)
    ("EC" . SPARSER::PROTEIN) ("caveolin-1-Rac1" . SPARSER::COLLECTION)
    ("caveolin-1 and caveolin-2" . SPARSER::COLLECTION)
    ("caveolins" . SPARSER::PROTEIN-FAMILY) ("clathrin" . SPARSER::PROTEIN)
    ("FITC" . SPARSER::MOLECULE) ("TER" . SPARSER::PROTEIN)
    ("Rac1 and the endothelial barrier" . SPARSER::COLLECTION)
    ("the endothelial barrier" . SPARSER::PROTEIN)
    ("Rac1-cortactin" . SPARSER::COLLECTION) ("cortactin" . SPARSER::PROTEIN)
    ("receptor proteins" . SPARSER::RECEPTOR-PROTEIN)
    ("NF-κB" . SPARSER::PROTEIN) ("TNFR-1" . SPARSER::PROTEIN)
    ("Tumor necrosis factor receptor" . SPARSER::PROTEIN)
    ("tumor necrosis factor" . SPARSER::PROTEIN) ("Vav2" . SPARSER::PROTEIN)
    ("Dock180" . SPARSER::PROTEIN)
    ("exchange factors" . SPARSER::EXCHANGE-FACTOR)
    ("Arp2/3" . SPARSER::PROTEIN) ("S1P" . SPARSER::PROTEIN)
    ("Sphingosine-1-phosphate" . SPARSER::DRUG) ("phenol red" . SPARSER::DRUG)
    ("Fluorescein Isothiocyanate" . SPARSER::MOLECULE)
    ("tyrosine kinase" . SPARSER::PROTEIN) ("F-actin" . SPARSER::BIO-COMPLEX)
    ("Rho GTPase" . SPARSER::PROTEIN) ("Cav-1" . SPARSER::PROTEIN)
    ("Caveolin-1" . SPARSER::PROTEIN) ("caveolin-2" . SPARSER::PROTEIN)
    ("caveolin-1" . SPARSER::PROTEIN)
    ("attractive therapeutic targets" . SPARSER::TARGET-PROTEIN)
    ("GSK3 or PAK1" . SPARSER::COLLECTION)
    ("MAP4 and Stathmin" . SPARSER::COLLECTION)
    ("proteins or MAPs" . SPARSER::COLLECTION)
    ("Rac1, Cdc42 and PI3K" . SPARSER::COLLECTION)
    ("threonine" . SPARSER::AMINO-ACID) ("PDK" . SPARSER::PROTEIN)
    ("PLC/PKC/GSK3" . SPARSER::COLLECTION) ("PLC" . SPARSER::PROTEIN)
    ("cofilin" . SPARSER::PROTEIN) ("AB" . SPARSER::PROTEIN)
    ("DN-Cdc42" . SPARSER::COLLECTION) ("Par6/aPKC" . SPARSER::COLLECTION)
    ("anchor" . SPARSER::ANCHOR) ("dynein" . SPARSER::PROTEIN)
    ("filaments" . SPARSER::PROTEIN-FAMILY) ("kinase-" . SPARSER::KINASE)
    ("DN-PAK1" . SPARSER::COLLECTION) ("Rac1 or Cdc42" . SPARSER::COLLECTION)
    ("PAK" . SPARSER::PROTEIN) ("PI3K and GSK3" . SPARSER::COLLECTION)
    ("GSK3 and Stathmin" . SPARSER::COLLECTION)
    ("PI3K or Akt" . SPARSER::COLLECTION)
    ("ErbB2/PI3K/Akt" . SPARSER::COLLECTION) ("MAP" . SPARSER::PROTEIN)
    ("stabilizing and destabilizing microtubule-associated proteins"
     . SPARSER::PROTEIN)
    ("MAPs" . SPARSER::PROTEIN) ("LiCl" . SPARSER::DRUG)
    ("PI3K ( xref ) or Akt (data not shown)" . SPARSER::COLLECTION)
    ("soluble tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("VIII" . SPARSER::PROTEIN) ("polymerized microtubules" . SPARSER::PROTEIN)
    ("PKCα and PKCζ" . SPARSER::COLLECTION)
    ("myristoylated" . SPARSER::PROTEIN)
    ("PLCγ and cPKCs" . SPARSER::COLLECTION) ("CCKVL" . SPARSER::PROTEIN)
    ("PKCδ (an nPKC) or PKCζ (an aPKC)" . SPARSER::COLLECTION)
    ("abnormal peripheral microtubules" . SPARSER::PROTEIN)
    ("aPKC" . SPARSER::PROTEIN) ("DAG and phospholipids" . SPARSER::COLLECTION)
    ("the atypical PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DAG and Ca 2+" . SPARSER::COLLECTION)
    ("Ca 2+ or DAG" . SPARSER::COLLECTION)
    ("phospholipids" . SPARSER::PHOSPHOLIPID)
    ("diacylglycerol (DAG) and inositol 1,4,5-trisphosphate"
     . SPARSER::COLLECTION)
    ("DAG" . SPARSER::DAG) ("diacylglycerol" . SPARSER::PROTEIN)
    ("PKCs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Kinases" . SPARSER::KINASE)
    ("GSK3 and APC" . SPARSER::COLLECTION) ("DN-GSK3" . SPARSER::COLLECTION)
    ("PLCγ and Memo/ACF7" . SPARSER::COLLECTION)
    ("peripheral microtubules" . SPARSER::PROTEIN)
    ("ACF7-CCKVL" . SPARSER::COLLECTION)
    ("effectors, mDia1 and APC" . SPARSER::COLLECTION)
    ("DN-RhoA" . SPARSER::COLLECTION)
    ("dominant negative (DN) Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DN" . SPARSER::PROTEIN) ("HRG" . SPARSER::PROTEIN)
    ("heregulin" . SPARSER::PROTEIN) ("APC and ACF7" . SPARSER::COLLECTION)
    ("mDia1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("APC" . SPARSER::PROTEIN)
    ("mDia" . SPARSER::PROTEIN) ("acto-myosin" . SPARSER::COLLECTION)
    ("myosin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("organized around integrins" . SPARSER::PROTEIN)
    ("integrins" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Akt/PI3K" . SPARSER::COLLECTION) ("PTB" . SPARSER::PROTEIN)
    ("tyrosines" . SPARSER::AMINO-ACID) ("Receptor" . SPARSER::RECEPTOR)
    ("dimers" . SPARSER::DIMER)
    ("receptor homodimers and ErbB2-containing heterodimers"
     . SPARSER::COLLECTION)
    ("heterodimers" . SPARSER::HETERODIMER) ("homodimers" . SPARSER::HOMODIMER)
    ("known ligand" . SPARSER::LIGAND)
    ("ErbB3 and ErbB4" . SPARSER::COLLECTION) ("Neu" . SPARSER::PROTEIN)
    ("Stathmin" . SPARSER::PROTEIN) ("defective chemotaxis" . SPARSER::PROTEIN)
    ("PI3K/Akt" . SPARSER::COLLECTION) ("Cdc42 and RhoA" . SPARSER::COLLECTION)
    ("microtubules and chemotaxis" . SPARSER::COLLECTION)
    ("microtubules" . SPARSER::PROTEIN) ("MgCl 2" . SPARSER::MOLECULE)
    ("monoclonal antibody" . SPARSER::DRUG) ("6.3" . SPARSER::PROTEIN)
    ("IPA-3" . SPARSER::MOLECULE) ("SB203580" . SPARSER::DRUG)
    ("UO126" . SPARSER::DRUG) ("PD098059" . SPARSER::DRUG)
    ("LY294002" . SPARSER::MOLECULE) ("N3" . SPARSER::PROTEIN)
    ("PLCγ1" . SPARSER::PROTEIN) ("assembly/disassembly" . SPARSER::PROTEIN)
    ("MAP4" . SPARSER::PROTEIN) ("Par6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("diacylglycerol kinase" . SPARSER::PROTEIN) ("mDia2" . SPARSER::PROTEIN)
    ("Receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PAK1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("GSK3β" . SPARSER::PROTEIN)
    ("PKCε" . SPARSER::PROTEIN) ("PKCζ" . SPARSER::PROTEIN)
    ("PKCδ" . SPARSER::PROTEIN) ("PKCγ" . SPARSER::PROTEIN)
    ("PKCβ" . SPARSER::PROTEIN) ("PKCα" . SPARSER::PROTEIN)
    ("Ca 2+" . SPARSER::CALCIUM-ION)
    ("inositol 1,4,5-trisphosphate" . SPARSER::MOLECULE)
    ("SiRNA-mediated" . SPARSER::PROTEIN) ("DRF1" . SPARSER::PROTEIN)
    ("p38" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ErbB3" . SPARSER::PROTEIN)
    ("ErbB1" . SPARSER::PROTEIN) ("GSK3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PLCγ" . SPARSER::PROTEIN-FAMILY) ("phospholipase C" . SPARSER::PROTEIN)
    ("ACF7" . SPARSER::PROTEIN) ("ErbB2" . SPARSER::PROTEIN)
    ("the putative receptor or specific inhibitors" . SPARSER::COLLECTION)
    ("antibodies or antibodies" . SPARSER::COLLECTION)
    ("viral proteins" . SPARSER::PROTEIN)
    ("cellular cytokines" . SPARSER::PROTEIN) ("pox" . SPARSER::PROTEIN)
    ("a polymorphic receptor" . SPARSER::PROTEIN)
    ("IL-10 or other cytokines" . SPARSER::COLLECTION)
    ("inducing IL-10 and other cytokines ( xref )" . SPARSER::COLLECTION)
    ("-NH 2" . SPARSER::MOLECULE) ("-COOH" . SPARSER::COLLECTION)
    ("Soluble peptides" . SPARSER::PEPTIDE) ("CKS" . SPARSER::PROTEIN)
    ("Il-6 and IL-10" . SPARSER::COLLECTION) ("Il-6" . SPARSER::PROTEIN)
    ("Se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("selenium" . SPARSER::MOLECULE)
    ("Monocyte-derived macrophages" . SPARSER::PROTEIN)
    ("TNF-α, IL-1, IL-6, RANTES, MIP-1α, and MIP-1β" . SPARSER::COLLECTION)
    ("MCP-1/CCL2" . SPARSER::COLLECTION)
    ("monocytes and neutrophils" . SPARSER::COLLECTION)
    ("IL-8, TNF-alpha, and MCP-1" . SPARSER::COLLECTION)
    ("neutrophils" . SPARSER::PROTEIN) ("MMPs" . SPARSER::PROTEIN)
    ("monocytes/macrophages" . SPARSER::COLLECTION)
    ("IL-8, MCP-1 and TNF-alpha" . SPARSER::COLLECTION)
    ("soluble TREM-1" . SPARSER::PROTEIN)
    ("MMP-1 and TREM-1" . SPARSER::COLLECTION)
    ("a strong immunosuppressive cytokine" . SPARSER::PROTEIN)
    ("IL-10 and other cytokines" . SPARSER::COLLECTION)
    ("Supplementary tables S5 and S6" . SPARSER::COLLECTION)
    ("cytokines and other genes" . SPARSER::COLLECTION)
    ("IFNgamma" . SPARSER::PROTEIN) ("RANTES" . SPARSER::PROTEIN)
    ("MDC" . SPARSER::PROTEIN)
    ("IL-10 and the described SNP" . SPARSER::COLLECTION)
    ("Promoter" . SPARSER::PROMOTER) ("Nucleotide" . SPARSER::NUCLEOTIDE)
    ("TREM-1 and MMP-1" . SPARSER::COLLECTION) ("examples" . SPARSER::EXAMPLE)
    ("a soluble form" . SPARSER::FORM)
    ("FCN1, CXCL9 and SEPP1" . SPARSER::COLLECTION) ("MIG" . SPARSER::PROTEIN)
    ("monocytes and macrophages" . SPARSER::COLLECTION)
    ("protease" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("a healthy blood donor 24 hrs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CXCL9 and IL-2" . SPARSER::COLLECTION)
    ("cytokines and chemokines" . SPARSER::COLLECTION)
    ("chemokines" . SPARSER::PROTEIN)
    ("IL-1 alpha and IL-13" . SPARSER::COLLECTION)
    ("IL-10 and IFN gamma" . SPARSER::COLLECTION) ("ConA" . SPARSER::PROTEIN)
    ("pg" . SPARSER::MOLECULE) ("IL-10 and IL-6" . SPARSER::COLLECTION)
    ("homopolymer" . SPARSER::MOLECULE)
    ("an immunosuppressive polymer" . SPARSER::MOLECULE)
    ("polymer" . SPARSER::MOLECULE) ("PHA" . SPARSER::PROTEIN)
    ("COOH" . SPARSER::PROTEIN) ("hydrochloride" . SPARSER::MOLECULE)
    ("EDC" . SPARSER::MOLECULE) ("polymers" . SPARSER::MOLECULE)
    ("bovine serum albumin (BSA)" . SPARSER::PROTEIN)
    ("BSA" . SPARSER::PROTEIN) ("Cytokines" . SPARSER::PROTEIN)
    ("Peptides" . SPARSER::PEPTIDE)
    ("IL-6 and other genes" . SPARSER::COLLECTION)
    ("a trimeric conformation" . SPARSER::BIO-CONFORMATION)
    ("endotoxin" . SPARSER::MOLECULE) ("PKC" . SPARSER::PROTEIN)
    ("mers" . SPARSER::PROTEIN)
    ("different retroviral TM proteins" . SPARSER::PROTEIN)
    ("TM" . SPARSER::PROTEIN) ("FCN1 and SEPP1" . SPARSER::COLLECTION)
    ("MMP-1, TREM-1 and IL-1beta" . SPARSER::COLLECTION)
    ("IL-2 and CXCL9" . SPARSER::COLLECTION)
    ("homopolymers" . SPARSER::MOLECULE)
    ("Recombinant gp41 and a synthetic peptide" . SPARSER::COLLECTION)
    ("IL-6 and IL-10" . SPARSER::COLLECTION) ("mitogen" . SPARSER::MITOGEN)
    ("target cell" . SPARSER::PROTEIN) ("MIP-1β" . SPARSER::PROTEIN)
    ("MIP-1α" . SPARSER::PROTEIN) ("CCL2" . SPARSER::PROTEIN)
    ("chemoattractant protein-1" . SPARSER::PROTEIN)
    ("MMP-9" . SPARSER::PROTEIN) ("TGF-alpha" . SPARSER::PROTEIN)
    ("IL-1" . SPARSER::PROTEIN) ("TNF-alpha" . SPARSER::PROTEIN)
    ("CXCR3" . SPARSER::PROTEIN) ("CXCL11" . SPARSER::PROTEIN)
    ("CXCL10" . SPARSER::PROTEIN)
    ("selenoprotein P" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("IFNγ" . SPARSER::PROTEIN)
    ("triggering receptor expressed on myeloid cells 1" . SPARSER::PROTEIN)
    ("matrix metalloproteinase" . SPARSER::PROTEIN)
    ("IL-13" . SPARSER::PROTEIN) ("IL-1 alpha" . SPARSER::PROTEIN)
    ("IFN gamma" . SPARSER::PROTEIN) ("MIP-3alpha" . SPARSER::PROTEIN)
    ("MCP-2" . SPARSER::DRUG) ("MCP-1" . SPARSER::PROTEIN)
    ("NH 2" . SPARSER::MOLECULE) ("Concanavalin A" . SPARSER::PROTEIN)
    ("Sulfo-NHS" . SPARSER::DRUG) ("serum albumin" . SPARSER::PROTEIN)
    ("NKp44" . SPARSER::PROTEIN) ("NKp44L" . SPARSER::PROTEIN)
    ("gC1qR" . SPARSER::PROTEIN) ("SEPP1" . SPARSER::PROTEIN)
    ("FCN1" . SPARSER::PROTEIN) ("IL-1beta" . SPARSER::PROTEIN)
    ("TREM-1" . SPARSER::PROTEIN) ("MMP-1" . SPARSER::PROTEIN)
    ("IL-8" . SPARSER::PROTEIN) ("CXCL9" . SPARSER::PROTEIN)
    ("gp41" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("polymorphic variants" . SPARSER::VARIANT)
    ("P53 and BRCA1/2" . SPARSER::COLLECTION)
    ("the polymorphic alleles" . SPARSER::ALLELE)
    ("hormone" . SPARSER::PROTEIN) ("variant" . SPARSER::VARIANT)
    ("rest" . SPARSER::PROTEIN) ("P53 and MDM2" . SPARSER::COLLECTION)
    ("TG" . SPARSER::PROTEIN) ("TT" . SPARSER::PROTEIN)
    ("het  " . SPARSER::HUMAN-PROTEIN-FAMILY) ("CI " . SPARSER::PROTEIN)
    ("Sp1" . SPARSER::PROTEIN)
    ("transcriptional activator" . SPARSER::PROTEIN-FAMILY)
    ("ligase activity" . SPARSER::PROTEIN)
    ("tumor suppressor p53" . SPARSER::PROTEIN)
    ("tumor suppressor gene" . SPARSER::PROTEIN) ("SNP309" . SPARSER::PROTEIN)
    ("Double Minute 2" . SPARSER::PROTEIN)
    ("CyclinD1and CyclinE1" . SPARSER::COLLECTION)
    ("cyclin D1 and cyclin E1, and luciferase" . SPARSER::COLLECTION)
    ("cyclin E1, and luciferase" . SPARSER::COLLECTION)
    ("theoretical targets" . SPARSER::TARGET-PROTEIN)
    ("Ding" . SPARSER::PROTEIN) ("MEKK2 or cyclin D1" . SPARSER::COLLECTION)
    ("Cyclin D1, Cyclin E1, E2F3 and CCND3" . SPARSER::COLLECTION)
    ("E2F3 and CCND3" . SPARSER::COLLECTION) ("microRNA" . SPARSER::MICRO-RNA)
    ("GSE" . SPARSER::PROTEIN)
    ("a tumor suppressor miRNA and downregulation" . SPARSER::COLLECTION)
    ("suppressors or oncogenes" . SPARSER::COLLECTION)
    ("Cyclin/CDKs" . SPARSER::COLLECTION)
    ("cyclin-dependent kinases (CDK)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclin/CDK" . SPARSER::COLLECTION)
    ("Cyclin D1, cyclin E1 and pRb" . SPARSER::COLLECTION)
    ("cyclin D1, cyclin E1 and pRb" . SPARSER::COLLECTION)
    ("phosphorylated pRb and proliferative marker PCNA" . SPARSER::COLLECTION)
    ("Cyclin D1 or Cyclin E1" . SPARSER::COLLECTION) ("ORF" . SPARSER::PROTEIN)
    ("cyclin E1-3" . SPARSER::COLLECTION) ("cyclin D1-3" . SPARSER::COLLECTION)
    ("cyclin D1 or cyclin E1" . SPARSER::COLLECTION)
    ("GFP-γ-tubulin" . SPARSER::COLLECTION)
    ("CDK2 and p21" . SPARSER::COLLECTION)
    ("the phosphorylated pRb (p-pRb) and proliferative marker PCNA"
     . SPARSER::COLLECTION)
    ("p-pRb" . SPARSER::COLLECTION)
    ("Cyclin D1 and Cyclin E1" . SPARSER::COLLECTION)
    ("MTT" . SPARSER::MOLECULE) ("LN18" . SPARSER::PROTEIN)
    ("past" . SPARSER::PROTEIN) ("glial" . SPARSER::PROTEIN)
    ("miRNAs" . SPARSER::MICRO-RNA) ("RNAs" . SPARSER::RNA)
    ("MicroRNAs" . SPARSER::MICRO-RNA) ("pRb/E2F" . SPARSER::COLLECTION)
    ("kinase (CAK)" . SPARSER::KINASE) ("cyclin D1/CDK4" . SPARSER::COLLECTION)
    ("CAK" . SPARSER::PROTEIN) ("CDK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Cyclin D1 and cyclin E1" . SPARSER::COLLECTION)
    ("Cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CDKs" . SPARSER::PROTEIN)
    ("cyclins" . SPARSER::HUMAN-PROTEIN-FAMILY) ("miRNA" . SPARSER::MICRO-RNA)
    ("cyclin D1 and cyclin E1" . SPARSER::COLLECTION)
    ("-UTR" . SPARSER::COLLECTION) ("UTR" . SPARSER::PROTEIN)
    ("pRb and PCNA" . SPARSER::COLLECTION)
    ("phosphorylated retinoblastoma (pRb) and proliferating cell nuclear antigen (PCNA)"
     . SPARSER::COLLECTION)
    ("PCNA" . SPARSER::PROTEIN) ("retinoblastoma" . SPARSER::PROTEIN)
    ("miR" . SPARSER::MICRO-RNA)
    ("important epigenetic modulators" . SPARSER::PROTEIN)
    ("microRNAs" . SPARSER::MICRO-RNA) ("CyclinE1" . SPARSER::PROTEIN)
    ("cyclin D2" . SPARSER::PROTEIN) ("MEKK2" . SPARSER::PROTEIN)
    ("its 3" . SPARSER::PROTEIN) ("cyclin family" . SPARSER::PROTEIN)
    ("CCND3" . SPARSER::PROTEIN) ("E2F3" . SPARSER::PROTEIN)
    ("cyclin-dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cyclinE1" . SPARSER::PROTEIN) ("γ-tubulin" . SPARSER::PROTEIN)
    ("small nuclear RNA" . SPARSER::RNA) ("as 2" . SPARSER::PROTEIN)
    ("pGL3" . SPARSER::PROTEIN) ("E2" . SPARSER::MOLECULE)
    ("G1-S" . SPARSER::PROTEIN)
    ("cyclin dependent kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("proliferating cell nuclear antigen" . SPARSER::PROTEIN)
    ("a principal inhibitor" . SPARSER::INHIBITOR)
    ("fibrin" . SPARSER::PROTEIN) ("OR1, OR2 and OR3" . SPARSER::COLLECTION)
    ("serpin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("States" . SPARSER::BIO-STATE)
    ("CIs" . SPARSER::PROTEIN) ("t-PA" . SPARSER::PROTEIN)
    ("plasminogen activator" . SPARSER::PROTEIN) ("OR2 " . SPARSER::MOLECULE)
    ("OR1 " . SPARSER::PROTEIN) ("OR2" . SPARSER::PROTEIN)
    ("OR1" . SPARSER::PROTEIN) ("SERPINE1" . SPARSER::PROTEIN)
    ("serine protease inhibitor" . SPARSER::PROTEIN)
    ("CI 1" . SPARSER::PROTEIN) ("PAI-1" . SPARSER::PROTEIN)
    ("plasminogen activator inhibitor-1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase (MAPK) and Akt" . SPARSER::COLLECTION)
    ("Pyk2, focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK) and Akt"
     . SPARSER::COLLECTION)
    ("kinase (FAK)" . SPARSER::KINASE) ("FAK" . SPARSER::PROTEIN)
    ("/Akt" . SPARSER::COLLECTION) ("formin" . SPARSER::PROTEIN)
    ("P27RF-Rho, MMP2, MMP9, and VEGF" . SPARSER::COLLECTION)
    ("MMP2 and MMP9" . SPARSER::COLLECTION)
    ("Cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("MCL" . SPARSER::PROTEIN)
    ("para" . SPARSER::PROTEIN-FAMILY) ("an aggressive form" . SPARSER::FORM)
    ("P27RF-Rho, MMP2, MMP9 and VEGF" . SPARSER::COLLECTION)
    ("Cyclin G1, Cyclin A, Cyclin D1 and CDK4" . SPARSER::COLLECTION)
    ("cyclin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Genes" . SPARSER::GENE)
    ("Hepatocytes" . SPARSER::PROTEIN) ("RhoA and RhoC" . SPARSER::COLLECTION)
    ("RhoB and RhoC" . SPARSER::COLLECTION) ("RhoB" . SPARSER::PROTEIN)
    ("GTPases" . SPARSER::GTPASE) ("Rho" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Proteins" . SPARSER::PROTEIN) ("alcohol" . SPARSER::DRUG)
    ("toxin" . SPARSER::PROTEIN) ("aflatoxin" . SPARSER::MOLECULE)
    ("MMP9 and vascular endothelial growth factor" . SPARSER::COLLECTION)
    ("VEGF" . SPARSER::PROTEIN) ("metalloprotease" . SPARSER::PROTEIN)
    ("Gene" . SPARSER::GENE) ("HL" . SPARSER::PROTEIN)
    ("HCC" . SPARSER::PROTEIN) ("RhoC" . SPARSER::PROTEIN)
    ("Pyk2" . SPARSER::PROTEIN) ("phosphatidylinositol-3" . SPARSER::PROTEIN)
    ("FMNL3" . SPARSER::PROTEIN) ("FMNL2" . SPARSER::PROTEIN)
    ("formin-like" . SPARSER::PROTEIN) ("kip1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cell membrane" . SPARSER::PROTEIN) ("Rho family" . SPARSER::PROTEIN)
    ("P27RF-Rho" . SPARSER::PROTEIN)
    ("alkaline phosphatase" . SPARSER::PROTEIN-FAMILY)
    ("polyvinylidene fluoride" . SPARSER::DRUG)
    ("p27RF-Rho" . SPARSER::PROTEIN) ("Cyclin D1" . SPARSER::PROTEIN)
    ("Cyclin G1" . SPARSER::PROTEIN) ("Cyclin A" . SPARSER::PROTEIN)
    ("α-tubulin" . SPARSER::PROTEIN) ("G418" . SPARSER::MOLECULE)
    ("vascular endothelial growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MMP2" . SPARSER::PROTEIN) ("vasculature" . SPARSER::PROTEIN)
    ("matrices" . SPARSER::PROTEIN-FAMILY)
    ("PDGFR and P-Rex1" . SPARSER::COLLECTION)
    ("P-Rex1 and an RTK (PDGFRβ)" . SPARSER::COLLECTION)
    ("receptors and RTKs" . SPARSER::COLLECTION)
    ("the RacGEF P-Rex1 or the related molecule" . SPARSER::COLLECTION)
    ("P-Rex1 and the receptor tyrosine kinase PDGFRβ" . SPARSER::COLLECTION)
    ("family or PI3K" . SPARSER::COLLECTION)
    ("PDGFRβ or PI3K" . SPARSER::COLLECTION)
    ("either PDGFR (PDGFRi; 5 µM) or PI3K (PI-103, 1 µM)"
     . SPARSER::COLLECTION)
    ("P-Rex1 or PDGFRβ" . SPARSER::COLLECTION)
    ("PDGFRβ or P-Rex1" . SPARSER::COLLECTION) ("PDGFR" . SPARSER::PROTEIN)
    ("PDGFRα and PDGFRβ" . SPARSER::COLLECTION)
    ("polypeptides" . SPARSER::PROTEIN)
    ("PDGFRα and P-Rex1" . SPARSER::COLLECTION)
    ("P-Rex1 and PDGFRs" . SPARSER::COLLECTION) ("PDGFRs" . SPARSER::PROTEIN)
    ("GD and Tiam1" . SPARSER::COLLECTION) ("PDGFRβ-GFP" . SPARSER::COLLECTION)
    ("myc-Tiam1" . SPARSER::COLLECTION) ("myc-P-Rex1" . SPARSER::COLLECTION)
    ("P-Rex1 and receptors" . SPARSER::COLLECTION)
    ("Heregulin/NRG1" . SPARSER::COLLECTION)
    ("Neuregulin/ErbB" . SPARSER::COLLECTION) ("Heregulin" . SPARSER::PROTEIN)
    ("Neuregulin" . SPARSER::PROTEIN) ("P-Rex1 and PDGF" . SPARSER::COLLECTION)
    ("PDGF" . SPARSER::PROTEIN)
    ("epidermal growth factor (EGF) and lysophosphatidic acid (LPA)"
     . SPARSER::COLLECTION)
    ("LPA" . SPARSER::PROTEIN) ("oligonucleotides" . SPARSER::MOLECULE)
    ("Matrigel" . SPARSER::PROTEIN) ("Rex" . SPARSER::PROTEIN)
    ("FMI" . SPARSER::PROTEIN) ("Substrates" . SPARSER::SUBSTRATE)
    ("P-Rex1 or Tiam1" . SPARSER::COLLECTION)
    ("the parental line" . SPARSER::PROTEIN)
    ("P-Rex1-GD" . SPARSER::COLLECTION) ("GD" . SPARSER::PROTEIN)
    ("TRITC-phalloidin staining" . SPARSER::MOLECULE)
    ("TRITC-phalloidin" . SPARSER::MOLECULE) ("phalloidin" . SPARSER::MOLECULE)
    ("TRITC" . SPARSER::MOLECULE) ("actin" . SPARSER::PROTEIN)
    ("P-Rex1 and Tiam1" . SPARSER::COLLECTION) ("GTPase" . SPARSER::GTPASE)
    ("myc" . SPARSER::PROTEIN) ("PDGFRβ and P-Rex1" . SPARSER::COLLECTION)
    ("P-Rex1 and the PDGFRβ receptor tyrosine kinase" . SPARSER::COLLECTION)
    ("receptor tyrosine kinases (RTKs), phosphatidyl inositol 3-kinase (PI3K) and PTEN"
     . SPARSER::COLLECTION)
    ("inositol" . SPARSER::PROTEIN) ("phosphatidyl" . SPARSER::MOLECULE)
    ("RTKs" . SPARSER::PROTEIN)
    ("the phospholipid PI(3,4,5)P 3 and βγ subunits" . SPARSER::COLLECTION)
    ("subunits" . SPARSER::FRAGMENT) ("GEF" . SPARSER::PROTEIN)
    ("regulators" . SPARSER::REGULATOR)
    ("approximately 60 independent Dbl family GEFs" . SPARSER::GEF)
    ("GEFs" . SPARSER::PROTEIN) ("GTP" . SPARSER::NUCLEOTIDE)
    ("Dbl" . SPARSER::PROTEIN) ("RhoGEFs" . SPARSER::PROTEIN)
    ("Rac1, RhoA or Cdc42" . SPARSER::COLLECTION) ("RhoA" . SPARSER::PROTEIN)
    ("RTK" . SPARSER::PROTEIN)
    ("the same macromolecular complex" . SPARSER::BIO-COMPLEX)
    ("P-Rex1 and PDGFRβ" . SPARSER::COLLECTION) ("RacGEF" . SPARSER::PROTEIN)
    ("Rac" . SPARSER::HUMAN-PROTEIN-FAMILY) ("anti-oxidant" . SPARSER::DRUG)
    ("a 3" . SPARSER::HUMAN-PROTEIN-FAMILY) ("RAC1" . SPARSER::PROTEIN)
    ("TUB2" . SPARSER::PROTEIN) ("β-tubulin" . SPARSER::PROTEIN)
    ("PREX1" . SPARSER::PROTEIN) ("a 3D" . SPARSER::PROTEIN)
    ("growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("exchange factor" . SPARSER::EXCHANGE-FACTOR) ("S5" . SPARSER::MOLECULE)
    ("PI-103" . SPARSER::DRUG) ("PDGFRα" . SPARSER::PROTEIN)
    ("myc-tagged" . SPARSER::PROTEIN) ("NRG1" . SPARSER::PROTEIN)
    ("PDGF-BB" . SPARSER::PROTEIN) ("lysophosphatidic acid" . SPARSER::LPA)
    ("min −1" . SPARSER::PROTEIN) ("S4" . SPARSER::PROTEIN-FAMILY)
    ("filamentous actin" . SPARSER::BIO-COMPLEX) ("Tiam1" . SPARSER::PROTEIN)
    ("receptor tyrosine kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor tyrosine kinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("G-proteins" . SPARSER::PROTEIN) ("P 3" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("guanine nucleotide exchange factors" . SPARSER::GEF)
    ("Cdc42" . SPARSER::PROTEIN) ("Rac1" . SPARSER::PROTEIN)
    ("PDGFRβ" . SPARSER::PROTEIN) ("PDGF receptor" . SPARSER::PROTEIN)
    ("derived growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("P-Rex1" . SPARSER::PROTEIN)
    ("guanine nucleotide exchange factor" . SPARSER::GEF)
    ("a HDL-associated antioxidant enzyme" . SPARSER::PROTEIN)
    ("lipoprotein" . SPARSER::PROTEIN) ("LDL" . SPARSER::PROTEIN)
    ("statin" . SPARSER::MOLECULE) ("versa" . SPARSER::PROTEIN)
    ("angiographically demonstrable CAD" . SPARSER::PROTEIN)
    ("n " . SPARSER::PROTEIN) ("drugs and statins" . SPARSER::COLLECTION)
    ("statins" . SPARSER::DRUG) ("troponin" . SPARSER::PROTEIN)
    ("ST" . SPARSER::PROTEIN) ("HDL-associated enzyme PON1" . SPARSER::PROTEIN)
    ("a HDL-associated enzyme" . SPARSER::ENZYME) ("PON" . SPARSER::PROTEIN)
    ("Paraoxonase" . SPARSER::PROTEIN) ("CAD and ACS" . SPARSER::COLLECTION)
    ("monocytes" . SPARSER::PROTEIN) ("HDL" . SPARSER::PROTEIN)
    ("CAD or ACS" . SPARSER::COLLECTION) ("Monocytes" . SPARSER::PROTEIN)
    ("CAD" . SPARSER::PROTEIN) ("Sirt1" . SPARSER::PROTEIN)
    ("C-reactive protein" . SPARSER::PROTEIN)
    ("Paraoxonase 1" . SPARSER::PROTEIN) ("interleukin-6" . SPARSER::PROTEIN)
    ("creatine kinase" . SPARSER::PROTEIN) ("g protein" . SPARSER::PROTEIN)
    ("Na 3 VO 4" . SPARSER::MOLECULE) ("Interleukin-6" . SPARSER::PROTEIN)
    ("S12" . SPARSER::PROTEIN) ("murine leukemia virus" . SPARSER::PROTEIN)
    ("Troponin T" . SPARSER::PROTEIN) ("PON1" . SPARSER::PROTEIN)
    ("PDB" . SPARSER::MOLECULE) ("Red" . SPARSER::PROTEIN)
    ("green" . SPARSER::PROTEIN) ("ligand-receptor" . SPARSER::PROTEIN)
    ("MEP" . SPARSER::PROTEIN)
    ("the structurally and electrostatically diverse antagonists"
     . SPARSER::MOLECULE)
    ("antagonists" . SPARSER::MOLECULE)
    ("Mol-6 receptors and the inhibitors" . SPARSER::COLLECTION)
    ("each representative receptor" . SPARSER::PROTEIN)
    ("NF675" . SPARSER::PROTEIN)
    ("the representative SIRT2 complex" . SPARSER::BIO-COMPLEX)
    ("re-docked all the inhibitors" . SPARSER::INHIBITOR)
    ("nf675" . SPARSER::PROTEIN) ("gauge" . SPARSER::PROTEIN-FAMILY)
    ("SIRT2-nf675" . SPARSER::PROTEIN-PAIR) ("salermide" . SPARSER::DRUG)
    ("ASn" . SPARSER::AMINO-ACID) ("Ile" . SPARSER::AMINO-ACID)
    ("Thr" . SPARSER::AMINO-ACID) ("Ser" . SPARSER::AMINO-ACID)
    ("Suramin" . SPARSER::DRUG) ("NF" . SPARSER::PROTEIN)
    ("gold" . SPARSER::MOLECULE) ("GOLD" . SPARSER::MOLECULE)
    ("antagonist" . SPARSER::MOLECULE)
    ("the optimal docked conformations" . SPARSER::BIO-CONFORMATION)
    ("SIRT2 and its inhibitors" . SPARSER::COLLECTION)
    ("Bim" . SPARSER::PROTEIN) ("tubulin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pro-apoptotic genes" . SPARSER::GENE) ("Salermide" . SPARSER::DRUG)
    ("rDNA" . SPARSER::PROTEIN) ("fat" . SPARSER::PROTEIN)
    ("adenine" . SPARSER::NUCLEOBASE) ("cofactor" . SPARSER::MOLECULE)
    ("protein and NAD +" . SPARSER::COLLECTION)
    ("4 invariant cysteine's" . SPARSER::AMINO-ACID)
    ("a structural zinc atom" . SPARSER::MOLECULE)
    ("dinucleotide" . SPARSER::MOLECULE) ("zinc-binding" . SPARSER::PROTEIN)
    ("approximately 250 amino acids" . SPARSER::AMINO-ACID)
    ("sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("histones and various proteins" . SPARSER::COLLECTION)
    ("nicotinamide, and O-acetyl-ADP-ribose" . SPARSER::COLLECTION)
    ("nicotinamide" . SPARSER::PROTEIN) ("histones" . SPARSER::PROTEIN)
    ("deacetylases and adenosine" . SPARSER::COLLECTION)
    ("adenosine" . SPARSER::PROTEIN) ("Sirtuins" . SPARSER::PROTEIN-FAMILY)
    ("The Sir2 (silence information regulator 2) or sirtuin family"
     . SPARSER::COLLECTION)
    ("class I and II histone deacetylases (HDACs)" . SPARSER::COLLECTION)
    ("deacetylases" . SPARSER::PROTEIN) ("fit" . SPARSER::PROTEIN-FAMILY)
    ("van" . SPARSER::PROTEIN) ("Gln" . SPARSER::AMINO-ACID)
    ("sirtinol" . SPARSER::DRUG) ("suramin" . SPARSER::DRUG)
    ("MM-PBSA" . SPARSER::COLLECTION) ("PBSA" . SPARSER::PROTEIN)
    ("oxygen atom" . SPARSER::MOLECULE)
    ("SIR2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Na +" . SPARSER::MOLECULE)
    ("TIP3" . SPARSER::PROTEIN) ("zinc atom" . SPARSER::MOLECULE)
    ("O-acetyl-ADP-ribose" . SPARSER::MOLECULE) ("SIRT1" . SPARSER::PROTEIN)
    ("NAD +" . SPARSER::MOLECULE) ("Sir2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("histone deacetylase" . SPARSER::PROTEIN) ("SIRT2" . SPARSER::PROTEIN)
    ("Sirtuin 2" . SPARSER::PROTEIN)
    ("various external factors" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Enzymes" . SPARSER::ENZYME)
    ("further N -glycan biomarkers" . SPARSER::MOLECULE)
    ("A2 and A2G1" . SPARSER::COLLECTION) ("autoantibody" . SPARSER::PROTEIN)
    ("Class" . CLASS) ("a potential indirect regulator" . SPARSER::PROTEIN)
    ("Ikaros" . SPARSER::PROTEIN) ("substrates" . SPARSER::SUBSTRATE)
    ("N -linked type complex glycopeptides" . SPARSER::MOLECULE)
    ("GDP-fucose" . SPARSER::NUCLEOTIDE) ("GDP" . SPARSER::NUCLEOTIDE)
    ("therapeutics" . SPARSER::THERAPEUTICS)
    ("-galactosyltransferase" . SPARSER::COLLECTION)
    ("one separate cohort" . SPARSER::MOLECULE) ("HNF1a" . SPARSER::PROTEIN)
    ("minor and non-systemic" . SPARSER::COLLECTION)
    ("minor" . SPARSER::PROTEIN) ("Afro" . SPARSER::PROTEIN)
    ("N -glycans and SLE" . SPARSER::COLLECTION) ("held" . SPARSER::PROTEIN)
    ("CRP" . SPARSER::PROTEIN)
    ("Systemic Lupus Erythematosus" . SPARSER::PROTEIN)
    ("Weaker" . SPARSER::PROTEIN) ("FN" . SPARSER::PROTEIN)
    ("tryptic glycopeptides" . SPARSER::MOLECULE)
    ("IgG1 and IgG2" . SPARSER::COLLECTION)
    ("glycopeptides" . SPARSER::MOLECULE)
    ("both Fc and Fab glycans" . SPARSER::COLLECTION) ("Fc" . SPARSER::PROTEIN)
    ("peroxisomal protein" . SPARSER::PROTEIN)
    ("tripeptide" . SPARSER::MOLECULE)
    ("a strong suppressor" . SPARSER::SUPPRESSOR)
    ("metalloproteinases" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("complex (npBAF complex) and the neuron-specific chromatin-remodelling complex (nBAF complex)"
     . SPARSER::COLLECTION)
    ("the neural progenitors-specific chromatin" . SPARSER::PROTEIN)
    ("ABCF2" . SPARSER::PROTEIN)
    ("RECK (rs4878639 was suggestively associated with IGP17; p = 3.51×10 −8 ) and PEX5 (rs12828421 suggestively associated with IGP41; p = 4.48×10 −8 )"
     . SPARSER::COLLECTION)
    ("ABCF2-SMARCD3" . SPARSER::COLLECTION) ("RECK" . SPARSER::PROTEIN)
    ("antiporter" . SPARSER::PROTEIN)
    ("HLA-DQA2-HLA-DQB2" . SPARSER::COLLECTION)
    ("proline" . SPARSER::AMINO-ACID) ("lipid" . SPARSER::LIPID)
    ("phospholipid" . SPARSER::PHOSPHOLIPID)
    ("suppressor or promoter" . SPARSER::COLLECTION)
    ("the intestinal epithelial barrier" . SPARSER::PROTEIN)
    ("laminin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Variants" . SPARSER::VARIANT)
    ("OSM" . SPARSER::PROTEIN) ("LIF" . SPARSER::PROTEIN)
    ("CNTF" . SPARSER::PROTEIN) ("GGT" . SPARSER::PROTEIN)
    ("luminal" . SPARSER::DRUG) ("ER" . SPARSER::PROTEIN)
    ("BG1" . SPARSER::PROTEIN) ("ADHD" . SPARSER::PROTEIN)
    ("cirrhosis" . SPARSER::PROTEIN)
    ("MGAT3 genes and ST6GAL1" . SPARSER::COLLECTION)
    ("ST6GAL1-MGAT3" . SPARSER::COLLECTION)
    ("ST6GAL1-B4GALT1" . SPARSER::COLLECTION)
    ("FUT8-MGAT3" . SPARSER::COLLECTION) ("FUT8-B4GALT1" . SPARSER::COLLECTION)
    ("protein-protein" . SPARSER::COLLECTION) ("beta" . SPARSER::PROTEIN)
    ("glycoprotein" . SPARSER::PROTEIN)
    ("SYNGR1-TAB1-MGAT3-CACNA1I" . SPARSER::COLLECTION)
    ("A2, A2G1 and A2G2" . SPARSER::COLLECTION)
    ("total and neutral fractions" . SPARSER::COMPONENT)
    ("the total neutral fraction" . SPARSER::COMPONENT)
    ("the total and neutral fraction" . SPARSER::COMPONENT)
    ("GlcNAc" . SPARSER::PROTEIN-FAMILY) ("FA" . SPARSER::PROTEIN)
    ("galactosyltransferase" . SPARSER::PROTEIN) ("CI" . SPARSER::PROTEIN)
    ("GC" . SPARSER::PROTEIN)
    ("ST6GAL1 , B4GALT1 , FUT8 and MGAT3" . SPARSER::COLLECTION)
    ("SUV420H1-CHKA" . SPARSER::COLLECTION) ("CHKA" . SPARSER::PROTEIN)
    ("the former cohort" . SPARSER::MOLECULE)
    ("the latter cohort" . SPARSER::MOLECULE) ("cohorts" . SPARSER::MOLECULE)
    ("Vis" . SPARSER::DRUG) ("each available cohort" . SPARSER::MOLECULE)
    ("art" . SPARSER::HUMAN-PROTEIN-FAMILY) ("LLS" . SPARSER::MOLECULE)
    ("monoclonal antibodies" . SPARSER::ANTIBODY)
    ("IgG-Fc" . SPARSER::PROTEIN-PAIR) ("ADCC" . SPARSER::PROTEIN)
    ("fucose" . SPARSER::MOLECULE) ("IgGs" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("galactose" . SPARSER::MOLECULE) ("Asn" . SPARSER::AMINO-ACID)
    ("complex bi-antennary oligosaccharides" . SPARSER::MOLECULE)
    ("oligosaccharides" . SPARSER::MOLECULE)
    ("a single covalently attached bi-antennary N -glycan" . SPARSER::MOLECULE)
    ("asparagine" . SPARSER::AMINO-ACID)
    ("a well-documented example" . SPARSER::EXAMPLE)
    ("example" . SPARSER::EXAMPLE) ("glycoproteins" . SPARSER::PROTEIN)
    ("their substantial biomarker" . SPARSER::MOLECULE)
    ("biomarker" . SPARSER::MOLECULE) ("traits" . SPARSER::PROTEIN)
    ("Ikzf1" . SPARSER::PROTEIN)
    ("systemic lupus erythematosus" . SPARSER::PROTEIN)
    ("ST6GAL1 , B4GALT1 , FUT8 , and MGAT3" . SPARSER::COLLECTION)
    ("SMARCB1-DERL3" . SPARSER::COLLECTION)
    ("glycosyltransferases" . SPARSER::PROTEIN)
    ("B4GALT1 and MGAT3" . SPARSER::COLLECTION) ("MS" . SPARSER::PROTEIN)
    ("PAX5" . SPARSER::PROTEIN) ("etc." . SPARSER::PROTEIN)
    ("Alpha-" . SPARSER::PROTEIN)
    ("interleukin 6 signal transducer" . SPARSER::PROTEIN)
    ("beta1" . SPARSER::PROTEIN) ("ST6GALI" . SPARSER::PROTEIN)
    ("HNF1" . SPARSER::PROTEIN) ("2/3" . SPARSER::PROTEIN)
    ("N-glycans" . SPARSER::MOLECULE) ("−3" . SPARSER::PROTEIN)
    ("IgG2" . SPARSER::BIO-COMPLEX) ("PTS1" . SPARSER::PROTEIN)
    ("PEX 5" . SPARSER::PROTEIN) ("nuclear receptor" . SPARSER::PROTEIN)
    ("member 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ATP-binding cassette" . SPARSER::PROTEIN) ("PEX5" . SPARSER::PROTEIN)
    ("SLC38A10" . SPARSER::PROTEIN) ("HLA-DQB2" . SPARSER::PROTEIN)
    ("HLA-DQA2" . SPARSER::PROTEIN)
    ("transmembrane protein 1" . SPARSER::PROTEIN) ("PRRT1" . SPARSER::PROTEIN)
    ("FA1" . SPARSER::PROTEIN) ("IL-2" . SPARSER::PROTEIN)
    ("BACH2" . SPARSER::PROTEIN) ("beta 1" . SPARSER::PROTEIN)
    ("LAMB1" . SPARSER::PROTEIN) ("oncostatin M" . SPARSER::PROTEIN)
    ("ciliary neurotrophic factor" . SPARSER::PROTEIN)
    ("interleukin 6" . SPARSER::PROTEIN)
    ("transcriptional regulator" . SPARSER::PROTEIN-FAMILY)
    ("DNA-binding protein Ikaros" . SPARSER::PROTEIN)
    ("γ-glutamyl" . SPARSER::MOLECULE)
    ("Type 2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("(beta" . SPARSER::PROTEIN)
    ("CACNA1I" . SPARSER::PROTEIN) ("TAB1" . SPARSER::PROTEIN)
    ("SYNGR1" . SPARSER::PROTEIN) ("A2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("fucosyltransferase 8" . SPARSER::PROTEIN)
    ("N-glycan" . SPARSER::MOLECULE) ("FcγRIIIa" . SPARSER::PROTEIN)
    ("sialic acid" . SPARSER::MOLECULE) ("CH2" . SPARSER::PROTEIN)
    ("N -glycan" . SPARSER::MOLECULE)
    ("type 1" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DERL3" . SPARSER::PROTEIN)
    ("SMARCB1" . SPARSER::PROTEIN) ("SUV420H1" . SPARSER::PROTEIN)
    ("SMARCD3" . SPARSER::PROTEIN) ("IL6ST" . SPARSER::PROTEIN)
    ("IKZF1" . SPARSER::PROTEIN) ("FUT8" . SPARSER::PROTEIN)
    ("ST6GAL1" . SPARSER::PROTEIN) ("MGAT3" . SPARSER::PROTEIN)
    ("B4GALT1" . SPARSER::PROTEIN) ("N -glycans" . SPARSER::MOLECULE)
    ("TLR" . SPARSER::PROTEIN) ("the mucosal barrier" . SPARSER::PROTEIN)
    ("GALT" . SPARSER::PROTEIN) ("barrier" . SPARSER::PROTEIN)
    ("pro-apoptotic ASK-1" . SPARSER::PROTEIN) ("caspase" . SPARSER::PROTEIN)
    ("the downstream anti-apoptotic components Bcl-2 ( xref ) and Bcl-xL ( xref )"
     . SPARSER::COLLECTION)
    ("weaker" . SPARSER::PROTEIN) ("MHC" . SPARSER::PROTEIN)
    ("CD80, CD86, CD83 and CCR7" . SPARSER::COLLECTION)
    ("LPS/TNFα/IL-1β" . SPARSER::COLLECTION)
    ("DC-SIGN or MCLRs" . SPARSER::COLLECTION)
    ("DC-SIGN or other MCLRs" . SPARSER::COLLECTION)
    ("monomeric form" . SPARSER::FORM)
    ("presumably gp120 immune complexes" . SPARSER::BIO-COMPLEX)
    ("soluble ICAM-3" . SPARSER::PROTEIN)
    ("cross-linked gp120 and HIV(+) sera" . SPARSER::COLLECTION)
    ("antagonistic mAbs" . SPARSER::DRUG)
    ("more prominent AV" . SPARSER::MOLECULE)
    ("AV or PI" . SPARSER::COLLECTION)
    ("virtually all the gp120" . SPARSER::PROTEIN)
    ("gp120 and anti-gp120" . SPARSER::COLLECTION) ("mask" . SPARSER::PROTEIN)
    ("DC-SIGN and mannose" . SPARSER::COLLECTION)
    ("a retroviral envelope component" . SPARSER::COMPONENT)
    ("bacterial LPS and the pro-inflammatory cytokines TNF-α and IL-1β ( xref )"
     . SPARSER::COLLECTION)
    ("bacterial LPS" . SPARSER::PROTEIN)
    ("gp120/DC-SIGN" . SPARSER::COLLECTION) ("fraction" . SPARSER::COMPONENT)
    ("IgG" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("either virion-bound gp120 and/or gp120" . SPARSER::COLLECTION)
    ("recombinant gp120 ( xref ) and viral RNA" . SPARSER::COLLECTION)
    ("viral RNA" . SPARSER::RNA) ("the viral RNA" . SPARSER::RNA)
    ("p-ASK1" . SPARSER::COLLECTION) ("p-Raf-1" . SPARSER::COLLECTION)
    ("HIV(+) sera-treated moDC" . SPARSER::PROTEIN)
    ("sera, and co-cultured" . SPARSER::COLLECTION)
    ("LPS, TNFα or IL1β" . SPARSER::COLLECTION)
    ("LPS, TNFα or IL-1β" . SPARSER::COLLECTION)
    ("CD4/CCR5" . SPARSER::COLLECTION)
    ("LPS, TNF-α or IL-1β" . SPARSER::COLLECTION) ("MoDC" . SPARSER::PROTEIN)
    ("LPS, TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("gp120, and DC-SIGN" . SPARSER::COLLECTION)
    ("CD40 and CD11c" . SPARSER::COLLECTION)
    ("EndoH-treated gp120" . SPARSER::PROTEIN)
    ("these respective fractions" . SPARSER::COMPONENT)
    ("HIV-1(+) serum-treated moDC" . SPARSER::PROTEIN)
    ("anti-DC-SIGN mAbs ( xref ) or anti-CD40L mAbs ( xref )"
     . SPARSER::COLLECTION)
    ("TdT" . SPARSER::PROTEIN)
    ("the HIV-1(+) sera-treated moDC" . SPARSER::PROTEIN)
    ("fractions" . SPARSER::COMPONENT) ("sera" . SPARSER::PROTEIN)
    ("mere" . SPARSER::PROTEIN-FAMILY)
    ("the immune-complex EndoH-treated gp120" . SPARSER::PROTEIN)
    ("dimeric form" . SPARSER::FORM)
    ("the deglycosylated monomeric gp120" . SPARSER::PROTEIN)
    ("FcR" . SPARSER::PROTEIN-FAMILY) ("mannan" . SPARSER::MOLECULE)
    ("Abs" . SPARSER::PROTEIN) ("endo" . SPARSER::PROTEIN)
    ("lectin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("mannose" . SPARSER::MOLECULE)
    ("carbohydrate" . SPARSER::MOLECULE)
    ("CD4/chemokine" . SPARSER::COLLECTION)
    ("these antagonistic mAbs" . SPARSER::DRUG)
    ("first pre-treated moDC" . SPARSER::PROTEIN)
    ("anti-CD4/chemokine receptor" . SPARSER::COLLECTION)
    ("the adherent CD40L transfectants" . SPARSER::PROTEIN)
    ("DC-SIGN-transfectants" . SPARSER::COLLECTION)
    ("transfectants" . SPARSER::PROTEIN) ("mAbs" . SPARSER::DRUG)
    ("an antagonistic anti-CD40L mAb" . SPARSER::DRUG)
    ("CD40/CD40L" . SPARSER::COLLECTION) ("mAb" . SPARSER::DRUG)
    ("CD40-CD40L" . SPARSER::COLLECTION) ("dimeric gp120" . SPARSER::PROTEIN)
    ("monomeric gp120" . SPARSER::PROTEIN) ("iodide" . SPARSER::PROTEIN)
    ("propidium" . SPARSER::MOLECULE) ("AV" . SPARSER::MOLECULE)
    ("/DC-SIGN" . SPARSER::COLLECTION)
    ("recombinant gp120 (gp120-DC) and co-cultured for 3"
     . SPARSER::COLLECTION)
    ("CD40L-" . SPARSER::PROTEIN) ("moDC" . SPARSER::PROTEIN)
    ("chemotaxis" . SPARSER::PROTEIN) ("p-ASK-1" . SPARSER::COLLECTION)
    ("MAPKKK" . SPARSER::PROTEIN) ("p-Raf" . SPARSER::COLLECTION)
    ("Raf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("signalosome" . SPARSER::PROTEIN)
    ("Bcl-2 and Bcl-xL" . SPARSER::COLLECTION) ("p-Akt" . SPARSER::COLLECTION)
    ("Akt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("anti- and pro-apoptotic molecules" . SPARSER::COLLECTION)
    ("pro-apoptotic molecules" . SPARSER::MOLECULE)
    ("TNF-α and IL-β" . SPARSER::COLLECTION) ("IL" . SPARSER::PROTEIN)
    ("LN" . SPARSER::PROTEIN) ("integrin" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD4 and chemokine" . SPARSER::COLLECTION)
    ("CCR5 or CXCR4" . SPARSER::COLLECTION) ("chemokine" . SPARSER::PROTEIN)
    ("viral gp120" . SPARSER::PROTEIN)
    ("pro-apoptotic molecule ASK-1" . SPARSER::PROTEIN)
    ("bacterial product lipopolysaccharide or pro-inflammatory cytokines"
     . SPARSER::PROTEIN)
    ("TNF-α and IL-1β" . SPARSER::COLLECTION)
    ("antigen" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the pro-apoptotic molecule ASK-1" . SPARSER::PROTEIN)
    ("either cross-linked recombinant gp120 or immune-complex gp120"
     . SPARSER::COLLECTION)
    ("TNFα and IL-1β" . SPARSER::COLLECTION) ("LPS" . SPARSER::PROTEIN)
    ("viral envelope protein gp120" . SPARSER::PROTEIN)
    ("p24" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD20" . SPARSER::PROTEIN)
    ("mitomycin C" . SPARSER::DRUG) ("and 1 µ" . SPARSER::PROTEIN)
    ("CD45RA" . SPARSER::PROTEIN) ("CD45RO" . SPARSER::PROTEIN)
    ("IgG1" . SPARSER::BIO-COMPLEX) ("IgG2a" . SPARSER::PROTEIN)
    ("CD56" . SPARSER::PROTEIN) ("CD19" . SPARSER::PROTEIN)
    ("CD16" . SPARSER::PROTEIN) ("CD8" . SPARSER::PROTEIN)
    ("IL-4" . SPARSER::PROTEIN) ("CCR7" . SPARSER::PROTEIN)
    ("CD83" . SPARSER::PROTEIN) ("CD86" . SPARSER::PROTEIN)
    ("CD80" . SPARSER::PROTEIN) ("Fc receptor" . SPARSER::PROTEIN)
    ("IL-12" . SPARSER::PROTEIN) ("IL-10" . SPARSER::PROTEIN)
    ("ASK1" . SPARSER::PROTEIN) ("IL1β" . SPARSER::PROTEIN)
    ("CD11c" . SPARSER::PROTEIN) ("3 d" . SPARSER::PROTEIN-FAMILY)
    ("ICAM-3" . SPARSER::PROTEIN) ("chemokine receptor" . SPARSER::PROTEIN)
    ("HLA-DR" . SPARSER::PROTEIN) ("DC28" . SPARSER::PROTEIN)
    ("Annexin-V" . SPARSER::PROTEIN) ("kinase-1" . SPARSER::PROTEIN)
    ("Raf-1" . SPARSER::PROTEIN) ("Bcl-xL" . SPARSER::PROTEIN)
    ("Bcl-2" . SPARSER::PROTEIN) ("CD40L" . SPARSER::PROTEIN)
    ("CD40 ligand" . SPARSER::PROTEIN) ("annexin V" . SPARSER::PROTEIN)
    ("CD14" . SPARSER::PROTEIN) ("CXCR4" . SPARSER::PROTEIN)
    ("CCR5" . SPARSER::PROTEIN) ("CD4" . SPARSER::PROTEIN)
    ("TNF-α" . SPARSER::PROTEIN) ("surface protein" . SPARSER::PROTEIN)
    ("ASK-1" . SPARSER::PROTEIN) ("IL-1β" . SPARSER::PROTEIN)
    ("CD40" . SPARSER::PROTEIN) ("gp120" . SPARSER::PROTEIN)
    ("envelope protein" . SPARSER::PROTEIN) ("DC-SIGN" . SPARSER::PROTEIN)
    ("KEAP1, NRF2, and DPP3" . SPARSER::COLLECTION)
    ("KEAP1, DPP3, and NRF2" . SPARSER::COLLECTION)
    ("NRF2 and KEAP1" . SPARSER::COLLECTION) ("MCMBP" . SPARSER::PROTEIN)
    ("WTX, DPP3, and PALB2" . SPARSER::COLLECTION)
    ("KEAP1-associated proteins" . SPARSER::PROTEIN)
    ("KEAP1/NRF2/CUL3" . SPARSER::COLLECTION)
    ("KEAP1/NRF2" . SPARSER::COLLECTION) ("KEAP1-NRF2" . SPARSER::COLLECTION)
    ("tBHQ" . SPARSER::DRUG)
    ("a sterically unfavorable conformation" . SPARSER::BIO-CONFORMATION)
    ("agonist" . SPARSER::AGONIST) ("HMOX1 and GCSm" . SPARSER::COLLECTION)
    ("heme" . SPARSER::PROTEIN)
    ("ARE" . SPARSER::ANTI-OXIDANT-RESPONSE-ELEMENT)
    ("ala" . SPARSER::AMINO-ACID) ("dimeric KEAP1" . SPARSER::PROTEIN)
    ("exogenous NRF2" . SPARSER::PROTEIN)
    ("both the KEAP1-KEAP1 homodimer and KEAP1-BTB heterodimer"
     . SPARSER::COLLECTION)
    ("KEAP1-KEAP1" . SPARSER::COLLECTION)
    ("heterodimer" . SPARSER::HETERODIMER)
    ("streptavidin and FLAG" . SPARSER::COLLECTION)
    ("monomer" . SPARSER::MONOMER) ("streptavidin" . SPARSER::PROTEIN)
    ("SBPHA-KEAP1" . SPARSER::COLLECTION)
    ("monomeric KEAP1" . SPARSER::PROTEIN)
    ("homodimeric KEAP1" . SPARSER::PROTEIN)
    ("phenylalanine" . SPARSER::AMINO-ACID)
    ("similar tertiary conformations" . SPARSER::BIO-CONFORMATION)
    ("DPP3 and NRF2" . SPARSER::COLLECTION)
    ("propeller" . SPARSER::PROTEIN-FAMILY) ("alanine" . SPARSER::AMINO-ACID)
    ("SBPHA" . SPARSER::PROTEIN) ("DPP3 or DPP3" . SPARSER::COLLECTION)
    ("both exogenous and endogenous KEAP1 protein" . SPARSER::PROTEIN)
    ("SBPHA-DPP3" . SPARSER::COLLECTION)
    ("DPP3 and KEAP1" . SPARSER::COLLECTION)
    ("Streptavidin" . SPARSER::PROTEIN) ("DPP3" . SPARSER::PROTEIN)
    ("FLAG-KEAP1" . SPARSER::COLLECTION) ("KEAP1-DPP3" . SPARSER::COLLECTION)
    ("FLAG" . SPARSER::PROTEIN-FAMILY)
    ("the integrated PIN revealed no common interacting proteins"
     . SPARSER::PROTEIN)
    ("KEAP1 and DPP3" . SPARSER::COLLECTION) ("III" . SPARSER::PROTEIN)
    ("FAM117B, MCM3, TSC22D4, WDR1, DPP3 and SLK" . SPARSER::COLLECTION)
    ("WDR1 and TSC22D4" . SPARSER::COLLECTION)
    ("KEAP1, DPP3, FAM117B, MCM3, SLK and MAD2L1" . SPARSER::COLLECTION)
    ("map" . SPARSER::PROTEIN)
    ("exogenous TSC22D4 and WDR1" . SPARSER::COLLECTION)
    ("TSC22D4 and WDR1" . SPARSER::COLLECTION) ("SLK" . SPARSER::PROTEIN)
    ("FAM" . SPARSER::PROTEIN) ("PIN" . SPARSER::PROTEIN)
    ("detergent" . SPARSER::MOLECULE) ("shotgun" . SPARSER::PROTEIN)
    ("functionally control NRF2" . SPARSER::PROTEIN)
    ("WTX and PALB2" . SPARSER::COLLECTION)
    ("PALB2, and p21" . SPARSER::COLLECTION)
    ("p62/SQSTM1" . SPARSER::COLLECTION)
    ("KEAP1 or NRF2" . SPARSER::COLLECTION)
    ("DLG or ETGE" . SPARSER::COLLECTION)
    ("KEAP1 and NRF2" . SPARSER::COLLECTION)
    ("NRF2 or KEAP1" . SPARSER::COLLECTION) ("homodimer" . SPARSER::HOMODIMER)
    ("cysteines" . SPARSER::AMINO-ACID) ("DLG and ETGE" . SPARSER::COLLECTION)
    ("KEAP1:NRF2" . SPARSER::BIO-COMPLEX) ("monomers" . SPARSER::MONOMER)
    ("DLG" . SPARSER::PROTEIN)
    ("a homodimeric E3 ubiquitin ligase complex" . SPARSER::BIO-COMPLEX)
    ("scaffold" . SPARSER::SCAFFOLD)
    ("clear electrophilic xenobiotics" . SPARSER::MOLECULE)
    ("xenobiotics" . SPARSER::MOLECULE) ("n" . SPARSER::PROTEIN)
    ("WTX, PALB2, and SQSTM1" . SPARSER::COLLECTION)
    ("DPP" . SPARSER::MOLECULE) ("peptidase" . SPARSER::PROTEIN)
    ("associated proteins" . SPARSER::PROTEIN)
    ("PALB2 and SQSTM1" . SPARSER::COLLECTION) ("WTX" . SPARSER::PROTEIN)
    ("the KEAP1 ubiquitin ligase or its substrate NRF2 (NFE2L2)"
     . SPARSER::COLLECTION)
    ("cytoprotective genes" . SPARSER::GENE)
    ("exopeptidase activity" . SPARSER::PROTEIN) ("CUL3" . SPARSER::PROTEIN)
    ("tert-butylhydroquinone" . SPARSER::DRUG) ("HMOX1" . SPARSER::PROTEIN)
    ("siRNA-mediated" . SPARSER::PROTEIN) ("WDR1" . SPARSER::PROTEIN)
    ("TSC22D4" . SPARSER::PROTEIN) ("MAD2L1" . SPARSER::PROTEIN)
    ("MCM3" . SPARSER::PROTEIN) ("LSM5" . SPARSER::PROTEIN)
    ("NPM1" . SPARSER::PROTEIN) ("UB1" . SPARSER::PROTEIN)
    ("Dual-Luciferase" . SPARSER::PROTEIN) ("hNQO1" . SPARSER::PROTEIN)
    ("CO2" . SPARSER::PROTEIN) ("a 37" . SPARSER::PROTEIN)
    ("p62" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("tumor suppressor protein" . SPARSER::PROTEIN)
    ("protein can" . SPARSER::PROTEIN) ("a 2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("cullin-3" . SPARSER::PROTEIN)
    ("NF-E2-related factor 2" . SPARSER::PROTEIN) ("SQSTM1" . SPARSER::PROTEIN)
    ("PALB2" . SPARSER::PROTEIN) ("AMER1" . SPARSER::PROTEIN)
    ("NFE2L2" . SPARSER::PROTEIN) ("NRF2" . SPARSER::PROTEIN)
    ("KEAP1" . SPARSER::PROTEIN) ("myogenic" . SPARSER::PROTEIN)
    ("astrocytes" . SPARSER::PROTEIN) ("c-Myc and HRAS" . SPARSER::COLLECTION)
    ("pan-cytokeratin" . SPARSER::COLLECTION)
    ("cytokeratin" . SPARSER::PROTEIN) ("pan" . SPARSER::PROTEIN)
    ("Metastatic foci" . SPARSER::PROTEIN) ("red" . SPARSER::PROTEIN)
    ("PET" . SPARSER::PROTEIN) ("c-Myc, HRAS and shp53" . SPARSER::COLLECTION)
    ("NRAS" . SPARSER::PROTEIN) ("hepatocytes" . SPARSER::PROTEIN)
    ("cancer cause various histological subtypes" . SPARSER::PROTEIN)
    ("subtypes" . SPARSER::PROTEIN) ("variants" . SPARSER::VARIANT)
    ("transposase" . SPARSER::PROTEIN)
    ("HRAS, c-Myc and shp53" . SPARSER::COLLECTION)
    ("shp" . SPARSER::HUMAN-PROTEIN-FAMILY) ("HRAS" . SPARSER::PROTEIN)
    ("CDK4" . SPARSER::PROTEIN)
    ("cyclin-dependent kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("double minute 2" . SPARSER::PROTEIN)
    ("cytokeratin 20" . SPARSER::PROTEIN) ("cytokeratin 7" . SPARSER::PROTEIN)
    ("α-SMA" . SPARSER::PROTEIN) ("S100" . SPARSER::PROTEIN)
    ("HMB45" . SPARSER::DRUG) ("CD163" . SPARSER::PROTEIN)
    ("tumor suppressor P53" . SPARSER::PROTEIN) ("c-Myc" . SPARSER::PROTEIN)
    ("CD34-LSKs" . SPARSER::PROTEIN-PAIR) ("GMP" . SPARSER::GMP)
    ("CD34-" . SPARSER::PROTEIN) ("GMPs" . SPARSER::PROTEIN)
    ("Nuclear" . SPARSER::PROTEIN) ("myeloid and AML" . SPARSER::COLLECTION)
    ("dys" . SPARSER::PROTEIN)
    ("AKT and the chromosome 21 gene ERG" . SPARSER::COLLECTION)
    ("ERK1/2 and STAT" . SPARSER::COLLECTION) ("STAT" . SPARSER::PROTEIN)
    ("Flt3, Jak2, Jak3 and Mpl" . SPARSER::COLLECTION)
    ("Mpl" . SPARSER::PROTEIN) ("CMK and CHRF" . SPARSER::COLLECTION)
    ("cytarabine" . SPARSER::MOLECULE)
    ("kinases and a component" . SPARSER::COLLECTION)
    ("JNK" . SPARSER::PROTEIN) ("AP-1" . SPARSER::PROTEIN)
    ("p-4EBP1" . SPARSER::COLLECTION) ("p-FOXO3a" . SPARSER::COLLECTION)
    ("serine" . SPARSER::AMINO-ACID)
    ("both CMK (DS-AMKL cell line) and CHRF (non-DS AMKL cell line)"
     . SPARSER::COLLECTION)
    ("DMSO" . SPARSER::MOLECULE) ("BrdU" . SPARSER::DRUG)
    ("trypan" . SPARSER::DRUG) ("receptors and tyrosine" . SPARSER::COLLECTION)
    ("PI3K/AKT/mTOR" . SPARSER::COLLECTION) ("KIT" . SPARSER::PROTEIN)
    ("JAK" . SPARSER::PROTEIN) ("tyrosine" . SPARSER::AMINO-ACID)
    ("CMK and CMY" . SPARSER::COLLECTION)
    ("GATA1 and JAK3" . SPARSER::COLLECTION) ("IGF/IGFR" . SPARSER::COLLECTION)
    ("IGFR" . SPARSER::PROTEIN) ("IGF" . SPARSER::PROTEIN)
    ("CMK" . SPARSER::PROTEIN) ("DS and non-DS" . SPARSER::COLLECTION)
    ("ERG or GATA1s" . SPARSER::COLLECTION)
    ("FOXO1 and FOXO3a" . SPARSER::COLLECTION) ("p-AKT" . SPARSER::COLLECTION)
    ("leukemia" . SPARSER::PROTEIN)
    ("phospho-AKT, phospho-c-Jun and FOXOs" . SPARSER::COLLECTION)
    ("phospho-AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("FOXOs" . SPARSER::PROTEIN-FAMILY)
    ("ERG and myrAKT+ERG" . SPARSER::COLLECTION)
    ("ERG or myrAKT+ERG" . SPARSER::COLLECTION)
    ("MLL-AF9" . SPARSER::COLLECTION)
    ("c-Kit, CD41 and CD42" . SPARSER::COLLECTION)
    ("ERG and Migr1" . SPARSER::COLLECTION) ("cytometry" . SPARSER::PROTEIN)
    ("TPO, IL3, IL6 and SCF" . SPARSER::COLLECTION) ("RPMI" . SPARSER::PROTEIN)
    ("ERG and GATA1s" . SPARSER::COLLECTION)
    ("methylcellulose" . SPARSER::DRUG)
    ("ERG, GATA1s and myrAKT" . SPARSER::COLLECTION)
    ("TPO and SCF" . SPARSER::COLLECTION) ("SCF" . SPARSER::PROTEIN)
    ("TPO" . SPARSER::PROTEIN) ("mcherry" . SPARSER::PROTEIN)
    ("MIGR" . SPARSER::PROTEIN) ("Migr" . SPARSER::PROTEIN)
    ("GFP and m-cherry" . SPARSER::COLLECTION) ("GFP" . SPARSER::PROTEIN)
    ("the GATA-1 leukemic isoform" . SPARSER::PROTEIN)
    ("DS- and non-DS" . SPARSER::COLLECTION) ("DS-" . SPARSER::PROTEIN)
    ("AMKL" . SPARSER::PROTEIN) ("FOXO1/FOXO3a" . SPARSER::COLLECTION)
    ("ERG and GATA1" . SPARSER::COLLECTION)
    ("JAK2 , JAK3 , MPL , and FLT3" . SPARSER::COLLECTION)
    ("DS-AMKL" . SPARSER::COLLECTION) ("MPL" . SPARSER::PROTEIN)
    ("DS-TMD" . SPARSER::PROTEIN-PAIR) ("TMD" . SPARSER::PROTEIN)
    ("DS" . SPARSER::PROTEIN) ("FOXO3a, or AML" . SPARSER::COLLECTION)
    ("AML" . SPARSER::PROTEIN) ("MKs" . SPARSER::PROTEIN)
    ("PI3K/AKT" . SPARSER::COLLECTION) ("ERG" . SPARSER::PROTEIN)
    ("BCR-ABL" . SPARSER::PROTEIN) ("Jak3" . SPARSER::PROTEIN)
    ("Jak2" . SPARSER::PROTEIN) ("Flt3" . SPARSER::PROTEIN)
    ("Ara-C" . SPARSER::DRUG) ("co-factor" . SPARSER::MOLECULE)
    ("4EBP1" . SPARSER::PROTEIN) ("AF9" . SPARSER::PROTEIN)
    ("CD11b" . SPARSER::PROTEIN) ("CD42" . SPARSER::BIO-COMPLEX)
    ("GATA-1" . SPARSER::PROTEIN) ("ribosomal protein" . SPARSER::PROTEIN)
    ("c-jun" . SPARSER::PROTEIN) ("Annexin V" . SPARSER::PROTEIN)
    ("2B" . SPARSER::HUMAN-PROTEIN-FAMILY) ("CD117" . SPARSER::PROTEIN)
    ("GPIbα" . SPARSER::PROTEIN) ("CD42b" . SPARSER::PROTEIN)
    ("CD41" . SPARSER::PROTEIN) ("ERG1" . SPARSER::PROTEIN)
    ("hERG1" . SPARSER::PROTEIN) ("IL6" . SPARSER::PROTEIN)
    ("IL3" . SPARSER::PROTEIN) ("ex2" . SPARSER::PROTEIN)
    ("IGF-1" . SPARSER::PROTEIN) ("FLT3" . SPARSER::PROTEIN)
    ("JAK3" . SPARSER::PROTEIN) ("JAK2" . SPARSER::PROTEIN)
    ("MK2206" . SPARSER::DRUG) ("FOXO3a" . SPARSER::PROTEIN)
    ("c-Jun" . SPARSER::PROTEIN) ("FOXO1" . SPARSER::PROTEIN)
    ("Gata1" . SPARSER::PROTEIN) ("AKT-induced" . SPARSER::PROTEIN)
    ("PI3K" . SPARSER::PROTEIN) ("GATA1" . SPARSER::PROTEIN)
    ("LP" . SPARSER::PROTEIN) ("FS" . SPARSER::PROTEIN)
    ("DF" . SPARSER::PROTEIN)
    ("Food and Drug Administration" . SPARSER::COLLECTION)
    ("phenylindole" . SPARSER::MOLECULE) ("Grid" . SPARSER::PROTEIN)
    ("LAN" . SPARSER::PROTEIN) ("HER2 and CEP17" . SPARSER::COLLECTION)
    ("DAPI" . SPARSER::DRUG) ("Tec" . SPARSER::PROTEIN)
    ("HSR" . SPARSER::PROTEIN) ("n " . SPARSER::PROTEIN)
    ("CEP" . SPARSER::PROTEIN)
    ("several Food and Drug Administration (FDA)-approved methods to evaluate HER2 status"
     . SPARSER::COLLECTION)
    ("FDA" . SPARSER::PROTEIN) ("Drug" . SPARSER::DRUG)
    ("Food" . SPARSER::MOLECULE) ("trastuzumab" . SPARSER::DRUG)
    ("automated quantitative HER2 FISH" . SPARSER::PROTEIN)
    ("aim" . SPARSER::PROTEIN) ("call" . SPARSER::PROTEIN)
    ("Chromosome 17" . SPARSER::PROTEIN) ("brain)" . SPARSER::PROTEIN)
    ("green fluorescent" . SPARSER::PROTEIN) ("Core2" . SPARSER::PROTEIN)
    ("tyrosine kinase receptor" . SPARSER::PROTEIN)
    ("chromosome 17" . SPARSER::PROTEIN) ("HER2" . SPARSER::PROTEIN)
    ("adjuvant" . SPARSER::DRUG)
    ("c-MET and anaplastic lymphoma kinase" . SPARSER::COLLECTION)
    ("ATP-competitive" . SPARSER::ATP) ("kinases" . SPARSER::KINASE)
    ("ATP" . SPARSER::ATP) ("Crizotinib" . SPARSER::DRUG)
    ("DLBL and MM" . SPARSER::COLLECTION)
    ("So far MET gene CN" . SPARSER::PROTEIN) ("cut" . SPARSER::PROTEIN)
    ("GCB" . SPARSER::PROTEIN) ("bcl-2 and MUM1" . SPARSER::COLLECTION)
    ("MUM1/IRF4" . SPARSER::COLLECTION) ("Rituximab" . SPARSER::DRUG)
    ("cyclophosphamide, doxorubicin, vincristine, and prednisolone"
     . SPARSER::COLLECTION)
    ("CHOP" . SPARSER::PROTEIN) ("prednisolone" . SPARSER::DRUG)
    ("vincristine" . SPARSER::DRUG) ("cyclophosphamide" . SPARSER::DRUG)
    ("IE" . SPARSER::PROTEIN) ("the prognostic impact" . SPARSER::PROTEIN)
    ("primary intestinal DLBL" . SPARSER::PROTEIN)
    ("the sole clinicopathological prognostic factor"
     . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CNA" . SPARSER::PROTEIN) ("MM" . SPARSER::PROTEIN)
    ("activator" . SPARSER::ACTIVATOR) ("HGF/MET" . SPARSER::COLLECTION)
    ("/MET" . SPARSER::COLLECTION) ("HGF" . SPARSER::PROTEIN)
    ("CNAs" . SPARSER::PROTEIN)
    ("a poor prognostic factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI-DLBL" . SPARSER::COLLECTION) ("DLBL" . SPARSER::PROTEIN)
    ("the sole clinicopathological factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("PI-DLBLs" . SPARSER::PROTEIN-PAIR) ("PI" . SPARSER::PROTEIN)
    ("CN" . SPARSER::PROTEIN) ("MET" . SPARSER::PROTEIN)
    ("anaplastic lymphoma kinase" . SPARSER::PROTEIN)
    ("c-MET" . SPARSER::PROTEIN) ("PF-02341066" . SPARSER::DRUG)
    ("CD10" . SPARSER::PROTEIN) ("IRF4" . SPARSER::PROTEIN)
    ("MUM1" . SPARSER::PROTEIN) ("bcl-6" . SPARSER::PROTEIN)
    ("bcl-2" . SPARSER::PROTEIN) ("6-carboxyfluorescein" . SPARSER::DRUG)
    ("Hepatocyte growth factor" . SPARSER::PROTEIN)
    ("proto-oncogene" . SPARSER::PROTO-ONCOGENE)
    ("DAPK1 and DAPK3" . SPARSER::COLLECTION)
    ("DAPK1, DAPK2, DRAK1, and DRAK2" . SPARSER::COLLECTION)
    ("DAP" . SPARSER::PROTEIN) ("ZIPK" . SPARSER::PROTEIN)
    ("MLL" . SPARSER::PROTEIN) ("SH3" . SPARSER::PROTEIN)
    ("truncal ataxia" . SPARSER::PROTEIN)
    ("autosomal recessive Cayman cerebellar ataxia" . SPARSER::PROTEIN)
    ("ataxia" . SPARSER::PROTEIN) ("caytaxin" . SPARSER::PROTEIN)
    ("Rhodopsin" . SPARSER::PROTEIN) ("rod" . SPARSER::PROTEIN)
    ("base" . SPARSER::PROTEIN) ("retina" . SPARSER::DRUG)
    ("homeobox" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("the enzyme and cause autosomal recessive lethal congenital contractural syndrome type 3 ( xref )"
     . SPARSER::COLLECTION)
    ("cause autosomal recessive lethal congenital contractural syndrome type 3"
     . SPARSER::PROTEIN)
    ("PIPKI-gamma" . SPARSER::COLLECTION)
    ("phosphatidylinositol" . SPARSER::PROTEIN) ("gamma" . SPARSER::PROTEIN)
    ("TBXA2R or another gene" . SPARSER::COLLECTION)
    ("nonsyndromic sensorineural deafness" . SPARSER::PROTEIN)
    ("an autosomal recessive form" . SPARSER::FORM)
    ("deafness" . SPARSER::PROTEIN)
    ("GIPC3 , TBXA2R , PIP5K1C , RAX2 , ATCAY , and SH3GL1"
     . SPARSER::COLLECTION)
    ("ATCAY" . SPARSER::PROTEIN)
    ("MEK2, P-MEK1/2, and Sprouty1" . SPARSER::COLLECTION)
    ("malformations" . SPARSER::PROTEIN) ("modulators" . SPARSER::PROTEIN)
    ("Sprouty" . SPARSER::PROTEIN-FAMILY)
    ("ERK" . SPARSER::HUMAN-PROTEIN-FAMILY) ("min" . SPARSER::PROTEIN)
    ("four percutaneous tube" . SPARSER::PROTEIN) ("CPAP" . SPARSER::PROTEIN)
    ("ASD" . SPARSER::PROTEIN) ("San" . SPARSER::PROTEIN)
    ("Quad" . SPARSER::DRUG) ("arm" . SPARSER::PROTEIN)
    ("UK" . SPARSER::PROTEIN) ("FISH" . SPARSER::PROTEIN)
    ("SNP" . SPARSER::PROTEIN) ("XX" . SPARSER::PROTEIN)
    ("hg" . SPARSER::MOLECULE) ("CGH" . SPARSER::PROTEIN)
    ("oligonucleotide" . SPARSER::MOLECULE) ("CMA" . SPARSER::PROTEIN)
    ("classical CFC" . SPARSER::PROTEIN)
    ("only one known gene" . SPARSER::GENE) ("known gene" . SPARSER::GENE)
    ("NF1 and Noonan" . SPARSER::COLLECTION) ("CS" . SPARSER::PROTEIN)
    ("NS" . SPARSER::PROTEIN)
    ("Ras/mitogen-activated protein kinase" . SPARSER::COLLECTION)
    ("cohort" . SPARSER::MOLECULE) ("MEK2 and Sprouty1" . SPARSER::COLLECTION)
    ("tip" . SPARSER::PROTEIN) ("seven" . SPARSER::PROTEIN)
    ("BRAF, MEK1, MEK2 , and KRAS" . SPARSER::COLLECTION)
    ("KRAS" . SPARSER::PROTEIN) ("BRAF" . SPARSER::PROTEIN)
    ("CFC" . SPARSER::PROTEIN) ("Ras/MAPK" . SPARSER::COLLECTION)
    ("DRAK2" . SPARSER::PROTEIN) ("DRAK1" . SPARSER::PROTEIN)
    ("DAPK2" . SPARSER::PROTEIN) ("DAPK1" . SPARSER::PROTEIN)
    ("death associated protein" . SPARSER::PROTEIN)
    ("DAPK3" . SPARSER::PROTEIN)
    ("death associated protein kinase" . SPARSER::PROTEIN)
    ("type 3" . SPARSER::PROTEIN)
    ("phosphatidylinositol 4,5-bisphosphate" . SPARSER::PIP2)
    ("autosomal dominant" . SPARSER::PROTEIN)
    ("G-protein coupled" . SPARSER::PROTEIN)
    ("thromboxane A2 receptor" . SPARSER::PROTEIN)
    ("SH3GL1" . SPARSER::PROTEIN) ("RAX2" . SPARSER::PROTEIN)
    ("PIP5K1C" . SPARSER::PROTEIN) ("TBXA2R" . SPARSER::PROTEIN)
    ("GIPC3" . SPARSER::PROTEIN) ("ERK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("MEK1/2" . SPARSER::HUMAN-PROTEIN-FAMILY) ("I19" . SPARSER::PROTEIN)
    ("RP11" . SPARSER::PROTEIN) ("Sprouty 1" . SPARSER::PROTEIN)
    ("P-ERK1/2" . SPARSER::PROTEIN)
    ("beta-mercaptoethanol" . SPARSER::MOLECULE)
    ("Epidermal Growth Factor" . SPARSER::PROTEIN)
    ("L-glutamine" . SPARSER::MOLECULE) ("Amino Acid" . SPARSER::AMINO-ACID)
    ("MAP2K2" . SPARSER::PROTEIN) ("NF1" . SPARSER::PROTEIN)
    ("mitogen-activated protein kinase" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Sprouty1" . SPARSER::PROTEIN) ("P-MEK1" . SPARSER::PROTEIN)
    ("p13" . SPARSER::PROTEIN) ("MEK2" . SPARSER::PROTEIN)
    ("MEK1" . SPARSER::PROTEIN)
    ("cyclin E1 and RSF chromatin" . SPARSER::COLLECTION)
    ("fallopian tube" . SPARSER::PROTEIN) ("tube" . SPARSER::PROTEIN)
    ("cyclin E1 and Rsf-1" . SPARSER::COLLECTION)
    ("CCNE1 and RSF1" . SPARSER::COLLECTION) ("type" . TYPE)
    ("T antigen and H-RAS" . SPARSER::COLLECTION)
    ("Rsf-1-cyclin E1" . SPARSER::COLLECTION)
    ("cyclin E1 and p53" . SPARSER::COLLECTION)
    ("Rsf-1, cyclin E1 and TP53" . SPARSER::COLLECTION)
    ("CDK2/cyclin E" . SPARSER::COLLECTION) ("trigger" . SPARSER::PROTEIN)
    ("Mutant" . SPARSER::MUTANT)
    ("Rsf-1, cyclin E1, and p53" . SPARSER::COLLECTION)
    ("Complex" . SPARSER::BIO-COMPLEX)
    ("Rsf-1 and CCNE1" . SPARSER::COLLECTION)
    ("excessive Rsf-1" . SPARSER::PROTEIN) ("variety" . SPARSER::VARIETY)
    ("Rsf-1/cyclin E1" . SPARSER::COLLECTION)
    ("hrs, and re-stimulated" . SPARSER::COLLECTION) ("FBS" . SPARSER::PROTEIN)
    ("double-thymidine" . SPARSER::PROTEIN) ("PHD" . SPARSER::PROTEIN)
    ("DDT" . SPARSER::PROTEIN) ("fragments" . SPARSER::FRAGMENT)
    ("GST" . SPARSER::PROTEIN) ("mutants" . SPARSER::MUTANT)
    ("Rsf-1, cyclin E1 and p53" . SPARSER::COLLECTION)
    ("Rsf-1, p53 R175H , and cyclin E1" . SPARSER::COLLECTION)
    ("tetra" . SPARSER::MOLECULE)
    ("Rsf-1, cyclin E1, and p53 R175H" . SPARSER::COLLECTION)
    ("Western blot" . SPARSER::PROTEIN)
    ("potential oncogenes" . SPARSER::ONCOGENE)
    ("cyclin E1 and human p53 R175H" . SPARSER::COLLECTION)
    ("Rsf-1 and cyclin E1, and JH574" . SPARSER::COLLECTION)
    ("cyclin E1, and JH574" . SPARSER::COLLECTION) ("JH" . SPARSER::PROTEIN)
    ("RSF1 and CCNE1" . SPARSER::COLLECTION) ("rank" . SPARSER::PROTEIN)
    ("cyclin E1 and RSF complex" . SPARSER::COLLECTION)
    ("approximately 47 kDa" . SPARSER::PROTEIN)
    ("a robust protein" . SPARSER::PROTEIN) ("kDa" . SPARSER::PROTEIN)
    ("cancer-associated genes" . SPARSER::GENE)
    ("cytotoxic" . SPARSER::PROTEIN) ("ISWI" . SPARSER::PROTEIN)
    ("Factor" . SPARSER::HUMAN-PROTEIN-FAMILY) ("ATPase" . SPARSER::PROTEIN)
    ("paclitaxel" . SPARSER::DRUG)
    ("ARID1A ( BAF250A ) in endometrium-related carcinoma [ xref – xref ] and ARID2 in hepatocellular carcinoma [ xref ]"
     . SPARSER::COLLECTION)
    ("SWI/SNF" . SPARSER::COLLECTION) ("SNF" . SPARSER::PROTEIN)
    ("SWI" . SPARSER::PROTEIN) ("constituent proteins" . SPARSER::PROTEIN)
    ("nucleosome" . SPARSER::PROTEIN)
    ("/Rsf-1/cyclin E1" . SPARSER::COLLECTION)
    ("the first 441 amino acids of Rsf-1" . SPARSER::PROTEIN)
    ("cyclin E1 or Rsf-1" . SPARSER::COLLECTION)
    ("cyclin E1-associated kinase" . SPARSER::KINASE)
    ("mut" . SPARSER::PROTEIN) ("Rsf-1 and cyclin E1" . SPARSER::COLLECTION)
    ("the major Rsf-1" . SPARSER::PROTEIN) ("HBXAP" . SPARSER::PROTEIN)
    ("H-RAS" . SPARSER::PROTEIN) ("T antigen" . SPARSER::MOLECULE)
    ("cyclin E" . SPARSER::PROTEIN) ("RAD51" . SPARSER::PROTEIN)
    ("Full-length" . SPARSER::PROTEIN) ("G2/M" . SPARSER::PROTEIN)
    ("full-length" . SPARSER::PROTEIN) ("6B" . SPARSER::PROTEIN)
    ("Cyclin E" . SPARSER::PROTEIN) ("ARID2" . SPARSER::PROTEIN)
    ("BAF250A" . SPARSER::PROTEIN) ("ARID1A" . SPARSER::PROTEIN)
    ("BAF180" . SPARSER::PROTEIN) ("PBRM1" . SPARSER::PROTEIN)
    ("SMARCA4" . SPARSER::PROTEIN) ("BRG1" . SPARSER::PROTEIN)
    ("TP53" . SPARSER::PROTEIN) ("CDK2" . SPARSER::PROTEIN)
    ("CCNE1" . SPARSER::PROTEIN) ("SNF2H" . SPARSER::PROTEIN)
    ("cyclin E1" . SPARSER::PROTEIN) ("Rsf-1" . SPARSER::PROTEIN)
    ("RSF1" . SPARSER::PROTEIN)
    ("a haploinsufficient tumor suppressor" . SPARSER::SUPPRESSOR)
    ("allele" . SPARSER::ALLELE) ("BRCA" . SPARSER::PROTEIN-FAMILY)
    ("BRCA1 and BRCA2" . SPARSER::COLLECTION)
    ("γH2AX, MDC1, RNF8 and RNF168" . SPARSER::COLLECTION)
    ("TIP60 and HDACs" . SPARSER::COLLECTION) ("HDACs" . SPARSER::PROTEIN)
    ("nucleosomes and H4K16" . SPARSER::COLLECTION)
    ("H2A-H2B" . SPARSER::COLLECTION) ("nucleosomes" . SPARSER::BIO-COMPLEX)
    ("solution" . SPARSER::MOLECULE) ("BRCA1 and Rad51" . SPARSER::COLLECTION)
    ("class" . CLASS)
    ("chromatin-associated DNA damage response proteins" . SPARSER::PROTEIN)
    ("53BP1 and TIP60" . SPARSER::COLLECTION) ("Olaparib" . SPARSER::DRUG)
    ("HDR" . SPARSER::PROTEIN) ("homology" . SPARSER::PROTEIN)
    ("RVB1 or TIP60" . SPARSER::COLLECTION)
    ("RPA and Rad51" . SPARSER::COLLECTION) ("RPA" . SPARSER::PROTEIN)
    ("TIP60 and 53BP1" . SPARSER::COLLECTION) ("patch" . SPARSER::PROTEIN)
    ("cation" . SPARSER::MOLECULE) ("chemical" . SPARSER::MOLECULE)
    ("Trp" . SPARSER::AMINO-ACID) ("indole" . SPARSER::DRUG)
    ("Asp" . SPARSER::AMINO-ACID) ("Phe" . SPARSER::AMINO-ACID)
    ("Tyr" . SPARSER::AMINO-ACID) ("HN" . SPARSER::PROTEIN)
    ("conformation" . SPARSER::BIO-CONFORMATION)
    ("conformations" . SPARSER::BIO-CONFORMATION) ("Leu" . SPARSER::AMINO-ACID)
    ("Val" . SPARSER::AMINO-ACID) ("His" . SPARSER::AMINO-ACID)
    ("Ala" . SPARSER::AMINO-ACID) ("Gly" . SPARSER::AMINO-ACID)
    ("nuclear" . SPARSER::PROTEIN) ("Arg" . SPARSER::AMINO-ACID)
    ("electron" . SPARSER::MOLECULE) ("NMR" . SPARSER::PROTEIN)
    ("53BP1 and its cognate recognition element H4K20" . SPARSER::COLLECTION)
    ("LacI-FokI" . SPARSER::COLLECTION) ("peptide" . SPARSER::PEPTIDE)
    ("peptides" . SPARSER::PEPTIDE) ("mCherry-LacI-FokI" . SPARSER::COLLECTION)
    ("doxycycline" . SPARSER::DRUG) ("FokI" . SPARSER::PROTEIN)
    ("acetyltransferase and deacetylase" . SPARSER::COLLECTION)
    ("deacetylase" . SPARSER::PROTEIN) ("TRF1-FokI" . SPARSER::COLLECTION)
    ("γH2AX, 53BP1, and BRCA1" . SPARSER::COLLECTION)
    ("subtelomeric chromatin" . SPARSER::PROTEIN)
    ("Ubiquitin" . SPARSER::PROTEIN)
    ("associated ubiquitin foci" . SPARSER::PROTEIN)
    ("TIP60, RVB1, TRRAP, and p400" . SPARSER::COLLECTION)
    ("TRRAP" . SPARSER::PROTEIN) ("HDAC1 and HDAC2" . SPARSER::COLLECTION)
    ("IP" . SPARSER::PROTEIN) ("Chromatin" . SPARSER::PROTEIN)
    ("ligand and 4-OHT" . SPARSER::COLLECTION) ("fused" . SPARSER::PROTEIN)
    ("nuclease" . SPARSER::PROTEIN) ("LacI" . SPARSER::PROTEIN)
    ("mCherry" . SPARSER::PROTEIN)
    ("TSA and several other Class I and II HDACi" . SPARSER::COLLECTION)
    ("several other Class I and II HDACi" . SPARSER::COLLECTION)
    ("a class I and II HDAC inhibitor (HDACi)" . SPARSER::COLLECTION)
    ("Nicotinamide" . SPARSER::MOLECULE) ("HDACi" . SPARSER::MOLECULE)
    ("TSA" . SPARSER::PROTEIN) ("trichostatin" . SPARSER::MOLECULE)
    ("IRIF" . SPARSER::PROTEIN) ("class I" . SPARSER::PROTEIN)
    ("inactive" . SPARSER::INACTIVE)
    ("ionizing radiation-induced foci (IRIF)" . SPARSER::PROTEIN)
    ("TIP60 or RVB1" . SPARSER::COLLECTION)
    ("ubiquitin and 53BP1" . SPARSER::COLLECTION) ("RNF8-" . SPARSER::PROTEIN)
    ("RNF8 and RNF168" . SPARSER::COLLECTION)
    ("component" . SPARSER::COMPONENT)
    ("both degradative and nondegradative ubiquitin" . SPARSER::PROTEIN)
    ("ubiquitin" . SPARSER::PROTEIN) ("53BP1 and BRCA1" . SPARSER::COLLECTION)
    ("γH2AX, MDC1, RNF8, and RNF168" . SPARSER::COLLECTION)
    ("lysine" . SPARSER::AMINO-ACID) ("polymerase" . SPARSER::PROTEIN)
    ("ADP" . SPARSER::PROTEIN) ("exon" . SPARSER::PROTEIN)
    ("BRCA1 (Breast cancer early onset 1) and 53BP1 (p53 Binding Protein 1)"
     . SPARSER::COLLECTION)
    ("relative BRCA1 and 53BP1" . SPARSER::COLLECTION)
    ("cis" . SPARSER::PROTEIN) ("PARP" . SPARSER::PROTEIN)
    ("HR" . SPARSER::PROTEIN) ("Glu" . SPARSER::AMINO-ACID)
    ("salt" . SPARSER::MOLECULE) ("HDAC" . SPARSER::PROTEIN)
    ("acetyltransferase" . SPARSER::PROTEIN)
    ("BRCA1 and 53BP1" . SPARSER::COLLECTION) ("Lys" . SPARSER::AMINO-ACID)
    ("a 15" . SPARSER::PROTEIN) ("Amino acid" . SPARSER::AMINO-ACID)
    ("GB1" . SPARSER::PROTEIN) ("de-" . SPARSER::MOLECULE)
    ("NaHCO 3" . SPARSER::DRUG) ("MGCD0103" . SPARSER::DRUG)
    ("BRCA2" . SPARSER::PROTEIN) ("Orc1" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("H2B" . SPARSER::PROTEIN) ("H2A" . SPARSER::PROTEIN)
    ("I-SceI" . SPARSER::PROTEIN) ("Rad51" . SPARSER::PROTEIN)
    ("H4R" . SPARSER::PROTEIN) ("amino acid" . SPARSER::AMINO-ACID)
    ("C 20" . SPARSER::PROTEIN) ("TRF1" . SPARSER::PROTEIN)
    ("p400" . SPARSER::PROTEIN)
    ("histone acetyltransferase" . SPARSER::PROTEIN)
    ("HDAC2" . SPARSER::PROTEIN) ("HDAC1" . SPARSER::PROTEIN)
    ("4-OHT" . SPARSER::DRUG) ("estradiol receptor" . SPARSER::PROTEIN)
    ("Class I" . SPARSER::PROTEIN)
    ("acetyltransferase activity" . SPARSER::PROTEIN)
    ("RVB1" . SPARSER::PROTEIN) ("NuA4" . SPARSER::PROTEIN-FAMILY)
    ("ubiquitin ligase" . SPARSER::PROTEIN) ("K63" . SPARSER::PROTEIN)
    ("RAP80" . SPARSER::PROTEIN) ("RNF168" . SPARSER::PROTEIN)
    ("RNF8" . SPARSER::PROTEIN) ("MDC1" . SPARSER::PROTEIN)
    ("H4K20me1" . SPARSER::PROTEIN)
    ("p53 Binding Protein 1" . SPARSER::PROTEIN) ("K16" . SPARSER::PROTEIN)
    ("TIP60" . SPARSER::PROTEIN) ("53BP1" . SPARSER::PROTEIN)
    ("BRCA1" . SPARSER::PROTEIN) ("highly repetitive DNA" . SPARSER::DNA)
    ("mediators" . SPARSER::PROTEIN) ("modifiers" . SPARSER::MOLECULE)
    ("wave" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("SUV39H1/2 double-null MEFs" . SPARSER::PROTEIN)
    ("ras" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("senescence-associated heterochromatin foci (SAHF)" . SPARSER::PROTEIN)
    ("foci (SAHF)" . SPARSER::PROTEIN) ("SAHF" . SPARSER::BIO-COMPLEX)
    ("p21 or p27" . SPARSER::COLLECTION)
    ("a temperature-sensitive p53" . SPARSER::PROTEIN)
    ("IR and doxorubicin" . SPARSER::COLLECTION) ("pro" . SPARSER::PROTEIN)
    ("SUV39H1 and JMJD2b" . SPARSER::COLLECTION)
    ("condensation" . SPARSER::PROTEIN-FAMILY) ("lab" . SPARSER::PROTEIN)
    ("doxorubicin and etoposide" . SPARSER::COLLECTION)
    ("etoposide" . SPARSER::DRUG) ("tet" . SPARSER::PROTEIN)
    ("tri" . SPARSER::PROTEIN) ("thymidine" . SPARSER::MOLECULE)
    ("γH2AX and p53" . SPARSER::COLLECTION)
    ("γH2AX and p53 S15" . SPARSER::COLLECTION)
    ("TR" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Tetracycline" . SPARSER::DRUG)
    ("Tet" . SPARSER::PROTEIN) ("tetracycline" . SPARSER::DRUG)
    ("luciferase" . SPARSER::PROTEIN) ("fragment" . SPARSER::FRAGMENT)
    ("-PuPuPuC(A/T)(T/A)GPyPyPy-3" . SPARSER::COLLECTION)
    ("GPyPyPy-3" . SPARSER::COLLECTION) ("AGC" . SPARSER::PROTEIN)
    ("AC" . SPARSER::PROTEIN)
    ("Nutlin or low dose actinomycin D" . SPARSER::COLLECTION)
    ("JMJD2a" . SPARSER::PROTEIN) ("protein and mRNA" . SPARSER::COLLECTION)
    ("IR and Nutlin" . SPARSER::COLLECTION) ("Nutlin" . SPARSER::DRUG)
    ("demethylases" . SPARSER::PROTEIN) ("GAPDH" . SPARSER::PROTEIN)
    ("active genes" . SPARSER::GENE) ("etc" . SPARSER::PROTEIN)
    ("pericentric alpha satellite DNA" . SPARSER::DNA)
    ("IR and γH2AX" . SPARSER::COLLECTION) ("Alu" . SPARSER::PROTEIN)
    ("LINE" . SPARSER::PROTEIN) ("ChIP" . SPARSER::PROTEIN)
    ("western blot" . SPARSER::PROTEIN)
    ("abnormal elongation" . SPARSER::PROTEIN)
    ("elongation" . SPARSER::PROTEIN) ("pericentric H3 K9" . SPARSER::PROTEIN)
    ("the histone methyltransferase SUV39H1 and the testes-specific isoform SUV39H2 ( xref )"
     . SPARSER::COLLECTION)
    ("the testes-specific isoform SUV39H2" . SPARSER::PROTEIN)
    ("isoform" . SPARSER::PROTEIN) ("methyltransferase" . SPARSER::PROTEIN)
    ("more accessible chromatin" . SPARSER::PROTEIN)
    ("Heterochromatin" . SPARSER::PROTEIN)
    ("heterochromatin and euchromatin" . SPARSER::COLLECTION)
    ("foci" . SPARSER::PROTEIN) ("euchromatin" . SPARSER::BIO-COMPLEX)
    ("HC" . SPARSER::PROTEIN) ("chromatin" . SPARSER::PROTEIN)
    ("se" . SPARSER::HUMAN-PROTEIN-FAMILY) ("partial" . SPARSER::PROTEIN)
    ("line" . SPARSER::PROTEIN) ("MEFs" . SPARSER::PROTEIN)
    ("ATM" . SPARSER::PROTEIN) ("IR" . SPARSER::PROTEIN) ("types" . TYPE)
    ("JMJD2b and SUV39H1" . SPARSER::COLLECTION) ("JMJD2b" . SPARSER::PROTEIN)
    ("demethylase" . SPARSER::PROTEIN)
    ("pericentric heterochromatin" . SPARSER::PROTEIN)
    ("hrs" . SPARSER::HUMAN-PROTEIN-FAMILY) ("fast" . SPARSER::PROTEIN)
    ("heterochromatin" . SPARSER::PROTEIN) ("Triton X-100" . SPARSER::MOLECULE)
    ("protein A" . SPARSER::PROTEIN) ("H2AX" . SPARSER::PROTEIN)
    ("JMJD2B" . SPARSER::PROTEIN) ("Anti-" . SPARSER::ANTIBODY)
    ("Tween 20" . SPARSER::MOLECULE) ("NP-40" . SPARSER::DRUG)
    ("M2" . SPARSER::MOLECULE) ("M1" . SPARSER::MOLECULE)
    ("Actinomycin D" . SPARSER::MOLECULE) ("Nutlin-3a" . SPARSER::DRUG)
    ("T-REX" . SPARSER::PROTEIN-FAMILY) ("HP1β" . SPARSER::PROTEIN)
    ("E2F1" . SPARSER::PROTEIN) ("PC3" . SPARSER::PROTEIN)
    ("demethylase activity" . SPARSER::PROTEIN) ("5-FU" . SPARSER::PROTEIN)
    ("β-gal" . SPARSER::PROTEIN) ("p53 S" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("E2Fs" . SPARSER::PROTEIN-FAMILY) ("E2F" . SPARSER::PROTEIN)
    ("retinoblastoma protein" . SPARSER::PROTEIN) ("-3" . SPARSER::PROTEIN)
    ("MG132" . SPARSER::PROTEIN) ("E6" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("actinomycin D" . SPARSER::MOLECULE) ("Jumonji domain" . SPARSER::PROTEIN)
    ("SUV39H2" . SPARSER::PROTEIN) ("KAP1" . SPARSER::PROTEIN)
    ("γH2AX" . SPARSER::PROTEIN) ("E3" . SPARSER::MOLECULE)
    ("MDM2" . SPARSER::PROTEIN) ("SUV39H1" . SPARSER::PROTEIN)
    ("JMJD2" . SPARSER::PROTEIN) ("H3 K9" . SPARSER::PROTEIN)
    ("H3K9" . SPARSER::PROTEIN) ("HB-EGF and TGFα" . SPARSER::COLLECTION)
    ("promoters" . SPARSER::PROMOTER)
    ("transmembrane growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Src" . SPARSER::PROTEIN) ("Hck" . SPARSER::PROTEIN)
    ("Ampk" . SPARSER::HUMAN-PROTEIN-FAMILY) ("AMP" . SPARSER::AMP)
    ("Rheb" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("phospholipase" . SPARSER::PROTEIN) ("activators" . SPARSER::ACTIVATOR)
    ("phosphorylated p70 S6 kinase and its target" . SPARSER::COLLECTION)
    ("Kras G12D and HB-EGF" . SPARSER::COLLECTION)
    ("PI3 Kinase/AKT" . SPARSER::COLLECTION)
    ("MAPK" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptors and Ras" . SPARSER::COLLECTION)
    ("family" . SPARSER::PROTEIN-FAMILY) ("Egfr" . SPARSER::PROTEIN)
    ("effector" . SPARSER::EFFECTOR) ("media" . SPARSER::PROTEIN)
    ("Macrophage" . SPARSER::PROTEIN)
    ("at least some inducers" . SPARSER::MOLECULE)
    ("inducers" . SPARSER::MOLECULE) ("Smad4/DPP4" . SPARSER::COLLECTION)
    ("tp53" . SPARSER::PROTEIN) ("II" . SPARSER::PROTEIN)
    ("suppressors" . SPARSER::SUPPRESSOR) ("p70S6K" . SPARSER::PROTEIN)
    ("KrasG12D/sHB-EGF" . SPARSER::COLLECTION) ("KrasG" . SPARSER::PROTEIN)
    ("effectors" . SPARSER::EFFECTOR)
    ("a viral Ras homolog) and c-myc" . SPARSER::COLLECTION)
    ("a viral EGFR homolog)" . SPARSER::PROTEIN)
    ("homolog) and c-myc" . SPARSER::COLLECTION)
    ("v-Hras" . SPARSER::COLLECTION) ("v-ErbB" . SPARSER::COLLECTION)
    ("Ras" . SPARSER::HUMAN-PROTEIN-FAMILY) ("Hras" . SPARSER::PROTEIN)
    ("ErbB" . SPARSER::PROTEIN) ("oncogenes" . SPARSER::ONCOGENE)
    ("Erk1/2, Mek1/2 and AKT" . SPARSER::COLLECTION)
    ("Mek1/2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Mek" . SPARSER::HUMAN-PROTEIN-FAMILY) ("kinase" . SPARSER::KINASE)
    ("only four proteins" . SPARSER::PROTEIN) ("Protein" . SPARSER::PROTEIN)
    ("components" . SPARSER::COMPONENT)
    ("HB-EGF and Kras" . SPARSER::COLLECTION)
    ("EGFR/ErbB4" . SPARSER::COLLECTION)
    ("Cdkn1a (p21 Cip ) or Cdkn1b (p27 Kip )" . SPARSER::COLLECTION)
    ("Cdkn1b" . SPARSER::PROTEIN) ("Cdkn1a" . SPARSER::PROTEIN)
    ("Cdkn2d" . SPARSER::PROTEIN) ("Cdkn2a" . SPARSER::PROTEIN)
    ("Cip" . SPARSER::PROTEIN) ("histone" . SPARSER::PROTEIN)
    ("intestinal macrophages" . SPARSER::PROTEIN)
    ("Arginase" . SPARSER::PROTEIN) ("sHB-EGF/Kras" . SPARSER::COLLECTION)
    ("simple" . SPARSER::PROTEIN) ("matrix" . SPARSER::PROTEIN-FAMILY)
    ("promoter" . SPARSER::PROMOTER) ("invasive PDAC" . SPARSER::PROTEIN)
    ("mucin" . SPARSER::HUMAN-PROTEIN-FAMILY) ("amylase" . SPARSER::PROTEIN)
    ("no structural acini" . SPARSER::PROTEIN)
    ("few structural acini" . SPARSER::PROTEIN) ("acini" . SPARSER::PROTEIN)
    ("the postnatal period" . SPARSER::PROTEIN)
    ("cytokines and growth factors" . SPARSER::COLLECTION)
    ("cancer-associated macrophages" . SPARSER::PROTEIN)
    ("HB-EGF and CD68" . SPARSER::COLLECTION) ("Hbegf" . SPARSER::PROTEIN)
    ("Macrophages" . SPARSER::PROTEIN)
    ("the early neonatal period" . SPARSER::PROTEIN)
    ("sHB-EGF" . SPARSER::COLLECTION) ("EGF" . SPARSER::PROTEIN)
    ("sHB" . SPARSER::PROTEIN) ("transgene" . SPARSER::PROTEIN)
    ("ligand" . SPARSER::LIGAND)
    ("epidermal growth factor receptor (EGFR)" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("ligands" . SPARSER::LIGAND) ("EGFR" . SPARSER::PROTEIN)
    ("Extracellular" . SPARSER::PROTEIN) ("LSL-Kras" . SPARSER::COLLECTION)
    ("LSL" . SPARSER::PROTEIN) ("Cre" . SPARSER::PROTEIN)
    ("mutant" . SPARSER::MUTANT) ("PDAC" . SPARSER::PROTEIN)
    ("oncogene" . SPARSER::ONCOGENE) ("biomarkers" . SPARSER::MOLECULE)
    ("Ink4A/Arf" . SPARSER::COLLECTION) ("p16/p19" . SPARSER::COLLECTION)
    ("Arf" . SPARSER::HUMAN-PROTEIN-FAMILY) ("active" . SPARSER::ACTIVE)
    ("macrophage" . SPARSER::PROTEIN) ("macrophages" . SPARSER::PROTEIN)
    ("heparin" . SPARSER::PROTEIN) ("suppressor" . SPARSER::SUPPRESSOR)
    ("Kras" . SPARSER::PROTEIN) ("Phospho-Kinase" . SPARSER::PROTEIN)
    ("Phospho-kinase" . SPARSER::PROTEIN) ("anti-β" . SPARSER::PROTEIN)
    ("reverse transcriptase" . SPARSER::PROTEIN)
    ("cyclin D1" . SPARSER::PROTEIN) ("Ki67" . SPARSER::PROTEIN)
    ("TGFα" . SPARSER::PROTEIN) ("protein kinase" . SPARSER::PROTEIN)
    ("mTORC1" . SPARSER::PROTEIN) ("PI3 Kinase" . SPARSER::PROTEIN)
    ("type II" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("colon cancer" . SPARSER::PROTEIN) ("Receptor type" . SPARSER::PROTEIN)
    ("TGFβ" . SPARSER::HUMAN-PROTEIN-FAMILY) ("DPP4" . SPARSER::PROTEIN)
    ("Smad4" . SPARSER::PROTEIN) ("p70S6" . SPARSER::PROTEIN)
    ("c-myc" . SPARSER::PROTEIN) ("homolog)" . SPARSER::PROTEIN)
    ("Erk1/2" . SPARSER::PROTEIN) ("GSK3α" . SPARSER::PROTEIN)
    ("p70 S6" . SPARSER::PROTEIN) ("ErbB4" . SPARSER::PROTEIN)
    ("caspase 3" . SPARSER::PROTEIN) ("p27" . SPARSER::PROTEIN)
    ("p21" . SPARSER::PROTEIN) ("p19 Arf" . SPARSER::PROTEIN)
    ("p16 Ink4A" . SPARSER::PROTEIN) ("cyclinD1" . SPARSER::PROTEIN)
    ("Pdx1" . SPARSER::PROTEIN) ("CD45" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CD3" . SPARSER::PROTEIN) ("CK19" . SPARSER::PROTEIN)
    ("growth factors" . SPARSER::GROWTH-FACTOR) ("Ptf1a" . SPARSER::PROTEIN)
    ("CD68" . SPARSER::PROTEIN)
    ("epidermal growth factor receptor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Ink4A" . SPARSER::PROTEIN) ("p19" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("p16" . SPARSER::PROTEIN) ("Cdkn2" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("CyclinD1" . SPARSER::PROTEIN) ("HB-EGF" . SPARSER::PROTEIN)
    ("growth factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("RNS and ICAM1" . SPARSER::COLLECTION)
    ("RNS and ICAM 1" . SPARSER::COLLECTION) ("antioxidants" . SPARSER::DRUG)
    ("GSH" . SPARSER::DRUG) ("ROS/RNS" . SPARSER::COLLECTION)
    ("Arginine" . SPARSER::AMINO-ACID) ("extracellular" . SPARSER::PROTEIN)
    ("functional p53" . SPARSER::PROTEIN) ("nNOS" . SPARSER::PROTEIN)
    ("isoforms" . SPARSER::ISOFORM) ("esterase" . SPARSER::PROTEIN)
    ("group" . SPARSER::MOLECULE) ("acetyl" . SPARSER::MOLECULE)
    ("DAF and DCF" . SPARSER::COLLECTION) ("DAF-FM" . SPARSER::COLLECTION)
    ("dye" . SPARSER::MOLECULE) ("parts" . SPARSER::COMPONENT)
    ("ester" . SPARSER::MOLECULE) ("FM" . SPARSER::PROTEIN)
    ("Het and DCF" . SPARSER::COLLECTION) ("-wt" . SPARSER::COLLECTION)
    ("wt" . SPARSER::PROTEIN) ("light" . SPARSER::PROTEIN)
    ("ICAM" . SPARSER::PROTEIN-FAMILY) ("melanoma" . SPARSER::PROTEIN)
    ("both soluble and cellular form" . SPARSER::FORM)
    ("its secretory form" . SPARSER::FORM)
    ("yielding soluble factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("receptor" . SPARSER::PROTEIN) ("RNS-ICAM1" . SPARSER::COLLECTION)
    ("its soluble form" . SPARSER::FORM)
    ("mRNA and protein" . SPARSER::COLLECTION)
    ("N-acetylcysteine (NAC)" . SPARSER::DRUG)
    ("the key inducer" . SPARSER::PROTEIN) ("Antioxidant" . SPARSER::PROTEIN)
    ("p53-wt" . SPARSER::COLLECTION) ("a key cytokine" . SPARSER::PROTEIN)
    ("protein and gene" . SPARSER::COLLECTION)
    ("protein and ICAM-1" . SPARSER::COLLECTION) ("mRNA" . SPARSER::RNA)
    ("protein" . SPARSER::PROTEIN) ("blot" . SPARSER::PROTEIN)
    ("soluble ICAM1" . SPARSER::PROTEIN) ("polypeptide" . SPARSER::PEPTIDE)
    ("only one cytokine" . SPARSER::PROTEIN) ("Cytokine" . SPARSER::PROTEIN)
    ("the key cytokine" . SPARSER::PROTEIN)
    ("oxygen and nitrogen" . SPARSER::COLLECTION)
    ("GM-CSF, sICAM-1 and Serpin E1" . SPARSER::COLLECTION)
    ("post" . SPARSER::PROTEIN) ("ANOVA" . SPARSER::PROTEIN)
    ("proteins" . SPARSER::PROTEIN) ("molecules" . SPARSER::MOLECULE)
    ("cellular thiols" . SPARSER::MOLECULE)
    ("transcription factor, GCLC and GCLM" . SPARSER::COLLECTION)
    ("enzyme" . SPARSER::PROTEIN) ("ligase" . SPARSER::LIGASE)
    ("cysteine" . SPARSER::AMINO-ACID) ("subunit" . SPARSER::FRAGMENT)
    ("GCLM" . SPARSER::PROTEIN) ("GCLC" . SPARSER::PROTEIN)
    ("thiols" . SPARSER::MOLECULE) ("Gua" . SPARSER::MOLECULE)
    ("states" . SPARSER::BIO-STATE) ("glutathione" . SPARSER::DRUG)
    ("iNOS" . SPARSER::PROTEIN) ("NOS" . SPARSER::PROTEIN)
    ("enzymes" . SPARSER::ENZYME) ("SNAP" . SPARSER::PROTEIN)
    ("NOSs" . SPARSER::PROTEIN) ("derivatives" . SPARSER::DERIVATIVE)
    ("DCF" . SPARSER::PROTEIN) ("Het" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("DAF" . SPARSER::PROTEIN)
    ("mitochondrial" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("mesenchymal marker MMP9" . SPARSER::PROTEIN) ("EMT" . SPARSER::PROTEIN)
    ("collagen" . SPARSER::HUMAN-PROTEIN-FAMILY) ("TERT" . SPARSER::PROTEIN)
    ("keratinocytes" . SPARSER::PROTEIN) ("doxorubicin" . SPARSER::PROTEIN)
    ("NOF/hTERT" . SPARSER::COLLECTION) ("hTERT" . SPARSER::PROTEIN)
    ("NOF" . SPARSER::PROTEIN) ("RNA" . SPARSER::RNA)
    ("state" . SPARSER::BIO-STATE) ("target" . SPARSER::TARGET-PROTEIN)
    ("molecule" . SPARSER::MOLECULE) ("factor" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("pRb" . SPARSER::PROTEIN) ("gene and cancer" . SPARSER::COLLECTION)
    ("factors" . SPARSER::HUMAN-PROTEIN-FAMILY) ("his" . SPARSER::AMINO-ACID)
    ("ROS and RNS" . SPARSER::COLLECTION) ("ROS" . SPARSER::PROTEIN)
    ("a key inducer" . SPARSER::PROTEIN) ("inducer" . SPARSER::PROTEIN)
    ("redox" . SPARSER::PROTEIN) ("eNOS or antioxidant" . SPARSER::COLLECTION)
    ("NAC" . SPARSER::PROTEIN) ("antioxidant" . SPARSER::PROTEIN)
    ("endothelial nitric oxide synthase" . SPARSER::PROTEIN)
    ("eNOS" . SPARSER::PROTEIN) ("DNA" . SPARSER::DNA)
    ("cytokine" . SPARSER::PROTEIN) ("RNS" . SPARSER::PROTEIN)
    ("nitrogen" . SPARSER::MOLECULE) ("CM-H" . SPARSER::MOLECULE)
    ("ICAM 1" . SPARSER::PROTEIN) ("its receptor" . SPARSER::PROTEIN)
    ("N-acetylcysteine" . SPARSER::DRUG) ("–3" . SPARSER::PROTEIN)
    ("membrane-bound" . SPARSER::PROTEIN) ("ICAM-1" . SPARSER::PROTEIN)
    ("Serpin E1" . SPARSER::PROTEIN) ("GM-CSF" . SPARSER::PROTEIN)
    ("transcription factor" . SPARSER::PROTEIN)
    ("endothelial NOS" . SPARSER::PROTEIN) ("Nitric oxide" . SPARSER::MOLECULE)
    ("L-NAME" . SPARSER::MOLECULE) ("P53" . SPARSER::PROTEIN)
    ("MMP9" . SPARSER::PROTEIN) ("E-cadherin" . SPARSER::PROTEIN)
    ("nitric oxide" . SPARSER::MOLECULE) ("CO 2" . SPARSER::PROTEIN)
    ("β-actin" . SPARSER::PROTEIN) ("Nrf-2" . SPARSER::PROTEIN)
    ("DCF-DA" . SPARSER::DRUG) ("CMH2" . SPARSER::PROTEIN)
    (NIL . SPARSER::PROTEIN) ("hydrogen peroxide" . SPARSER::DRUG)
    ("β-mercaptoethanol" . SPARSER::MOLECULE) ("for 3" . SPARSER::PROTEIN)
    ("and 1" . SPARSER::PROTEIN) ("N-Acetylcysteine" . SPARSER::DRUG)
    ("L-Glutamine" . SPARSER::MOLECULE) ("sodium bicarbonate" . SPARSER::DRUG)
    ("epidermal growth factor" . SPARSER::PROTEIN)
    ("nitric oxide synthase" . SPARSER::PROTEIN) ("ICAM1" . SPARSER::PROTEIN)
    ("3D" . SPARSER::PROTEIN-FAMILY) ("p53" . SPARSER::PROTEIN)
    ("inhibitors" . SPARSER::INHIBITOR) ("form" . SPARSER::FORM)
    ("pilot" . SPARSER::PROTEIN) ("IPEX and IPEX-like" . SPARSER::COLLECTION)
    ("sirolimus" . SPARSER::DRUG) ("insulin" . SPARSER::PROTEIN)
    ("lymphoid, myeloid and erythroid" . SPARSER::COLLECTION)
    ("substrate" . SPARSER::SUBSTRATE)
    ("inflammatory cytokines" . SPARSER::PROTEIN)
    ("IL-6 and TNFα" . SPARSER::COLLECTION) ("cytokines" . SPARSER::PROTEIN)
    ("oxygen" . SPARSER::MOLECULE) ("radical" . SPARSER::MOLECULE)
    ("Tsc1" . SPARSER::PROTEIN) ("FOXO" . SPARSER::PROTEIN-FAMILY)
    ("Pten" . SPARSER::PROTEIN) ("differentially" . SPARSER::PROTEIN)
    ("TORC1 and TORC2" . SPARSER::COLLECTION) ("Raptor" . SPARSER::PROTEIN)
    ("complexes" . SPARSER::BIO-COMPLEX) ("forms" . SPARSER::FORM)
    ("AMPK" . SPARSER::PROTEIN) ("Wnt" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("GSK" . SPARSER::PROTEIN) ("TSC" . SPARSER::PROTEIN)
    ("a multi-functional negative regulator of cellular signaling and genomic stability"
     . SPARSER::COLLECTION)
    ("a multi-functional negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("PTEN" . SPARSER::PROTEIN) ("TSC1/TSC2" . SPARSER::COLLECTION)
    ("complex" . SPARSER::BIO-COMPLEX) ("AKT" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("targets" . SPARSER::TARGET-PROTEIN) ("age" . SPARSER::PROTEIN)
    ("cyclosporine" . SPARSER::DRUG) ("ATG" . SPARSER::DRUG)
    ("erythroid, myeloid and lymphoid" . SPARSER::COLLECTION)
    ("myeloid" . SPARSER::PROTEIN) ("erythroid" . SPARSER::PROTEIN)
    ("autoantibodies and drug" . SPARSER::COLLECTION)
    ("side" . SPARSER::PROTEIN) ("autoantibodies" . SPARSER::PROTEIN)
    ("receptors" . SPARSER::PROTEIN) ("case" . SPARSER::PROTEIN)
    ("the immune-associated nucleotide (Ian)-related genes" . SPARSER::GENE)
    ("genes" . SPARSER::GENE) ("Ian" . SPARSER::PROTEIN-FAMILY)
    ("nucleotide" . SPARSER::NUCLEOTIDE) ("rat" . SPARSER::PROTEIN)
    ("alleles" . SPARSER::ALLELE) ("mixture" . SPARSER::MOLECULE)
    ("the perinatal period" . SPARSER::PROTEIN) ("step" . SPARSER::PROTEIN)
    ("gene" . SPARSER::GENE) ("ago" . SPARSER::PROTEIN)
    ("IPEX" . SPARSER::PROTEIN) ("antigens" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("lymphoid" . SPARSER::PROTEIN) ("the neonatal period" . SPARSER::PROTEIN)
    ("period" . SPARSER::PROTEIN) ("methotrexate" . SPARSER::DRUG)
    ("drugs" . SPARSER::DRUG) ("ACR" . SPARSER::PROTEIN)
    ("impact" . SPARSER::PROTEIN) ("HP" . SPARSER::PROTEIN)
    ("the popular drug" . SPARSER::DRUG) ("drug" . SPARSER::DRUG)
    ("prednisone" . SPARSER::DRUG) ("Methotrexate" . SPARSER::DRUG)
    ("autoreactive antibodies" . SPARSER::ANTIBODY)
    ("leukocytes" . SPARSER::PROTEIN) ("antibodies" . SPARSER::ANTIBODY)
    ("inhibitor" . SPARSER::INHIBITOR) ("rapamycin" . SPARSER::DRUG)
    ("mTOR" . SPARSER::PROTEIN) ("regulator" . SPARSER::REGULATOR)
    ("HSC" . SPARSER::PROTEIN) ("part" . SPARSER::COMPONENT)
    ("antibody" . SPARSER::ANTIBODY) ("prism" . SPARSER::PROTEIN)
    ("BB" . SPARSER::PROTEIN) ("NOD" . SPARSER::PROTEIN)
    ("RA" . SPARSER::PROTEIN) ("SLE" . SPARSER::PROTEIN)
    ("TNFα" . SPARSER::PROTEIN) ("IL-6" . SPARSER::PROTEIN)
    ("AKT1" . SPARSER::PROTEIN) ("TORC2" . SPARSER::PROTEIN)
    ("TORC1" . SPARSER::PROTEIN) ("amino acids" . SPARSER::AMINO-ACID)
    ("IKKβ" . SPARSER::PROTEIN)
    ("negative regulator" . SPARSER::NEGATIVE-REGULATOR)
    ("TSC2" . SPARSER::PROTEIN) ("TSC1" . SPARSER::PROTEIN)
    ("CD34" . SPARSER::PROTEIN) ("CD48" . SPARSER::PROTEIN)
    ("CD150" . SPARSER::PROTEIN) ("c-Kit" . SPARSER::PROTEIN)
    ("Flt2" . SPARSER::PROTEIN) ("anti-" . SPARSER::ANTIBODY)
    ("Y chromosome" . SPARSER::PROTEIN) ("CD24" . SPARSER::PROTEIN)
    ("Erbb2" . SPARSER::PROTEIN) ("FOXP3" . SPARSER::PROTEIN)
    ("x-linked" . SPARSER::PROTEIN) ("X-linked" . SPARSER::PROTEIN)
    ("T-cell" . SPARSER::PROTEIN) ("type I" . SPARSER::HUMAN-PROTEIN-FAMILY)
    ("Foxp3" . SPARSER::PROTEIN)))